<SEC-DOCUMENT>0000859737-21-000012.txt : 20210428
<SEC-HEADER>0000859737-21-000012.hdr.sgml : 20210428
<ACCEPTANCE-DATETIME>20210428160831
ACCESSION NUMBER:		0000859737-21-000012
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		95
CONFORMED PERIOD OF REPORT:	20210327
FILED AS OF DATE:		20210428
DATE AS OF CHANGE:		20210428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		21864283

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx-20210327.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7,d:db3695e9835747c6b3438a7b262e54ea--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:holx="http://www.hologic.com/20210327" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20210327</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV8yLTEtMS0xLTA_8eead972-6a34-4d64-a07c-c52eb9526201">false</ix:nonNumeric><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV8zLTEtMS0xLTA_be4d0572-5ddb-4128-b407-9bf0113f7f40">2021</ix:nonNumeric><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV80LTEtMS0xLTA_71cfd17e-b709-4955-98b5-3b9ea489e432">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV81LTEtMS0xLTA_ef5eb96e-0034-45cd-a245-7768b79b97ca">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV82LTEtMS0xLTA_1b632f2c-f3d1-4e1e-bb31-bb29e8955133">9-28</ix:nonNumeric><ix:nonNumeric contextRef="if46e15e1bfd3413a999b55b314fd2cac_I20210327" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfMi0yLTEtMS0w_da2825fc-ae74-4a11-95a0-351ee9700ea6">P6M</ix:nonNumeric><ix:nonNumeric contextRef="i3bd010f371544b988fa10466d658968c_I20210327" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfMy0yLTEtMS0w_3628fe74-39a4-4111-947f-339f42cb12bc">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i182d5713bd6d47afae7e3dc66fab5669_I20210327" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNC0yLTEtMS0w_9d685e4e-692d-4f71-914d-c79b88b1e135">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ief14d4f38aad49c6b6a004ccbac446b1_I20210327" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNS0yLTEtMS0w_d72c9c27-cc1d-4735-9f04-b1cbd5e701e6">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ied9231b3ebdc44af8052059ea35f7d96_I20210327" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNi0yLTEtMS0w_7b9b1191-f47c-476e-bd95-a875b0cf0696">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20210327.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i710d748173ea42b5a70732702905ae98_I20210422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ica30c3f907d343549ada504d940ce936_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i64d64acb56824c3484cb34d66ff95151_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e832ad751c74be3a002a605f07e03a4_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ad3a928b064f93a707adcef8b085ef_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86f19e338624c03becbf38fdc443b83_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52eae1f2a4d04d28a7067bbadc18fd4c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9527df9991fb4a508abd170595d3765f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0f7c20571c473dbb3538c19161061b_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5308a8db9a248b4a503886d28172438_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b0a1c130c914da2aed9de46ede4189e_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib58207b8d4894dd4af272ce1eca54244_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f07a9be8b684974a2a20fab9aa2e50c_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib48dedaf55ee438786b6134c8b28e49c_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bee588f40e14c72bd3cc02f47cadda7_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254148f3b274432aa86d0721403fa1d6_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc98874159a4652a12358cbde3c0dd0_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01ffa50611c48bcae532eb4d244ad15_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57574c7cb017407e95bc7d6674fc7041_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22b1aad0446c43c899085af5db94daa0_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37479dda543e4e848a6b2a065e778421_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a0a29026de4c14b1ca906b3d06512f_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00148f02d5ac434ab8455c4bfdb18794_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1b90c41f7d4bd2acfb7ecf220b375d_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a5203734044addaed9c920967a2c5a_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70e7059977d242968ebf9c8a01c8083e_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532492042bba44aa888e1a014048de52_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd50b93acba342a4995202317212867c_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6160ec5704084a74ab06ae3ef0b25d89_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32babe6c9a5a4075a97af1479d07d7f5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e162ffb5f4d46748b4e62688b0c4db3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d9c4520de640f7837c8a8db74e7a29_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf7dda3e20214bc7b64a4430da73c356_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cff19231e714132bf4dc7ccaa04d77a_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id823f47b65a04844af628de4c871ffb5_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i599e6bb573174ab9946c1b0e7a65a1ee_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f41c1c1b96640ce8c37aa114378b5af_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c8bb166454744ccbffadde0265cdfd4_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib547cd16894c496aaa14272f3e33f8fa_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247efccf5d6947e48ecee24ca732c483_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e744d8762c4825aa1a4d2b4bdf2cf3_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0da21f00cf470eabc24e01c7fc5fa2_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96a2d286b76948e3a2d91063189e66b9_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d291e0f9c0b402da8343bcc6b51f9f2_D20210408-20210408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-08</xbrli:startDate><xbrli:endDate>2021-04-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2dff062ce5742cd9f8ec548f170b3b3_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90763f49a0da4076b8324779a162e6a4_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9a123d4d3f4bd282939064c3e109ab_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26ef905de85948f8bdd806e8ca63fe1d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec54e8e340d5457e910be1d441c98063_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26927080ee34404080aa7911ade83d18_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf8f71a8497491c86ce651b76d4b795_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6ae7d35265f4897bdfb34c7ccae119e_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cc0d7ae9e74ca8a9ff4d198d78501f_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied817d099e4b480faed0980ac29438b8_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if128eb894bce4b3085c7eaa916a5bfb8_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfd76ed5cab498ab2ab0d727bb2b083_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib64a089977c64ec0b379ab8be5a289a0_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe9760506e145efb1273a91972bd7e6_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a06780affc4452b0a0a9c31aecf31b_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic51d744e73d9470889480aef44867b64_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ffa4cd943fc4ae697fcf28ee9dafa69_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id617caf99d314fb4a8f7f5fb37a854ad_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eb8417c24934037bf730f4f45fd1dac_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic949542e55314c0e90e75d07a6a7cc95_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ca6cd87d9346f8b4d6b257b76f1599_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9fc6529dcd456a8fe760d48006a3e4_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c343532655149f1a030365f026ac439_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0120a99d97456999e5ddc37d3d7309_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3faa6d77c258415e86dcf4d8129eac6e_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857265c2f31341619b24eb60b43b0fb5_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad34163568284cdc83c1e20070c4cea2_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7082eff3d7ef4efc80ee731afa776eac_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc01a3ba376e4dbcb32a1e598e325b13_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f692bdf106e49fd9aaf7fce303fffe4_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3a06fe0c864a24885a1ba3a58df54e_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c810b9218b4cd4a2163bfaa2fb7c03_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942d891a356341019e4507b3365c2ba1_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6e50b3ca2f146f9a5608d79b8d0845f_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d9a60d400a14336a1e90394d3d649fb_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8341e0c83b50432d92002e51dc1d415a_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id259ac18b2c14a708dcfb664de4fede3_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765b92cf3fcb456b940d23ea47f28bd0_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1725b5668d3e4a858551fd8eb7138677_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb26cd5cf96841d99340d97a2844a812_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce8a0b09e77488b9facc4bf5ffb533d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bbb18bc92ff4414b39e894a76fab932_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231dbd6cca1f4e44b1648addc4f9b83d_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i136ee5e50cad46c9878d11c256642bfe_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i014ec62aff694cd984436a0315313b3e_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i921dfcf8a3d74f3c9e2967faea2a2c23_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e0e2bca7514b3c85c5bf5e035db201_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c75b6298a974b8c93d3c5a118504b01_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c4f0fb353d74058a1441937e80c0438_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf735ef79384b248873abab375129b4_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie927f60bf6f24e25bfd16b54244ee885_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9b232304f94408904a99c1ae44eafe_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95f2ae3f5fa742d7a917b5c8ed7f9fb8_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736988332f4142f9ac9feecbb79164b1_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ddb6816eec49e8ab3f15d0f66f2334_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78313136a484fd781c8813953a0cf7a_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i145a6fe21b194a67bef28af17d19bc6f_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i190143611a554923926b1ae36be81fda_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2269cd37c22f4b219c9519c04e7be995_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23b5154647642809bedb5594b430f24_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba116bd00a7046bf8c91f0d6b892314b_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i995e19c951b14bfea6e4d26e9cd4d486_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c1c56aa05ee45ffafd1f1ffda0164a5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d6a37b17e74d0fbf1668eb8dcd7a91_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56dfdce3eb6d424d86b58122d2f5ee1f_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280feb419f2b4e1bbd5f84cbc2b56e78_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9a96273a62543e085fdd72cbb24282e_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65621f54c26c4015a221bacce5212e11_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7b7a78e84c49fc9efb0c922ae148a2_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b99b53db764f00a7bae9226ea58a55_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1996dc2670f44d885b459e6b7844ca1_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7aea66c3b64c15aa4fc1fcbcd3ad08_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71e20d39915246d8b5d89b9fedd7385f_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaacb7d97fbf041878e9f9f0a4f583432_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f6361d96ee24d73b8046575850f64d3_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib66008fadaf74341aed6338aed1d6e58_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a75015d04d4338ad7cfca21a6493a8_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20fc49c576e34cc69859aff92990662d_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7973bfa616db4dc483c4bd851ccb1a56_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa248859d134c8f8dcb2fb68862b1b0_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id274d4645da042b1bf61995fe9215df2_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac781329d4b4af88611a402bc50fa21_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c130431784f4c5b939e3a7eb06020d9_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e191d17f2624a8e81a271bf9ff484f2_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9c15aeb74a40068d4ecb624e590739_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425d67db4aff4b68954adb976a9fc71d_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5450315dcdd74fee9c2c005920e5f504_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1be8d9825a04deeaa24e83a941f2408_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ab6df387644866a1e1f37f2257d845_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9617c714041343938ba7ef699d01cf6e_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8973c410d7ec480da813338cbd127421_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54e7336610d4110af7dd72bfff88912_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae83a94d7df432fa13620889d678fae_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5a0963e8a641ba8cb8cddc994ab7ce_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d453c23af194ce1aba1c816f84a132a_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6291de291de2479caa52ef9e87358c20_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5631a9f85ff741a3a15fdc5c8a9c57b9_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54761927cec14e1084e6842f2cc38ca3_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d34e883adcf48439ad208f5fae59f1f_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd6b40e625a344d7a0f8da5f98f78b54_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98200202399d411bbdfbce88f2f94963_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8edfb836d2d449d190d430b4b98bdcfc_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bafcaa157cc4f9d9b98d3058f7eeebb_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7997ee1de01404282896cf8569615c5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17cf60230e4e486ba1456a31ba6436af_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89fb351d8bbc4b2fa26f6615870eeb22_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6757b7ae6a1b4d1294b382cd6f764364_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32bcec04d2a142c7bd7b162f66b47ad0_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26482dabb124918adc0604c2a60d13c_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f3b7da661c4ac082d4c50ea8fd4d7f_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17dd3ec43b24fc5a2f910d62e42f2d2_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecac37f9117440f69e07c69f6c281b92_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21cde2e619f4402f8c02912c9692b840_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd830b6572e0425dadd30a387a2f967d_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ffcc41a2144eca91b9b631142afd54_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7270d96442eb4541ad8022d39d4faa96_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a971158920f420a836957e0f5793380_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d8b948617f4e3896d6b721b4c3de4c_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i692dade7414a46f982273b0535c5635c_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib847a33bcd64486598d58cc210134d1a_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a8c6e16440945bcac1fc0101a8a1fa3_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if46e15e1bfd3413a999b55b314fd2cac_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd010f371544b988fa10466d658968c_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182d5713bd6d47afae7e3dc66fab5669_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief14d4f38aad49c6b6a004ccbac446b1_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied9231b3ebdc44af8052059ea35f7d96_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb420ef6cfc84582bf032f47d6a027bc_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8a5fc5bf9d241f8b4cb0d73a7fec6cc_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2734474741b84d60825585c9ac1c91f5_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46916ca5297d4242bef1fa39c66d7e97_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6010a3ff92e436b8c62582e9e6636cd_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1637c5182047b68c601bf5077bf90c_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea5abde7d1984b098731ea86ba1d2df4_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e512ddea06f4f369efec1ac01a1f83a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11affe9143244d30961013f4deced4e9_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0083bdc783434585b6f36d4e8c4070_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411f528b6c8248d19b4b06059ce6bcca_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie108ffe2f2254cc596ceea6a1cd09226_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d2a977915524e99a25863296c0eccea_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04083b4b022e4637936c0abcc453bb78_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac27ddf7a3c42c6973c1c345f1d6188_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee78cb2f382242a08b2526f42f5e8853_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic97ef3233317455a9da5ec9463b03856_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ed7e22fc59649ab8ef2826b21239f52_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c62e4c25694a3cbdeaeda3e071ac2c_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792a247ac57f4a1089a48d766d5774c8_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ed6c8444b04ecbaf65664fe32f3d62_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-22</xbrli:startDate><xbrli:endDate>2021-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f9778c427b44c7882e336e11228595a_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2161ff7d37284a2dbbe1f9d7e633bc5c_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435467f75e1440c58e0143cfcc330473_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0181482365764743a89827be06286048_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7426f16cedf841448aae7ae840121295_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf6cae33a60643238b5a53b8e12438d0_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9edcaeb855249e29f00eca57f1ce93e_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie02a040d45524cb3a962860ca78ed797_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca8eccdc4f847d0aeb6a2cca823b5f3_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd0231067df452087445e7fbabe93de_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i617c581a0868425eaa81de8cdba59691_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if077f38ecd2c48708cc0f3b18a2b893e_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de817e6de5942b5bda9b79a83fe36ea_D20200203-20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-03</xbrli:startDate><xbrli:endDate>2020-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4af1ff49936044139ca360cf68be0400_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie858e36180d444f9b36ec6e99f4ec80c_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if549c33be4504150b2d638a7c2ab1792_I20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60c529de5f984b318d75f347b0e4df65_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8f228b16744f66922f21381cb7e421_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bae2329807348b380f218edb5d9aa9c_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0360e3cd8884f838b4339be49501e41_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f6eb5453d7428e9d35cb9246d2bd17_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i304fc8df211141afae93e91cffb8fe19_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae67d1fe265e4f30b9319216ed36d801_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedbd096de9694df1a3c2ff99b2436eed_I20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6b0c817b1c74f18a87cbf0cda7cd036_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96962f8c6503408c97e137b4ff6b485d_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i985c7e4ecc8945d29a5d65e3cacc1ebd_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bae11f6c164f1fba7c9157ff4bdaaa_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic07ffd9a39b1497facd26bd931d9a0b6_D20191120-20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-20</xbrli:startDate><xbrli:endDate>2019-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c59ec3344504f85a8c3c6bf6b0a9e13_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e0da39af5cf4280a9f5c65fb51b024a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7491822dd55f413ea8c24c98a7aa72d5_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a56920a822e4f1fa2a21d3567b1df3c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i469614de5d734baeb90118c04073db54_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie330a629ad37467d89cd606e0af17679_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3bea13b544c4f13b09760c5c6e726ba_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15b184ad14442c987ce0303bbedd19b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47d3d66108d5494eaf7a55ca46e00d87_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77ff68ab585743f5bd2a75882d831360_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9cffcc6d27f4a828ad2f580a9df3cbd_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723b2fa7383c40148a7b8c9527df6ddc_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d4c152cb32642be87eab1b00b94cdf0_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18b2329bbd884176a354e0fd702f2ff9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1975b32bc204e5683343cfb111a310b_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3392dcaea61411f8afc5b0dcf1dec2f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia50b3adc77744a7c824bbecca70c011a_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7560c0f9556346c095bd908abc52ce26_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091fabb2fcfb4658b0d9f415869cc240_I20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id264070af63b43f48399ea213c8af8a2_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8b998b09854bb695d9efc1050df7c4_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4f39288d0b45248bab5af271dabb3b_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3da1322564b4ca89777bef210350bd7_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377b4457fa40451d9934553b73788461_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3f87ee7c184b3d92090d91611fff9e_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83419ad698fd45cd9a641d83cdf6a7fb_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f7fe74bada44325807efbeacb2146be_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42acc5ed62724f79bd2e68d140fe8dce_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765ee743cd8d4c30a3e089f9a5063ad1_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a626c6885434dc39de0b254189dd899_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976b8217dd0340c8848abf4604793c09_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida59e22f7f6c46b19f9d458fa92fe312_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54dcf56176214275896ff1d60bc84906_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88918075f107400cba5e6d495691837d_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade8ee6fa1e44937ad93cb3264cfa057_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2015de2d01ea4eb6b943c7070cd7b61c_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166a72cd198a4c67b1e33412975acb38_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2018dad9ea214f19a994a89fec2b62b5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b31ce11b7874197821ee16e0e8acb8c_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5aac920f34f491293ef3c6b911a0e0e_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i728508ff257d45269fd226b6e4007b29_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c0e131c95e14da199d151225685419d_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9310ce69fb254103a98583ec7e3a8f90_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ab14cc2c1b434da9b16b16b3ce59e1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc1821170fb4c9a801bdfc34109bcde_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d059976369410a807492037e5cb3e7_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie88aa4de2fa84889ad42f389e367d075_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11b59cf4e28d42bf8a4e9c8c7e429ac8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd16785dea0a4ca1bf8304136ec99d08_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief9fc2fa9591462dad0bf17824d2a9fa_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d55ca8ee94483dac7f5b658cc31fa8_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic413e8139a5c40468c33462fc5941e98_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie803f3fd1bff41419202ea94b2221474_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a81172412bc4ff681f76e0d333e25d1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2f2cfebe3b48139e592af29012bf6c_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561329732ffc467eb03c4950ee15a00e_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16d36f0eba664708ad3e485d531f2d15_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic190c456cf6a49e5b0ec99b8038929ce_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86fb83a62a8c4fd59a58fdd0e8af7e97_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298880826ca146b98d400d387598be5a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba496bae81354f87b7905994ea233dd8_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5715660627c4c0c814c4bd2577fe6cb_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb56657e29a54018978922a7e1c3a629_I20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>holx:petition</xbrli:measure></xbrli:unit><xbrli:context id="iba238290a69f46b1a533fe0940b1cca4_D20160304-20160304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-04</xbrli:startDate><xbrli:endDate>2016-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b0b8127ce934cd9b79a11ee9f9c7acf_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9f918de2cf4d88a84b71df72163bf3_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie144f499b7fd4eb998be1642c636dc03_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e1e58fe46ca4c779247bd692e2e4185_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i070793615ded4840820fd755341d20f1_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8577ab468434cffae8cbb51873099ce_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e4f871073d422ea5def9c529807699_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d86786c1ac4e81846655e4acbc0c6e_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d272ac0e09f419a956e9fb6c0361bc3_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5089e6cd6df24ba38788f0b1f4ec9aa4_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1385d9f85d114662986d5770c3b9c5eb_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i042387ddd4d94b5f97f7b3f7f7794495_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc6eacddf2c14e2da413620ca0ddd0de_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4081d628500a407e83b46bf2fe3b0005_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b5c87f950614503ba2efd4bb0004547_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0df38cfcac340ca926931a8815bd86a_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7406c1b94a0341b89142d4308dd7bd26_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd2eec347a984124b6b6980c85d40599_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad3c625ba65468dad8446d8c5ca3463_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic72750901e9646aebae40d076b3f86f8_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47c626852f1c4ff2a5ab8807eabc7a53_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d4f38c2b6ee4d35ae4e4fc855b5c593_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662994515dee4071be41921dd55091a9_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20cab64438a419fb7e15f3b2d30abfd_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f3dc155fff485eb786e0c5e0b8f79f_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ecf187b743a46929a3cbc82c74daecd_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia292e0f0da204d90bd17cc07a6c83088_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d7d1bb69ae44c12932fd6147a4a1819_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a10ffdc26ba439aae8e83d553aa4523_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99a9d88b27994530817b5d3d5f55a648_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1102657f7bd4468812eef9239214f33_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6780dc391a714a25af687af04d21768a_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74ce39dfecd44f08e7d1c91ebc01c9d_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5862a7e8fb46483da33faa01de3b39c5_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="ib7935a6d79614132b0ef2b639930f553_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if07be3a2248e454e9dd29011bf561fdf_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b3b1ebbb344b0eba9a071b5285028a_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a70e04c2c044d488ee49e04a7c4fd8_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cedd2956ea24251b4f2e787ee87f9a5_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec342590d7ad4942a989e8c33e8523db_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id20db54379ba4b51b5f77937a37f9d8f_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i505981465edc4002ab0c7d672cbd8b85_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa735e311c9c4edcb8b2ed934d611d72_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88906e66fdfd4730958ab7edc6ddc342_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i115120608b9744b4af122d696c198769_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4e33c2ae18a474398d2f7aa204f4b0a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0538b1651d4e9fa01727c276c6aca8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id59d4cf165f84163b8612267a6672818_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia004d21122de40a7acb047f75711b230_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie735f493b8a74552a82fa762497a7e0c_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360d05187d17434f9f024ea0b654414a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7d8695f726474288c5904ad677e50a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e72d51c8ba435b837b8d83097e66c6_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c207776416743ffb080dcba5b532a33_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc0c502bf9714b0abe90c2966356a47d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90941e17deef4e38869d1a6989d08bc3_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic405c49964c945a2b2cccad0f50d104d_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife89e43900064dce8b3534de88f844cd_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b99bb878ba141d7a47254b83dc0764a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6926d7469494d35baaacd55a1ab864f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a66f6cac0f45bca6d865851d97bc1a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35518212539f4b2e9962deef5956862b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d4e68863886433791b7edc1d16c8b5f_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81080c9b2330438fa474bbe7a4003179_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662c27c8d79044699ea38a30b7e68432_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922d3d1beef1487f9f2d4c412ede7a12_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cf7b370790144619ad4a8964a5c1818_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5923eed9f67437e97eaed167c1389b0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0ccccc76e945f4978ee19754f4ad89_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c3b36745514581af776cf34c7004fc_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd85d51ab164407876eccc003e0ccf9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i800b03ee604347afbc07632cb45b6fc2_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd2d36767f54a4ebd52a5d5864f3448_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78273368483c4226a5ea04c7d811d3fe_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10dfe3110de4427967f3a4b8e5a5f11_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4363fed50fdd460494577b4618dbf686_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79509a51d6da43a78e7aff6191ec7651_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70664359f90341ed8b7b4035eab2e658_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c63fca0f209477d9e2d3001848cc2d0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f9926be54074c05bb1382ed55335276_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc5a52321694c0f850b13ff882001db_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4689b60d23744f289cb544253b4f814_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia06b01fcedd04f3a85eb4bc29746d312_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbe154820b94abb9f5b6c0d26716326_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab882e96099247859e4ec48ec2cb938a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae07c79726f4de98b04adaa90df5781_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic38386d5f6ba40fb9d5d20588a27487e_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efa40c8aa78435a86f84bf7940cae2c_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2dd1ea20daa4f4089320c0fa6f87da0_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a5a29aba88e419589c3a2f9fed50569_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7430ac3155b74726add1cbc2e862b58b_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8b78544c617454991ea1abde3fc0128_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6dda121f07348d9b40b999f1945cf6e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa1b4b017d74905880304f384c057b2_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d0130d8988c45bbac97673c8e2ce744_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0078ba73a24f819d70857c6b061aec_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e7212338e6d4a7fb971feed57bf398c_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04964732adf14196a87e9aeb38f71672_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c79daa201df43a4b63c18f0297a823a_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a12e09486e470bbfebd7bc5df72fa0_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4303fcd9add84b19b7bd0ac918b9aa95_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idb3695e9835747c6b3438a7b262e54ea_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg1_b48a94b8-3735-4e6b-9b13-4bd1dc6582b9">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;__________________________________________________________&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6NDYwZDQ0MGI5ZmQ1NGI2OTk1NzY2Yjg4MTYyZWU4ODMvdGFibGVyYW5nZTo0NjBkNDQwYjlmZDU0YjY5OTU3NjZiODgxNjJlZTg4M18wLTAtMS0xLTA_7eec05ed-9b4a-46b6-b007-c40d56f04164">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yNjA_af5320b0-486e-413b-87df-925a89ffbf1d">March&#160;27, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ODgyZWMxNzJkZGRiNGVhM2E0OWNhMWI2MDAzMDljNDIvdGFibGVyYW5nZTo4ODJlYzE3MmRkZGI0ZWEzYTQ5Y2ExYjYwMDMwOWM0Ml8wLTAtMS0xLTA_70d0af34-2d52-48b6-a040-5a261b83a4e5">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg4_d67fbb5e-d411-4c8a-a443-cf0d71be826a">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgx_f0b3c3c3-4def-4e2d-9a4e-7fd8a3e7d531">HOLOGIC, INC</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8wLTAtMS0xLTA_f02e4082-de0f-4001-be50-2cd31f8b22ee">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8wLTItMS0xLTA_8fab6309-4e4d-49f0-8c73-2b9d90019e56">04-2902449</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8yLTAtMS0xLTA_d0bb4bb7-f197-475e-9021-5bee456f8f38">250 Campus Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8zLTAtMS0xLTA_fac881bd-4f31-4de3-9f85-e05c70813144">Marlborough,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF80LTAtMS0xLTA_749aca31-2cc7-450f-86c1-f084c54b947d">Massachusetts</ix:nonNumeric><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF80LTItMS0xLTA_799bdc82-40d0-4551-b983-adf1ad3ba4a7">01752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg2_b7530b62-d0dc-4c73-9715-0aeef17507a4">(508)</ix:nonNumeric> <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgy_d4defa49-fb19-4314-85b0-3749df7e504f">263-2900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">*Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTAtMS0xLTA_beee8325-579e-44a3-ba81-335ad85cd0f5">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTEtMS0xLTA_841b3356-ec8e-41cc-8921-0953d1810cf0">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTItMS0xLTA_e996334e-80fd-40cd-904c-a7546c184b0e">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgz_d14a983b-be90-4d19-b90a-7a772f359f04">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg3_d1e9b12e-090f-4f3f-a15a-db05888c71b9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8wLTAtMS0xLTA_4659c4f1-6d4a-4d8f-9349-ffb9b00768ad">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8xLTYtMS0xLTA_8ff11094-3d45-46e2-a74d-470549b8afe4">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8yLTYtMS0xLTA_7d4effeb-9d33-4aae-b88c-a29d983d1b9e">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg0_e4907e58-ba60-48ab-8688-1c7239a6ab84">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;22, 2021, <ix:nonFraction unitRef="shares" contextRef="i710d748173ea42b5a70732702905ae98_I20210422" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjAx_f88983b2-fc48-4074-a0a7-f68f1355c8c9">256,233,027</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_13">Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_16">Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_16">Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_16"> for the Three and Six Months Ended March 27, 2021 and March 28, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_19">Consolidated Statements of Comprehensive Income for the Three and Six Months Ended March 27, 2021 and March 28, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_22">Consolidated Balance Sheets as of March 27, 2021 and September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_25">Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended March 27, 2021 and Year Ended September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_25">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_28">Consolidated Statements of Cash Flows for the Six Months Ended March 27, 2021 and March 28, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_28">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_31">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_100">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_100">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_121">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_124">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_127">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_130">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_133">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_136">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_139">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_139">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_142">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_142">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements (unaudited)</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:43.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy0xLTEtMS0w_d1d18387-ef93-41e2-92b5-f4e0be5dc1a5">1,378.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy0zLTEtMS0w_2b69a8b9-d5ae-46eb-a254-aceb97c944b9">623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy01LTEtMS0w_5b278ce9-21e2-495b-9343-d4d92e2d1b2c">2,834.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy03LTEtMS0w_b0888d2e-5c2b-47e1-86c2-8f13e5e52d0d">1,322.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC0xLTEtMS0w_1e0e7a52-c03b-49dc-bfeb-57dc66e4131a">158.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC0zLTEtMS0w_044cedcb-4895-4679-b420-66978579f39d">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC01LTEtMS0w_a10cd101-7dcb-4215-afb1-136e4320eebd">313.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC03LTEtMS0w_2cd0306d-f521-4382-9f8e-8158488d2d09">283.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS0xLTEtMS0w_32c3bf40-5151-4f6b-8ba1-de6ce033364d">1,537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS0zLTEtMS0w_3f52bf93-aa0e-421d-a08f-c4a4d1b8c2f7">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS01LTEtMS0w_dc6fcc89-cb7e-47bd-8d6f-4c9b87d2f59d">3,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS03LTEtMS0w_6a634f37-0270-48a3-b86a-fc27a725138f">1,606.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy0xLTEtMS0w_4ebafa6f-8ab2-4252-9b80-e9c412e85de0">300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy0zLTEtMS0w_99825ac0-c3a3-4d2e-bda4-d71ba97cd9c3">223.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy01LTEtMS0w_8d85933b-778f-4293-acff-bc02f3a7a7c6">585.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy03LTEtMS0w_d9349771-dfd9-48a8-9a60-20c96241e56e">460.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC0xLTEtMS0w_979b04ad-9971-4c12-be80-d9a627e3389f">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC0zLTEtMS0w_faf4015e-4b90-4af5-ac09-2ae9fc7d18d5">62.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC01LTEtMS0w_c9e3179a-8cc4-4250-8213-6df0bb05a386">126.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC03LTEtMS0w_8a1aa88b-dea8-464a-b2a4-f759d41e2b22">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS0xLTEtMS0w_028d847f-c84d-47e0-a1eb-7138dcdc98db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS0zLTEtMS0w_f906285a-bb84-4c02-a38b-01bf16097656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS01LTEtMS0w_632edf0f-948a-41bd-b6de-b8cff10d243a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS03LTEtMS0w_97ec1276-fdd2-4b51-a737-37aec7971ce5">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtMS0xLTEtMA_84324d9e-0220-4c8c-a4f4-09a64cdc41b3">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtMy0xLTEtMA_ef1aab23-6dbf-4d6c-9439-5d970af2a77c">74.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtNS0xLTEtMA_629d082e-16a6-417d-8536-b5177e667366">170.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtNy0xLTEtMA_88e2c943-7b43-42c3-9783-3e8af0e9fe6a">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtMS0xLTEtMA_302dfff9-21d7-4002-9c37-c84685244a85">1,085.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtMy0xLTEtMA_a368cd72-0dd9-4b60-811d-b5e0d1d33e3b">395.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtNS0xLTEtMA_0076facd-e73c-4ce7-a7b8-659b33568247">2,266.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtNy0xLTEtMA_a13b7f5a-0ba9-4a98-93e1-12fb1af0ae86">829.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtMS0xLTEtMA_f47dc13f-bb5a-4181-9bf0-3afcc8b26068">71.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtMy0xLTEtMA_b3cc28b5-6853-4a29-bf95-c0308c2e068c">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtNS0xLTEtMA_1f230253-81b1-490f-bb40-a61c5b99b2b4">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtNy0xLTEtMA_14286fb7-878e-41cd-9cda-71648719ba3a">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtMS0xLTEtMA_8f22895a-7091-49ef-870a-75b8e3fe9927">131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtMy0xLTEtMA_6d468185-bf49-4109-b55b-471d5cda1e3c">110.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtNS0xLTEtMA_b1ac5a06-3dc4-4217-af27-b8ca17cd15e4">259.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtNy0xLTEtMA_8380fd7b-18c8-4541-9b6d-23ce9e410c66">255.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtMS0xLTEtMA_27bfef56-a36f-41cd-b083-6f6734db11d4">88.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtMy0xLTEtMA_c41403ac-5219-49d0-97f7-0b49e68458d6">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtNS0xLTEtMA_a1fdf881-a325-4b0b-b5ce-0d66c8fed842">180.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtNy0xLTEtMA_7f255341-35a9-44bc-a63e-742d699356d5">154.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtMS0xLTEtMA_6a730497-3b01-4aed-9d57-95876d5e3dea">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtMy0xLTEtMA_f06a864c-1a32-469c-bb82-193b54bebe6a">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtNS0xLTEtMA_d58e710b-d891-4452-9536-1945b4a31f3a">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtNy0xLTEtMA_5bea0682-2ccd-4e37-a41e-09f81879c535">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctMS0xLTEtMA_2328055a-3989-4a54-bf0a-7d8f803c2553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctMy0xLTEtMA_e6f5b339-ef53-424f-b1eb-742c9ce975d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctNS0xLTEtMA_24da63c1-099c-4e80-878a-53498f8a38ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctNy0xLTEtMA_2b41b948-ca57-4779-b753-66617e752445">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktMS0xLTEtMA_421cb7a2-9598-4b0c-bf7d-c08476da5591">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktMy0xLTEtMA_23e6c125-12af-4e03-9819-7d535fb14948">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktNS0xLTEtMA_fa95afea-7a02-4e1f-96de-977be6ed5b48">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktNy0xLTEtMA_1e4836a5-9f32-4266-9fb0-43df0120950b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItMS0xLTEtMA_37e73a52-220c-4d64-ba78-6efb5af1d308">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItMy0xLTEtMA_050adb3f-156d-485d-b0d5-19b635a68afa">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItNS0xLTEtMA_1c163f1d-89da-48f4-aaa1-be3c54bd1eaf">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItNy0xLTEtMA_5b5f924a-6d58-442c-9459-c687f90efabf">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtMS0xLTEtMA_14cce1cb-cd58-49f6-8404-0b972fa8a1dc">289.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtMy0xLTEtMA_70fdd5e9-9780-440e-983e-e68a0dc3863c">239.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtNS0xLTEtMA_5097540d-707d-4332-9507-ce8637d240ff">583.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtNy0xLTEtMA_4433d3fd-18df-4508-949f-77ac99b0db38">548.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtMS0xLTEtMA_347e7573-054c-40d3-b414-e6716f87cb47">796.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtMy0xLTEtMA_dd15b7ba-1369-431b-96a8-632f7c9b8d93">156.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtNS0xLTEtMA_da73b59a-4b76-45e2-874e-1be30fc0ad03">1,682.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtNy0xLTEtMA_f301ee98-e02c-4d48-acdc-3f78a3e840cb">281.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtMS0xLTEtMA_83462141-fe8c-4578-a014-e954da85c5a4">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtMy0xLTEtMA_22c310c8-d72b-47bd-9521-fd9a99ab6d33">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtNS0xLTEtMA_9c370e6d-97e5-444b-84dc-0b1c19fcfbf6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtNy0xLTEtMA_4fbbd986-1715-498d-9c43-286f2041c7c9">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtMS0xLTEtMA_7a7cab9b-39a9-4162-982c-e69f752c1a16">21.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtMy0xLTEtMA_a8d9f85e-274c-4256-8573-35aefd082ad3">31.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtNS0xLTEtMA_ed083ae5-0e64-44f5-b8d3-54a317a9a031">49.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtNy0xLTEtMA_5f7fcc89-4375-453e-aed4-1ce461a4b673">64.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctMS0xLTEtMA_94d3e17c-4b1d-46d1-beec-5456fecbea71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctMy0xLTEtMA_8fe4980b-2f73-4ec5-8cd8-90a55f8eeb3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctNS0xLTEtMA_9effcecd-f4e2-4f8a-b727-3c78124234fb">21.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctNy0xLTEtMA_f4b961e2-084c-4920-9250-a94e173f373f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtMS0xLTEtMA_985c6f34-c845-48c5-96c3-8570a4e897ed">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtMy0xLTEtMA_275672fc-8ed4-4732-a534-520a801ed864">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtNS0xLTEtMA_4820e4a9-3321-4620-938a-3b85220fb405">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtNy0xLTEtMA_2d808ba0-4534-4f75-86b2-fee996808e7c">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktMS0xLTEtMA_69e215c8-0aab-465e-9514-bc50f45717b2">780.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktMy0xLTEtMA_7b1b4444-dd43-4885-a5e1-999e3795828c">118.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktNS0xLTEtMA_61400880-b8f1-4d74-ba18-1f8138d3ae2b">1,612.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktNy0xLTEtMA_e929a1e9-1da8-4ed0-9111-a4d4cfa00acb">216.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtMS0xLTEtMA_55c49765-6195-4d64-81ca-a6dc6c189afa">161.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtMy0xLTEtMA_b4d9371b-b128-4b17-ae72-9229c5f88513">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtNS0xLTEtMA_ac0d1f30-e5de-4c9b-aae1-63c148b8ac79">340.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtNy0xLTEtMA_c1e11b0f-677a-4391-909a-e669737752f6">264.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtMS0xLTEtMA_4e1b62a1-10fd-4749-ba12-bc1134a2de48">619.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtMy0xLTEtMA_a29338cf-440e-4183-bfdc-4cf81445c4c3">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtNS0xLTEtMA_b509b295-d27a-4e53-9132-2560c1b44371">1,272.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtNy0xLTEtMA_f97f14e6-c7c5-4f90-8c87-168f49b58bc6">480.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItMS0xLTEtMA_98a61d84-8699-4464-a1ef-d7f03aa9da0e">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItMy0xLTEtMA_605186ed-d86f-49c7-9738-3027ea4efc73">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItNS0xLTEtMA_be641065-e6c8-44ec-b793-5dd245790a37">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItNy0xLTEtMA_95b23973-44ac-4990-b118-73a368cf7d6d">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Hologic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtMS0xLTEtMA_52142656-e9af-4d49-a37c-9a5bb29010cd">619.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtMy0xLTEtMA_86ded29b-7528-4962-a010-721ab8f7603a">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtNS0xLTEtMA_9f369643-6799-4af0-9b81-c03634236d80">1,274.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtNy0xLTEtMA_c7568433-eecb-4db5-832a-1694390ff10b">482.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share attributable to Hologic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtMS0xLTEtMA_6af1e6b8-dfa2-44ee-a240-7140dba280c9">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtMy0xLTEtMA_04b5d70d-7538-4353-a9fa-7b8e71295169">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtNS0xLTEtMA_56faa85f-1c7b-4250-bbf2-304419a30857">4.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtNy0xLTEtMA_1c7aa462-10fb-4ae2-863e-646de981e821">1.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtMS0xLTEtMA_4771a474-5407-402d-a1a5-85f500503543">2.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtMy0xLTEtMA_f6a54f5f-3dee-4584-a1a8-88c4950bbd84">0.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtNS0xLTEtMA_415441fa-e030-4376-8113-4e5df9b79d23">4.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtNy0xLTEtMA_be3b961a-d6a1-4500-a869-7a3733306bfe">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtMS0xLTEtMA_391fee84-ca73-4b67-b9c5-fe1dcbe47467">258,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtMy0xLTEtMA_d5be14d4-8159-4d10-bc50-454640983d1e">263,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtNS0xLTEtMA_fb25923a-78a4-4d4c-81a2-3c6c92f79ef8">258,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtNy0xLTEtMA_d7c370e3-db16-41f9-b4fd-e54027b28287">265,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktMS0xLTEtMA_5d5c5c33-24fb-4089-9a29-dbf05fcb398d">260,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktMy0xLTEtMA_79edbb4b-464a-4c4d-a148-7ad5b080ed66">264,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktNS0xLTEtMA_f3046678-a261-437b-ba95-aa54dcd1f122">261,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktNy0xLTEtMA_4f34f397-7a20-4cca-b5a5-c77f3cad9941">267,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:45.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi0xLTEtMS0w_53893ed2-695c-4048-90bd-9dbbd0cee590">619.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi0zLTEtMS0w_36a4b486-9d9b-43ae-9da9-ef322002983e">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi01LTEtMS0w_b509b295-d27a-4e53-9132-2560c1b44371">1,272.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi03LTEtMS0w_7a0b928b-652c-43ea-9b10-8959c98852f3">480.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy0xLTEtMS0w_6a207b9e-b98f-4e9c-b793-c1757e3f0c76">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy0zLTEtMS0w_f10f36b8-b8fc-49bf-b932-705ced2a484a">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy01LTEtMS0w_1a06e221-44df-4208-b99d-a09da16de1aa">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy03LTEtMS0w_8bd0f58e-daa9-4b67-bf4b-babfd7475f76">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfODk_702e5fe4-27ba-4f7d-a1b7-3dfdc6432e6a">1.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTA5OTUxMTYyODA5Nw_4b93970f-1fe1-4215-9ae8-6b22d726d1be">1.2</ix:nonFraction> for the three and six months ended March 27, 2021 and $(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTQx_aa2f6ad5-3c87-4f4d-9dde-13511450a3ef">8.1</ix:nonFraction>)  and $(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTA5OTUxMTYyODExNg_6c674d05-daeb-4040-8965-12630090dbf6">6.4</ix:nonFraction>) for the three and six months ended March 28, 2020.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other comprehensive income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS0xLTEtMS0w_d6de6667-e38e-466a-a8ad-1cccc8e4de55">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS0zLTEtMS0w_7fbf4f9c-8251-414e-9e46-5882b031dfa7">25.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS01LTEtMS0w_74a17854-7053-4b44-a246-12bcec237a29">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS03LTEtMS0w_ff9a373e-4eef-48cb-9571-56ed2efb575f">21.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss reclassified from accumulated other comprehensive loss to the statements of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtMS0xLTEtMA_8b9207e0-9e32-42fe-a46d-425eb31450d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtMy0xLTEtMA_cca0ae3c-3a87-4ffe-8389-84acb29c141b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtNS0xLTEtMA_33ee786b-468c-4f4d-9b4f-e65144754d2c">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtNy0xLTEtMA_aa8f0c5d-e1e3-4450-ba6b-1a7fa2280237">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtMS0xLTEtMA_2c4bd063-2c15-478a-81e5-b46b8a45f5a5">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtMy0xLTEtMA_2a2cd466-c57d-4024-8de9-177ed33501bf">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtNS0xLTEtMA_ebee09c2-2be3-478f-934f-0ffc4b453a3f">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtNy0xLTEtMA_eea642e0-6bde-490d-856f-1e64ef4cde0a">16.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItMS0xLTEtMA_e601cbab-0bd7-44eb-b341-98a89482d0b5">614.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItMy0xLTEtMA_c8de4669-0c70-4efa-b720-678868700346">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItNS0xLTEtMA_5f411006-f6ef-43bb-8ec6-d2b1f349e62a">1,286.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItNy0xLTEtMA_a88d7a01-af3e-414e-b52d-9a5c17954634">464.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of comprehensive income attributable to noncontrolling interest:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtMS0xLTEtMA_40ce7d4b-651e-4509-a70e-1681e0da1dca">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtMy0xLTEtMA_5f2a90f7-c97a-4434-ba11-b74db6c6ba5c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtNS0xLTEtMA_d9b10ed4-f358-467d-a04e-8506d7104d37">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtNy0xLTEtMA_f14d907e-759c-42cb-9415-28af4d6070fe">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtMS0xLTEtMA_9f125dc0-a883-44d5-aea9-aeb92999109d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtMy0xLTEtMA_01cd0d31-9cfe-497c-a4a2-60b645e0911b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtNS0xLTEtMA_2874ddec-e8a0-4813-9965-ab022b590166">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtNy0xLTEtMA_2682e6b5-0f31-423e-a9fb-a67bdd9d065c">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Hologic</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtMS0xLTEtMA_96b80fe6-e3d2-48d0-9e82-d2df6e13eae9">614.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtMy0xLTEtMA_920c0596-8c74-4784-9ff2-d749a00235ce">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtNS0xLTEtMA_39452b0a-221b-411f-9b70-94d9c3d3042a">1,288.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtNy0xLTEtMA_832bbca1-14f6-4052-a7de-e052228f0ccf">465.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMy0xLTEtMS0w_1846af7c-abe3-4d60-a511-224894d53752">816.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMy0zLTEtMS0w_ade6a9e9-d772-4c5c-99ef-09963ebcb0dc">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves of $<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0wLTEtMS0wL3RleHRyZWdpb246ZWJhMGQwMWZlYjJkNDYyZWIxNDFmYTQxNGMwZjYwNWVfNDM_f3b4c772-6d4f-42dc-8694-17ab029cdb93">41.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0wLTEtMS0wL3RleHRyZWdpb246ZWJhMGQwMWZlYjJkNDYyZWIxNDFmYTQxNGMwZjYwNWVfNTE_06055e7b-bf4b-4a31-8cd9-1dc07a1b790d">31.6</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0xLTEtMS0w_4d3e0f31-5c2f-49e1-b626-2ea085ee00de">1,212.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0zLTEtMS0w_96641ff9-4227-4989-a328-eb2ff43f59c9">1,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNy0xLTEtMS0w_ec36a144-4014-4f8e-8aaa-9a0070080421">456.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNy0zLTEtMS0w_b70652c0-78dd-420a-8c52-49c50d8fac6a">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOC0xLTEtMS0w_f97966f8-9bea-4e37-a854-95591773be0f">85.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOC0zLTEtMS0w_adb05eb8-ef96-4668-ad63-39731a809652">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOS0xLTEtMS0w_3952383f-8b8f-457b-a1a5-075d6b3f9eaf">92.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOS0zLTEtMS0w_fdc35058-9933-4434-be77-c2a45fe0b89b">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTItMS0xLTEtMA_b1d1a2aa-7c31-4e63-99ae-5226fc048ce0">2,662.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTItMy0xLTEtMA_0cac005b-c94d-4bb8-a29b-dacad8b70a1d">2,222.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTMtMS0xLTEtMA_fc93fc9b-2e46-4422-b6a7-4b731fbfae3a">533.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTMtMy0xLTEtMA_1c92da61-450e-4152-aba2-26f817355c4c">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTQtMS0xLTEtMA_3fc95da8-9060-4976-9bb7-64351c5e19d8">1,447.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTQtMy0xLTEtMA_5f5225b8-7dcd-4d52-b571-4c447bcd3e0e">1,307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTUtMS0xLTEtMA_f907f25f-2fee-41d0-88bd-f19af4f7069d">2,857.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTUtMy0xLTEtMA_0dde2658-542e-488c-9678-500dc4a553a4">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTYtMS0xLTEtMA_26f0d1d8-aa64-46b1-95c2-4cb3b200096a">543.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTYtMy0xLTEtMA_404280e5-38e9-4a49-9c09-003dc4e3faef">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTctMS0xLTEtMA_370389e2-fd37-4f08-9969-b0305fd0a9b4">8,044.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTctMy0xLTEtMA_50a1bb0d-3029-4828-a8da-57a8a840e419">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjAtMS0xLTEtMA_cec5c6c1-a4a5-4800-ae81-e2358d64c7d5">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjAtMy0xLTEtMA_c37a7909-5514-4320-899a-fc2c3a6c62c8">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjEtMS0xLTEtMA_9033a398-2e31-4c29-a960-4ef5cd1f28da">225.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjEtMy0xLTEtMA_914b518b-f5cd-4ed6-a669-1109f224f6ff">178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjItMS0xLTEtMA_2bda2491-dbdf-4b52-9dbb-d653b192f922">534.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjItMy0xLTEtMA_1aa55bdc-cb67-45b3-a6fe-248aaf13dfbc">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjMtMS0xLTEtMA_d9742056-ab92-410f-80f0-0a75949a342d">198.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjMtMy0xLTEtMA_436e29a0-9873-4b25-9155-54bb729a74e5">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjQtMS0xLTEtMA_e0b88d6b-ea49-4d57-bfc6-0ba003543e69">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjQtMy0xLTEtMA_18c39da0-627f-433a-9f72-4caef319e781">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjctMS0xLTEtMA_d34d7908-c78e-48b0-9fc4-ef5241666c58">1,036.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjctMy0xLTEtMA_6a8b9d3c-92e0-4e9f-a1fc-7951091c122f">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjgtMS0xLTEtMA_ec26875e-f476-4f31-aa2f-7a6b18ba6f54">2,672.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjgtMy0xLTEtMA_df7d6c4c-0b4e-4b6f-b3ac-cbb85643ec3d">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations - long term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjktMS0xLTEtMA_4274ea41-4d2d-4414-9a1e-81248c1fb5d7">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjktMy0xLTEtMA_b842a42c-4109-42e9-a72c-91d9b9a459ed">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzAtMS0xLTEtMA_9e75afa1-346e-4cde-8055-493eb364ccf1">229.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzAtMy0xLTEtMA_b1ea6be0-ac99-4a02-a7e5-b1950fcf1e4d">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzEtMS0xLTEtMA_4623c09e-1ade-4a9d-8844-5b70611d7579">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzEtMy0xLTEtMA_d58b2086-9c63-4e54-ae8c-d7a94fff1492">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzItMS0xLTEtMA_8b93c774-8617-4b35-a68b-cef1e6ca205d">273.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzItMy0xLTEtMA_98794641-338e-49e8-a7c6-462e25b0fa3b">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzIx_21c6dc67-493e-44ae-830f-e6f3eb2028f9"><ix:nonFraction unitRef="usdPerShare" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzIx_683a5c9b-2c56-4f1b-a831-f55e50920476">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzM2_47c2f737-b474-49ee-80a2-804c5da0b4be"><ix:nonFraction unitRef="shares" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzM2_50d8e86b-6d80-488d-9fc9-862246113b8b">1,623</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzU4_959b7b40-a3f8-4363-9bf0-062986b40565"><ix:nonFraction unitRef="shares" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzU4_a137feeb-4ecd-4ff9-b32e-d001373418ad">0</ix:nonFraction></ix:nonFraction> shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMS0xLTEtMA_d559bedb-a09b-4fe4-94c6-c13a49a534ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMy0xLTEtMA_702c946f-5fa7-4f92-bf71-a640a7ac40d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzE4_2c28cfaf-fb2e-413f-ae0b-fb0b327a96e3"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzE4_b053ad5f-c238-45f8-bb2f-1569e2db99ea">0.01</ix:nonFraction></ix:nonFraction> par value &#8211;<ix:nonFraction unitRef="shares" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzMy_6ecfb919-4dd3-4e18-a824-c9f7001e302b"><ix:nonFraction unitRef="shares" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzMy_f96c25ec-8562-4ada-96e6-175662ba0a03">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzU0_409bce50-8577-4b18-b5a8-af3cd85f95be">296,887</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzYx_a8aafc66-c164-479e-a86a-7698a7c0420c">295,107</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMS0xLTEtMA_d25765c3-b152-481f-99ac-747193cd99ba">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMy0xLTEtMA_4fea15fc-b6e7-46ac-89d6-e5b1f0d9aa18">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzYtMS0xLTEtMA_ef424523-f6dc-42a0-9529-b8d51e17295c">5,927.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzYtMy0xLTEtMA_b43e705f-45de-43db-b604-702ca036a4f6">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzctMS0xLTEtMA_20d43350-8167-4738-81a7-e7c10179bcd5">298.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzctMy0xLTEtMA_bbbf4e9e-d295-47c7-bddc-6b332c1c3fcc">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjAxYjk1ZmIxYjk4MjQ3MzRiMzdiMWE3NDk2NDNkNGFiXzMw_09c782c1-2481-426b-89e8-59377bdd6969">40,682</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjAxYjk1ZmIxYjk4MjQ3MzRiMzdiMWE3NDk2NDNkNGFiXzM3_6c749a09-cdb9-4f2a-8a0a-f865bdab3e99">37,609</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMS0xLTEtMA_821a9fc4-b8cc-4d62-b9d0-fc663a951b8d">1,801.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMy0xLTEtMA_a7182324-27e1-49eb-a7a7-3366c64d4479">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzktMS0xLTEtMA_59a40ea5-5c5e-4943-961c-b58b424c8fa1">35.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzktMy0xLTEtMA_35e56850-0052-49f5-ac27-f8abd2628266">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDAtMS0xLTEtMA_c0698e4c-b551-4b9a-88f8-fdce7f40bcaf">3,794.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDAtMy0xLTEtMA_49312791-22ff-4e58-9392-4f765ca0b6ba">2,705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDEtMS0xLTEtMA_711a1fcf-f445-4455-8580-c3d6ac8fa1e1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDEtMy0xLTEtMA_1925d27e-3908-459f-9c82-0fba14ada9c1">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDItMS0xLTEtMA_f9ba4a96-2662-4474-ae6b-62b1ee1c8d03">3,795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDItMy0xLTEtMA_07fa4c21-ea09-4925-b12f-b7ff5011e5d7">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDMtMS0xLTEtMA_64f2bdeb-021b-40b6-b8b0-6f401afe7b06">8,044.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDMtMy0xLTEtMA_76746c5b-eb29-4091-af39-3db2603a3a49">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58ad3a928b064f93a707adcef8b085ef_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTItMS0xLTA_572cd419-2e0f-43b7-b860-2154328dffab">292,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ad3a928b064f93a707adcef8b085ef_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTQtMS0xLTA_7807e2df-95f9-4a19-ab10-d4ae5f5d1605">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86f19e338624c03becbf38fdc443b83_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTYtMS0xLTA_ee383d0f-ed7d-41a9-bda5-47c17bc4e096">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52eae1f2a4d04d28a7067bbadc18fd4c_I20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTgtMS0xLTA_ecffbfcb-a492-412c-855f-51b127a106ca">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527df9991fb4a508abd170595d3765f_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTEwLTEtMS0w_c848d181-d195-4079-9ae6-e3de617a0642">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f0f7c20571c473dbb3538c19161061b_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTEyLTEtMS0w_1a0fe963-f255-40c4-ae9e-81e99e4f608a">24,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f0f7c20571c473dbb3538c19161061b_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE0LTEtMS0w_f5113719-8929-4831-a797-8dbc956694e5">926.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE2LTEtMS0w_95de2594-2a34-4e9d-bac5-7053758f960c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE4LTEtMS0w_39e957d8-700c-45b0-988e-015105320c5c">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest created in acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE3LTE2LTEtMS0w_7e335d61-cb7e-4978-9e25-041be5fa2a86">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE3LTE4LTEtMS0w_66558f70-f845-4542-b118-15a946d6dcc5">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5308a8db9a248b4a503886d28172438_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE4LTgtMS0xLTA_8ed23669-518c-46be-8ff4-f58d693c6d76">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5308a8db9a248b4a503886d28172438_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE4LTE4LTEtMS0w_38cddd73-1329-402d-b0f9-96196f9b3a37">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTItMS0xLTA_670ed7c5-cfd6-411f-bc86-3a871d3d4c20">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTYtMS0xLTA_29ee4db6-1623-46db-ac86-63df08adbae3">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTE4LTEtMS0w_aa83bcc1-4e45-4824-9182-03a9634708e1">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTItMS0xLTA_965f5382-6f74-4752-a3d4-bb2bbac08545">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTYtMS0xLTA_93bf9386-3fd1-4c4b-80b9-b33d945ab48d">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTE4LTEtMS0w_0a341737-4016-431d-a74a-46ec48a87544">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIyLTYtMS0xLTA_8e8f4f6e-b0f9-41f0-8bda-4a1091b5adc8">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIyLTE4LTEtMS0w_7c1efbb1-36a6-4178-910d-219c968a0d55">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTgtMS0xLTA_2c8fc1f0-8a65-4db2-b833-d6e3914c719e">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTE2LTEtMS0w_d623c24b-fdec-4c49-b7ed-b49fa72a9163">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTE4LTEtMS0w_a8527754-06e4-4f8b-8555-555d52dc58c1">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI0LTEwLTEtMS0w_a2997a34-fd6a-4b16-869d-3aaf44616a51">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI0LTE4LTEtMS0w_ba520e5c-051b-4ae1-b31d-e1f30ca6006f">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTEyLTEtMS0w_11f3e365-d788-415c-9249-2f2e47aa50f6">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTE0LTEtMS0w_0d934c04-2293-43b5-89ff-7ceb9490a497">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTE4LTEtMS0w_86690f80-52d8-44ed-b03e-d6c7aa6f5162">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTYtMS0xLTA_74c74638-c17c-4fa7-b2c6-2787494977cc">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTEyLTEtMS0w_fdda401c-b0f9-42c8-9a62-a11609ae898f">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228" decimals="-3" sign="-" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTE0LTEtMS0w_fabf0f3c-0a08-4fea-b3b2-9fff12fe6a97">164.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTE4LTEtMS0w_1c7ec856-5483-424e-8fa2-117f68aa4ba0">205.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI3LTE2LTEtMS0w_3a486c72-945e-463d-b5d7-7a8f6f4bc503">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI3LTE4LTEtMS0w_635a1991-cf7b-460e-a969-d3d0f0f05bb0">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b0a1c130c914da2aed9de46ede4189e_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTItMS0xLTA_902c669d-b2d2-4d42-983f-4ec88a0efe0b">293,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0a1c130c914da2aed9de46ede4189e_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTQtMS0xLTA_57e08429-b927-4b33-ada7-cb2bc8bbf7a3">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58207b8d4894dd4af272ce1eca54244_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTYtMS0xLTA_49a0fc8d-4777-4c18-8bce-79c5dc6dbff9">5,749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f07a9be8b684974a2a20fab9aa2e50c_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTgtMS0xLTA_4f511b92-0c78-4f16-ac26-4fb056b84359">2,302.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib48dedaf55ee438786b6134c8b28e49c_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTEwLTEtMS0w_1996c870-efd9-48a2-b531-7878175b2312">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bee588f40e14c72bd3cc02f47cadda7_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTEyLTEtMS0w_962079ff-3b56-4657-841f-f1cf509e607c">29,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bee588f40e14c72bd3cc02f47cadda7_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE0LTEtMS0w_138d74d0-6c1b-4dd1-989f-496f921f1c38">1,170.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE2LTEtMS0w_40f9778e-5c5a-4b02-bdad-dd91e891004f">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE4LTEtMS0w_5d06a664-d049-449b-afa1-95d5ac115a78">2,257.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTItMS0xLTA_534518b8-f705-4aac-88d9-2b1db295bb15">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTYtMS0xLTA_89a32d12-102e-4c5a-88d3-bc5c885f3ebe">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTE4LTEtMS0w_ed27a188-2b49-471f-8364-b64c8bfe8384">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTItMS0xLTA_a41f106c-c5c3-4965-b717-26a46d58da85">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTYtMS0xLTA_b4007f54-a4a8-4fa4-b4ec-9830b07837ed">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTE4LTEtMS0w_0c9c65c9-551e-4bfc-9921-450d147166e2">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTItMS0xLTA_10a9e6a8-b125-482d-9e6e-86d963b7d314">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTYtMS0xLTA_db944108-b9e2-4cd1-ab0c-846886d9161e">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTE4LTEtMS0w_5e974db6-2646-4e37-b5e3-2182ae98e6cd">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM0LTYtMS0xLTA_82288097-282f-4ff2-99b6-6e33a3314e32">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM0LTE4LTEtMS0w_506fee77-cb21-4689-932e-8fc617965c07">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTgtMS0xLTA_76970be9-0167-4d3e-920b-a6880287d88a">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTE2LTEtMS0w_7d260b99-1772-40d3-aaf9-9494ab096783">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTE4LTEtMS0w_e047f7ac-39e1-4746-99dd-b6ca27e7d761">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM2LTEwLTEtMS0w_277034a4-1083-4778-a94d-d5e7c5bd290d">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM2LTE4LTEtMS0w_8c6c7263-8127-49eb-9e5c-685f3de67500">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTEyLTEtMS0w_5e3406e0-d66e-4bfa-984e-70c904bb42be">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTE0LTEtMS0w_fa87a166-168c-4cb9-8ee8-5dce932968c7">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTE4LTEtMS0w_9ea5d305-eaba-48c5-ab58-2e3c01db0108">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Completion of Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328" decimals="-5" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTYtMS0xLTA_1af3e77b-851e-4105-9b9d-1dd1d5f9630d">41.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTEyLTEtMS0w_08bcdcc7-36a3-4bed-b768-4381f0b24b51">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328" decimals="-3" sign="-" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTE0LTEtMS0w_5f744cb0-2ec0-4954-96a9-a24f7fd63895">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTE4LTEtMS0w_5e93f148-eeba-499c-90c2-fee9e25462b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM5LTE2LTEtMS0w_459ec84b-dbf7-429f-bf0e-5f65ea3950c1">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM5LTE4LTEtMS0w_18f94d5c-f297-495c-b237-528dbcf5ccfc">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfc98874159a4652a12358cbde3c0dd0_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTItMS0xLTA_07150006-ebdc-43c7-bd26-f14da2a0c2ff">294,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc98874159a4652a12358cbde3c0dd0_I20200328" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTQtMS0xLTA_19960f88-fde6-4f46-a242-4cd187a02439">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01ffa50611c48bcae532eb4d244ad15_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTYtMS0xLTA_ea09a2a0-3273-472b-b4b4-de1782929322">5,827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57574c7cb017407e95bc7d6674fc7041_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTgtMS0xLTA_4a3b5ee6-7431-4308-aa59-4a71412a16d7">2,206.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTEwLTEtMS0w_fa855de6-3f9f-4e13-b4b5-40c2e9ad1335">58.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTEyLTEtMS0w_9dafa533-e60a-43d8-b17d-72121fe9a39c">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE0LTEtMS0w_6f5e79d4-8cc8-49f0-9009-cb0609adb09d">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE2LTEtMS0w_9d819ea6-689a-4e7d-b766-2a7b97fa6d8f">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE4LTEtMS0w_b2726eac-778b-4bef-82b4-44db28eab5f1">2,091.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37479dda543e4e848a6b2a065e778421_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTItMS0xLTA_5ecda383-5304-4ee4-850f-fce7e6c98bcf">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTYtMS0xLTA_6f689819-1309-491e-9d53-760f4940a26e">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTE4LTEtMS0w_816684a2-1d17-4815-bbc2-44031f6c6731">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37479dda543e4e848a6b2a065e778421_D20200329-20200627" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTItMS0xLTA_3bc8a690-2c7c-4cc6-8eee-1528201169b8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTYtMS0xLTA_f11366ef-2438-4f97-af33-02cf2ce02d95">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTE4LTEtMS0w_6043d1bd-e934-416e-9c8c-f5db2c52c6ff">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ0LTYtMS0xLTA_5bd7e64f-6c71-4a1b-96fa-ca0679e1f7cd">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ0LTE4LTEtMS0w_d21ccdb2-370f-41a9-8ce9-11a40a1dff1e">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTgtMS0xLTA_55c8718a-23ce-4dd6-bec5-a726875996c9">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTE2LTEtMS0w_3f8eb117-e4e9-4f8d-a182-c1518f654b5a">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTE4LTEtMS0w_5db6b79b-a9a3-43c2-82e0-497e7e2e6ff9">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ2LTEwLTEtMS0w_e60def84-530b-4ce6-a154-b4de1f1d197c">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ2LTE4LTEtMS0w_f47158fa-981f-44ca-9be4-dbf1fa04d6c1">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ5LTE2LTEtMS0w_7f2962b2-eb70-4b40-b3b5-f6edb52f35fe">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ5LTE4LTEtMS0w_be23c36b-dace-417e-a7b6-417a396b7f08">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55a0a29026de4c14b1ca906b3d06512f_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTItMS0xLTA_e36cfc9e-e121-4330-813f-660185bf754a">294,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a0a29026de4c14b1ca906b3d06512f_I20200627" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTQtMS0xLTA_2e6b0c53-4bca-43a2-ad64-f008e03e2326">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00148f02d5ac434ab8455c4bfdb18794_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTYtMS0xLTA_383970e2-a774-4ab8-bb48-2bd3187512f3">5,861.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b1b90c41f7d4bd2acfb7ecf220b375d_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTgtMS0xLTA_033be2b2-4e9f-40be-b65f-b0034ec9f01d">2,068.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13a5203734044addaed9c920967a2c5a_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTEwLTEtMS0w_2e99eb56-e8fd-40cb-855d-685523995f7b">61.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTEyLTEtMS0w_12cfa15e-b4c1-48f6-a1b3-02c8f4e0ae37">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE0LTEtMS0w_7883ccb3-751f-4e0e-b318-4f2a1fc22634">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e7059977d242968ebf9c8a01c8083e_I20200627" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE2LTEtMS0w_69c96945-3f11-47c4-971c-fab6cc8fc8ce">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e7059977d242968ebf9c8a01c8083e_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE4LTEtMS0w_42ade7da-6396-4e10-b088-32afb2b316fc">2,258.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTItMS0xLTA_4d15ebdd-172b-444c-8f64-0fe6d53f3585">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTYtMS0xLTA_86663dd0-9899-46d1-9ca5-fdc4f65f696a">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTE4LTEtMS0w_a4848293-8e1d-48fd-ba58-cb47368e01d9">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTItMS0xLTA_463423be-a7c4-49c7-8086-42be40d83b2d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTYtMS0xLTA_5dada3d3-0c97-49b0-a97e-f9d08f8c4576">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTE4LTEtMS0w_fb0becb2-c317-4a6e-be0b-79eea4a0066e">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTItMS0xLTA_a2fa438d-00bc-48ef-ae69-3f572275dc05">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTYtMS0xLTA_972ba0cf-4858-4548-be75-e1a47432e609">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTE4LTEtMS0w_f7a00fd2-6513-42bb-ae19-2ccae5d5ee53">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU0LTYtMS0xLTA_4ed45cdb-5acf-4f54-acc0-9d5642c23094">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU0LTE4LTEtMS0w_d63f3b88-654c-4423-8261-fbce0105c302">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTgtMS0xLTA_636d2788-ce39-4808-9f6d-b265d869e513">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTE2LTEtMS0w_0235bcdc-4bc1-490d-8b76-8a6c3a6afcba">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTE4LTEtMS0w_8e83574e-bd60-4a27-ad54-f50849092748">493.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU2LTEwLTEtMS0w_fa5da5ba-a0c5-4145-b2eb-c27f37b2ff9e">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU2LTE4LTEtMS0w_9b7e5c17-9a8b-489b-ab96-7304c2dbb4cf">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTEyLTEtMS0w_489a3970-ba88-4f3d-becb-a0951c6612cb">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTE0LTEtMS0w_3aaf8b90-007a-4f30-badb-5df1691e06dc">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTE4LTEtMS0w_b47cff8f-03c9-4159-9f38-85f5e7df4cfb">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6160ec5704084a74ab06ae3ef0b25d89_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTItMS0xLTA_972f46e5-cc7b-4461-a201-8043ac98dfc6">295,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6160ec5704084a74ab06ae3ef0b25d89_I20200926" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTQtMS0xLTA_80447a7a-222a-4b3e-96a0-a4ff373fd6c2">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32babe6c9a5a4075a97af1479d07d7f5_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTYtMS0xLTA_83779072-b08b-4262-9a3d-1875f3e11591">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e162ffb5f4d46748b4e62688b0c4db3_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTgtMS0xLTA_1b668a55-4a71-45c0-ad26-4519f18df196">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9d9c4520de640f7837c8a8db74e7a29_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTEwLTEtMS0w_6e76d3eb-deea-429e-87e2-5399250be686">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf7dda3e20214bc7b64a4430da73c356_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTEyLTEtMS0w_e0f54e74-14fe-446a-ad37-c7bcaa3973b8">37,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf7dda3e20214bc7b64a4430da73c356_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE0LTEtMS0w_b18dbded-d7ae-43a6-bae5-bbc2da754e87">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE2LTEtMS0w_f40e11ac-c9c1-4fbe-bc71-b6a565cb52f2">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE4LTEtMS0w_7d4d2f99-9ee1-47fd-92c8-5d1986d09f6f">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTItMS0xLTA_e6df127f-5c79-4dc4-93a7-e6112e704cd3">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTYtMS0xLTA_090987dd-0e8a-4532-a22f-16a246ae60b2">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTE4LTEtMS0w_b9ce04b0-cee0-4c6e-938d-8e04f4e00bf2">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTItMS0xLTA_6891edd8-4b3c-4f3d-98a1-5ecd79ead789">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="5" name="holx:ChangeInParValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTQtMS0xLTA_6c7b046e-0c3c-4b8e-9d2b-1c65efe00180">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTYtMS0xLTA_e86b8bf8-2578-427d-8787-a4d07f9e7f03">46.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTE4LTEtMS0w_0cf94a1a-3a04-403a-9e32-05d50d460d5d">46.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYyLTYtMS0xLTA_9f023bb4-00e3-49d7-9161-12d2bfbe7a9e">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYyLTE4LTEtMS0w_028d0280-40c9-4188-9403-7077a19b6e51">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTgtMS0xLTA_61d01c6e-ab3b-4278-a6ec-eb884edc1195"><ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTgtMS0xLTA_ced73742-63c6-4d2c-aad8-14f24f3c2c41">654.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTE2LTEtMS0w_408e8cda-2553-465b-bfa8-a17b8085f192">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTE4LTEtMS0w_37e03f26-76be-4d9c-8a82-ae12512b5f9a">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY0LTEwLTEtMS0w_4d35d18b-cd89-4952-a903-a825ff6145a9">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY0LTE4LTEtMS0w_2cd278f6-d5d5-430e-86f2-556d7d25a291">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTEyLTEtMS0w_b427a8e8-9cf3-427b-b87d-a4e679148685">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTE0LTEtMS0w_65bce905-8c54-45b3-9f03-6a90298919e2">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTE4LTEtMS0w_86f17a80-104f-4680-a15c-bf594f2dec9c">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cff19231e714132bf4dc7ccaa04d77a_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTItMS0xLTA_b016693d-40a1-487b-9671-35326f5a1e45">296,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cff19231e714132bf4dc7ccaa04d77a_I20201226" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTQtMS0xLTA_b369323e-f4c9-455c-a356-af970dd95b0f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id823f47b65a04844af628de4c871ffb5_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTYtMS0xLTA_791d4b13-3f35-44b1-a8e0-5b5de3fefba3">5,895.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i599e6bb573174ab9946c1b0e7a65a1ee_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTgtMS0xLTA_ed246682-afa9-41fc-9aab-a12165f70150">918.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f41c1c1b96640ce8c37aa114378b5af_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTEwLTEtMS0w_ea649f2f-3e5a-4c4e-9f86-0fbad14b82c1">30.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c8bb166454744ccbffadde0265cdfd4_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTEyLTEtMS0w_e46424f6-ef93-4823-ad35-471675a8eeaf">39,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c8bb166454744ccbffadde0265cdfd4_I20201226" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE0LTEtMS0w_c0c3df78-ba2d-463b-80f9-c96c53bb2f19">1,680.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE2LTEtMS0w_d3880deb-a7ab-4687-bf7a-9c3a59d6dfba">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE4LTEtMS0w_0b081170-2aa4-455f-9176-9175744da9b7">3,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTItMS0xLTcxMzM_7234820a-7c8b-4285-9492-f8ba40701c4f">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTYtMS0xLTQ0MjY_120a063d-f870-424c-b928-fca0d077ee22">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTE4LTEtMS03MTM3_db350894-ec69-46a5-95c4-6f86bd0d69d4">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTItMS0xLTcxMzk_bbe595b4-4793-4837-a41f-a077296ba8b1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTYtMS0xLTcxNDE_95d39cfb-c92e-4eb0-85aa-5ac47b3e53fd">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTE4LTEtMS03MTQz_0f1ec5b3-c74f-4bfb-98a6-58e408a7ece6">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTItMS0xLTcxNDU_dfb2206f-0ca3-403e-b172-fe37d3f93ac7">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTYtMS0xLTcxNDc_21311a5c-f213-4af9-b97f-148f556a2f80">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTE4LTEtMS03MTQ5_e8138374-15cf-43d7-8dc5-014d888e347f">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcwLTYtMS0xLTcxNTE_080fcdf4-a5ce-4c35-9761-80f5ba034e2b">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcwLTE4LTEtMS03MTUz_04ccabb5-0331-442a-8596-55524293b109">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTgtMS0xLTcxNTU_97ff2a01-f4a2-474a-b6c2-3be6f333302b">619.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTE2LTEtMS03MTU3_a981a93f-020c-4bf2-8b78-e78f11d22795">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTE4LTEtMS03MTU5_c039186c-d99f-4120-a816-475bd8b39e09">619.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcyLTEwLTEtMS03MTYx_fab6561d-4159-4e1d-bac6-dfee8fb31166">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcyLTE4LTEtMS03MTYz_be016ea0-12ed-40e5-9ddf-1c36cec6dc13">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTEyLTEtMS03MTY1_489d7da4-a115-4898-a397-61cdc883b4f9">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTE0LTEtMS03MTY3_7c6de8a2-2105-4a98-905b-a49ee90ca9e8">120.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTE4LTEtMS03MTY5_faa85b30-eb7f-4360-b646-9879dbd16c1e">120.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i247efccf5d6947e48ecee24ca732c483_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTItMS0xLTcxNzE_bbf7153d-2c5e-4b7c-8365-87e4f83c8ecd">296,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247efccf5d6947e48ecee24ca732c483_I20210327" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTQtMS0xLTcxNzM_b4cc6d34-c2ec-4776-9784-6075f1b52ea6">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e744d8762c4825aa1a4d2b4bdf2cf3_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTYtMS0xLTQ0Mjg_82268788-3ebe-4dcf-99fa-b1303e4cd51a">5,927.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0da21f00cf470eabc24e01c7fc5fa2_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTgtMS0xLTcxNzc_40004f1c-a246-47e8-ae61-630d02e267a0">298.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTEwLTEtMS03MTc5_c7da1f9d-fa3a-4255-aa3c-00d7f37007e3">35.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTEyLTEtMS03MTgx_cc6231f9-155c-4b98-b465-fdd52cfba02a">40,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE0LTEtMS03MTgz_fd78429c-3ba5-4bb4-932d-5df6b1a4bf1e">1,801.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE2LTEtMS03MTg1_d90f916b-b87b-45a6-a7d4-482943f50e45">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE4LTEtMS00NDMx_3d1b09b1-9b9d-4c70-bc5f-bc048396fb6d">3,795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMy0xLTEtMS0w_d988bd82-abef-4291-be07-1f8739649e3e">1,272.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMy0zLTEtMS0w_7a0b928b-652c-43ea-9b10-8959c98852f3">480.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNS0xLTEtMS0w_46af07d4-8b84-4e28-88aa-73b1e9f6745f">41.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNS0zLTEtMS0w_1c5dd15a-7aff-42ea-84ec-6d5602d9d1dd">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNi0xLTEtMS0w_cea9452e-5a56-4cf7-9c1e-8fd42acde9d2">146.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNi0zLTEtMS0w_26d996f1-b100-49ff-9447-cbbd5f6ea3de">145.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOC0xLTEtMS0w_43109a73-ad76-49ef-9a4f-d86d25a85427">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOC0zLTEtMS0w_e798a514-9dc7-4134-8aff-f1a005e7223c">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOS0xLTEtMS0w_b3425b4e-6f36-450a-b08f-626b0709a1e7">23.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOS0zLTEtMS0w_c8204689-48a9-419f-9d8d-34b7243b3d8d">44.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset and equipment impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTEtMS0xLTEtMA_ef5e6e88-9b46-405b-838b-309af8b28b96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTEtMy0xLTEtMA_f55fb0fc-f5cc-402c-ac17-359d6c980606">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTMtMS0xLTEtMA_1b774da0-b635-4e5a-895f-fb09f96004d1">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTMtMy0xLTEtMA_ae3017f8-6f9b-43c7-ad93-d2903c77640e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjAtMS0xLTEtMA_ef8d66e6-3f24-4bd4-ab7c-6d963dfe6c65">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjAtMy0xLTEtMA_77bd8058-45fe-4c55-a0e9-e2d361e73e35">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjItMS0xLTEtMA_0a3b6e57-4529-47ae-a42e-3502d4eec8af">171.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjItMy0xLTEtMA_3d2b2956-ba35-4d31-bf3e-3972cc710e16">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjMtMS0xLTEtMA_a187f630-8bb2-4bb7-8216-a6d910540780">46.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjMtMy0xLTEtMA_88e46ece-ff8e-49e1-843d-2c3568a7b3ea">33.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjQtMS0xLTEtMA_52eef0c7-03ca-4734-b5bf-dac57af344be">46.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjQtMy0xLTEtMA_900554f5-286a-4547-9d7e-3f3afa6aa0e4">27.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjUtMS0xLTEtMA_e7d9766b-ab86-49ad-8622-e3ce2640c03d">36.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjUtMy0xLTEtMA_b35d7e16-34d7-46f5-a911-1c76dfe41a41">317.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjYtMS0xLTEtMA_946440a2-6def-4ddb-9ad7-fc4f6d8787ec">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjYtMy0xLTEtMA_80a717c3-9c61-469d-aeab-8a0ff50f1092">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjctMS0xLTEtMA_bc1570f9-17d6-4ddd-b920-1253aee932b3">50.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjctMy0xLTEtMA_6fcedd72-ac7c-452b-8ee7-2e1aaad8959e">50.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjgtMS0xLTEtMA_b728dcc4-18ad-44c4-914b-35c4e9c04d8f">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjgtMy0xLTEtMA_62e8ea4a-de6b-4b65-a23b-01c5728e152d">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjktMS0xLTEtMA_a477342f-fa46-420b-b092-141755e4d4da">1,202.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjktMy0xLTEtMA_74f9155a-0593-4a06-8b67-bf6f591e9931">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzEtMS0xLTEtMA_efc89981-3700-4da8-989d-fe7fa0f7fa93">440.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzEtMy0xLTEtMA_d2d8f23a-fdb4-440a-9263-a8111e758bf2">43.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="holx:ProceedsFromSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzMtMS0xLTEtMA_f3cc9645-df84-44a9-8e03-28b60309b2d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:ProceedsFromSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzMtMy0xLTEtMA_c85fb1b1-7aff-45d2-a95d-25ee578414af">142.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzQtMS0xLTEtMA_e574a665-9204-4240-beb1-d21913681fc0">51.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzQtMy0xLTEtMA_5979779f-2d2a-439a-be55-b098b584a5c9">29.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzUtMS0xLTEtMA_15bf3a9f-ec0b-4955-a7b2-f24608d7db6b">27.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzUtMy0xLTEtMA_a0e61f47-d598-45d1-8e01-6b90275497f5">33.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDEtMS0xLTEtMA_e427f461-f320-45a4-b509-5baf53c01a69">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDEtMy0xLTEtMA_0a736f46-51e6-4989-9c3c-1a0dc492030c">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:PurchaseOfIntellectualProperty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDMtMS0xLTEtMA_198b9d54-044d-4fcf-9107-ecfa42a848d5">6.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="holx:PurchaseOfIntellectualProperty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDMtMy0xLTEtMA_ab2bbbb6-f742-44ce-99f1-03240a88da16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDUtMS0xLTEtMA_e5caa76e-cef6-4dba-837e-d3b970255010">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDUtMy0xLTEtMA_a239d07e-8e44-4ccd-b883-ffd70c49985b">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDYtMS0xLTEtMA_a93ea678-1e26-49a7-ad94-f60899e6c786">528.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDYtMy0xLTEtMA_c943bd32-613f-4875-ab73-632b5d854376">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDktMS0xLTEtMA_69e7f5b1-52dc-45ef-8ff8-fa1787e0f95a">37.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDktMy0xLTEtMA_170c2bc4-7e2f-41cb-b54b-7c1887b3cc15">27.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="5" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTAtMS0xLTEtMA_321a2f05-dfd0-4a86-bbea-34cfb0bdefab">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="5" format="ixt:zerodash" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTAtMy0xLTEtMA_d12daf08-c396-4927-a848-21922ecbede3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="5" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTEtMS0xLTEtMA_10d2872c-f701-4337-9a80-bdc3a369c2f8">970.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="5" format="ixt:zerodash" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTEtMy0xLTEtMA_a480ff21-0ef8-4760-922e-bfbca32dace8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from revolving credit line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTMtMS0xLTEtMA_4a106725-4364-4354-a599-6f2d9b364472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTMtMy0xLTEtMA_478f8876-5804-4576-83ba-1b21df9c8334">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment under revolving credit line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTQtMS0xLTEtMA_50ec0659-1aae-49b4-8425-9f4314c80067">250.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTQtMy0xLTEtMA_5d20888c-788d-4c78-a841-f40d0c648d62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTUtMS0xLTEtMA_21d1b730-2d32-4e7d-b7ee-9ea337b4f74d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTUtMy0xLTEtMA_db94c4e6-0e11-4d8f-8633-aa9472346515">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment under accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTYtMS0xLTEtMA_a4dd24f6-8c0b-418e-b123-4cedf6b5e3f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTYtMy0xLTEtMA_5916c549-31f0-4368-8303-74880e3979d2">250.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTctMS0xLTEtMA_c493f71f-90fc-44a0-8f2b-8e16afff16f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTctMy0xLTEtMA_05830674-5be5-4399-acde-91d3a4dbbcfe">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTgtMS0xLTEtMA_7b062f7a-7d17-4553-9ff1-5964247b9087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTgtMy0xLTEtMA_aa777be5-b870-44ce-9fe5-4dabd0f04c11">24.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjAtMS0xLTEtMA_1cefb2a3-63ec-437a-b15c-c7630fd7d682">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjAtMy0xLTEtMA_6338a84c-76f3-49aa-a7b9-763828f9c208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjItMS0xLTEtMA_3e3c369a-2408-4767-8473-5748067852e4">221.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjItMy0xLTEtMA_25067832-0398-448b-8e00-ef7413b157e4">553.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjQtMS0xLTEtMA_2a84e30e-ec3c-464f-8885-9fc576f88e4e">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjQtMy0xLTEtMA_a600771a-acbf-4a0c-ade3-9a8c46a200e3">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjUtMS0xLTEtMA_9379850c-9035-457f-bf0b-94bd13d47b15">46.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjUtMy0xLTEtMA_b42071dd-47c7-4100-9dcd-f47994da0f02">12.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjYtMS0xLTEtMA_fa3b6564-c2c2-4a44-b40d-979ca2b70fa6">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjYtMy0xLTEtMA_28937963-185d-404a-8fbd-162e9917ee47">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjctMS0xLTEtMA_fd66e322-cc2d-4ada-a623-e87acd974e84">557.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjctMy0xLTEtMA_022e1bbe-5f69-45bc-9dd4-f8f632df6e7f">67.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjgtMS0xLTEtMA_a7164859-a433-4796-9354-acdcd17027b8">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjgtMy0xLTEtMA_d8154071-2fd5-42ab-be23-d98316815fa1">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjktMS0xLTEtMA_1a8e076d-022f-4c1d-8da0-905e08082a8e">115.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjktMy0xLTEtMA_1d07e529-dc58-4c11-a533-d44b18e1eba5">198.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzAtMS0xLTEtMA_ade6a9e9-d772-4c5c-99ef-09963ebcb0dc">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzAtMy0xLTEtMA_ece19ff0-c0a7-4ba9-888c-7636fef4cdc8">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzEtMS0xLTEtMA_97db4150-f5ca-4737-a32d-4ecfbead6947">816.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzEtMy0xLTEtMA_9ef5098b-ac26-40e3-9337-df499b8f7f55">799.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) <ix:nonNumeric contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNC9mcmFnOmFiZGQ5NjlmNWEwODQ4M2JhOTM4ZGRjMmQ1NjUzZmVhL3RleHRyZWdpb246YWJkZDk2OWY1YTA4NDgzYmE5MzhkZGMyZDU2NTNmZWFfNDgyMg_7066f15f-e15a-4123-8c69-25c2136b356b" continuedAt="i99f6bd6e2f66441cad475f3a736202cf" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i99f6bd6e2f66441cad475f3a736202cf"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended March&#160;27, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended March&#160;27, 2021. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was one unrecognized subsequent event related to the acquisition of Mobidiag Oy ("Mobidiag"). On April 8, 2021, the Company announced that it had entered into an agreement to acquire Mobidiag for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i3d291e0f9c0b402da8343bcc6b51f9f2_D20210408-20210408" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNC9mcmFnOmFiZGQ5NjlmNWEwODQ4M2JhOTM4ZGRjMmQ1NjUzZmVhL3RleHRyZWdpb246YWJkZDk2OWY1YTA4NDgzYmE5MzhkZGMyZDU2NTNmZWFfMTA5OTUxMTYzNzY0NA_80f919d7-f694-4d36-8e68-4a3e3b2f3bd6">795</ix:nonFraction>&#160;million. The closing is subject to certain regulatory approvals and other customary closing conditions. Mobidiag, located in Finland and France, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. The Company expects this acquisition to close in the fourth quarter of fiscal 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC Update No. 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNzg2Nw_66086564-a0a1-4ff8-87b6-588acefb903d" continuedAt="i2a1ce3112a7c46059c0273d267f06e3b" escape="true">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="i2a1ce3112a7c46059c0273d267f06e3b" continuedAt="i907e2e279545466397e102c0122dfc18"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dff062ce5742cd9f8ec548f170b3b3_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy0yLTEtMS0w_cf02aea0-576c-4ef0-96a0-7c13129178b8">76.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90763f49a0da4076b8324779a162e6a4_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy0zLTEtMS0w_80e10e16-2cae-4915-ab4c-0923bc2e44b2">40.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9a123d4d3f4bd282939064c3e109ab_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy00LTEtMS0w_6948ab65-fbae-4412-afcf-36a29c03f30c">117.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26ef905de85948f8bdd806e8ca63fe1d_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy02LTEtMS0w_96eca4a2-5b8b-4fcb-b935-32936e4cff6d">73.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec54e8e340d5457e910be1d441c98063_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy03LTEtMS0w_b9aa4a65-66ec-4a0b-937e-f22a1f32c97a">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26927080ee34404080aa7911ade83d18_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy04LTEtMS0w_80efb9a1-7231-4cc1-a17e-1e409dc7ff5e">113.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf8f71a8497491c86ce651b76d4b795_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC0yLTEtMS0w_625dcd16-9c16-4755-a56d-1e1e68958ec3">616.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ae7d35265f4897bdfb34c7ccae119e_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC0zLTEtMS0w_67b4e102-1f4b-496a-af19-abaa9189e304">318.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22cc0d7ae9e74ca8a9ff4d198d78501f_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC00LTEtMS0w_a932f9e7-dc8e-4332-9940-4ce4f88e6d97">935.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied817d099e4b480faed0980ac29438b8_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC02LTEtMS0w_533650c6-4be1-4809-bfd0-48a3b65e9e4b">149.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if128eb894bce4b3085c7eaa916a5bfb8_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC03LTEtMS0w_e2cf1387-57c5-4092-994c-755db44706e6">40.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfd76ed5cab498ab2ab0d727bb2b083_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC04LTEtMS0w_15e26ec6-175d-4678-9669-94ffac562008">190.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64a089977c64ec0b379ab8be5a289a0_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS0yLTEtMS0w_0091c686-ea2b-4996-aa91-745d12c3db24">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe9760506e145efb1273a91972bd7e6_D20201227-20210327" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS0zLTEtMS0w_019a7c43-fca4-4acb-8f6a-a03ab70f41b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a06780affc4452b0a0a9c31aecf31b_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS00LTEtMS0w_4793a6d6-0268-4902-aa24-06f7871f8a16">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic51d744e73d9470889480aef44867b64_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS02LTEtMS0w_8a5d29f7-208d-400f-ba29-9aa11ccf4818">15.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffa4cd943fc4ae697fcf28ee9dafa69_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS03LTEtMS0w_624ce350-0db4-4865-966b-2310d8ee2f53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id617caf99d314fb4a8f7f5fb37a854ad_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS04LTEtMS0w_1a99a69b-d337-4f1a-a18a-62e497d677c5">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb8417c24934037bf730f4f45fd1dac_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi0yLTEtMS0w_34fa77db-9e35-452e-bd5c-8854b3100374">705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic949542e55314c0e90e75d07a6a7cc95_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi0zLTEtMS0w_ac277fd4-0f17-4364-a53d-5e2fd16da412">359.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi00LTEtMS0w_e5e5e382-5a50-4671-9136-4eb960459936">1,064.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ca6cd87d9346f8b4d6b257b76f1599_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi02LTEtMS0w_62ec9f68-06e8-4c85-bb80-8be1cc855268">238.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9fc6529dcd456a8fe760d48006a3e4_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi03LTEtMS0w_95117953-3e60-40e6-be9d-895ab1a4bd78">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi04LTEtMS0w_df1a61c1-0cb1-4be2-8f96-e6ba432fb186">319.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c343532655149f1a030365f026ac439_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS0yLTEtMS0w_8ef00a2c-0734-4339-9e8d-ec692ff4b935">198.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0120a99d97456999e5ddc37d3d7309_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS0zLTEtMS0w_15f939d1-0aed-48fa-92bc-53c49b687fb0">71.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faa6d77c258415e86dcf4d8129eac6e_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS00LTEtMS0w_d936843e-7e8a-4308-86a6-87514a336cc9">269.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857265c2f31341619b24eb60b43b0fb5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS02LTEtMS0w_260e0636-9d9d-4e1b-896c-72de363a3545">186.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad34163568284cdc83c1e20070c4cea2_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS03LTEtMS0w_0d5e086d-4f91-4d31-a11c-210c56531c23">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7082eff3d7ef4efc80ee731afa776eac_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS04LTEtMS0w_50dfaeb9-2dee-4be8-98c5-cca8eb2b0d4a">250.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc01a3ba376e4dbcb32a1e598e325b13_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtMi0xLTEtMA_9882d9dd-6ed2-4a6e-90a1-b90dfbf8e74f">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f692bdf106e49fd9aaf7fce303fffe4_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtMy0xLTEtMA_c83c1ad4-695d-44ec-a594-a5aa3a540b0c">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3a06fe0c864a24885a1ba3a58df54e_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNC0xLTEtMA_1ac90d82-e9ec-44ed-94c3-c5e0b672a86e">66.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c810b9218b4cd4a2163bfaa2fb7c03_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNi0xLTEtMA_1f6d4997-7019-4b4d-a801-ed3277d8ead0">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942d891a356341019e4507b3365c2ba1_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNy0xLTEtMA_e9cedebd-6c4b-44d9-b00c-a1b08b26a1dc">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6e50b3ca2f146f9a5608d79b8d0845f_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtOC0xLTEtMA_d948a29c-f34d-4cdb-bd26-aad1e03dd92e">57.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d9a60d400a14336a1e90394d3d649fb_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItMi0xLTEtMA_cbb49f25-2aa5-49b2-903a-a8dbd05a5602">253.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8341e0c83b50432d92002e51dc1d415a_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItMy0xLTEtMA_a66d0de5-b739-41ca-9f82-69c5b3654c3c">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNC0xLTEtMA_be13dd62-85f0-4b9b-8374-0c3db49b3f46">336.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id259ac18b2c14a708dcfb664de4fede3_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNi0xLTEtMA_5f83c477-120b-4b2e-b80f-b86da7a343c5">234.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765b92cf3fcb456b940d23ea47f28bd0_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNy0xLTEtMA_644f2a3e-a047-4649-8a27-6edda2b7caaf">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItOC0xLTEtMA_dc958e22-a514-47d9-a0ed-a00778997301">307.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1725b5668d3e4a858551fd8eb7138677_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtMi0xLTEtMA_b677771d-0c71-4e73-bf45-ad8037fbd562">91.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb26cd5cf96841d99340d97a2844a812_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtMy0xLTEtMA_c378d4b1-0d92-41f1-bd3d-d5680835cb28">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNC0xLTEtMA_1cd8ec2b-6512-44bd-bfc0-162515e3c9e7">114.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce8a0b09e77488b9facc4bf5ffb533d_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNi0xLTEtMA_f203bf3c-3950-45c3-b869-caa7fb5b1e1e">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bbb18bc92ff4414b39e894a76fab932_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNy0xLTEtMA_946c21b0-be3a-449c-8a07-f9554425f8c9">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtOC0xLTEtMA_7751225b-afa2-4209-836b-dfe417157783">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231dbd6cca1f4e44b1648addc4f9b83d_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtMi0xLTEtMA_5635cc3a-5bde-4e45-9d70-0c8b740def56">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136ee5e50cad46c9878d11c256642bfe_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtMy0xLTEtMA_620cf09d-2538-4f3f-9865-8a914fb33ac6">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNC0xLTEtMA_28a50c44-9345-4789-af33-c7019409ef22">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ec62aff694cd984436a0315313b3e_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNi0xLTEtMA_b8540369-bd0f-4c1c-8564-0f645b1867f2">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921dfcf8a3d74f3c9e2967faea2a2c23_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNy0xLTEtMA_21397bd7-57ad-426c-9cd8-bfd4ad56c6da">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtOC0xLTEtMA_7f003961-51dc-4cd7-b078-f51d1dc53d30">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktMi0xLTEtMA_f7f440b8-95b6-4888-9c54-b60d49269d40">1,064.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e0e2bca7514b3c85c5bf5e035db201_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktMy0xLTEtMA_2b39b91c-d564-4640-a1d4-83c4088f8b22">473.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNC0xLTEtMA_e0958dae-9fc1-47a5-900a-ae78e5d805f3">1,537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNi0xLTEtMA_b9cfa1df-bb14-491e-a7e0-5a30497afa74">574.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c75b6298a974b8c93d3c5a118504b01_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNy0xLTEtMA_497d4042-478a-4a92-a549-7861eda8358f">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktOC0xLTEtMA_ee356dd1-4ad6-4ba9-9a89-53f019cf447e">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4f0fb353d74058a1441937e80c0438_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy0yLTEtMS0w_4de84d90-49c7-4867-b471-b39c4f5c9a59">156.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf735ef79384b248873abab375129b4_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy0zLTEtMS0w_6cddc522-5440-4062-ba3e-f5cb885f3b44">85.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie927f60bf6f24e25bfd16b54244ee885_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy00LTEtMS0w_a701970c-1bb3-4568-8e67-55f6754ac825">242.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9b232304f94408904a99c1ae44eafe_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy02LTEtMS0w_e6d6f1fb-a41f-4d82-8e99-807ea9ebf8d0">150.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f2ae3f5fa742d7a917b5c8ed7f9fb8_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy03LTEtMS0w_0d3bbfe7-7c1f-4165-a64f-3dd95ab92e37">83.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736988332f4142f9ac9feecbb79164b1_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy04LTEtMS0w_f6e6de0b-cff1-4d6a-881f-e111a8177912">234.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ddb6816eec49e8ab3f15d0f66f2334_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC0yLTEtMS0w_bce74ccc-dee2-4dbe-9c88-57ee09872f03">1,291.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78313136a484fd781c8813953a0cf7a_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC0zLTEtMS0w_5b4323c9-06cd-4a05-b2ff-4fded733515b">639.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i145a6fe21b194a67bef28af17d19bc6f_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC00LTEtMS0w_0d343df1-20ff-4dac-8d17-ab38a514f275">1,930.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i190143611a554923926b1ae36be81fda_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC02LTEtMS0w_fc7105bf-bd43-4434-82b4-e7da83b42332">291.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2269cd37c22f4b219c9519c04e7be995_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC03LTEtMS0w_4d080c5d-7d77-4680-aa9b-40cc0e411f43">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23b5154647642809bedb5594b430f24_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC04LTEtMS0w_6d8ef6d3-7124-4973-a1de-0df8cce6f5da">369.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba116bd00a7046bf8c91f0d6b892314b_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS0yLTEtMS0w_ca87aab5-41ff-44fc-a0a8-07b4e6f34064">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i995e19c951b14bfea6e4d26e9cd4d486_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS0zLTEtMS0w_85d2dcca-3c62-4d1f-92f4-1e4c12c23972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1c56aa05ee45ffafd1f1ffda0164a5_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS00LTEtMS0w_d6e895e0-496c-422d-8cf5-db37ecc345dc">20.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d6a37b17e74d0fbf1668eb8dcd7a91_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS02LTEtMS0w_6c701e2e-f396-4aad-8d5b-5696f49ed11d">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56dfdce3eb6d424d86b58122d2f5ee1f_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS03LTEtMS0w_008e1ba5-b6c9-477a-b582-ae2454302726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280feb419f2b4e1bbd5f84cbc2b56e78_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS04LTEtMS0w_9cd50424-ef61-4242-a647-a14e2d8f9e66">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a96273a62543e085fdd72cbb24282e_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi0yLTEtMS0w_a4ad6f2b-b6d7-4656-b956-a8f387307035">1,468.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65621f54c26c4015a221bacce5212e11_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi0zLTEtMS0w_e1c954b4-041c-4070-ad6f-dbe34500e6c7">724.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi00LTEtMS0w_c878d0f3-be3e-4081-8034-75135ffa64a3">2,192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7b7a78e84c49fc9efb0c922ae148a2_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi02LTEtMS0w_52de160e-bc83-46d4-8881-a8d516c1c30c">469.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b99b53db764f00a7bae9226ea58a55_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi03LTEtMS0w_6ff1af5e-c607-43b9-a2c1-ae79067e1224">160.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi04LTEtMS0w_6b4cf48a-778c-44d9-a379-b3211efa6e8a">630.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1996dc2670f44d885b459e6b7844ca1_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS0yLTEtMS0w_8b045927-f2b7-4371-bdc1-6c9d60f096c9">401.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7aea66c3b64c15aa4fc1fcbcd3ad08_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS0zLTEtMS0w_b1edaebb-386f-4d2d-87f6-3b601da3750d">136.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e20d39915246d8b5d89b9fedd7385f_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS00LTEtMS0w_1d243321-8820-4d3e-8d99-1396efba41f0">537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaacb7d97fbf041878e9f9f0a4f583432_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS02LTEtMS0w_f0de75a1-53ac-41e8-9a60-5579d86dd471">395.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f6361d96ee24d73b8046575850f64d3_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS03LTEtMS0w_9b04a7a8-2d87-40ea-8bfb-9b6a2927534b">129.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66008fadaf74341aed6338aed1d6e58_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS04LTEtMS0w_4bea4c3a-b281-4b7e-8f70-065a1fe2fd90">525.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a75015d04d4338ad7cfca21a6493a8_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtMi0xLTEtMA_d2a0eec6-b4a0-42c2-9d2a-d9f103ce9bb0">110.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20fc49c576e34cc69859aff92990662d_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtMy0xLTEtMA_e813ca72-a5f6-4866-94ff-24c7d06087f7">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7973bfa616db4dc483c4bd851ccb1a56_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNC0xLTEtMA_afb6bc2f-f981-44da-8955-755fc7a2b3b7">131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaa248859d134c8f8dcb2fb68862b1b0_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNi0xLTEtMA_b8d9da18-94a6-4674-a8a6-08bafa602f35">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274d4645da042b1bf61995fe9215df2_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNy0xLTEtMA_ff010210-a4bf-471b-acc5-8d6ce33c6dd3">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac781329d4b4af88611a402bc50fa21_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtOC0xLTEtMA_d3e03c10-f2c9-464d-b9f7-291bb8a77132">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c130431784f4c5b939e3a7eb06020d9_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItMi0xLTEtMA_ee4ae0f5-8901-4229-a550-5487a8d421d3">511.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e191d17f2624a8e81a271bf9ff484f2_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItMy0xLTEtMA_202f94a2-9194-4713-8703-b896abd17801">157.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNC0xLTEtMA_280478ec-f1e4-47c4-8c20-8146d055bcc6">669.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9c15aeb74a40068d4ecb624e590739_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNi0xLTEtMA_62786eed-083d-4e11-8a05-4bd0e41164c1">490.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425d67db4aff4b68954adb976a9fc71d_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNy0xLTEtMA_3c539884-cebb-4f97-ba3c-a6f357ceae05">148.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItOC0xLTEtMA_95ce9a35-27a4-45e9-b01a-9165b4ebc11e">638.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5450315dcdd74fee9c2c005920e5f504_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtMi0xLTEtMA_df3d3e98-17b7-4e31-b88e-e2740a88e08c">192.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1be8d9825a04deeaa24e83a941f2408_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtMy0xLTEtMA_7adcd239-b8eb-4fec-8140-5258cc719cc7">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNC0xLTEtMA_facd7111-44c2-4adb-ab31-58db211ecd09">238.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ab6df387644866a1e1f37f2257d845_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNi0xLTEtMA_2db60439-13da-42d4-bb88-7904c2b0e57a">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9617c714041343938ba7ef699d01cf6e_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNy0xLTEtMA_2efcb3d4-49f6-47b6-8b39-718d393ae3de">39.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtOC0xLTEtMA_77767863-dcdf-41cc-a30c-78a11f8d69db">224.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8973c410d7ec480da813338cbd127421_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtMi0xLTEtMA_e92ae872-37a1-4746-b530-2852d8397f1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54e7336610d4110af7dd72bfff88912_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtMy0xLTEtMA_ba49af41-d282-465e-b6e5-910f547020cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNC0xLTEtMA_3c79aa8f-710f-4137-82dc-6b90b53abe92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae83a94d7df432fa13620889d678fae_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNi0xLTEtMA_77506ac5-8796-4edc-9418-dab7274ed8e4">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5a0963e8a641ba8cb8cddc994ab7ce_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNy0xLTEtMA_d8a06f02-67c9-4a52-91bc-68a2eadec9b2">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtOC0xLTEtMA_698295af-9e50-47a7-bb23-3c05e0b79b14">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d453c23af194ce1aba1c816f84a132a_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtMi0xLTEtMA_9d90e369-1655-47ed-840d-49f88b1ad6bc">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6291de291de2479caa52ef9e87358c20_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtMy0xLTEtMA_430172ad-1373-41e8-b02a-3dd38703b6cd">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNC0xLTEtMA_28eda619-4d09-4561-bda7-313681975474">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5631a9f85ff741a3a15fdc5c8a9c57b9_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNi0xLTEtMA_511b6015-0263-47d4-8f5c-250e90e1c1db">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54761927cec14e1084e6842f2cc38ca3_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNy0xLTEtMA_b1bda767-9930-4e4e-92b0-407a4c378fca">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtOC0xLTEtMA_6fbf4bb8-6732-4547-9930-d8f14fd4f970">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktMi0xLTEtMA_03d02c2f-e1ed-4a15-8010-68f019b2606d">2,201.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d34e883adcf48439ad208f5fae59f1f_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktMy0xLTEtMA_5a8c22f6-5271-49e0-a4ae-ea923cc60c3e">945.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNC0xLTEtMA_708d1d9d-2337-4c9d-b366-e87c5883d83e">3,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNi0xLTEtMA_99496313-9cb6-4731-b7fd-154af8eb64d4">1,207.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd6b40e625a344d7a0f8da5f98f78b54_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNy0xLTEtMA_783e5594-e71d-4194-ba52-f7081ad5198d">399.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktOC0xLTEtMA_6280f345-a267-46c0-9563-a8c71ee0ee1e">1,606.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i907e2e279545466397e102c0122dfc18"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:30.358%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi0yLTEtMS0w_34a87f9c-4826-44c8-b0dd-d2131f14e38f">1,064.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi0zLTEtMS0w_ec557357-122e-4e19-96d5-9e9b2a41e640">574.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi01LTEtMS0w_60c03e25-963c-49db-9365-624869baee59">2,201.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi02LTEtMS0w_8f68a635-f33e-4a1b-b88f-7e7a5ce77764">1,207.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy0yLTEtMS0w_8aa9f846-5633-4c1c-b4e2-765fad3a3ba8">336.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy0zLTEtMS0w_4f79aca6-7e42-4a2f-9a6e-b0b136589d10">111.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy01LTEtMS0w_19663015-a0fe-45aa-b905-e344e93fb2d0">675.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98200202399d411bbdfbce88f2f94963_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy02LTEtMS0w_fe9b1041-9f32-4eb2-ba66-e91031bdcf50">221.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC0yLTEtMS0w_ffd02491-b957-4344-aaaf-b998453e0ec3">90.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC0zLTEtMS0w_3400020d-9fba-4229-baa5-517a2a30e6db">41.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC01LTEtMS0w_ca74b75c-9ca3-4afb-806c-c8481ced6be6">178.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC02LTEtMS0w_fe013bf9-c28b-45d8-9dbe-93e8b6b07603">111.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edfb836d2d449d190d430b4b98bdcfc_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS0yLTEtMS0w_1ad1f548-8774-4147-9484-161b4246644f">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bafcaa157cc4f9d9b98d3058f7eeebb_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS0zLTEtMS0w_cfcfc74d-622d-4f2b-9bd7-daec299ec1e1">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7997ee1de01404282896cf8569615c5_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS01LTEtMS0w_55a679a3-4877-429c-a493-4112ff5f3f12">92.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17cf60230e4e486ba1456a31ba6436af_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS02LTEtMS0w_6a735ece-9d44-4747-aa92-23af5eddb5af">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi0yLTEtMS0w_e937e86e-5987-423a-bb32-71c3bc608d37">1,537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi0zLTEtMS0w_f6cd78ed-ee8e-4eea-89ab-6b57f42fb864">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi01LTEtMS0w_742aa66f-2795-4069-a82e-5bc75a6419af">3,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi02LTEtMS0w_f29cbaaf-59c7-40cb-9be6-8b9f17b555dd">1,606.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:31.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fb351d8bbc4b2fa26f6615870eeb22_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi0yLTEtMS0w_af66284f-2d74-4532-934a-c6e3e9f87a12">1,178.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6757b7ae6a1b4d1294b382cd6f764364_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi0zLTEtMS0w_e6e497e6-9c8d-402b-8c46-422de91b1406">457.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32bcec04d2a142c7bd7b162f66b47ad0_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi01LTEtMS0w_d5b4f963-1234-4dd3-a6dc-1b81e4fd76dc">2,441.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26482dabb124918adc0604c2a60d13c_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi02LTEtMS0w_eb740e1f-b2f4-4f5b-8a68-d912820d4066">923.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f3b7da661c4ac082d4c50ea8fd4d7f_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy0yLTEtMS0w_78d451bc-0df3-4ba3-85f3-d1d1ef411823">200.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17dd3ec43b24fc5a2f910d62e42f2d2_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy0zLTEtMS0w_d7d74f58-96d1-4b19-89d7-ce31599668e7">166.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecac37f9117440f69e07c69f6c281b92_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy01LTEtMS0w_ef0f7c77-867c-410a-8833-00d5f7ea2366">392.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21cde2e619f4402f8c02912c9692b840_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy02LTEtMS0w_2b7aa2d2-8820-4701-b25f-187edb2a19e8">399.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd830b6572e0425dadd30a387a2f967d_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC0yLTEtMS0w_44d15bb9-df2e-4339-85aa-34b3fc22931f">141.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ffcc41a2144eca91b9b631142afd54_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC0zLTEtMS0w_5e718351-147d-4019-8cfa-75a4f11cfb6a">127.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7270d96442eb4541ad8022d39d4faa96_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC01LTEtMS0w_66df5740-8237-48fc-8cbe-b16595e590ec">278.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a971158920f420a836957e0f5793380_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC02LTEtMS0w_4e459b0e-1fc4-402a-a6ab-c37b550bb977">272.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d8b948617f4e3896d6b721b4c3de4c_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS0yLTEtMS0w_13d20854-0ee2-42d2-b9df-97a6dbfff925">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692dade7414a46f982273b0535c5635c_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS0zLTEtMS0w_be31acd5-8e3c-4bb4-8782-18caf3c81edf">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib847a33bcd64486598d58cc210134d1a_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS01LTEtMS0w_f38766a9-3cfd-4eba-a143-96b5d739dd2a">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8c6e16440945bcac1fc0101a8a1fa3_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS02LTEtMS0w_fea951f2-86f2-405a-946d-a7be263f1191">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi0yLTEtMS0w_f13b432f-3d7f-40b5-b6d4-b465e5970594">1,537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi0zLTEtMS0w_c67643e7-66bd-4ae3-9cb7-0872528d82d2">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi01LTEtMS0w_09138993-8961-4e1e-bc41-8019fb7f7b17">3,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi02LTEtMS0w_359e94ff-2615-4234-9c54-975efdf9678d">1,606.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the benefits of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over three to twelve month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that could cause reversal of revenue. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjA0OQ_00ff37ee-835f-435f-a6db-06bd94d118b8">749.8</ix:nonFraction> million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="if46e15e1bfd3413a999b55b314fd2cac_I20210327" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjI5MQ_530ace4f-2af2-4fb6-a431-b04361c93bfe">22</ix:nonFraction>% of this amount as revenue in 2021, <ix:nonFraction unitRef="number" contextRef="i3bd010f371544b988fa10466d658968c_I20210327" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjMyOQ_2abd9870-ad28-449b-a0e7-2ba40b543940">33</ix:nonFraction>% in 2022, <ix:nonFraction unitRef="number" contextRef="i182d5713bd6d47afae7e3dc66fab5669_I20210327" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM0MQ_6d2c7daa-6aa2-4415-903c-127eea062e3a">23</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="ief14d4f38aad49c6b6a004ccbac446b1_I20210327" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM1Mw_69dd8b2e-76da-47ff-a4d5-9460bb7a05d8">14</ix:nonFraction>% in 2024, and <ix:nonFraction unitRef="number" contextRef="ied9231b3ebdc44af8052059ea35f7d96_I20210327" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM2OQ_a184619c-a91a-4cbb-9174-e7f3e30d8db2">8</ix:nonFraction>% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the reporting period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUwMg_94fd4b05-4750-455f-8e2c-dda17607b405">30.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUxNw_cbb7c75a-7b63-49dc-8b3f-79908d409b1a">80.8</ix:nonFraction>&#160;million for the three and six months ended March 27, 2021, respectively, that was included in the contract liability balance at September 26, 2020. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNzc0NQ_58a73ee2-59b0-499d-95a0-916c95cba57e">26.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUzMg_a3c07be8-02bf-4c4e-8ce4-6b1ad766fe5a">77.5</ix:nonFraction>&#160;million for the three and six months ended March 28, 2020, respectively, that was included in the contract liability balance at September 28, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfMTA2Mg_5c45e558-bf4a-4364-8835-3cd2d875c6ab" continuedAt="id1ddddc98ae14f25a3d5ed7e461aa410" escape="true"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfMTA2Mg_c11210df-d8a2-4832-95ed-4213b48c83b3" continuedAt="icff92051f87b4d95bc474a292e536cce" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="id1ddddc98ae14f25a3d5ed7e461aa410" continuedAt="i49b1921fd5cf43dcb45afb989a6c51d0"><ix:continuation id="icff92051f87b4d95bc474a292e536cce" continuedAt="id04d0ed9c35e40348199cf33bea9a0c7">Lessor Activity - Leases where Hologic is the Lessor</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i49b1921fd5cf43dcb45afb989a6c51d0"><ix:continuation id="id04d0ed9c35e40348199cf33bea9a0c7">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than <ix:nonFraction unitRef="number" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfOTQ2_16c2b04c-d1cd-4231-afd3-b02da290a10b">5</ix:nonFraction>% of the Company's consolidated revenue for all periods presented.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_46"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzM4MA_c1bd8e71-b730-4394-81b6-fb0638ed5c9d" continuedAt="i35bad4dbb3e04c50b2edcffd0a7fd153" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i35bad4dbb3e04c50b2edcffd0a7fd153" continuedAt="i68b3c4797057486da63f87d0e53f3de1"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i68b3c4797057486da63f87d0e53f3de1" continuedAt="i25b923ad347a40429e855a65770d9d29"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzM3Ng_d3ec9398-06b8-4a6e-a1a3-7d7fec393d52" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at March&#160;27, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:37.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb420ef6cfc84582bf032f47d6a027bc_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS0xLTEtMS0w_9a3bae98-d30e-4eff-a6c9-d2ace580528e">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a5fc5bf9d241f8b4cb0d73a7fec6cc_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS0zLTEtMS0w_f88445f1-f240-4e1d-8010-a50aa1679084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2734474741b84d60825585c9ac1c91f5_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS01LTEtMS0w_4be869c0-2a31-4e87-af47-c3bce8dc8eba">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46916ca5297d4242bef1fa39c66d7e97_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS03LTEtMS0w_b1940142-27a8-4582-b18f-4fdefae7abbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy0xLTEtMS0w_540145f2-96a3-431a-a320-936b240a09c4">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6010a3ff92e436b8c62582e9e6636cd_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy0zLTEtMS0w_8bac669d-e80a-403b-b68e-770b8fe58130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy01LTEtMS0w_d5df74b9-8516-407d-bcaa-cf85fcdde684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1637c5182047b68c601bf5077bf90c_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy03LTEtMS0w_eb667d3b-cf40-4af8-877c-91d4c312b5c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea5abde7d1984b098731ea86ba1d2df4_I20210327" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS0xLTEtMS0w_ac08a450-7248-41d2-be5f-af5e7d906d58">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e512ddea06f4f369efec1ac01a1f83a_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS0zLTEtMS0w_c794ce79-c8e0-4d37-8106-7f2b1ce778e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11affe9143244d30961013f4deced4e9_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS01LTEtMS0w_93ae5c89-7b84-47aa-a452-54ba2003091a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0083bdc783434585b6f36d4e8c4070_I20210327" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS03LTEtMS0w_e50ed49b-66a2-4574-b486-bb46902fa39c">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411f528b6c8248d19b4b06059ce6bcca_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtMS0xLTEtMA_d81c93e8-2df6-4f3a-b58b-962ce263085b">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie108ffe2f2254cc596ceea6a1cd09226_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtMy0xLTEtMA_c9084a8d-9978-4a90-b8b3-11dfa0afb36d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d2a977915524e99a25863296c0eccea_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtNS0xLTEtMA_84adce18-1f20-479c-8b9b-d2fb91fbc007">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04083b4b022e4637936c0abcc453bb78_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtNy0xLTEtMA_d98f240b-6116-4685-95e1-c1f175ff0df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac27ddf7a3c42c6973c1c345f1d6188_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtMS0xLTEtMA_1abc6b63-bba2-4f20-b601-1c8d90877df7">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee78cb2f382242a08b2526f42f5e8853_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtMy0xLTEtMA_2e900847-a0ad-4dd7-9a9a-419f4278fb90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97ef3233317455a9da5ec9463b03856_I20210327" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtNS0xLTEtMA_5d1529b0-8aaa-4b6d-8042-07b85f68493a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ed7e22fc59649ab8ef2826b21239f52_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtNy0xLTEtMA_b05ac325-a117-4ec4-92e9-3433fd46af0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItMS0xLTEtMA_fbf67b75-a949-401c-87e3-f7b790454255">99.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6010a3ff92e436b8c62582e9e6636cd_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItMy0xLTEtMA_b06db864-997b-416c-a33b-8e855cd4b513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItNS0xLTEtMA_4ccd477f-7892-4110-9b0c-ebc8d888d0d5">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1637c5182047b68c601bf5077bf90c_I20210327" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItNy0xLTEtMA_598ccccf-df77-4501-9be7-239bdb5356b0">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended March 27, 2021 and March 28, 2020 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:6.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi0yLTEtMS0w_6c40832d-5eb0-4bb1-a436-1da9e0f3d955">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi00LTEtMS0w_b8bee9b9-66fb-4fc7-adeb-6e7d35cce3c9">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi02LTEtMS02Mjcw_de42f989-18ba-4e67-b96d-1bf226aca41d">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi04LTEtMS02Mjc3_9f85da77-8ac0-4dbd-b62a-d12b16f0acd0">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy0yLTEtMS0w_a164794f-56d1-4eb7-a2f1-f6dcc2479cd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy00LTEtMS0w_ba0860b3-c37c-47e5-9561-38947eebff2a">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy02LTEtMS02MzMz_c56c269e-a244-49d5-a4fa-370e87ad6bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy04LTEtMS02MzE4_e3a8c074-ef6d-44b8-a50d-1c72dbf27711">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC0yLTEtMS0w_61772224-5f2f-4c24-b762-d846e343cb34">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC00LTEtMS0w_4d6b3422-427d-4e7b-b699-3d8a877bfb4b">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC02LTEtMS02Mjg4_f9b74c72-4704-4d2a-aade-504f29c6baf0">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC04LTEtMS02MzIw_37f2eb71-c24a-446c-83ac-ee858ddff758">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS0yLTEtMS0w_218000cc-6113-4c6a-8b0a-4b2e14e5a9ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS00LTEtMS0w_3a24f0b3-9328-4fed-ace7-4d287939b609">9.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS02LTEtMS02Mjk1_6bee01c2-7d3e-4577-8bfb-19bf419aa148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS04LTEtMS02MzI2_bb102792-766c-4c75-b0b7-8a20e23951b0">9.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi0yLTEtMS0w_ab81fffd-5d07-49de-8b8c-2ae495ce13f4">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi00LTEtMS0w_7ed997de-dd7d-47d8-84e3-5e774bd9eb32">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi02LTEtMS02MzAz_22a5ecfb-4a49-4c54-a658-0d563a01fedb">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi04LTEtMS02MzI4_cbdd37ea-74f6-460a-82b1-38159a1e39a5">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ie0c62e4c25694a3cbdeaeda3e071ac2c_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMTcxNA_02e03b04-3e9e-4ae0-b152-47fdeb9af51e">30.2</ix:nonFraction> million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i25b923ad347a40429e855a65770d9d29">Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $<ix:nonFraction unitRef="usd" contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMjg4NQ_a11ace27-013a-4b32-9d76-482ecff9a7d0">1.4</ix:nonFraction> billion aggregate principal as of March&#160;27, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $<ix:nonFraction unitRef="usd" contextRef="i792a247ac57f4a1089a48d766d5774c8_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzE3Mg_8a6c57d1-3e6f-4cbe-b693-acd7c0a4351f">421.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i13ed6c8444b04ecbaf65664fe32f3d62_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzE3OQ_29782ffe-8837-4399-8946-9f013eee3d9f">932.2</ix:nonFraction> million, respectively, as of March&#160;27, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#8217;s debt.</ix:continuation></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_52"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfOTQ3Mg_0e076a8e-b0c5-4a69-948f-103d8b23f32e" continuedAt="i5b5f28f25c0b47659527d024a832e066" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="i5b5f28f25c0b47659527d024a832e066" continuedAt="ifdf4c9608a9b447e8284f7650a29062b"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2021 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkwOA_81ae4524-2683-4a76-bb6e-8bebb8ab40eb">232.5</ix:nonFraction>&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's consolidated statement of income and within service revenue in our disclosure of disaggregated revenue in Note 2.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkwNg_1f11ecdb-d4fd-4ee7-a130-6c1c074a7854" continuedAt="ie84374ca7a244d1e8e4f5742a02d801b" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMS0yLTEtMS03OTEw_839bd759-c7f6-4219-98ed-162957c83674">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMi0yLTEtMS03OTEw_aae7ee7b-acd0-4f54-b141-e4da5326dac1">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNS0yLTEtMS03OTEw_8282bbb8-717b-4716-a21d-2b56db6ae8dd">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNi0yLTEtMS03OTEw_fee4d564-002c-4ea5-a441-b4a14940d14b">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNy0yLTEtMS03OTEw_745e1724-ca39-426c-9970-ed40dd83d89b">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfOS0yLTEtMS03OTEw_1c59bd12-76d4-4ac0-87a6-37bb08ae6112">160.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTEtMi0xLTEtNzkxMA_f13443d2-1108-4e2a-869c-a68d82bde1ee">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTQtMi0xLTEtNzkxMA_566da1af-7ce1-482e-bff5-5935a3fb5381">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTUtMi0xLTEtNzkxMA_489d18cc-d250-4ac0-b97b-0a59f7f8c9de">85.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTYtMi0xLTEtNzkxMA_05d52a5f-68a9-45d1-932b-1c01b8bb62c7">232.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranotics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkyNA_09a92d8d-6bd8-43e3-abd8-ef2cdc9c2058">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkzNw_0281ac40-eb3f-4d29-bd5c-896af2658394">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="ifdf4c9608a9b447e8284f7650a29062b" continuedAt="i810c617a1a05458da78d83715a1d85a5"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i3f9778c427b44c7882e336e11228595a_D20210301-20210301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk1Mw_d735430d-7ab3-4741-be05-4b108ad4e703">153.4</ix:nonFraction>&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="ie84374ca7a244d1e8e4f5742a02d801b" continuedAt="ia6a31a2fda5348b2aa560fd79668f4ed"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMS0yLTEtMS03OTQz_84dbf0d3-f977-449b-8e70-668f989e1039">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMi0yLTEtMS03OTQz_bc4436cc-2830-4a2b-8fc9-97bb13aca0e5">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMy0yLTEtMS03OTQz_a5dfc416-dcb0-4bb0-b634-1180732e3dad">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNS0yLTEtMS03OTQz_f7c451a4-c79f-4386-bbe2-d3252fd2c19c">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNi0yLTEtMS03OTQz_7d7f98a3-53ce-4947-84a8-2a38caca0f1a">9.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNy0yLTEtMS03OTQz_a2499a8f-8a22-477f-b1de-03c06ccc354c">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfOS0yLTEtMS03OTQ1_c56adf40-e280-4c2b-ac73-03fa40ada589">69.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTEtMi0xLTEtNzk0NQ_e751148c-d680-4a19-bf18-807e333ae1bd">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTQtMi0xLTEtNzk0NQ_7012e7d2-1a33-4014-9a2a-a3b61f915b4d">19.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTUtMi0xLTEtNzk0NQ_922c2c69-37f5-4082-9849-a81f867895c4">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTYtMi0xLTEtNzk0NQ_a69b57ae-2bd6-40d4-8caa-e39107252f1c">153.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i2161ff7d37284a2dbbe1f9d7e633bc5c_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk2OQ_faa64ab3-1ab2-4446-a4c7-5439ac7abf4c">14.5</ix:nonFraction>% rate for developed technology and a <ix:nonFraction unitRef="number" contextRef="i435467f75e1440c58e0143cfcc330473_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk3Ng_85dc1a8f-18d9-423d-a105-8493fa591be3">13.5</ix:nonFraction>% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is <ix:nonNumeric contextRef="i3f9778c427b44c7882e336e11228595a_D20210301-20210301" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk4OQ_06efdf4d-9f41-41f9-bdf6-58c5976b5282">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2021, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i0181482365764743a89827be06286048_D20210104-20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAwMg_25c43ceb-f639-43e0-8e41-08c63d0a6c06">62.8</ix:nonFraction>&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $<ix:nonFraction unitRef="usd" contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAxNw_5626e0f4-6464-43fb-b2a8-a48be7602301">38.0</ix:nonFraction>&#160;million to the preliminary value of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAzMg_c9d34511-0fca-4498-a89d-da128e10fc98">1.2</ix:nonFraction>&#160;million to customer relationships, $<ix:nonFraction unitRef="usd" contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA0Ng_9b6b3dd3-c419-4f34-b9ff-0e4a55df4ac8">0.9</ix:nonFraction>&#160;million to trade names and $<ix:nonFraction unitRef="usd" contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA2MA_6489b4aa-d870-4488-8167-36db5273562c">32.0</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA3NQ_59e65b93-122a-4023-a0dc-c4ec872f6e9b">9.3</ix:nonFraction>&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i810c617a1a05458da78d83715a1d85a5" continuedAt="i3495aeefc2d04f1cba7c9f2129c1e306"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i7426f16cedf841448aae7ae840121295_D20200928-20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMTA5OTUxMTY0MTExNA_92e98df8-6e0c-43f8-aabf-01d360e26ff9">5.6</ix:nonFraction>&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="iaf6cae33a60643238b5a53b8e12438d0_D20200928-20200928" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMTA5OTUxMTY0MTM4Mw_6f2e2f44-f148-42f5-bdb3-9eb09aa35ddb">5</ix:nonNumeric> years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2020 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzEw_ea5a6a1a-8b0a-47a5-865e-6285c392304a">161.3</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="ie9edcaeb855249e29f00eca57f1ce93e_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzQ0_5d86c05c-4402-4962-b884-d2146640e997">3.0</ix:nonFraction>&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $<ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODU3_cf13d7f9-eb11-4d4d-9967-17797d043fdd">81.8</ix:nonFraction>&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a <ix:nonNumeric contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823" format="ixt-sec:durwordsen" name="holx:AnnualIncrementalRevenueGrowthPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfOTQ2OA_9b2ab7e8-200a-47a0-874f-f5489d1acb0b">three-year</ix:nonNumeric> period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the three and six month periods ended March 27, 2021, the Company remeasured the contingent consideration liability and decreased the contingent consideration liability by $<ix:nonFraction unitRef="usd" contextRef="i3ca8eccdc4f847d0aeb6a2cca823b5f3_D20201227-20210327" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA4OQ_f51b1eb5-2de3-40a3-9b0b-55286deb1c17">14.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9dd0231067df452087445e7fbabe93de_D20200927-20210327" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODEwNA_36940b0d-cc22-4e10-9a61-a4641ba66bda">10.1</ix:nonFraction>&#160;million, respectively, to record the liability at fair value as of March 27, 2021. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ia6a31a2fda5348b2aa560fd79668f4ed" continuedAt="i612651f9520b404d910e80ed07a605b7"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"></td><td style="width:7.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMC0yLTEtMS0w_beeb458a-a052-4410-ab77-c5e2606a65b0">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMS0yLTEtMS0w_797032d0-fe34-4e06-ae3f-e3dc050f16e7">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMi0yLTEtMS0w_25daa91f-2a73-4fca-bc60-1cd850ca3003">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMy0yLTEtMS01MTgy_bb273bd9-0b63-4cc4-a99d-23c7d59a2af3">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfNC0yLTEtMS0w_f6c0c4de-3dc6-4059-ac03-0ef80b0c3065">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfNi0yLTEtMS0w_1238e88a-1150-4d74-8689-9e6fe26bbd9d">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfOC0yLTEtMS0w_3b073546-b18f-4c14-9242-891e413c2379">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfOS0yLTEtMS0w_30a04dae-3a11-499d-b23b-902cea979423">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMTAtMi0xLTEtMA_f7364af7-87d2-4e8f-964c-3c7cef4d5910">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzQ0NQ_cdf22860-8677-4f6d-9fee-ea323ddc592f">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="i617c581a0868425eaa81de8cdba59691_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzc1Mw_8ca838a7-5795-4a7d-aec1-be70630605b0"><ix:nonNumeric contextRef="if077f38ecd2c48708cc0f3b18a2b893e_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzc1Mw_c84267d0-1078-4de2-94bc-bf4ef306c544">10</ix:nonNumeric></ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i3495aeefc2d04f1cba7c9f2129c1e306" continuedAt="ia36fc128ca514ec78b24af7f754fab31"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i7de817e6de5942b5bda9b79a83fe36ea_D20200203-20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDQzNw_69131652-6b98-492d-ac20-b6d203c81b45">19.7</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i4af1ff49936044139ca360cf68be0400_I20200203" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDQ3MA_aacb7dc0-ad58-4980-9c36-28dc60fe9421">2.3</ix:nonFraction>&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $<ix:nonFraction unitRef="usd" contextRef="i4af1ff49936044139ca360cf68be0400_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDY1Mg_ca5aa65c-4db0-4bde-9947-7bf9e28e7b95">10.7</ix:nonFraction>&#160;million to developed technology and $<ix:nonFraction unitRef="usd" contextRef="i4af1ff49936044139ca360cf68be0400_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDczMA_46067d81-93cd-43d1-8b57-4975a7d545c3">6.2</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i4af1ff49936044139ca360cf68be0400_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDc2MA_4c5b57ec-3205-462e-ab19-bba1ef46d433">2.8</ix:nonFraction>&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ie858e36180d444f9b36ec6e99f4ec80c_D20191230-20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTI3Ng_4a3c4375-a514-4b43-b0d6-7c3f7e20ea47">18.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="if549c33be4504150b2d638a7c2ab1792_I20191230" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTMxMA_9ea246ea-a7dc-40b3-9b38-53e51cd4ef58">1.0</ix:nonFraction>&#160;million and contingent consideration which the Company has estimated at $<ix:nonFraction unitRef="usd" contextRef="if549c33be4504150b2d638a7c2ab1792_I20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTM3Nw_04b46c31-5cfb-43ea-8b33-27acb9eb86f9">0.9</ix:nonFraction>&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="i60c529de5f984b318d75f347b0e4df65_D20191230-20191230" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTcyOQ_503ae42c-6baa-4e28-afed-5475181df62f">5</ix:nonNumeric> years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased <ix:nonFraction unitRef="number" contextRef="i3b8f228b16744f66922f21381cb7e421_I20190801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTc5NQ_ff43b528-ca76-42d1-9f10-8b696696354f">46</ix:nonFraction>% of the outstanding shares of SuperSonic Imagine ("SSI") for $<ix:nonFraction unitRef="usd" contextRef="i2bae2329807348b380f218edb5d9aa9c_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTg1OA_36a9b20f-fc40-481c-8cec-12ebd486acdf">18.2</ix:nonFraction> million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;<ix:nonFraction unitRef="usdPerShare" contextRef="ic0360e3cd8884f838b4339be49501e41_D20190901-20190930" decimals="INF" name="holx:BusinessAcquisitionCashTenderOfferPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjEwOA_fdd42338-1bd0-4d49-b005-3c463f7210a3">1.50</ix:nonFraction> per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded <ix:nonFraction unitRef="number" contextRef="ie9f6eb5453d7428e9d35cb9246d2bd17_I20191120" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjQyOA_ca6b4108-021d-4199-85eb-4e420edec908">50</ix:nonFraction>%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional <ix:nonFraction unitRef="shares" contextRef="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NA_65d03eb2-b249-4723-80ff-3547387b9a16">7.6</ix:nonFraction> million shares of SSI for $<ix:nonFraction unitRef="usd" contextRef="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjYxNQ_ee1955c2-1dc2-42cd-b54e-7b88f3a37951">12.6</ix:nonFraction> million. As a result, the Company's ownership interest increased to approximately <ix:nonFraction unitRef="number" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="2" name="holx:BusinessCombinationOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjY5Mg_fa52042d-ab43-4641-88c4-3cb804a8f5f2">78</ix:nonFraction>% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of <ix:nonFraction unitRef="number" contextRef="i3b8f228b16744f66922f21381cb7e421_I20190801" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzEwOA_81dafa50-7051-4826-a465-f1efff13d494">46</ix:nonFraction>% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzIxMA_57f07831-24e0-4b0d-bd76-498a4f0daef7">3.2</ix:nonFraction> million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $<ix:nonFraction unitRef="usd" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzI5OQ_ceed993f-423c-49c0-8fa8-706b095b47d8">69.3</ix:nonFraction> million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzMyMg_b1ce6854-1f8d-4d51-9b91-3b8dd3b9f0d7">17.9</ix:nonFraction> million for the equity method investment in SSI, $<ix:nonFraction unitRef="usd" contextRef="i304fc8df211141afae93e91cffb8fe19_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzM2Ng_350c647c-30fe-46ac-9ebe-a4f8a59d31a2">12.6</ix:nonFraction> million for shares acquired on November 21, 2019, $<ix:nonFraction unitRef="usd" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzQxMQ_1cf2d5ef-f4de-473f-8a60-79b4b5dcd9d8">30.2</ix:nonFraction> million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $<ix:nonFraction unitRef="usd" contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzU2MQ_5e22771d-27ca-4576-8e78-f3da69095015">8.6</ix:nonFraction> million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional <ix:nonFraction unitRef="shares" contextRef="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODMwOA_723b5690-8d60-437c-97e8-d78c121e604b">1.1</ix:nonFraction>&#160;million outstanding shares in fiscal 2020 for $<ix:nonFraction unitRef="usd" contextRef="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODI5NA_ae323317-3ef0-4d95-9df0-f24c16a1a83d">1.8</ix:nonFraction>&#160;million, and as of March 27, 2021, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="iae67d1fe265e4f30b9319216ed36d801_I20210327" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzgwOQ_5428891d-99f1-4d41-a91b-569afe4d7de0">80</ix:nonFraction>% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i612651f9520b404d910e80ed07a605b7" continuedAt="ia372056ef96e407cac1cdbdc2e622ae9">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="ia36fc128ca514ec78b24af7f754fab31"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ia372056ef96e407cac1cdbdc2e622ae9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:78.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMC0xLTEtMS0w_b4dcc9fa-1304-48ec-8893-b6c641d85e52">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMS0xLTEtMS0w_ed7ab451-e5a8-47ad-804b-4f1590d12abb">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMi0xLTEtMS0w_0e40c558-7679-4908-902f-6f62619ba2f4">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMy0xLTEtMS0w_a8de70de-4c3f-4cf9-a59f-ccb381dec4ee">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNC0xLTEtMS0w_c835aad4-55a1-49c7-b00c-53ff18448f65">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNS0xLTEtMS0w_da8102a0-cab9-4959-b76b-a83ccd647200">24.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNi0xLTEtMS0w_1832d769-c467-487b-bccb-2b43e385ccb3">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNy0xLTEtMS0w_599ebf17-dd29-4223-b4ee-303724d8b26c">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfOC0xLTEtMS0w_59fb0553-0d62-490f-87c4-f644a3aecada">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTAtMS0xLTEtMA_cd7f0ab9-fedd-49a1-a4fc-136630eab77d">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTEtMS0xLTEtMA_155dd2a2-6979-4c93-a3c5-27587982e57d">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTItMS0xLTEtMA_1ea828ce-6f40-42dc-a652-f88ce0a2ca06">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTMtMS0xLTEtMA_d8852cb9-7986-42b0-992d-5f8a802d6e21">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTQtMS0xLTEtMA_c01482d3-2d38-4d51-8b24-00c1db4db542">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTUtMS0xLTEtMA_e05d82d5-bfba-4d9b-b842-adde480b3d97">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="3" name="holx:FairValueAssumptionDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODU5Mw_d5a43f6c-da74-47ea-838f-8dae94f6e23d">12.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is <ix:nonNumeric contextRef="ia6b0c817b1c74f18a87cbf0cda7cd036_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODg5Mg_8e26388a-cad3-49f2-becd-50c87bab64c1">9</ix:nonNumeric> years, customer relationships is <ix:nonNumeric contextRef="i96962f8c6503408c97e137b4ff6b485d_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODkyMg_e4a8ef60-37d3-40dc-9b0c-47db01cffe9c">9</ix:nonNumeric> years and trade names is <ix:nonNumeric contextRef="i985c7e4ecc8945d29a5d65e3cacc1ebd_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODk0NA_bdc94cef-79d3-41ec-92dd-6f64b5f72985">8.6</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div id="idb3695e9835747c6b3438a7b262e54ea_58"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) <ix:nonNumeric contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjU5NQ_5986dd71-a294-4e75-baa3-6daaad9a066c" continuedAt="ic56d6e93e93f4f638705050bb8e1db31" escape="true">Disposition - Sale of Medical Aesthetics</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="ic56d6e93e93f4f638705050bb8e1db31" continuedAt="i87f5e40e79eb4bd68f7d2b55767a6334"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$<ix:nonFraction unitRef="usd" contextRef="i47bae11f6c164f1fba7c9157ff4bdaaa_I20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjE3_b4b01b98-0472-4644-8d93-cbda8ea1fae0">205.0</ix:nonFraction> million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic07ffd9a39b1497facd26bd931d9a0b6_D20191120-20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMzQy_49ebe28f-c507-4518-9aa4-9f7c475bbecf">153.4</ix:nonFraction> million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $<ix:nonNumeric contextRef="i3c59ec3344504f85a8c3c6bf6b0a9e13_D20200628-20200926" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfNTI0_73dca631-43ee-4dd0-9e18-86b18992e989">150.0&#160;million</ix:nonNumeric> in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $<ix:nonFraction unitRef="usd" contextRef="i6e0da39af5cf4280a9f5c65fb51b024a_I20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:IndemnificationLiabily" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfOTEy_4d315c98-2a5d-4e91-b8ab-228625334cb1">10.9</ix:nonFraction>&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMTg4Mg_891e6c06-1a53-4077-a47c-e1f6477a3526">30.2</ix:nonFraction> million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $<ix:nonFraction unitRef="usd" contextRef="i7491822dd55f413ea8c24c98a7aa72d5_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjAwOA_a2e23748-edcb-40a2-a247-c38ccc63874b">25.8</ix:nonFraction> million was allocated to cost of product revenues and $<ix:nonFraction unitRef="usd" contextRef="i3a56920a822e4f1fa2a21d3567b1df3c_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjA1Nw_79325238-8aee-4a2d-8e33-b88c81128250">4.4</ix:nonFraction> million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjE3MA_6a3cf3e4-d0c6-4c5b-848b-c2ef65d5ec75">46.5</ix:nonFraction>&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87f5e40e79eb4bd68f7d2b55767a6334">primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first and second quarters of fiscal 2021.</ix:continuation></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQ0MA_2d1308cd-bf95-45ad-b653-809756275ee6" continuedAt="i1a60668cbc4c4f919d1ffa1cc7871b18" escape="true">Borrowings and Credit Arrangements</ix:nonNumeric></span></div><ix:continuation id="i1a60668cbc4c4f919d1ffa1cc7871b18" continuedAt="i0830b907d2364a9aaaf4798131e609a6"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQxNQ_001c3add-1720-4b24-8a0f-336ba4dcc550" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469614de5d734baeb90118c04073db54_I20210327" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMi0xLTEtMS0w_96ecec5e-50c5-467b-ba08-9f15950f9b69">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMi0zLTEtMS0w_a8d83022-d607-48a6-be18-c493d9eb42df">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMy0xLTEtMS0w_fff340b0-6cb8-4f59-8129-b961745412a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie330a629ad37467d89cd606e0af17679_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMy0zLTEtMS0w_f00c7eb1-04d4-4656-8ff9-855572c73cf4">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfNi0xLTEtMS0w_47a56c60-fece-47d1-8d8e-fec68501ee07">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfNi0zLTEtMS0w_c37a7909-5514-4320-899a-fc2c3a6c62c8">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469614de5d734baeb90118c04073db54_I20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfOC0xLTEtMS0w_c4ee7665-9c94-480c-9eb8-62b1c0e07cee">1,343.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfOC0zLTEtMS0w_fcf39c80-6d51-42c2-948b-608f4d2457fc">1,379.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3bea13b544c4f13b09760c5c6e726ba_I20210327" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTAtMS0xLTEtMA_1f7b585c-bcb4-482b-b607-ce6d4b169946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id15b184ad14442c987ce0303bbedd19b_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTAtMy0xLTEtMA_39c92886-f66d-42dd-9447-edfeb056d271">939.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTEtMS0xLTEtMA_4e4faa28-d47b-43ab-af6b-41bff7ceada5">395.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47d3d66108d5494eaf7a55ca46e00d87_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTEtMy0xLTEtMA_bccd1436-0f88-4e7d-b854-d225b930056c">394.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ff68ab585743f5bd2a75882d831360_I20210327" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTItMS0xLTEtMA_ec451138-331e-404c-b988-65624766aad2">933.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9cffcc6d27f4a828ad2f580a9df3cbd_I20200926" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTItMy0xLTEtMA_3cb73ea3-81e7-40db-869b-dd9cca528070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTMtMS0xLTEtMA_8bb4c781-b3b4-44cf-ac49-6f8c8bb58f89">2,672.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTMtMy0xLTEtMA_df7d6c4c-0b4e-4b6f-b3ac-cbb85643ec3d">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTQtMS0xLTEtMA_1a24e65e-958e-49d0-8842-10f0dfad8060">2,747.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTQtMy0xLTEtMA_8ccf4282-b100-4ebb-9b00-cc935eeb08b5">3,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of March 27, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $<ix:nonFraction unitRef="usd" contextRef="i469614de5d734baeb90118c04073db54_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfODAz_d0ea5fca-61e9-4957-854b-29925add9b47">1.4</ix:nonFraction>&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was <ix:nonFraction unitRef="number" contextRef="i723b2fa7383c40148a7b8c9527df6ddc_D20200927-20210327" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfOTQz_dde551e8-5c02-4cdc-9721-3e29c0a77697">1.00</ix:nonFraction>% as of March 27, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $<ix:nonFraction unitRef="usd" contextRef="i1d4c152cb32642be87eab1b00b94cdf0_I20181217" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfOTk1_786475f6-ae86-45c6-8cec-73f7270fe321">1.5</ix:nonFraction>&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of March 27, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i18b2329bbd884176a354e0fd702f2ff9_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTM0Mw_d9ad9bfb-1dcb-4c1a-aa9c-b08cb8793b69">750.0</ix:nonFraction> million under the Revolver, $<ix:nonFraction unitRef="usd" contextRef="ic1975b32bc204e5683343cfb111a310b_D20190929-20200328" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTM2Ng_9dd357cf-11f5-4e86-9b0f-1bad517e33f4">250.0</ix:nonFraction> million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="if3392dcaea61411f8afc5b0dcf1dec2f_D20200927-20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTYwMQ_fc2e1842-90e7-48da-a9fc-19ebaa4d0b6f">250.0</ix:nonFraction>&#160;million. As of March 27, 2021, the full amount of the Revolver ($<ix:nonFraction unitRef="usd" contextRef="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTY2Mw_802d5e09-2c7d-45e4-9739-049635cf935a">1.5</ix:nonFraction> billion) was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQxOA_70c55e14-9be7-484c-8871-45f702288d07" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi0xLTEtMS0w_05e436ad-aae7-477a-ad58-e7cfb6476c66">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi0zLTEtMS0w_de82dd7d-5a28-4058-9c10-26a1697f2c60">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi01LTEtMS0w_7e842fc4-bf85-4511-bef8-07208e397a12">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi03LTEtMS0w_0ca86494-4c6b-4d50-a8e1-e5778177091f">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy0xLTEtMS0w_73e848e3-4fe3-4010-b805-bb6808c22f57">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy0zLTEtMS0w_d4676d3b-2c49-4a27-95aa-5f929a32e614">2.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy01LTEtMS0w_ecfc9d95-666c-4610-b658-293697320a27">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy03LTEtMS0w_a32178ea-9d10-4e6a-85a8-d5963eda140d">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC0xLTEtMS0w_f5099d17-83ab-42d5-b60e-de574a421ed6">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC0zLTEtMS0w_83211a4c-28a5-4c8c-b603-1e5a33ac8a4a">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC01LTEtMS0w_75bdac0f-e3e9-4916-b456-864096eec3d8">1.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC03LTEtMS0w_f3415fcd-a8fb-418d-b07b-5654b62eb075">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of March 27, 2021, the Company was in compliance with these covenants.</span></div></ix:continuation><div style="padding-left:72pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i0830b907d2364a9aaaf4798131e609a6" continuedAt="i7acb7fecb9534db08822f46429f6bd5d"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjI5Nw_e22676d8-6ee3-4b5b-819e-101a662cc32f">950</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjMzNA_8877124a-c7a1-42ef-be82-d65efaabc974">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjQwOQ_2cc8607c-6c68-415b-9838-2db8b305905f">100</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its <ix:nonFraction unitRef="number" contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjU5Nw_d11ff5a3-cd91-400c-b0f8-57de46aed166">4.375</ix:nonFraction>% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i091fabb2fcfb4658b0d9f415869cc240_I20201015" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQyNg_63f20246-601d-4418-b960-6b7d870da994">950.0</ix:nonFraction>&#160;million on October 15, 2020 at an aggregate redemption price of $<ix:nonFraction unitRef="usd" contextRef="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjc0Mw_15dddeb4-e555-4c7f-9554-9123951621d5">970.8</ix:nonFraction>&#160;million, including a premium payment $<ix:nonFraction unitRef="usd" contextRef="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="holx:DebtRedemptionPremiumPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjc3NQ_5cd678c0-2ad9-4bb2-aa1f-cd0c098aa906">20.8</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjg5OQ_095206ff-f5ad-4521-a646-ccd87dcedf31">950.0</ix:nonFraction> million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $<ix:nonFraction unitRef="usd" contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzQ2Ng_090b6c0a-0559-4d56-a53a-36222c6d142e">21.6</ix:nonFraction>&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $<ix:nonFraction unitRef="usd" contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzgyNQ_560fd4f8-b158-4559-96dd-0a5438c3bef9">5.8</ix:nonFraction>&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzkyMg_85f1fbca-4e97-4137-bebb-83a9227ec115">7.9</ix:nonFraction>&#160;million and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzk0Ng_64a69b9b-79c3-432b-8b5c-236706a3e6e3">6.4</ix:nonFraction>&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the Company had <ix:nonFraction unitRef="number" contextRef="i6f8b998b09854bb695d9efc1050df7c4_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDEwOQ_49417f1d-cbd3-4ef2-98a8-3a46463cdecb">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDIxMA_7323cb5b-5b07-4e49-b291-a73a2ee89c15">400</ix:nonFraction> million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQzOQ_fed16434-cb19-41a1-89be-592375449a69" continuedAt="ifa1a080c9cf2432b96e2a9dc98075cc3" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDUwOA_ecc24487-1e9c-44c5-aee5-bb53bcdfa738">950</ix:nonFraction>&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDc1NA_f217092d-b69a-4d16-bfbc-8271fbac44f3">3.250</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to <ix:nonFraction unitRef="number" contextRef="i5a4f39288d0b45248bab5af271dabb3b_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDk3MQ_83021e0a-a801-450c-9b49-f242d18402b2">100</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to <ix:nonFraction unitRef="number" contextRef="ib3da1322564b4ca89777bef210350bd7_D20200928-20200928" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTE3Mw_c3f92d27-e67e-420d-a2fc-965a3c0fdd68">40</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i377b4457fa40451d9934553b73788461_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTM4Mg_f95772b5-5b94-4e6a-8553-5f40639abfb3">103.250</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at <ix:nonFraction unitRef="number" contextRef="ida3f87ee7c184b3d92090d91611fff9e_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTYyNA_2aa24711-b7bd-4f28-be85-2624c07d761f">101.625</ix:nonFraction>% of par; September 28, 2024 through September 27, 2025 at <ix:nonFraction unitRef="number" contextRef="i83419ad698fd45cd9a641d83cdf6a7fb_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTY4NA_ac93831c-707a-4a88-bfb5-9f9d3cfdefeb">100.813</ix:nonFraction>% of par; and September 28, 2025 and thereafter at <ix:nonFraction unitRef="number" contextRef="i6f7fe74bada44325807efbeacb2146be_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTczNg_6ced5c13-21ca-4db5-bc61-b80f9078bc63">100</ix:nonFraction>% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i42acc5ed62724f79bd2e68d140fe8dce_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTk4MA_e04e05e9-5a5e-4d5b-8b99-f32d3e96b7b1">101</ix:nonFraction>% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i7acb7fecb9534db08822f46429f6bd5d"><ix:continuation id="ifa1a080c9cf2432b96e2a9dc98075cc3"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC0xLTEtMS0w_a30a561c-1657-4088-8848-94213982a6a6">4.375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC0zLTEtMS0w_a06309ac-bd2d-418e-8c4e-1724e6190b26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765ee743cd8d4c30a3e089f9a5063ad1_D20191229-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC01LTEtMS0w_978e687e-c12a-488e-b257-a602206da549">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a626c6885434dc39de0b254189dd899_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC03LTEtMS0w_2cb54290-7964-435c-bf8f-8d5f950d68d5">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976b8217dd0340c8848abf4604793c09_D20190929-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC05LTEtMS0w_cc3747e8-d55c-4297-9af6-3c761a510fe2">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f8b998b09854bb695d9efc1050df7c4_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0xLTEtMS0yMzUy_c870dc39-feed-4142-8c04-da0844527338">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida59e22f7f6c46b19f9d458fa92fe312_D20201227-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0zLTEtMS0yMzUy_bff1dc90-cc67-4e5a-9fcb-55b3f2cf3eb0">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54dcf56176214275896ff1d60bc84906_D20191229-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS01LTEtMS0yMzUy_afe23591-f9f5-41b7-9e29-a80e4560b86f">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88918075f107400cba5e6d495691837d_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS03LTEtMS0yMzUy_2f5ed0d1-3794-43bb-a92f-3e5424264f18">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade8ee6fa1e44937ad93cb3264cfa057_D20190929-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS05LTEtMS0yMzUy_a61257b6-c63c-4b58-a437-aaf3a95d2049">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0xLTEtMS0w_aa14541d-8e38-45ff-8260-b93209e7939b">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2015de2d01ea4eb6b943c7070cd7b61c_D20201227-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0zLTEtMS0w_6d518206-5f8a-4e45-8ea4-990c37933d88">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i166a72cd198a4c67b1e33412975acb38_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS01LTEtMS0w_7c47219e-79bf-4d76-a10b-a07c80f1b14e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2018dad9ea214f19a994a89fec2b62b5_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS03LTEtMS03MDk2_644fd9d3-61d4-4c3e-a186-8cb5902dca7a">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b31ce11b7874197821ee16e0e8acb8c_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS05LTEtMS03MDk4_3a2508f9-b8c6-4a16-84d1-df2956a48ff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi0zLTEtMS0w_691a38e4-4033-4b70-8bae-cb6bb89c24f6">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi01LTEtMS0w_0a45919a-c779-4440-a20f-818de43cdac6">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi03LTEtMS0w_a7e0b6ba-6a03-45b8-8c1f-01b81d8dfcdb">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi05LTEtMS0w_846c6071-16d3-44e2-aee4-b0842cca8c12">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RleHRyZWdpb246NDM0NmVhNzEyM2RiNDZlOTk5MjQ2MmIxNGI1OTk5OGVfMTg0Ng_5a8c7ae6-71ea-4372-9170-d64a033bda43" continuedAt="i08733c340778432faedf65e3c14fa95e" escape="true">Trade Receivables and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i08733c340778432faedf65e3c14fa95e"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RleHRyZWdpb246NDM0NmVhNzEyM2RiNDZlOTk5MjQ2MmIxNGI1OTk5OGVfMTg0Nw_5f152cc7-ba8a-47ca-9a10-9d1273ac88a3" escape="true">The following is a rollforward of the allowance for credit losses as of March 27, 2021 compared to March 28, 2020:</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified as Assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi0yLTEtMS0w_a1507788-4b9a-4cae-9183-be4e0c4a4d08">31.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi00LTEtMS0w_30864c94-7b1b-4cc6-9673-80bb8b834ea9">12.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi02LTEtMS0w_a5820047-e37d-4f34-97f5-3abfdc919a4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi04LTEtMS0w_7286540f-f303-43a8-a829-6c9034c54ca2">2.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi0xMC0xLTEtMA_cb25ac14-e2d5-43ba-9ff4-3e4776ca7cab">41.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy0yLTEtMS0w_e48e50ff-4c0d-4dc2-ae3b-bbef59321251">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy00LTEtMS0w_7bd4a0fe-61d7-4fcd-b436-6bd0b55474d3">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy02LTEtMS0w_9af5d1c4-59ea-47c4-a8a3-622977f71116">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy04LTEtMS0w_8e7be188-3917-4aad-921c-110e0624bfeb">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy0xMC0xLTEtMA_4d709963-6b48-45b1-aa8d-3815bae993e2">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjU5NzA2OTc3NDQ1OA_3ed1081c-45bc-4c63-b848-bef6390e66a8" continuedAt="if9604b772b264d7daf5c3bdf279326c2" escape="true">Derivatives</ix:nonNumeric></span></div><ix:continuation id="if9604b772b264d7daf5c3bdf279326c2" continuedAt="ic6a9e11233234a5fab7e9ce649605c5d"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $<ix:nonFraction unitRef="usd" contextRef="id5aac920f34f491293ef3c6b911a0e0e_D20180930-20181229" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTM4NA_319ced0d-653e-49f5-abcb-78d53d3cdaa7">3.7</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $<ix:nonFraction unitRef="usd" contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTc0NQ_2e0ea4e8-3b56-404f-b0ed-77cb66ef9c9a">1.5</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="ic6a9e11233234a5fab7e9ce649605c5d" continuedAt="ie7f9ce3faeef4e35b4c7c47c6ce46810"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjIzMw_2a51d447-2b07-4b54-80f8-20ee816a06a9">1.0</ix:nonFraction> billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreements matured as of December 26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjgzNQ_f9fcf1c2-f8a1-4f47-b296-8afa3026eb00">1.0</ix:nonFraction> billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjkzMw_abf7e49b-2176-46e9-95ef-5e0c759a438a">1.0</ix:nonFraction> billion of the notional amount under the 2018 Credit Agreement at <ix:nonFraction unitRef="number" contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjk5NA_7d9efc5e-9375-44cb-96fb-92d2df1d6208">1.23</ix:nonFraction>%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMzM0MA_3d74ae74-4b73-454a-b680-a7ecbde61de7">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $<ix:nonFraction unitRef="usd" contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMzU4NQ_46e03fe4-ecf5-467e-8803-75398c4b6815">24.9</ix:nonFraction> million as of March&#160;27, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended March 27, 2021 and March 28, 2020, respectively, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjExOQ_9c0489fa-f08c-4a32-ba46-8dc329f5e0c2" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy0xLTEtMS0w_7c71c1fb-224b-4e03-b62d-8af07256eb35">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy0zLTEtMS0w_1d76d0aa-6cc3-4f8c-a7fd-3f74669af7ee">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy01LTEtMS0w_2d63e309-bc3f-4d2e-8e4a-1d6d65e90cee">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy03LTEtMS0w_a21830de-103d-490b-b0bc-fa75e5cf547f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC0xLTEtMS0w_cdb3a3ad-dc07-4b87-9cb3-db2fcfc9d746">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728508ff257d45269fd226b6e4007b29_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC0zLTEtMS0w_bbdb690c-e44f-4773-bc8b-4a68c6337663">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC01LTEtMS0w_fadb46a7-abd0-491d-b7f0-fb370e2b0ff4">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC03LTEtMS0w_f375b76f-e78f-4a17-93c4-38c5714d2f1e">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS0xLTEtMS0w_0547872b-1c3c-4783-96b5-5f03ee9bb84c">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS0zLTEtMS0w_73a37875-81eb-45cd-8239-bd02345e0448">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS01LTEtMS0w_4f837d33-e9bb-4757-bc9d-2d36e987c068">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS03LTEtMS0w_a5884341-eabc-4219-8107-49841687818c">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC0xLTEtMS0w_4512bf32-656f-4070-99e5-5bf8c6288b89">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC0zLTEtMS0w_468316f6-632f-4f20-b975-6ff39e8c7a81">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC01LTEtMS0w_b564e3d8-27cb-4894-a20f-4a1c58fc6841">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC03LTEtMS0w_72751c28-1021-4cbd-883c-27da68d75ea2">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS0xLTEtMS0w_de5e5fc7-0898-4c19-96ae-8826cdad3574">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728508ff257d45269fd226b6e4007b29_D20191229-20200328" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS0zLTEtMS0w_8863936e-d3f2-42e4-bf98-b4bfdde1fecc">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS01LTEtMS0w_c9f5299d-45e6-4814-b7a4-f38c44878b50">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS03LTEtMS0w_4456997f-9b82-4b9d-93cd-8668ddf4a532">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtMS0xLTEtMA_c46dabec-af25-4001-a0a6-705577955e69">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtMy0xLTEtMA_576e64f4-5989-443b-8568-60481e7f7e35">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtNS0xLTEtMA_f6468c92-4da1-47c8-b7b1-09cbdd6a176e">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtNy0xLTEtMA_ec7df6b5-b3a2-4ba4-9711-e9a219121eae">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItMS0xLTEtNjgyMQ_bb30e1fb-6470-4dc0-a98d-ecd807dca1dc">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItMy0xLTEtNjgyMw_9fd56013-920d-4e7c-aecb-47022c7c06cb">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItNS0xLTEtNjgyNQ_c8a6a9b2-829e-43d8-99a8-b5e3a44aaae7">11.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItNy0xLTEtNjgyNw_b97ce2e6-e351-417b-8f89-e6d30e8459d7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;27, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="holx:NotationalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTA5OTUxMTYzNDkyOA_45a6fbaa-bc64-415b-af0d-4b37267cc866">415.8</ix:nonFraction>&#160;million. As of March&#160;27, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i2c0e131c95e14da199d151225685419d_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNTUxMw_b2c52310-34cd-4a40-87c5-1835d8091de8">133.5</ix:nonFraction> million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="ie7f9ce3faeef4e35b4c7c47c6ce46810"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjEwMw_212a4a4b-f997-4a61-97c6-066f22913e7e" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of March&#160;27, 2021: </span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9310ce69fb254103a98583ec7e3a8f90_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfOS0zLTEtMS0w_5d442449-82c2-49ce-8058-5ad49e97065b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ab14cc2c1b434da9b16b16b3ce59e1_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfOS01LTEtMS0w_599b3c36-0ea6-43a9-96ca-7eaa5aa24322">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc1821170fb4c9a801bdfc34109bcde_I20210327" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTAtMy0xLTEtMA_67dee021-03fe-4c72-82a8-db0d3b157107">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d059976369410a807492037e5cb3e7_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTAtNS0xLTEtMA_695ac405-6704-4f4c-a30c-c04ff452a952">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88aa4de2fa84889ad42f389e367d075_I20210327" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTEtMy0xLTEtMA_42882011-98ca-4f51-8363-43a606432893">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b59cf4e28d42bf8a4e9c8c7e429ac8_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTEtNS0xLTEtMA_0b97804f-3daf-4185-b750-04bce3a7ba3a">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd16785dea0a4ca1bf8304136ec99d08_I20210327" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTUtMy0xLTEtMA_5e0be365-37ef-4fc4-a07c-c60f507bc2d6">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief9fc2fa9591462dad0bf17824d2a9fa_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTUtNS0xLTEtMA_313abfe9-2b15-4319-b2ce-692f6da546ce">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d55ca8ee94483dac7f5b658cc31fa8_I20210327" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTYtMy0xLTEtMA_7391daec-8166-4263-ab6a-b0bda2974ac9">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic413e8139a5c40468c33462fc5941e98_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTYtNS0xLTEtMA_cee94c7b-311c-42cd-abd1-5ccfd8cddc8f">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTctMy0xLTEtMA_2316f235-6011-4ddd-930c-e39fbcf339db">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTctNS0xLTEtMA_3c49fe06-5ead-452b-aa8f-c567af974d5a">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie803f3fd1bff41419202ea94b2221474_I20210327" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTktMy0xLTEtMA_1c6c2dfc-0fda-4927-9c91-f5153a9c4fe2">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a81172412bc4ff681f76e0d333e25d1_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTktNS0xLTEtMA_ab0f6e93-0435-49ec-9126-6ded927adac7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjExNQ_348be35a-65eb-479c-a9cc-9a99628eb0ad" escape="true"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2f2cfebe3b48139e592af29012bf6c_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy0xLTEtMS0w_87572c60-35c7-45a3-9bcd-1fe8bc6e3aec">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561329732ffc467eb03c4950ee15a00e_D20191229-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy0zLTEtMS0w_743cf288-5ac6-4efc-8350-4b5d084069d9">25.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16d36f0eba664708ad3e485d531f2d15_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy01LTEtMS0w_ec618e11-ba8b-43be-ae20-6c0ec384374b">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic190c456cf6a49e5b0ec99b8038929ce_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy03LTEtMS0w_b95eaa53-7ae6-4576-886f-118fb02c41c1">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86fb83a62a8c4fd59a58fdd0e8af7e97_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC0xLTEtMS0w_9094951c-74f6-4fc1-8a67-a72695f4fec6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i298880826ca146b98d400d387598be5a_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC0zLTEtMS0w_d81ef466-7cf7-4796-b5d7-217591ea2d37">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba496bae81354f87b7905994ea233dd8_D20200927-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC01LTEtMS0w_9668b594-9645-45c1-bfd1-51cc8871e8ca">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5715660627c4c0c814c4bd2577fe6cb_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC03LTEtMS0w_575febf9-9500-4eeb-bdce-c193a30610da">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS0xLTEtMS0w_34b303f8-7087-437d-a2d6-f9e0761dc0c5">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS0zLTEtMS0w_1129d57e-b259-4f32-a70a-3c21a656f16f">25.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS01LTEtMS0w_d288391a-f0dd-4fcf-b3c5-238e35e7a9d8">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS03LTEtMS0w_0b8aabc6-de69-4ec5-bb11-e358b4c384a4">21.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfNjg0NQ_41b64dd8-7594-4aaa-aa77-8337dd56154c" continuedAt="i3008ffb8f30e4764b8abdda8299d4833" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i3008ffb8f30e4764b8abdda8299d4833" continuedAt="i7cc7669200064e479ebe4b9599faf283"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="ieb56657e29a54018978922a7e1c3a629_I20180727" decimals="-5" format="ixt:numdotdecimal" name="holx:AmountAssessedInDamages" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfMTk4Mg_6e8ffeb2-a85f-45fc-b4c2-5172f3c28bd5">4.8</ix:nonFraction> million in damages for Minerva&#8217;s </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i7cc7669200064e479ebe4b9599faf283"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed <ix:nonFraction unitRef="petition" contextRef="iba238290a69f46b1a533fe0940b1cca4_D20160304-20160304" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfMjUzMA_e8e5e332-ad1e-437a-8689-0c90047c9bd8">two</ix:nonFraction> petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 7, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $<ix:nonFraction unitRef="usd" contextRef="i8b0b8127ce934cd9b79a11ee9f9c7acf_I20210327" decimals="5" format="ixt:numdotdecimal" name="holx:LegalAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfNjAzMQ_f78e7aba-ecd2-4965-8782-7b58aecf4a69">10.0</ix:nonFraction>&#160;million accrued for such matters as of March&#160;27, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RleHRyZWdpb246NjlmZmMxNTAzYzY0NGE5YWJhZDViOTFmNGQxYTFhNzBfMTA4_ba6e9ee5-94a9-4c76-a94c-5af046fa84a8" continuedAt="i0b4e122c15204d82bfcfea0a8911dc22" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="i0b4e122c15204d82bfcfea0a8911dc22"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RleHRyZWdpb246NjlmZmMxNTAzYzY0NGE5YWJhZDViOTFmNGQxYTFhNzBfMTA2_f567918a-9682-4bed-9f25-087fc1f6c893" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi0xLTEtMS0w_391fee84-ca73-4b67-b9c5-fe1dcbe47467">258,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi0zLTEtMS0w_d5be14d4-8159-4d10-bc50-454640983d1e">263,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi01LTEtMS0w_fb25923a-78a4-4d4c-81a2-3c6c92f79ef8">258,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi03LTEtMS0w_d7c370e3-db16-41f9-b4fd-e54027b28287">265,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy0xLTEtMS0w_b5e8773e-bbb0-4ef3-a3f2-3e660ccc19c4">2,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy0zLTEtMS0w_c805f5dd-7a0f-49b4-a372-b032b6682d81">1,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy01LTEtMS0w_48f4e926-bc18-4784-a045-dfe70737957f">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy03LTEtMS0w_01377580-3367-45c0-8b96-7fe793fd2df6">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS0xLTEtMS0w_c14a51f7-e3c6-4d70-aba3-f4c7a50acbde">260,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS0zLTEtMS0w_a98801e7-4f6b-4971-86bf-bbc5f79daef7">264,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS01LTEtMS0w_a91eb562-d8f2-4ae4-8f6c-6089ff5fbe30">261,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS03LTEtMS0w_6e75cf1c-3e1a-4c93-91b2-3faa52bf9cbf">267,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c9f918de2cf4d88a84b71df72163bf3_D20201227-20210327" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy0xLTEtMS0w_5e21e475-0660-4010-9055-ae8fd6efa9f2">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie144f499b7fd4eb998be1642c636dc03_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy0zLTEtMS0w_1eca100a-da88-452b-bb1c-733504c55b12">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7e1e58fe46ca4c779247bd692e2e4185_D20200927-20210327" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy01LTEtMS0w_ec516545-6b50-4c3c-9ed3-ffcd9909b10c">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i070793615ded4840820fd755341d20f1_D20190929-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy03LTEtMS0w_6387ed5c-8adc-4577-a13d-d1fdd64f4a59">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8577ab468434cffae8cbb51873099ce_D20201227-20210327" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC0xLTEtMS0w_857967b5-d45a-4c2a-bf4e-1145af07218b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7e4f871073d422ea5def9c529807699_D20191229-20200328" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC0zLTEtMS0w_19e61294-89e8-48bb-a15c-ee82ad86ec32">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46d86786c1ac4e81846655e4acbc0c6e_D20200927-20210327" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC01LTEtMS0w_fd16ab81-79cd-4601-9a56-1c5080a92eaa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d272ac0e09f419a956e9fb6c0361bc3_D20190929-20200328" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC03LTEtMS0w_6c8f85e2-6e16-4297-b75b-a181806e61fb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMyOQ_94ec6866-b6fa-41b9-a71a-58cd208338aa" continuedAt="i607e60e5d7b34a76aa5ce4d1c9f3cb86" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i607e60e5d7b34a76aa5ce4d1c9f3cb86" continuedAt="i6a2ef8d1894643e8846f6287856dbcc4"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMzNg_cc9d5af0-a9b8-43db-ae0f-2ef5e3a7d930" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5089e6cd6df24ba38788f0b1f4ec9aa4_D20201227-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi0xLTEtMS0w_23e263ff-455b-4688-9b43-5f4892217d09">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1385d9f85d114662986d5770c3b9c5eb_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi0zLTEtMS0w_14f82ae1-dfcb-4f57-82a3-6dbc8f2a7d0c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i042387ddd4d94b5f97f7b3f7f7794495_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi01LTEtMS0w_8f330dfe-f0b4-4ce9-9ba9-d47ee7a97850">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc6eacddf2c14e2da413620ca0ddd0de_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi03LTEtMS0w_6513c38e-9f63-45e7-9e32-d1c5abbbd23f">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4081d628500a407e83b46bf2fe3b0005_D20201227-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy0xLTEtMS0w_7116012a-ec5c-48b2-b196-e8deb9152727">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5c87f950614503ba2efd4bb0004547_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy0zLTEtMS0w_c82d290d-fa5d-4814-91ad-eff6e0cd8443">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0df38cfcac340ca926931a8815bd86a_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy01LTEtMS0w_310d74ae-073f-4a3a-9f55-9f6f6fdc20a9">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7406c1b94a0341b89142d4308dd7bd26_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy03LTEtMS0w_51d2a6a1-14f0-4ab3-a412-78d90fd3d8d7">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd2eec347a984124b6b6980c85d40599_D20201227-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC0xLTEtMS0w_f2409565-0878-46db-9567-b48f6f5a6538">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad3c625ba65468dad8446d8c5ca3463_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC0zLTEtMS0w_dea82c64-5cd4-4733-a52d-066798205869">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic72750901e9646aebae40d076b3f86f8_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC01LTEtMS0w_1f875503-0fb0-40df-b86c-a1a07ece31ac">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c626852f1c4ff2a5ab8807eabc7a53_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC03LTEtMS0w_8c5f206e-f8ad-4c5b-8651-027efa77a298">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4f38c2b6ee4d35ae4e4fc855b5c593_D20201227-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS0xLTEtMS0w_a1a0c45a-0339-4874-a607-d93f3d9cc097">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662994515dee4071be41921dd55091a9_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS0zLTEtMS0w_a9c1eb84-3c6b-4673-ab8e-45fde0c95c12">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20cab64438a419fb7e15f3b2d30abfd_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS01LTEtMS0w_ab68d38c-c480-4428-882a-3db544986a0a">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f3dc155fff485eb786e0c5e0b8f79f_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS03LTEtMS0w_3d0a7fc1-10d8-4022-8131-1b04c79528b2">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecf187b743a46929a3cbc82c74daecd_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi0xLTEtMS0w_517ef977-8a9d-4094-9ed8-083bd3ed784f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia292e0f0da204d90bd17cc07a6c83088_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi0zLTEtMS0w_72f518ed-953f-4ac2-9da1-88c46b85d180">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7d1bb69ae44c12932fd6147a4a1819_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi01LTEtMS0w_338f2f8a-5137-47d1-9626-4a6502b04ed1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a10ffdc26ba439aae8e83d553aa4523_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi03LTEtMS0w_ee943d30-b6e4-4113-a756-3d10b6cfd18e">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy0xLTEtMS0w_8ea8d099-3668-4f38-8d0f-c395cb99193a">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy0zLTEtMS0w_cf1b7aca-7f83-4a04-8242-c9418ec2bf5f">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy01LTEtMS0w_43109a73-ad76-49ef-9a4f-d86d25a85427">35.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy03LTEtMS0w_e798a514-9dc7-4134-8aff-f1a005e7223c">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTg5_4591423f-6619-4581-8479-b9918218dec8">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTk2_493cc8d2-fed6-4d75-a4d0-ba9491abb5b2">0.9</ix:nonFraction> million shares of the Company's common stock during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzE2_2444ab25-b740-46e2-a105-2819e23e1c5d">68.64</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzIz_718af4b0-5419-4426-b8b7-e09a522e86e5">45.82</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzUy_6a1a0f63-3d3d-46a5-8007-7845e155ff8b">4.5</ix:nonFraction> million options outstanding at March&#160;27, 2021 with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNDIz_9cb48532-957b-4005-81ab-5999cb17ca20">44.53</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMyOA_100d81e9-f984-4b41-9541-46015f7febd2" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi0xLTEtMS0w_5eca8588-6477-4205-bca9-4d838bac613d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi0zLTEtMS0w_25cea9fb-9e27-46dc-ac41-50715a78cef8">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi01LTEtMS0w_ba5a08e6-bb16-4746-ab3b-5d928da4a142">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi03LTEtMS0w_0381bec8-6f49-4ae7-9b5d-7f997935e6c7">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy0xLTEtMS0w_add71567-b618-45dd-b853-5984e2516e03">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy0zLTEtMS0w_d7648433-9290-49c5-9374-e86f09a5dd1e">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy01LTEtMS0w_e11b0bb3-0568-4c04-b02a-0bedfefe2f24">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy03LTEtMS0w_f8a2f03d-8018-48bf-88f1-d9ab9f7968e5">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC0xLTEtMS0w_e78666af-7614-4e1f-be33-32ec836bddee">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC0zLTEtMS0w_1b03556d-6d09-41a5-aeab-0a35e7d10430">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC01LTEtMS0w_3f80f59e-6f97-4c62-a834-ae960153053b">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC03LTEtMS0w_c9860d77-f879-4bf6-8fd3-92d5541c4ac3">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS0xLTEtMS0w_e5b77474-889a-4f8d-a8e0-ff949631faa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS0zLTEtMS0w_00a4b4a3-5997-4cf4-bf4b-1a31467e9fcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS01LTEtMS0w_c9b7c233-641e-46f6-a4b0-1aa5204901aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS03LTEtMS0w_3f031f88-a0d4-4e65-9532-c59f6d771b96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi0xLTEtMS0w_97650a89-e0f4-404a-bf3f-0a25220df2ba">21.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi0zLTEtMS0w_350af76c-ad0b-425d-982f-75a267c14fdf">14.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi01LTEtMS0w_6ed14d94-1dc8-4736-92b4-4f85ba462bc9">20.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi03LTEtMS0w_6cc36892-6d63-437e-acd0-c220a512ca65">13.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNjQ0_13b3888f-0eea-4ce3-acc6-42a7efe9c600">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNjUx_cf15308a-1994-47c8-bc79-7ac021056fe0">0.8</ix:nonFraction> million restricted stock units (RSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNzg0_d11ef31b-6945-4580-8413-263116f00c9b">68.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNzkx_dc8a29ed-0ae6-47a7-b933-906227493cf9">45.76</ix:nonFraction> per unit, respectively. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfODUx_9c6afc63-9af2-4c7e-a97a-d53cb6dda4ac">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic1102657f7bd4468812eef9239214f33_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfODU4_82b9fb73-3845-4809-b243-7af884e91e8a">0.1</ix:nonFraction> million performance stock units (PSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTA0MQ_48f727e4-1e05-49c2-86a3-704db165f8a0">68.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ic1102657f7bd4468812eef9239214f33_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTA0OA_59699cc6-f951-42b9-a28f-e7b9673eaf84">45.76</ix:nonFraction> per unit, respectively. Each recipient of PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTEyOQ_ea10ffa0-413f-46cd-b860-7962a3ae6b74">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTEzNg_73ffa8be-2582-47dd-a386-c2ed3d30b04d">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTIxNA_308d72de-22d7-44d6-9665-3c840f663b09">three years</ix:nonNumeric> provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTMyMg_128b1f09-03eb-4e12-a330-dba4622676d3">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTMyOQ_88ab5832-ea7d-4660-8367-68cf4e4efa23">0.1</ix:nonFraction>&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i6a2ef8d1894643e8846f6287856dbcc4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTQ1Nw_bad345a0-b4d3-4c47-a09e-2f978d226f4f">68.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTQ2NA_12aa1d0c-5cac-4eb1-8e5f-5d2621b77c8a">45.76</ix:nonFraction> per unit during the six months ended March 27, 2021 and March 28, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and <ix:nonFraction unitRef="number" contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTYyOA_b44a95cf-97c4-4eae-b1f3-eb170e727808">200</ix:nonFraction>% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjQwMw_4b434dd2-3bfc-4901-865e-196785d17a3d">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i6780dc391a714a25af687af04d21768a_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjQxMA_9df11df3-0788-450a-b98f-606d45f6daca">0.1</ix:nonFraction> million market-based awards (MSUs) to its senior management team during the three months ended March&#160;27, 2021 and March&#160;28, 2020, respectively. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjU3OQ_ea10ffa0-413f-46cd-b860-7962a3ae6b74">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjU4Ng_73ffa8be-2582-47dd-a386-c2ed3d30b04d">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjY2NA_308d72de-22d7-44d6-9665-3c840f663b09">three years</ix:nonNumeric> based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjc4MQ_b88e7539-5682-4dc8-894c-42fce7e1e303">82.31</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i6780dc391a714a25af687af04d21768a_D20190929-20200328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjc4OA_9e89bba5-df66-4c37-9287-ea52f0bcf508">43.90</ix:nonFraction> per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At March&#160;27, 2021, there was <ix:nonFraction unitRef="shares" contextRef="if74ce39dfecd44f08e7d1c91ebc01c9d_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzAxMg_d7723bc3-353c-47af-8386-ebede2c2e3e9">3.1</ix:nonFraction> million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;27, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzA4OQ_c4942900-6881-4f69-843a-a7ff5173e701">23.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5862a7e8fb46483da33faa01de3b39c5_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzA5Ng_4b8a71f3-dae1-45ff-b859-2ed7c19d29fc">71.7</ix:nonFraction> million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzI4OA_032ca53c-bd75-4977-8046-5e848192abfd">2.5</ix:nonNumeric> and <ix:nonNumeric contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzI5NQ_db15a625-810a-4447-a559-5e8385c74027">2.1</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div id="idb3695e9835747c6b3438a7b262e54ea_76"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="holx:DetailsOfCertainBalanceSheetAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNTA_81a79570-eb92-48a9-b308-53fabd9687a4" continuedAt="i24af295d28cd4d12ae86f5a9ff18995d" escape="true">Other Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="i24af295d28cd4d12ae86f5a9ff18995d"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNjg_75457b0e-59bf-43c0-aff1-5db27a3e7f50" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMi0xLTEtMS0w_450703b8-72b3-41f2-aa7d-703be779c8e3">154.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMi0zLTEtMS0w_77f4ae23-ca57-4184-9183-3b6d5c6dd89d">152.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMy0xLTEtMS0w_0a20f3f4-4cc0-447d-9e71-3c9b001d6822">56.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMy0zLTEtMS0w_2cecf3a6-319f-41d4-ad27-62eee4d26161">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNC0xLTEtMS0w_3854b3d0-9913-4b6c-b0c4-50d5fd594656">245.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNC0zLTEtMS0w_ad4f37dd-9bf7-4cdb-aa1a-62e269beb670">196.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNS0xLTEtMS0w_063ce310-ab17-4148-aaa8-d23db2320ac8">456.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNS0zLTEtMS0w_b70652c0-78dd-420a-8c52-49c50d8fac6a">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:23pt;margin-top:5pt"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNjU_d723fba2-79b5-4d05-911b-ef425effc50a" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMS0xLTEtMS0w_17a84bb2-7e95-4ada-9469-3e2a5a834d4d">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMS0zLTEtMS0w_9eddce4f-d688-4cc2-89f9-9b72392d0c24">460.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMi0xLTEtMS0w_94ec958b-c4e4-4a5f-a62e-42f6f96d2455">471.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMi0zLTEtMS0w_d68b0946-2035-4d2f-bb7e-528727b6986a">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMy0xLTEtMS0w_361e1feb-8e7b-48b6-ba0e-b362b0d73ce2">178.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMy0zLTEtMS0w_436086b1-b991-4fdd-a910-da2ee996b05f">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNC0xLTEtMS0w_d76f6ca3-07af-4eb2-91d4-c77cef6604a5">47.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNC0zLTEtMS0w_f292cf35-4a0d-474e-b296-ab55f98c0df8">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNS0xLTEtMS0w_bc5a3302-6774-48b3-b46d-b6fe436194a4">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNS0zLTEtMS0w_6b250587-cff0-45a6-af5f-019b78764f0d">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNi0xLTEtMS0w_221ca66a-5815-49aa-9484-2309d0e8f90b">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNi0zLTEtMS0w_ad7b7bc6-80cf-497e-bf75-a1c3fc2a7caf">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0xLTEtMS03MDQ1_dc88a994-1541-4d28-9661-f3daaa36d29e">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0zLTEtMS03MDQ3_0fcfd3bb-0a47-40c9-84a5-ed0873d7372b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0xLTEtMS0w_7aa025a5-090d-400a-a2b6-3ad9cda3a9d4">1,255.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0zLTEtMS0w_9a07d2eb-5b71-4353-8d8e-909e73347245">1,185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOC0xLTEtMS0w_146d3b26-674a-467f-bd2d-573402299210">721.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOC0zLTEtMS0w_c61e4490-ea73-466e-92af-3afd10d54bbd">694.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOS0xLTEtMS0w_cffb5a69-9fcc-40c3-a516-a8cb04574b28">533.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOS0zLTEtMS0w_1c92da61-450e-4152-aba2-26f817355c4c">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company received grants of $7.6 million and $119.3 million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. In the current three and six month periods, the Company received $11.1 million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.</span></div><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk2NQ_0c1d33e0-17eb-40fa-adce-3ad5fda9aabf" continuedAt="i1b766e8a87f849cfb2bf54b71ab9a490" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b766e8a87f849cfb2bf54b71ab9a490" continuedAt="id182ead67db149f5828c74c5b9c49fa1">During fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had <ix:nonFraction unitRef="segment" contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMjU3_6641f83c-8d23-4d8f-a010-a03267da5460"><ix:nonFraction unitRef="segment" contextRef="ib7935a6d79614132b0ef2b639930f553_D20190929-20200627" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMjU3_7c66ffd3-4b6c-4020-a9f8-a1a96937d734">five</ix:nonFraction></ix:nonFraction> reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="id182ead67db149f5828c74c5b9c49fa1" continuedAt="i1c1cb022137f429f989fc16e735b5183"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="if07be3a2248e454e9dd29011bf561fdf_D20200927-20210327" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_291570bb-a1af-461d-8917-5356f29285c3"><ix:nonFraction unitRef="usd" contextRef="i34b3b1ebbb344b0eba9a071b5285028a_D20190929-20200328" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_52e3f242-8213-42b4-845b-e54ea2ed3df1"><ix:nonFraction unitRef="usd" contextRef="ib7a70e04c2c044d488ee49e04a7c4fd8_D20191229-20200328" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_7a57222f-74e2-49ea-88f9-63113e184aa5"><ix:nonFraction unitRef="usd" contextRef="i0cedd2956ea24251b4f2e787ee87f9a5_D20201227-20210327" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_9bb5e2de-b696-42b0-894e-f4dc8d2d8850">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> inter-segment revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. S<ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk2Mg_374ab25c-8e80-4c2b-918a-765fd8472609" continuedAt="i75b2e38f1dcf4740b8b4fd43c0197fd9" escape="true">egment information is as follows:</ix:nonNumeric></span></div><ix:continuation id="i75b2e38f1dcf4740b8b4fd43c0197fd9" continuedAt="idf9460aa095045f6992a684fed4257a8"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy0xLTEtMS0w_41f8956d-6576-4236-a15c-9a210045e1df">1,064.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy0zLTEtMS0w_6327c1f3-7937-442f-b414-046c34c8ec30">319.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy01LTEtMS0w_1a1dc459-b628-4d8f-8f9c-6b758782eb22">2,192.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy03LTEtMS0w_b45b39f1-e76d-4da2-be45-07dc901f2839">630.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC0xLTEtMS0w_615624ad-65c4-4248-9885-9629eb360b66">336.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC0zLTEtMS0w_2d0fe4c6-17c5-493a-9a73-42a5bac771a4">307.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC01LTEtMS0w_fa037f6d-e579-4395-a163-1178be8121ed">669.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC03LTEtMS0w_8e66f0ac-dcc1-498c-a59d-65a9c10c13da">638.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS0xLTEtMS0w_95b7bd11-1ab5-47a8-885a-8db8092ca765">114.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS0zLTEtMS0w_c328e74b-7111-4818-a0a8-6ea6b3509967">105.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS01LTEtMS0w_b1e5ede0-c21a-4093-939a-fc88acaf4d21">238.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS03LTEtMS0w_0356cd5e-e766-4d54-81bf-f272aa7beb00">224.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi0xLTEtMS0w_e6ac245e-cfa6-4a5e-acb8-976f354ff7b0">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi0zLTEtMS0w_5abc0ed2-c475-42e2-93f9-c12bf348b8cb">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi01LTEtMS0w_6a643646-bf53-4ae4-ad1c-94fb315268d8">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi03LTEtMS0w_0618b25e-532c-4aeb-9fa2-c189b4e80717">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy0xLTEtMS0w_ee839144-fb9b-488b-9a36-ccd536df70dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy0zLTEtMS0w_00da1a17-a26e-4a06-97ee-509e82aaf0d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy01LTEtMS0w_eb662142-9634-43cb-a6ac-f9e937de34b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy03LTEtMS0w_2075aa15-a73f-4533-a70e-53365f7f631b">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC0xLTEtMS0w_25040906-e80e-455f-84f6-8c8a3ef5b11c">1,537.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC0zLTEtMS0w_e2bedb8d-f22a-4003-b654-41e1d6770962">756.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC01LTEtMS0w_6693e929-02af-4979-ba99-9950ec258fcb">3,147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC03LTEtMS0w_4d3f2fa8-6ab9-4908-9ae8-8584e83e4f66">1,606.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtMS0xLTEtMA_ee7c9d2e-576d-4339-8177-99d4b43c8ceb">700.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtMy0xLTEtMA_a946e6c9-26fb-4b95-bf5d-ae7a350e066f">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtNS0xLTEtMA_7b665d81-b4d1-4933-87e6-849c039039b0">1,485.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtNy0xLTEtMA_064d1611-12db-40fc-bd09-a5efdb56dde4">106.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtMS0xLTEtMA_4f21c936-ce5d-465b-aa94-2de27b4edda3">67.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtMy0xLTEtMA_a5a1cdbd-153e-4625-be6f-78f0acf1fcb1">75.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtNS0xLTEtMA_660d7588-5dbb-4e69-85c9-7b912f115cc9">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtNy0xLTEtMA_3c6ef7a6-81e4-4403-809e-0ca2ac944754">169.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItMS0xLTEtMA_f82a9ede-ceb1-4cb3-adfd-37aaec6764f3">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItMy0xLTEtMA_627ffc03-be14-4c8b-860a-4afdc665945d">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItNS0xLTEtMA_7e26c0e1-ddf5-4d41-a291-aa7e2292979e">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItNy0xLTEtMA_797e9cb4-ccc7-4530-98f5-eb220c97defe">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtMS0xLTEtMA_f858d95b-10ce-418f-aa95-091cbb393407">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtMy0xLTEtMA_8e4da37f-62bf-47fc-a9a4-6914916ff85c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtNS0xLTEtMA_39cdd5a1-c35c-4961-97de-591cf0779f97">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtNy0xLTEtMA_2c9b7764-7201-4bb6-aa0e-8ae5ec36e2e2">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtMS0xLTEtMA_0751cdba-26cd-4365-a091-e847a0d41c64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtMy0xLTEtMA_f453a31f-131e-482e-8a67-4f8fae156a36">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtNS0xLTEtMA_293007fa-b49c-43f6-ba01-62046e096142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtNy0xLTEtMA_abe3ded6-9705-4825-9289-7c37b3b20edb">53.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtMS0xLTEtMA_30e42645-44a8-4316-8a27-cdea94463e84">796.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtMy0xLTEtMA_ef59999d-bdf4-4752-9150-3e42f95ef2e7">156.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtNS0xLTEtMA_0ff7096b-594a-43a5-96e8-2f459745e13d">1,682.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtNy0xLTEtMA_76e8ffc7-8cf2-47d2-95b7-998d47de854d">281.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctMS0xLTEtMA_535e03db-2c69-4c1a-b3dd-6710c4aa95af">59.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctMy0xLTEtMA_4a276573-cf89-4f00-9dd5-62146edf434c">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctNS0xLTEtMA_5140a430-3b2c-41df-8cb4-91b569faf2a1">115.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctNy0xLTEtMA_168456a7-a178-4182-9e04-6066074655eb">118.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtMS0xLTEtMA_cf0c54b6-9455-4270-993d-b74df79120db">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtMy0xLTEtMA_d8d6b8a4-7715-408a-982a-4f38a4b6d8c1">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtNS0xLTEtMA_21dd866a-3a31-4290-9580-e34a3b8310d3">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtNy0xLTEtMA_0b1a703e-f404-47b0-9b23-20557dfefa7b">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktMS0xLTEtMA_e373f175-e8e6-4cb3-92d8-18f7d3221da9">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktMy0xLTEtMA_5a23c2e0-5c5a-42fc-8df6-98f931b8de4a">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktNS0xLTEtMA_5625c20b-cdeb-4496-8769-3c37d741ba82">46.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktNy0xLTEtMA_ee10572c-9bb4-4c4e-a985-6bd2883071dc">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtMS0xLTEtMA_62188058-6e22-4c9e-af5f-ac6f998029a0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtMy0xLTEtMA_5db72edd-a8b9-4c90-b6cb-3376e360101f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtNS0xLTEtMA_978d4f63-595b-48c0-abb7-bcf012cd67dc">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtNy0xLTEtMA_9648560a-0714-4274-8ffc-238952edd445">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtMS0xLTEtMA_2a6ae426-5067-480b-b021-32685cd469e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtMy0xLTEtMA_f3bee36e-ca92-4fa2-ab5d-6a3ea9ae7806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtNS0xLTEtMA_c3253fe5-4e43-49b7-bf78-8750e4e427de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtNy0xLTEtMA_b7963ff5-7fd5-435c-878c-a9ae5751a3cf">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItMS0xLTEtMA_d6196c5e-a620-4fee-a57f-869df76d5033">95.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItMy0xLTEtMA_886194e0-70c1-4478-81c2-b4ec7f253644">93.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItNS0xLTEtMA_2c33a92c-2ecb-4813-9f14-6769d391daf3">188.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItNy0xLTEtMA_763dfc11-ee27-49a6-b2ea-1dd9d580ca01">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtMS0xLTEtMA_817445f9-8b06-4442-9c2e-f4e2d3454bff">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtMy0xLTEtMA_c6ba5122-97a8-4092-8b94-b1953f353cf8">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtNS0xLTEtMA_cbadb346-426c-4f52-9270-dfa47810180f">77.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtNy0xLTEtMA_c671d9cf-b6ee-429e-b93d-98fdf6b67899">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtMS0xLTEtMA_e51166dc-68ba-442f-97b0-eef18f8a3fd1">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtMy0xLTEtMA_d70154ef-d17a-424f-bb4c-94b99cb81b7f">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtNS0xLTEtMA_78374cf6-6eda-474d-95d9-0c30ea601846">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtNy0xLTEtMA_220de8ff-e999-41a2-a503-3b52b143278b">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtMS0xLTEtMA_fba870ce-2aef-469b-9c0b-75e606da9a7d">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtMy0xLTEtMA_2a2f90d0-17d7-490f-98ea-520348db96d1">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtNS0xLTEtMA_72204e9e-ccae-46fc-8c9e-fc04be0e5545">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtNy0xLTEtMA_1e1bb384-8f12-4a1f-a008-5b7acb969401">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctMS0xLTEtMA_3bd04f6b-c46f-4dbe-8a7b-221632186acb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctMy0xLTEtMA_607f3ced-0dd0-4871-8581-3c29acdecc3b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctNS0xLTEtMA_202bf543-61bb-463c-b355-d180e6bb8979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctNy0xLTEtMA_c01ecd0b-bea7-485d-a318-2c5220e9705a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtMS0xLTEtMA_d46e4369-a014-406d-b1a2-7377e0c4803c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtMy0xLTEtMA_61f51920-65fa-4a4b-9b80-63daf7f37c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtNS0xLTEtMA_95d0ca0b-03fb-4ad3-b007-c4fbb4504296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtNy0xLTEtMA_b5b1b170-5de2-41ae-8d06-366ef2e37197">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec342590d7ad4942a989e8c33e8523db_D20201227-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktMS0xLTEtMA_f57d902b-a2ae-47f1-9795-43c3dc2937f7">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20db54379ba4b51b5f77937a37f9d8f_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktMy0xLTEtMA_f72759be-d15d-4c14-b2f5-dc7ae2bbccf1">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i505981465edc4002ab0c7d672cbd8b85_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktNS0xLTEtMA_ef8b3b42-48f7-4a54-a2d9-3bb6123699bd">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa735e311c9c4edcb8b2ed934d611d72_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktNy0xLTEtMA_c1983f91-7a14-4219-858e-307c56d39849">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtMS0xLTEtMA_9010f757-8c89-4904-8f65-470b2fc3d541">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtMy0xLTEtMA_70aba4b1-c3d8-41a2-bcb2-c4d72bcd02c5">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtNS0xLTEtMA_8ef3dad2-daf5-4768-b2a5-ec2d71b52cdf">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtNy0xLTEtMA_99bf2181-9797-43fc-9ef4-8d35d205b795">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i1c1cb022137f429f989fc16e735b5183"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="idf9460aa095045f6992a684fed4257a8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:69.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88906e66fdfd4730958ab7edc6ddc342_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMi0xLTEtMS0w_5e350b19-eae8-4b7b-850a-ee901a581ea7">2,584.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i115120608b9744b4af122d696c198769_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMi0zLTEtMS0w_3aaa5651-d9ce-4cf8-a7a2-024a19310192">2,161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4e33c2ae18a474398d2f7aa204f4b0a_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMy0xLTEtMS0w_6d1c3e32-4ffd-4403-a8a2-a0edd6703bed">1,266.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0538b1651d4e9fa01727c276c6aca8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMy0zLTEtMS0w_b50b55c9-dbe0-49fd-98bb-479730d59e02">1,200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59d4cf165f84163b8612267a6672818_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNC0xLTEtMS0w_db780417-075f-4465-b816-c54301b574a2">1,402.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia004d21122de40a7acb047f75711b230_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNC0zLTEtMS0w_74aae4ec-f105-4cfb-8f50-3dde81610d31">1,438.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie735f493b8a74552a82fa762497a7e0c_I20210327" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNi0xLTEtMS0w_c485e79d-ac09-4ab5-9a61-c374817566fa">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i360d05187d17434f9f024ea0b654414a_I20200926" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNi0zLTEtMS0w_aebdf8b5-6c5a-46f3-9865-6b169e6324f1">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7d8695f726474288c5904ad677e50a_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNy0xLTEtMS0w_e12c71a0-5782-42d8-85b2-b73f71f006d4">2,760.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e72d51c8ba435b837b8d83097e66c6_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNy0zLTEtMS0w_159621ee-7316-4082-8384-768debebb680">2,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfOC0xLTEtMS0w_7e35c30d-2f4e-42f7-a320-60ad15c795e8">8,044.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfOC0zLTEtMS0w_31dc259d-8bb4-4bb9-80e9-cc54b372a17e">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk1Ng_9cfc0585-c5a3-46bf-afb4-3490418aaffe" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi0xLTEtMS0w_2d28df0f-c126-4a69-b455-c23a4c0d62c2">69.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi0zLTEtMS0w_e724bf82-c223-420e-8942-614b7cf70243">76.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi01LTEtMS0w_ef2bab88-594e-4d5c-b5d4-a68af590eff8">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi03LTEtMS0w_69e041ac-ed66-478e-b4ed-b563d850db13">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy0xLTEtMS0w_2f12073a-6a85-48c2-a4d3-f3ade70aad1d">21.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy0zLTEtMS0w_56643d18-eb42-4653-9757-db7833cdc67a">14.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy01LTEtMS0w_ba19456e-022e-490b-afcf-29337a17707c">21.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98200202399d411bbdfbce88f2f94963_D20190929-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy03LTEtMS0w_e9b99ac3-be6d-4d29-903c-88074b6587e4">13.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC0xLTEtMS0w_32378d55-00e6-4350-9330-bc5e0a6b61ac">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC0zLTEtMS0w_40df99d2-09b8-4bb0-bf9d-bf4958a5e102">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC01LTEtMS0w_9f598794-cf63-4a29-bac7-e1227fcce9d7">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC03LTEtMS0w_316a2de6-fb42-4818-8bbb-844a8ef99b3a">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c207776416743ffb080dcba5b532a33_D20201227-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS0xLTEtMS0w_d713e1ed-4e0b-41d0-9424-ecfda711ac89">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc0c502bf9714b0abe90c2966356a47d_D20191229-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS0zLTEtMS0w_d5d1db2f-49b2-489e-b675-fcf1d85532b8">3.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90941e17deef4e38869d1a6989d08bc3_D20200927-20210327" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS01LTEtMS0w_85100377-a384-4e04-aa1b-fee6fca208ae">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic405c49964c945a2b2cccad0f50d104d_D20190929-20200328" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS03LTEtMS0w_6ea1b0cb-0bbf-4582-8415-a6eeca8f2e7e">4.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi0xLTEtMS0w_4e53e00d-85c9-4207-a766-1dfd6cbcb623">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi0zLTEtMS0w_bf645248-b324-40c6-919d-f45d8c6733f7">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi01LTEtMS0w_377f2278-1d78-4f7a-9d0b-2c2d9be51a89">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi03LTEtMS0w_1bb2045a-5a85-4f9a-9f3d-7ff31298249f">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfMjkzNg_847803c9-0be5-4c71-aede-51a983570329" continuedAt="i10f308e58cb3420794bdede36ee152b0" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i10f308e58cb3420794bdede36ee152b0" continuedAt="i76caef27bc7d4658a612b4fbd4516735"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three and six months ended March 27, 2021 was a provision of <ix:nonFraction unitRef="number" contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjA1_1a38646e-16ac-4939-97a8-2e425583486c">20.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjU5NzA2OTc3NTgyMQ_d372c673-bcab-4392-ae5b-f3a956cef3ae">21.1</ix:nonFraction>%. respectively, compared to a provision of <ix:nonFraction unitRef="number" contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjU5NzA2OTc3NTgyOA_6b6c99f7-0b0a-4731-af88-4eeb9b699eb2">20.3</ix:nonFraction>% and a net benefit of <ix:nonFraction unitRef="number" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjM3_81459108-0087-483f-b63c-12fb5e03b9e2">122.1</ix:nonFraction>%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended March 27, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes. The effective tax rate for the six months ended March 27, 2021 was higher than the U.S. statutory tax rate primarily due to state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended March 28, 2020 differed from the U.S. statutory tax rate primarily due to taxation of foreign earnings at tax rates lower than the U.S. statutory tax rate including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, partially offset by unbenefited foreign losses. The effective tax rate for the six months ended March 28, 2020 differed from the statutory tax rate primarily due to a $<ix:nonFraction unitRef="usd" contextRef="ife89e43900064dce8b3534de88f844cd_I20200328" decimals="5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfMTMxNA_cb4051ba-c883-474d-88a1-70ca4d0b4b7c">310.9</ix:nonFraction>&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><ix:continuation id="i76caef27bc7d4658a612b4fbd4516735"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) <ix:nonNumeric contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQx_2eb17a77-0c28-495c-8122-02766c6955f0" continuedAt="i1a2dde9acbfe4153a71cd231bda0ce92" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i1a2dde9acbfe4153a71cd231bda0ce92"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQ2_fd6964b5-4992-4577-bd2c-ba7e23147ae3" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b99bb878ba141d7a47254b83dc0764a_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy0xLTEtMS0w_f5303e44-9477-4049-8da4-83a97ae9029e">4,320.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b99bb878ba141d7a47254b83dc0764a_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy0zLTEtMS0w_3f372455-875c-4792-989a-88828132d086">3,033.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6926d7469494d35baaacd55a1ab864f_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy01LTEtMS0w_bf183f69-cdef-41fb-b512-dd8c456739ca">4,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6926d7469494d35baaacd55a1ab864f_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy03LTEtMS0w_ff2638f2-9653-497d-88fe-356cfde181b6">2,907.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a66f6cac0f45bca6d865851d97bc1a_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS0xLTEtMS0w_6855de29-ec7d-461b-b40e-b0b892467099">570.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a66f6cac0f45bca6d865851d97bc1a_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS0zLTEtMS0w_9ebaa851-7e39-47a3-8511-17daf72b8c7b">493.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35518212539f4b2e9962deef5956862b_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS01LTEtMS0w_2c6358bc-675c-48f4-b628-34dbe8be719a">549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35518212539f4b2e9962deef5956862b_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS03LTEtMS0w_2e811b10-46f1-47c8-a6bf-2fedb8799e7c">477.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4e68863886433791b7edc1d16c8b5f_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi0xLTEtMS0w_0bddd6e6-783e-427f-80c0-79d01033b27a">248.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4e68863886433791b7edc1d16c8b5f_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi0zLTEtMS0w_b85c866d-de90-4f9f-b033-c75cdf9a9450">186.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi01LTEtMS0w_0a1be65e-f97a-41b8-928e-bbb6ef8f86c7">245.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi03LTEtMS0w_0db2a122-277a-4066-b940-7b3885b5bdf7">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81080c9b2330438fa474bbe7a4003179_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC0xLTEtMS0w_b1dfed13-00dd-4221-ba95-c29ef65a3f33">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81080c9b2330438fa474bbe7a4003179_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC0zLTEtMS0w_7a5cd81b-0891-4457-beaa-1605507b868b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662c27c8d79044699ea38a30b7e68432_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC01LTEtMS0w_63a7f8d4-86ce-4a5e-8ac3-e4530c794951">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662c27c8d79044699ea38a30b7e68432_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC03LTEtMS0w_eeff1ee0-f28f-4541-957e-779c2bea0f8c">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS0xLTEtMS0w_4a76e34f-2f2c-448b-81f0-30b970198ccc">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS0zLTEtMS0w_44177386-c5a4-468e-ae87-08eb0a16b1fb">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922d3d1beef1487f9f2d4c412ede7a12_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS01LTEtMS0w_ec9f75c8-92cc-4b7d-998e-f9ba7f7e5c81">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922d3d1beef1487f9f2d4c412ede7a12_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS03LTEtMS0w_9e37429b-0bc2-4450-9256-c69aab4b17a6">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf7b370790144619ad4a8964a5c1818_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtMS0xLTEtMA_c2bdfc41-cba3-46c0-a796-8e5bff86d99b">5,143.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf7b370790144619ad4a8964a5c1818_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtMy0xLTEtMA_da8b3067-fc64-4608-899f-daba6469982a">3,718.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5923eed9f67437e97eaed167c1389b0_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtNS0xLTEtMA_624e2185-31e4-4182-a084-3418242e7bea">4,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5923eed9f67437e97eaed167c1389b0_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtNy0xLTEtMA_02d090fc-1049-4396-9e96-03cafe406ccd">3,569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0ccccc76e945f4978ee19754f4ad89_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItMS0xLTEtMA_5427b1f4-9c53-40a5-bc92-470b162b307d">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0ccccc76e945f4978ee19754f4ad89_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItMy0xLTEtMA_26d68e47-5406-4f1c-9312-303731adef67">46.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItNS0xLTEtMA_27b31df8-0055-46ed-923a-ada4ec4c8eaa">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItNy0xLTEtMA_c42e5f9e-c4c0-4a81-a530-a959020168f3">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c3b36745514581af776cf34c7004fc_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtMS0xLTEtMA_dcebcb31-409e-4bad-91cc-58a04390bade">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c3b36745514581af776cf34c7004fc_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtMy0xLTEtMA_ffd402c2-3ee4-406d-b331-16a8047f883b">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd85d51ab164407876eccc003e0ccf9_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtNS0xLTEtMA_90fdf294-4663-4aa7-8a0d-bfa99e41933e">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd85d51ab164407876eccc003e0ccf9_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtNy0xLTEtMA_cc45513b-091a-4166-8c56-4c800dc96eb3">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtMS0xLTEtMA_c7e815b4-584c-4bff-8fff-93209912e2a5">5,224.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtMy0xLTEtMA_5dac457a-9261-4308-ab97-6539a787f1b8">3,777.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtNS0xLTEtMA_4bb6cc05-9f3b-446f-84df-3da92963776e">4,931.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtNy0xLTEtMA_01f1b508-326b-4d47-92f5-633fb4f8fb9d">3,623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQ4_853c0dad-1a4f-4443-95ae-284c826496a4" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of March&#160;27, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMC0xLTEtMS0w_d8746217-694a-4ccc-b018-535cae4963fe">153.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMS0xLTEtMS0w_5206ee0c-f31b-450b-a8e5-b663cf80b327">303.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMi0xLTEtMS0w_f644a562-8981-44ae-8bb7-48d75365193e">207.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMy0xLTEtMS0w_6b874991-107c-475d-a912-88468a590f07">195.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfNC0xLTEtMS0w_731f2523-e062-4ea4-b8d8-00c463648297">181.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RleHRyZWdpb246Y2VlNzIxYTIxZTJjNDU5Yzk2OWVmZGE1YmFmMjQ2MzNfNzU_5667a4a1-7af4-4785-a9e2-1c4ac58b79b2" continuedAt="i9be68048d4e54485aa4a01c35792bb53" escape="true">Product Warranties</ix:nonNumeric></span></div><ix:continuation id="i9be68048d4e54485aa4a01c35792bb53"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RleHRyZWdpb246Y2VlNzIxYTIxZTJjNDU5Yzk2OWVmZGE1YmFmMjQ2MzNfNzc_8399406e-a377-44d8-8ff3-75d6178a4bd1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0xLTEtMS0w_fcd10b56-7df9-48cc-8aa2-51082afa9385">9.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0zLTEtMS0w_989f8961-6d57-4976-8e73-318d11f5c8d6">4.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi01LTEtMS0w_d70d33ad-2f7f-424e-b8bb-343e415b963d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi03LTEtMS0w_ade9dfe1-f076-4a40-a4fe-564806e8a268">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi05LTEtMS0w_0b7c311e-ce7b-4f00-8bf6-8bad2bc8f671">5.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0xMS0xLTEtMA_efded1eb-9569-4dc1-9199-b7106cbfa0cc">9.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0xLTEtMS0w_b810c0c5-b8fa-45e2-a766-461c50fb86aa">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0zLTEtMS0w_6bdb9bc8-a98a-4b43-9ad3-9c63ac552b0b">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy01LTEtMS0w_cedd6429-001a-4302-9545-9f05de799ddc">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy03LTEtMS0w_ba4547f5-f8af-4cb1-a389-c429e8c2eba7">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy05LTEtMS0w_227d67e4-9e7a-4f4f-8042-3f37d53e1b35">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0xMS0xLTEtMA_b1bc50cb-7512-45e2-9da1-88cf5d38e273">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RleHRyZWdpb246MjlkZTA5NDI0NDgwNGIxZDgzNjZjYTM2NzMyNTM5ZTBfMTky_f332e61c-56f0-48d6-9a13-1e01061d6b9c" continuedAt="i97da9f14652a4cba8e72a9c2afee378a" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i97da9f14652a4cba8e72a9c2afee378a"><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RleHRyZWdpb246MjlkZTA5NDI0NDgwNGIxZDgzNjZjYTM2NzMyNTM5ZTBfMTk0_80fc12e1-4a6d-4bad-8839-cc63a279d5e1" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 27, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i800b03ee604347afbc07632cb45b6fc2_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xLTEtMS0w_8b4cf1a5-72ee-4f46-9d9f-f1e4f163d128">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fd2d36767f54a4ebd52a5d5864f3448_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0zLTEtMS0w_49f4b175-7bfe-4505-b33d-1288da1afa74">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78273368483c4226a5ea04c7d811d3fe_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi01LTEtMS0w_a5ad289f-d461-4f49-8837-7efcb4eadb4b">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10dfe3110de4427967f3a4b8e5a5f11_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi03LTEtMS0w_767d06be-c972-4649-a50c-71be9570c7e1">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f41c1c1b96640ce8c37aa114378b5af_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi05LTEtMS0w_96fb0629-f732-4362-aafc-24ea2a48a583">30.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4363fed50fdd460494577b4618dbf686_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xMS0xLTEtMA_1089ec42-cd9c-45b2-b199-ca0400ccc4dd">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79509a51d6da43a78e7aff6191ec7651_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xMy0xLTEtMA_3d136000-b21f-41a0-b7b0-93b9fa2faf17">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70664359f90341ed8b7b4035eab2e658_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xNS0xLTEtMA_7e8ac80b-2548-46ae-ab2e-97d5df638a49">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c63fca0f209477d9e2d3001848cc2d0_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xNy0xLTEtMA_7a8d9dc0-8d63-4eaa-a01a-4f5f33ea8fad">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9d9c4520de640f7837c8a8db74e7a29_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xOC0xLTEtMA_9d02d6e1-c2f9-4918-b314-c84a9b801187">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f9926be54074c05bb1382ed55335276_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xLTEtMS0w_71d22965-750f-46d8-8b7d-0284bbceba1e">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0zLTEtMS0w_335072b5-f9bb-42bc-9114-df82f969374d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc5a52321694c0f850b13ff882001db_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy01LTEtMS0w_1384fa6b-9874-431e-b064-85934aba6d4f">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy03LTEtMS0w_0c4011d4-0145-49fa-806b-1ae936fe977d">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy05LTEtMS0w_3df443f6-2f6d-4a53-9847-e9d2259d88e3">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xMS0xLTEtMA_991e1282-c344-4d72-981a-8438b88efdd9">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xMy0xLTEtMA_644b5bd3-e9a8-49ec-97eb-58e52f12d633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xNS0xLTEtMA_d9977fc5-ad61-4866-9594-1503000c98bb">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xNy0xLTEtMA_813c1445-28ea-4dd2-a449-50e49c6eb845">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4689b60d23744f289cb544253b4f814_D20200927-20210327" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xOC0xLTEtMA_6b887257-54a8-42cc-96b7-fe8803ea09cc">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f9926be54074c05bb1382ed55335276_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xLTEtMS0w_e10c6907-83d2-472b-bcc1-32ee7a4d7c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0zLTEtMS0w_4ffebf4a-a614-48ed-9121-0d4b7144d3eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc5a52321694c0f850b13ff882001db_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC01LTEtMS0w_5b97fcc4-a196-4987-97fc-a256fb311d7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC03LTEtMS0w_6f68af97-2900-40c7-90d1-bc7bfc7217d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC05LTEtMS0w_2426ea69-0cae-468c-b432-66eb64b425e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xMS0xLTEtMA_7ffe71cd-785f-4bb5-a74e-5dba6c4d152b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xMy0xLTEtMA_7880b666-9faa-429d-9f5b-e2b9c24fdec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xNS0xLTEtMA_bb564afb-05a2-4e6b-a485-705717846762">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xNy0xLTEtMA_fa976ac6-713c-4a3b-9bc3-22ba3abdea6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4689b60d23744f289cb544253b4f814_D20200927-20210327" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xOC0xLTEtMA_576554c2-0a96-4fd3-b3b7-ee8d44032738">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06b01fcedd04f3a85eb4bc29746d312_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xLTEtMS0w_d4815685-d32f-4ad6-942d-fb580fdcaf39">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fbe154820b94abb9f5b6c0d26716326_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0zLTEtMS0w_816281a2-f0b2-4176-8200-8aedef83acbd">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab882e96099247859e4ec48ec2cb938a_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi01LTEtMS0w_0db19bc9-e129-4c4d-8db3-59cce7d277e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi03LTEtMS0w_937faee7-8d59-4ea1-8fe1-f522288deb5e">19.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi05LTEtMS0w_9a09d903-0a0b-40ad-b9d2-565c8ed00d4b">35.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06b01fcedd04f3a85eb4bc29746d312_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xMS0xLTEtMA_05a6103c-828c-46f4-8696-c6fd49a60a36">14.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fbe154820b94abb9f5b6c0d26716326_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xMy0xLTEtMA_649f874b-c258-4a92-86c1-2249ef2d381b">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab882e96099247859e4ec48ec2cb938a_I20210327" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xNS0xLTEtMA_141fa22b-0427-4dab-b203-fa584b00d090">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xNy0xLTEtMA_051b27c5-e6d0-4f46-b825-76e5efaa8120">19.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xOC0xLTEtMA_4482f441-4a1a-4803-adb2-33036f0a2183">35.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ae07c79726f4de98b04adaa90df5781_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xLTEtMS0w_f9cf5ae0-d4ec-44dc-8de1-92fcbf4c1b62">33.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic38386d5f6ba40fb9d5d20588a27487e_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi01LTEtMS0w_0771c384-5e79-4261-affa-4cc51b0a0a35">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0efa40c8aa78435a86f84bf7940cae2c_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi03LTEtMS0w_3d3ac212-065d-4806-b502-27cb3fbf00e0">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2dd1ea20daa4f4089320c0fa6f87da0_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi05LTEtMS0w_3f13fd61-ca9f-4097-aa42-94508e491d00">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib48dedaf55ee438786b6134c8b28e49c_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xMS0xLTEtMA_12b1a1b8-db13-474a-ab04-cdbf2f303f6e">28.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a5a29aba88e419589c3a2f9fed50569_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xMy0xLTEtMA_5303a1cb-f0ac-4a69-9ba2-67b8a2198fc8">41.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7430ac3155b74726add1cbc2e862b58b_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xNy0xLTEtMA_ba330520-4ee2-49b5-ab94-6483d0cc6c94">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8b78544c617454991ea1abde3fc0128_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xOS0xLTEtMA_aefbbc62-2938-4e05-8ed0-81e9acfe3ca0">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6dda121f07348d9b40b999f1945cf6e_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xOS0xLTEtNzA2Ng_e245498e-bf95-4f28-b667-3b3c02f80d90">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527df9991fb4a508abd170595d3765f_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0yMS0xLTEtMA_db5e419e-4fcd-44b3-bc5d-efb81ae9a1ac">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xLTEtMS0w_42fb00fe-b148-40ba-87ac-cedf559d5622">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy01LTEtMS0w_8bf75849-bb1f-4029-9953-20c3c4facd21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy03LTEtMS0w_e8a1394d-64fb-4e01-a3e1-a3a3074a2ff7">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy05LTEtMS0w_ac2dd21c-a52e-4aaf-be84-15af1c8b0bfb">25.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xMS0xLTEtMA_0fd92d51-6f58-4c8f-bafc-d4d89c2ea31a">30.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xMy0xLTEtMA_9656c54f-04b3-4d25-94a8-fd338cc065d7">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xNy0xLTEtMA_af0e55c1-8b1d-4464-845d-f0ee3ae66d63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa1b4b017d74905880304f384c057b2_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xOS0xLTEtMA_9284b27e-1c60-437d-bdfd-a5cf1f1d3650">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xOS0xLTEtNzA2OA_ffbf38ec-fbe7-4901-9708-780546f101c9">21.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0yMS0xLTEtMA_937b4a44-78de-4125-acc2-6eddecb0d4bc">18.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xLTEtMS0w_93800da6-b1ca-467e-959c-3018abca5277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC01LTEtMS0w_1f62e122-3c91-475f-b791-3b9843a1dd2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC03LTEtMS0w_63c89377-ebd4-4efb-b5b4-b9f4d26c297e">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC05LTEtMS0w_7564e642-eac0-40b8-a02f-58264dc64897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xMS0xLTEtMA_fe56a83b-ef66-402b-af09-60f048b7db9a">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xMy0xLTEtMA_e5b17b78-e3d0-4c84-bd8f-0468b9493ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xNy0xLTEtMA_0f0014f5-bb21-4519-baf2-996b6e3e415a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa1b4b017d74905880304f384c057b2_D20190929-20200328" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xOS0xLTEtMA_c4ee9557-de54-4456-9221-ff4a885c8e51">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xOS0xLTEtNzA3MA_abe3ef87-a307-4750-aff1-608d597a1ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0yMS0xLTEtMA_cbcd296a-a3ea-4268-920a-dc9e5c21fc85">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d0130d8988c45bbac97673c8e2ce744_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xLTEtMS0w_1154d656-d170-492e-ba65-c7301f996275">38.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd0078ba73a24f819d70857c6b061aec_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS01LTEtMS0w_c1c46e79-cd7a-48ba-a1a9-8767cbaa11a0">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e7212338e6d4a7fb971feed57bf398c_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS03LTEtMS0w_596c3625-3946-4a52-b960-b83121075db7">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04964732adf14196a87e9aeb38f71672_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS05LTEtMS0w_047f6698-d0a6-4a46-8033-56eff261471b"><ix:nonFraction unitRef="usd" contextRef="i04964732adf14196a87e9aeb38f71672_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS05LTEtMS0w_24c6109f-3fe0-44ac-b6e5-d024247bc98e">17.6</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xMS0xLTEtMA_1f417929-2ed0-40ea-ad19-6121d08a95e9">58.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d0130d8988c45bbac97673c8e2ce744_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xMy0xLTEtMA_2b667977-4755-43a7-be2a-f7d4c1f886a0">38.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd0078ba73a24f819d70857c6b061aec_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xNy0xLTEtMA_8496a3f0-2b2c-4f8e-b9f1-df3b2b46cca8">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e7212338e6d4a7fb971feed57bf398c_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xOS0xLTEtMA_ab54f945-87fe-4288-8ad1-640bfa502a24">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04964732adf14196a87e9aeb38f71672_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xOS0xLTEtNzA3Mg_9cb4b7d2-7703-4fee-bba4-fe02ca7329b2">17.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0yMS0xLTEtMA_6ab86e7e-f150-492c-80b0-3b9051b6f699">58.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19) Share Repurchase</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i1c79daa201df43a4b63c18f0297a823a_I20191211" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTI3_4bfc8eb0-5467-4740-975c-93ccdf67a768">500.0</ix:nonFraction>&#160;million of the Company's outstanding common stock, effective March 2, 2020, as amended. During the first quarter of fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNDU0_279fa5bc-c91e-444a-b719-b022c9e1e44e">1.5</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNTEz_7a64778c-6340-4b9f-9467-824354ad3b36">101.3</ix:nonFraction>&#160;million. On December 9, 2020, the Board of Directors authorized a new share repurchase plan, which is effective for five years, to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="id7a12e09486e470bbfebd7bc5df72fa0_I20191211" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNjU2_84a0bdeb-46a7-422f-b33a-3a09767585bd">1.0</ix:nonFraction>&#160;billion of the Company's outstanding common stock effective December 11, 2020. The prior plan was terminated in connection with this new authorization. During the second quarter of fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTgxNg_59e7b203-2902-4358-a8ea-cd865a799bfc">1.6</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTgyOQ_d5aee2cb-8cb8-41bd-84b5-94cf8fce3bc8">120.1</ix:nonFraction>&#160;million. As of March 27, 2021, $<ix:nonFraction unitRef="usd" contextRef="i4303fcd9add84b19b7bd0ac918b9aa95_I20210327" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTAzNA_305e4eee-21ae-481d-98ad-498b1d0dbc92">880.0</ix:nonFraction>&#160;million remained available under this authorization.</span></div><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(20) <ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85Ny9mcmFnOjZhNTdjYTkyZGJiYTQzZjg5ZjM2MmQ0YzdhNjQ0YzUxL3RleHRyZWdpb246NmE1N2NhOTJkYmJhNDNmODlmMzYyZDRjN2E2NDRjNTFfMjgwNQ_56d27527-1e66-4c00-a570-e99fd3f02de7" continuedAt="i63937eea028a4d4497909b754395177d" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i63937eea028a4d4497909b754395177d" continuedAt="i09e54b31009f448ab629c883c9cd4ab6"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 for Recently Adopted Accounting Pronouncements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85Ny9mcmFnOjZhNTdjYTkyZGJiYTQzZjg5ZjM2MmQ0YzdhNjQ0YzUxL3RleHRyZWdpb246NmE1N2NhOTJkYmJhNDNmODlmMzYyZDRjN2E2NDRjNTFfMjgwMw_f977c78c-15ae-45c7-b740-5c4799482826" continuedAt="i014a76baf6264780ae0f822fc3151b61" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:continuation id="i09e54b31009f448ab629c883c9cd4ab6" continuedAt="i27e0b33afd9045e0a22b784146677783"><ix:continuation id="i014a76baf6264780ae0f822fc3151b61" continuedAt="iab64603151614fbb8fb919340b8dbaf1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></ix:continuation></ix:continuation></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:continuation id="i27e0b33afd9045e0a22b784146677783" continuedAt="ia959157dbdff46d7860747d4929a9442"><ix:continuation id="iab64603151614fbb8fb919340b8dbaf1" continuedAt="i9807952cebb64a67a3c28541588bea89"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia959157dbdff46d7860747d4929a9442"><ix:continuation id="i9807952cebb64a67a3c28541588bea89">The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic and associated economic disruptions on our business, financial condition, results of operations and cash flows and our ability to further draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic on our customers and suppliers;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture, on a scale necessary to meet demand, our COVID-19 assays as well as the systems on which the assays run; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the continuing worldwide macroeconomic uncertainty, including the UK's decision to leave the European Union (known as Brexit), on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the current trade war between the U.S. and other nations, most notably China, and the impending impact of tariffs on the sale of our products in those countries and potential increased costs we may incur to purchase materials from our suppliers to manufacture our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of new competitive technologies and products, and the impact and anticipated benefits of completed acquisitions and acquisitions we may complete in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the new European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business strategies;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimated asset and liability values;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact and costs and expenses of any litigation we may be subject to now or in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with covenants contained in our debt agreements;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations, including the potential impact of the proposed phase out of LIBOR by the end of 2023; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our liquidity, capital resources and the adequacy thereof.</span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy." &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including those set forth under "Risk Factors" set forth in Part II, Item 1A of this Quarterly Report, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_103"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Diagnostics segment, we offer a wide range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause the common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or CTGC, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis. In addition, in 2017 and 2018 we introduced the Aptima quantitative viral load tests for HIV, Hepatitis C and Hepatitis B. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-Cov-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay were launched at the end of our second quarter and in the third quarter of fiscal 2020, respectively. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care for radiology, pathology and surgery. These solutions include breast imaging and analytics, such as our 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, ultrasound and connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. With the acquisition of SuperSonic Imagine in the first quarter of fiscal 2020, we now offer premium ultrasound imaging, further connecting Hologic capabilities across the continuum of breast care from screening to diagnosis and treatment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets we sell our products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, we started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the second quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on our operating results and cash flows in fiscal 2020, however, the impact of the commercial release of our COVID-19 assays more than offset those negative impacts as we generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the second quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of our COVID-19 assays as well the continued recovery of our other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on our operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. We expect that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for our COVID-19 assays. Accordingly, we expect that revenues generated from the sale of our COVID-19 assays, primarily in the U.S., will decrease significantly in the third quarter of fiscal 2021 compared to the second quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on our business, in April 2020, we initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but we also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, employee terminations. Further in April 2020, we shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of our products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities were back to pre-COVID-19 pandemic levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also taken and continue to take measures to ensure the safety of our employees and to comply with governmental orders. These measures could require that our employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in our commercial and marketing activities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademark Notice</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, Acessa, Acessa Health, Acessa ProVu, Affirm, Affirm Prone, Alpha Imaging, Aptima, Biotheranostics, Brevera, Clarity HD, Diagenode, Fluent, Fluoroscan, Genius 3D, Genius 3D Mammography, Health Beacons, Hologic, Horizon DXA, Insight, Intelligent 2D, LOCalizer, MyoSure, NovaSure, NXC Imaging, Panther, Panther Fusion, Rapid fFN, Selenia, Selenia Dimensions, SmartCurve, Somatex, SuperSonic Imagine, ThinPrep, Tigris, and Tumark. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective owners. Hologic's use or display of other parties' trademarks, trade dress or products in this offering circular does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners.</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_106"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth descriptions of acquisitions and dispositions we have completed in fiscal 2020 and the first and second quarters of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, we completed the acquisition of Biotheranostics, Inc., or Biotheranostics, for a purchase price of $232.5 million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs lab testing procedures at its facility. Biotheranostics' results of operations are included in our Diagnostics segment and its revenues are reported within Service and other revenue in our consolidated statement of income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Diagenode SA, or Diagenode, for a purchase price of $153.4 million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are included in our Diagnostics segment.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, we completed the acquisition of Somatex Medical Technologies GmbH, or Somatex, for a purchase price of $62.8 million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. Somatex's results of operations are included in our Breast Health segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed the acquisition of assets from NXC Imaging, for a purchase price of $5.6 million. NXC Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S. NXC's results of operations are included in our Breast Health and Skeletal segment, as applicable to their operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, we completed the acquisition of Acessa Health, Inc., or Acessa, for a purchase price of $161.3 million, which included contingent consideration and was estimated at $81.8 million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its Acessa ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are included in our GYN Surgical segment. The contingent consideration is based on annual incremental revenue growth over a three-year period ending annually in December. The contingent consideration is payable after each annual measurement period. We remeasure the contingent consideration liability on a quarterly basis and recorded a gain of $14.7 million to decrease the liability to its fair value in the three months ended March 27, 2021. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period. In the first quarter of fiscal 2021, we recorded a loss of $4.6 to record the liability at fair value.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed the acquisition of Health Beacons, Inc., or Health Beacons, for a purchase price of $19.7 million. Health Beacons manufactures the LOCalizer product and its results of operations are included in our Breast Health segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the acquisition of assets from Alpha Imaging, LLC, or Alpha Imaging, for a purchase price of $18.0 million. Alpha Imaging was a long-standing distributor of our Breast and Skeletal Health products in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Alpha Imaging's result of operations are included in our Breast Health and Skeletal segment, as applicable to their operations. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, we acquired approximately 46% of the outstanding shares of SuperSonic Imagine S.A., or SSI, which is headquartered in France. SSI specializes in ultrasound imaging and designs, and develops and markets an ultrasound platform used in the non-invasive care path for the characterization of breast, liver or prostate diseases. We initially accounted for this investment as an equity method investment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, we acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, we owned approximately 78% of the outstanding shares of SSI at November 21, 2019 and controlled SSI's voting interest and operations. We performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within our consolidated financial statements within our Breast Health segment. We remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded in Other income (expense), net in the first quarter of fiscal 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, we owned approximately 80% of SSI, and accordingly we have recorded an adjustment to our net income for the non-controlling interest we do not own of $0.5 million and $1.5 million for the three and six months ended March 27, 2021, respectively, and $1.5 million and $1.8 million for the three and six months ended March 28, 2020, respectively.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disposition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the sale of our Medical Aesthetics business. At the closing, we received cash proceeds of $153.4 million. The sales price was finalized in the fourth quarter of fiscal 2020, and we paid $3.4 million, resulting in a final sales price of $150.0 million. As a result of the sale, we recorded a $30.2 million impairment charge in the first quarter of fiscal 2020 to record the asset group at fair value less costs to dispose as it met the assets held-for-sale criteria. For additional information, see Note 6 to our consolidated financial statements included herein. Following the sale of our Medical Aesthetics business, we have not generated any further product revenue related to this business, although additional expenses will be incurred primarily in connection with the indemnification of legal and tax matters that existed as of the date of disposition. In addition, we agreed to provide transition services for a period of up to 15 months, which primarily ended in March 2021.</span></div><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_109"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts in tables are presented in millions.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,043.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">314.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,156.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,535.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">247.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">205.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">395.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Skeletal&#160;Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,378.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">623.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">755.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,834.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,322.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,511.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated an increase in product revenues in both the current three and six month periods of 121.1% and 114.2%, respectively, compared to the corresponding periods in the prior year primarily due to the significant increase in revenues in the Diagnostics business principally from sales of our two COVID-19 assays, one of which was launched near the end of the second quarter of fiscal 2020 and the other in the third quarter of fiscal 2020. The increase in product revenues in the current six </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">month period compared to the corresponding prior year period was partially offset by no revenues from the Medical Aesthetics business in the current fiscal year as we disposed of this business segment on December 30, 2019, the beginning of our second quarter of fiscal 2020. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues increased $729.1 million and $1,535.7 million, or 231.9% and 247.4%, respectively, in the three and six month periods compared to the corresponding periods in the prior year primarily due to increases in Molecular Diagnostics of $728.2 million and $1,533.7 million, respectively, increases in Cytology &amp; Perinatal of $3.4 million and $6.9 million, respectively, partially offset by decreases of $2.4 million and $5.0 million in Blood Screening. While we divested our Blood Screening business in the second quarter of fiscal 2017, we continue to provide long-term access to Panther instrumentation and certain supplies to the purchaser of that business. Molecular Diagnostics product revenue was $917.2 million and $1,899.4 million, respectively, in the current three and six month periods compared to $189.1 million and $365.7 million in the corresponding periods in the prior year. The increases were primarily attributable to revenues of $679.7 and $1,425.1 million, respectively, in the current three and six month periods from our two SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay), an increase in collection kits and Panther and Panther Fusion instrument sales primarily due to demand for increased testing capacity for COVID-19. We are actively working to increase capacity production to meet worldwide demand of these assays. However, we do expect that sales of our COVID-19 assays will decline significantly, primarily in the U.S. where approximately two-thirds of these sales occur, in the third quarter of fiscal 2021 compared to the current quarter due to the continued distribution of vaccines and higher inventory levels at our laboratory customers. Our Aptima assays (exclusive of our Aptima SARS-CoV-2 assay) increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in HPV assays in the U.S. in the current quarter and on a worldwide basis for the current six month period largely driven by co-testing in Germany and to a lesser extent in the UK, partially offset by lower volumes of our CTGC assay in both current year periods as well as slightly lower average selling prices. In addition, we had an increase in our Fusion flu assays in both current year periods. Cytology &amp; Perinatal product revenue increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to higher ThinPrep test volumes in the U.S. and Asia-Pacific, which we primarily attribute to the recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic, partially offset by lower average selling prices and lower Perinatal product volumes. The inclusion of Diagenode contributed $3.5 million of product revenue in the current quarter. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues increased $18.6 million and $10.7 million, or 10.0% and 2.7%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year. These increases were primarily due to increases in our interventional breast solutions products, primarily our Brevera system and disposables as we relaunched this product line in the fourth quarter of fiscal 2020 and our breast conserving surgery products primarily due to increased biopsy procedures, which we attribute to recovery of elective procedures and exams that had been previously delayed or cancelled in response to the COVID-19 pandemic and an increase in sales volume of our workflow products, consisting primarily of Intelligent 2D, Clarity HD and SmartCurve. These increases in revenue were partially offset by a decrease in sales volume and average selling prices of our digital mammography systems and Affirm Prone breast biopsy tables. While these sales have declined moderately compared to the prior year comparable period, they have increased sequentially from the fourth quarter of fiscal 2020 and first quarter of fiscal 2021 as we believe many of our customers were purchasing to fulfill their budgets and demand has increased in the sequential quarters, which we primarily attribute to a recovery of elective procedures and exams as elective procedures and wellness visits have begun to recover from the initial cancellation and deferrals due to the COVID-19 pandemic in fiscal 2020. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased $8.9 million and $14.1 million, or 8.5% and 6.3%, respectively, in the current three and six month periods compared to the corresponding periods in the prior year primarily due to increases in the volume of MyoSure systems, Fluent Fluid Management systems and sales of ProVu systems, acquired in the Acessa acquisition in the fourth quarter of fiscal 2020. We primarily attribute the increases in the current year periods to the recovery of elective medical procedures that had previously been delayed or cancelled in response to the COVID-19 pandemic. These increases were partially offset by decreases in NovaSure system sales in the current year periods compared to the corresponding periods in the prior year, which we believe is primarily due to a contraction in the gynecological endometrial ablation market. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues decreased $1.4 million or 8.0% in the current three month period and increased $0.5 or 1.5% in the current six month period compared to the corresponding periods in the prior year. The decrease in the current three month period is primarily due to a decrease in sales volume of our Horizon DXA systems. The increase in the current six month period is primarily due to an increase in sales volume of our Insight FD mini C-arm system, partially offset by lower sales volume of our Horizon DXA systems.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total product revenues were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current three and six month periods compared to the corresponding periods in the prior year, the percentage of product revenue derived from the U.S. decreased while Europe increased, which we primarily attributed to strong sales of our SARS-CoV-2 assays in Europe and growth in our Aptima assays in Europe as we expanded our customer base and increased sales from the adoption of co-testing for cervical cancer screening in Germany and to a lesser extent in the UK. Asia-Pacific product revenue as a percentage of total product revenue increased in the current three month period compared to the corresponding period in the prior year, which we primarily attribute to increased sales of our mammography systems and growth in ThinPrep and Molecular Diagnostics due to recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic. Asia-Pacific product revenue as a percentage of total product revenue decreased in the current six month period compared to the corresponding period in the prior year primarily due to lower sales of our SARS-CoV-2 assays in the Asia-Pacific region compared to the U.S. and Europe and the prior year period included sales from Medical Aesthetics.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation and repair of our products. The majority of these revenues are generated within our Breast Health segment. The increase in service and other revenue in the current three and six month periods compared to the corresponding periods in the prior year was primarily due to an increase in Breast Health service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period as well as additions from our distributor acquisitions, and an increase in spare parts revenue in the current three and six month periods for services that had previously been delayed or cancelled due to the COVID-19 pandemic. In our Diagnostics business, we had additional royalty revenue in the current three and six month periods of $11.2 million, and $22.8 million, respectively, from Grifols related to licensing our intellectual property related to our COVID-19 assays for their sale in Spain. In addition, the inclusion of Biotheranostics added $4.0 million in the current three and six month periods. These increases were partially offset by the sale of the Medical Aesthetics business which contributed $15.6 million of revenue in the prior year six month period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">223.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">585.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">460.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Impairment of Intangible Assets and Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">286.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">711.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 21.8% and 20.6% in the current three and six month periods, respectively, compared to 35.8% and 34.8% in the corresponding periods in the prior year, respectively. Cost of product revenues as a percentage of revenue decreased in the current three and six month periods primarily due to sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 49.3% and 50.3%, respectively, of total product revenue in the current three and six month periods. Also benefiting the gross margin was the disposition of Medical Aesthetics, which had lower gross margins compared to our remaining businesses. Partially offsetting these decreases was higher field service costs for the instrument installed base for the Diagnostics business and higher freight costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to sales of our SARS-CoV-2 assays and higher overall production reducing fixed overhead on a unit basis, and increased volumes of our ThinPrep Pap Test, partially offset by higher field service costs for our expanded instrument installed base, freight charges internationally and an increase in inventory reserves.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue decreased slightly in the current three and six month periods compared to the corresponding periods in the prior year primarily due an increase in sales volume of our breast biopsy and breast conserving surgery disposable products, an increase in our higher-margin workflow products, consisting of Intelligent 2D, Clarity HD and SmartCurve upgrades, and lower inventory reserves, partially offset by a decline in volumes and average selling prices of our 3D systems and related components and the step-up in fair value of inventory acquired in the Somatex acquisition resulting in additional costs of $2.3 million in the current quarter.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the product mix of higher volumes of lower margin products, including higher volumes of MyoSure devices, Fluent Fluid Management systems and ProVu systems, acquired in the Acessa acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue increased in the current three and six month periods compared to the corresponding periods in the prior year due to lower sales volume and lower average selling prices of our Horizon DXA system.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense increased in the current three month period and was relatively flat in the current six month period compared to the corresponding periods in the prior year. The increase in the current quarter was primarily due to intangible assets acquired in the Biotheranostics, Diagenode, Somatex and Acessa acquisitions, partially offset by lower amortization of intangible assets acquired in the Cytyc acquisition which reduces over time.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 6 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets, of which $25.8 million was allocated to developed technology assets and written off to cost of revenues. </span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">170.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin increased to 45.5% and 45.7%, respectively, in the current three and six month periods compared to 44.1% and 42.3%, respectively, in the corresponding periods in the prior year. The increase in the current year periods was primarily due to additional royalty revenue from Grifols related to licensing our intellectual property related to our COVID-19 assays for their sale in Spain, which has a high margin. In addition, in the current year periods the Breast Health business had an increase in service contract revenue which benefited gross margin as service contract revenue has higher margins compared to revenue from spare parts, installation and training.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">180.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and Divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">289.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">239.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">583.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">548.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses increased 45.0% and 18.4% in the current three and six month periods compared to the corresponding periods in the prior year primarily due to higher compensation and benefits, primarily from our deferred compensation plan and higher bonus, a $7.0 million charge related to the purchase of intellectual property in the current quarter in Breast Health, higher R&amp;D project spend in Breast Health and Surgical, the inclusion of expenses from the Acessa, Biotheranostics and Diagenode acquisitions and increased spending to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements. Partially offsetting these increases was the disposition of the Medical Aesthetics business which contributed $7.3 million of expense in the prior </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year six month period. In addition, in the current three and six month periods we recorded a reduction to research and development expenses of $1.3 million and $7.7 million, respectively, from the Biomedical Advanced Research and Development Authority (BARDA) in connection with a grant to expand manufacturing capacity and obtain FDA approval of our SARS-CoV-2 assays. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses increased 18.9% and 1.6% in the current three and six months periods compared to the corresponding periods in the prior year primarily due to an increase in commissions in Breast Health, Surgical and Diagnostics from higher revenues, higher bonus, an increase in marketing initiatives and consulting spending, and the inclusion of expenses in the aggregate from the Acessa, Biotheranostics and Diagenode acquisitions of $6.1 million and $8.7 million in the current three and six month periods, respectively, partially offset by lower travel expenses and trade shows in response to the COVID pandemic. Partially offsetting these increases in the current six month period was the disposition of the Medical Aesthetics business which contributed $23.7 million of expense in the prior year six month period and decreases related to our national sales meeting and the RSNA conference as a result of the COVID pandemic.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 32.7% and 16.6% in the current three and six month periods compared to the corresponding periods in the prior year primarily due to higher compensation and benefits, primarily from our deferred compensation plan, stock compensation and bonus, the inclusion of expenses from the Acessa, Biotheranostics, and Diagenode acquisitions, higher litigation and settlement costs, increased acquisition transaction related costs, higher consulting spend for corporate initiatives and information system implementation projects, partially offset by a $3.3 million benefit due to reversal of a tax reserve and lower travel. In the current six month period, we had higher expenses from an increase in bad debt expense of $7.0 million and a charitable donation of $5.0 million partially offset by the disposition of the Medical Aesthetics business, which contributed $5.5 million of expenses in the prior year period, expenses incurred to separate and dispose of that business, and in the current six month period we recorded a credit of $3.3 million related to services provided under the transition services agreement with Cynosure. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 2 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense was relatively consistent in both periods compared to the prior year periods as we had increases from recent acquisitions offset by assets from older acquisitions becoming fully amortized. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa, we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December. As of the acquisition date for Acessa, we recorded a contingent consideration liability for the estimated fair value of the amount we expected to pay to the former shareholders of the acquired business. This liability is not contingent on future employment and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liabilities can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. In the current quarter, we recorded a gain of $14.7 million to decrease the liability to its fair value, and the reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period. In the first quarter of fiscal 2021, we recorded a loss of $4.6 million to record the liability at fair value.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As discussed in Note 6 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets of which $4.4 million was written off to operating expenses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Divestiture Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have implemented various cost reduction initiatives to align our cost structure with our operations and related integration activities. These actions have primarily resulted in the termination of employees. As a result, we recorded charges of $1.6 million and $3.0 million in the current three and six month periods, respectively, and $2.9 million and $3.9 million in the prior year periods, respectively, primarily related to severance benefits. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.858%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense in the current three and six month periods decreased primarily due to a decrease in LIBOR year over year, the basis for determining interest expense under our 2018 Credit Agreement, lower interest rates on our Senior Notes due to issuing our 2029 Senior Notes and paying off our 2025 Senior Notes, and the pay-off of amounts outstanding under our accounts receivable asset securitization agreement in the prior year, partially offset by issuance costs expensed from the issuance of the 2029 Senior Notes and higher interest rate swap expenses.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we completed a private placement of $950 million aggregate principal amount of our 2029 Senior Notes. The proceeds under the 2029 Senior Notes offering, together with available cash, were used to redeem our 2025 Senior Notes in the same principal amount. In connection with this transaction, we recorded a debt extinguishment loss of $21.6 million in the first quarter of fiscal 2021.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current three month period, this account primarily consisted of a gain of $2.7 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains and net foreign currency exchange gains of $2.1 million, primarily from the mark-to-market of outstanding forward foreign currency exchange and foreign currency option contracts. For the second quarter of fiscal 2020, this account primarily consisted of a loss of $9.0 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven primarily by stock market losses, partially offset by miscellaneous income and net foreign currency exchange gains were negligible as hedging activities offset realized losses. </span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current six month period, this account primarily consisted of a gain of $8.9 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains, partially offset by net foreign currency exchange losses of $7.4 million, primarily from the mark-to-market of outstanding forward foreign currency exchange and foreign currency option contracts. For the prior year corresponding six month period, this account primarily consisted of a loss of $6.1 million on the cash surrender value of life insurance contracts driven primarily by stock market losses, net foreign currency exchange losses of $1.7 million primarily from mark-to-market of outstanding forward foreign currency and foreign currency option exchange contracts, partially offset by a net gain of $3.2 million to reflect an adjustment to remeasure our initial investment in SSI in connection with purchase accounting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision (Benefit) for Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three and six months ended March 27, 2021 was a provision of 20.6% and 21.1%, respectively, compared to a provision of 20.3% and a net benefit of 122.1%, respectively, for the corresponding periods in the prior year. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended March 27, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes. Our effective tax rate for the six months ended March 27, 2021 was higher than the U.S. statutory tax rate primarily due to state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended March 28, 2020 differed from the U.S. statutory tax rate primarily due to taxation of foreign earnings at tax rates lower than the U.S. statutory tax rate including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, partially offset by unbenefited foreign losses. Our effective tax rate for the six months ended March 28, 2020 differed from the statutory tax rate primarily due to a $310.9 million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div><div style="text-indent:24pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_112"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the disposition of the Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. We measure segment performance based on total revenues and operating income (loss). Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,064.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">745.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,192.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,562.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,122.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,485.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,290.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues associated with the introduction of our SARS-CoV-2 assays discussed above and an increase in royalty revenue from Grifols related to licensing intellectual property related to our COVID-19 assays for their sale in Spain.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and six month periods compared to the corresponding periods in the prior year due to an increase in gross profit from higher revenues with higher gross margins, partially offset by an increase in operating expenses. Gross margin was 77.3% and 78.7% in the current three and six month </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">periods, respectively, compared to 47.4% and 48.2% in the corresponding periods in the prior year, respectively. The increase in gross profit was primarily due to sales of our SARS-CoV-2 assays and royalty revenue, partially offset by an increase in freight costs to ship product internationally, an increase in inventory reserves, and higher field service costs.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to higher compensation and benefits driven by our deferred compensation plan and bonus, an increase in headcount in the operations and sales departments, an increase in marketing initiatives, an increase in R&amp;D project spend, higher acquisition transaction related expenses and additional expenses from the Biotheranostics and Diagenode acquisitions. In addition, in the current six month period we had higher bad debt expense. These increases were partially offset by the BARDA credit of 1.3 million and $7.7 million in the current three and six month periods, respectively, and a decrease in spending for travel, consulting and trade shows.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.7)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase of $18.6 million and $10.7 million in product revenue, respectively, discussed above and an increase of $10.0 and $19.5 million in service revenue, respectively. The increase in service revenue in the current three and six month periods was primarily due to an increase in service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, the addition of service contracts from the NXC Imaging acquisition and an increase in spare parts revenue.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in operating expenses partially offset by an increase in gross profit from higher service revenues. Gross margin was 56.2% and 57.0% in the current three and six month periods, respectively, compared to 55.2% and 56.3% in the corresponding periods in the prior year, respectively. The increase in gross profit was primarily due to higher product margins related to an increase in sales volume of our breast biopsy and breast conserving surgery disposable products and an increase in our higher-margin workflow products discussed above, and an increase in service margins from higher service contract revenue, partially offset by a charge of $2.3 million related to the impact of stepping-up the acquired inventory to fair value in purchase accounting for the Somatex acquisition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a $7.0 million charge related to the purchase of intellectual property in the current quarter, an increase in R&amp;D project spend, an increase in marketing initiatives, higher compensation and benefits driven by our deferred compensation plan and bonus, and higher commissions. These increases were partially offset by a decrease in travel and trade show expenses. The increase in the current quarter is also a result of the prior year period including a benefit from the reversal of acquisition related accruals and a holdback.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for the current three and six month periods include a gain of $14.7 million and $10.1 million, respectively, related to the fair value adjustments for contingent consideration related to the Acessa acquisition. Excluding the fair value adjustment for contingent consideration, operating income for this business segment decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to an increase in operating expense, partially offset by an increase in gross profit from higher revenues. Gross margin was 59.5% and 61.1% in the current three and six month periods, respectively, compared to 62.3% and 64.4% in the corresponding periods in the prior year, respectively. The decrease in gross margin was primarily due to a decrease in product margins related to unfavorable product mix discussed above and higher amortization expense from intangible assets due to the Acessa acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the fair value adjustment for contingent consideration, operating expenses increased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to the inclusion in the current three and six month periods of Acessa expenses of $3.7 million and $7.9 million, respectively, increased spending on research and development projects, higher marketing initiative spend, higher consulting spend, higher compensation and benefits driven by our deferred compensation plan and bonus and higher commissions from the increase in sales, partially offset by a decrease in travel and trade show expenses.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111.8)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues decreased in the current three month period and increased in the current six month period compared to the corresponding periods in the prior year primarily due to the change in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current three and six month periods compared to the corresponding periods in the prior year primarily due to a decrease in gross profit from lower gross margins. Gross margin was 35.4% and 35.5% in the current three and six month periods, respectively, compared to 38.7% and 40.4% in the corresponding periods in the prior year, respectively. The decrease in gross margin was primarily due to lower sales volume and lower average selling prices of our Horizon DXA system.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three month period compared to the corresponding period in the prior year primarily due to higher compensation and benefits. Operating expenses decreased in the current six month period compared to the corresponding period in the prior year primarily due to lower research and development expenses from reduced headcount, partially offset by higher compensation and benefits.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Aesthetics</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Aesthetics revenue and operating loss decreased in the current three and six month periods compared to the corresponding periods in the prior year due to the divestiture of the Medical Aesthetics segment on December 30, 2019, the first </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">day of our second quarter of fiscal 2020. The operating loss in the second quarter of fiscal 2020 included an intangible assets and equipment impairment charges of $30.2 million.</span></div><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;27, 2021, we had $1,626.0 million of working capital and our cash and cash equivalents totaled $816.4 million. Our cash and cash equivalents balance increased by $115.4 million during the first six months of fiscal 2021 primarily due to cash generated from operating activities, partially offset by cash used in investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2021, our operating activities provided cash of $1,202.2 million, primarily due to net income of $1,272.8 million, non-cash charges for depreciation and amortization aggregating $188.0 million, stock-based compensation expense of $35.6 million, and a debt extinguishment loss of $21.6 million, partially offset by a decrease in deferred income taxes of $23.5 million primarily due to the amortization of intangible assets. Cash provided by operations was negatively impacted by a net cash outflow of $311.2 million from changes in our operating assets and liabilities. The net cash outflow was primarily driven by a $171.4 million increase in accounts receivable primarily due to an increase in our COVID-19 assay sales in our Diagnostics division, a decrease in accrued expenses of $50.1 million primarily due to net payments on accrued compensation primarily related to the annual bonuses, and interest payments, partially offset by an increase in accrued federal income taxes, an increase in inventory of $46.0 million primarily due to an increase in Diagnostics inventory to support the SARS-CoV-2 assay demand and production, and a reduction of prepaid income taxes of $46.6 million. These cash outflows were partially offset by an increase in accounts payable of $32.8 million primarily due to the timing of payments. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2021, our investing activities used cash of $528.1 million primarily related to net cash paid for the acquisitions of Biotheranostics, Diagenode, and Somatex of $440.0 million and capital expenditures of $79.5 million, which primarily consisted of the placement of equipment under customer usage agreements and purchases of manufacturing equipment to expand capacity of our molecular diagnostics manufacturing facilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of fiscal 2021, our financing activities used cash of $557.4 million primarily related to $970.8 million for the repayment of our 2025 Senior Notes, $250.0 million for the net repayment of amounts borrowed under our revolving credit line, $221.4 million for repurchases of our common stock, $46.7 million for the payment of employee taxes withheld for the net share settlement of vested restricted stock units and $37.5 million for scheduled principal payments under our 2018 Credit Agreement. Partially offsetting these uses of cash were net proceeds of $950.0 million under our 2029 Senior Notes and $33.6 million from our equity plans, primarily from the exercise of stock options.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $2.75 billion at March&#160;27, 2021, which was comprised of amounts outstanding under our 2018 Credit Agreement of $1.42 billion (principal of $1.43 billion), 2029 Senior Notes of $933.5 million (principal of $950.0 million), and 2028 Senior Notes of $395.0 million (principal of $400.0 million).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018 Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, we refinanced our term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, amended and restated as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consisted of:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A $1.5 billion secured term loan ("2018 Amended Term Loan") with a maturity date of December 17, 2023; and</span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A secured revolving credit facility (the "2018 Amended Revolver") under which the Company may borrow up to $1.5 </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings of the 2018 Amended Term Loan bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was equal to 1.0% as of March 27, 2021. The borrowings of the 2018 Amended Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.0% as of March 27, 2021. At March 27, 2021, borrowings under the 2018 Amended Term Loan were subject to an interest rate of 1.11%.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2018 Amended Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Amended Term Loan after the scheduled principal payments, which </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $1.2 billion as of March 27, 2021, and any amount outstanding under the 2018 Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by us,&#160;first, to the 2018 Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under a qualifying  accounts receivable securitization program.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting our ability, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires us to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants (a total net leverage ratio and an interest coverage ratio) measured as of the last day of each fiscal quarter. As of March 27, 2021, we were in compliance with these covenants.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which has been extended to June 30, 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2028 Senior Notes is $400.0 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2028 Senior Notes were issued pursuant to an indenture, dated as of January 19, 2018, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February 15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February 15, 2021. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2021, we  entered into an agreement to acquire Mobidiag Oy, or Mobidiag, for an purchase price of approximately $795 million (based upon current Euro conversion rates into U.S. Dollars). Mobidiag, located in Finland and France, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. The closing is subject to customary closing conditions, including, among others, (i) our having obtained requisite clearances from Finnish and French governmental authorities, (ii) at least ninety percent (90%) of the equityholders of Mobidiag becoming party to the purchase agreement and (iii) compliance by the sellers with their obligations under the purchase agreement (subject to certain materiality thresholds). The purchase agreement also contains certain customary termination rights for us and the sellers, including, among other events, if the transaction has not been completed on or prior to August 6, 2021 (which date may be extended to September 5, 2021 under certain circumstances). Subject to the timely satisfaction or waiver of the conditions to closing, we expect this acquisition to close in the fourth quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our acquisitions, we have incurred the obligation to make contingent earn-out payments tied to performance criteria, principally revenue growth of the acquired business over a specified period. In addition, contractual provisions relating to these contingent earn-out obligations may result in the risk of litigation relating to the calculation of the amount due or our operation of the acquired business. Such litigation could be expensive and divert management attention and resources. Our obligation to make contingent payments may also result in significant operating expenses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent consideration arrangements are recorded as either additional purchase price or compensation expense if continuing employment is required to receive such payments. Pursuant to ASC 805, contingent consideration that is deemed to be part of the purchase price is recorded as a liability based on the estimated fair value of the consideration we expect to pay to the former shareholders of the acquired business as of the acquisition date. This liability is re-measured each reporting period with the change in fair value recorded through a separate line item within our Consolidated Statements of Income. Increases or decreases in the fair value of contingent consideration liabilities can result from changes in discount rates, changes in the timing, probabilities and amount of revenue estimates, and accretion of the liability for the passage of time. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary contingent consideration liability is from our acquisition of Acessa. We have an obligation to the former Acessa shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. At March 27, 2021 this liability was recorded at its fair value of $71.7 million, and no contingent payments have been earned or made.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new share repurchase plan, which is effective for five years, to repurchase up to $1.0&#160;billion of our outstanding common stock effective December 11, 2020. The prior plan was terminated in connection with this new authorization. During the second quarter of fiscal 2021, we repurchased 1.6 million shares of our common stock for a total consideration of $120.1 million. As of March 27, 2021, $880.0&#160;million remained available under this authorization.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions that we believe will complement our current or future business. Subject to the &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report, if any, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports, and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this MD&amp;A, we believe that our cash and cash equivalents, cash flows from operations, and the cash available under our 2018 Amended Revolver will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2018 Credit Agreement, 2028 Senior Notes and 2029 Senior Notes. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see &#8220;Risk Factors&#8221; in Part I, Item&#160;1A in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; above and &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency derivative (forward or option) contracts, interest rate swap agreements, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 Senior Notes and 2029 Senior Notes, the fair value of these financial instruments approximates their carrying amount. The fair value of our 2028 Senior Notes and 2029 Senior Notes as of March&#160;27, 2021 was $421.7 million and $932.2 million, respectively. Amounts outstanding under our 2018 Credit Agreement of $1.4 billion as of March&#160;27, 2021 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 Senior Notes, 2029 Senior Notes and 2018 Credit Agreement. The 2028 Senior Notes and 2029 Senior Notes have fixed interest rates. Borrowings under our 2018 Credit Agreement currently bear interest at the Eurocurrency Rate (i.e., LIBOR) plus the applicable margin of 1.0% per annum.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, as of March&#160;27, 2021, there was $1.4 billion of aggregate principal outstanding under the 2018 Credit Agreement. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A hypothetical 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $0.2 million. We entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding. The critical terms of the interest rate swap were designed to mirror the terms of our LIBOR-based borrowings under the 2018 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. These interest rate swap contract expires on December 17, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which was recently extended to the end of 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement and related interest rate swap agreements, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the United States as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Renminbi. The majority of our foreign subsidiaries' functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely affected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Chinese Yuan and Canadian dollar. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Income due to (i) the impact of unrealized gains and losses reported in other income (expense), net from the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income (expense), net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against them and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. A hypothetical 10% increase or decrease in foreign currencies in which we transact would not have a material adverse impact on our business, financial condition or results of operations.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of March&#160;27, 2021. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="idb3695e9835747c6b3438a7b262e54ea_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="idb3695e9835747c6b3438a7b262e54ea_133"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020 or any of our subsequently filed reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs  <br/>(in millions)      ($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 27, 2020 &#8211; January 23, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 24, 2021 &#8211; February 20, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2021 &#8211; March 27, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604,431&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On December 9, 2020, the Board of Directors authorized a new share repurchase plan to repurchase up to $1.0 billion of the Company's outstanding common stock, effective December 11, 2020. In connection with this authorization, the prior plan was terminated. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Exhibits </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521110358/d75473dex21.htm">Share Purchase Agreement, dated as of April 8, 2021, by and among Hologic, Inc. and certain sellers listed therein.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">04/08/2021</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2021xex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2021xex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2021xex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q2-2021xex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*             Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="idb3695e9835747c6b3438a7b262e54ea_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idb3695e9835747c6b3438a7b262e54ea_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan<br/>Chairman, President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Karleen M. Oberton&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>holx_q2-2021xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2480a49943854c08824de5da1de706c8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>holx_q2-2021xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic5b9ccbc985e49dda8381d06d2cffc77_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>holx_q2-2021xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iac1032981a6049d39d0a5c322e16c958_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended March 27, 2021 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; April 28, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>holx_q2-2021xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i95f67c5c52014905966fe021cc639a3e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended March 27, 2021 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; April 28, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>holx-20210327.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20210327" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20210327">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210327_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210327_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210327_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210327_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>1001002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1006007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.hologic.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetailsDetails" roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails">
        <link:definition>2402401 - Disclosure - Basis of Presentation Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.hologic.com/role/Revenue">
        <link:definition>2103102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>2304301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>2405402 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>2406403 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>2407404 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>2408405 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails">
        <link:definition>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1">
        <link:definition>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>2110103 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>2411407 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>2112104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>2313302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollForwardDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails">
        <link:definition>2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>2117105 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>2318303 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>2419411 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLosses" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses">
        <link:definition>2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesTables" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables">
        <link:definition>2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesDetails" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails">
        <link:definition>2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>2124107 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionDetails" roleURI="http://www.hologic.com/role/DispositionDetails">
        <link:definition>2425414 - Disclosure - Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>2126108 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>2132109 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.hologic.com/role/DerivativesTables">
        <link:definition>2333306 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>2434419 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
        <link:definition>2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueofDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
        <link:definition>2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
        <link:definition>2437422 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>2138110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetail" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail">
        <link:definition>2439423 - Disclosure - Commitments and Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.hologic.com/role/NetIncomeLossPerShare">
        <link:definition>2140111 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables">
        <link:definition>2341307 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>2442424 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>2143112 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>2344308 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
        <link:definition>2445425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>2446426 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail">
        <link:definition>2447427 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>2148113 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>2349309 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail">
        <link:definition>2450428 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail">
        <link:definition>2451429 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>2152114 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>2353310 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>2454430 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>2455431 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>2456432 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>2157115 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>2458433 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill">
        <link:definition>2159116 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>2360311 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
        <link:definition>2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>2163117 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>2364312 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>2465436 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2166118 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2367313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>2468437 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchaseSharerepurchaseDetails" roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails">
        <link:definition>2469438 - Disclosure - Share Repurchase Share repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.hologic.com/role/NewAccountingPronouncements">
        <link:definition>2170119 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2271201 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_FairValueAssumptionDiscountRate" abstract="false" name="FairValueAssumptionDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessAcquisitionCashTenderOfferPricePerShare" abstract="false" name="BusinessAcquisitionCashTenderOfferPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_ProceedsFromSeniorNotes" abstract="false" name="ProceedsFromSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" abstract="false" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MobidiagMember" abstract="true" name="MobidiagMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AlphaImagingMember" abstract="true" name="AlphaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PurchaseOfIntellectualProperty" abstract="false" name="PurchaseOfIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BasisofPresentationAbstract" abstract="true" name="BasisofPresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ChangeInParValue" abstract="false" name="ChangeInParValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BiotheranosticsMember" abstract="true" name="BiotheranosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_LegalAccrual" abstract="false" name="LegalAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AssetsofBusinessHeldforSaleAbstract" abstract="true" name="AssetsofBusinessHeldforSaleAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_SharerepurchaseplanLineItems" abstract="true" name="SharerepurchaseplanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentHoldbackMember" abstract="true" name="ContingentHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" abstract="false" name="CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_December112020Member" abstract="true" name="December112020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NotationalAmount" abstract="false" name="NotationalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmendedTermLoanMember" abstract="true" name="AmendedTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredValue" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AnnualIncrementalRevenueGrowthPeriod" abstract="false" name="AnnualIncrementalRevenueGrowthPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_PercentageAddedtoEurodollarRateMember" abstract="true" name="PercentageAddedtoEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ServiceRevenue" abstract="false" name="ServiceRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MarketBasedAwardsMember" abstract="true" name="MarketBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmountAssessedInDamages" abstract="false" name="AmountAssessedInDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_December112019Member" abstract="true" name="December112019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagenodeMember" abstract="true" name="DiagenodeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RepaymentOfSeniorNotes" abstract="false" name="RepaymentOfSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmortizationCostofGoodsSold" abstract="false" name="AmortizationCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Purchaseofinsurancecontracts" abstract="false" name="Purchaseofinsurancecontracts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_HealthBeaconsMember" abstract="true" name="HealthBeaconsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Acceleratedsharerepurchaseagreement" abstract="false" name="Acceleratedsharerepurchaseagreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" abstract="false" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_RSUPSUMSUMember" abstract="true" name="RSUPSUMSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_IndemnificationLiabily" abstract="false" name="IndemnificationLiabily" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharerepurchaseplanTable" abstract="true" name="SharerepurchaseplanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ProceedsFromSaleOfBusiness" abstract="false" name="ProceedsFromSaleOfBusiness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveIncomeAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DebtInstrumentOfferingPricePercentOfFaceValue" abstract="false" name="DebtInstrumentOfferingPricePercentOfFaceValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Netincome" abstract="false" name="Netincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredShares" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_BusinessCombinationSharesAcquired" abstract="false" name="BusinessCombinationSharesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_MinervaMember" abstract="true" name="MinervaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ComprehensiveIncome" abstract="false" name="ComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountsReceivableSecuritizationMember" abstract="true" name="AccountsReceivableSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Holdback" abstract="false" name="Holdback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_AccountsReceivableAllowanceForCreditLossTransfers" abstract="false" name="AccountsReceivableAllowanceForCreditLossTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Costofservice" abstract="false" name="Costofservice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessLicensesMember" abstract="true" name="BusinessLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SomatexMedicalTechnologiesMember" abstract="true" name="SomatexMedicalTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MedicalAestheticsMember" abstract="true" name="MedicalAestheticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtRedemptionPremiumPaid" abstract="false" name="DebtRedemptionPremiumPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NXCImagingMember" abstract="true" name="NXCImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PrepaidIncomeTaxesCurrent" abstract="false" name="PrepaidIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SuperSonicImagineMember" abstract="true" name="SuperSonicImagineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_BusinessCombinationOwnershipPercentage" abstract="false" name="BusinessCombinationOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" abstract="false" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>holx-20210327_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20210327.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_07d365e4-3a92-4a1e-8aac-1dea8ec9603a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_429da116-71ab-4bb9-87a4-51090a183c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_07d365e4-3a92-4a1e-8aac-1dea8ec9603a" xlink:to="loc_us-gaap_GrossProfit_429da116-71ab-4bb9-87a4-51090a183c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0c049202-0605-475b-834f-759153886935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_07d365e4-3a92-4a1e-8aac-1dea8ec9603a" xlink:to="loc_us-gaap_OperatingExpenses_0c049202-0605-475b-834f-759153886935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c28aff36-9071-4cfa-af05-42b368e14803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:to="loc_us-gaap_OperatingIncomeLoss_c28aff36-9071-4cfa-af05-42b368e14803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2fb43c4b-a97b-4f2b-a491-3355bd711470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2fb43c4b-a97b-4f2b-a491-3355bd711470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ed3caa19-8071-4394-92e8-7a984c5452c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:to="loc_us-gaap_InterestExpense_ed3caa19-8071-4394-92e8-7a984c5452c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_283d0ca0-3610-433a-a2f0-67ff009ee303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_283d0ca0-3610-433a-a2f0-67ff009ee303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4b3856f9-5cb6-4731-b688-a98ad4c44611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c9e2b48c-35a0-459e-9015-510d6b07a0a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4b3856f9-5cb6-4731-b688-a98ad4c44611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e5fece31-6a17-4ef2-9358-d17a12a04820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:to="loc_us-gaap_Revenues_e5fece31-6a17-4ef2-9358-d17a12a04820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c10f656e-7d71-4edf-b2f3-d1c9f02d0a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c10f656e-7d71-4edf-b2f3-d1c9f02d0a2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_83225811-5b71-4cae-88c4-768a611efba1" xlink:href="holx-20210327.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:to="loc_holx_AmortizationCostofGoodsSold_83225811-5b71-4cae-88c4-768a611efba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_7face5e3-59c0-47e2-a2b3-703b698aada7" xlink:href="holx-20210327.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_7face5e3-59c0-47e2-a2b3-703b698aada7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_72cdcd92-a320-4594-a5d2-91cc9803db04" xlink:href="holx-20210327.xsd#holx_Costofservice"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0155a0f8-d0dc-413f-86be-fdac55bb301b" xlink:to="loc_holx_Costofservice_72cdcd92-a320-4594-a5d2-91cc9803db04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_63ce909e-1940-45e7-a7c2-d675d5a48723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_63ce909e-1940-45e7-a7c2-d675d5a48723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c1e27b36-784b-449d-a0d6-24b23a799008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c1e27b36-784b-449d-a0d6-24b23a799008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_03ec6f58-90f0-48d6-8309-4d5a3a6e9d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_SellingAndMarketingExpense_03ec6f58-90f0-48d6-8309-4d5a3a6e9d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f4b31e22-ab02-4c38-ac24-0ae15ce251ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f4b31e22-ab02-4c38-ac24-0ae15ce251ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4faa348b-24fd-4bbe-b7fa-5936a7dae90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_RestructuringCharges_4faa348b-24fd-4bbe-b7fa-5936a7dae90b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_cece9080-2227-402e-bc35-a0c8b67d1a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_cece9080-2227-402e-bc35-a0c8b67d1a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4889ed20-3e9b-4a3c-aee0-ca2bee710022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_73758c25-c2cd-4a7b-ba7c-566f96a53dad" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4889ed20-3e9b-4a3c-aee0-ca2bee710022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b1384943-c05e-430c-9637-45fb3137d782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_66a86bfd-fb8c-4a9b-90c6-fc14bcda160e" xlink:href="holx-20210327.xsd#holx_ProductRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b1384943-c05e-430c-9637-45fb3137d782" xlink:to="loc_holx_ProductRevenue_66a86bfd-fb8c-4a9b-90c6-fc14bcda160e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_91d343f6-4046-4069-a575-e19a1945d234" xlink:href="holx-20210327.xsd#holx_ServiceRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b1384943-c05e-430c-9637-45fb3137d782" xlink:to="loc_holx_ServiceRevenue_91d343f6-4046-4069-a575-e19a1945d234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_4eb09f62-4888-41e3-a287-09cb55c1ad17" xlink:href="holx-20210327.xsd#holx_Netincome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84837d65-9085-4d5f-b784-b4409e6122b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_4eb09f62-4888-41e3-a287-09cb55c1ad17" xlink:to="loc_us-gaap_NetIncomeLoss_84837d65-9085-4d5f-b784-b4409e6122b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c89edee0-e5c7-4ff0-9f1d-50bf202d3a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_4eb09f62-4888-41e3-a287-09cb55c1ad17" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c89edee0-e5c7-4ff0-9f1d-50bf202d3a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2205ba64-49fe-43f0-a977-6b2166f0b5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dc507c6d-998c-42ba-b606-87c6fe6285e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2205ba64-49fe-43f0-a977-6b2166f0b5dd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dc507c6d-998c-42ba-b606-87c6fe6285e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_48f918ca-a938-4885-9d91-5af4c551e42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2205ba64-49fe-43f0-a977-6b2166f0b5dd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_48f918ca-a938-4885-9d91-5af4c551e42c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_9818a5ce-216e-4ab2-aaef-a30b738b2024" xlink:href="holx-20210327.xsd#holx_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_24bb7d26-a128-453b-b030-52f0a813631c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_9818a5ce-216e-4ab2-aaef-a30b738b2024" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_24bb7d26-a128-453b-b030-52f0a813631c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_81649556-b56b-43b6-937f-53f6bbb454ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_9818a5ce-216e-4ab2-aaef-a30b738b2024" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_81649556-b56b-43b6-937f-53f6bbb454ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ef51895-ef7b-4356-950c-a0a1a10a828a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_746b4483-612d-47cc-ad2c-9214bcfcf9f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ef51895-ef7b-4356-950c-a0a1a10a828a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_746b4483-612d-47cc-ad2c-9214bcfcf9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7a2d1ba5-9124-45a0-813a-d19584807c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ef51895-ef7b-4356-950c-a0a1a10a828a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_7a2d1ba5-9124-45a0-813a-d19584807c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_735863db-8236-4212-b773-259ead8b6d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0ef51895-ef7b-4356-950c-a0a1a10a828a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_735863db-8236-4212-b773-259ead8b6d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ffb654d-df3b-432c-b654-b25fc8d2b1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7ed71568-3fa3-4594-969b-859c919cd401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ffb654d-df3b-432c-b654-b25fc8d2b1eb" xlink:to="loc_us-gaap_NetIncomeLoss_7ed71568-3fa3-4594-969b-859c919cd401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d67b0d0d-7108-4f26-ad71-fa742a39b7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ffb654d-df3b-432c-b654-b25fc8d2b1eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d67b0d0d-7108-4f26-ad71-fa742a39b7b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f95f7533-cb3d-4c6b-80f6-531947133d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_LiabilitiesCurrent_f95f7533-cb3d-4c6b-80f6-531947133d4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9f8179a1-53fb-4bcc-a724-e88d1bbb573e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9f8179a1-53fb-4bcc-a724-e88d1bbb573e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_95a4d11a-eaec-4069-bff5-f53ca6285009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_95a4d11a-eaec-4069-bff5-f53ca6285009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f77f141d-a044-49dd-9fae-1cd0e808cb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f77f141d-a044-49dd-9fae-1cd0e808cb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_9b6d8631-7343-4b7e-9e71-b135acf7c4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_9b6d8631-7343-4b7e-9e71-b135acf7c4ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d256dddd-33dc-4be0-bda8-957af716db6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d256dddd-33dc-4be0-bda8-957af716db6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78b9332f-bd07-4f96-83e9-019a59173669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_75671939-1cf8-4d90-bc88-b4bcbdf7ff24" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78b9332f-bd07-4f96-83e9-019a59173669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b951571-df1e-4be4-9abe-b00565412cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b951571-df1e-4be4-9abe-b00565412cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_715c01f9-750c-4327-9dd7-164712c35053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_715c01f9-750c-4327-9dd7-164712c35053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8459d412-547d-4c2d-a928-40755fdf1335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:to="loc_us-gaap_InventoryNet_8459d412-547d-4c2d-a928-40755fdf1335" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_1e1beffd-52a4-4343-bdc9-3bd24a37d3a6" xlink:href="holx-20210327.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_1e1beffd-52a4-4343-bdc9-3bd24a37d3a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_110c1640-f89a-490a-bef8-88fcae38d67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a34ce-a6f5-4963-ba17-1186518b3615" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_110c1640-f89a-490a-bef8-88fcae38d67d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a0611061-1d75-4299-9e3b-2ee04e5d0aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_PreferredStockValue_a0611061-1d75-4299-9e3b-2ee04e5d0aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_054c6197-991a-42d1-8f2a-1b832942d3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_CommonStockValue_054c6197-991a-42d1-8f2a-1b832942d3de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_81436697-bc92-4da5-996a-86435b1a299d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_AdditionalPaidInCapital_81436697-bc92-4da5-996a-86435b1a299d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_268fb926-e1bd-45b1-817d-92df68d4ce6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_268fb926-e1bd-45b1-817d-92df68d4ce6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_36becea8-3bad-4f92-8c2b-73b51b162998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_TreasuryStockValue_36becea8-3bad-4f92-8c2b-73b51b162998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9a4bed6-f724-40cc-8f91-76c6c575b5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_dd7550a0-8b4b-4693-9f7c-b72175b3ff63" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9a4bed6-f724-40cc-8f91-76c6c575b5e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_83227d66-db9c-43b8-af99-ba55620a05ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:to="loc_us-gaap_LongTermDebtCurrent_83227d66-db9c-43b8-af99-ba55620a05ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2fe4c4f8-6e81-47c7-9e8e-b98bba8dd20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:to="loc_us-gaap_AccountsPayableCurrent_2fe4c4f8-6e81-47c7-9e8e-b98bba8dd20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9ff2cbb8-7d19-48bd-9695-96d21b4fe11e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9ff2cbb8-7d19-48bd-9695-96d21b4fe11e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_2575f413-b23c-40e4-8e1d-21f1d7128cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:to="loc_us-gaap_DeferredRevenueCurrent_2575f413-b23c-40e4-8e1d-21f1d7128cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_ba748658-915e-4938-9d9c-0a1095692a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8b09d51-0601-4054-83e5-35fd1180cf72" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_ba748658-915e-4938-9d9c-0a1095692a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fadcf45-46f8-485d-aa32-f4bbfb131ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e969ab7-150c-403a-a8ae-7a26683d83aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fadcf45-46f8-485d-aa32-f4bbfb131ace" xlink:to="loc_us-gaap_StockholdersEquity_8e969ab7-150c-403a-a8ae-7a26683d83aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1cfba777-feed-4d45-8e40-5b6137711b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fadcf45-46f8-485d-aa32-f4bbfb131ace" xlink:to="loc_us-gaap_MinorityInterest_1cfba777-feed-4d45-8e40-5b6137711b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_45d9aa82-6f2f-4274-97b1-f132306628ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:to="loc_us-gaap_AssetsCurrent_45d9aa82-6f2f-4274-97b1-f132306628ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dccc33de-5c08-41a4-aa17-c964834efed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_dccc33de-5c08-41a4-aa17-c964834efed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_04b8c7b5-9550-4d28-bb12-0d7fcd48f055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_04b8c7b5-9550-4d28-bb12-0d7fcd48f055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b597d4ef-88a2-4fb6-a851-a0f7da78f363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:to="loc_us-gaap_Goodwill_b597d4ef-88a2-4fb6-a851-a0f7da78f363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_68ccc529-bd7d-4088-8232-d57bb117ca92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_81be050a-fa63-487c-b482-131c253316ea" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_68ccc529-bd7d-4088-8232-d57bb117ca92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_4967ed52-2e47-47c3-8cb9-aaba5e32e3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_4967ed52-2e47-47c3-8cb9-aaba5e32e3fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_645b32d3-3e6b-44e8-a1b0-ddf500eb63b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_645b32d3-3e6b-44e8-a1b0-ddf500eb63b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_ef2ff3a8-53ba-4150-bcb2-5ea7c18ace5e" xlink:href="holx-20210327.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_holx_RepaymentOfSeniorNotes_ef2ff3a8-53ba-4150-bcb2-5ea7c18ace5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_99edf12b-b153-44cd-a971-2f0a35570940" xlink:href="holx-20210327.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_holx_ProceedsFromSeniorNotes_99edf12b-b153-44cd-a971-2f0a35570940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_7eaf5030-f0d3-485b-b3c1-7ffcdf32cd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_7eaf5030-f0d3-485b-b3c1-7ffcdf32cd00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_59c73246-f082-497a-a74a-58299649b0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_59c73246-f082-497a-a74a-58299649b0fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_232b3c7b-3fb3-4b9c-be69-627b50a49aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_232b3c7b-3fb3-4b9c-be69-627b50a49aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5ae81668-d5c6-443a-8238-a713fcc92713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5ae81668-d5c6-443a-8238-a713fcc92713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_d575d8ee-7505-4536-922d-483046a760e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_d575d8ee-7505-4536-922d-483046a760e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e489b5f0-68d5-47c9-87ca-65724a44b120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e489b5f0-68d5-47c9-87ca-65724a44b120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_60a41524-af42-4aa7-ac0f-c4da5a499ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_60a41524-af42-4aa7-ac0f-c4da5a499ae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2ea71e2a-196c-4e06-b444-4ec89afafde4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2ea71e2a-196c-4e06-b444-4ec89afafde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_f0f7a95b-a22c-495d-bff6-054c0726714b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_f0f7a95b-a22c-495d-bff6-054c0726714b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_73587823-f701-47de-b2b6-f17913fddf81" xlink:href="holx-20210327.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f47160ca-7163-4718-a35a-62231bc6129f" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_73587823-f701-47de-b2b6-f17913fddf81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1bc143c3-2d4f-41c5-be89-9ded86df77ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_ShareBasedCompensation_1bc143c3-2d4f-41c5-be89-9ded86df77ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_4ed30e14-9f81-4a0d-875a-6aac59e7c762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_4ed30e14-9f81-4a0d-875a-6aac59e7c762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ac0865b5-6a9c-43cb-bd17-28de5c9062f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ac0865b5-6a9c-43cb-bd17-28de5c9062f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bb5ee821-39eb-411e-b8fc-e3b3e1ae40a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_NetIncomeLoss_bb5ee821-39eb-411e-b8fc-e3b3e1ae40a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_88aaf56e-78a3-4f9f-a2d9-94805a26f84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_AdjustmentForAmortization_88aaf56e-78a3-4f9f-a2d9-94805a26f84f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0b092c79-1f70-4e24-82f6-4a503b90f669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0b092c79-1f70-4e24-82f6-4a503b90f669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9c944c79-7be9-4082-ade7-fb8f55483509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_Depreciation_9c944c79-7be9-4082-ade7-fb8f55483509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f3b6818d-7570-4746-8339-92d96c2ded70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f3b6818d-7570-4746-8339-92d96c2ded70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_113b1f2e-8cdb-485c-9c11-51da6ae65780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_AssetImpairmentCharges_113b1f2e-8cdb-485c-9c11-51da6ae65780" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_765231e7-5801-4f82-8520-0b4a5c981054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_765231e7-5801-4f82-8520-0b4a5c981054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f93d25c6-2879-4ba4-bd2e-a4f10cba9484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f93d25c6-2879-4ba4-bd2e-a4f10cba9484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2405bb46-32c1-427f-b897-4b8836d6d063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2405bb46-32c1-427f-b897-4b8836d6d063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8141840-0bb4-4b20-87cd-a83252c16de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8141840-0bb4-4b20-87cd-a83252c16de8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_911f3872-7318-4e9f-b3ba-bd4c6fff287c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_911f3872-7318-4e9f-b3ba-bd4c6fff287c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_df54dc00-210d-4240-a78c-7a552b5de122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a1e05bc3-01e9-4d9c-ac29-4464e12d5247" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_df54dc00-210d-4240-a78c-7a552b5de122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_058f9357-ec62-4726-93c3-4c7f6139a7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eeb7c123-b1d6-4a58-bca1-db0f9f1aa07e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_058f9357-ec62-4726-93c3-4c7f6139a7f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eeb7c123-b1d6-4a58-bca1-db0f9f1aa07e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_014dbf63-93ea-4a03-85c0-e9789646c5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_058f9357-ec62-4726-93c3-4c7f6139a7f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_014dbf63-93ea-4a03-85c0-e9789646c5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba5d27ef-a458-4532-98dc-0f964bc736f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_058f9357-ec62-4726-93c3-4c7f6139a7f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ba5d27ef-a458-4532-98dc-0f964bc736f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fc7de17f-0e4d-46cf-9dc5-a55a8884fdd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_058f9357-ec62-4726-93c3-4c7f6139a7f6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fc7de17f-0e4d-46cf-9dc5-a55a8884fdd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_8e285900-bcec-4b42-9cd3-e9705977f381" xlink:href="holx-20210327.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_8e285900-bcec-4b42-9cd3-e9705977f381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_a48b704a-1449-4d83-a31d-35f28a2fcb2e" xlink:href="holx-20210327.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_holx_Purchaseofinsurancecontracts_a48b704a-1449-4d83-a31d-35f28a2fcb2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_7fb30939-7a5e-43a1-890a-ff586dab4c64" xlink:href="holx-20210327.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_7fb30939-7a5e-43a1-890a-ff586dab4c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_282bb8b2-681c-4bed-a7af-d1f5b98e7ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_282bb8b2-681c-4bed-a7af-d1f5b98e7ac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_251bca48-0cb0-45a5-9ffe-f30819e4c250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_251bca48-0cb0-45a5-9ffe-f30819e4c250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_807f7284-e204-4522-b024-4e705c7f9b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_807f7284-e204-4522-b024-4e705c7f9b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty_47fee794-280e-452a-91b2-59d0b04c0a39" xlink:href="holx-20210327.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a378c316-f83a-4df7-95c3-39a851b72d13" xlink:to="loc_holx_PurchaseOfIntellectualProperty_47fee794-280e-452a-91b2-59d0b04c0a39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentationDetailsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20210327.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueBusinessRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueGeographicalRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRevenuebyTypeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20210327.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f69a0f5-72e1-4a35-be6c-e8d55a6a0b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f69a0f5-72e1-4a35-be6c-e8d55a6a0b38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e52dffb0-4e94-4175-8f44-7ca09ff177a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e52dffb0-4e94-4175-8f44-7ca09ff177a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a2872685-2b94-476c-b7e2-3b8a3a139039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a2872685-2b94-476c-b7e2-3b8a3a139039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_85dfbf93-7c3e-4bac-8eb0-7ad9319306fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_85dfbf93-7c3e-4bac-8eb0-7ad9319306fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4028814d-bc43-4bdd-a21f-70649d07f7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4028814d-bc43-4bdd-a21f-70649d07f7f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_68aeec99-2ee1-4fac-9878-5948824fe0cc" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_68aeec99-2ee1-4fac-9878-5948824fe0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f96c7ff5-103f-4ad7-bd34-b598fc43b332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f96c7ff5-103f-4ad7-bd34-b598fc43b332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_def0180f-8e27-47b5-ab03-0cdaa0e33332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_def0180f-8e27-47b5-ab03-0cdaa0e33332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_fbfb566e-842d-4592-8a40-6886966d64bf" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_fbfb566e-842d-4592-8a40-6886966d64bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_10e4b223-d928-43c6-bdd0-e8a58297ba92" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_10e4b223-d928-43c6-bdd0-e8a58297ba92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_258da87e-ac39-49fd-a094-b8c5aac084c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_Goodwill_258da87e-ac39-49fd-a094-b8c5aac084c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_5ef402dc-15c3-4934-a1fb-fdf541a9c9e7" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_5ef402dc-15c3-4934-a1fb-fdf541a9c9e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_5b550df6-a985-4435-a59a-84e78110071e" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_5b550df6-a985-4435-a59a-84e78110071e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_577cbd99-e18d-4dab-8b12-b970859ec26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_25ad97c6-8614-4fcc-bae9-1eb9de81fe04" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_577cbd99-e18d-4dab-8b12-b970859ec26b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20210327.xsd#Disposition"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DispositionDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_715948e7-5175-4585-9c64-394a39eca6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_92bb3757-6a4f-4ef5-a961-9299c9d202d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_715948e7-5175-4585-9c64-394a39eca6d7" xlink:to="loc_us-gaap_LongTermDebtCurrent_92bb3757-6a4f-4ef5-a961-9299c9d202d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_77102ee8-7f02-4219-a83a-1df8f2bb0b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_715948e7-5175-4585-9c64-394a39eca6d7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_77102ee8-7f02-4219-a83a-1df8f2bb0b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_242e181b-fbb8-4156-b9cb-42da92d62cd9" xlink:href="holx-20210327.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_715948e7-5175-4585-9c64-394a39eca6d7" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_242e181b-fbb8-4156-b9cb-42da92d62cd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20210327.xsd#Derivatives"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingenciesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShare"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3792760b-08df-40b8-93bb-f8b69fd576bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9d59c58c-690d-4761-8392-93e941c4304f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3792760b-08df-40b8-93bb-f8b69fd576bd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9d59c58c-690d-4761-8392-93e941c4304f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b046a370-1a09-44f1-80b6-d939a0dbe7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3792760b-08df-40b8-93bb-f8b69fd576bd" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b046a370-1a09-44f1-80b6-d939a0dbe7e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fcf8e71f-0ca1-4999-9aa6-5feee73436aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e4466f4d-235f-4f3d-9f5c-45f4714abd74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fcf8e71f-0ca1-4999-9aa6-5feee73436aa" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e4466f4d-235f-4f3d-9f5c-45f4714abd74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8448e693-e153-4262-8751-a6e2c538ab03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fcf8e71f-0ca1-4999-9aa6-5feee73436aa" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8448e693-e153-4262-8751-a6e2c538ab03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a08c73b6-e548-463b-a16d-79530b4003fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_fcf8e71f-0ca1-4999-9aa6-5feee73436aa" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_a08c73b6-e548-463b-a16d-79530b4003fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_7f49c680-f806-4216-9d91-33eb0e7f8925" xlink:href="holx-20210327.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_7f49c680-f806-4216-9d91-33eb0e7f8925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_f912adb9-02ca-4534-a6f3-a8c554871b7c" xlink:href="holx-20210327.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_f912adb9-02ca-4534-a6f3-a8c554871b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_60046483-b273-4bcb-8dec-80745e53e249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_60046483-b273-4bcb-8dec-80745e53e249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_799f9384-0e23-4c2c-b3f7-a56febc0d67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_799f9384-0e23-4c2c-b3f7-a56febc0d67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d641a4e2-d47e-4c92-aef2-8b8eb1c52d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_us-gaap_Land_d641a4e2-d47e-4c92-aef2-8b8eb1c52d36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_f1d1b639-3b92-468f-81be-570dae170328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_680cc5cd-a929-4926-b015-8553ac099f51" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_f1d1b639-3b92-468f-81be-570dae170328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17460bed-4aff-4bf8-ac39-03d036509a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9769882c-2ff6-48ab-8346-5cbd3311324d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_17460bed-4aff-4bf8-ac39-03d036509a40" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9769882c-2ff6-48ab-8346-5cbd3311324d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42ae1f1b-7cb7-4a10-a2b7-771596379c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_17460bed-4aff-4bf8-ac39-03d036509a40" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_42ae1f1b-7cb7-4a10-a2b7-771596379c9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwill"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarranties"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_30cdb492-0b02-42ac-a667-f3a83613b427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_356c3322-ae28-4d96-97da-11417895378f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_30cdb492-0b02-42ac-a667-f3a83613b427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_356c3322-ae28-4d96-97da-11417895378f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f5bcefbe-2ed4-4b56-a6f3-c561a3651acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_30cdb492-0b02-42ac-a667-f3a83613b427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f5bcefbe-2ed4-4b56-a6f3-c561a3651acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dc331b6-ad1e-46be-8ce0-283a7d45bb61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_30cdb492-0b02-42ac-a667-f3a83613b427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dc331b6-ad1e-46be-8ce0-283a7d45bb61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c750c949-261d-4a97-91e2-8945154251e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_30cdb492-0b02-42ac-a667-f3a83613b427" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_c750c949-261d-4a97-91e2-8945154251e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>holx-20210327_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20210327.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended" id="i290b4281f436426c80b584e5328cc4c3_CoverPage"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="i8b66dadf67054ab9a59fd4bc697955c3_ConsolidatedStatementsofIncome"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="if486a51ee73b46f6b6489fb873292d81_ConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended" id="i335ad7acc4b346e9859339ada8af6636_ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i29796c76e7444ac08907191185993cd1_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i45d1dd83053b4de99e18d41c0916b073_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i2a340714d96c4a119dd9b54d32086d77_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_08de72c1-6cd2-44de-8adb-357d5a36444a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_08de72c1-6cd2-44de-8adb-357d5a36444a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4467b1d8-9d4f-45fa-99e0-6cee8a888e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4467b1d8-9d4f-45fa-99e0-6cee8a888e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_cf2ea7b6-bcd2-4c07-bc42-9f80a4b68c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_SharesIssued_cf2ea7b6-bcd2-4c07-bc42-9f80a4b68c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_006464b9-24e3-4f87-9014-f34d0a9b3f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockholdersEquity_006464b9-24e3-4f87-9014-f34d0a9b3f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8aaeab54-08a8-4a37-9e96-5f6920b989c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8aaeab54-08a8-4a37-9e96-5f6920b989c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_43c02031-1c2f-400b-94e1-3cd06784ee04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_43c02031-1c2f-400b-94e1-3cd06784ee04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_fb3cf889-0789-4124-b1b2-07ddde6f3f89" xlink:href="holx-20210327.xsd#holx_ChangeInParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_ChangeInParValue_fb3cf889-0789-4124-b1b2-07ddde6f3f89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_f1e22d98-2254-487f-bc86-6800dc4bfc80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_f1e22d98-2254-487f-bc86-6800dc4bfc80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_d5d279cf-1461-4812-a642-762d2c6ae9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_d5d279cf-1461-4812-a642-762d2c6ae9ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9c663db6-c0e8-4fd7-88da-093c38537001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9c663db6-c0e8-4fd7-88da-093c38537001" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90a2ee79-62c8-4b75-bd08-0526f5293657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90a2ee79-62c8-4b75-bd08-0526f5293657" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80e2b7d3-c4c0-4275-9eb5-2f513a966a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80e2b7d3-c4c0-4275-9eb5-2f513a966a21" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_40c3f06e-dbe6-45c6-9d68-df0a8c4c7979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_NetIncomeLoss_40c3f06e-dbe6-45c6-9d68-df0a8c4c7979" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_01776476-4089-4914-a095-fbd0aca20e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_01776476-4089-4914-a095-fbd0aca20e2a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_db7bd2c4-a00f-4ba5-97df-52461db00b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_db7bd2c4-a00f-4ba5-97df-52461db00b31" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e6a7f218-2516-4092-8a93-8fe2e4a01260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e6a7f218-2516-4092-8a93-8fe2e4a01260" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_ef0e604c-5d42-4a07-ae50-3088e57873ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_ef0e604c-5d42-4a07-ae50-3088e57873ae" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4f7eab33-f1b4-4575-919f-54291a549987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c8f1a7d-86ab-4902-a8ca-fae1d26364e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a1cbc9fb-c33b-4550-8654-e679eaf834b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a1cbc9fb-c33b-4550-8654-e679eaf834b2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_a4d01419-0ba6-42ac-bb35-21d9c8481d17" xlink:href="holx-20210327.xsd#holx_Netincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_Netincome_a4d01419-0ba6-42ac-bb35-21d9c8481d17" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_15ab6e26-828d-410f-b36a-cf25f729faeb" xlink:href="holx-20210327.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_15ab6e26-828d-410f-b36a-cf25f729faeb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_9dc9a7ec-c9e8-4f5f-9fee-28f010b88a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_9dc9a7ec-c9e8-4f5f-9fee-28f010b88a0f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9df9f4f7-8e53-4651-8726-98412fd47c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9df9f4f7-8e53-4651-8726-98412fd47c1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_2581fd93-dc67-4ec5-b8be-d8fbab2078ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_2581fd93-dc67-4ec5-b8be-d8fbab2078ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_8f45b060-9969-4bf8-be33-1442768fb64d" xlink:href="holx-20210327.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:to="loc_holx_ShareRepurchaseProgramMember_8f45b060-9969-4bf8-be33-1442768fb64d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5f2833fc-4c21-4abe-ab38-d6f3120ae235_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:to="loc_us-gaap_EquityComponentDomain_5f2833fc-4c21-4abe-ab38-d6f3120ae235_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:to="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_004c02b1-ad60-4f4b-82ef-617f46e07ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_CommonStockMember_004c02b1-ad60-4f4b-82ef-617f46e07ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f67738c1-7780-49b2-b2ee-d5d7913b7972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f67738c1-7780-49b2-b2ee-d5d7913b7972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d8133672-4ea7-4c01-9e4b-8e8bd8504397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_RetainedEarningsMember_d8133672-4ea7-4c01-9e4b-8e8bd8504397" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e0adfe-1213-439d-ad4e-fb5c0546b1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e0adfe-1213-439d-ad4e-fb5c0546b1e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_055dc42d-fed7-4218-b7af-f2534b3ecbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_TreasuryStockMember_055dc42d-fed7-4218-b7af-f2534b3ecbce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e50be522-bf6b-4940-aef4-e85498718740_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e50be522-bf6b-4940-aef4-e85498718740_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:to="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_dbd192d0-5d5b-47d8-96ef-8d561be0a458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_dbd192d0-5d5b-47d8-96ef-8d561be0a458" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i81cd634c453742ce84f225836cd05afc_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended" id="i92ba2b7e450c45539ad99521ca948d02_BasisofPresentation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentationDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended" id="iba026681484b49d2b11b3c5a548ab5d0_BasisofPresentationDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cbea617c-b43d-4ffb-9ad0-0c2579a97146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cbea617c-b43d-4ffb-9ad0-0c2579a97146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:to="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34a2d2c9-97bb-47bd-9198-fbfe2f726a47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34a2d2c9-97bb-47bd-9198-fbfe2f726a47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagMember_d47a0055-8e1c-48c3-9ca6-f431d1a9915f" xlink:href="holx-20210327.xsd#holx_MobidiagMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:to="loc_holx_MobidiagMember_d47a0055-8e1c-48c3-9ca6-f431d1a9915f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_850871e1-3192-4ce7-a62a-d966da70b289_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_850871e1-3192-4ce7-a62a-d966da70b289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e6089fb-9c61-449f-9241-e68768b552f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:to="loc_us-gaap_SubsequentEventMember_4e6089fb-9c61-449f-9241-e68768b552f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20210327.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended" id="iaee123949cb440bca1f966412c224c4f_Revenue"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended" id="i11b3dd1a62164a6fb4f96280dd78322b_RevenueTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="if9c31b40680040c08995f3a109e5e5c1_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa938d0e-3c1e-4b8e-a3f3-d84e19d2770d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:to="loc_us-gaap_Revenues_fa938d0e-3c1e-4b8e-a3f3-d84e19d2770d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55cd2a0e-a764-400c-aa22-81083109eee0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:to="loc_us-gaap_SegmentDomain_55cd2a0e-a764-400c-aa22-81083109eee0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:to="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_21ae7d6a-9f53-4f28-badc-2e7ce36726ea" xlink:href="holx-20210327.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_DiagnosticsMember_21ae7d6a-9f53-4f28-badc-2e7ce36726ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_32437c7c-45b1-4754-8c0b-21287c9abb82" xlink:href="holx-20210327.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_BreastHealthMember_32437c7c-45b1-4754-8c0b-21287c9abb82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_61d688a7-4376-409e-ba49-2a0071977da0" xlink:href="holx-20210327.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_GynSurgicalMember_61d688a7-4376-409e-ba49-2a0071977da0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_fdef821c-bf17-42f2-b9dc-41fdb8d09b08" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_MedicalAestheticsMember_fdef821c-bf17-42f2-b9dc-41fdb8d09b08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_f71db905-1ae5-47e5-9680-c500eda10fb8" xlink:href="holx-20210327.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_SkeletalHealthMember_f71db905-1ae5-47e5-9680-c500eda10fb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_465a04b3-5e05-4821-8e94-9802d7117945_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:to="loc_srt_ProductsAndServicesDomain_465a04b3-5e05-4821-8e94-9802d7117945_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:to="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_ca4bf9a9-2a81-4abf-ae88-876fedfa6803" xlink:href="holx-20210327.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_CytologyPerinatalMember_ca4bf9a9-2a81-4abf-ae88-876fedfa6803" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_98287be8-013c-4972-8fee-92856b8e2cd0" xlink:href="holx-20210327.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_MolecularDiagnosticsMember_98287be8-013c-4972-8fee-92856b8e2cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_71259935-c06b-4ec3-8048-a6426a3c92a0" xlink:href="holx-20210327.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_BloodScreeningMember_71259935-c06b-4ec3-8048-a6426a3c92a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_6e37ea92-bc67-42ee-b0c5-96ae2ac73aaf" xlink:href="holx-20210327.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_BreastImagingMember_6e37ea92-bc67-42ee-b0c5-96ae2ac73aaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_1dffa561-1a9b-40fc-aa85-41742806f518" xlink:href="holx-20210327.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_InterventionalBreastSolutionsMember_1dffa561-1a9b-40fc-aa85-41742806f518" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52599d4d-0309-430c-8bb6-fc3b7d6cd081_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:to="loc_srt_SegmentGeographicalDomain_52599d4d-0309-430c-8bb6-fc3b7d6cd081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:to="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0a080ec9-4f61-4767-a555-d1b1d41d76b3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:to="loc_country_US_0a080ec9-4f61-4767-a555-d1b1d41d76b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_5207cbad-75f6-4c56-8e07-394de516c74d" xlink:href="holx-20210327.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:to="loc_holx_InternationalMember_5207cbad-75f6-4c56-8e07-394de516c74d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="i91498c14cfde419bb6c721f18eb97bf6_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7a7d1141-78da-4e2f-9e71-d6ec98b18b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:to="loc_us-gaap_Revenues_7a7d1141-78da-4e2f-9e71-d6ec98b18b18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:to="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:to="loc_srt_SegmentGeographicalDomain_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:to="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_792fdff5-2a6a-4442-87d7-cdc21b2a05a2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_country_US_792fdff5-2a6a-4442-87d7-cdc21b2a05a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6375b771-b7da-4343-8818-2f7ee4d84f9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_srt_EuropeMember_6375b771-b7da-4343-8818-2f7ee4d84f9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_1d2bc019-305d-4233-8b6f-9e41c481809e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_srt_AsiaPacificMember_1d2bc019-305d-4233-8b6f-9e41c481809e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_bc0694f5-7581-49e1-8e39-994335391ba8" xlink:href="holx-20210327.xsd#holx_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_holx_RestofWorldMember_bc0694f5-7581-49e1-8e39-994335391ba8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="i78f5d63a99ef49a69ad2781f1710940b_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f09a1e82-1408-458b-b8aa-fd8086096f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:to="loc_us-gaap_Revenues_f09a1e82-1408-458b-b8aa-fd8086096f26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:to="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d33927d2-2d75-46c0-8fbe-e1b20c94f218_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:to="loc_srt_ProductsAndServicesDomain_d33927d2-2d75-46c0-8fbe-e1b20c94f218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:to="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_c879cbda-c496-48c0-a020-6afd13401228" xlink:href="holx-20210327.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_ConsumablesMember_c879cbda-c496-48c0-a020-6afd13401228" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4acb069d-08bb-4521-9c00-344ef29c742d" xlink:href="holx-20210327.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4acb069d-08bb-4521-9c00-344ef29c742d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_dc5d7442-16e3-4ab7-89e9-b290f523463e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_us-gaap_ServiceMember_dc5d7442-16e3-4ab7-89e9-b290f523463e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_f5639a09-731a-401a-ba6b-576e397b5d47" xlink:href="holx-20210327.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_OtherTypeofRevenueMember_f5639a09-731a-401a-ba6b-576e397b5d47" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended" id="ib0d1e90b719743a385a750785eaed294_RevenueNarrativeDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="ic0e2efcce7d04fb1867c51d97eaff7de_RevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45dcfb90-b7e3-409e-8f82-e22091b355af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45dcfb90-b7e3-409e-8f82-e22091b355af" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i7ac5d1948b7b4add90bd0343b6b05338_RevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20210327.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended" id="ie165d30f50f94cca905da5a9b2ef7c1b_Leases"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended" id="i6c4c398fa4d744e793aaeb7374fc36e6_LeasesAdditionalLeaseInformationDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended" id="ib462640fdc784ebaa713133d31b33411_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended" id="iaacb46b94c064063b93aa21234393dc7_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="id89a2fb0378248e08040dafa7a382dd8_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9debc699-8297-4712-9d68-dfce6829fa59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9debc699-8297-4712-9d68-dfce6829fa59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_88cec624-9224-4f37-b43e-5a19378a82f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_88cec624-9224-4f37-b43e-5a19378a82f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4efd0b9c-6ea6-47f3-8b2b-fe893d8f230d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4efd0b9c-6ea6-47f3-8b2b-fe893d8f230d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_623c21ce-0c85-4854-a763-27534abcb0ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_623c21ce-0c85-4854-a763-27534abcb0ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b002b35a-103b-42ec-9d8e-27d9de3aa806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b002b35a-103b-42ec-9d8e-27d9de3aa806" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4640163f-a912-4f6b-b775-e4749188939b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4640163f-a912-4f6b-b775-e4749188939b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0f9c1181-273f-49a3-810a-e60ad9111bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0f9c1181-273f-49a3-810a-e60ad9111bb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_226fd1c8-4ab2-4b9a-8ff2-74dff1921669_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_226fd1c8-4ab2-4b9a-8ff2-74dff1921669_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_702274f5-18d5-458e-b991-f2a1c36cb52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_702274f5-18d5-458e-b991-f2a1c36cb52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_05b0512a-c5b9-4366-a76b-45efb8d46a6c" xlink:href="holx-20210327.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_holx_ContingentConsiderationMember_05b0512a-c5b9-4366-a76b-45efb8d46a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f26ecd09-26dc-4af2-8ea3-e1dab9dbe41d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_InterestRateSwapMember_f26ecd09-26dc-4af2-8ea3-e1dab9dbe41d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7844a34a-b65e-4ea9-90f2-0329eb991fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7844a34a-b65e-4ea9-90f2-0329eb991fb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eb7e074c-4688-4652-a977-3d5977b6f028_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eb7e074c-4688-4652-a977-3d5977b6f028_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_49dc1978-2312-4612-b054-5e97ffc5fc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:to="loc_us-gaap_LiabilityMember_49dc1978-2312-4612-b054-5e97ffc5fc52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i2ac79528f62b4eb499288d9663b84e12_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_73a8c4d9-35f1-4b38-851e-17505f148926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_us-gaap_AssetImpairmentCharges_73a8c4d9-35f1-4b38-851e-17505f148926" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_8da46c89-55d5-47d2-8f85-9eb7b8d4f8e4" xlink:href="holx-20210327.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_holx_PrincipalAmountOfBorrowings_8da46c89-55d5-47d2-8f85-9eb7b8d4f8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5fe061dc-196c-4abf-8804-50e7a5dff2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5fe061dc-196c-4abf-8804-50e7a5dff2dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ec244f4-74c0-4fef-b07e-8feb23eac10b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:to="loc_us-gaap_SegmentDomain_7ec244f4-74c0-4fef-b07e-8feb23eac10b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:to="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1717c505-8f29-485a-84d9-6ae07979c39e" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:to="loc_holx_MedicalAestheticsMember_1717c505-8f29-485a-84d9-6ae07979c39e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:to="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_197d3238-239e-4132-b887-e756e904929e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_197d3238-239e-4132-b887-e756e904929e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_9ccd9955-4cac-4cde-8eef-b1c093624214" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_CreditAgreementMember_9ccd9955-4cac-4cde-8eef-b1c093624214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_72242126-e18a-4beb-b936-c92a4b8bea43" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_A2025SeniorNotesMember_72242126-e18a-4beb-b936-c92a4b8bea43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3b55527e-232d-4dc3-92f5-dc2b7742c1fc" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_A2028SeniorNotesMember_3b55527e-232d-4dc3-92f5-dc2b7742c1fc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended" id="i88ccce9f202542998143f94cdf9e4011_FairValueMeasurementsRollForwardDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended" id="i6a75ec98e0da4b40a2d527472e65caa0_BusinessCombinations"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended" id="id4e8d72fc276477f9e0aae54d532269a_BusinessCombinationsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="i69d59687182747fdb332c1170544e60e_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_90dbca21-538e-4998-8005-3f7bfe4fe00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_90dbca21-538e-4998-8005-3f7bfe4fe00a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_26439e0f-cb3d-42b8-a239-5dfac4f4525d" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_26439e0f-cb3d-42b8-a239-5dfac4f4525d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2e8523dc-eec0-4ab9-8cdb-0c1bac8cdd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2e8523dc-eec0-4ab9-8cdb-0c1bac8cdd45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_2ea836d7-dd8f-41f9-971c-aa161992b9ab" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_2ea836d7-dd8f-41f9-971c-aa161992b9ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_ae51e471-38dc-45b4-ad23-084876dbe1d0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_ae51e471-38dc-45b4-ad23-084876dbe1d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cd6da3d9-4344-4b6a-a97b-98e7eab0b6ee" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cd6da3d9-4344-4b6a-a97b-98e7eab0b6ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b51de257-fac3-445f-8f9e-a7801fa14c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b51de257-fac3-445f-8f9e-a7801fa14c82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbb4d53d-a59a-4325-9313-560b13402e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbb4d53d-a59a-4325-9313-560b13402e58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_73e0f44a-a48f-4204-937f-c6b2d5e325cf" xlink:href="holx-20210327.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_73e0f44a-a48f-4204-937f-c6b2d5e325cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1978a3a8-4647-4b48-95b7-40dfbbc6c33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1978a3a8-4647-4b48-95b7-40dfbbc6c33e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_ff79823f-5ec5-48a3-a06a-626101a323b2" xlink:href="holx-20210327.xsd#holx_Holdback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_Holdback_ff79823f-5ec5-48a3-a06a-626101a323b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c79f8cb-5383-41f9-af63-58ef7872cf38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c79f8cb-5383-41f9-af63-58ef7872cf38" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3d3a920e-a58c-4088-a5fd-63d179f18232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_Goodwill_3d3a920e-a58c-4088-a5fd-63d179f18232" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5ac2f9ab-5399-4489-9d47-6ac03c505184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5ac2f9ab-5399-4489-9d47-6ac03c505184" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5bd9fad8-9c48-4909-98e1-98cb55e017b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5bd9fad8-9c48-4909-98e1-98cb55e017b0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_39f7e5fb-29e3-4da6-9d93-b6339beb7ac8" xlink:href="holx-20210327.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_39f7e5fb-29e3-4da6-9d93-b6339beb7ac8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_4828b25c-0dc5-4f5d-b3fc-24d06872405e" xlink:href="holx-20210327.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationSharesAcquired_4828b25c-0dc5-4f5d-b3fc-24d06872405e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_e063c807-d686-4c27-bf64-d308902ed0c0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_e063c807-d686-4c27-bf64-d308902ed0c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_d6c062a6-8b62-4aa0-bb10-57aabc1cb0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_d6c062a6-8b62-4aa0-bb10-57aabc1cb0a4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0b5ad7d9-3fbe-42f1-96aa-2cf45c795c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0b5ad7d9-3fbe-42f1-96aa-2cf45c795c50" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_c5314b68-e78d-4587-952a-be1c037af64e" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_c5314b68-e78d-4587-952a-be1c037af64e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f12138f2-a6e0-4cd2-922d-6360157e9874" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f12138f2-a6e0-4cd2-922d-6360157e9874" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_141c7f8c-0247-46f0-b660-29912ae6a317" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_141c7f8c-0247-46f0-b660-29912ae6a317" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_bb4a632b-c253-45b9-8880-0512341368c0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_bb4a632b-c253-45b9-8880-0512341368c0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_019127a2-4048-4249-9e2a-ea5fea1607d8" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_019127a2-4048-4249-9e2a-ea5fea1607d8" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_596a242f-645e-4e93-8da6-647cc1c01c8f" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_596a242f-645e-4e93-8da6-647cc1c01c8f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_ad0c06fb-177c-4bf2-a65e-b4144e5f179c" xlink:href="holx-20210327.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_FairValueAssumptionDiscountRate_ad0c06fb-177c-4bf2-a65e-b4144e5f179c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_523bc8e9-90a5-4f18-b68b-ccd580a922ea" xlink:href="holx-20210327.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_BiotheranosticsMember_523bc8e9-90a5-4f18-b68b-ccd580a922ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_b686e735-bfbb-4ac4-9a36-1d0a1c7e0d68" xlink:href="holx-20210327.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_DiagenodeMember_b686e735-bfbb-4ac4-9a36-1d0a1c7e0d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_8a47f55f-7375-44f2-b854-8c065be5713f" xlink:href="holx-20210327.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_8a47f55f-7375-44f2-b854-8c065be5713f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_beae9f28-8e4b-437c-96a8-bc921dbd2dcb" xlink:href="holx-20210327.xsd#holx_NXCImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_NXCImagingMember_beae9f28-8e4b-437c-96a8-bc921dbd2dcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_67d32338-8b7e-4c15-8cc2-386f9e1847dc" xlink:href="holx-20210327.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_AcessaHealthMember_67d32338-8b7e-4c15-8cc2-386f9e1847dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_e5c77e2f-ec88-4c6a-8866-82bb8fea0eb2" xlink:href="holx-20210327.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_HealthBeaconsMember_e5c77e2f-ec88-4c6a-8866-82bb8fea0eb2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_5ada1263-3b5a-4082-8ee7-be174a293bdc" xlink:href="holx-20210327.xsd#holx_AlphaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_AlphaImagingMember_5ada1263-3b5a-4082-8ee7-be174a293bdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_249532a1-9d7c-4683-81f2-fca6ffa2d7b2" xlink:href="holx-20210327.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_SuperSonicImagineMember_249532a1-9d7c-4683-81f2-fca6ffa2d7b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9f285134-f6c9-4a07-881e-df43dfe7ffda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9f285134-f6c9-4a07-881e-df43dfe7ffda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_5594adf2-e33a-4cd7-be95-8888c6bc0ebd" xlink:href="holx-20210327.xsd#holx_ContingentHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:to="loc_holx_ContingentHoldbackMember_5594adf2-e33a-4cd7-be95-8888c6bc0ebd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7a59d181-9c06-450c-bcd4-c1e838d03c8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7a59d181-9c06-450c-bcd4-c1e838d03c8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_483ece6e-2452-4d4f-a937-e08f19978f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_483ece6e-2452-4d4f-a937-e08f19978f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_1c51bde5-901c-400b-880e-9a931374f683" xlink:href="holx-20210327.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_holx_DevelopedTechnologyMember_1c51bde5-901c-400b-880e-9a931374f683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_96374da3-6dc8-49c3-98cd-633d57944873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_us-gaap_TradeNamesMember_96374da3-6dc8-49c3-98cd-633d57944873" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i64cb068885e74b46becbed6ff10b2492_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_821b0c27-1d70-4b04-81b1-cd38adb68f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_821b0c27-1d70-4b04-81b1-cd38adb68f6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d973606-e482-4491-8588-1f7e0002e8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d973606-e482-4491-8588-1f7e0002e8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_8409d195-0072-4731-86c7-5de8493e833c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_8409d195-0072-4731-86c7-5de8493e833c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_442b1236-4a3b-4ccd-99b5-43ab27d7d223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_442b1236-4a3b-4ccd-99b5-43ab27d7d223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d27b265e-753d-4916-9ab8-eee5df8bb5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d27b265e-753d-4916-9ab8-eee5df8bb5b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2c6c63e-e260-4785-b5b9-c0e631bfced2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2c6c63e-e260-4785-b5b9-c0e631bfced2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4aac6e7d-794f-42e2-b987-9c06693c33c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4aac6e7d-794f-42e2-b987-9c06693c33c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_11838368-9202-403f-9299-0c7c9c61d79d" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_11838368-9202-403f-9299-0c7c9c61d79d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a2fbbc8b-0cd5-4f9b-94c4-8d8dc5fe88b7" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a2fbbc8b-0cd5-4f9b-94c4-8d8dc5fe88b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_75296c1c-b461-4dc3-a8e0-e4e7b6c31bbc" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_75296c1c-b461-4dc3-a8e0-e4e7b6c31bbc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f3413d68-cbbc-40d1-926b-3f3dee2ae040" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f3413d68-cbbc-40d1-926b-3f3dee2ae040" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a4767380-ecff-4cdb-bde2-a001a3c11384" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a4767380-ecff-4cdb-bde2-a001a3c11384" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_915b9f73-88ec-4ea9-89fd-3f277b0a8a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_915b9f73-88ec-4ea9-89fd-3f277b0a8a54" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af5b9701-346a-48be-956a-08035f21d34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_Goodwill_af5b9701-346a-48be-956a-08035f21d34d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_46c05271-16dc-4ccb-ac82-130a11e16eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_46c05271-16dc-4ccb-ac82-130a11e16eca" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0273c4f2-41fa-4915-91b6-814ab1a1a153_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0273c4f2-41fa-4915-91b6-814ab1a1a153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_9b9c09d4-a9e1-40cd-99d2-dcf95f4a4f5b" xlink:href="holx-20210327.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_BiotheranosticsMember_9b9c09d4-a9e1-40cd-99d2-dcf95f4a4f5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_beec3003-f25e-4935-aa0f-a62584193f73" xlink:href="holx-20210327.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_DiagenodeMember_beec3003-f25e-4935-aa0f-a62584193f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_3abaa7ef-823f-4d0f-923f-1f15c0b4a92e" xlink:href="holx-20210327.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_SuperSonicImagineMember_3abaa7ef-823f-4d0f-923f-1f15c0b4a92e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_88c86431-1fee-4042-a0e0-62601776c43f" xlink:href="holx-20210327.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_AcessaHealthMember_88c86431-1fee-4042-a0e0-62601776c43f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended" id="i1210ba1ac126490bb9426bb9e786ad70_TradeReceivablesandAllowanceforCreditLosses"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended" id="ic5db501f302540eab79f3167e2aa9061_TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended" id="i878f1303a0524bad829abe5f53ddc1c4_TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20210327.xsd#Disposition"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended" id="ib3757c3aedf048449722c7a6d80e182f_Disposition"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DispositionDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended" id="iaea6e076f3aa49bb96629b99899ea725_DispositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d84c2507-6e8f-4115-92b2-7662465b527d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d84c2507-6e8f-4115-92b2-7662465b527d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5c6d5fc8-f6c1-4cd4-8e59-1cf8b2102975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5c6d5fc8-f6c1-4cd4-8e59-1cf8b2102975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_1ad99c0a-4d68-4988-ad7b-3b6fd41a6a3e" xlink:href="holx-20210327.xsd#holx_IndemnificationLiabily"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_holx_IndemnificationLiabily_1ad99c0a-4d68-4988-ad7b-3b6fd41a6a3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_462290de-f261-4515-9706-a254a5235f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_AssetImpairmentCharges_462290de-f261-4515-9706-a254a5235f52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c4dbc99-113c-4ceb-b5db-e8d0344bfa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c4dbc99-113c-4ceb-b5db-e8d0344bfa5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_abb42555-6961-4def-9697-26f9d5284893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_abb42555-6961-4def-9697-26f9d5284893" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_24dcd7be-65b7-4202-a912-49cdfbb04b59_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_24dcd7be-65b7-4202-a912-49cdfbb04b59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_96c7462c-0fbf-454f-8167-8b61d4fa753a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:to="loc_us-gaap_CostOfSalesMember_96c7462c-0fbf-454f-8167-8b61d4fa753a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_b5f8cc68-4d1c-421d-93d2-464420891393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:to="loc_us-gaap_OperatingExpenseMember_b5f8cc68-4d1c-421d-93d2-464420891393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a2cb4eb9-0b58-4281-866e-0e56aa4658ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a2cb4eb9-0b58-4281-866e-0e56aa4658ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ec85e4cb-304e-4691-b1f7-a78018a6c178_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ec85e4cb-304e-4691-b1f7-a78018a6c178_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9b129e49-7acb-4318-ac68-9dc9dda19f16" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:to="loc_holx_MedicalAestheticsMember_9b129e49-7acb-4318-ac68-9dc9dda19f16" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended" id="i0e035aa5ddce4b4c8157efe861e12375_BorrowingsandCreditArrangements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended" id="i6eb11ea792b04e91a1039f7dc164bf7c_BorrowingsandCreditArrangementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="ib49f0e9bc8624dbea4cfcf1b8d3c1441_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7a763fea-70a8-43df-851d-eeae477d8c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebtCurrent_7a763fea-70a8-43df-851d-eeae477d8c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_6e496708-3472-4337-8438-c02748b43887" xlink:href="holx-20210327.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_6e496708-3472-4337-8438-c02748b43887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ebad37ee-da99-4630-a8ac-21413bd2d832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ebad37ee-da99-4630-a8ac-21413bd2d832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_88fcaa24-157a-47e1-abbe-d9e102b2ea4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebt_88fcaa24-157a-47e1-abbe-d9e102b2ea4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c0701580-1a33-4f47-8cf2-a44bfea84681_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c0701580-1a33-4f47-8cf2-a44bfea84681_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_222a9684-b1ca-4539-8209-39cf8a7d8ffb" xlink:href="holx-20210327.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_TermLoanMember_222a9684-b1ca-4539-8209-39cf8a7d8ffb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_a50eb3a6-d8da-494a-81db-24e311e3105d" xlink:href="holx-20210327.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_RevolverMember_a50eb3a6-d8da-494a-81db-24e311e3105d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_5df595f7-3bbc-4938-a47a-c7c46b4e5e66" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2025SeniorNotesMember_5df595f7-3bbc-4938-a47a-c7c46b4e5e66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3c2ae8a0-2ed8-400b-9b13-79f4167184a7" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2028SeniorNotesMember_3c2ae8a0-2ed8-400b-9b13-79f4167184a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_6ba66392-e735-43f4-9883-c3301d03ec78" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2029SeniorNotesMember_6ba66392-e735-43f4-9883-c3301d03ec78" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="if6bc7d794ea143f6ac4478412a155b4c_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e466cff-4141-44f2-9ff5-d5b2b7caf22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e466cff-4141-44f2-9ff5-d5b2b7caf22d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad3f7cdf-8773-4d57-9b86-6b1a5d5a0fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LongTermDebt_ad3f7cdf-8773-4d57-9b86-6b1a5d5a0fc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29b9c45d-989e-437b-beb1-2363cd77217c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29b9c45d-989e-437b-beb1-2363cd77217c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96774c94-2974-4bf8-8105-8fdd5b525bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96774c94-2974-4bf8-8105-8fdd5b525bdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5b477a12-a97d-4a38-b740-b853189e1017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5b477a12-a97d-4a38-b740-b853189e1017" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7a8011ff-6c7a-41e0-887c-388c1c8b509d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LongTermDebtCurrent_7a8011ff-6c7a-41e0-887c-388c1c8b509d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ade8049a-716d-4ca6-bb55-5e33113ec444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_RepaymentsOfDebt_ade8049a-716d-4ca6-bb55-5e33113ec444" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a4ad1db9-5174-42cb-a2f5-698831821eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a4ad1db9-5174-42cb-a2f5-698831821eda" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2a5c0ed3-ab75-4ba7-a4bd-cd242c573d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_SeniorNotes_2a5c0ed3-ab75-4ba7-a4bd-cd242c573d32" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_a49715ce-8c49-4785-82b9-d41b2410fd64" xlink:href="holx-20210327.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_a49715ce-8c49-4785-82b9-d41b2410fd64" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c61bdd54-9a72-40dd-9406-21cb62dce6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c61bdd54-9a72-40dd-9406-21cb62dce6b3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ba9640d9-0c0e-467f-bbd9-5455dcb29ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_InterestExpenseDebt_ba9640d9-0c0e-467f-bbd9-5455dcb29ec9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_803244a7-4cf5-4bd7-ad74-3dd3b788cec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_803244a7-4cf5-4bd7-ad74-3dd3b788cec0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4a0c0539-f7b8-454f-ba65-87a62a171d82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4a0c0539-f7b8-454f-ba65-87a62a171d82" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d2d5f95b-6124-4a57-ac6d-de240950a658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d2d5f95b-6124-4a57-ac6d-de240950a658" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_75e0bfc3-d442-423d-b41d-0c2a2fc2d245" xlink:href="holx-20210327.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_holx_DebtRedemptionPremiumPaid_75e0bfc3-d442-423d-b41d-0c2a2fc2d245" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_778b27e3-3106-4a81-a1ce-d296da667957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_778b27e3-3106-4a81-a1ce-d296da667957" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f985f790-48ef-4e61-9f6e-6506e724a034_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f985f790-48ef-4e61-9f6e-6506e724a034_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_985f0921-ee3b-4ebe-b9a5-5d5274b6f778" xlink:href="holx-20210327.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_RevolverMember_985f0921-ee3b-4ebe-b9a5-5d5274b6f778" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_dba48df8-b0dd-468b-b4a8-332b9bca432f" xlink:href="holx-20210327.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_AmendedTermLoanMember_dba48df8-b0dd-468b-b4a8-332b9bca432f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e1f6d225-8934-461f-825e-7b873a3eac1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_us-gaap_SeniorNotesMember_e1f6d225-8934-461f-825e-7b873a3eac1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_c80d4dcd-f099-41e1-ba42-01f13c4ea07b" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_A2025SeniorNotesMember_c80d4dcd-f099-41e1-ba42-01f13c4ea07b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_13b7a625-d0e4-422c-bdf8-3027c0d1b14e" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_A2028SeniorNotesMember_13b7a625-d0e4-422c-bdf8-3027c0d1b14e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_37048a73-2005-4b23-a44b-b1da3a3baf38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_37048a73-2005-4b23-a44b-b1da3a3baf38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7803f539-0197-4f95-aec1-2409543e95a1" xlink:href="holx-20210327.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_TermLoanMember_7803f539-0197-4f95-aec1-2409543e95a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_31f1e25a-0668-47ef-b8d9-54ca61bba08a" xlink:href="holx-20210327.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_31f1e25a-0668-47ef-b8d9-54ca61bba08a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_3970dbcf-c7a8-457b-8e32-eba049b232c4" xlink:href="holx-20210327.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_AmendedTermLoanMember_3970dbcf-c7a8-457b-8e32-eba049b232c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_21387a36-1378-4e00-80b2-c18551f98d9a" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_CreditAgreementMember_21387a36-1378-4e00-80b2-c18551f98d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_1d452022-6d77-4f7b-8170-1df8e614be01" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2025SeniorNotesMember_1d452022-6d77-4f7b-8170-1df8e614be01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_16ebda44-5c53-47cc-b048-c4490c7d9f71" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2028SeniorNotesMember_16ebda44-5c53-47cc-b048-c4490c7d9f71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_52039f39-596e-4a55-ac7d-8a6b0b4c625a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_us-gaap_SeniorNotesMember_52039f39-596e-4a55-ac7d-8a6b0b4c625a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_90f88736-4da3-4395-b8af-55aa169a3732" xlink:href="holx-20210327.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_90f88736-4da3-4395-b8af-55aa169a3732" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_00fb643f-788c-4124-b54d-5b8315e939d8" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2029SeniorNotesMember_00fb643f-788c-4124-b54d-5b8315e939d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75ca1919-6a73-4783-aea8-e20e65090d4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75ca1919-6a73-4783-aea8-e20e65090d4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_f52db8a3-329f-4382-bb5c-842b992ffd4a" xlink:href="holx-20210327.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_f52db8a3-329f-4382-bb5c-842b992ffd4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d37d0d7d-e063-454f-acc9-2157e76c8409_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d37d0d7d-e063-454f-acc9-2157e76c8409_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f66978b4-b4ed-4b96-839d-e11b7f97b5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f66978b4-b4ed-4b96-839d-e11b7f97b5d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_701b8016-7a04-4c3c-bded-73ca6c27547c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_701b8016-7a04-4c3c-bded-73ca6c27547c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_35ec3dc3-9d3a-4d52-9e41-6ea179f950a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_35ec3dc3-9d3a-4d52-9e41-6ea179f950a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_97836772-999b-4a11-ad5e-bbb2454a03e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_97836772-999b-4a11-ad5e-bbb2454a03e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_5f719f42-bf3a-496a-9250-17248a19bf68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_5f719f42-bf3a-496a-9250-17248a19bf68" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="ib6c530110aa14b9cba541b7a79ed5bf2_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b7add696-dbc6-41c7-878a-7e6e406759cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b7add696-dbc6-41c7-878a-7e6e406759cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_82d4099e-5c79-4a99-b8c8-8bb53f1aa5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_82d4099e-5c79-4a99-b8c8-8bb53f1aa5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_80366ce9-8479-4a02-a147-559b91b93559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_80366ce9-8479-4a02-a147-559b91b93559" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:to="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_392e4dd4-7089-480a-a1ce-be07eee931ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_392e4dd4-7089-480a-a1ce-be07eee931ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_32d27a62-5eee-4434-85e8-e5aedefc1dd6" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:to="loc_holx_CreditAgreementMember_32d27a62-5eee-4434-85e8-e5aedefc1dd6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="icf575042723e46629f1446afef5a4394_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab4208e8-4c6b-40bd-a4ba-b1c3b0a194f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab4208e8-4c6b-40bd-a4ba-b1c3b0a194f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_4b750179-c329-4b5d-a64b-71c2d6a9c71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:to="loc_us-gaap_InterestExpenseBorrowings_4b750179-c329-4b5d-a64b-71c2d6a9c71a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e50a597f-484f-4c15-96e2-5925476def36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e50a597f-484f-4c15-96e2-5925476def36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f3c443e0-4ecb-4b40-bf7a-3e69d46cab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:to="loc_us-gaap_SeniorNotesMember_f3c443e0-4ecb-4b40-bf7a-3e69d46cab7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:to="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c64222a3-983f-41cf-a3d5-0277e4d4ff67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c64222a3-983f-41cf-a3d5-0277e4d4ff67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_04ba1ad6-ed2e-472d-9a42-580a5ba5a878" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2028SeniorNotesMember_04ba1ad6-ed2e-472d-9a42-580a5ba5a878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_a5d38b66-55c7-4d72-9c2e-21ee44bd47e2" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2025SeniorNotesMember_a5d38b66-55c7-4d72-9c2e-21ee44bd47e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_7782866f-56c5-4b13-b2d7-2767e62d2e74" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2029SeniorNotesMember_7782866f-56c5-4b13-b2d7-2767e62d2e74" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20210327.xsd#Derivatives"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended" id="i5b5d3b1c88d24a9a8669fc2295fde45c_Derivatives"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended" id="ifbf65f0428fa49289654ec6dac43f7e7_DerivativesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" id="ia87f818b809e423b9be6bba78fe49e72_DerivativesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_ba944c65-657d-4e0e-acf7-81fdbc5a821e" xlink:href="holx-20210327.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_ba944c65-657d-4e0e-acf7-81fdbc5a821e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_392c329b-2c1d-413b-9ed7-ea0764301a60" xlink:href="holx-20210327.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_PrincipalAmountOfBorrowings_392c329b-2c1d-413b-9ed7-ea0764301a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9574b1b6-9346-4f73-a910-d2b6e07d13e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9574b1b6-9346-4f73-a910-d2b6e07d13e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_767d9908-95e3-4a20-95b3-e1eabc19c28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_767d9908-95e3-4a20-95b3-e1eabc19c28b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_e4750f07-dbf4-4e1b-8afb-2a084410d0c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_e4750f07-dbf4-4e1b-8afb-2a084410d0c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_41298cc2-dc97-41b3-be24-3ededfeaf77b" xlink:href="holx-20210327.xsd#holx_NotationalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_NotationalAmount_41298cc2-dc97-41b3-be24-3ededfeaf77b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e7b0cc41-55eb-477f-a174-5af24d5cb492_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e7b0cc41-55eb-477f-a174-5af24d5cb492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_38ea5829-4268-4dd0-b933-602d8f022164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:to="loc_us-gaap_InterestRateSwapMember_38ea5829-4268-4dd0-b933-602d8f022164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_3c899126-1144-4162-aefb-caef9c094797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_3c899126-1144-4162-aefb-caef9c094797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:to="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_09d2520c-e7c2-442f-9c14-3c9fa14e0eec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_09d2520c-e7c2-442f-9c14-3c9fa14e0eec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_823959d5-233c-4df6-b2ff-e6c39e3ea123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:to="loc_us-gaap_InterestRateCapMember_823959d5-233c-4df6-b2ff-e6c39e3ea123" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended" id="i44d84af60eaa460bbb62898dc819a93a_DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21e01142-972f-4a5a-83a9-6758445655e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21e01142-972f-4a5a-83a9-6758445655e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_c76bdfce-4fc0-45ae-acfc-c94316a77875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_c76bdfce-4fc0-45ae-acfc-c94316a77875" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_0c1d6644-e295-4946-a015-7294ec30fef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_0c1d6644-e295-4946-a015-7294ec30fef7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b77962e-61d8-49e8-b946-2ee0d81145af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b77962e-61d8-49e8-b946-2ee0d81145af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e0dba48e-a156-44a9-9266-c4a048a69697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e0dba48e-a156-44a9-9266-c4a048a69697" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_309e5e07-3b05-4f06-a1e9-ef87c33ae667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_309e5e07-3b05-4f06-a1e9-ef87c33ae667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:to="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_01097a0a-7b48-446a-a3d7-2502ff8cc9d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_01097a0a-7b48-446a-a3d7-2502ff8cc9d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_60daf714-f990-420e-bf17-de333476eae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:to="loc_us-gaap_NondesignatedMember_60daf714-f990-420e-bf17-de333476eae1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i71fe423507354f02afc8fc66c862d873_DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_135dac2f-b721-483d-a3b3-153dda96c9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_135dac2f-b721-483d-a3b3-153dda96c9bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ac48eef5-8f6a-4a42-8bd9-af7714eb085d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_DerivativeLiabilities_ac48eef5-8f6a-4a42-8bd9-af7714eb085d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5df6a084-85c3-4308-ab28-3a78a2b6bd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5df6a084-85c3-4308-ab28-3a78a2b6bd1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_86966fb8-3840-4f64-b024-4c5d27cda1dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:to="loc_us-gaap_HedgingDesignationDomain_86966fb8-3840-4f64-b024-4c5d27cda1dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:to="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5c3ce999-b8b8-404c-8c11-5a33d124571a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:to="loc_us-gaap_NondesignatedMember_5c3ce999-b8b8-404c-8c11-5a33d124571a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_028911bd-c436-4049-8c84-084c3648950a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_028911bd-c436-4049-8c84-084c3648950a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3d2197bc-efe7-4402-8fad-94370da0023c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3d2197bc-efe7-4402-8fad-94370da0023c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_67c0e2ab-02ee-4152-99fb-f17edb6d0050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_67c0e2ab-02ee-4152-99fb-f17edb6d0050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b83ee2b9-f8ae-48b7-b2e1-717d4a0a901f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_InterestRateSwapMember_b83ee2b9-f8ae-48b7-b2e1-717d4a0a901f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c4a32c2d-e593-4ec8-814c-e2798686a4f3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c4a32c2d-e593-4ec8-814c-e2798686a4f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f910d5d9-9cba-46f8-8762-3ff17607dd9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f910d5d9-9cba-46f8-8762-3ff17607dd9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d201313d-3463-4dc6-9156-6dd18bd7fc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d201313d-3463-4dc6-9156-6dd18bd7fc9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_22a016d7-9d41-4ddf-9063-6e8d0524bf71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_22a016d7-9d41-4ddf-9063-6e8d0524bf71" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended" id="ib4460232c2fc4283ab5145f30871aa00_DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_84d8a4ec-9943-4603-a34f-52d7d0c4807a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_84d8a4ec-9943-4603-a34f-52d7d0c4807a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d51486ce-2a28-4171-a1dd-c23f2842493c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d51486ce-2a28-4171-a1dd-c23f2842493c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_47be48f2-9033-4877-9033-ea5fc8a07399_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_47be48f2-9033-4877-9033-ea5fc8a07399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5211fab8-353b-4722-8edc-c441c76efd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:to="loc_us-gaap_InterestRateSwapMember_5211fab8-353b-4722-8edc-c441c76efd10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_b1ff9251-6076-4bc6-8c07-14ab28a6d086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:to="loc_us-gaap_InterestRateCapMember_b1ff9251-6076-4bc6-8c07-14ab28a6d086" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended" id="id6cb398865854aa58ab0398eb23aab82_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended" id="i4b10ec2161d648d8991b69ea7615d42d_CommitmentsandContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_84a018f0-9f35-4921-9c9b-14ac4f5b9d45" xlink:href="holx-20210327.xsd#holx_AmountAssessedInDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_holx_AmountAssessedInDamages_84a018f0-9f35-4921-9c9b-14ac4f5b9d45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_57250ed9-2d06-44c3-8996-c881a0677467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_57250ed9-2d06-44c3-8996-c881a0677467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_01fb0ebc-da35-49ad-b71a-82b035068ea5" xlink:href="holx-20210327.xsd#holx_LegalAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_holx_LegalAccrual_01fb0ebc-da35-49ad-b71a-82b035068ea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:to="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_057f3b10-6fb7-45ac-94cf-2aa298414a68_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:to="loc_dei_EntityDomain_057f3b10-6fb7-45ac-94cf-2aa298414a68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:to="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_ea8584c1-8192-4599-89b1-19995e02146a" xlink:href="holx-20210327.xsd#holx_MinervaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:to="loc_holx_MinervaMember_ea8584c1-8192-4599-89b1-19995e02146a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_0985a508-5241-4371-9358-71cdaebcf519" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:to="loc_holx_MedicalAestheticsMember_0985a508-5241-4371-9358-71cdaebcf519" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShare"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended" id="i7cce0265eb3e4010b1c16a4a2b02d0c3_NetIncomeLossPerShare"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended" id="i86a76d90f6aa42ab97a380f62a92f9c4_NetIncomeLossPerShareTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i60696c3ef05d4545a4a3a752477c911c_NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:href="holx-20210327.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c84406f6-661d-4c55-8f0f-cdca5300b3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c84406f6-661d-4c55-8f0f-cdca5300b3ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_348b07cf-77a2-4b05-8ba5-9e6d6b1677e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_348b07cf-77a2-4b05-8ba5-9e6d6b1677e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ec3781e-2e9d-4ee5-b655-3580692633ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ec3781e-2e9d-4ee5-b655-3580692633ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4c4b96b3-2793-4f66-abde-bdcfc2958159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4c4b96b3-2793-4f66-abde-bdcfc2958159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:href="holx-20210327.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fdf6640c-0d5e-4f58-813e-6700e794782a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fdf6640c-0d5e-4f58-813e-6700e794782a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_ebc47d5d-5d93-42a2-8695-fa60806d5c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:to="loc_us-gaap_StockCompensationPlanMember_ebc47d5d-5d93-42a2-8695-fa60806d5c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e8d06580-98a1-4895-b10c-addbe997ac61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e8d06580-98a1-4895-b10c-addbe997ac61" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended" id="i2096cf68eaf04331b7b52f62e6774d81_StockBasedCompensation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended" id="i51f3b19278834269b1c23805fc427933_StockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended" id="ida32601c667243d7b60d01aac6046aef_StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a38485df-3b04-44ce-accb-f64c0e3d2a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:to="loc_us-gaap_ShareBasedCompensation_a38485df-3b04-44ce-accb-f64c0e3d2a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0e7f81fb-f23d-4b74-9a88-6f83447fa61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_CostOfSalesMember_0e7f81fb-f23d-4b74-9a88-6f83447fa61e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8503a1c6-56f5-44d5-924b-071d73c7b5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8503a1c6-56f5-44d5-924b-071d73c7b5e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_16bf307c-6aa0-4312-859e-386432b49519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_16bf307c-6aa0-4312-859e-386432b49519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_032d7c36-f03f-4814-8dc7-ad15a6dee875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_032d7c36-f03f-4814-8dc7-ad15a6dee875" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_a5a018de-b6d3-4ff2-b3d5-0a6db9b19f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_RestructuringChargesMember_a5a018de-b6d3-4ff2-b3d5-0a6db9b19f0e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="iec8eca49d9bc486d944f3d107bad2c68_StockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_22643f3b-70f9-451c-b9d9-4680a68c1d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_22643f3b-70f9-451c-b9d9-4680a68c1d4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_66a3896a-77e1-4db8-ab3a-f954bbbeabcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_66a3896a-77e1-4db8-ab3a-f954bbbeabcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9be4e13f-eb71-47d8-b565-e15068315a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9be4e13f-eb71-47d8-b565-e15068315a90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f6215292-414a-477d-8aaf-d8b6806170ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f6215292-414a-477d-8aaf-d8b6806170ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4fcc7b4c-afbf-43e7-a637-615851bd2d9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4fcc7b4c-afbf-43e7-a637-615851bd2d9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_add41633-429d-4314-92b2-13f11773e301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_add41633-429d-4314-92b2-13f11773e301" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6bebf72c-a1ff-476c-b845-5cb5e39d41ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6bebf72c-a1ff-476c-b845-5cb5e39d41ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_cca9a2cd-dd2f-47d2-900b-2ca2af70c2bd" xlink:href="holx-20210327.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_cca9a2cd-dd2f-47d2-900b-2ca2af70c2bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_63097cdb-17e8-4700-a1c1-bdbc20243f6f" xlink:href="holx-20210327.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_63097cdb-17e8-4700-a1c1-bdbc20243f6f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_04e5129c-19b0-4024-bf7f-7bcd1a65f4dd" xlink:href="holx-20210327.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_04e5129c-19b0-4024-bf7f-7bcd1a65f4dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a80cb5bf-3cf6-4e24-b80f-f432f076d830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a80cb5bf-3cf6-4e24-b80f-f432f076d830" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_51948dab-41f4-4ae9-9da3-33bac80f0835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_51948dab-41f4-4ae9-9da3-33bac80f0835" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:to="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_210e179e-3a04-452d-b6c1-aa6633cd1647_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_210e179e-3a04-452d-b6c1-aa6633cd1647_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1470a9f-f023-453d-a0ed-2eb1f420b183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1470a9f-f023-453d-a0ed-2eb1f420b183" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6fca00df-1fa6-4636-863e-654c7cbf1ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6fca00df-1fa6-4636-863e-654c7cbf1ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3b4619c8-5cd2-4637-823b-8c218116e640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_PerformanceSharesMember_3b4619c8-5cd2-4637-823b-8c218116e640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_4c498595-fb77-42ab-a3ae-829cbabdf844" xlink:href="holx-20210327.xsd#holx_MarketBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_MarketBasedAwardsMember_4c498595-fb77-42ab-a3ae-829cbabdf844" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_94d0eff9-543b-48b2-87b6-6f16636a8fe7" xlink:href="holx-20210327.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_PSUFreeCashFlowMember_94d0eff9-543b-48b2-87b6-6f16636a8fe7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_ac7db966-7201-4f5b-b91c-ae5bee770458" xlink:href="holx-20210327.xsd#holx_RSUPSUMSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_RSUPSUMSUMember_ac7db966-7201-4f5b-b91c-ae5bee770458" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended" id="i3f679ce1b475405caec224215143f9ff_StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended" id="i7fdb467ac1d8465c970373c86af4f30d_OtherBalanceSheetInformation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended" id="id3400514294e4768b5c8d3dbdeb78041_OtherBalanceSheetInformationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended" id="ieb2f95f1bcc34181b64c9d002162dc8f_OtherBalanceSheetInformationInventoriesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended" id="i4a707026d2b6463cb4420d3a3d67ff68_OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended" id="i9628c62ce1be471898e56f74b6fdfdd0_BusinessSegmentsandGeographicInformation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended" id="i73ba738244e9472d83034ed226061a81_BusinessSegmentsandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="ib7119da9c0ef4360b2ed01cbb0432bb2_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:href="holx-20210327.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b5d20c2d-8e34-47c4-b837-27c4afd13936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:to="loc_us-gaap_NumberOfReportableSegments_b5d20c2d-8e34-47c4-b837-27c4afd13936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4086bdd4-092f-4fe4-9acc-4e35fdca34ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:to="loc_us-gaap_Revenues_4086bdd4-092f-4fe4-9acc-4e35fdca34ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:to="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e92b174d-473b-49fb-a4b7-0a29d71ca4ec_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:to="loc_srt_ConsolidationItemsDomain_e92b174d-473b-49fb-a4b7-0a29d71ca4ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:to="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_091c83f0-da87-4b8b-b909-e908fd86fdad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:to="loc_us-gaap_IntersegmentEliminationMember_091c83f0-da87-4b8b-b909-e908fd86fdad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i47a3b02a380e4bd6ae5a9b30aa5d75f5_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fc19b83e-6847-4691-9d7e-a9f8f36eff1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_Revenues_fc19b83e-6847-4691-9d7e-a9f8f36eff1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a5ba2dc4-1981-417f-a999-3454b5b790bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_OperatingIncomeLoss_a5ba2dc4-1981-417f-a999-3454b5b790bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1b68f9c8-f961-44c0-b26f-b63234ad7c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1b68f9c8-f961-44c0-b26f-b63234ad7c09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_a09fbaa0-eff4-480e-8187-5472d1364284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_a09fbaa0-eff4-480e-8187-5472d1364284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5f193e62-227d-4da2-9275-ad0f76b94f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_Assets_5f193e62-227d-4da2-9275-ad0f76b94f80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25179352-f0cf-4411-8c9b-9b346121197b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:to="loc_us-gaap_SegmentDomain_25179352-f0cf-4411-8c9b-9b346121197b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:to="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5085b1fc-974c-482b-b8e5-f61673f5ada9" xlink:href="holx-20210327.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_DiagnosticsMember_5085b1fc-974c-482b-b8e5-f61673f5ada9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_e6bdc833-e7b5-4dc4-9720-1756006826ad" xlink:href="holx-20210327.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_BreastHealthMember_e6bdc833-e7b5-4dc4-9720-1756006826ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_9ad2d27c-c053-4449-9922-2d0f7b6f71e0" xlink:href="holx-20210327.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_GynSurgicalMember_9ad2d27c-c053-4449-9922-2d0f7b6f71e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_2675d8b9-5440-443a-9d44-27f607896713" xlink:href="holx-20210327.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_SkeletalHealthMember_2675d8b9-5440-443a-9d44-27f607896713" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1dcaa485-61ad-494d-ba67-f8ef7ba97e08" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_MedicalAestheticsMember_1dcaa485-61ad-494d-ba67-f8ef7ba97e08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_a26e3b0d-700b-42e9-84f3-4b5cfbf5df7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_us-gaap_CorporateMember_a26e3b0d-700b-42e9-84f3-4b5cfbf5df7c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="ifce756a42ca64f4c9bbe1adcf9f7921f_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_a806d4a0-7c9a-45f2-aa5f-fef942392946" xlink:href="holx-20210327.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:to="loc_holx_PercentageOfRevenues_a806d4a0-7c9a-45f2-aa5f-fef942392946" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:to="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:to="loc_srt_SegmentGeographicalDomain_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:to="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e9ad7463-35fc-4834-89c7-49c6a3bfb24a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_country_US_e9ad7463-35fc-4834-89c7-49c6a3bfb24a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f7d3b475-d801-488a-93b2-4f90a364392d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_srt_EuropeMember_f7d3b475-d801-488a-93b2-4f90a364392d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a72a1669-86ce-494c-be1b-0803019d1f39" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_srt_AsiaPacificMember_a72a1669-86ce-494c-be1b-0803019d1f39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_2f5e859c-b6df-4872-b67d-42e65522c2fd" xlink:href="holx-20210327.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_holx_AllOtherCountriesMember_2f5e859c-b6df-4872-b67d-42e65522c2fd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended" id="id3cbfe71aa404e17b2c57acaccb39a87_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended" id="iff984f0ea2d84a92af11edac49489087_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_df7f8fb9-99b2-41d5-aac4-74f9e67b867d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_df7f8fb9-99b2-41d5-aac4-74f9e67b867d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8bc9a051-9c69-4bb7-97e2-cdd3cbe32be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8bc9a051-9c69-4bb7-97e2-cdd3cbe32be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fc432c6-744d-4aa7-8402-93c098db859b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:to="loc_us-gaap_SegmentDomain_0fc432c6-744d-4aa7-8402-93c098db859b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:to="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1283c0c1-4bda-4633-ba45-e9d711bee6e7" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:to="loc_holx_MedicalAestheticsMember_1283c0c1-4bda-4633-ba45-e9d711bee6e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwill"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended" id="ib60f0926d4b14c3aae2f01f11ed155e8_IntangibleAssetsandGoodwill"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended" id="i2395791f95e94e5dad458f89e3c2cde2_IntangibleAssetsandGoodwillTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended" id="i61d8e9def8db46378093edb49062c772_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_765f9b17-7e43-44ca-9200-0eb8dfeee900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_765f9b17-7e43-44ca-9200-0eb8dfeee900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccf3f29d-b1a6-4e03-982d-560e9de2750a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccf3f29d-b1a6-4e03-982d-560e9de2750a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_90113bc1-658c-4595-b65a-31dd63fcab1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_90113bc1-658c-4595-b65a-31dd63fcab1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_6c6c91b1-bc45-4102-bdc0-3d79b4c6be70" xlink:href="holx-20210327.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_DevelopedTechnologyMember_6c6c91b1-bc45-4102-bdc0-3d79b4c6be70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_6b8c2be6-ba84-4af8-932f-08d04015f99d" xlink:href="holx-20210327.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_CustomerRelationshipsContractsMember_6b8c2be6-ba84-4af8-932f-08d04015f99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_001d9318-1c7a-4b65-aebe-d21e8aed1b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_us-gaap_TradeNamesMember_001d9318-1c7a-4b65-aebe-d21e8aed1b8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_aa0b0f94-c96b-49cc-af5d-5b37670c788a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_aa0b0f94-c96b-49cc-af5d-5b37670c788a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_76f6fac3-0e7f-43d8-9bc0-72dae4e42ea8" xlink:href="holx-20210327.xsd#holx_BusinessLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_BusinessLicensesMember_76f6fac3-0e7f-43d8-9bc0-72dae4e42ea8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_8b882f42-27fa-4108-a8ef-53230e5b3626" xlink:href="holx-20210327.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_AcquiredintangibleassetsMember_8b882f42-27fa-4108-a8ef-53230e5b3626" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_8689a6c8-cd64-4f5e-bdb5-74d86ab338b7" xlink:href="holx-20210327.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_InternalusesoftwareMember_8689a6c8-cd64-4f5e-bdb5-74d86ab338b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_9c4b634c-5362-4316-9470-8190eb63a9fc" xlink:href="holx-20210327.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_CapitalizedsoftwareMember_9c4b634c-5362-4316-9470-8190eb63a9fc" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended" id="i92a4381fb1cc415ea27d862056c9b69a_IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarranties"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended" id="i5769a07fc26e4f34945530612cb9c31f_ProductWarranties"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended" id="i89a7f99cf613473db2cb99eacdda4e4a_ProductWarrantiesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended" id="ie2d91369375e428fbea8761a8fda49e2_ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="icade3655909f41dc94423364e0c9c89f_AccumulatedOtherComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="i003408778ab94664b3cef9b4ba2387bb_AccumulatedOtherComprehensiveLossTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended" id="i3541ea7e0aea41198ea187f7c618e8ef_AccumulatedOtherComprehensiveIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_943adffa-1904-467b-aaf4-14a70cb3833f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_StockholdersEquity_943adffa-1904-467b-aaf4-14a70cb3833f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6053ce9a-6f4b-42bc-8972-57469826af1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6053ce9a-6f4b-42bc-8972-57469826af1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c753069-71c5-4b0e-9e33-8aa5890a110d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c753069-71c5-4b0e-9e33-8aa5890a110d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c528f01c-7103-40cb-ad1c-d12b08e85b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c528f01c-7103-40cb-ad1c-d12b08e85b5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_796bbc2d-1b1b-42cf-82e9-186011072003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_796bbc2d-1b1b-42cf-82e9-186011072003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_605f877d-ca48-460d-a9cb-82212614a3f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_605f877d-ca48-460d-a9cb-82212614a3f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e046877c-4d6a-4681-9a5e-3f957cdb77d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e046877c-4d6a-4681-9a5e-3f957cdb77d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ef6cbdf0-fc80-4f26-a56b-ff2706e85686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c9af11d3-2993-4bb4-85db-9a0dc760870c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c9af11d3-2993-4bb4-85db-9a0dc760870c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1c8cea60-b4e9-4280-adc7-4f921a5b236a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:to="loc_us-gaap_InterestRateCapMember_1c8cea60-b4e9-4280-adc7-4f921a5b236a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e5b18882-9b7e-4ea4-970b-0c58aa4e98b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:to="loc_us-gaap_InterestRateSwapMember_e5b18882-9b7e-4ea4-970b-0c58aa4e98b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3a92743b-15f8-4add-8fb1-d2918aadf243_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:to="loc_us-gaap_EquityComponentDomain_3a92743b-15f8-4add-8fb1-d2918aadf243_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:to="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_74f7bb62-f407-43ec-b613-4e7571983137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_74f7bb62-f407-43ec-b613-4e7571983137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_caa4b6aa-0271-459a-91c4-7945001d2257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_caa4b6aa-0271-459a-91c4-7945001d2257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9d322aae-6dd1-4e0a-a733-234c7dc30112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9d322aae-6dd1-4e0a-a733-234c7dc30112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ed21d52-aabc-44f0-b05f-05db030aecf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ed21d52-aabc-44f0-b05f-05db030aecf1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended" id="i15e6ced59cde42a8bd5cc5f92d354547_ShareRepurchaseSharerepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_58a6e5d7-d648-45c0-8134-fb971330e27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_58a6e5d7-d648-45c0-8134-fb971330e27b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_70cdb1c2-e303-4f30-98a7-4e0f460d8c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_70cdb1c2-e303-4f30-98a7-4e0f460d8c91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_015019ec-79a0-472e-b887-6bc7da3ca0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_015019ec-79a0-472e-b887-6bc7da3ca0d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_50d07360-c491-4caf-a160-528b722916dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_50d07360-c491-4caf-a160-528b722916dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cc7c2766-c40f-412b-936f-887b45235b2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cc7c2766-c40f-412b-936f-887b45235b2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_a794e1e0-bf63-4760-823a-8924f351e3f1" xlink:href="holx-20210327.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:to="loc_holx_December112019Member_a794e1e0-bf63-4760-823a-8924f351e3f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_825bda53-4e23-4295-a55b-1a93fc638fe0" xlink:href="holx-20210327.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:to="loc_holx_December112020Member_825bda53-4e23-4295-a55b-1a93fc638fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_73d347ec-fd7b-4e29-bd7f-ad68eef18ca4" xlink:href="holx-20210327.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:to="loc_holx_December112019Member_73d347ec-fd7b-4e29-bd7f-ad68eef18ca4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_462e89be-e5a5-43d6-8a97-ff18f3e0fb42" xlink:href="holx-20210327.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:to="loc_holx_December112020Member_462e89be-e5a5-43d6-8a97-ff18f3e0fb42" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended" id="iac726cb850104c529db3a47c70498736_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended" id="ie0dec275f317443aac72085d548dde89_NewAccountingPronouncementsPolicies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>holx-20210327_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_57dacd85-8dc2-4c7a-8a5d-4df7300ba691_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_f0a461e5-32ee-4c25-9c14-58f227faf0ed_terseLabel_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium payment</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_label_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_documentation_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid" xlink:href="holx-20210327.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtRedemptionPremiumPaid" xlink:to="lab_holx_DebtRedemptionPremiumPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6118988e-2b74-453c-9be0-524e3c17f77e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5fe52692-c96b-4047-aa11-d8e894870969_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_1491d30d-0a39-4f29-9fdd-b5a9b90b30fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0267a70d-5d68-46f6-a47b-337037140d44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments/Accruals</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d07ab417-91a4-4703-b7c4-06077187f326_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_c7760888-e359-474c-a9ff-48be491bb041_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_892daf14-40b3-45ec-8c24-8b1c32facb10_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8ac3ade0-0e52-44bb-ad20-773f46de9380_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_71a38ce5-50a3-4c68-bf06-b522398bf784_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_e42aee96-445c-4506-8e24-059c1391cc1f_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210327.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8ecb8ff8-7826-48a4-8eb5-cbf64de2d186_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d18401a5-3cdf-4f50-980d-5f8f3091ece3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_988ca01c-37fb-47c3-99ce-6b9c7998c8c4_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased (in shares)</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_84bda7ff-cebc-48ab-a6f0-312796f8df19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_93111a49-6082-4a4a-965e-e6ae742808b7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_f8a2118d-f9e5-48d3-b700-2ae59c174af7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_dedc8323-23c8-4d91-8957-70d75aff1fc8_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20210327.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_728770ce-57b3-46a8-a305-dbd79d048b84_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_04623cd8-f8c2-4906-b3da-03d19a0431e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cf1e0bea-b48e-4654-a627-ad12a13173ee_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_bd7dae7d-3d0c-4adf-9ccf-3220c54f3cc9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c557eca7-68a2-4d96-b3f9-f31040a85bdd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0586ac10-decc-46d0-bbd6-f42cbdbc73a5_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_d0f18772-3cd3-4dcc-8679-f271c92277b6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_bacd9b40-e4e5-4ecb-b8c7-2eff453907e8_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_bdcb3b28-7283-441f-8a4a-444e21f82691_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_e3c46670-20bf-472f-b53f-7c05816e1eef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_592dcf8d-6eb5-45a9-bd86-535fb09aa41d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4b861d0d-1682-4e26-aeef-7c55aa11c192_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_bee81aa8-9043-4cb1-b634-d37d8c1436f9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_5f746c97-a1f1-4ee9-885b-e8019852ad23_verboseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:href="holx-20210327.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_4be63f58-b8bb-4f56-b887-ddf856ef473f_negatedTerseLabel_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_label_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_documentation_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement" xlink:href="holx-20210327.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Acceleratedsharerepurchaseagreement" xlink:to="lab_holx_Acceleratedsharerepurchaseagreement" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_60e3db49-553f-42ef-8df2-01866dbebf0a_negatedTerseLabel_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_label_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_documentation_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes" xlink:href="holx-20210327.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RepaymentOfSeniorNotes" xlink:to="lab_holx_RepaymentOfSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c5d85095-a7b7-43bb-8bbb-89eb388a5218_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_d03c34fe-c3b8-4140-8b79-cc7b1a39c022_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d1f528d7-d0bc-4e43-bc6c-c54ceb644109_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_577f035f-b4fa-4a7d-a112-ea67715102da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_e6f6c1e5-a4aa-4852-90ab-4bc8acfde9e4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_ee380ad4-0cda-4bc8-abf6-c09d1f0bf3cf_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20210327.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_3a3f65d7-3088-4a78-af9e-fa742271dd8e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_248eeccc-d4ff-4180-ba86-e547dfd3be90_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1f819bd1-f4bc-4ba6-81d6-9256afc5caaa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4d245f47-bcd1-44d8-bb4a-cacb48799714_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_129628a6-dca0-4f23-9939-982110ace9b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_f420cadc-6ae0-4974-acb5-dc8357d8e752_terseLabel_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual incremental revenue growth period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_label_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_documentation_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:href="holx-20210327.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:to="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_a93d0652-6cd7-46d0-8f1e-8b65d2d6586c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AlphaImagingMember_c98050b0-9b1b-4dbb-9716-5d020637e0ae_terseLabel_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging</link:label>
    <link:label id="lab_holx_AlphaImagingMember_label_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:label id="lab_holx_AlphaImagingMember_documentation_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember" xlink:href="holx-20210327.xsd#holx_AlphaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AlphaImagingMember" xlink:to="lab_holx_AlphaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessLicensesMember_db0ad07a-40f0-4363-85f5-6b35fdf71375_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_label_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember" xlink:href="holx-20210327.xsd#holx_BusinessLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember" xlink:to="lab_holx_BusinessLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4d36d12e-9135-4b80-b31b-3e4d1c92acf1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fb88a72d-515d-4dd0-a779-46c9c15e39d5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_7dfc81e9-619f-41eb-970e-af07e2d3b7c3_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_c1520a68-fd2a-43ae-8206-5bf3d0f5af6a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_efde2e97-6b78-4fec-9d8d-695436b709c7_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_a796b1b1-c363-4dd3-a644-f01ce2494a8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_49b8c89b-b38b-48d6-bfe5-40e51db82508_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_6583da67-4da8-4138-ada8-59caff6a3499_terseLabel_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_label_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies [Member]</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_documentation_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember" xlink:href="holx-20210327.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SomatexMedicalTechnologiesMember" xlink:to="lab_holx_SomatexMedicalTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fcafaefd-ed2d-420b-9b36-0a0d38d9fc3a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_c24afb26-80fa-42bd-a55a-ff6170bf225c_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_3452a002-e5df-411b-915a-5019ef9dfac8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_bcf1b2ef-1bd9-4800-af3f-4028e5128dd7_negatedTerseLabel_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_label_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_documentation_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty" xlink:href="holx-20210327.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchaseOfIntellectualProperty" xlink:to="lab_holx_PurchaseOfIntellectualProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b4ca0be-0de6-4710-af41-0798643ed163_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, stock option outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a526919f-191f-4cea-aae7-5c1e02f7bd76_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_794f6c44-dbf3-49ee-ad96-64c49ff31613_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d4f116f4-0d67-4d34-8534-4ab1dc4fd5eb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_ccee11e9-9e74-4b42-b6c2-ac0777f13f4b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_18146602-609f-4383-aff4-17e6dace20ec_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified as Assets held for sale</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_label_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:href="holx-20210327.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:to="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_8bee4c06-4d6b-4802-ba6a-61ecaf7698b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_b3dff73d-baa5-4602-92a7-d6f9b528437e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_bd5544aa-e552-4ea7-8958-60175848aa29_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20210327.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_105680e8-bcde-4ab0-a06d-0590d4c374ea_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_436e8dc5-27ae-4e49-856d-00519e7ab372_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_45420b95-ff59-420a-b9fd-cbea596859f0_terseLabel_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_label_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_documentation_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:href="holx-20210327.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:to="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fa82b4b7-c51f-49a7-93d1-fcd2cd0fee2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_e75c47c4-57ac-491e-ad79-e68ec484c271_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_0df45fad-bdfc-4d0d-ac01-b1429efabf36_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3cda8c23-aa9d-4ce6-9c15-001bfd22b328_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_320ddc2f-01e8-4848-9d90-3e10f9b58388_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_2b2df115-7f38-4496-a36c-562ad929b32d_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_934633f3-dee4-4fa9-bebc-7d4bf6b01c90_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_6723d526-d892-4b9c-8b26-b20025095dbe_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_7d17521e-a7b7-421c-b1fe-8a67be710221_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8e744ffb-c064-43a2-a4dd-5fec4c94b3ee_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_70752ff7-5cea-4975-8eca-574abe8725e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_08daa6c4-cade-4131-909f-97213863fe18_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_e3e159e8-7f1f-455d-8b30-b4d1385c37dc_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_007328e5-83a1-42df-b033-161fbd4a6378_verboseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20210327.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_adeb2c15-cdd6-41a5-abdd-3f8cf68e7ad3_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20210327.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_8ae61635-c1c9-4b89-b1c4-54a3d83b93cd_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_5eaf50e3-0fa0-47e7-bc13-9e2ff885582d_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20210327.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_63356b97-6891-4cfa-8365-a1df5719665a_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, fair value (percentage)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_13217db5-d660-43c5-925b-06c859cc3051_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_37dcd0e4-74b5-4e21-8d55-db93bf3a249e_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20210327.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_48ba8f88-d74d-4e42-b867-5a571c879d8b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_270255b5-629c-49a2-b324-2802b256f01d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write- offs and Payments</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_4723612c-9544-47c3-918f-add57607a92c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Costofservice_514b8275-8eaa-4e79-97e5-c8317efc2046_terseLabel_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_Costofservice_label_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_holx_Costofservice_documentation_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice" xlink:href="holx-20210327.xsd#holx_Costofservice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Costofservice" xlink:to="lab_holx_Costofservice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d3730615-c6f0-43aa-98ae-5aaecc8d503b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_a0f9bc7e-411e-4455-8731-933721909756_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_eba88de3-22ae-4170-9ad2-4f144bc1e4f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7085b027-f029-46b1-b50e-5597d3d265bd_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_448b579f-84a1-4ae4-a4be-7885ff6a3913_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember" xlink:href="holx-20210327.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember" xlink:to="lab_holx_AccountsReceivableSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c41d68d6-ae9a-48a0-a1f6-09e6ce8640c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_9887970f-5234-437e-848c-dcfbc18bfc8e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:to="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_8a0c43f5-dc87-4a0f-aabd-5f745719ccb9_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20210327.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_014e854c-5626-4e9e-abbb-d9c779b697e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0a1ad2bd-77a6-4db2-a1b4-ea0c4f1e7b71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_9284e6f5-e923-4a9e-98ad-23525292b697_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4acb0d3e-9e0c-4da5-85f7-41a951bf0876_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_9f245690-a99a-4dba-9643-952246cee2a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedAwardsMember_056ec642-9249-4dbb-a4ec-76dae16c86be_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember" xlink:href="holx-20210327.xsd#holx_MarketBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember" xlink:to="lab_holx_MarketBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c1c368e8-c397-400b-86cd-f0e78fcee8e2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c792185d-03fd-411d-9447-f8b2e311668c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3bcdd6a6-bec6-4dea-87a2-50eda8012504_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_62487db7-29f9-4644-a625-f5e185f65f7c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_8bd983ff-c183-4407-abc8-c21f5ecffaf0_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bea4d059-b60a-4e6d-83cb-b346385ec8e6_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4c0abeeb-4014-4522-87cc-24b5a0a1082c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_17ed2b59-ffff-4c52-814d-e3e1500f401a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_13aa8b0f-ca20-48a9-9468-83c8d5d97ad9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f785bd7c-59e4-4438-8015-f70edc91bf9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_c93ab346-9f8a-4f11-bdd4-b44f18575e7f_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20210327.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_cff6c6fa-a65c-4038-8395-0c14814877f9_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_c60713ec-8628-49e4-b18a-739ad6a6ba6a_verboseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_b0206923-f636-4f88-9c43-3f19e114714c_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20210327.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_e744db92-b215-4997-831b-5f4dc6eab0d0_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20210327.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_1bd5cf38-fabf-4a05-8425-3c9f4b7d327e_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3b9e3fec-1f2a-4337-9cf1-f579aa35b75e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_37b0a850-22a2-44a9-a8e1-dbd3f371cf33_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_346f9498-4a1b-4bdc-a42f-879229fa8323_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_b0e8049f-a3ad-45da-b243-a504e5424beb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_f1a05e7a-1bae-4c42-8864-64677ba9c1e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_92958da1-b217-491e-8283-eaf97c31b29e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ecf4c5cd-0ace-4d3d-953f-63405278f4f4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_c626ab2f-f13f-4de4-b00d-61370f03b717_terseLabel_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_label_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_documentation_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold" xlink:href="holx-20210327.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationCostofGoodsSold" xlink:to="lab_holx_AmortizationCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_fd4765e0-143b-43af-849c-51f57696729d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_dd9c501c-7e9a-4836-9b26-c108a6f96a90_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of realized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4a1540c3-6a2a-40f1-9b0b-fc3d3625e52d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_f4aab633-053a-4532-b1d4-bb1170415b5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_b7be36e5-61b3-4a58-8c22-97c405030fbb_terseLabel_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_label_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_documentation_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:href="holx-20210327.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:to="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_fec47918-b345-475c-b837-a8e8994c043a_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20210327.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_a676ef7f-58c2-401e-865d-229a5b60a792_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b42e0170-8f13-49d7-9b60-ab8b66bd5570_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComprehensiveIncome_7969e28c-b758-4251-a246-7294f772cf2a_totalLabel_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_label_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_documentation_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome" xlink:href="holx-20210327.xsd#holx_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComprehensiveIncome" xlink:to="lab_holx_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_c3d27f1d-40a8-4447-a67e-b21d0c5cde1c_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_label_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanLineItems" xlink:to="lab_holx_SharerepurchaseplanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_e8b2e5d5-b317-4e76-88b2-847f5026a38a_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_72dd912e-9a63-4796-aca3-3aaf9710e405_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to newly acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_944e6d90-5600-4fc9-b17f-947b2318ccd5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_3e276cec-2ff1-4445-890d-4caa2a677b3b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b53e88dc-1c3d-42c7-b818-5525540eb251_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_363ba184-c844-4487-a57c-85aca2bdcb89_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20210327.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_d1a386ad-fe7a-4554-86c0-2c34ccd4981f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fb505789-2ce2-4d5a-894a-543d54dd19c3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_912709ba-e633-4d94-a85d-24b1d69b44cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_98edcb1c-54fd-484c-b4d8-ae2121e62101_terseLabel_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_label_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_documentation_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts" xlink:href="holx-20210327.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseofinsurancecontracts" xlink:to="lab_holx_Purchaseofinsurancecontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9acc9860-ded2-4509-8678-d5f72c481697_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, reserves</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_98c1622a-c50f-417f-838c-71e61c439021_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_84c05206-60bf-49fc-9f83-45d75d6003c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_17732e19-86f2-46cf-9e9c-7a1789d41563_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_b283aaca-3c3a-4971-b4c5-4ffd3a1c6215_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_label_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_documentation_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:href="holx-20210327.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:to="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_89afdb5e-c67d-4311-b38e-ee67a0f55df1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_d78af4c0-49e1-49b1-a8e1-de249cb1ca03_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:href="holx-20210327.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_df9035a7-d82b-4b0a-84a6-1aac94c90cf5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_76603384-8119-447f-9d34-6718bd08ce79_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_29122b21-eb63-4a7c-be96-6302d2ff01f7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_2410131d-7c5b-4bed-8bb6-79dd94a2e9ff_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e3020d92-7d50-462b-9d15-654d66ced236_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_348a0c67-df83-405d-a685-d0b126e1f05d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_54d7fb45-7392-46e3-b4c3-fe01ad494ad6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_c786bd35-644c-47b6-ac48-5f0f4ab81e2a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_443e01aa-df3d-4f49-988b-caeaea113187_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_a81d20d4-59cc-47cb-af3b-d70e2149438a_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquired intangible assets</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20210327.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3e6b9e16-2373-491c-93e1-529f547c8d79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ac3a0d79-c857-470e-9ef0-806315862215_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_d4295345-4255-4f31-9f75-a55c5e29be18_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_c3fb4f41-1968-40bf-9d87-8445ee7b864c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8c9c5102-5e3c-43b4-873b-7345438d1433_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_6baaa004-2a0a-40c7-b177-1c8fb35656bb_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20210327.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_32b38c76-7662-411d-b58f-b15b853d7630_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20210327.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_25d095d4-cd5b-49f3-b469-d449e2f96821_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_413b5bda-f75a-4c9b-abce-634ae3dd7e28_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_598b3e65-0481-40ce-a528-1f419d6fc2dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5d256ef1-d97d-45c8-8ff1-07c8caffde43_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_0972bff8-10db-46d9-8618-9ef653d23a17_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_45dfe6aa-eac8-4baf-bb76-a23337a66f86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a5e47265-4976-4f15-876d-f5f764cee629_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_10c5bfd6-676c-4173-998b-f083211fdd71_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_383c6a0d-c75a-4f00-9a10-96c5c3709191_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_4b49a2de-bb35-48c2-810d-ba34e6a18036_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20210327.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_4e80ab0e-43c3-4be0-bb1c-a489ada3121d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations - long term</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_67f56423-21f4-4531-919e-ae29deb681d8_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_1e34a816-926d-4ced-8176-72b078a44d11_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20210327.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_61551239-32d4-4a1b-a758-4d59e3c56722_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_f6712b2a-7815-4007-bd25-0ad09b5df326_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:to="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7233ed1f-7882-4981-9234-bae6be25a79f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_be7258ad-07bb-4967-a91e-e23f95fb13a6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_fca52a8d-5301-4e9f-8ad5-4a01641d8773_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:href="holx-20210327.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BiotheranosticsMember_d75389d0-a56b-4785-89f4-8ab58575950f_terseLabel_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_label_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics [Member]</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_documentation_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember" xlink:href="holx-20210327.xsd#holx_BiotheranosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BiotheranosticsMember" xlink:to="lab_holx_BiotheranosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d479fa71-c204-408d-ae65-1d31ae463bf7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_de6d6615-6d17-4f53-8dd3-7b488d4ab387_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_206ee0bc-64fa-405e-a345-f9f0176eca1c_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8e3b6ee8-2333-491b-8e19-0326c690d6ee_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41c6f0dc-7e58-414c-98b5-7f26eb3786a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_cb143a3b-e909-4a0e-be3e-8b3919c73684_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_6a692a11-2545-4a43-aa94-aac45b86d3e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_411d5775-20b5-43b5-a97b-031422b2cba2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6d51f556-5b91-4ffa-8c6c-d12cee74cbff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_477060ab-b750-4ecd-a5e7-24c3df57f8cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_2a667466-4b35-4247-bec0-df6b94a29ff6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_9dffff7f-a637-4efe-a6ca-828230a047c2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_1806d5c3-0e73-48a0-bf57-746dc2f8833e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_445b6de0-5ccc-4e09-b459-69c6abc2d91f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of capital lease obligations</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_f15e68ff-582f-4ef5-a962-be9bb2e4fa99_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20210327.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2b6cdc16-c9e1-49b0-a9f0-9f0b4f3ab2a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3913c126-4f54-4569-b715-c42f66eecf5a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_2001ec4a-700c-4cb5-af5b-e2fe40362af6_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20210327.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9a193484-82dd-45e7-88bd-a529e948a035_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_e3042569-8021-429c-8ac9-d96c1a462840_terseLabel_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_label_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Impairment Of Intangible Assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_documentation_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:href="holx-20210327.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:to="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountAssessedInDamages_dd6a8463-2d51-4fd2-bf9c-7f58058d379c_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages" xlink:href="holx-20210327.xsd#holx_AmountAssessedInDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages" xlink:to="lab_holx_AmountAssessedInDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_d24073fc-e8e9-4f11-8935-d5354194f62a_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d0b36990-bcb5-4bac-9a6c-7646f5be2f4b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_2a5986fb-b03f-4f0c-9925-bf1ca023b896_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_71aae574-a585-4e25-801b-1451287dceed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statements of income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_7bd6a3f3-cc5b-4cf1-843a-1b7327c5f177_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_e7b18169-ad02-4335-8773-20f62470c7af_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20210327.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d3f925c0-e654-4667-8f7c-5ff5a5c36e43_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_b350358d-f9f5-473a-9281-bea66fa0b854_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_ecafb3d6-60c1-4091-8af2-f23a4e81bc5a_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a702234f-9293-47b1-85ed-29ef63c1fbf2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_6c899513-594e-45ff-b31b-6a15af551fae_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_185b41bf-8213-4f26-9202-84f2a5f059e5_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20210327.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112020Member_33ce3ac5-ce15-4400-a751-3a7c31eaf62f_terseLabel_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:label id="lab_holx_December112020Member_label_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020 [Member]</link:label>
    <link:label id="lab_holx_December112020Member_documentation_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member" xlink:href="holx-20210327.xsd#holx_December112020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112020Member" xlink:to="lab_holx_December112020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_d2e9371a-22d9-4b69-affd-e8fc65f6a6a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_c53752c0-8fd3-425d-8470-9eb23e0a2820_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total (percentage)</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20210327.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_cb898dec-6bde-435b-b883-dec3667b7d17_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_ce793460-ec21-4d82-a831-bbe19938ed04_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20210327.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8a5045bc-2caf-4fef-b02c-a842b1cf08e9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c318b9b5-289d-456c-a365-9a904beaf5df_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1a5d68f0-1c2c-4983-9f24-458f99b72312_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_6968f2e0-5636-4b6d-bfcf-335049ccba87_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20210327.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4f54b14e-dc72-48a7-a220-a816ad1fdb5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b5b1f63f-bcc5-4ab0-b829-0aa13e8797f7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8ca132d6-db24-4e30-a693-e91b6ba841fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5c2f9e11-38ee-414a-ba98-845adae52409_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f0efc06f-086f-4ba9-9744-bce06c9039ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_38e11d39-55b6-4044-9e1f-9fb2b6598800_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_80706895-64ad-4724-8851-58a126772321_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_529b2a97-fb33-47c7-94d2-c1c055d08d0b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_e222679d-ac9f-48d6-981f-5e0da96b3362_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsMember_ad64b2de-9b5c-4f26-a2fc-e0ad1d806403_verboseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_dbf4b3cd-61d6-4939-9ed5-67e1eb543803_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsMember" xlink:to="lab_holx_MedicalAestheticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasisofPresentationAbstract_a366ab30-b99b-45b3-8ffb-a932eb7c623d_terseLabel_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_label_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_documentation_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract" xlink:href="holx-20210327.xsd#holx_BasisofPresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasisofPresentationAbstract" xlink:to="lab_holx_BasisofPresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_3f643b8b-24be-4e20-968e-047093dab9e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2e2578f3-96b6-4308-bc92-c7e349ef0634_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dbad9752-c535-4ff4-a3b5-662b94ec3d7b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4ead785a-6887-428f-9695-1cef8f23e5e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_4cec2acd-431e-4656-8f75-1f3104aa503b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:to="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_456639a2-9fa9-485e-b1a2-3f610354d737_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_574025fb-4954-425f-812c-3f523a080218_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_afbf3c94-6097-4cc0-80a3-366ef56c0a55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.4 and $1.2 for the three and six months ended March 27, 2021 and $(8.1) and $(6.4) for the three and six months ended March 28, 2020.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_dc7b8656-883e-42e8-97e4-2587498ac89c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_589ea3d1-ea04-4605-bd55-c2a0013ebf81_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_7da48fcf-dfdc-4a01-9172-4817a4972a9d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b5dceb1d-ac0f-489c-82f9-813b6bb5d8ce_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_32341a27-62ae-4a58-b8f0-ccf7afc737d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_bf453005-e2f6-4259-a840-3685a463caf4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_42f2f481-57ca-494a-9a7e-8ecbdf9315ca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangibles</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_5926d4a4-4296-4a8a-91f0-640a95644121_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_372c7077-56f9-40eb-8163-999b04205039_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_16c6c7a5-3141-451c-bef2-149ac33c5583_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2a72bca1-d11b-437d-a5da-3ed58005f264_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_6686bdae-f469-431a-a69d-7684ec11fbe5_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20210327.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_93e2ae67-3f39-4aa9-88cb-46080bf487ea_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20210327.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_c4293d8b-21a0-4d40-862d-f72c815879b0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_2abc27b5-3753-48d3-a858-fccef82300ff_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_38fee031-080a-4f05-a36e-883f982bcbd4_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ccf154f5-aa84-44dc-b3d7-ddb075e841c4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f53add05-bac7-4ba1-8a64-4ceecd9a330a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2a279a75-b40b-4011-a08d-069d45cbf5d3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_68e18526-feed-4350-9371-33ffd267ce15_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_18f48b77-acaa-4e79-8976-c7b88bae7e80_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_658b4d48-c3a7-402d-9f7d-136513bd442a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3fe2aa43-4225-43a3-b81c-ac68dbc2ef79_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price withheld</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112019Member_30f7e93b-fbc4-4cf7-8a96-7c5904e41406_terseLabel_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:label id="lab_holx_December112019Member_label_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_December112019Member_documentation_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member" xlink:href="holx-20210327.xsd#holx_December112019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112019Member" xlink:to="lab_holx_December112019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Holdback_7d9444a5-ac7b-4ef8-a42d-8ce5a6867e9d_terseLabel_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_label_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_documentation_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback" xlink:href="holx-20210327.xsd#holx_Holdback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Holdback" xlink:to="lab_holx_Holdback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_af443c11-3b64-44e3-8d3b-dc4a8f01030d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_de66a941-f213-4db3-b24b-a2375c333612_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_label_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_documentation_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes" xlink:href="holx-20210327.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSeniorNotes" xlink:to="lab_holx_ProceedsFromSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e4f5cff8-bca1-4b41-b261-6804e76b3456_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_f2a6767f-392d-46b2-8e04-1f4116d903c6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e197d25b-9a73-43cf-9b14-46e96153c24e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1451b428-7d44-4a93-af79-20febb8b494e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to statement of income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b8a081ca-3936-42dc-93b6-0d57f0b56bc6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_b6d2a5eb-3e8f-4674-841e-dd4ffc2ae5da_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20210327.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_b6087929-c9bc-4224-b957-71796d5c5966_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedTermLoanMember_cb5eb4e2-0997-4394-ba03-352277541c95_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_label_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_documentation_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember" xlink:href="holx-20210327.xsd#holx_AmendedTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoanMember" xlink:to="lab_holx_AmendedTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_cc5684fe-2d8c-4cdc-bd64-82ae703c6e4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_43af94e8-d49a-4d52-af25-fa8de2590ac7_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c77f11d3-d09f-426a-8e68-edb469f2dc1e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_11a1cd42-2923-40a5-999b-a04a1e562f94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_e3bcc1d1-2b3a-45f5-827a-6e4a65a6cf8a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_b3c47870-86b7-425e-b993-b28150885567_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LegalAccrual_5093c9ff-0ef2-4878-b4ff-0fd36ad90b22_terseLabel_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_label_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_documentation_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual" xlink:href="holx-20210327.xsd#holx_LegalAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LegalAccrual" xlink:to="lab_holx_LegalAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_62158c17-5db0-41dc-9af2-3263c3fc00c0_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased, amount</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_449d94f2-c476-4351-9478-6f816af5098e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_18ce43e5-4299-4fc3-b809-5c81ba1e6f1f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_cf9d942d-46fc-426b-9b5b-33ea5cb2f874_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b061ef81-f22c-45d9-9fe7-71e5ed039be5_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_ad97f230-5c06-43a2-8244-6577bc470c55_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ef15c8cd-cd82-4b73-9a26-4e61ee02de8d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_a20c5ab5-7e93-4a30-82e9-abd95422c290_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_label_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_documentation_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired" xlink:href="holx-20210327.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationSharesAcquired" xlink:to="lab_holx_BusinessCombinationSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SuperSonicImagineMember_7e3123b6-ecc5-43b1-af59-dea668365c65_terseLabel_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_label_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_documentation_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember" xlink:href="holx-20210327.xsd#holx_SuperSonicImagineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SuperSonicImagineMember" xlink:to="lab_holx_SuperSonicImagineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_27acc271-85a7-4dcb-a007-aa4801134ad8_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_f0ef80ef-9a4b-44f6-ab40-641651663219_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a5849c4d-a7a6-42af-b0e8-ac04fb111a5b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_b1376fae-3026-4e06-ae48-489f27ee06fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_46113903-eca8-40bf-bfe5-9a017c03310c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentHoldbackMember_339087a3-7389-47e2-98ca-ba4e32d05cf3_terseLabel_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_label_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_documentation_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember" xlink:href="holx-20210327.xsd#holx_ContingentHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentHoldbackMember" xlink:to="lab_holx_ContingentHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_eb9474c7-5320-4bcb-abf0-daa7e8804f51_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration, portion related to loan repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2f7fcd9a-7cb5-49c7-a7ba-624225e50e41_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_1c02b8af-5733-4d6b-8d16-4a5a531b047d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_a4b749f8-d8a9-420d-8035-a88ea847dfd4_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20210327.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e0e15b3b-9dd6-4736-8007-055d5f4f02d9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_1c4eb7ca-8bdc-4396-91e1-78d99bf8a316_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_44d5f54e-a0a0-4ab7-a691-03e18a5de338_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e6ddd546-0b01-4b77-b2a3-466b40160e90_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4905d056-4c23-4b0c-9864-401b2e33160b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_740de705-356c-43b5-95cd-f65f624eb873_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_HealthBeaconsMember_1f294d13-7a45-4923-89ed-8c9b6953de2d_terseLabel_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_label_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_documentation_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember" xlink:href="holx-20210327.xsd#holx_HealthBeaconsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_HealthBeaconsMember" xlink:to="lab_holx_HealthBeaconsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_085909b2-9437-44b3-9a9b-48d615401e4f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_4974e26c-def2-4ef8-abd8-37444effc5f0_terseLabel_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate percentage</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_label_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_documentation_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate" xlink:href="holx-20210327.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FairValueAssumptionDiscountRate" xlink:to="lab_holx_FairValueAssumptionDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_36ac02b1-ec09-4496-a661-ccb8d3979402_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_efd612e8-60ac-473f-8d98-391e0af04574_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_55350dc0-fc18-4e2a-9031-e28d3c9fbd44_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_c63dbed4-327b-4f62-877a-ff4a013a121b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c6c82d32-2b21-4e23-b40e-b1459b37e89c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7bde4dd3-9635-404b-b7dc-825df19389e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_99277360-02e4-47c6-862a-317a7a36116d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_bfa47c20-48c4-4d9b-8fae-c1f35762b2c0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_60a5b978-50a9-4b09-b2e8-4f9452bb3027_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_3675f069-1fcc-4765-bc1d-7a0294de1756_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_01df5262-9544-4167-b9f4-9ebf85003706_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ServiceRevenue_710df53a-e527-4728-bd97-cb4d05cdc3a9_terseLabel_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_ServiceRevenue_label_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_holx_ServiceRevenue_documentation_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue" xlink:href="holx-20210327.xsd#holx_ServiceRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ServiceRevenue" xlink:to="lab_holx_ServiceRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_f1fa6f9b-c863-48e7-92d2-4a18dc598efc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_290372f2-1931-4035-85b9-79f1d237ebd0_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_46b948e6-5b8c-4d93-9454-32a41b6c689f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a78df5bd-479c-4c92-ab8c-2e033a416e4d_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_ff8af99c-b864-4cc2-a8a3-a274565d7454_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_33ab0199-5476-428b-af57-9da7dba83e61_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4fb06513-9131-45f3-b43c-fd66d9f4bbbd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_69c0364a-85ac-4744-8a56-cabb8e7d5de7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_da0059e7-8703-429d-b998-a2ce5e7fc1b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_909bbcf8-d77a-456c-a87a-6862172c1118_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_f5f335c1-3a65-4d37-8a83-994978640215_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_1bf0e043-71ab-482d-9a19-2047524e5876_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset and equipment impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_19696600-c3b9-4703-b7bf-924bbc951718_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5d292802-deb5-492d-9909-3f85b258a531_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_92e89a14-6758-4608-97f5-93548a185232_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_225d85e3-aa36-42de-a604-3c0fbc4ba1a5_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20210327.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_a3decea8-9be4-4649-943d-a005e1a9388d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_14d64b1b-90e5-4638-9d0a-4c140bbe39b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_14f561c8-c214-4061-bd44-3d7c67506a83_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_5b903f88-cbd2-4b16-87bf-82dc67f6ef47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:to="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f76fc779-10ce-4704-8130-b98220606eb2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_516b3916-69b6-4341-88e6-5944c1c6f979_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_0dbfad49-2b61-438a-8d98-cd0a4c790809_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_a2047137-a0bb-47bc-83c7-2f529c84e458_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotationalAmount_052fd4f1-c501-408b-a935-8041b8e6fda4_terseLabel_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_label_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_documentation_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount" xlink:href="holx-20210327.xsd#holx_NotationalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotationalAmount" xlink:to="lab_holx_NotationalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9145a877-1455-4a6e-8783-09e33195a009_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4ad30f52-15ff-43cc-90b3-efdb75d1187f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves of $41.7 and $31.6, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_58946a2f-8c0e-4444-be77-cd6c3e7eb5af_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_b21dab9b-b8b9-493d-85af-56b944d77a2d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_bf5a1623-0128-44a5-872e-92e2e3953090_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_f2fa3e2c-e85a-45cb-b725-9ee95562bcad_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20210327.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_257975cd-93b3-40ef-af98-a858ffbc79e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ef61fc6f-d0b5-4313-bc04-ccfe60d332d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d7d0877a-37be-4edd-9bcf-1f415cc53fdc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_3602ab80-3e40-4821-a44c-7c5ab94131f6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MobidiagMember_c37ff222-a749-4590-b53c-0d46d07a6fe9_terseLabel_en-US" xlink:label="lab_holx_MobidiagMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag</link:label>
    <link:label id="lab_holx_MobidiagMember_label_en-US" xlink:label="lab_holx_MobidiagMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag [Member]</link:label>
    <link:label id="lab_holx_MobidiagMember_documentation_en-US" xlink:label="lab_holx_MobidiagMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagMember" xlink:href="holx-20210327.xsd#holx_MobidiagMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MobidiagMember" xlink:to="lab_holx_MobidiagMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c0ade7d4-08bb-473b-8788-e9463294ca40_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_908b53a0-2663-496a-9fa7-49a525140359_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c9370a7a-3fec-4967-93af-1ef8103f046c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_576f8ce7-e65b-4dd3-82a6-25482af9f0f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_d9236cac-ef8d-4055-a88e-85e2ab085430_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_a59d79fa-0558-4a24-ba95-bcf108a00f4b_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20210327.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_c8d938c4-cf15-45bc-836b-492fa4349b07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ChangeInParValue_e440f957-be84-49c4-a7ed-6de357c9dd68_terseLabel_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_label_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_documentation_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue" xlink:href="holx-20210327.xsd#holx_ChangeInParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ChangeInParValue" xlink:to="lab_holx_ChangeInParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9e5ac1d6-5621-4035-a56f-e4bf6624df0d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9272e82e-2b22-4def-ae35-a88f4d62f46b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_94db157c-c5af-4470-843d-3b4e2f31987d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_eae87749-f74d-49cd-afda-0f90d1c0c2bc_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_d0274cb4-230b-48a8-a01a-c0fb5856e42a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_f1e6c5b6-29c0-400b-bb6d-1cc3534f1ae6_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_label_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_documentation_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness" xlink:href="holx-20210327.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSaleOfBusiness" xlink:to="lab_holx_ProceedsFromSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_db6c0913-95f6-4c36-8196-340124f14102_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_1658e5cf-0581-4cb0-9e02-24cfd80f3cc5_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_11042d6b-0ae8-45a1-aa74-366147ebc647_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f7a09d84-f742-463e-b3c7-f72fd49a838d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise prices</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b1774354-059a-4ab4-b463-d2bb798aad0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7eaa3795-b7b8-4b69-b3fd-b0e755eb67cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_93d253c7-f47c-4c88-9734-28f7313922e5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_410e9fff-7a89-4f07-ab9b-7e17b876b6e2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4dbfc648-6257-40a1-bcde-85ec17be4850_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_62862ce0-50b0-416d-8f5c-f28a50123cca_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_79983062-28fe-4c6a-9c59-6ca41a63c8e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9fc1c9ab-a90f-47ab-8af5-107c837d7198_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1663136f-53c0-492c-a271-baae474fff68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_539fe2dc-782b-4542-ae13-e81bfe2b50aa_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_628ea4ef-f6d6-4356-920e-c461912acd8c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_81870fe3-b99a-4603-8699-f91bfc1cf7dc_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagenodeMember_c8942268-f9d0-4859-bd36-8712bcb51556_terseLabel_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:label id="lab_holx_DiagenodeMember_label_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode [Member]</link:label>
    <link:label id="lab_holx_DiagenodeMember_documentation_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember" xlink:href="holx-20210327.xsd#holx_DiagenodeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagenodeMember" xlink:to="lab_holx_DiagenodeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_13745ad6-3437-47a8-9fcf-f36e43ad1160_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_67790324-4674-4e5d-b5d1-5e7720cc3ae0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5bcf8030-fbb8-4018-8729-5a9cdb7194ef_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2d4b612d-458f-4387-89a1-5200a2a88aef_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ba5d0e46-43b4-457d-8e9e-3e4ce65e7240_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,887 and 295,107 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_556d1766-be7e-4612-8025-ba4ae6c82eab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d93c73b4-3503-4781-b855-7570787d767c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_2fb1f931-2ccc-4b9d-9d9a-9995ed7cfc28_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8ba36e66-1d04-4895-a8c7-a806e2dbcb6c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e508baf8-aa63-42ab-847c-360f4b6a355f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_3d5023b4-9b34-4d47-8b38-20d5525227ef_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_63b55a6c-2d29-45a2-9326-e8e48b1f0d25_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_089a2d99-5ff9-469d-ab20-313a61452630_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e2be0b25-75f9-4467-ad61-36eb3e800b59_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a640b08b-d3d7-4269-bc6e-e27bc6850855_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_c7b18141-0d61-4810-a9bc-f29c3a35d841_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinervaMember_3dddb2cc-3cfd-48f4-a05a-1a40bea27e81_terseLabel_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva</link:label>
    <link:label id="lab_holx_MinervaMember_label_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:label id="lab_holx_MinervaMember_documentation_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember" xlink:href="holx-20210327.xsd#holx_MinervaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinervaMember" xlink:to="lab_holx_MinervaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_b900b695-2cee-435b-8cfb-7809f317f93c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_d4ce2724-90c6-4fb9-8d3c-b1d4b30c540e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4aeddfbe-a702-4d3b-9a4e-aed5c5c4ad24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_8549e8b9-fe2f-4a39-a156-fd021118e0e0_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember" xlink:href="holx-20210327.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchaseProgramMember" xlink:to="lab_holx_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_611e6dfc-14d9-4eb1-8654-4470c8ca5a4a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquired tangible assets and liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_89a92fa4-f84b-4574-b340-0e61fcb58940_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_767c7f04-34bd-42bc-8f9d-dfba2815ab72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_154ed719-74d6-4882-bda8-ac37e2bf54e2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_43257a99-2fe7-46f0-b0af-d3733b745e7b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_081deb14-6977-4629-b8cf-046e5823ca51_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a5bd14b1-83a6-48b6-8f37-2fa44e711476_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash less assets held for sale</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_90069ae9-7fee-45db-921d-3e0af0c7c28e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6276012a-53df-427c-ae36-cfbc997f5ed8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_b42d073f-174c-4579-ac62-09f992f35d47_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_6d775c81-75a5-4311-9e21-ecedc5dbe65e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_eac8d681-749b-42b7-a4da-4a3e9a501e5b_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_66e1cd81-1640-4601-afb5-40869df5f704_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4d1db549-d367-4e26-b19e-21d2f17a7636_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_51e1ed68-515a-4d5d-84de-a0e7eaf53803_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_23cf6e99-6ac2-45c9-8d8b-37e9b16e1235_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_47a988fd-1955-465b-a168-a63072726b4b_terseLabel_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tender offer price (per share)</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_label_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_documentation_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:href="holx-20210327.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:to="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1a838a63-9f8f-4b73-86a6-0137d9255c82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_bb7ae0a5-a53e-4e3b-ba0c-f27e7d994471_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3c220d54-cbe1-4776-ab15-045616a6ddf1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Hologic's stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_562c1fe1-4650-41ef-bc79-60a732ffbf25_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4ecd0475-27b2-4b76-acba-d3eb82f91371_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48791d92-e92e-467f-9d43-b3f9abce323e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0ff64478-2948-4a9f-b657-af9275fa6cbe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e766377b-5104-487a-b1dc-f57631f3ab9c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_55829b3c-e8fe-4428-b4a5-46ca1484da9c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7c573d99-2130-485f-b1c4-b58430ec4f93_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_efa9e50b-16c5-462f-bffd-7e00df97df44_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ecfc9a65-620d-4c78-90ce-ff1ba8400058_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ce2abdce-4a70-44cf-bf55-e9ccaec17803_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3e764487-e857-452e-bcd7-5a3d84ec45c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f373d6f6-1f05-4a3d-a7a3-410a38893b42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_429f4b18-07e3-4269-908c-65823e2e082d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestofWorldMember_b52607cd-f3e8-4476-8bed-67057b5fd28b_terseLabel_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_RestofWorldMember_label_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_holx_RestofWorldMember_documentation_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember" xlink:href="holx-20210327.xsd#holx_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestofWorldMember" xlink:to="lab_holx_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_178dad52-79f2-4267-b274-07a7cfd6655a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_df55643d-231c-44d6-a40a-e96b8b624f1a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_2381ae8f-f826-4ce7-887a-d6982a6fb7ab_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IndemnificationLiabily_d55076e0-2b65-49fa-8ccc-34069dad58a8_terseLabel_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_label_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_documentation_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily" xlink:href="holx-20210327.xsd#holx_IndemnificationLiabily"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IndemnificationLiabily" xlink:to="lab_holx_IndemnificationLiabily" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a918e926-1fdb-4bf9-941f-ebccc305dd0f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_0ac47992-8865-458b-b943-28461c176bcb_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_4387eab1-81a5-4102-b3db-c7ea3aabf228_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20210327.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_3848df09-9ea2-418b-b16f-4bf09b776485_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0925306-b343-4e42-befb-037cecf130b4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_3e8bd13a-2c09-44c7-8569-d979367f4a9f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_81bcfc5e-84b5-4f7d-bab9-bc89b29f8755_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_59488673-7098-4ee0-9db1-80a5f6c579c1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_98ec1354-339a-4407-8e61-2e6770228bbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e8aba70f-322d-43f9-99ba-81864a2ec74e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d366be35-1e3e-4b39-aa5f-f4c9cd99da30_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f6c4106a-5bab-48a1-b3ef-4acfaf9454b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_33d86faf-0f76-4e4e-86ff-b1b5d74211f1_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f5f4068f-cd02-43cb-9aef-5a4827a8d036_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_85fe8628-f50c-40df-a8f7-d074feff4112_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2a109eef-335a-493a-b807-9e9f42a1a623_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2025SeniorNotesMember_a669edcc-9bc1-461e-ba38-ec00ddf8bcd7_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember" xlink:to="lab_holx_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_92cc2c5e-ab7b-4824-b6c6-d923e957c1a7_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20210327.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_eb1897a7-6d05-44b2-84c9-ca52234537ad_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_935f573a-bede-4189-980b-568de24f639d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8133f87c-56f2-4a5e-b9e4-fa9e869c8fbf_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_16b71b6f-d7eb-494c-b7b4-debc0588602c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8339434f-e38f-4246-a751-45a330c9e6c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_ee6e975e-8404-4ab0-9bff-08d11d6e53fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eac5e212-3317-461c-aeb4-5b37b3584ad4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_1daff500-20c7-40b2-afff-afa421f7b660_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_90e3b0ae-13af-462a-9462-4fa4c7adf6ab_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_6a1c9a44-c2da-4bd4-afe7-de276dbebbf0_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_264d05b4-6893-4970-8433-b08f9942e97e_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_86be5687-d811-46fe-bad9-aa7eb0ec1499_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1fba1acf-1a2c-45b1-bb9c-c6fd4cf22463_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8b48e1c9-6473-45cf-9a9d-aa796ff71888_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_361491cf-5bab-453d-948e-887ee4ecfb14_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_b0231f73-f022-4c3e-9008-f70a3cda7c26_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_02d7592d-a519-431a-8d11-a39c2d695beb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share attributable to Hologic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProductRevenue_23ee148e-afb9-432e-bea0-0866b1e422cb_terseLabel_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_holx_ProductRevenue_label_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_holx_ProductRevenue_documentation_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue" xlink:href="holx-20210327.xsd#holx_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductRevenue" xlink:to="lab_holx_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_6d0853e0-1d90-4682-9357-c8cc37e0c85a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and divestiture charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RSUPSUMSUMember_715c253d-7303-4ca6-af67-7ecef605ae71_terseLabel_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_label_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_documentation_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember" xlink:href="holx-20210327.xsd#holx_RSUPSUMSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RSUPSUMSUMember" xlink:to="lab_holx_RSUPSUMSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_9b267fe5-238d-4de2-946c-fb14e65ca413_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_53855fe3-640d-4bde-b842-12cf349b6717_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NXCImagingMember_4c0bac29-1962-4992-9e11-8ce8ecdfbb85_terseLabel_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:label id="lab_holx_NXCImagingMember_label_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging [Member]</link:label>
    <link:label id="lab_holx_NXCImagingMember_documentation_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember" xlink:href="holx-20210327.xsd#holx_NXCImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NXCImagingMember" xlink:to="lab_holx_NXCImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c6a6b532-cc5e-4613-8be4-a9d86591d346_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_ef7a726f-d4fd-4dd2-8bb6-7360852c4208_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:href="holx-20210327.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_c4cdfeaa-9d4e-446c-ab29-1f80ad44f57d_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20210327.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_93b23f07-2b5b-4c2d-b67b-960d514a60db_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_825fc97d-9d33-4a3f-9384-cb341c55cb58_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2b96d1c3-2192-4e5e-9c0c-5b7e4ce0e91b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_eb0e72ac-7705-4a12-9822-3e4f91a15288_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f8432e92-b9dc-41b5-b7d1-9494969b0161_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_fa952a3b-62f7-4fc1-ae70-194f3d40e253_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4c4ba317-1bd8-49a6-9c49-eadcaef14761_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_96054169-cd16-4ff4-bda2-57ded2af4a3d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1e735dec-11db-4df5-be2c-02f8a7ac56d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_44d65179-2725-4714-afb1-f85558b51341_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a75333bd-ffea-484a-91da-66594f87c8aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_8fd3ae5a-1d71-4f66-8b43-f26a45c486a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_77a7535f-f9b1-467f-9242-3df29cf95189_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_0dcbe95a-1d9a-41e9-8813-3b354d231b51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_940fd8c2-27cc-469a-b6ba-d9466085df83_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_e23308ab-c419-4e57-bc7a-2eac36366790_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20210327.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e0c2c125-8f1a-4a37-9767-dfcd46f25e9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Netincome_2960ef8b-a33f-4783-9535-13d4cfd84334_totalLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:label id="lab_holx_Netincome_59fde46b-6ab6-41d4-92a2-c133d502600b_terseLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_label_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_documentation_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome" xlink:href="holx-20210327.xsd#holx_Netincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Netincome" xlink:to="lab_holx_Netincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_6d4388d1-3133-4940-91d1-81e7f07ddbf3_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_5c141a0e-7b52-4a35-80fc-c975f516149a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_e088e380-77e2-4a33-9bee-8f5b2841b149_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_07636fcf-e829-4716-be52-66cae64128f2_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to fair value of noncontrolling interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7c19b9cf-6655-4447-b993-242cb30b040a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_47597c95-a979-41ff-bf72-e9d20d51fada_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e08c5133-395b-4942-b01f-514c1443e9ed_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanTable_8751855f-7e98-4808-aed9-2e3317c69d85_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_label_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanTable" xlink:to="lab_holx_SharerepurchaseplanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_9eaf0233-fbdf-4d6a-8c30-0a1a86984322_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5242a4bd-6094-4fd9-9b74-c91464341d50_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e62b00cb-8df2-4069-9e2c-b88088063965_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c85c9e3e-57d5-4693-96d6-c8aa87c94fe1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_d1610f92-b227-4b75-9a3a-d8e69109a98c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0fb2a6d2-18ad-490c-9cf4-512a651db493_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_26e28ea4-989b-4eaa-b55e-81bbef4f943c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_feb86d14-e4e0-49f0-9e0a-6e76b26f801b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1de9f104-c76a-420e-ab12-16e062678473_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0c9e1aa3-6328-4453-8112-e2431c669e3d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d2d6d91d-613b-4fa6-8751-a9bb1b924662_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_b6865f88-e4c8-443e-a6e5-0e47fdae6c4b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_fa85f908-09dd-4ae1-9508-77fa59d5a06d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_f1b18ab2-6961-4293-a475-09a8919e67d3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_1ad0391f-a72a-4550-8a2e-9a800e5f2e5f_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_de54d17e-81ab-4fc6-8703-13119ad28a08_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_efdefa17-529d-4722-86fa-1afc123f35ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_31209345-b7a7-4660-85cf-5b99478e57b3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_3bde2823-0764-4f6c-b91e-76871335ae2e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6e52ab6e-ffa0-4732-8f04-8cf406d4c292_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a9979381-b59b-4382-91e0-cd455995d11f_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_366998e3-274a-4a86-afad-1f3b383d64ad_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_73528c5f-c554-4531-bbc7-84e5e7f07ba8_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_fbaece9b-95d0-4853-b950-3cb094aa8c51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ca594b61-9c05-49af-93ee-5fe566eaa09a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_0c504ce9-2acf-4c2e-94c8-31b88055abd9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_79a1d691-dc5c-4793-a4f8-348767d3ded6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_42e9cd0f-c58d-4a55-9dce-59bb92bcdd50_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7165fd73-a528-4479-8b7c-c8ffdcf2fff4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3ceaea81-df6c-4fcc-96f9-ef4555f4f05f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a616d40-46cb-4480-a4cf-043bdf2b22d3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_48ef422a-50d5-468a-a14d-c5c5a9ebac72_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_d5782413-7b88-4e61-b975-2598db063df8_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_67350f09-4256-48fa-96e0-8fd8ca133b3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_4ffd3400-4c90-46c1-b8b5-e82c47a41f03_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of hedged interest rate swap and interest rate cap, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_dbd867a0-f44b-47ca-b6b3-be37352bcc14_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_bce3bbd4-ce19-4101-aab3-970e2e1cea62_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_0d323738-cc7f-44bb-baee-87ab4f20dd5e_terseLabel_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_label_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent" xlink:href="holx-20210327.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrepaidIncomeTaxesCurrent" xlink:to="lab_holx_PrepaidIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5386281f-91de-4f7c-a945-58c7654834d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_e80fb7d7-4161-4807-bc84-ee463d7656a8_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_14c6c0e5-605a-4f41-9fbe-fc0ff782bbe9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_f71b7e8c-cbc3-40ae-826e-1b0f886d8096_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210327.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7930b22d-cff0-43d8-9088-9b3fdde04395_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_22663931-018b-4212-8392-ec6ce74c35a1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db73ca83-89f3-4a4c-9a49-5c4f77408941_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_94806697-8821-46d3-a71d-89f802abd445_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_9e3bdcbf-2fae-4fc3-9d5d-e24007c2638a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_0c0b1aa4-c5cd-40fd-a07b-f4ee9997c7f0_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software embedded in products</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20210327.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_26336742-5e44-4e5a-91b7-0a6a5797bc07_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c46ac71f-f776-4995-baee-c8e116bde8ba_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_90eaf208-52f9-4768-b531-2a5fc628bbe1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fe0a9cf2-b306-4358-8147-8dd59f12aa25_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a44067bb-4686-4c9c-90bf-0d46d4de0a38_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_35935ae3-af53-4544-a1df-35492add1a5d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_095fa98c-7ae9-4282-9006-31ec9a15c256_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_628a3ee6-80a4-42e2-9917-ae8a33ead3b6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ced6bea0-20cc-4b23-b066-6aea0cdccb30_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b12a6589-0f86-42ef-9d13-02f902c89598_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6fc30bcf-233e-414d-aaad-8e3ef4887ee2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_46acf8bf-e8da-4097-b5d1-bae5ed6a142e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Petitions filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f990a4a7-f1ea-453f-93bc-03cd840031bf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6dbd6e9b-820c-4d98-9181-3d29b39dd268_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fffcd8a-6363-4754-a118-b8e9823ec4e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_27ec4c3d-5aa9-4d64-b8bb-c692a5c9e5c1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_6c8c48a2-209c-4aba-9a04-07190e794b22_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short and long-term debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4a427e8f-5887-44f8-9234-24b6f4f31766_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bbc32f4d-f8bd-48cf-990f-d6a75ec598b9_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_361e5bb1-fd58-404b-88c5-ad224ae29356_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5268b3fd-4b68-4457-bb81-1e284ee1f936_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_40d36d27-a235-4a91-8c47-4a15e18697d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_c05d8697-4924-45ea-b28c-882b9bbd9eb1_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap at fair value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d420015d-b86d-42fc-af20-96c56665bc44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 40,682 and 37,609 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7aa60c6c-2476-437f-b980-918bb25833bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_bdf1924c-ea6c-45eb-8617-fcd33d3c9d6e_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to equity method investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_c1867a98-4f5d-453d-a650-cf5496530ec3_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_label_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_documentation_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage" xlink:href="holx-20210327.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationOwnershipPercentage" xlink:to="lab_holx_BusinessCombinationOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_064c525a-bbf1-460b-ac4a-828fe85d69e9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d21b5641-c26c-404b-b1e1-af4a37dd7900_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_f5d42973-4641-4aff-8a8b-5abf615ad871_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0ddac134-69d5-47ae-9d07-75ef923e9e7f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_5d30530d-0e0b-4dd5-9678-74477c48ffb6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit line</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_45b1386b-8c6d-43df-9603-5dd080a6e1e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>holx-20210327_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:6956e089-1e71-42c4-b60a-a2057ed692c8,g:9a6ba754-14df-4ea9-a17b-5756ae02c6e7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20210327.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6e73cf40-096f-4b87-92b7-9622b2282c59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_Security12bTitle_6e73cf40-096f-4b87-92b7-9622b2282c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_685598b0-a8a6-48e3-9e7e-ccb645348c80" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentTransitionReport_685598b0-a8a6-48e3-9e7e-ccb645348c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_c9fc48d0-a8e3-4588-b7d1-2368eba4a690" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentQuarterlyReport_c9fc48d0-a8e3-4588-b7d1-2368eba4a690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0895a44a-1d6d-4afa-bca7-a3fd6e20332d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0895a44a-1d6d-4afa-bca7-a3fd6e20332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0ee974fe-d78a-45e1-9a71-b7298ae54c69" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityAddressPostalZipCode_0ee974fe-d78a-45e1-9a71-b7298ae54c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f48d9b40-ad40-4d34-8eea-7ac0bc4dc4b6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityFileNumber_f48d9b40-ad40-4d34-8eea-7ac0bc4dc4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e7c38f8a-4816-4d36-b0e4-5fd0e8eeb22c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentType_e7c38f8a-4816-4d36-b0e4-5fd0e8eeb22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b9fd3ce9-7ed9-4c13-bc1f-b314ccbb79cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_AmendmentFlag_b9fd3ce9-7ed9-4c13-bc1f-b314ccbb79cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_cca86f91-bc49-4ff9-ae46-bff8b88b5fd3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentPeriodEndDate_cca86f91-bc49-4ff9-ae46-bff8b88b5fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_73920c8f-f8e1-40bc-a47e-88890421ab73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentFiscalYearFocus_73920c8f-f8e1-40bc-a47e-88890421ab73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5920e40b-2ade-43d6-b153-9a4cc06d94ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5920e40b-2ade-43d6-b153-9a4cc06d94ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b42634b0-36b9-4255-b6a4-e6f7a5c56a63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityRegistrantName_b42634b0-36b9-4255-b6a4-e6f7a5c56a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf9eeae2-4dbf-426a-920a-65d313b061d9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityCentralIndexKey_cf9eeae2-4dbf-426a-920a-65d313b061d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1e16b9ec-7172-4d64-8586-645d05be2373" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_CurrentFiscalYearEndDate_1e16b9ec-7172-4d64-8586-645d05be2373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cd7b6ace-8e5c-47f4-8d2c-69ac14bfe54f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityFilerCategory_cd7b6ace-8e5c-47f4-8d2c-69ac14bfe54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bc4ea51b-1e42-464a-b7a0-4bdf08f1ec60" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityEmergingGrowthCompany_bc4ea51b-1e42-464a-b7a0-4bdf08f1ec60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_acb29447-919a-41b6-8045-18ea02fcc230" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntitySmallBusiness_acb29447-919a-41b6-8045-18ea02fcc230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b28bae5c-096a-4cad-aa4f-dc09bf8afba4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b28bae5c-096a-4cad-aa4f-dc09bf8afba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c9fa7ffa-02f9-4e6f-a5ea-d2240ab1239a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityShellCompany_c9fa7ffa-02f9-4e6f-a5ea-d2240ab1239a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6af55216-be31-428e-b851-fb7856b008f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityCurrentReportingStatus_6af55216-be31-428e-b851-fb7856b008f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b564803f-69cb-4774-af48-d8b9080c3a18" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityInteractiveDataCurrent_b564803f-69cb-4774-af48-d8b9080c3a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_eb31a681-eca3-41b1-b89b-1933f6e01423" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_CityAreaCode_eb31a681-eca3-41b1-b89b-1933f6e01423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_27c74e21-bdab-4025-afee-902b58617721" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_LocalPhoneNumber_27c74e21-bdab-4025-afee-902b58617721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4a929df7-271e-4b26-bace-b78e3b483911" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityTaxIdentificationNumber_4a929df7-271e-4b26-bace-b78e3b483911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1a442dfb-777a-42b7-ba6a-e6ebe8aabcbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityAddressAddressLine1_1a442dfb-777a-42b7-ba6a-e6ebe8aabcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_51cd6af6-6ddf-45b3-adba-65f4b8d6b87d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityAddressCityOrTown_51cd6af6-6ddf-45b3-adba-65f4b8d6b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_46591b2b-dd19-40fa-8f14-d0407ae3a7f1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_EntityAddressStateOrProvince_46591b2b-dd19-40fa-8f14-d0407ae3a7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_309645f3-e9ad-453a-9295-5a53fcc712a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_TradingSymbol_309645f3-e9ad-453a-9295-5a53fcc712a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_26f49472-4ff4-42f1-b2e3-1f732ccd3b03" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4609aa24-6e30-4e1b-a678-47bc368b136d" xlink:to="loc_dei_SecurityExchangeName_26f49472-4ff4-42f1-b2e3-1f732ccd3b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_758e8c71-a07e-4e81-bd11-e4fb509155bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:to="loc_us-gaap_RevenuesAbstract_758e8c71-a07e-4e81-bd11-e4fb509155bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_1f2dccf7-ab3f-4285-ae48-ea021984ee1f" xlink:href="holx-20210327.xsd#holx_ProductRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_758e8c71-a07e-4e81-bd11-e4fb509155bc" xlink:to="loc_holx_ProductRevenue_1f2dccf7-ab3f-4285-ae48-ea021984ee1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_cdea9290-16db-48c4-aef7-4665dabf4303" xlink:href="holx-20210327.xsd#holx_ServiceRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_758e8c71-a07e-4e81-bd11-e4fb509155bc" xlink:to="loc_holx_ServiceRevenue_cdea9290-16db-48c4-aef7-4665dabf4303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_24cb5a78-ca29-40a7-a92b-23fdc4ee6521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_758e8c71-a07e-4e81-bd11-e4fb509155bc" xlink:to="loc_us-gaap_Revenues_24cb5a78-ca29-40a7-a92b-23fdc4ee6521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:to="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f5b92140-ace3-4dad-9d57-baa55b3cc50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f5b92140-ace3-4dad-9d57-baa55b3cc50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_d017919d-a6e9-4e08-adb2-fe1bbdd38875" xlink:href="holx-20210327.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:to="loc_holx_AmortizationCostofGoodsSold_d017919d-a6e9-4e08-adb2-fe1bbdd38875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_f136c206-ce0d-41f1-b279-c5033fbde5e5" xlink:href="holx-20210327.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_f136c206-ce0d-41f1-b279-c5033fbde5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_94290281-1682-460f-9ac3-91408079cbbd" xlink:href="holx-20210327.xsd#holx_Costofservice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:to="loc_holx_Costofservice_94290281-1682-460f-9ac3-91408079cbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_92247e63-baf3-4801-bfd8-a1b2b5c64e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_4070c8ef-c127-4126-8e14-0000e1f871bc" xlink:to="loc_us-gaap_GrossProfit_92247e63-baf3-4801-bfd8-a1b2b5c64e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:to="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_47619caa-e0b7-4fae-a3e5-ecb172f115f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_47619caa-e0b7-4fae-a3e5-ecb172f115f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9282397d-4dc0-4796-b6e8-97da50943d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9282397d-4dc0-4796-b6e8-97da50943d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_34a21ac0-9125-4eb1-a8aa-7feca2325c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_34a21ac0-9125-4eb1-a8aa-7feca2325c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b12d93f3-8e07-49a6-87ac-2517e4322340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b12d93f3-8e07-49a6-87ac-2517e4322340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1c8e3877-fdeb-42a0-98d8-7719485fcc9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1c8e3877-fdeb-42a0-98d8-7719485fcc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_159065bd-46df-4c80-9cff-fcfaf46c44f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_159065bd-46df-4c80-9cff-fcfaf46c44f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4eb651cc-7f82-490b-8b1a-3647ebed856d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_RestructuringCharges_4eb651cc-7f82-490b-8b1a-3647ebed856d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8345ced0-23a1-4fde-a0c0-795d2f139dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_OperatingExpenses_8345ced0-23a1-4fde-a0c0-795d2f139dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_21774be2-0327-41a9-8f28-604d29dcd667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_OperatingIncomeLoss_21774be2-0327-41a9-8f28-604d29dcd667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9e7eb232-c8d8-4109-b555-f3128268a070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9e7eb232-c8d8-4109-b555-f3128268a070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9a5dcd2d-a624-4936-b709-54f142e12c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_InterestExpense_9a5dcd2d-a624-4936-b709-54f142e12c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ac2be850-d7ef-47e0-a339-b88e3caaa66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ac2be850-d7ef-47e0-a339-b88e3caaa66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cbfbd18c-7c23-457c-a3f6-f00ec8aa01e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cbfbd18c-7c23-457c-a3f6-f00ec8aa01e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_58f525d0-6e19-4cbb-bec9-a7cd981736a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_58f525d0-6e19-4cbb-bec9-a7cd981736a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_433ee672-a5fa-47bb-998c-0d402c0b5100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_433ee672-a5fa-47bb-998c-0d402c0b5100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_41f6ec0c-9d0f-4685-8bb7-9a4bdf34d080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_NetIncomeLoss_41f6ec0c-9d0f-4685-8bb7-9a4bdf34d080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_4c249cb9-5619-4faf-88bb-909925d879ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_4c249cb9-5619-4faf-88bb-909925d879ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_4f2e52b2-a8e7-4c8b-8beb-148efda0a9e0" xlink:href="holx-20210327.xsd#holx_Netincome"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_fd0dc28a-b5b0-424b-bdb8-bf6de48300bd" xlink:to="loc_holx_Netincome_4f2e52b2-a8e7-4c8b-8beb-148efda0a9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_97ee2418-a0cf-41cc-99b0-999b675910e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:to="loc_us-gaap_EarningsPerShareAbstract_97ee2418-a0cf-41cc-99b0-999b675910e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_65f2971a-1ed8-4d19-a903-642c0bbe1431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_97ee2418-a0cf-41cc-99b0-999b675910e3" xlink:to="loc_us-gaap_EarningsPerShareBasic_65f2971a-1ed8-4d19-a903-642c0bbe1431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a86fa579-66c7-44fe-9440-b730c95de7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_97ee2418-a0cf-41cc-99b0-999b675910e3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a86fa579-66c7-44fe-9440-b730c95de7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5d827f7-1227-4599-89d3-9d6ed71e462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e02039fb-d715-4c1b-8695-5de87f60eb64" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5d827f7-1227-4599-89d3-9d6ed71e462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77e324bf-6ae0-4f8d-b3ef-c4216c17c67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5d827f7-1227-4599-89d3-9d6ed71e462a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77e324bf-6ae0-4f8d-b3ef-c4216c17c67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e35ff032-b863-49c8-b162-cf0b0f0c3d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5d827f7-1227-4599-89d3-9d6ed71e462a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e35ff032-b863-49c8-b162-cf0b0f0c3d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_976cb1c8-6081-4e09-9de0-cc0259bb99e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_NetIncomeLoss_976cb1c8-6081-4e09-9de0-cc0259bb99e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_264ebafa-da66-4103-8db3-2b8444f8d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_264ebafa-da66-4103-8db3-2b8444f8d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9d405ccc-1957-48bb-922d-0300a8f75e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9d405ccc-1957-48bb-922d-0300a8f75e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_70d321d9-390d-4cd5-8a7f-d586ca2adfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_70d321d9-390d-4cd5-8a7f-d586ca2adfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_35bd4f76-b2a7-41c5-bddd-9071ae593818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_35bd4f76-b2a7-41c5-bddd-9071ae593818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c9aef40-7857-42ae-a590-0cc0db7fd58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c9aef40-7857-42ae-a590-0cc0db7fd58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6061266a-8a3e-4bee-ad39-0f27747b4921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6061266a-8a3e-4bee-ad39-0f27747b4921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_7cc3f088-71b1-4dc7-85a9-21cf3e225f5a" xlink:href="holx-20210327.xsd#holx_ComprehensiveIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7022109-5900-454d-a383-a86eed502cca" xlink:to="loc_holx_ComprehensiveIncome_7cc3f088-71b1-4dc7-85a9-21cf3e225f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c244290c-d8ff-4389-a91d-30afbbd5b1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_676dcd74-bf3a-4d20-bdb1-427eac6d5ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c244290c-d8ff-4389-a91d-30afbbd5b1ee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_676dcd74-bf3a-4d20-bdb1-427eac6d5ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2f020e9f-664d-44b9-aa7f-d2074a82f7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2f020e9f-664d-44b9-aa7f-d2074a82f7f5" xlink:to="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_38bcb5db-1817-42b5-a9a2-007865c8b5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_38bcb5db-1817-42b5-a9a2-007865c8b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7db20648-7633-4c52-9778-f8dd213a4ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7db20648-7633-4c52-9778-f8dd213a4ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_681eaef6-8ee1-4eac-abd7-79602b4acc9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_us-gaap_InventoryNet_681eaef6-8ee1-4eac-abd7-79602b4acc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_c8b868e3-586d-41ab-aea9-6080243bc533" xlink:href="holx-20210327.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_c8b868e3-586d-41ab-aea9-6080243bc533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3e64a469-4e48-41e1-a2ad-b047a1d6e7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3e64a469-4e48-41e1-a2ad-b047a1d6e7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f19abb3-e04d-45e2-9344-f31e65be0827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8230633c-3f14-4195-86a0-1e12aebfe65c" xlink:to="loc_us-gaap_AssetsCurrent_8f19abb3-e04d-45e2-9344-f31e65be0827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4aae2bcf-6125-401e-9f03-070ace8d99da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4aae2bcf-6125-401e-9f03-070ace8d99da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c43723c8-cd02-406c-bd1e-8d685926f8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c43723c8-cd02-406c-bd1e-8d685926f8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_47b2de8d-569f-4a43-8003-1e931c5f0d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_Goodwill_47b2de8d-569f-4a43-8003-1e931c5f0d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_30970be0-2984-4960-b211-d694dffc7f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_30970be0-2984-4960-b211-d694dffc7f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a1c89437-581b-4f9d-bc9f-3dbc5e4e678c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_aff99c80-9162-47b3-817f-1ea5c0693664" xlink:to="loc_us-gaap_Assets_a1c89437-581b-4f9d-bc9f-3dbc5e4e678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2f020e9f-664d-44b9-aa7f-d2074a82f7f5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_18d7e558-bbf0-4564-a295-3dd0c9f61865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_LongTermDebtCurrent_18d7e558-bbf0-4564-a295-3dd0c9f61865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ea1bff83-d454-4467-abe4-0c4439c32833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_AccountsPayableCurrent_ea1bff83-d454-4467-abe4-0c4439c32833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4cb64375-b482-4780-b314-eccdfaef1bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4cb64375-b482-4780-b314-eccdfaef1bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_e5c23fe4-b3cb-424c-900b-343cb08ff6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_DeferredRevenueCurrent_e5c23fe4-b3cb-424c-900b-343cb08ff6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_c9808b1a-4418-483f-beb3-bd80724384ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_c9808b1a-4418-483f-beb3-bd80724384ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_50b7e863-4ef7-42e3-be24-56ffb0996156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_84fff526-62b3-47af-8725-661e7224ccd8" xlink:to="loc_us-gaap_LiabilitiesCurrent_50b7e863-4ef7-42e3-be24-56ffb0996156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e3ad5264-5f58-44af-ab2c-7af6679951f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e3ad5264-5f58-44af-ab2c-7af6679951f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_2ce9af1c-f51a-4de6-b0e1-c9e6c8d71644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_2ce9af1c-f51a-4de6-b0e1-c9e6c8d71644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_14d67b64-32a6-4024-83fb-2cff2a6de8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_14d67b64-32a6-4024-83fb-2cff2a6de8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_c92d3b0f-7606-42a5-ad97-dfefe3e67914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_c92d3b0f-7606-42a5-ad97-dfefe3e67914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6a67701e-ba54-4b3a-b60a-085e07b0473a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6a67701e-ba54-4b3a-b60a-085e07b0473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_91c02814-31eb-4980-b436-3a52421be0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_PreferredStockValue_91c02814-31eb-4980-b436-3a52421be0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d1a101fd-df24-4eb2-864f-fcb50b290172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_CommonStockValue_d1a101fd-df24-4eb2-864f-fcb50b290172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0f02a576-b461-4e74-aecd-676efcd85b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0f02a576-b461-4e74-aecd-676efcd85b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c4a1822-3105-4237-91f6-bc35b6a4285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c4a1822-3105-4237-91f6-bc35b6a4285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f20f8f3a-3c8e-423a-a024-98b9428f5ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_TreasuryStockValue_f20f8f3a-3c8e-423a-a024-98b9428f5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_120c646a-e9bf-4b32-bc62-4d67c6829327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_120c646a-e9bf-4b32-bc62-4d67c6829327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7da7deb-2cab-4b94-a40a-c2b89dc1c0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a19b441-f8b7-456a-899a-14ab5fb388d4" xlink:to="loc_us-gaap_StockholdersEquity_e7da7deb-2cab-4b94-a40a-c2b89dc1c0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_30338365-3aac-424b-a7e7-b3e158b2c5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_MinorityInterest_30338365-3aac-424b-a7e7-b3e158b2c5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cfb12647-d2c1-4870-9822-5ab7e4872ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cfb12647-d2c1-4870-9822-5ab7e4872ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_965beb42-d3a5-4350-b9eb-0fd91f747727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9714f492-3cc0-4daa-a4b0-3ce5ee445db7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_965beb42-d3a5-4350-b9eb-0fd91f747727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d93bb812-4e49-4793-b61e-e427376e4c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d93bb812-4e49-4793-b61e-e427376e4c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cbf2f875-b739-4e3c-843f-64dbb6a50ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cbf2f875-b739-4e3c-843f-64dbb6a50ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_29bd0159-02e7-4485-8f21-b813dfdf9b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_29bd0159-02e7-4485-8f21-b813dfdf9b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_51c815b7-7d3a-4ef4-9a3a-14e77890eef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_51c815b7-7d3a-4ef4-9a3a-14e77890eef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc5c3f26-ab8a-470f-ab7e-868b0a3c758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fc5c3f26-ab8a-470f-ab7e-868b0a3c758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ee1a3f54-9fd7-47af-97c7-96c4b6a23326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ee1a3f54-9fd7-47af-97c7-96c4b6a23326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_edd3a101-1401-4563-bbb3-f4b5a37e205b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_CommonStockSharesIssued_edd3a101-1401-4563-bbb3-f4b5a37e205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c7cc24b8-0755-4703-a1b9-57598f4be629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e89e004f-d761-47b7-8461-64237c3f407c" xlink:to="loc_us-gaap_TreasuryStockShares_c7cc24b8-0755-4703-a1b9-57598f4be629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_76c52caa-f538-4a70-825b-4b3e0596e1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_76c52caa-f538-4a70-825b-4b3e0596e1f0" xlink:to="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2581fd93-dc67-4ec5-b8be-d8fbab2078ea" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_8f45b060-9969-4bf8-be33-1442768fb64d" xlink:href="holx-20210327.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_b6225f14-87db-4e4b-8085-f04e6f3b4735" xlink:to="loc_holx_ShareRepurchaseProgramMember_8f45b060-9969-4bf8-be33-1442768fb64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5f2833fc-4c21-4abe-ab38-d6f3120ae235" xlink:to="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_004c02b1-ad60-4f4b-82ef-617f46e07ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_CommonStockMember_004c02b1-ad60-4f4b-82ef-617f46e07ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f67738c1-7780-49b2-b2ee-d5d7913b7972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f67738c1-7780-49b2-b2ee-d5d7913b7972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d8133672-4ea7-4c01-9e4b-8e8bd8504397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_RetainedEarningsMember_d8133672-4ea7-4c01-9e4b-8e8bd8504397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e0adfe-1213-439d-ad4e-fb5c0546b1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e0adfe-1213-439d-ad4e-fb5c0546b1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_055dc42d-fed7-4218-b7af-f2534b3ecbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_527f8a13-8413-4812-8472-4e4e74e985b8" xlink:to="loc_us-gaap_TreasuryStockMember_055dc42d-fed7-4218-b7af-f2534b3ecbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e50be522-bf6b-4940-aef4-e85498718740" xlink:to="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_dbd192d0-5d5b-47d8-96ef-8d561be0a458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_98d24872-f9a3-446b-814c-0caec41d5692" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_dbd192d0-5d5b-47d8-96ef-8d561be0a458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_367282d0-33ca-49b2-bc4f-d0b191a951ba" xlink:to="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_08de72c1-6cd2-44de-8adb-357d5a36444a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_08de72c1-6cd2-44de-8adb-357d5a36444a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4467b1d8-9d4f-45fa-99e0-6cee8a888e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4467b1d8-9d4f-45fa-99e0-6cee8a888e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_cf2ea7b6-bcd2-4c07-bc42-9f80a4b68c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_SharesIssued_cf2ea7b6-bcd2-4c07-bc42-9f80a4b68c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_006464b9-24e3-4f87-9014-f34d0a9b3f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockholdersEquity_006464b9-24e3-4f87-9014-f34d0a9b3f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8aaeab54-08a8-4a37-9e96-5f6920b989c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8aaeab54-08a8-4a37-9e96-5f6920b989c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_43c02031-1c2f-400b-94e1-3cd06784ee04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_43c02031-1c2f-400b-94e1-3cd06784ee04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_fb3cf889-0789-4124-b1b2-07ddde6f3f89" xlink:href="holx-20210327.xsd#holx_ChangeInParValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_ChangeInParValue_fb3cf889-0789-4124-b1b2-07ddde6f3f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_f1e22d98-2254-487f-bc86-6800dc4bfc80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_f1e22d98-2254-487f-bc86-6800dc4bfc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_d5d279cf-1461-4812-a642-762d2c6ae9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_d5d279cf-1461-4812-a642-762d2c6ae9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9c663db6-c0e8-4fd7-88da-093c38537001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9c663db6-c0e8-4fd7-88da-093c38537001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90a2ee79-62c8-4b75-bd08-0526f5293657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90a2ee79-62c8-4b75-bd08-0526f5293657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80e2b7d3-c4c0-4275-9eb5-2f513a966a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80e2b7d3-c4c0-4275-9eb5-2f513a966a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_40c3f06e-dbe6-45c6-9d68-df0a8c4c7979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_NetIncomeLoss_40c3f06e-dbe6-45c6-9d68-df0a8c4c7979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_01776476-4089-4914-a095-fbd0aca20e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_01776476-4089-4914-a095-fbd0aca20e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_db7bd2c4-a00f-4ba5-97df-52461db00b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_db7bd2c4-a00f-4ba5-97df-52461db00b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e6a7f218-2516-4092-8a93-8fe2e4a01260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e6a7f218-2516-4092-8a93-8fe2e4a01260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_ef0e604c-5d42-4a07-ae50-3088e57873ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_ef0e604c-5d42-4a07-ae50-3088e57873ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_4f7eab33-f1b4-4575-919f-54291a549987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_SharesIssued_4f7eab33-f1b4-4575-919f-54291a549987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c8f1a7d-86ab-4902-a8ca-fae1d26364e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_StockholdersEquity_2c8f1a7d-86ab-4902-a8ca-fae1d26364e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a1cbc9fb-c33b-4550-8654-e679eaf834b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_a1cbc9fb-c33b-4550-8654-e679eaf834b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_a4d01419-0ba6-42ac-bb35-21d9c8481d17" xlink:href="holx-20210327.xsd#holx_Netincome"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_Netincome_a4d01419-0ba6-42ac-bb35-21d9c8481d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_15ab6e26-828d-410f-b36a-cf25f729faeb" xlink:href="holx-20210327.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_15ab6e26-828d-410f-b36a-cf25f729faeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_9dc9a7ec-c9e8-4f5f-9fee-28f010b88a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae11a22a-9fdc-4c00-a199-1966ee9d0268" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_9dc9a7ec-c9e8-4f5f-9fee-28f010b88a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9df9f4f7-8e53-4651-8726-98412fd47c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ae17817a-602c-4d37-ae09-2f3db2e2f38f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9df9f4f7-8e53-4651-8726-98412fd47c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210327.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_79df2fea-082f-4427-b82a-11e253d88217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:to="loc_us-gaap_NetIncomeLoss_79df2fea-082f-4427-b82a-11e253d88217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0c5053c2-4fca-4426-9b5a-54dbdcf89145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_Depreciation_0c5053c2-4fca-4426-9b5a-54dbdcf89145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_67698276-17d3-47ec-aa73-abde445de68c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_AdjustmentForAmortization_67698276-17d3-47ec-aa73-abde445de68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6921bce1-9b8c-41b8-a2f3-adeccf91daf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_ShareBasedCompensation_6921bce1-9b8c-41b8-a2f3-adeccf91daf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_66050c52-2c26-414e-bcb7-5f70a0896166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_66050c52-2c26-414e-bcb7-5f70a0896166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_68245a64-76dc-46bf-a4ad-e69031ab6b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_AssetImpairmentCharges_68245a64-76dc-46bf-a4ad-e69031ab6b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26278730-505a-41f8-85d1-ddc70d9d54e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_26278730-505a-41f8-85d1-ddc70d9d54e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5c03e1e3-397e-4af3-baa3-28e1d1c651af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9486e42e-2284-4862-8a39-23058358a195" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5c03e1e3-397e-4af3-baa3-28e1d1c651af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52fc2dea-64aa-420c-909a-54b0e86233d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_52fc2dea-64aa-420c-909a-54b0e86233d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_78cd7c56-46d8-462d-af5f-4bb2714cf466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_78cd7c56-46d8-462d-af5f-4bb2714cf466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_5a9b6989-0116-4e9e-ba13-973a6ba9c19b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_5a9b6989-0116-4e9e-ba13-973a6ba9c19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c54587b5-a3e1-4f31-8d4f-39c63c606969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c54587b5-a3e1-4f31-8d4f-39c63c606969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b83cd0a9-4847-4477-88a8-af3c54e27d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b83cd0a9-4847-4477-88a8-af3c54e27d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e362c679-f14c-4b77-9d43-7e1e83f57256" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e362c679-f14c-4b77-9d43-7e1e83f57256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_eb06d644-eaa4-4fb4-9c4c-6ab3055a6a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94f7652f-5271-4895-9c27-c98af8e72ffa" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_eb06d644-eaa4-4fb4-9c4c-6ab3055a6a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_102b01ba-0b74-4f0e-935d-609e69dcea64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_53e941d1-bc14-489c-9320-7b5f5f4896ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_102b01ba-0b74-4f0e-935d-609e69dcea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c0481aaf-b4f9-47e4-a102-a7b4c49cc6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c0481aaf-b4f9-47e4-a102-a7b4c49cc6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_f370f871-44f0-44a8-a81a-6786a649123d" xlink:href="holx-20210327.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_f370f871-44f0-44a8-a81a-6786a649123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_70e7a055-d7c7-4a3a-b2fc-2e6dee165ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_70e7a055-d7c7-4a3a-b2fc-2e6dee165ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_6350e57e-0152-49bb-bf97-f1ad7902416c" xlink:href="holx-20210327.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_6350e57e-0152-49bb-bf97-f1ad7902416c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_8d1230b8-cf0e-4e41-96e5-7c33e1fe12b2" xlink:href="holx-20210327.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_holx_Purchaseofinsurancecontracts_8d1230b8-cf0e-4e41-96e5-7c33e1fe12b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty_25a7940d-9b4c-4ec5-806c-b761bead4922" xlink:href="holx-20210327.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_holx_PurchaseOfIntellectualProperty_25a7940d-9b4c-4ec5-806c-b761bead4922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ae24c8b6-520a-4084-b11b-9f2f78f5827a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ae24c8b6-520a-4084-b11b-9f2f78f5827a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8c03b3d-ba08-4a0f-b03c-c990dc813dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4a6e8767-a11a-4e53-8ff4-4b7a870fefad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8c03b3d-ba08-4a0f-b03c-c990dc813dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_bc2d8456-2fd4-4379-8783-cd27c2faf4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_bc2d8456-2fd4-4379-8783-cd27c2faf4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_c44ae521-7ada-4d61-b189-c084f5acaef9" xlink:href="holx-20210327.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_holx_ProceedsFromSeniorNotes_c44ae521-7ada-4d61-b189-c084f5acaef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_d6b3158d-7b9b-415d-82fb-c2e1f0bbe96e" xlink:href="holx-20210327.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_holx_RepaymentOfSeniorNotes_d6b3158d-7b9b-415d-82fb-c2e1f0bbe96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_71a91b80-8376-4a75-b5ff-6694e84b2fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_71a91b80-8376-4a75-b5ff-6694e84b2fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1625b547-58b1-4992-80e1-f7b3e982bc12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1625b547-58b1-4992-80e1-f7b3e982bc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_be5df232-27a2-4db0-8865-dea1359b4b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_be5df232-27a2-4db0-8865-dea1359b4b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_bf642761-cfc3-4c59-b018-bd0a42f05121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_bf642761-cfc3-4c59-b018-bd0a42f05121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_9306212d-eccc-402b-ba92-01e40811f8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_9306212d-eccc-402b-ba92-01e40811f8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f252d5fe-dd39-458c-9a49-c705ac3801f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_f252d5fe-dd39-458c-9a49-c705ac3801f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_55030f2d-d1be-4de2-9fbc-468e1699aaeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_55030f2d-d1be-4de2-9fbc-468e1699aaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9a8fef62-9b68-4b1d-b658-acf7b618e27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9a8fef62-9b68-4b1d-b658-acf7b618e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e4335b3b-01d8-492c-b3af-b25ffa54dbba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e4335b3b-01d8-492c-b3af-b25ffa54dbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_cdc3dd37-4e4c-4636-ad7a-4b4d470122c8" xlink:href="holx-20210327.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_cdc3dd37-4e4c-4636-ad7a-4b4d470122c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_ac3dcbe1-0998-414f-9a25-3583232dd5a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_ac3dcbe1-0998-414f-9a25-3583232dd5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd08c150-1459-4eed-8f3e-da8803a05c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_361c3bfc-9dea-45b2-98f1-4295d3eaf772" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd08c150-1459-4eed-8f3e-da8803a05c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_40096e5e-b716-4d76-a315-fec42c9dfadf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_40096e5e-b716-4d76-a315-fec42c9dfadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_37f82558-fabb-4594-9847-2eb47b78f96d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_37f82558-fabb-4594-9847-2eb47b78f96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd986c9e-fc12-47e2-8d7b-5aaf2c25b8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd986c9e-fc12-47e2-8d7b-5aaf2c25b8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_319ded89-bf61-46a4-8deb-5fc64027df03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_fa6520bd-861e-47b6-b4c7-c0164d270cba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_319ded89-bf61-46a4-8deb-5fc64027df03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_711c9c00-c952-41c2-893e-0896dd1bd862" xlink:href="holx-20210327.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3b53671b-6a75-4446-a9df-e7c1755e3119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_711c9c00-c952-41c2-893e-0896dd1bd862" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3b53671b-6a75-4446-a9df-e7c1755e3119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BasisofPresentationDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_18bf962f-c39f-4875-be47-6542d44566ce" xlink:href="holx-20210327.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_18bf962f-c39f-4875-be47-6542d44566ce" xlink:to="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34a2d2c9-97bb-47bd-9198-fbfe2f726a47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagMember_d47a0055-8e1c-48c3-9ca6-f431d1a9915f" xlink:href="holx-20210327.xsd#holx_MobidiagMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8634c338-1375-43dc-a0a6-09817852b138" xlink:to="loc_holx_MobidiagMember_d47a0055-8e1c-48c3-9ca6-f431d1a9915f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_850871e1-3192-4ce7-a62a-d966da70b289" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e6089fb-9c61-449f-9241-e68768b552f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_857fa23b-e8bf-4773-aec9-c8099ee8814b" xlink:to="loc_us-gaap_SubsequentEventMember_4e6089fb-9c61-449f-9241-e68768b552f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79b16a68-87c5-4892-bbe8-fb57d85e2568" xlink:to="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cbea617c-b43d-4ffb-9ad0-0c2579a97146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a4b1a8f-8d67-400b-bcbe-4053c67e4f39" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cbea617c-b43d-4ffb-9ad0-0c2579a97146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20210327.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7c54f75-6e48-48bd-9754-5c1cb9d8024a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_77820782-be0e-4be4-bc93-5854881a039a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7c54f75-6e48-48bd-9754-5c1cb9d8024a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_77820782-be0e-4be4-bc93-5854881a039a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e753f3e-bedd-4cca-b6f6-d8b376a36cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e753f3e-bedd-4cca-b6f6-d8b376a36cc7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55cd2a0e-a764-400c-aa22-81083109eee0" xlink:to="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_21ae7d6a-9f53-4f28-badc-2e7ce36726ea" xlink:href="holx-20210327.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_DiagnosticsMember_21ae7d6a-9f53-4f28-badc-2e7ce36726ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_32437c7c-45b1-4754-8c0b-21287c9abb82" xlink:href="holx-20210327.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_BreastHealthMember_32437c7c-45b1-4754-8c0b-21287c9abb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_61d688a7-4376-409e-ba49-2a0071977da0" xlink:href="holx-20210327.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_GynSurgicalMember_61d688a7-4376-409e-ba49-2a0071977da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_fdef821c-bf17-42f2-b9dc-41fdb8d09b08" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_MedicalAestheticsMember_fdef821c-bf17-42f2-b9dc-41fdb8d09b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_f71db905-1ae5-47e5-9680-c500eda10fb8" xlink:href="holx-20210327.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3b8a4e13-c48e-4023-8fa9-1e9d0765fdb1" xlink:to="loc_holx_SkeletalHealthMember_f71db905-1ae5-47e5-9680-c500eda10fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_465a04b3-5e05-4821-8e94-9802d7117945" xlink:to="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_ca4bf9a9-2a81-4abf-ae88-876fedfa6803" xlink:href="holx-20210327.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_CytologyPerinatalMember_ca4bf9a9-2a81-4abf-ae88-876fedfa6803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_98287be8-013c-4972-8fee-92856b8e2cd0" xlink:href="holx-20210327.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_MolecularDiagnosticsMember_98287be8-013c-4972-8fee-92856b8e2cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_71259935-c06b-4ec3-8048-a6426a3c92a0" xlink:href="holx-20210327.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_BloodScreeningMember_71259935-c06b-4ec3-8048-a6426a3c92a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_6e37ea92-bc67-42ee-b0c5-96ae2ac73aaf" xlink:href="holx-20210327.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_BreastImagingMember_6e37ea92-bc67-42ee-b0c5-96ae2ac73aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_1dffa561-1a9b-40fc-aa85-41742806f518" xlink:href="holx-20210327.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dd8dd587-edbf-4bd6-aa4d-14f4a234de2d" xlink:to="loc_holx_InterventionalBreastSolutionsMember_1dffa561-1a9b-40fc-aa85-41742806f518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_52599d4d-0309-430c-8bb6-fc3b7d6cd081" xlink:to="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0a080ec9-4f61-4767-a555-d1b1d41d76b3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:to="loc_country_US_0a080ec9-4f61-4767-a555-d1b1d41d76b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_5207cbad-75f6-4c56-8e07-394de516c74d" xlink:href="holx-20210327.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b29277ed-d7f6-497a-82a0-2541fee302cd" xlink:to="loc_holx_InternationalMember_5207cbad-75f6-4c56-8e07-394de516c74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_17fabcac-b200-4d41-9400-70180cc307dd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa938d0e-3c1e-4b8e-a3f3-d84e19d2770d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6b474cbd-92e6-4c25-8b67-d29188d3b26a" xlink:to="loc_us-gaap_Revenues_fa938d0e-3c1e-4b8e-a3f3-d84e19d2770d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4e490e53-36d8-4359-9cbd-b25f3192de43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e753f3e-bedd-4cca-b6f6-d8b376a36cc7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4e490e53-36d8-4359-9cbd-b25f3192de43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a17aca4e-3ee7-4aa3-b557-bc39ae90b819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a17aca4e-3ee7-4aa3-b557-bc39ae90b819" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:to="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_dcbbd220-e7dc-4d7a-9115-0d9a5a688ede" xlink:to="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_792fdff5-2a6a-4442-87d7-cdc21b2a05a2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_country_US_792fdff5-2a6a-4442-87d7-cdc21b2a05a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_6375b771-b7da-4343-8818-2f7ee4d84f9d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_srt_EuropeMember_6375b771-b7da-4343-8818-2f7ee4d84f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_1d2bc019-305d-4233-8b6f-9e41c481809e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_srt_AsiaPacificMember_1d2bc019-305d-4233-8b6f-9e41c481809e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_bc0694f5-7581-49e1-8e39-994335391ba8" xlink:href="holx-20210327.xsd#holx_RestofWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ba168ef4-61c3-454d-a766-55ecb43ed669" xlink:to="loc_holx_RestofWorldMember_bc0694f5-7581-49e1-8e39-994335391ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fca02e70-130a-4785-8dc2-86ed6eae7471" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7a7d1141-78da-4e2f-9e71-d6ec98b18b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d94f6ada-98c7-4bf0-841e-6b6c810616d4" xlink:to="loc_us-gaap_Revenues_7a7d1141-78da-4e2f-9e71-d6ec98b18b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d6708581-077b-4461-bb8c-9e438171ae65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d6708581-077b-4461-bb8c-9e438171ae65" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:to="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d33927d2-2d75-46c0-8fbe-e1b20c94f218" xlink:to="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_c879cbda-c496-48c0-a020-6afd13401228" xlink:href="holx-20210327.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_ConsumablesMember_c879cbda-c496-48c0-a020-6afd13401228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4acb069d-08bb-4521-9c00-344ef29c742d" xlink:href="holx-20210327.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_4acb069d-08bb-4521-9c00-344ef29c742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_dc5d7442-16e3-4ab7-89e9-b290f523463e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_us-gaap_ServiceMember_dc5d7442-16e3-4ab7-89e9-b290f523463e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_f5639a09-731a-401a-ba6b-576e397b5d47" xlink:href="holx-20210327.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_10478fe4-18ab-4772-a8f0-98c89a1309ee" xlink:to="loc_holx_OtherTypeofRevenueMember_f5639a09-731a-401a-ba6b-576e397b5d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ba90f54e-a480-45a5-9adb-917b76e91847" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f09a1e82-1408-458b-b8aa-fd8086096f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e4a75beb-1967-4732-b041-0a2197bb1cd4" xlink:to="loc_us-gaap_Revenues_f09a1e82-1408-458b-b8aa-fd8086096f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cf62a4ee-c6fd-4b0c-baf3-bfee412f0ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d6708581-077b-4461-bb8c-9e438171ae65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cf62a4ee-c6fd-4b0c-baf3-bfee412f0ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fdd8bc78-85d2-4279-baea-3f82093c6dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_23c0cd6b-a7e2-4ef8-a1c3-5be2b1876e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fdd8bc78-85d2-4279-baea-3f82093c6dd9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_23c0cd6b-a7e2-4ef8-a1c3-5be2b1876e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f2c1a47f-5aef-4f6d-bdf1-39891187287c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fdd8bc78-85d2-4279-baea-3f82093c6dd9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f2c1a47f-5aef-4f6d-bdf1-39891187287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_326b745e-a629-4df0-88cf-f78b9ed03b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_326b745e-a629-4df0-88cf-f78b9ed03b85" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45dcfb90-b7e3-409e-8f82-e22091b355af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_45dcfb90-b7e3-409e-8f82-e22091b355af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_9f1fded3-fe39-46ce-8fbe-ca5a89d5acdb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_a20c5c8a-1521-4287-8b2a-0730fd12a98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e95d520e-3c9f-4508-9860-f70c51321a45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_5dd96b91-41ad-49bf-82c6-52f18b0222dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20210327.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20210327.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e3b33368-a966-4613-9f56-ebaeeecdea68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f7e49386-5f66-400d-929b-1b1c7bb0df2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e3b33368-a966-4613-9f56-ebaeeecdea68" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f7e49386-5f66-400d-929b-1b1c7bb0df2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_fb2d965e-6a9f-4226-8f4a-d07bb12d600b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e3b33368-a966-4613-9f56-ebaeeecdea68" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_fb2d965e-6a9f-4226-8f4a-d07bb12d600b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_332a791d-7794-4768-a3da-ffad14b432cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_ee393009-25d5-4367-b449-617e64eab322" xlink:href="holx-20210327.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_332a791d-7794-4768-a3da-ffad14b432cb" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_ee393009-25d5-4367-b449-617e64eab322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b6eed802-131d-408d-9e4a-29acee698d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_afbaf793-62c7-460f-814f-931a7c5da239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b6eed802-131d-408d-9e4a-29acee698d59" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_afbaf793-62c7-460f-814f-931a7c5da239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_419fcacd-63e9-42d8-ad0f-facb46ebfb78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6bdb65d3-a3a5-44d0-b0b6-c3f31ae400fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_419fcacd-63e9-42d8-ad0f-facb46ebfb78" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6bdb65d3-a3a5-44d0-b0b6-c3f31ae400fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_885eb8cb-8aa4-4491-af34-e4da38440874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_885eb8cb-8aa4-4491-af34-e4da38440874" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_623c21ce-0c85-4854-a763-27534abcb0ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b002b35a-103b-42ec-9d8e-27d9de3aa806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b002b35a-103b-42ec-9d8e-27d9de3aa806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4640163f-a912-4f6b-b775-e4749188939b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4640163f-a912-4f6b-b775-e4749188939b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0f9c1181-273f-49a3-810a-e60ad9111bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf153cb5-3a59-4327-b19e-658a56c8b174" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0f9c1181-273f-49a3-810a-e60ad9111bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_226fd1c8-4ab2-4b9a-8ff2-74dff1921669" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_702274f5-18d5-458e-b991-f2a1c36cb52e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_702274f5-18d5-458e-b991-f2a1c36cb52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_05b0512a-c5b9-4366-a76b-45efb8d46a6c" xlink:href="holx-20210327.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_holx_ContingentConsiderationMember_05b0512a-c5b9-4366-a76b-45efb8d46a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f26ecd09-26dc-4af2-8ea3-e1dab9dbe41d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_InterestRateSwapMember_f26ecd09-26dc-4af2-8ea3-e1dab9dbe41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_7844a34a-b65e-4ea9-90f2-0329eb991fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a79d3d8-c9e4-4a5e-8a92-fc3e0be23f63" xlink:to="loc_us-gaap_ForeignExchangeContractMember_7844a34a-b65e-4ea9-90f2-0329eb991fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_eb7e074c-4688-4652-a977-3d5977b6f028" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_49dc1978-2312-4612-b054-5e97ffc5fc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ec86db2-68a8-4cb8-bca5-9cdb98b963aa" xlink:to="loc_us-gaap_LiabilityMember_49dc1978-2312-4612-b054-5e97ffc5fc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ecf0b7bc-c205-465d-8390-6422b7cc53df" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9debc699-8297-4712-9d68-dfce6829fa59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_855c1bd3-21cf-41e1-b1a9-2a934252d005" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9debc699-8297-4712-9d68-dfce6829fa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f6841b41-c3ce-42e5-a28d-21f2f7e9de39" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_88cec624-9224-4f37-b43e-5a19378a82f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_88cec624-9224-4f37-b43e-5a19378a82f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4efd0b9c-6ea6-47f3-8b2b-fe893d8f230d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_b0c2d836-1b10-452d-8f17-346c6b868523" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4efd0b9c-6ea6-47f3-8b2b-fe893d8f230d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9888a1a7-2d8c-4f53-969a-93ff2cc319af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9888a1a7-2d8c-4f53-969a-93ff2cc319af" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ec244f4-74c0-4fef-b07e-8feb23eac10b" xlink:to="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1717c505-8f29-485a-84d9-6ae07979c39e" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31f7f8d7-d67b-486e-a8e2-cb1d14c209c2" xlink:to="loc_holx_MedicalAestheticsMember_1717c505-8f29-485a-84d9-6ae07979c39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:to="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_197d3238-239e-4132-b887-e756e904929e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_9ccd9955-4cac-4cde-8eef-b1c093624214" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_CreditAgreementMember_9ccd9955-4cac-4cde-8eef-b1c093624214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_72242126-e18a-4beb-b936-c92a4b8bea43" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_A2025SeniorNotesMember_72242126-e18a-4beb-b936-c92a4b8bea43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3b55527e-232d-4dc3-92f5-dc2b7742c1fc" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cdcbbac4-77a3-4c07-9017-e5cc527ea095" xlink:to="loc_holx_A2028SeniorNotesMember_3b55527e-232d-4dc3-92f5-dc2b7742c1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ab815b53-8ec5-4794-9b45-6fca47e6a289" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_73a8c4d9-35f1-4b38-851e-17505f148926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_us-gaap_AssetImpairmentCharges_73a8c4d9-35f1-4b38-851e-17505f148926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_8da46c89-55d5-47d2-8f85-9eb7b8d4f8e4" xlink:href="holx-20210327.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_holx_PrincipalAmountOfBorrowings_8da46c89-55d5-47d2-8f85-9eb7b8d4f8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5fe061dc-196c-4abf-8804-50e7a5dff2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_278d8ed4-f99d-4dab-9a3a-9043a9607686" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5fe061dc-196c-4abf-8804-50e7a5dff2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_16b7729e-d14d-4a5f-919c-a71122581fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_16b7729e-d14d-4a5f-919c-a71122581fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_9cc02b93-283f-4e6d-9d49-fa0500515e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_9cc02b93-283f-4e6d-9d49-fa0500515e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7a3ae7d6-f87e-41e3-8a29-f6b9c2f22884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_7a3ae7d6-f87e-41e3-8a29-f6b9c2f22884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ed3c58fb-bfc9-456d-a2fb-0d0922bae3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ed3c58fb-bfc9-456d-a2fb-0d0922bae3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c117d927-d9ce-4053-ae73-be911a7cad5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e6f0b4-3193-4fae-a880-fa6acb0970ab" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c117d927-d9ce-4053-ae73-be911a7cad5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9c6c8c25-3f95-4bd1-93bc-41a03d5f7dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_225426ad-27af-4f17-9be2-7b2aed888f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9c6c8c25-3f95-4bd1-93bc-41a03d5f7dc2" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_225426ad-27af-4f17-9be2-7b2aed888f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8d5864c8-24d2-41ac-9538-bb2d4d071b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1b6744f6-1a0c-46d2-a741-37ab81888fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8d5864c8-24d2-41ac-9538-bb2d4d071b9b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1b6744f6-1a0c-46d2-a741-37ab81888fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b05c6f7e-8aac-4dee-8490-9b3b1e2c33d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b05c6f7e-8aac-4dee-8490-9b3b1e2c33d5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8c4e8967-3f58-4f3c-8c4f-bf7d1ad84f9a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_523bc8e9-90a5-4f18-b68b-ccd580a922ea" xlink:href="holx-20210327.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_BiotheranosticsMember_523bc8e9-90a5-4f18-b68b-ccd580a922ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_b686e735-bfbb-4ac4-9a36-1d0a1c7e0d68" xlink:href="holx-20210327.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_DiagenodeMember_b686e735-bfbb-4ac4-9a36-1d0a1c7e0d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_8a47f55f-7375-44f2-b854-8c065be5713f" xlink:href="holx-20210327.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_8a47f55f-7375-44f2-b854-8c065be5713f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_beae9f28-8e4b-437c-96a8-bc921dbd2dcb" xlink:href="holx-20210327.xsd#holx_NXCImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_NXCImagingMember_beae9f28-8e4b-437c-96a8-bc921dbd2dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_67d32338-8b7e-4c15-8cc2-386f9e1847dc" xlink:href="holx-20210327.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_AcessaHealthMember_67d32338-8b7e-4c15-8cc2-386f9e1847dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_e5c77e2f-ec88-4c6a-8866-82bb8fea0eb2" xlink:href="holx-20210327.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_HealthBeaconsMember_e5c77e2f-ec88-4c6a-8866-82bb8fea0eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_5ada1263-3b5a-4082-8ee7-be174a293bdc" xlink:href="holx-20210327.xsd#holx_AlphaImagingMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_AlphaImagingMember_5ada1263-3b5a-4082-8ee7-be174a293bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_249532a1-9d7c-4683-81f2-fca6ffa2d7b2" xlink:href="holx-20210327.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab424f51-b595-4c21-b587-ced145cacc67" xlink:to="loc_holx_SuperSonicImagineMember_249532a1-9d7c-4683-81f2-fca6ffa2d7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9f285134-f6c9-4a07-881e-df43dfe7ffda" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_5594adf2-e33a-4cd7-be95-8888c6bc0ebd" xlink:href="holx-20210327.xsd#holx_ContingentHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e65fe9da-06a3-4532-9b7a-9469d10da412" xlink:to="loc_holx_ContingentHoldbackMember_5594adf2-e33a-4cd7-be95-8888c6bc0ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7a59d181-9c06-450c-bcd4-c1e838d03c8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_483ece6e-2452-4d4f-a937-e08f19978f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_us-gaap_CustomerRelationshipsMember_483ece6e-2452-4d4f-a937-e08f19978f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_1c51bde5-901c-400b-880e-9a931374f683" xlink:href="holx-20210327.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_holx_DevelopedTechnologyMember_1c51bde5-901c-400b-880e-9a931374f683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_96374da3-6dc8-49c3-98cd-633d57944873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a5469ea5-2e8c-4213-af97-d83e006e8ff8" xlink:to="loc_us-gaap_TradeNamesMember_96374da3-6dc8-49c3-98cd-633d57944873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_800a88da-b99c-480c-8878-692412048216" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_90dbca21-538e-4998-8005-3f7bfe4fe00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_90dbca21-538e-4998-8005-3f7bfe4fe00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_26439e0f-cb3d-42b8-a239-5dfac4f4525d" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_26439e0f-cb3d-42b8-a239-5dfac4f4525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2e8523dc-eec0-4ab9-8cdb-0c1bac8cdd45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2e8523dc-eec0-4ab9-8cdb-0c1bac8cdd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_2ea836d7-dd8f-41f9-971c-aa161992b9ab" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_2ea836d7-dd8f-41f9-971c-aa161992b9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_ae51e471-38dc-45b4-ad23-084876dbe1d0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_ae51e471-38dc-45b4-ad23-084876dbe1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cd6da3d9-4344-4b6a-a97b-98e7eab0b6ee" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cd6da3d9-4344-4b6a-a97b-98e7eab0b6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b51de257-fac3-445f-8f9e-a7801fa14c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b51de257-fac3-445f-8f9e-a7801fa14c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbb4d53d-a59a-4325-9313-560b13402e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_cbb4d53d-a59a-4325-9313-560b13402e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_73e0f44a-a48f-4204-937f-c6b2d5e325cf" xlink:href="holx-20210327.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_73e0f44a-a48f-4204-937f-c6b2d5e325cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1978a3a8-4647-4b48-95b7-40dfbbc6c33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1978a3a8-4647-4b48-95b7-40dfbbc6c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_ff79823f-5ec5-48a3-a06a-626101a323b2" xlink:href="holx-20210327.xsd#holx_Holdback"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_Holdback_ff79823f-5ec5-48a3-a06a-626101a323b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c79f8cb-5383-41f9-af63-58ef7872cf38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6c79f8cb-5383-41f9-af63-58ef7872cf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3d3a920e-a58c-4088-a5fd-63d179f18232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_Goodwill_3d3a920e-a58c-4088-a5fd-63d179f18232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5ac2f9ab-5399-4489-9d47-6ac03c505184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5ac2f9ab-5399-4489-9d47-6ac03c505184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5bd9fad8-9c48-4909-98e1-98cb55e017b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5bd9fad8-9c48-4909-98e1-98cb55e017b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_39f7e5fb-29e3-4da6-9d93-b6339beb7ac8" xlink:href="holx-20210327.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_39f7e5fb-29e3-4da6-9d93-b6339beb7ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_4828b25c-0dc5-4f5d-b3fc-24d06872405e" xlink:href="holx-20210327.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationSharesAcquired_4828b25c-0dc5-4f5d-b3fc-24d06872405e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_e063c807-d686-4c27-bf64-d308902ed0c0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_e063c807-d686-4c27-bf64-d308902ed0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_d6c062a6-8b62-4aa0-bb10-57aabc1cb0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_d6c062a6-8b62-4aa0-bb10-57aabc1cb0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0b5ad7d9-3fbe-42f1-96aa-2cf45c795c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_0b5ad7d9-3fbe-42f1-96aa-2cf45c795c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_c5314b68-e78d-4587-952a-be1c037af64e" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_c5314b68-e78d-4587-952a-be1c037af64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f12138f2-a6e0-4cd2-922d-6360157e9874" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f12138f2-a6e0-4cd2-922d-6360157e9874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_141c7f8c-0247-46f0-b660-29912ae6a317" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_141c7f8c-0247-46f0-b660-29912ae6a317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_bb4a632b-c253-45b9-8880-0512341368c0" xlink:href="holx-20210327.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_bb4a632b-c253-45b9-8880-0512341368c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_019127a2-4048-4249-9e2a-ea5fea1607d8" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_019127a2-4048-4249-9e2a-ea5fea1607d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_596a242f-645e-4e93-8da6-647cc1c01c8f" xlink:href="holx-20210327.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_596a242f-645e-4e93-8da6-647cc1c01c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_ad0c06fb-177c-4bf2-a65e-b4144e5f179c" xlink:href="holx-20210327.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a813f5fd-8e4e-4124-8065-fac711bfceb2" xlink:to="loc_holx_FairValueAssumptionDiscountRate_ad0c06fb-177c-4bf2-a65e-b4144e5f179c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_cf4741a6-5c62-4de9-81f1-ff18a0918a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cf4741a6-5c62-4de9-81f1-ff18a0918a14" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0273c4f2-41fa-4915-91b6-814ab1a1a153" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_9b9c09d4-a9e1-40cd-99d2-dcf95f4a4f5b" xlink:href="holx-20210327.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_BiotheranosticsMember_9b9c09d4-a9e1-40cd-99d2-dcf95f4a4f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_beec3003-f25e-4935-aa0f-a62584193f73" xlink:href="holx-20210327.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_DiagenodeMember_beec3003-f25e-4935-aa0f-a62584193f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_3abaa7ef-823f-4d0f-923f-1f15c0b4a92e" xlink:href="holx-20210327.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_SuperSonicImagineMember_3abaa7ef-823f-4d0f-923f-1f15c0b4a92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_88c86431-1fee-4042-a0e0-62601776c43f" xlink:href="holx-20210327.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_82e54bad-2f07-4ad3-879a-6a2fafa01df4" xlink:to="loc_holx_AcessaHealthMember_88c86431-1fee-4042-a0e0-62601776c43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5037b5b6-1983-4727-9dd5-6b99cd6130ae" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_821b0c27-1d70-4b04-81b1-cd38adb68f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_821b0c27-1d70-4b04-81b1-cd38adb68f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d973606-e482-4491-8588-1f7e0002e8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d973606-e482-4491-8588-1f7e0002e8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_8409d195-0072-4731-86c7-5de8493e833c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_8409d195-0072-4731-86c7-5de8493e833c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_442b1236-4a3b-4ccd-99b5-43ab27d7d223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_442b1236-4a3b-4ccd-99b5-43ab27d7d223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d27b265e-753d-4916-9ab8-eee5df8bb5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d27b265e-753d-4916-9ab8-eee5df8bb5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2c6c63e-e260-4785-b5b9-c0e631bfced2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d2c6c63e-e260-4785-b5b9-c0e631bfced2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4aac6e7d-794f-42e2-b987-9c06693c33c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4aac6e7d-794f-42e2-b987-9c06693c33c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_11838368-9202-403f-9299-0c7c9c61d79d" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_11838368-9202-403f-9299-0c7c9c61d79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a2fbbc8b-0cd5-4f9b-94c4-8d8dc5fe88b7" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a2fbbc8b-0cd5-4f9b-94c4-8d8dc5fe88b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_75296c1c-b461-4dc3-a8e0-e4e7b6c31bbc" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_75296c1c-b461-4dc3-a8e0-e4e7b6c31bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f3413d68-cbbc-40d1-926b-3f3dee2ae040" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f3413d68-cbbc-40d1-926b-3f3dee2ae040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a4767380-ecff-4cdb-bde2-a001a3c11384" xlink:href="holx-20210327.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_a4767380-ecff-4cdb-bde2-a001a3c11384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_915b9f73-88ec-4ea9-89fd-3f277b0a8a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_915b9f73-88ec-4ea9-89fd-3f277b0a8a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af5b9701-346a-48be-956a-08035f21d34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_Goodwill_af5b9701-346a-48be-956a-08035f21d34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_46c05271-16dc-4ccb-ac82-130a11e16eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0215011c-64ae-4503-85c2-eb4f8551fd20" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_46c05271-16dc-4ccb-ac82-130a11e16eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_6453f605-5782-4206-99b7-2c0ca52ebd69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_bf498e99-346f-4ae4-89f4-4a7a21766cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_6453f605-5782-4206-99b7-2c0ca52ebd69" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_bf498e99-346f-4ae4-89f4-4a7a21766cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_8b04a067-bdd9-4570-bdc8-88f06c7663ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_226f923b-3f05-4b32-a5ab-1d277d9c1141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_8b04a067-bdd9-4570-bdc8-88f06c7663ca" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_226f923b-3f05-4b32-a5ab-1d277d9c1141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_68d63895-840c-4cd0-ac48-33c8a323b56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_68d63895-840c-4cd0-ac48-33c8a323b56e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_46d91180-0f13-4ed0-818e-f24030f3b1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_46d91180-0f13-4ed0-818e-f24030f3b1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_06ce75bd-4105-4a10-b5b0-d0b72bf78d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_06ce75bd-4105-4a10-b5b0-d0b72bf78d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_98c1686a-dfb6-46fb-ba72-e763b5c177b0" xlink:href="holx-20210327.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:to="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_98c1686a-dfb6-46fb-ba72-e763b5c177b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_74b89821-f5ec-4d34-b66d-d48deeb4f86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_74b89821-f5ec-4d34-b66d-d48deeb4f86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_304b9d63-e0b8-4b18-832b-d9bf59c16f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5f69c20d-14f2-4ff2-a987-402c74a9606f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_304b9d63-e0b8-4b18-832b-d9bf59c16f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20210327.xsd#Disposition"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_83770027-3038-4e41-b8b3-8702b6bd6732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_f317ffc4-e2ba-42ef-9566-f7898e79b7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_83770027-3038-4e41-b8b3-8702b6bd6732" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_f317ffc4-e2ba-42ef-9566-f7898e79b7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DispositionDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f89f7f68-089c-4987-8c82-093c3a6b1e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract_49dd1ab3-3f76-4f5c-a68f-20c84c4398f4" xlink:href="holx-20210327.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f89f7f68-089c-4987-8c82-093c3a6b1e1a" xlink:to="loc_holx_AssetsofBusinessHeldforSaleAbstract_49dd1ab3-3f76-4f5c-a68f-20c84c4398f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract_49dd1ab3-3f76-4f5c-a68f-20c84c4398f4" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_24dcd7be-65b7-4202-a912-49cdfbb04b59" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_96c7462c-0fbf-454f-8167-8b61d4fa753a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:to="loc_us-gaap_CostOfSalesMember_96c7462c-0fbf-454f-8167-8b61d4fa753a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_b5f8cc68-4d1c-421d-93d2-464420891393" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1f00e629-b62b-48fc-aadd-aa8b20a5bedf" xlink:to="loc_us-gaap_OperatingExpenseMember_b5f8cc68-4d1c-421d-93d2-464420891393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0ebcaf6f-2ea2-462a-bf38-6c2472306a5e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a2cb4eb9-0b58-4281-866e-0e56aa4658ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6733f919-7e40-4f21-8e49-83b55eae7ef8" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a2cb4eb9-0b58-4281-866e-0e56aa4658ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ec85e4cb-304e-4691-b1f7-a78018a6c178" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9b129e49-7acb-4318-ac68-9dc9dda19f16" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3463f121-f05d-49e9-b52b-4473ecb60151" xlink:to="loc_holx_MedicalAestheticsMember_9b129e49-7acb-4318-ac68-9dc9dda19f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_35f0c3cf-9e0d-4f64-86f7-82d36ce6c079" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d84c2507-6e8f-4115-92b2-7662465b527d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d84c2507-6e8f-4115-92b2-7662465b527d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5c6d5fc8-f6c1-4cd4-8e59-1cf8b2102975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5c6d5fc8-f6c1-4cd4-8e59-1cf8b2102975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_1ad99c0a-4d68-4988-ad7b-3b6fd41a6a3e" xlink:href="holx-20210327.xsd#holx_IndemnificationLiabily"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_holx_IndemnificationLiabily_1ad99c0a-4d68-4988-ad7b-3b6fd41a6a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_462290de-f261-4515-9706-a254a5235f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_AssetImpairmentCharges_462290de-f261-4515-9706-a254a5235f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c4dbc99-113c-4ceb-b5db-e8d0344bfa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c4dbc99-113c-4ceb-b5db-e8d0344bfa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_abb42555-6961-4def-9697-26f9d5284893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_41b15272-622b-4721-8d19-e6e2be1ca2d3" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_abb42555-6961-4def-9697-26f9d5284893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_67586f1b-23e0-4573-a55b-18a02de2c6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_46d7d51e-bff8-4cca-a048-9f65beec0a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67586f1b-23e0-4573-a55b-18a02de2c6f7" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_46d7d51e-bff8-4cca-a048-9f65beec0a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bd158ded-671b-4711-a13c-c71e71bc238d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_5b2887c0-9ea6-4cd2-890b-ab9a26ad49f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd158ded-671b-4711-a13c-c71e71bc238d" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_5b2887c0-9ea6-4cd2-890b-ab9a26ad49f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_b170c77a-eda2-4959-baa1-86b05e505018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd158ded-671b-4711-a13c-c71e71bc238d" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_b170c77a-eda2-4959-baa1-86b05e505018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_0c90d657-7034-463e-9773-4a61d7c1a7bb" xlink:href="holx-20210327.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd158ded-671b-4711-a13c-c71e71bc238d" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_0c90d657-7034-463e-9773-4a61d7c1a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f1c9809a-89cf-45fa-9264-46f2fb09e048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1c9809a-89cf-45fa-9264-46f2fb09e048" xlink:to="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0701580-1a33-4f47-8cf2-a44bfea84681" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_222a9684-b1ca-4539-8209-39cf8a7d8ffb" xlink:href="holx-20210327.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_TermLoanMember_222a9684-b1ca-4539-8209-39cf8a7d8ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_a50eb3a6-d8da-494a-81db-24e311e3105d" xlink:href="holx-20210327.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_RevolverMember_a50eb3a6-d8da-494a-81db-24e311e3105d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_5df595f7-3bbc-4938-a47a-c7c46b4e5e66" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2025SeniorNotesMember_5df595f7-3bbc-4938-a47a-c7c46b4e5e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_3c2ae8a0-2ed8-400b-9b13-79f4167184a7" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2028SeniorNotesMember_3c2ae8a0-2ed8-400b-9b13-79f4167184a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_6ba66392-e735-43f4-9883-c3301d03ec78" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fba41ebb-4900-4476-8280-9d81be526f7d" xlink:to="loc_holx_A2029SeniorNotesMember_6ba66392-e735-43f4-9883-c3301d03ec78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c32526a7-ec8d-4b38-85ae-70ff3cd2b507" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7a763fea-70a8-43df-851d-eeae477d8c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebtCurrent_7a763fea-70a8-43df-851d-eeae477d8c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_6e496708-3472-4337-8438-c02748b43887" xlink:href="holx-20210327.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_6e496708-3472-4337-8438-c02748b43887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ebad37ee-da99-4630-a8ac-21413bd2d832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ebad37ee-da99-4630-a8ac-21413bd2d832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_88fcaa24-157a-47e1-abbe-d9e102b2ea4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e501b499-2afe-474d-ba29-913cbbddb692" xlink:to="loc_us-gaap_LongTermDebt_88fcaa24-157a-47e1-abbe-d9e102b2ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4ab4605b-edd6-4577-9375-17cf67dd961b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4ab4605b-edd6-4577-9375-17cf67dd961b" xlink:to="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f985f790-48ef-4e61-9f6e-6506e724a034" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_985f0921-ee3b-4ebe-b9a5-5d5274b6f778" xlink:href="holx-20210327.xsd#holx_RevolverMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_RevolverMember_985f0921-ee3b-4ebe-b9a5-5d5274b6f778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_dba48df8-b0dd-468b-b4a8-332b9bca432f" xlink:href="holx-20210327.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_AmendedTermLoanMember_dba48df8-b0dd-468b-b4a8-332b9bca432f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e1f6d225-8934-461f-825e-7b873a3eac1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_us-gaap_SeniorNotesMember_e1f6d225-8934-461f-825e-7b873a3eac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_c80d4dcd-f099-41e1-ba42-01f13c4ea07b" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_A2025SeniorNotesMember_c80d4dcd-f099-41e1-ba42-01f13c4ea07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_13b7a625-d0e4-422c-bdf8-3027c0d1b14e" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_A2028SeniorNotesMember_13b7a625-d0e4-422c-bdf8-3027c0d1b14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_37048a73-2005-4b23-a44b-b1da3a3baf38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_37048a73-2005-4b23-a44b-b1da3a3baf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7803f539-0197-4f95-aec1-2409543e95a1" xlink:href="holx-20210327.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_TermLoanMember_7803f539-0197-4f95-aec1-2409543e95a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_31f1e25a-0668-47ef-b8d9-54ca61bba08a" xlink:href="holx-20210327.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4c9845b3-b57d-441c-895d-0774110126e9" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_31f1e25a-0668-47ef-b8d9-54ca61bba08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_018b15c2-5ed5-4b5e-adc5-2afa2cecbf73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_3970dbcf-c7a8-457b-8e32-eba049b232c4" xlink:href="holx-20210327.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_AmendedTermLoanMember_3970dbcf-c7a8-457b-8e32-eba049b232c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_21387a36-1378-4e00-80b2-c18551f98d9a" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_CreditAgreementMember_21387a36-1378-4e00-80b2-c18551f98d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_1d452022-6d77-4f7b-8170-1df8e614be01" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2025SeniorNotesMember_1d452022-6d77-4f7b-8170-1df8e614be01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_16ebda44-5c53-47cc-b048-c4490c7d9f71" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2028SeniorNotesMember_16ebda44-5c53-47cc-b048-c4490c7d9f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_52039f39-596e-4a55-ac7d-8a6b0b4c625a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_us-gaap_SeniorNotesMember_52039f39-596e-4a55-ac7d-8a6b0b4c625a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_90f88736-4da3-4395-b8af-55aa169a3732" xlink:href="holx-20210327.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_90f88736-4da3-4395-b8af-55aa169a3732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_00fb643f-788c-4124-b54d-5b8315e939d8" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c96bcfc1-8251-4185-a84c-a8d73a7c3856" xlink:to="loc_holx_A2029SeniorNotesMember_00fb643f-788c-4124-b54d-5b8315e939d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75ca1919-6a73-4783-aea8-e20e65090d4c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_f52db8a3-329f-4382-bb5c-842b992ffd4a" xlink:href="holx-20210327.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aafbbf9b-0fe1-4ce7-b153-bcc39e4979c2" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_f52db8a3-329f-4382-bb5c-842b992ffd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d37d0d7d-e063-454f-acc9-2157e76c8409" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f66978b4-b4ed-4b96-839d-e11b7f97b5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_f66978b4-b4ed-4b96-839d-e11b7f97b5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_701b8016-7a04-4c3c-bded-73ca6c27547c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_701b8016-7a04-4c3c-bded-73ca6c27547c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_35ec3dc3-9d3a-4d52-9e41-6ea179f950a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_35ec3dc3-9d3a-4d52-9e41-6ea179f950a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_97836772-999b-4a11-ad5e-bbb2454a03e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_97836772-999b-4a11-ad5e-bbb2454a03e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_5f719f42-bf3a-496a-9250-17248a19bf68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_ccf28f4a-c13e-4958-b936-6ce9300ca03e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_5f719f42-bf3a-496a-9250-17248a19bf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eddf468d-fbd4-46f9-a5b8-13f265fc3578" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e466cff-4141-44f2-9ff5-d5b2b7caf22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e466cff-4141-44f2-9ff5-d5b2b7caf22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad3f7cdf-8773-4d57-9b86-6b1a5d5a0fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LongTermDebt_ad3f7cdf-8773-4d57-9b86-6b1a5d5a0fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29b9c45d-989e-437b-beb1-2363cd77217c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_29b9c45d-989e-437b-beb1-2363cd77217c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96774c94-2974-4bf8-8105-8fdd5b525bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96774c94-2974-4bf8-8105-8fdd5b525bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5b477a12-a97d-4a38-b740-b853189e1017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5b477a12-a97d-4a38-b740-b853189e1017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7a8011ff-6c7a-41e0-887c-388c1c8b509d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LongTermDebtCurrent_7a8011ff-6c7a-41e0-887c-388c1c8b509d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ade8049a-716d-4ca6-bb55-5e33113ec444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_RepaymentsOfDebt_ade8049a-716d-4ca6-bb55-5e33113ec444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a4ad1db9-5174-42cb-a2f5-698831821eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a4ad1db9-5174-42cb-a2f5-698831821eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2a5c0ed3-ab75-4ba7-a4bd-cd242c573d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_SeniorNotes_2a5c0ed3-ab75-4ba7-a4bd-cd242c573d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_a49715ce-8c49-4785-82b9-d41b2410fd64" xlink:href="holx-20210327.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_a49715ce-8c49-4785-82b9-d41b2410fd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c61bdd54-9a72-40dd-9406-21cb62dce6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_c61bdd54-9a72-40dd-9406-21cb62dce6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ba9640d9-0c0e-467f-bbd9-5455dcb29ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_InterestExpenseDebt_ba9640d9-0c0e-467f-bbd9-5455dcb29ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_803244a7-4cf5-4bd7-ad74-3dd3b788cec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_803244a7-4cf5-4bd7-ad74-3dd3b788cec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4a0c0539-f7b8-454f-ba65-87a62a171d82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4a0c0539-f7b8-454f-ba65-87a62a171d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d2d5f95b-6124-4a57-ac6d-de240950a658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d2d5f95b-6124-4a57-ac6d-de240950a658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_75e0bfc3-d442-423d-b41d-0c2a2fc2d245" xlink:href="holx-20210327.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_holx_DebtRedemptionPremiumPaid_75e0bfc3-d442-423d-b41d-0c2a2fc2d245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_778b27e3-3106-4a81-a1ce-d296da667957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c16e7112-3658-4f89-b974-596f37e1d73e" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_778b27e3-3106-4a81-a1ce-d296da667957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_88ad1fd0-33a6-4b56-8b14-8ee859055be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_88ad1fd0-33a6-4b56-8b14-8ee859055be2" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:to="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_392e4dd4-7089-480a-a1ce-be07eee931ca" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_32d27a62-5eee-4434-85e8-e5aedefc1dd6" xlink:href="holx-20210327.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9aed8c32-3546-4c21-b865-affe914e43d0" xlink:to="loc_holx_CreditAgreementMember_32d27a62-5eee-4434-85e8-e5aedefc1dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4093dd37-bb39-4757-a385-ba4b8ad815f3" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b7add696-dbc6-41c7-878a-7e6e406759cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b7add696-dbc6-41c7-878a-7e6e406759cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_82d4099e-5c79-4a99-b8c8-8bb53f1aa5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_82d4099e-5c79-4a99-b8c8-8bb53f1aa5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_80366ce9-8479-4a02-a147-559b91b93559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_6582a294-79f9-4a0c-bfa5-0d515dae47ca" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_80366ce9-8479-4a02-a147-559b91b93559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8f42044e-337d-4e12-a2c2-48172c7155f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8f42044e-337d-4e12-a2c2-48172c7155f9" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e50a597f-484f-4c15-96e2-5925476def36" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f3c443e0-4ecb-4b40-bf7a-3e69d46cab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c282870-7198-418d-b055-989fca5cf52c" xlink:to="loc_us-gaap_SeniorNotesMember_f3c443e0-4ecb-4b40-bf7a-3e69d46cab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:to="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c64222a3-983f-41cf-a3d5-0277e4d4ff67" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_04ba1ad6-ed2e-472d-9a42-580a5ba5a878" xlink:href="holx-20210327.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2028SeniorNotesMember_04ba1ad6-ed2e-472d-9a42-580a5ba5a878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_a5d38b66-55c7-4d72-9c2e-21ee44bd47e2" xlink:href="holx-20210327.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2025SeniorNotesMember_a5d38b66-55c7-4d72-9c2e-21ee44bd47e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_7782866f-56c5-4b13-b2d7-2767e62d2e74" xlink:href="holx-20210327.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12f779f0-4f96-4e08-9c37-8900e0039bb7" xlink:to="loc_holx_A2029SeniorNotesMember_7782866f-56c5-4b13-b2d7-2767e62d2e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_dc78c181-da6f-46dc-a67e-bf64c67096de" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab4208e8-4c6b-40bd-a4ba-b1c3b0a194f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ab4208e8-4c6b-40bd-a4ba-b1c3b0a194f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_4b750179-c329-4b5d-a64b-71c2d6a9c71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_ec2838a2-d31b-42de-9b1b-b80ca3c93d93" xlink:to="loc_us-gaap_InterestExpenseBorrowings_4b750179-c329-4b5d-a64b-71c2d6a9c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20210327.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a423ec0-4b57-4030-9e7c-8d629bf90230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_e2bba405-53b0-4ff4-8534-d5398bbf4da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a423ec0-4b57-4030-9e7c-8d629bf90230" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_e2bba405-53b0-4ff4-8534-d5398bbf4da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c91e8fbb-77ef-4d0a-bdd2-783de6d113a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_742a09b6-17b8-4d3f-9143-836c36c78d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c91e8fbb-77ef-4d0a-bdd2-783de6d113a7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_742a09b6-17b8-4d3f-9143-836c36c78d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5e9b38ec-4de5-4ca6-b505-b6d54c560d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c91e8fbb-77ef-4d0a-bdd2-783de6d113a7" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5e9b38ec-4de5-4ca6-b505-b6d54c560d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_16416cb1-9620-4d94-9385-6a7709eb7c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c91e8fbb-77ef-4d0a-bdd2-783de6d113a7" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_16416cb1-9620-4d94-9385-6a7709eb7c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_877fb4b7-9b3b-41b4-bcf4-6a83b4c90a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_877fb4b7-9b3b-41b4-bcf4-6a83b4c90a2a" xlink:to="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e7b0cc41-55eb-477f-a174-5af24d5cb492" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_38ea5829-4268-4dd0-b933-602d8f022164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:to="loc_us-gaap_InterestRateSwapMember_38ea5829-4268-4dd0-b933-602d8f022164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_3c899126-1144-4162-aefb-caef9c094797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_75339f44-8d87-4271-b8d3-274e92bc622c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_3c899126-1144-4162-aefb-caef9c094797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:to="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_09d2520c-e7c2-442f-9c14-3c9fa14e0eec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_823959d5-233c-4df6-b2ff-e6c39e3ea123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1796d947-58b6-466e-89df-f135d5008f92" xlink:to="loc_us-gaap_InterestRateCapMember_823959d5-233c-4df6-b2ff-e6c39e3ea123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_b2b1c418-e041-4338-a29d-a885188ed433" xlink:to="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_ba944c65-657d-4e0e-acf7-81fdbc5a821e" xlink:href="holx-20210327.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_ba944c65-657d-4e0e-acf7-81fdbc5a821e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_392c329b-2c1d-413b-9ed7-ea0764301a60" xlink:href="holx-20210327.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_PrincipalAmountOfBorrowings_392c329b-2c1d-413b-9ed7-ea0764301a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9574b1b6-9346-4f73-a910-d2b6e07d13e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9574b1b6-9346-4f73-a910-d2b6e07d13e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_767d9908-95e3-4a20-95b3-e1eabc19c28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_767d9908-95e3-4a20-95b3-e1eabc19c28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_e4750f07-dbf4-4e1b-8afb-2a084410d0c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_e4750f07-dbf4-4e1b-8afb-2a084410d0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_41298cc2-dc97-41b3-be24-3ededfeaf77b" xlink:href="holx-20210327.xsd#holx_NotationalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4d6b9b27-4ab6-40e3-a4d0-0e681bafc9df" xlink:to="loc_holx_NotationalAmount_41298cc2-dc97-41b3-be24-3ededfeaf77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_af2bb4b9-7c7a-443d-af69-a05876ad9d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_af2bb4b9-7c7a-443d-af69-a05876ad9d4d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2b77962e-61d8-49e8-b946-2ee0d81145af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e0dba48e-a156-44a9-9266-c4a048a69697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e0dba48e-a156-44a9-9266-c4a048a69697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_309e5e07-3b05-4f06-a1e9-ef87c33ae667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1ab4edc8-7b66-47ec-9207-51aaf3463ac4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_309e5e07-3b05-4f06-a1e9-ef87c33ae667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:to="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_01097a0a-7b48-446a-a3d7-2502ff8cc9d6" xlink:to="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_60daf714-f990-420e-bf17-de333476eae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b542c336-e1a0-49c7-b47c-6b937a5b661d" xlink:to="loc_us-gaap_NondesignatedMember_60daf714-f990-420e-bf17-de333476eae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5ea227aa-87cb-4e35-99fd-64c4331473e5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21e01142-972f-4a5a-83a9-6758445655e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21e01142-972f-4a5a-83a9-6758445655e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_c76bdfce-4fc0-45ae-acfc-c94316a77875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_c76bdfce-4fc0-45ae-acfc-c94316a77875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_0c1d6644-e295-4946-a015-7294ec30fef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c37cadd3-ca49-4340-ad6d-e6fbc9bdabb4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_0c1d6644-e295-4946-a015-7294ec30fef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c5b2396-5bc0-47c9-b45b-95b9f16e9068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2c5b2396-5bc0-47c9-b45b-95b9f16e9068" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_86966fb8-3840-4f64-b024-4c5d27cda1dd" xlink:to="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5c3ce999-b8b8-404c-8c11-5a33d124571a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_723e240d-a993-4486-94c2-0ebfc963b1e2" xlink:to="loc_us-gaap_NondesignatedMember_5c3ce999-b8b8-404c-8c11-5a33d124571a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_028911bd-c436-4049-8c84-084c3648950a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_3d2197bc-efe7-4402-8fad-94370da0023c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_3d2197bc-efe7-4402-8fad-94370da0023c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_67c0e2ab-02ee-4152-99fb-f17edb6d0050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_67c0e2ab-02ee-4152-99fb-f17edb6d0050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b83ee2b9-f8ae-48b7-b2e1-717d4a0a901f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c00fd518-5258-4d6d-9e05-ec8997a11122" xlink:to="loc_us-gaap_InterestRateSwapMember_b83ee2b9-f8ae-48b7-b2e1-717d4a0a901f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c4a32c2d-e593-4ec8-814c-e2798686a4f3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f910d5d9-9cba-46f8-8762-3ff17607dd9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_f910d5d9-9cba-46f8-8762-3ff17607dd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d201313d-3463-4dc6-9156-6dd18bd7fc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d201313d-3463-4dc6-9156-6dd18bd7fc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_22a016d7-9d41-4ddf-9063-6e8d0524bf71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1fbd51a5-3d17-474b-b921-48b5c1aacc27" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_22a016d7-9d41-4ddf-9063-6e8d0524bf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b19c75f6-9cea-4b4e-a0ad-c519cc093c2e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_135dac2f-b721-483d-a3b3-153dda96c9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_135dac2f-b721-483d-a3b3-153dda96c9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ac48eef5-8f6a-4a42-8bd9-af7714eb085d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_DerivativeLiabilities_ac48eef5-8f6a-4a42-8bd9-af7714eb085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5df6a084-85c3-4308-ab28-3a78a2b6bd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_993c1706-9cea-4582-ab0d-d41761a8dd2a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_5df6a084-85c3-4308-ab28-3a78a2b6bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57cb4c42-e100-4a8a-a54c-dc81169cfd37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57cb4c42-e100-4a8a-a54c-dc81169cfd37" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_47be48f2-9033-4877-9033-ea5fc8a07399" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5211fab8-353b-4722-8edc-c441c76efd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:to="loc_us-gaap_InterestRateSwapMember_5211fab8-353b-4722-8edc-c441c76efd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_b1ff9251-6076-4bc6-8c07-14ab28a6d086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bbea4427-1f8b-4239-8981-8c6702fa7f15" xlink:to="loc_us-gaap_InterestRateCapMember_b1ff9251-6076-4bc6-8c07-14ab28a6d086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1b491991-d9dd-4cf2-bd79-e2212f3a4ff4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_84d8a4ec-9943-4603-a34f-52d7d0c4807a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_84d8a4ec-9943-4603-a34f-52d7d0c4807a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d51486ce-2a28-4171-a1dd-c23f2842493c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1b462c12-5b2c-424c-b17b-780181288257" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_d51486ce-2a28-4171-a1dd-c23f2842493c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_30138e56-9598-4bf2-b413-d36ecfdec744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af057cda-7fb0-4929-8d01-7554f4ef0d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_30138e56-9598-4bf2-b413-d36ecfdec744" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af057cda-7fb0-4929-8d01-7554f4ef0d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#CommitmentsandContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41d04dfd-ba34-4ebc-b1db-7795aed377b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_41d04dfd-ba34-4ebc-b1db-7795aed377b1" xlink:to="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:to="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_057f3b10-6fb7-45ac-94cf-2aa298414a68" xlink:to="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_ea8584c1-8192-4599-89b1-19995e02146a" xlink:href="holx-20210327.xsd#holx_MinervaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:to="loc_holx_MinervaMember_ea8584c1-8192-4599-89b1-19995e02146a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_0985a508-5241-4371-9358-71cdaebcf519" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_590672ca-b010-44ac-81a1-47019a4e7a20" xlink:to="loc_holx_MedicalAestheticsMember_0985a508-5241-4371-9358-71cdaebcf519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_42cc4e5b-1721-4bbd-ba8e-f48cfa723be6" xlink:to="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_84a018f0-9f35-4921-9c9b-14ac4f5b9d45" xlink:href="holx-20210327.xsd#holx_AmountAssessedInDamages"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_holx_AmountAssessedInDamages_84a018f0-9f35-4921-9c9b-14ac4f5b9d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_57250ed9-2d06-44c3-8996-c881a0677467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_57250ed9-2d06-44c3-8996-c881a0677467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_01fb0ebc-da35-49ad-b71a-82b035068ea5" xlink:href="holx-20210327.xsd#holx_LegalAccrual"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ffd590e1-9928-4d18-9f8d-17b58d6749a7" xlink:to="loc_holx_LegalAccrual_01fb0ebc-da35-49ad-b71a-82b035068ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_373ecb92-54f1-4ae6-933a-ea00dab44638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a1b3ee62-f792-46b2-a4b4-8b1d33d20657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_373ecb92-54f1-4ae6-933a-ea00dab44638" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a1b3ee62-f792-46b2-a4b4-8b1d33d20657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a23e7e87-805c-4078-964e-a1cd452afb81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_95ce7837-df92-42fd-a604-eb7819af3b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a23e7e87-805c-4078-964e-a1cd452afb81" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_95ce7837-df92-42fd-a604-eb7819af3b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8b664725-4fbb-4cc7-8ea7-1891b79be413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:href="holx-20210327.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8b664725-4fbb-4cc7-8ea7-1891b79be413" xlink:to="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fdf6640c-0d5e-4f58-813e-6700e794782a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_ebc47d5d-5d93-42a2-8695-fa60806d5c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:to="loc_us-gaap_StockCompensationPlanMember_ebc47d5d-5d93-42a2-8695-fa60806d5c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e8d06580-98a1-4895-b10c-addbe997ac61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efebb20d-a646-46f1-96da-753d7bb74d28" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e8d06580-98a1-4895-b10c-addbe997ac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:href="holx-20210327.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_8ce382ab-5af1-4b25-88df-5ae25bb3af19" xlink:to="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c84406f6-661d-4c55-8f0f-cdca5300b3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c84406f6-661d-4c55-8f0f-cdca5300b3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_348b07cf-77a2-4b05-8ba5-9e6d6b1677e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_348b07cf-77a2-4b05-8ba5-9e6d6b1677e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ec3781e-2e9d-4ee5-b655-3580692633ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ec3781e-2e9d-4ee5-b655-3580692633ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_cf8e2c0d-91ea-41d0-9ec2-bd8a44d257d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4c4b96b3-2793-4f66-abde-bdcfc2958159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_0c100754-0c48-4b75-8fde-5043b6af0bfe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4c4b96b3-2793-4f66-abde-bdcfc2958159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_671ada80-c936-4030-8a34-b0ced6136ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_33be9aba-7c0b-490b-89aa-b3d33d2cf285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_671ada80-c936-4030-8a34-b0ced6136ce0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_33be9aba-7c0b-490b-89aa-b3d33d2cf285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc225177-03d6-4176-bc41-e46d31f164eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_b5a6d4cc-aab0-4822-807e-d8083f830e06" xlink:href="holx-20210327.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc225177-03d6-4176-bc41-e46d31f164eb" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_b5a6d4cc-aab0-4822-807e-d8083f830e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0ce5310d-eca2-4b9d-890b-22d5df1a9fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc225177-03d6-4176-bc41-e46d31f164eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0ce5310d-eca2-4b9d-890b-22d5df1a9fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f335eef-8038-4c60-ad26-1370724d09ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f335eef-8038-4c60-ad26-1370724d09ec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9768b39-2a7f-44b6-9a51-bed3e1f19d5b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0e7f81fb-f23d-4b74-9a88-6f83447fa61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_CostOfSalesMember_0e7f81fb-f23d-4b74-9a88-6f83447fa61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8503a1c6-56f5-44d5-924b-071d73c7b5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8503a1c6-56f5-44d5-924b-071d73c7b5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_16bf307c-6aa0-4312-859e-386432b49519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_16bf307c-6aa0-4312-859e-386432b49519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_032d7c36-f03f-4814-8dc7-ad15a6dee875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_032d7c36-f03f-4814-8dc7-ad15a6dee875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_a5a018de-b6d3-4ff2-b3d5-0a6db9b19f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ad858685-d9c4-440d-8d31-458d4996a123" xlink:to="loc_us-gaap_RestructuringChargesMember_a5a018de-b6d3-4ff2-b3d5-0a6db9b19f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_daff78ee-d049-4149-a380-44e1c75617ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a38485df-3b04-44ce-accb-f64c0e3d2a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb527749-d75d-4a4b-a944-3ed17a43cd27" xlink:to="loc_us-gaap_ShareBasedCompensation_a38485df-3b04-44ce-accb-f64c0e3d2a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a591f141-7d5a-4187-9152-c79674dfc612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a591f141-7d5a-4187-9152-c79674dfc612" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:to="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_210e179e-3a04-452d-b6c1-aa6633cd1647" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1470a9f-f023-453d-a0ed-2eb1f420b183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1470a9f-f023-453d-a0ed-2eb1f420b183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6fca00df-1fa6-4636-863e-654c7cbf1ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6fca00df-1fa6-4636-863e-654c7cbf1ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3b4619c8-5cd2-4637-823b-8c218116e640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_us-gaap_PerformanceSharesMember_3b4619c8-5cd2-4637-823b-8c218116e640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_4c498595-fb77-42ab-a3ae-829cbabdf844" xlink:href="holx-20210327.xsd#holx_MarketBasedAwardsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_MarketBasedAwardsMember_4c498595-fb77-42ab-a3ae-829cbabdf844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_94d0eff9-543b-48b2-87b6-6f16636a8fe7" xlink:href="holx-20210327.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_PSUFreeCashFlowMember_94d0eff9-543b-48b2-87b6-6f16636a8fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_ac7db966-7201-4f5b-b91c-ae5bee770458" xlink:href="holx-20210327.xsd#holx_RSUPSUMSUMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_61b21294-db7a-45b6-b1b6-d8d4e0f58d7f" xlink:to="loc_holx_RSUPSUMSUMember_ac7db966-7201-4f5b-b91c-ae5bee770458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41fb16ca-fba4-4e2a-9cee-52f6c780699e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_22643f3b-70f9-451c-b9d9-4680a68c1d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_22643f3b-70f9-451c-b9d9-4680a68c1d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_66a3896a-77e1-4db8-ab3a-f954bbbeabcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_66a3896a-77e1-4db8-ab3a-f954bbbeabcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9be4e13f-eb71-47d8-b565-e15068315a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9be4e13f-eb71-47d8-b565-e15068315a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f6215292-414a-477d-8aaf-d8b6806170ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f6215292-414a-477d-8aaf-d8b6806170ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4fcc7b4c-afbf-43e7-a637-615851bd2d9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4fcc7b4c-afbf-43e7-a637-615851bd2d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_add41633-429d-4314-92b2-13f11773e301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_add41633-429d-4314-92b2-13f11773e301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6bebf72c-a1ff-476c-b845-5cb5e39d41ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6bebf72c-a1ff-476c-b845-5cb5e39d41ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_cca9a2cd-dd2f-47d2-900b-2ca2af70c2bd" xlink:href="holx-20210327.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_cca9a2cd-dd2f-47d2-900b-2ca2af70c2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_63097cdb-17e8-4700-a1c1-bdbc20243f6f" xlink:href="holx-20210327.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_63097cdb-17e8-4700-a1c1-bdbc20243f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_04e5129c-19b0-4024-bf7f-7bcd1a65f4dd" xlink:href="holx-20210327.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_04e5129c-19b0-4024-bf7f-7bcd1a65f4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a80cb5bf-3cf6-4e24-b80f-f432f076d830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a80cb5bf-3cf6-4e24-b80f-f432f076d830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_51948dab-41f4-4ae9-9da3-33bac80f0835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e549349-08ce-4c85-bc0c-391c0476947a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_51948dab-41f4-4ae9-9da3-33bac80f0835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6fa0e70a-a0dd-47e8-b417-7da4df3690db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6fa0e70a-a0dd-47e8-b417-7da4df3690db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_95e1c25a-7fab-480f-a4b8-be9975a6bfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_95e1c25a-7fab-480f-a4b8-be9975a6bfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7676f588-3266-42a7-9f53-696a1e919c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7676f588-3266-42a7-9f53-696a1e919c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_a2b32d3f-eb8a-4197-abf2-31378ef61838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_a2b32d3f-eb8a-4197-abf2-31378ef61838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_509b8238-1c99-4826-9d51-6fd44fc4a95e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c0a797f-6659-455a-929c-14ce78a8dcdc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_509b8238-1c99-4826-9d51-6fd44fc4a95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d6fe0715-ff7b-4cb3-8777-98be05184cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_a6a8ec18-3041-4e66-a10d-4b635bad1838" xlink:href="holx-20210327.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d6fe0715-ff7b-4cb3-8777-98be05184cee" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_a6a8ec18-3041-4e66-a10d-4b635bad1838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3dd58dd5-3e7f-4ed2-acaf-537404449b46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0be7e36d-ff11-432a-8d66-d2324d45fbe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3dd58dd5-3e7f-4ed2-acaf-537404449b46" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0be7e36d-ff11-432a-8d66-d2324d45fbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0f8fe6f3-5f8c-43cf-814f-1ba67e1e9495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3dd58dd5-3e7f-4ed2-acaf-537404449b46" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0f8fe6f3-5f8c-43cf-814f-1ba67e1e9495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_9d11bc13-6c5b-4fea-b5e8-680016e83928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_de75af98-de2b-49f8-8f6c-9e9b688d7033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_9d11bc13-6c5b-4fea-b5e8-680016e83928" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_de75af98-de2b-49f8-8f6c-9e9b688d7033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b9845501-8322-42e4-b26e-f663b0293c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_9d11bc13-6c5b-4fea-b5e8-680016e83928" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_b9845501-8322-42e4-b26e-f663b0293c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ec8893e2-0877-481d-ae23-f5171dd439f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_9d11bc13-6c5b-4fea-b5e8-680016e83928" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ec8893e2-0877-481d-ae23-f5171dd439f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fb551e4e-584e-4dce-ac91-b5280f90f3a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_9d11bc13-6c5b-4fea-b5e8-680016e83928" xlink:to="loc_us-gaap_InventoryNet_fb551e4e-584e-4dce-ac91-b5280f90f3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_643afd49-aaef-408e-a93a-ce8135af8b80" xlink:href="holx-20210327.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_643afd49-aaef-408e-a93a-ce8135af8b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_b32440db-6815-42c5-be49-891f641b2674" xlink:href="holx-20210327.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_b32440db-6815-42c5-be49-891f641b2674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_c23917fd-caed-493d-8699-dac44af9793d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_c23917fd-caed-493d-8699-dac44af9793d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_3a2e1b68-fece-4487-ba5c-9a0e35f862c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_3a2e1b68-fece-4487-ba5c-9a0e35f862c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_f96878e4-9677-41a7-a9ab-8f88f6ba03fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_Land_f96878e4-9677-41a7-a9ab-8f88f6ba03fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_50b715e1-7ba3-4e7d-93b4-5811c0142f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_50b715e1-7ba3-4e7d-93b4-5811c0142f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e2d7b306-3094-4075-8b22-869b29bf2ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e2d7b306-3094-4075-8b22-869b29bf2ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fec94d92-1d4c-4a4a-98fe-77c20931ccad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fec94d92-1d4c-4a4a-98fe-77c20931ccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_726cc19c-b292-49f7-82ec-ab52763c8bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_726cc19c-b292-49f7-82ec-ab52763c8bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6c6e6bdd-212e-4d40-9dff-9da8d63fc39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_93a7a7f5-aa01-42b3-8e95-5a553176d93f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6c6e6bdd-212e-4d40-9dff-9da8d63fc39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4224bef2-ef49-47d9-8235-b4871b22558d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_71e843ef-8138-4d5c-8526-4f31881bc769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4224bef2-ef49-47d9-8235-b4871b22558d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_71e843ef-8138-4d5c-8526-4f31881bc769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dd4c5301-1b73-40e5-ad9f-5a7f87aaa3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_73cb274a-85f8-4f92-a81c-8ebfd9a3a484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dd4c5301-1b73-40e5-ad9f-5a7f87aaa3b1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_73cb274a-85f8-4f92-a81c-8ebfd9a3a484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_f0676f65-7066-4c0e-88c9-590e83d7b26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dd4c5301-1b73-40e5-ad9f-5a7f87aaa3b1" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_f0676f65-7066-4c0e-88c9-590e83d7b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4cbd47f4-0d96-48cc-813b-df119b168bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4cbd47f4-0d96-48cc-813b-df119b168bf2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:to="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e92b174d-473b-49fb-a4b7-0a29d71ca4ec" xlink:to="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_091c83f0-da87-4b8b-b909-e908fd86fdad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ad5de3c6-c990-4b94-9898-65f669fcbb8f" xlink:to="loc_us-gaap_IntersegmentEliminationMember_091c83f0-da87-4b8b-b909-e908fd86fdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:href="holx-20210327.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5b6a8312-558e-4d76-802d-8eedfd06baee" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b5d20c2d-8e34-47c4-b837-27c4afd13936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:to="loc_us-gaap_NumberOfReportableSegments_b5d20c2d-8e34-47c4-b837-27c4afd13936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4086bdd4-092f-4fe4-9acc-4e35fdca34ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_c76396d6-d7d3-4915-ac75-e2a45b3570ea" xlink:to="loc_us-gaap_Revenues_4086bdd4-092f-4fe4-9acc-4e35fdca34ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ecf6b66f-8ba8-4d2b-b070-cac06937397c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ecf6b66f-8ba8-4d2b-b070-cac06937397c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25179352-f0cf-4411-8c9b-9b346121197b" xlink:to="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5085b1fc-974c-482b-b8e5-f61673f5ada9" xlink:href="holx-20210327.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_DiagnosticsMember_5085b1fc-974c-482b-b8e5-f61673f5ada9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_e6bdc833-e7b5-4dc4-9720-1756006826ad" xlink:href="holx-20210327.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_BreastHealthMember_e6bdc833-e7b5-4dc4-9720-1756006826ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_9ad2d27c-c053-4449-9922-2d0f7b6f71e0" xlink:href="holx-20210327.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_GynSurgicalMember_9ad2d27c-c053-4449-9922-2d0f7b6f71e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_2675d8b9-5440-443a-9d44-27f607896713" xlink:href="holx-20210327.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_SkeletalHealthMember_2675d8b9-5440-443a-9d44-27f607896713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1dcaa485-61ad-494d-ba67-f8ef7ba97e08" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_holx_MedicalAestheticsMember_1dcaa485-61ad-494d-ba67-f8ef7ba97e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_a26e3b0d-700b-42e9-84f3-4b5cfbf5df7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f804be88-928d-4645-bca7-7feca162762c" xlink:to="loc_us-gaap_CorporateMember_a26e3b0d-700b-42e9-84f3-4b5cfbf5df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ca7b027b-9476-4bf7-8601-cf3c4b97bc64" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fc19b83e-6847-4691-9d7e-a9f8f36eff1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_Revenues_fc19b83e-6847-4691-9d7e-a9f8f36eff1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a5ba2dc4-1981-417f-a999-3454b5b790bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_OperatingIncomeLoss_a5ba2dc4-1981-417f-a999-3454b5b790bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1b68f9c8-f961-44c0-b26f-b63234ad7c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1b68f9c8-f961-44c0-b26f-b63234ad7c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_a09fbaa0-eff4-480e-8187-5472d1364284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_a09fbaa0-eff4-480e-8187-5472d1364284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5f193e62-227d-4da2-9275-ad0f76b94f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edda1c6a-3249-4af7-bfdc-35c3a0919230" xlink:to="loc_us-gaap_Assets_5f193e62-227d-4da2-9275-ad0f76b94f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d7fe5d56-aa34-4b4d-bd41-b7ca75096886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d7fe5d56-aa34-4b4d-bd41-b7ca75096886" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:to="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8e0a12be-fdcd-4806-a8d5-4bea42fc4ea2" xlink:to="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e9ad7463-35fc-4834-89c7-49c6a3bfb24a" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_country_US_e9ad7463-35fc-4834-89c7-49c6a3bfb24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f7d3b475-d801-488a-93b2-4f90a364392d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_srt_EuropeMember_f7d3b475-d801-488a-93b2-4f90a364392d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a72a1669-86ce-494c-be1b-0803019d1f39" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_srt_AsiaPacificMember_a72a1669-86ce-494c-be1b-0803019d1f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_2f5e859c-b6df-4872-b67d-42e65522c2fd" xlink:href="holx-20210327.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aa733149-06ba-467c-b283-23f8b4961d02" xlink:to="loc_holx_AllOtherCountriesMember_2f5e859c-b6df-4872-b67d-42e65522c2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:href="holx-20210327.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_06591bf9-63ed-4500-8e1d-d8a56e0adf23" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_a806d4a0-7c9a-45f2-aa5f-fef942392946" xlink:href="holx-20210327.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_67aa3062-6db4-4044-ac62-77c06c3d8d17" xlink:to="loc_holx_PercentageOfRevenues_a806d4a0-7c9a-45f2-aa5f-fef942392946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9c9f9f67-2dd9-41bf-b4e4-42e310aef7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_279a0aa6-3a86-4a4c-8254-4a140e66c9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c9f9f67-2dd9-41bf-b4e4-42e310aef7e0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_279a0aa6-3a86-4a4c-8254-4a140e66c9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b1db1c3d-9fc6-449d-b057-96e0d965cca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b1db1c3d-9fc6-449d-b057-96e0d965cca5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc432c6-744d-4aa7-8402-93c098db859b" xlink:to="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_1283c0c1-4bda-4633-ba45-e9d711bee6e7" xlink:href="holx-20210327.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2dc444f-8100-49e6-9b3c-043808ae05b9" xlink:to="loc_holx_MedicalAestheticsMember_1283c0c1-4bda-4633-ba45-e9d711bee6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4705ca7a-091a-43a6-8422-620a9e63653d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_df7f8fb9-99b2-41d5-aac4-74f9e67b867d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_df7f8fb9-99b2-41d5-aac4-74f9e67b867d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8bc9a051-9c69-4bb7-97e2-cdd3cbe32be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_570b36fe-d706-4f4f-988a-f7089c80ad71" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8bc9a051-9c69-4bb7-97e2-cdd3cbe32be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed03be66-ffbf-4dcf-ab36-acab6915f47a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8f2a4fbb-8eea-4825-bf81-0460d4d94ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed03be66-ffbf-4dcf-ab36-acab6915f47a" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8f2a4fbb-8eea-4825-bf81-0460d4d94ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_14667278-75fc-4221-b454-998cae2cdf07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_41e5a4e7-d523-4039-9446-1269c74b6331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_14667278-75fc-4221-b454-998cae2cdf07" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_41e5a4e7-d523-4039-9446-1269c74b6331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b20d8560-45e8-418c-938a-782bbc3b9f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_14667278-75fc-4221-b454-998cae2cdf07" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b20d8560-45e8-418c-938a-782bbc3b9f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7e7250a-df87-4eb3-bba1-f9592689dee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7e7250a-df87-4eb3-bba1-f9592689dee0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_90113bc1-658c-4595-b65a-31dd63fcab1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_6c6c91b1-bc45-4102-bdc0-3d79b4c6be70" xlink:href="holx-20210327.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_DevelopedTechnologyMember_6c6c91b1-bc45-4102-bdc0-3d79b4c6be70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_6b8c2be6-ba84-4af8-932f-08d04015f99d" xlink:href="holx-20210327.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_CustomerRelationshipsContractsMember_6b8c2be6-ba84-4af8-932f-08d04015f99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_001d9318-1c7a-4b65-aebe-d21e8aed1b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_us-gaap_TradeNamesMember_001d9318-1c7a-4b65-aebe-d21e8aed1b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_aa0b0f94-c96b-49cc-af5d-5b37670c788a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_aa0b0f94-c96b-49cc-af5d-5b37670c788a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_76f6fac3-0e7f-43d8-9bc0-72dae4e42ea8" xlink:href="holx-20210327.xsd#holx_BusinessLicensesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_BusinessLicensesMember_76f6fac3-0e7f-43d8-9bc0-72dae4e42ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_8b882f42-27fa-4108-a8ef-53230e5b3626" xlink:href="holx-20210327.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_AcquiredintangibleassetsMember_8b882f42-27fa-4108-a8ef-53230e5b3626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_8689a6c8-cd64-4f5e-bdb5-74d86ab338b7" xlink:href="holx-20210327.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_InternalusesoftwareMember_8689a6c8-cd64-4f5e-bdb5-74d86ab338b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_9c4b634c-5362-4316-9470-8190eb63a9fc" xlink:href="holx-20210327.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6dbf3b12-6086-4184-b639-b63abdf295d5" xlink:to="loc_holx_CapitalizedsoftwareMember_9c4b634c-5362-4316-9470-8190eb63a9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_72dfd783-7290-4d7d-a9ca-54b65a841031" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_765f9b17-7e43-44ca-9200-0eb8dfeee900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_765f9b17-7e43-44ca-9200-0eb8dfeee900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccf3f29d-b1a6-4e03-982d-560e9de2750a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb7d5e7-88d8-4b83-ab31-e1e8b1182eee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccf3f29d-b1a6-4e03-982d-560e9de2750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b2698cac-afdf-44ee-9a64-91cabfc75a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b2698cac-afdf-44ee-9a64-91cabfc75a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_65a7c176-f5cf-4bef-b17a-75c84c7c02da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_65a7c176-f5cf-4bef-b17a-75c84c7c02da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_044554d5-53f8-4190-824e-d735a0448e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_044554d5-53f8-4190-824e-d735a0448e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8f1a3c6-bd16-4452-8055-57a860682f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d8f1a3c6-bd16-4452-8055-57a860682f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3773b5f5-d626-46c8-97a6-8863e0e45c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1e9bb3ce-a7f2-470c-a64b-2bb453d9d785" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3773b5f5-d626-46c8-97a6-8863e0e45c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_dc237ce8-d66a-4dca-b9a4-e97d06c24159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_9492e8a5-852d-49b9-8068-1d9fbfb85bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_dc237ce8-d66a-4dca-b9a4-e97d06c24159" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_9492e8a5-852d-49b9-8068-1d9fbfb85bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_337820b0-7c22-4213-b666-8805efadde70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ba5ef69d-ae46-4503-8654-df0e46b91c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_337820b0-7c22-4213-b666-8805efadde70" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ba5ef69d-ae46-4503-8654-df0e46b91c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_95dae22c-f244-482e-8647-fc8228ffa767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_95dae22c-f244-482e-8647-fc8228ffa767" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_2b8a72eb-dad9-486c-a37e-7c778734e6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_ProductWarrantyAccrual_2b8a72eb-dad9-486c-a37e-7c778734e6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_e1162d60-43e7-4932-98bd-2e8b5a36255b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_e1162d60-43e7-4932-98bd-2e8b5a36255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_ea032083-b28f-44c3-8af2-26301c83feea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_ea032083-b28f-44c3-8af2-26301c83feea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_1380aef5-fa82-4ec6-a39b-f80a4b610846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_1380aef5-fa82-4ec6-a39b-f80a4b610846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_5d8111cb-fb78-4f4a-a01a-524ef35c1ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_5d8111cb-fb78-4f4a-a01a-524ef35c1ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_32ca848b-e28b-4109-b022-ca55a7e3b97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_cbcfe921-70af-4054-81ef-63ae476736e5" xlink:to="loc_us-gaap_ProductWarrantyAccrual_32ca848b-e28b-4109-b022-ca55a7e3b97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_f3bc08da-f91a-4d08-a0f4-5ff10d681ed1" xlink:href="holx-20210327.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fc6726df-21e4-4414-a274-c0872d2be1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_f3bc08da-f91a-4d08-a0f4-5ff10d681ed1" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fc6726df-21e4-4414-a274-c0872d2be1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_5a758056-13c3-48dc-8f90-88de84e0ef60" xlink:href="holx-20210327.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bc981355-152f-42c6-b6f9-f82c3d6ada41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_5a758056-13c3-48dc-8f90-88de84e0ef60" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bc981355-152f-42c6-b6f9-f82c3d6ada41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210327.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_2a8a7e59-8da4-4274-87fb-56045cf7a1e8" xlink:href="holx-20210327.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_2a8a7e59-8da4-4274-87fb-56045cf7a1e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c9af11d3-2993-4bb4-85db-9a0dc760870c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1c8cea60-b4e9-4280-adc7-4f921a5b236a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:to="loc_us-gaap_InterestRateCapMember_1c8cea60-b4e9-4280-adc7-4f921a5b236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e5b18882-9b7e-4ea4-970b-0c58aa4e98b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_156d691e-077a-4dc4-8f30-8aa7dfdd085c" xlink:to="loc_us-gaap_InterestRateSwapMember_e5b18882-9b7e-4ea4-970b-0c58aa4e98b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3a92743b-15f8-4add-8fb1-d2918aadf243" xlink:to="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_74f7bb62-f407-43ec-b613-4e7571983137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_74f7bb62-f407-43ec-b613-4e7571983137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_caa4b6aa-0271-459a-91c4-7945001d2257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_caa4b6aa-0271-459a-91c4-7945001d2257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9d322aae-6dd1-4e0a-a733-234c7dc30112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9d322aae-6dd1-4e0a-a733-234c7dc30112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ed21d52-aabc-44f0-b05f-05db030aecf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4538a4ed-5961-4b77-abe9-4b03593a8b5d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ed21d52-aabc-44f0-b05f-05db030aecf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cd03a55f-e7a9-429b-a6dd-83b6feb2025d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_943adffa-1904-467b-aaf4-14a70cb3833f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_StockholdersEquity_943adffa-1904-467b-aaf4-14a70cb3833f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6053ce9a-6f4b-42bc-8972-57469826af1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6053ce9a-6f4b-42bc-8972-57469826af1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c753069-71c5-4b0e-9e33-8aa5890a110d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c753069-71c5-4b0e-9e33-8aa5890a110d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c528f01c-7103-40cb-ad1c-d12b08e85b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c528f01c-7103-40cb-ad1c-d12b08e85b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_796bbc2d-1b1b-42cf-82e9-186011072003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_796bbc2d-1b1b-42cf-82e9-186011072003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_605f877d-ca48-460d-a9cb-82212614a3f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_605f877d-ca48-460d-a9cb-82212614a3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e046877c-4d6a-4681-9a5e-3f957cdb77d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e046877c-4d6a-4681-9a5e-3f957cdb77d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ef6cbdf0-fc80-4f26-a56b-ff2706e85686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f2273104-001c-4418-a55a-f62fba4d3189" xlink:to="loc_us-gaap_StockholdersEquity_ef6cbdf0-fc80-4f26-a56b-ff2706e85686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20210327.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4331529a-8649-4248-ae08-21ca59d672ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4331529a-8649-4248-ae08-21ca59d672ff" xlink:to="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cc7c2766-c40f-412b-936f-887b45235b2b" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_a794e1e0-bf63-4760-823a-8924f351e3f1" xlink:href="holx-20210327.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:to="loc_holx_December112019Member_a794e1e0-bf63-4760-823a-8924f351e3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_825bda53-4e23-4295-a55b-1a93fc638fe0" xlink:href="holx-20210327.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4d8aba81-e032-46e6-99e6-df8db7fed3a9" xlink:to="loc_holx_December112020Member_825bda53-4e23-4295-a55b-1a93fc638fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_b3461f31-81cd-40d5-8cc5-f5cfe1b96e2f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_73d347ec-fd7b-4e29-bd7f-ad68eef18ca4" xlink:href="holx-20210327.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:to="loc_holx_December112019Member_73d347ec-fd7b-4e29-bd7f-ad68eef18ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_462e89be-e5a5-43d6-8a97-ff18f3e0fb42" xlink:href="holx-20210327.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_066f3a06-7271-4e05-9185-f8e1df9d38a4" xlink:to="loc_holx_December112020Member_462e89be-e5a5-43d6-8a97-ff18f3e0fb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:href="holx-20210327.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_d40e90ee-d23a-4929-81fe-27a65bffa7fa" xlink:to="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_58a6e5d7-d648-45c0-8134-fb971330e27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_58a6e5d7-d648-45c0-8134-fb971330e27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_70cdb1c2-e303-4f30-98a7-4e0f460d8c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_70cdb1c2-e303-4f30-98a7-4e0f460d8c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_015019ec-79a0-472e-b887-6bc7da3ca0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_015019ec-79a0-472e-b887-6bc7da3ca0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_50d07360-c491-4caf-a160-528b722916dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_dd60a38c-1cce-40d6-aee9-8c42dea60fc3" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_50d07360-c491-4caf-a160-528b722916dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7d5ab539-4026-494c-99cf-a1fabdf06893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_9107627e-3969-4acb-9773-8f979876022b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7d5ab539-4026-494c-99cf-a1fabdf06893" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_9107627e-3969-4acb-9773-8f979876022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20210327.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_82d90f4d-bac7-4207-a5b4-fb8443e80f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_52fb1a7f-2ac5-463d-ada9-4422660f513b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_82d90f4d-bac7-4207-a5b4-fb8443e80f91" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_52fb1a7f-2ac5-463d-ada9-4422660f513b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>holx-20210327_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:holx="http://www.hologic.com/20210327"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="holx-20210327.xsd" xlink:type="simple"/>
    <context id="i5e045725247943fab0ef47b9a123aded_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i710d748173ea42b5a70732702905ae98_I20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-04-22</instant>
        </period>
    </context>
    <context id="ica30c3f907d343549ada504d940ce936_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i64d64acb56824c3484cb34d66ff95151_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i1e832ad751c74be3a002a605f07e03a4_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i58ad3a928b064f93a707adcef8b085ef_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia86f19e338624c03becbf38fdc443b83_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i52eae1f2a4d04d28a7067bbadc18fd4c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i9527df9991fb4a508abd170595d3765f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2f0f7c20571c473dbb3538c19161061b_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia5e8738289d14090b2a313cca454526f_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="id5308a8db9a248b4a503886d28172438_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0b0a1c130c914da2aed9de46ede4189e_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ib58207b8d4894dd4af272ce1eca54244_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i0f07a9be8b684974a2a20fab9aa2e50c_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ib48dedaf55ee438786b6134c8b28e49c_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i6bee588f40e14c72bd3cc02f47cadda7_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i254148f3b274432aa86d0721403fa1d6_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ibfc98874159a4652a12358cbde3c0dd0_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id01ffa50611c48bcae532eb4d244ad15_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i57574c7cb017407e95bc7d6674fc7041_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i22b1aad0446c43c899085af5db94daa0_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i37479dda543e4e848a6b2a065e778421_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i55a0a29026de4c14b1ca906b3d06512f_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i00148f02d5ac434ab8455c4bfdb18794_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i2b1b90c41f7d4bd2acfb7ecf220b375d_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i13a5203734044addaed9c920967a2c5a_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i70e7059977d242968ebf9c8a01c8083e_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i532492042bba44aa888e1a014048de52_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibd50b93acba342a4995202317212867c_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6160ec5704084a74ab06ae3ef0b25d89_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i32babe6c9a5a4075a97af1479d07d7f5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1e162ffb5f4d46748b4e62688b0c4db3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib9d9c4520de640f7837c8a8db74e7a29_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iaf7dda3e20214bc7b64a4430da73c356_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i87367de631f24b48bda162d20ba2e661_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1cff19231e714132bf4dc7ccaa04d77a_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="id823f47b65a04844af628de4c871ffb5_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i599e6bb573174ab9946c1b0e7a65a1ee_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9f41c1c1b96640ce8c37aa114378b5af_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i2c8bb166454744ccbffadde0265cdfd4_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ib547cd16894c496aaa14272f3e33f8fa_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i247efccf5d6947e48ecee24ca732c483_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i13e744d8762c4825aa1a4d2b4bdf2cf3_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i9b0da21f00cf470eabc24e01c7fc5fa2_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i96a2d286b76948e3a2d91063189e66b9_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3d291e0f9c0b402da8343bcc6b51f9f2_D20210408-20210408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-08</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="ie2dff062ce5742cd9f8ec548f170b3b3_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i90763f49a0da4076b8324779a162e6a4_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="idb9a123d4d3f4bd282939064c3e109ab_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i26ef905de85948f8bdd806e8ca63fe1d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iec54e8e340d5457e910be1d441c98063_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i26927080ee34404080aa7911ade83d18_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3bf8f71a8497491c86ce651b76d4b795_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id6ae7d35265f4897bdfb34c7ccae119e_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i22cc0d7ae9e74ca8a9ff4d198d78501f_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ied817d099e4b480faed0980ac29438b8_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="if128eb894bce4b3085c7eaa916a5bfb8_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i5bfd76ed5cab498ab2ab0d727bb2b083_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib64a089977c64ec0b379ab8be5a289a0_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i2fe9760506e145efb1273a91972bd7e6_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie8a06780affc4452b0a0a9c31aecf31b_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic51d744e73d9470889480aef44867b64_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i5ffa4cd943fc4ae697fcf28ee9dafa69_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id617caf99d314fb4a8f7f5fb37a854ad_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i9eb8417c24934037bf730f4f45fd1dac_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic949542e55314c0e90e75d07a6a7cc95_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i40ca6cd87d9346f8b4d6b257b76f1599_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="idb9fc6529dcd456a8fe760d48006a3e4_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4c343532655149f1a030365f026ac439_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i5c0120a99d97456999e5ddc37d3d7309_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3faa6d77c258415e86dcf4d8129eac6e_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i857265c2f31341619b24eb60b43b0fb5_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iad34163568284cdc83c1e20070c4cea2_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7082eff3d7ef4efc80ee731afa776eac_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ibc01a3ba376e4dbcb32a1e598e325b13_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i7f692bdf106e49fd9aaf7fce303fffe4_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3c3a06fe0c864a24885a1ba3a58df54e_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i85c810b9218b4cd4a2163bfaa2fb7c03_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i942d891a356341019e4507b3365c2ba1_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ie6e50b3ca2f146f9a5608d79b8d0845f_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6d9a60d400a14336a1e90394d3d649fb_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i8341e0c83b50432d92002e51dc1d415a_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id259ac18b2c14a708dcfb664de4fede3_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i765b92cf3fcb456b940d23ea47f28bd0_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i1725b5668d3e4a858551fd8eb7138677_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="icb26cd5cf96841d99340d97a2844a812_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id70cfee3e323440082edf592f7d7027e_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i4ce8a0b09e77488b9facc4bf5ffb533d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4bbb18bc92ff4414b39e894a76fab932_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i231dbd6cca1f4e44b1648addc4f9b83d_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i136ee5e50cad46c9878d11c256642bfe_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i014ec62aff694cd984436a0315313b3e_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i921dfcf8a3d74f3c9e2967faea2a2c23_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if2e0e2bca7514b3c85c5bf5e035db201_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6c75b6298a974b8c93d3c5a118504b01_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4c4f0fb353d74058a1441937e80c0438_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iecf735ef79384b248873abab375129b4_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie927f60bf6f24e25bfd16b54244ee885_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i8e9b232304f94408904a99c1ae44eafe_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i95f2ae3f5fa742d7a917b5c8ed7f9fb8_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i736988332f4142f9ac9feecbb79164b1_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i90ddb6816eec49e8ab3f15d0f66f2334_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie78313136a484fd781c8813953a0cf7a_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i145a6fe21b194a67bef28af17d19bc6f_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i190143611a554923926b1ae36be81fda_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2269cd37c22f4b219c9519c04e7be995_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ic23b5154647642809bedb5594b430f24_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iba116bd00a7046bf8c91f0d6b892314b_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i995e19c951b14bfea6e4d26e9cd4d486_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i8c1c56aa05ee45ffafd1f1ffda0164a5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i18d6a37b17e74d0fbf1668eb8dcd7a91_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i56dfdce3eb6d424d86b58122d2f5ee1f_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i280feb419f2b4e1bbd5f84cbc2b56e78_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia9a96273a62543e085fdd72cbb24282e_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i65621f54c26c4015a221bacce5212e11_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ida7b7a78e84c49fc9efb0c922ae148a2_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i54b99b53db764f00a7bae9226ea58a55_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ie1996dc2670f44d885b459e6b7844ca1_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i2a7aea66c3b64c15aa4fc1fcbcd3ad08_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i71e20d39915246d8b5d89b9fedd7385f_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iaacb7d97fbf041878e9f9f0a4f583432_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4f6361d96ee24d73b8046575850f64d3_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib66008fadaf74341aed6338aed1d6e58_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id7a75015d04d4338ad7cfca21a6493a8_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i20fc49c576e34cc69859aff92990662d_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i7973bfa616db4dc483c4bd851ccb1a56_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ieaa248859d134c8f8dcb2fb68862b1b0_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id274d4645da042b1bf61995fe9215df2_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3ac781329d4b4af88611a402bc50fa21_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2c130431784f4c5b939e3a7eb06020d9_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i1e191d17f2624a8e81a271bf9ff484f2_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i7a9c15aeb74a40068d4ecb624e590739_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i425d67db4aff4b68954adb976a9fc71d_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i5fafd907ef6544dab31e96d331494185_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i5450315dcdd74fee9c2c005920e5f504_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if1be8d9825a04deeaa24e83a941f2408_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i40ab6df387644866a1e1f37f2257d845_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i9617c714041343938ba7ef699d01cf6e_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8973c410d7ec480da813338cbd127421_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie54e7336610d4110af7dd72bfff88912_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iaae83a94d7df432fa13620889d678fae_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2d5a0963e8a641ba8cb8cddc994ab7ce_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6d453c23af194ce1aba1c816f84a132a_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i6291de291de2479caa52ef9e87358c20_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i5631a9f85ff741a3a15fdc5c8a9c57b9_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i54761927cec14e1084e6842f2cc38ca3_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i1d34e883adcf48439ad208f5fae59f1f_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="icd6b40e625a344d7a0f8da5f98f78b54_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i98200202399d411bbdfbce88f2f94963_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8edfb836d2d449d190d430b4b98bdcfc_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i1bafcaa157cc4f9d9b98d3058f7eeebb_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ie7997ee1de01404282896cf8569615c5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i17cf60230e4e486ba1456a31ba6436af_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i89fb351d8bbc4b2fa26f6615870eeb22_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i6757b7ae6a1b4d1294b382cd6f764364_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i32bcec04d2a142c7bd7b162f66b47ad0_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic26482dabb124918adc0604c2a60d13c_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i26f3b7da661c4ac082d4c50ea8fd4d7f_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if17dd3ec43b24fc5a2f910d62e42f2d2_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iecac37f9117440f69e07c69f6c281b92_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i21cde2e619f4402f8c02912c9692b840_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ifd830b6572e0425dadd30a387a2f967d_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i50ffcc41a2144eca91b9b631142afd54_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7270d96442eb4541ad8022d39d4faa96_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i4a971158920f420a836957e0f5793380_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ic2d8b948617f4e3896d6b721b4c3de4c_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i692dade7414a46f982273b0535c5635c_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib847a33bcd64486598d58cc210134d1a_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i0a8c6e16440945bcac1fc0101a8a1fa3_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="if46e15e1bfd3413a999b55b314fd2cac_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3bd010f371544b988fa10466d658968c_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i182d5713bd6d47afae7e3dc66fab5669_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ief14d4f38aad49c6b6a004ccbac446b1_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ied9231b3ebdc44af8052059ea35f7d96_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="idb420ef6cfc84582bf032f47d6a027bc_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ia8a5fc5bf9d241f8b4cb0d73a7fec6cc_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i2734474741b84d60825585c9ac1c91f5_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i46916ca5297d4242bef1fa39c66d7e97_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="id6010a3ff92e436b8c62582e9e6636cd_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3a1637c5182047b68c601bf5077bf90c_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="iea5abde7d1984b098731ea86ba1d2df4_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i7e512ddea06f4f369efec1ac01a1f83a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i11affe9143244d30961013f4deced4e9_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i5f0083bdc783434585b6f36d4e8c4070_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i411f528b6c8248d19b4b06059ce6bcca_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie108ffe2f2254cc596ceea6a1cd09226_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3d2a977915524e99a25863296c0eccea_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i04083b4b022e4637936c0abcc453bb78_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ifac27ddf7a3c42c6973c1c345f1d6188_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="iee78cb2f382242a08b2526f42f5e8853_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ic97ef3233317455a9da5ec9463b03856_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i2ed7e22fc59649ab8ef2826b21239f52_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie0c62e4c25694a3cbdeaeda3e071ac2c_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i792a247ac57f4a1089a48d766d5774c8_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i13ed6c8444b04ecbaf65664fe32f3d62_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-22</startDate>
            <endDate>2021-02-22</endDate>
        </period>
    </context>
    <context id="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="i3f9778c427b44c7882e336e11228595a_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i2161ff7d37284a2dbbe1f9d7e633bc5c_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i435467f75e1440c58e0143cfcc330473_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i0181482365764743a89827be06286048_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i7426f16cedf841448aae7ae840121295_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="iaf6cae33a60643238b5a53b8e12438d0_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="ie9edcaeb855249e29f00eca57f1ce93e_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="ie02a040d45524cb3a962860ca78ed797_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i3ca8eccdc4f847d0aeb6a2cca823b5f3_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i9dd0231067df452087445e7fbabe93de_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i617c581a0868425eaa81de8cdba59691_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="if077f38ecd2c48708cc0f3b18a2b893e_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i7de817e6de5942b5bda9b79a83fe36ea_D20200203-20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-03</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="i4af1ff49936044139ca360cf68be0400_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="ie858e36180d444f9b36ec6e99f4ec80c_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="if549c33be4504150b2d638a7c2ab1792_I20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-30</instant>
        </period>
    </context>
    <context id="i60c529de5f984b318d75f347b0e4df65_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="i3b8f228b16744f66922f21381cb7e421_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="i2bae2329807348b380f218edb5d9aa9c_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="ic0360e3cd8884f838b4339be49501e41_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie9f6eb5453d7428e9d35cb9246d2bd17_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i304fc8df211141afae93e91cffb8fe19_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iae67d1fe265e4f30b9319216ed36d801_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="iedbd096de9694df1a3c2ff99b2436eed_I20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-21</instant>
        </period>
    </context>
    <context id="ia6b0c817b1c74f18a87cbf0cda7cd036_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i96962f8c6503408c97e137b4ff6b485d_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i985c7e4ecc8945d29a5d65e3cacc1ebd_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i47bae11f6c164f1fba7c9157ff4bdaaa_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="ic07ffd9a39b1497facd26bd931d9a0b6_D20191120-20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-20</startDate>
            <endDate>2019-11-20</endDate>
        </period>
    </context>
    <context id="i3c59ec3344504f85a8c3c6bf6b0a9e13_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6e0da39af5cf4280a9f5c65fb51b024a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i7491822dd55f413ea8c24c98a7aa72d5_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3a56920a822e4f1fa2a21d3567b1df3c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i469614de5d734baeb90118c04073db54_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie330a629ad37467d89cd606e0af17679_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if3bea13b544c4f13b09760c5c6e726ba_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="id15b184ad14442c987ce0303bbedd19b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i47d3d66108d5494eaf7a55ca46e00d87_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i77ff68ab585743f5bd2a75882d831360_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="id9cffcc6d27f4a828ad2f580a9df3cbd_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i723b2fa7383c40148a7b8c9527df6ddc_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i1d4c152cb32642be87eab1b00b94cdf0_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="i18b2329bbd884176a354e0fd702f2ff9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic1975b32bc204e5683343cfb111a310b_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="if3392dcaea61411f8afc5b0dcf1dec2f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ia50b3adc77744a7c824bbecca70c011a_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="i7560c0f9556346c095bd908abc52ce26_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i091fabb2fcfb4658b0d9f415869cc240_I20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-15</instant>
        </period>
    </context>
    <context id="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <context id="id264070af63b43f48399ea213c8af8a2_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i6f8b998b09854bb695d9efc1050df7c4_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i5a4f39288d0b45248bab5af271dabb3b_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ib3da1322564b4ca89777bef210350bd7_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i377b4457fa40451d9934553b73788461_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ida3f87ee7c184b3d92090d91611fff9e_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i83419ad698fd45cd9a641d83cdf6a7fb_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i6f7fe74bada44325807efbeacb2146be_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i42acc5ed62724f79bd2e68d140fe8dce_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i765ee743cd8d4c30a3e089f9a5063ad1_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4a626c6885434dc39de0b254189dd899_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i976b8217dd0340c8848abf4604793c09_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ida59e22f7f6c46b19f9d458fa92fe312_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i54dcf56176214275896ff1d60bc84906_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i88918075f107400cba5e6d495691837d_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iade8ee6fa1e44937ad93cb3264cfa057_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2015de2d01ea4eb6b943c7070cd7b61c_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i166a72cd198a4c67b1e33412975acb38_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2018dad9ea214f19a994a89fec2b62b5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i9b31ce11b7874197821ee16e0e8acb8c_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="id5aac920f34f491293ef3c6b911a0e0e_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="ife8fbca01f344a7bbc6432bab75cc30c_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i728508ff257d45269fd226b6e4007b29_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2c0e131c95e14da199d151225685419d_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i9310ce69fb254103a98583ec7e3a8f90_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i87ab14cc2c1b434da9b16b16b3ce59e1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="idbc1821170fb4c9a801bdfc34109bcde_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i17d059976369410a807492037e5cb3e7_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie88aa4de2fa84889ad42f389e367d075_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i11b59cf4e28d42bf8a4e9c8c7e429ac8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ifd16785dea0a4ca1bf8304136ec99d08_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ief9fc2fa9591462dad0bf17824d2a9fa_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i93d55ca8ee94483dac7f5b658cc31fa8_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ic413e8139a5c40468c33462fc5941e98_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie803f3fd1bff41419202ea94b2221474_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i9a81172412bc4ff681f76e0d333e25d1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ied2f2cfebe3b48139e592af29012bf6c_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i561329732ffc467eb03c4950ee15a00e_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i16d36f0eba664708ad3e485d531f2d15_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic190c456cf6a49e5b0ec99b8038929ce_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i86fb83a62a8c4fd59a58fdd0e8af7e97_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i298880826ca146b98d400d387598be5a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iba496bae81354f87b7905994ea233dd8_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ib5715660627c4c0c814c4bd2577fe6cb_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ieb56657e29a54018978922a7e1c3a629_I20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="iba238290a69f46b1a533fe0940b1cca4_D20160304-20160304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-04</startDate>
            <endDate>2016-03-04</endDate>
        </period>
    </context>
    <context id="i8b0b8127ce934cd9b79a11ee9f9c7acf_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i7c9f918de2cf4d88a84b71df72163bf3_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie144f499b7fd4eb998be1642c636dc03_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7e1e58fe46ca4c779247bd692e2e4185_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i070793615ded4840820fd755341d20f1_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia8577ab468434cffae8cbb51873099ce_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic7e4f871073d422ea5def9c529807699_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i46d86786c1ac4e81846655e4acbc0c6e_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i2d272ac0e09f419a956e9fb6c0361bc3_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i5089e6cd6df24ba38788f0b1f4ec9aa4_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i1385d9f85d114662986d5770c3b9c5eb_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i042387ddd4d94b5f97f7b3f7f7794495_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ifc6eacddf2c14e2da413620ca0ddd0de_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i4081d628500a407e83b46bf2fe3b0005_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3b5c87f950614503ba2efd4bb0004547_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia0df38cfcac340ca926931a8815bd86a_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i7406c1b94a0341b89142d4308dd7bd26_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ibd2eec347a984124b6b6980c85d40599_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iaad3c625ba65468dad8446d8c5ca3463_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ic72750901e9646aebae40d076b3f86f8_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i47c626852f1c4ff2a5ab8807eabc7a53_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7d4f38c2b6ee4d35ae4e4fc855b5c593_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i662994515dee4071be41921dd55091a9_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ie20cab64438a419fb7e15f3b2d30abfd_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie4f3dc155fff485eb786e0c5e0b8f79f_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i9ecf187b743a46929a3cbc82c74daecd_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ia292e0f0da204d90bd17cc07a6c83088_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i8d7d1bb69ae44c12932fd6147a4a1819_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3a10ffdc26ba439aae8e83d553aa4523_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i99a9d88b27994530817b5d3d5f55a648_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic1102657f7bd4468812eef9239214f33_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6780dc391a714a25af687af04d21768a_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="if74ce39dfecd44f08e7d1c91ebc01c9d_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i5862a7e8fb46483da33faa01de3b39c5_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ib7935a6d79614132b0ef2b639930f553_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if07be3a2248e454e9dd29011bf561fdf_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i34b3b1ebbb344b0eba9a071b5285028a_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib7a70e04c2c044d488ee49e04a7c4fd8_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i0cedd2956ea24251b4f2e787ee87f9a5_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="iec342590d7ad4942a989e8c33e8523db_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="id20db54379ba4b51b5f77937a37f9d8f_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i505981465edc4002ab0c7d672cbd8b85_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="iaa735e311c9c4edcb8b2ed934d611d72_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i88906e66fdfd4730958ab7edc6ddc342_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i115120608b9744b4af122d696c198769_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie4e33c2ae18a474398d2f7aa204f4b0a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i9b0538b1651d4e9fa01727c276c6aca8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id59d4cf165f84163b8612267a6672818_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ia004d21122de40a7acb047f75711b230_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie735f493b8a74552a82fa762497a7e0c_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i360d05187d17434f9f024ea0b654414a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ied7d8695f726474288c5904ad677e50a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i66e72d51c8ba435b837b8d83097e66c6_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6c207776416743ffb080dcba5b532a33_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="idc0c502bf9714b0abe90c2966356a47d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i90941e17deef4e38869d1a6989d08bc3_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic405c49964c945a2b2cccad0f50d104d_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ife89e43900064dce8b3534de88f844cd_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i8b99bb878ba141d7a47254b83dc0764a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="if6926d7469494d35baaacd55a1ab864f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i74a66f6cac0f45bca6d865851d97bc1a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i35518212539f4b2e9962deef5956862b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7d4e68863886433791b7edc1d16c8b5f_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i81080c9b2330438fa474bbe7a4003179_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i662c27c8d79044699ea38a30b7e68432_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i922d3d1beef1487f9f2d4c412ede7a12_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7cf7b370790144619ad4a8964a5c1818_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie5923eed9f67437e97eaed167c1389b0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2f0ccccc76e945f4978ee19754f4ad89_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib4c3b36745514581af776cf34c7004fc_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ibfd85d51ab164407876eccc003e0ccf9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i800b03ee604347afbc07632cb45b6fc2_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6fd2d36767f54a4ebd52a5d5864f3448_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i78273368483c4226a5ea04c7d811d3fe_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="id10dfe3110de4427967f3a4b8e5a5f11_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i4363fed50fdd460494577b4618dbf686_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i79509a51d6da43a78e7aff6191ec7651_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i70664359f90341ed8b7b4035eab2e658_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0c63fca0f209477d9e2d3001848cc2d0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5f9926be54074c05bb1382ed55335276_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="idcc5a52321694c0f850b13ff882001db_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie4689b60d23744f289cb544253b4f814_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ia06b01fcedd04f3a85eb4bc29746d312_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3fbe154820b94abb9f5b6c0d26716326_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="iab882e96099247859e4ec48ec2cb938a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i5ae07c79726f4de98b04adaa90df5781_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ic38386d5f6ba40fb9d5d20588a27487e_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i0efa40c8aa78435a86f84bf7940cae2c_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ib2dd1ea20daa4f4089320c0fa6f87da0_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i0a5a29aba88e419589c3a2f9fed50569_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7430ac3155b74726add1cbc2e862b58b_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="if8b78544c617454991ea1abde3fc0128_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ie6dda121f07348d9b40b999f1945cf6e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="idaa1b4b017d74905880304f384c057b2_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i1d0130d8988c45bbac97673c8e2ce744_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ifd0078ba73a24f819d70857c6b061aec_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i4e7212338e6d4a7fb971feed57bf398c_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i04964732adf14196a87e9aeb38f71672_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i1c79daa201df43a4b63c18f0297a823a_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="id7a12e09486e470bbfebd7bc5df72fa0_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i4303fcd9add84b19b7bd0ac918b9aa95_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="petition">
        <measure>holx:petition</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV8yLTEtMS0xLTA_8eead972-6a34-4d64-a07c-c52eb9526201">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV8zLTEtMS0xLTA_be4d0572-5ddb-4128-b407-9bf0113f7f40">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV80LTEtMS0xLTA_71cfd17e-b709-4955-98b5-3b9ea489e432">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV81LTEtMS0xLTA_ef5eb96e-0034-45cd-a245-7768b79b97ca">0000859737</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80L2ZyYWc6NjI2YmJkMTc3M2M4NGUwMmE1MWZlN2RmODMxZGJhYTYvdGFibGU6MTk5ZTNmOWU1MDk1NDUzOTkwNDZhYjY2NzUwOGUxMDkvdGFibGVyYW5nZToxOTllM2Y5ZTUwOTU0NTM5OTA0NmFiNjY3NTA4ZTEwOV82LTEtMS0xLTA_1b632f2c-f3d1-4e1e-bb31-bb29e8955133">--09-28</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="if46e15e1bfd3413a999b55b314fd2cac_I20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfMi0yLTEtMS0w_da2825fc-ae74-4a11-95a0-351ee9700ea6">P6M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i3bd010f371544b988fa10466d658968c_I20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfMy0yLTEtMS0w_3628fe74-39a4-4111-947f-339f42cb12bc">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i182d5713bd6d47afae7e3dc66fab5669_I20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNC0yLTEtMS0w_9d685e4e-692d-4f71-914d-c79b88b1e135">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ief14d4f38aad49c6b6a004ccbac446b1_I20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNS0yLTEtMS0w_d72c9c27-cc1d-4735-9f04-b1cbd5e701e6">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ied9231b3ebdc44af8052059ea35f7d96_I20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80MC9mcmFnOjI2Mzc1ZTJlNGFiNzRiNGQ4OGMxNjJkMjcwZWY4MDM0L3RhYmxlOmFiZWZhZTA2ZTE2MjQwMjlhNjZhNjJhMTM5MjdjNTY5L3RhYmxlcmFuZ2U6YWJlZmFlMDZlMTYyNDAyOWE2NmE2MmExMzkyN2M1NjlfNi0yLTEtMS0w_7b9b1191-f47c-476e-bd95-a875b0cf0696">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg1_b48a94b8-3735-4e6b-9b13-4bd1dc6582b9">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6NDYwZDQ0MGI5ZmQ1NGI2OTk1NzY2Yjg4MTYyZWU4ODMvdGFibGVyYW5nZTo0NjBkNDQwYjlmZDU0YjY5OTU3NjZiODgxNjJlZTg4M18wLTAtMS0xLTA_7eec05ed-9b4a-46b6-b007-c40d56f04164">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yNjA_af5320b0-486e-413b-87df-925a89ffbf1d">2021-03-27</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ODgyZWMxNzJkZGRiNGVhM2E0OWNhMWI2MDAzMDljNDIvdGFibGVyYW5nZTo4ODJlYzE3MmRkZGI0ZWEzYTQ5Y2ExYjYwMDMwOWM0Ml8wLTAtMS0xLTA_70d0af34-2d52-48b6-a040-5a261b83a4e5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg4_d67fbb5e-d411-4c8a-a443-cf0d71be826a">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgx_f0b3c3c3-4def-4e2d-9a4e-7fd8a3e7d531">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8wLTAtMS0xLTA_f02e4082-de0f-4001-be50-2cd31f8b22ee">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8wLTItMS0xLTA_8fab6309-4e4d-49f0-8c73-2b9d90019e56">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8yLTAtMS0xLTA_d0bb4bb7-f197-475e-9021-5bee456f8f38">250 Campus Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF8zLTAtMS0xLTA_fac881bd-4f31-4de3-9f85-e05c70813144">Marlborough,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF80LTAtMS0xLTA_749aca31-2cc7-450f-86c1-f084c54b947d">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6N2YzN2Y3ZmJhZTU2NDU1ZGJiZTllNWUwMmYzYjkwNTAvdGFibGVyYW5nZTo3ZjM3ZjdmYmFlNTY0NTVkYmJlOWU1ZTAyZjNiOTA1MF80LTItMS0xLTA_799bdc82-40d0-4551-b983-adf1ad3ba4a7">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg2_b7530b62-d0dc-4c73-9715-0aeef17507a4">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgy_d4defa49-fb19-4314-85b0-3749df7e504f">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTAtMS0xLTA_beee8325-579e-44a3-ba81-335ad85cd0f5">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTEtMS0xLTA_841b3356-ec8e-41cc-8921-0953d1810cf0">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6OWYyZGNkMmU3ZGM2NGI3NTgxMGQ2Yjg0ZmQwNGRhOTUvdGFibGVyYW5nZTo5ZjJkY2QyZTdkYzY0Yjc1ODEwZDZiODRmZDA0ZGE5NV8xLTItMS0xLTA_e996334e-80fd-40cd-904c-a7546c184b0e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjgz_d14a983b-be90-4d19-b90a-7a772f359f04">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg3_d1e9b12e-090f-4f3f-a15a-db05888c71b9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8wLTAtMS0xLTA_4659c4f1-6d4a-4d8f-9349-ffb9b00768ad">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8xLTYtMS0xLTA_8ff11094-3d45-46e2-a74d-470549b8afe4">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGFibGU6ZjIzN2Y4ZDYzZTVjNDM2Y2IzOTQxNDRlMTE0YTkzMGQvdGFibGVyYW5nZTpmMjM3ZjhkNjNlNWM0MzZjYjM5NDE0NGUxMTRhOTMwZF8yLTYtMS0xLTA_7d4effeb-9d33-4aae-b88c-a29d983d1b9e">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjg0_e4907e58-ba60-48ab-8688-1c7239a6ab84">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i710d748173ea42b5a70732702905ae98_I20210422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xL2ZyYWc6ZDYxMjQzODNmNTM2NDcyN2ExNjdmZWViZjk2Y2RmM2YvdGV4dHJlZ2lvbjpkNjEyNDM4M2Y1MzY0NzI3YTE2N2ZlZWJmOTZjZGYzZl8yMjAx_f88983b2-fc48-4074-a0a7-f68f1355c8c9"
      unitRef="shares">256233027</dei:EntityCommonStockSharesOutstanding>
    <holx:ProductRevenue
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy0xLTEtMS0w_d1d18387-ef93-41e2-92b5-f4e0be5dc1a5"
      unitRef="usd">1378800000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy0zLTEtMS0w_2b69a8b9-d5ae-46eb-a254-aceb97c944b9"
      unitRef="usd">623600000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy01LTEtMS0w_5b278ce9-21e2-495b-9343-d4d92e2d1b2c"
      unitRef="usd">2834200000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMy03LTEtMS0w_b0888d2e-5c2b-47e1-86c2-8f13e5e52d0d"
      unitRef="usd">1322900000</holx:ProductRevenue>
    <holx:ServiceRevenue
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC0xLTEtMS0w_1e0e7a52-c03b-49dc-bfeb-57dc66e4131a"
      unitRef="usd">158800000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC0zLTEtMS0w_044cedcb-4895-4679-b420-66978579f39d"
      unitRef="usd">132500000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC01LTEtMS0w_a10cd101-7dcb-4215-afb1-136e4320eebd"
      unitRef="usd">313200000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNC03LTEtMS0w_2cd0306d-f521-4382-9f8e-8158488d2d09"
      unitRef="usd">283700000</holx:ServiceRevenue>
    <us-gaap:Revenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS0xLTEtMS0w_32c3bf40-5151-4f6b-8ba1-de6ce033364d"
      unitRef="usd">1537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS0zLTEtMS0w_3f52bf93-aa0e-421d-a08f-c4a4d1b8c2f7"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS01LTEtMS0w_dc6fcc89-cb7e-47bd-8d6f-4c9b87d2f59d"
      unitRef="usd">3147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNS03LTEtMS0w_6a634f37-0270-48a3-b86a-fc27a725138f"
      unitRef="usd">1606600000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy0xLTEtMS0w_4ebafa6f-8ab2-4252-9b80-e9c412e85de0"
      unitRef="usd">300700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy0zLTEtMS0w_99825ac0-c3a3-4d2e-bda4-d71ba97cd9c3"
      unitRef="usd">223300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy01LTEtMS0w_8d85933b-778f-4293-acff-bc02f3a7a7c6"
      unitRef="usd">585200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfNy03LTEtMS0w_d9349771-dfd9-48a8-9a60-20c96241e56e"
      unitRef="usd">460800000</us-gaap:CostOfGoodsAndServicesSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC0xLTEtMS0w_979b04ad-9971-4c12-be80-d9a627e3389f"
      unitRef="usd">64500000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC0zLTEtMS0w_faf4015e-4b90-4af5-ac09-2ae9fc7d18d5"
      unitRef="usd">62900000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC01LTEtMS0w_c9e3179a-8cc4-4250-8213-6df0bb05a386"
      unitRef="usd">126100000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOC03LTEtMS0w_8a1aa88b-dea8-464a-b2a4-f759d41e2b22"
      unitRef="usd">126500000</holx:AmortizationCostofGoodsSold>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS0xLTEtMS0w_028d847f-c84d-47e0-a1eb-7138dcdc98db"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS0zLTEtMS0w_f906285a-bb84-4c02-a38b-01bf16097656"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS01LTEtMS0w_632edf0f-948a-41bd-b6de-b8cff10d243a"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfOS03LTEtMS0w_97ec1276-fdd2-4b51-a737-37aec7971ce5"
      unitRef="usd">25800000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:Costofservice
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtMS0xLTEtMA_84324d9e-0220-4c8c-a4f4-09a64cdc41b3"
      unitRef="usd">86600000</holx:Costofservice>
    <holx:Costofservice
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtMy0xLTEtMA_ef1aab23-6dbf-4d6c-9439-5d970af2a77c"
      unitRef="usd">74100000</holx:Costofservice>
    <holx:Costofservice
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtNS0xLTEtMA_629d082e-16a6-417d-8536-b5177e667366"
      unitRef="usd">170000000.0</holx:Costofservice>
    <holx:Costofservice
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTAtNy0xLTEtMA_88e2c943-7b43-42c3-9783-3e8af0e9fe6a"
      unitRef="usd">163900000</holx:Costofservice>
    <us-gaap:GrossProfit
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtMS0xLTEtMA_302dfff9-21d7-4002-9c37-c84685244a85"
      unitRef="usd">1085800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtMy0xLTEtMA_a368cd72-0dd9-4b60-811d-b5e0d1d33e3b"
      unitRef="usd">395800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtNS0xLTEtMA_0076facd-e73c-4ce7-a7b8-659b33568247"
      unitRef="usd">2266100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTEtNy0xLTEtMA_a13b7f5a-0ba9-4a98-93e1-12fb1af0ae86"
      unitRef="usd">829600000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtMS0xLTEtMA_f47dc13f-bb5a-4181-9bf0-3afcc8b26068"
      unitRef="usd">71500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtMy0xLTEtMA_b3cc28b5-6853-4a29-bf95-c0308c2e068c"
      unitRef="usd">49300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtNS0xLTEtMA_1f230253-81b1-490f-bb40-a61c5b99b2b4"
      unitRef="usd">130700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTMtNy0xLTEtMA_14286fb7-878e-41cd-9cda-71648719ba3a"
      unitRef="usd">110400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtMS0xLTEtMA_8f22895a-7091-49ef-870a-75b8e3fe9927"
      unitRef="usd">131500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtMy0xLTEtMA_6d468185-bf49-4109-b55b-471d5cda1e3c"
      unitRef="usd">110600000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtNS0xLTEtMA_b1ac5a06-3dc4-4217-af27-b8ca17cd15e4"
      unitRef="usd">259500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTQtNy0xLTEtMA_8380fd7b-18c8-4541-9b6d-23ce9e410c66"
      unitRef="usd">255400000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtMS0xLTEtMA_27bfef56-a36f-41cd-b083-6f6734db11d4"
      unitRef="usd">88900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtMy0xLTEtMA_c41403ac-5219-49d0-97f7-0b49e68458d6"
      unitRef="usd">67000000.0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtNS0xLTEtMA_a1fdf881-a325-4b0b-b5ce-0d66c8fed842"
      unitRef="usd">180400000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTUtNy0xLTEtMA_7f255341-35a9-44bc-a63e-742d699356d5"
      unitRef="usd">154700000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtMS0xLTEtMA_6a730497-3b01-4aed-9d57-95876d5e3dea"
      unitRef="usd">10200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtMy0xLTEtMA_f06a864c-1a32-469c-bb82-193b54bebe6a"
      unitRef="usd">10100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtNS0xLTEtMA_d58e710b-d891-4452-9536-1945b4a31f3a"
      unitRef="usd">20400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTYtNy0xLTEtMA_5bea0682-2ccd-4e37-a41e-09f81879c535"
      unitRef="usd">19200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctMS0xLTEtMA_2328055a-3989-4a54-bf0a-7d8f803c2553"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctMy0xLTEtMA_e6f5b339-ef53-424f-b1eb-742c9ce975d0"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctNS0xLTEtMA_24da63c1-099c-4e80-878a-53498f8a38ec"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTctNy0xLTEtMA_2b41b948-ca57-4779-b753-66617e752445"
      unitRef="usd">4400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktMS0xLTEtMA_421cb7a2-9598-4b0c-bf7d-c08476da5591"
      unitRef="usd">14700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktMy0xLTEtMA_23e6c125-12af-4e03-9819-7d535fb14948"
      unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktNS0xLTEtMA_fa95afea-7a02-4e1f-96de-977be6ed5b48"
      unitRef="usd">10100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMTktNy0xLTEtMA_1e4836a5-9f32-4266-9fb0-43df0120950b"
      unitRef="usd">-400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItMS0xLTEtMA_37e73a52-220c-4d64-ba78-6efb5af1d308"
      unitRef="usd">1600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItMy0xLTEtMA_050adb3f-156d-485d-b0d5-19b635a68afa"
      unitRef="usd">2900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItNS0xLTEtMA_1c163f1d-89da-48f4-aaa1-be3c54bd1eaf"
      unitRef="usd">3000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjItNy0xLTEtMA_5b5f924a-6d58-442c-9459-c687f90efabf"
      unitRef="usd">3900000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtMS0xLTEtMA_14cce1cb-cd58-49f6-8404-0b972fa8a1dc"
      unitRef="usd">289000000.0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtMy0xLTEtMA_70fdd5e9-9780-440e-983e-e68a0dc3863c"
      unitRef="usd">239400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtNS0xLTEtMA_5097540d-707d-4332-9507-ce8637d240ff"
      unitRef="usd">583900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjMtNy0xLTEtMA_4433d3fd-18df-4508-949f-77ac99b0db38"
      unitRef="usd">548400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtMS0xLTEtMA_347e7573-054c-40d3-b414-e6716f87cb47"
      unitRef="usd">796800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtMy0xLTEtMA_dd15b7ba-1369-431b-96a8-632f7c9b8d93"
      unitRef="usd">156400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtNS0xLTEtMA_da73b59a-4b76-45e2-874e-1be30fc0ad03"
      unitRef="usd">1682200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjQtNy0xLTEtMA_f301ee98-e02c-4d48-acdc-3f78a3e840cb"
      unitRef="usd">281200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtMS0xLTEtMA_83462141-fe8c-4578-a014-e954da85c5a4"
      unitRef="usd">300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtMy0xLTEtMA_22c310c8-d72b-47bd-9521-fd9a99ab6d33"
      unitRef="usd">1300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtNS0xLTEtMA_9c370e6d-97e5-444b-84dc-0b1c19fcfbf6"
      unitRef="usd">700000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjUtNy0xLTEtMA_4fbbd986-1715-498d-9c43-286f2041c7c9"
      unitRef="usd">3500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtMS0xLTEtMA_7a7cab9b-39a9-4162-982c-e69f752c1a16"
      unitRef="usd">21300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtMy0xLTEtMA_a8d9f85e-274c-4256-8573-35aefd082ad3"
      unitRef="usd">31300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtNS0xLTEtMA_ed083ae5-0e64-44f5-b8d3-54a317a9a031"
      unitRef="usd">49300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjYtNy0xLTEtMA_5f7fcc89-4375-453e-aed4-1ce461a4b673"
      unitRef="usd">64100000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctMS0xLTEtMA_94d3e17c-4b1d-46d1-beec-5456fecbea71"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctMy0xLTEtMA_8fe4980b-2f73-4ec5-8cd8-90a55f8eeb3d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctNS0xLTEtMA_9effcecd-f4e2-4f8a-b727-3c78124234fb"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjctNy0xLTEtMA_f4b961e2-084c-4920-9250-a94e173f373f"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtMS0xLTEtMA_985c6f34-c845-48c5-96c3-8570a4e897ed"
      unitRef="usd">4700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtMy0xLTEtMA_275672fc-8ed4-4732-a534-520a801ed864"
      unitRef="usd">-7500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtNS0xLTEtMA_4820e4a9-3321-4620-938a-3b85220fb405"
      unitRef="usd">900000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjgtNy0xLTEtMA_2d808ba0-4534-4f75-86b2-fee996808e7c"
      unitRef="usd">-4200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktMS0xLTEtMA_69e215c8-0aab-465e-9514-bc50f45717b2"
      unitRef="usd">780500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktMy0xLTEtMA_7b1b4444-dd43-4885-a5e1-999e3795828c"
      unitRef="usd">118900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktNS0xLTEtMA_61400880-b8f1-4d74-ba18-1f8138d3ae2b"
      unitRef="usd">1612900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMjktNy0xLTEtMA_e929a1e9-1da8-4ed0-9111-a4d4cfa00acb"
      unitRef="usd">216400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtMS0xLTEtMA_55c49765-6195-4d64-81ca-a6dc6c189afa"
      unitRef="usd">161100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtMy0xLTEtMA_b4d9371b-b128-4b17-ae72-9229c5f88513"
      unitRef="usd">24100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtNS0xLTEtMA_ac0d1f30-e5de-4c9b-aae1-63c148b8ac79"
      unitRef="usd">340100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzAtNy0xLTEtMA_c1e11b0f-677a-4391-909a-e669737752f6"
      unitRef="usd">-264300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtMS0xLTEtMA_4e1b62a1-10fd-4749-ba12-bc1134a2de48"
      unitRef="usd">619400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtMy0xLTEtMA_a29338cf-440e-4183-bfdc-4cf81445c4c3"
      unitRef="usd">94800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtNS0xLTEtMA_b509b295-d27a-4e53-9132-2560c1b44371"
      unitRef="usd">1272800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzEtNy0xLTEtMA_f97f14e6-c7c5-4f90-8c87-168f49b58bc6"
      unitRef="usd">480700000</us-gaap:NetIncomeLoss>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItMS0xLTEtMA_98a61d84-8699-4464-a1ef-d7f03aa9da0e"
      unitRef="usd">-500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItMy0xLTEtMA_605186ed-d86f-49c7-9738-3027ea4efc73"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItNS0xLTEtMA_be641065-e6c8-44ec-b793-5dd245790a37"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzItNy0xLTEtMA_95b23973-44ac-4990-b118-73a368cf7d6d"
      unitRef="usd">-1800000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <holx:Netincome
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtMS0xLTEtMA_52142656-e9af-4d49-a37c-9a5bb29010cd"
      unitRef="usd">619900000</holx:Netincome>
    <holx:Netincome
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtMy0xLTEtMA_86ded29b-7528-4962-a010-721ab8f7603a"
      unitRef="usd">96300000</holx:Netincome>
    <holx:Netincome
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtNS0xLTEtMA_9f369643-6799-4af0-9b81-c03634236d80"
      unitRef="usd">1274300000</holx:Netincome>
    <holx:Netincome
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzMtNy0xLTEtMA_c7568433-eecb-4db5-832a-1694390ff10b"
      unitRef="usd">482500000</holx:Netincome>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtMS0xLTEtMA_6af1e6b8-dfa2-44ee-a240-7140dba280c9"
      unitRef="usdPerShare">2.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtMy0xLTEtMA_04b5d70d-7538-4353-a9fa-7b8e71295169"
      unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtNS0xLTEtMA_56faa85f-1c7b-4250-bbf2-304419a30857"
      unitRef="usdPerShare">4.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzUtNy0xLTEtMA_1c7aa462-10fb-4ae2-863e-646de981e821"
      unitRef="usdPerShare">1.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtMS0xLTEtMA_4771a474-5407-402d-a1a5-85f500503543"
      unitRef="usdPerShare">2.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtMy0xLTEtMA_f6a54f5f-3dee-4584-a1a8-88c4950bbd84"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtNS0xLTEtMA_415441fa-e030-4376-8113-4e5df9b79d23"
      unitRef="usdPerShare">4.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzYtNy0xLTEtMA_be3b961a-d6a1-4500-a869-7a3733306bfe"
      unitRef="usdPerShare">1.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtMS0xLTEtMA_391fee84-ca73-4b67-b9c5-fe1dcbe47467"
      unitRef="shares">258473000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtMy0xLTEtMA_d5be14d4-8159-4d10-bc50-454640983d1e"
      unitRef="shares">263238000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtNS0xLTEtMA_fb25923a-78a4-4d4c-81a2-3c6c92f79ef8"
      unitRef="shares">258539000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzgtNy0xLTEtMA_d7c370e3-db16-41f9-b4fd-e54027b28287"
      unitRef="shares">265566000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktMS0xLTEtMA_5d5c5c33-24fb-4089-9a29-dbf05fcb398d"
      unitRef="shares">260749000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktMy0xLTEtMA_79edbb4b-464a-4c4d-a148-7ad5b080ed66"
      unitRef="shares">264506000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktNS0xLTEtMA_f3046678-a261-437b-ba95-aa54dcd1f122"
      unitRef="shares">261267000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xNi9mcmFnOmNiZWNjMzIwZTRkNDQzYjliOGFlYmY3YTBkM2UwYWEyL3RhYmxlOmJjYTcxNWEyNmIxZjRjZjhiNzFhMTAyZjk0ODk5MWM3L3RhYmxlcmFuZ2U6YmNhNzE1YTI2YjFmNGNmOGI3MWExMDJmOTQ4OTkxYzdfMzktNy0xLTEtMA_4f34f397-7a20-4cca-b5a5-c77f3cad9941"
      unitRef="shares">267114000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi0xLTEtMS0w_53893ed2-695c-4048-90bd-9dbbd0cee590"
      unitRef="usd">619400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi0zLTEtMS0w_36a4b486-9d9b-43ae-9da9-ef322002983e"
      unitRef="usd">94800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi01LTEtMS0w_b509b295-d27a-4e53-9132-2560c1b44371"
      unitRef="usd">1272800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMi03LTEtMS0w_7a0b928b-652c-43ea-9b10-8959c98852f3"
      unitRef="usd">480700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy0xLTEtMS0w_6a207b9e-b98f-4e9c-b793-c1757e3f0c76"
      unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy0zLTEtMS0w_f10f36b8-b8fc-49bf-b932-705ced2a484a"
      unitRef="usd">-5400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy01LTEtMS0w_1a06e221-44df-4208-b99d-a09da16de1aa"
      unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMy03LTEtMS0w_8bd0f58e-daa9-4b67-bf4b-babfd7475f76"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfODk_702e5fe4-27ba-4f7d-a1b7-3dfdc6432e6a"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTA5OTUxMTYyODA5Nw_4b93970f-1fe1-4215-9ae8-6b22d726d1be"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTQx_aa2f6ad5-3c87-4f4d-9dde-13511450a3ef"
      unitRef="usd">-8100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOC0wLTEtMS0wL3RleHRyZWdpb246MWFjODI3NmQyNzZlNDIyM2E1Y2JmYmU2YWFhNTI0ZTFfMTA5OTUxMTYyODExNg_6c674d05-daeb-4040-8965-12630090dbf6"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS0xLTEtMS0w_d6de6667-e38e-466a-a8ad-1cccc8e4de55"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS0zLTEtMS0w_7fbf4f9c-8251-414e-9e46-5882b031dfa7"
      unitRef="usd">-25200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS01LTEtMS0w_74a17854-7053-4b44-a246-12bcec237a29"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfOS03LTEtMS0w_ff9a373e-4eef-48cb-9571-56ed2efb575f"
      unitRef="usd">-21200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtMS0xLTEtMA_8b9207e0-9e32-42fe-a46d-425eb31450d4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtMy0xLTEtMA_cca0ae3c-3a87-4ffe-8389-84acb29c141b"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtNS0xLTEtMA_33ee786b-468c-4f4d-9b4f-e65144754d2c"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTAtNy0xLTEtMA_aa8f0c5d-e1e3-4450-ba6b-1a7fa2280237"
      unitRef="usd">-1700000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtMS0xLTEtMA_2c4bd063-2c15-478a-81e5-b46b8a45f5a5"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtMy0xLTEtMA_2a2cd466-c57d-4024-8de9-177ed33501bf"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtNS0xLTEtMA_ebee09c2-2be3-478f-934f-0ffc4b453a3f"
      unitRef="usd">13900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTEtNy0xLTEtMA_eea642e0-6bde-490d-856f-1e64ef4cde0a"
      unitRef="usd">-16600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItMS0xLTEtMA_e601cbab-0bd7-44eb-b341-98a89482d0b5"
      unitRef="usd">614300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItMy0xLTEtMA_c8de4669-0c70-4efa-b720-678868700346"
      unitRef="usd">64600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItNS0xLTEtMA_5f411006-f6ef-43bb-8ec6-d2b1f349e62a"
      unitRef="usd">1286700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTItNy0xLTEtMA_a88d7a01-af3e-414e-b52d-9a5c17954634"
      unitRef="usd">464100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtMS0xLTEtMA_40ce7d4b-651e-4509-a70e-1681e0da1dca"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtMy0xLTEtMA_5f2a90f7-c97a-4434-ba11-b74db6c6ba5c"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtNS0xLTEtMA_d9b10ed4-f358-467d-a04e-8506d7104d37"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTQtNy0xLTEtMA_f14d907e-759c-42cb-9415-28af4d6070fe"
      unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtMS0xLTEtMA_9f125dc0-a883-44d5-aea9-aeb92999109d"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtMy0xLTEtMA_01cd0d31-9cfe-497c-a4a2-60b645e0911b"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtNS0xLTEtMA_2874ddec-e8a0-4813-9965-ab022b590166"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTUtNy0xLTEtMA_2682e6b5-0f31-423e-a9fb-a67bdd9d065c"
      unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <holx:ComprehensiveIncome
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtMS0xLTEtMA_96b80fe6-e3d2-48d0-9e82-d2df6e13eae9"
      unitRef="usd">614800000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtMy0xLTEtMA_920c0596-8c74-4784-9ff2-d749a00235ce"
      unitRef="usd">66100000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtNS0xLTEtMA_39452b0a-221b-411f-9b70-94d9c3d3042a"
      unitRef="usd">1288200000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8xOS9mcmFnOjUyYzI4YTgwZTlhZjRmNjc5MjMxZWUxZGE4MTZiN2ZhL3RhYmxlOjNlOTJkMGZlZGI1ZTQyNDhhMjM2NGIwYjEzMTRiZDNhL3RhYmxlcmFuZ2U6M2U5MmQwZmVkYjVlNDI0OGEyMzY0YjBiMTMxNGJkM2FfMTYtNy0xLTEtMA_832bbca1-14f6-4052-a7de-e052228f0ccf"
      unitRef="usd">465900000</holx:ComprehensiveIncome>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMy0xLTEtMS0w_1846af7c-abe3-4d60-a511-224894d53752"
      unitRef="usd">816400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMy0zLTEtMS0w_ade6a9e9-d772-4c5c-99ef-09963ebcb0dc"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0wLTEtMS0wL3RleHRyZWdpb246ZWJhMGQwMWZlYjJkNDYyZWIxNDFmYTQxNGMwZjYwNWVfNDM_f3b4c772-6d4f-42dc-8694-17ab029cdb93"
      unitRef="usd">41700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0wLTEtMS0wL3RleHRyZWdpb246ZWJhMGQwMWZlYjJkNDYyZWIxNDFmYTQxNGMwZjYwNWVfNTE_06055e7b-bf4b-4a31-8cd9-1dc07a1b790d"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0xLTEtMS0w_4d3e0f31-5c2f-49e1-b626-2ea085ee00de"
      unitRef="usd">1212300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNi0zLTEtMS0w_96641ff9-4227-4989-a328-eb2ff43f59c9"
      unitRef="usd">1028900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNy0xLTEtMS0w_ec36a144-4014-4f8e-8aaa-9a0070080421"
      unitRef="usd">456200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNy0zLTEtMS0w_b70652c0-78dd-420a-8c52-49c50d8fac6a"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOC0xLTEtMS0w_f97966f8-9bea-4e37-a854-95591773be0f"
      unitRef="usd">85400000</holx:PrepaidIncomeTaxesCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOC0zLTEtMS0w_adb05eb8-ef96-4668-ad63-39731a809652"
      unitRef="usd">38800000</holx:PrepaidIncomeTaxesCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOS0xLTEtMS0w_3952383f-8b8f-457b-a1a5-075d6b3f9eaf"
      unitRef="usd">92100000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfOS0zLTEtMS0w_fdc35058-9933-4434-be77-c2a45fe0b89b"
      unitRef="usd">58500000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTItMS0xLTEtMA_b1d1a2aa-7c31-4e63-99ae-5226fc048ce0"
      unitRef="usd">2662400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTItMy0xLTEtMA_0cac005b-c94d-4bb8-a29b-dacad8b70a1d"
      unitRef="usd">2222300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTMtMS0xLTEtMA_fc93fc9b-2e46-4422-b6a7-4b731fbfae3a"
      unitRef="usd">533600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTMtMy0xLTEtMA_1c92da61-450e-4152-aba2-26f817355c4c"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTQtMS0xLTEtMA_3fc95da8-9060-4976-9bb7-64351c5e19d8"
      unitRef="usd">1447600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTQtMy0xLTEtMA_5f5225b8-7dcd-4d52-b571-4c447bcd3e0e"
      unitRef="usd">1307500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTUtMS0xLTEtMA_f907f25f-2fee-41d0-88bd-f19af4f7069d"
      unitRef="usd">2857200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTUtMy0xLTEtMA_0dde2658-542e-488c-9678-500dc4a553a4"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTYtMS0xLTEtMA_26f0d1d8-aa64-46b1-95c2-4cb3b200096a"
      unitRef="usd">543200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTYtMy0xLTEtMA_404280e5-38e9-4a49-9c09-003dc4e3faef"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTctMS0xLTEtMA_370389e2-fd37-4f08-9969-b0305fd0a9b4"
      unitRef="usd">8044000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMTctMy0xLTEtMA_50a1bb0d-3029-4828-a8da-57a8a840e419"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjAtMS0xLTEtMA_cec5c6c1-a4a5-4800-ae81-e2358d64c7d5"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjAtMy0xLTEtMA_c37a7909-5514-4320-899a-fc2c3a6c62c8"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjEtMS0xLTEtMA_9033a398-2e31-4c29-a960-4ef5cd1f28da"
      unitRef="usd">225100000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjEtMy0xLTEtMA_914b518b-f5cd-4ed6-a669-1109f224f6ff"
      unitRef="usd">178800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjItMS0xLTEtMA_2bda2491-dbdf-4b52-9dbb-d653b192f922"
      unitRef="usd">534900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjItMy0xLTEtMA_1aa55bdc-cb67-45b3-a6fe-248aaf13dfbc"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjMtMS0xLTEtMA_d9742056-ab92-410f-80f0-0a75949a342d"
      unitRef="usd">198500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjMtMy0xLTEtMA_436e29a0-9873-4b25-9155-54bb729a74e5"
      unitRef="usd">186100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjQtMS0xLTEtMA_e0b88d6b-ea49-4d57-bfc6-0ba003543e69"
      unitRef="usd">3000000.0</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjQtMy0xLTEtMA_18c39da0-627f-433a-9f72-4caef319e781"
      unitRef="usd">1900000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjctMS0xLTEtMA_d34d7908-c78e-48b0-9fc4-ef5241666c58"
      unitRef="usd">1036400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjctMy0xLTEtMA_6a8b9d3c-92e0-4e9f-a1fc-7951091c122f"
      unitRef="usd">1239300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjgtMS0xLTEtMA_ec26875e-f476-4f31-aa2f-7a6b18ba6f54"
      unitRef="usd">2672100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjgtMy0xLTEtMA_df7d6c4c-0b4e-4b6f-b3ac-cbb85643ec3d"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjktMS0xLTEtMA_4274ea41-4d2d-4414-9a1e-81248c1fb5d7"
      unitRef="usd">23600000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMjktMy0xLTEtMA_b842a42c-4109-42e9-a72c-91d9b9a459ed"
      unitRef="usd">17400000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzAtMS0xLTEtMA_9e75afa1-346e-4cde-8055-493eb364ccf1"
      unitRef="usd">229800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzAtMy0xLTEtMA_b1ea6be0-ac99-4a02-a7e5-b1950fcf1e4d"
      unitRef="usd">201800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzEtMS0xLTEtMA_4623c09e-1ade-4a9d-8844-5b70611d7579"
      unitRef="usd">13400000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzEtMy0xLTEtMA_d58b2086-9c63-4e54-ae8c-d7a94fff1492"
      unitRef="usd">12900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzItMS0xLTEtMA_8b93c774-8617-4b35-a68b-cef1e6ca205d"
      unitRef="usd">273700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzItMy0xLTEtMA_98794641-338e-49e8-a7c6-462e25b0fa3b"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzIx_21c6dc67-493e-44ae-830f-e6f3eb2028f9"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzIx_683a5c9b-2c56-4f1b-a831-f55e50920476"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzM2_47c2f737-b474-49ee-80a2-804c5da0b4be"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzM2_50d8e86b-6d80-488d-9fc9-862246113b8b"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzU4_959b7b40-a3f8-4363-9bf0-062986b40565"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjU1ZDIzNzA4NzA3MjQyMjlhNGRlNGRkZmQ2ZmQ4MDEzXzU4_a137feeb-4ecd-4ff9-b32e-d001373418ad"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMS0xLTEtMA_d559bedb-a09b-4fe4-94c6-c13a49a534ca"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzQtMy0xLTEtMA_702c946f-5fa7-4f92-bf71-a640a7ac40d2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzE4_2c28cfaf-fb2e-413f-ae0b-fb0b327a96e3"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzE4_b053ad5f-c238-45f8-bb2f-1569e2db99ea"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzMy_6ecfb919-4dd3-4e18-a824-c9f7001e302b"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzMy_f96c25ec-8562-4ada-96e6-175662ba0a03"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzU0_409bce50-8577-4b18-b5a8-af3cd85f95be"
      unitRef="shares">296887000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMmE2MGE2ZTJiNjRjYTNiNTliMzM4OWNlZDk1OTc3XzYx_a8aafc66-c164-479e-a86a-7698a7c0420c"
      unitRef="shares">295107000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMS0xLTEtMA_d25765c3-b152-481f-99ac-747193cd99ba"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzUtMy0xLTEtMA_4fea15fc-b6e7-46ac-89d6-e5b1f0d9aa18"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzYtMS0xLTEtMA_ef424523-f6dc-42a0-9529-b8d51e17295c"
      unitRef="usd">5927100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzYtMy0xLTEtMA_b43e705f-45de-43db-b604-702ca036a4f6"
      unitRef="usd">5904800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzctMS0xLTEtMA_20d43350-8167-4738-81a7-e7c10179bcd5"
      unitRef="usd">-298900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzctMy0xLTEtMA_bbbf4e9e-d295-47c7-bddc-6b332c1c3fcc"
      unitRef="usd">-1573200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjAxYjk1ZmIxYjk4MjQ3MzRiMzdiMWE3NDk2NDNkNGFiXzMw_09c782c1-2481-426b-89e8-59377bdd6969"
      unitRef="shares">40682000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjAxYjk1ZmIxYjk4MjQ3MzRiMzdiMWE3NDk2NDNkNGFiXzM3_6c749a09-cdb9-4f2a-8a0a-f865bdab3e99"
      unitRef="shares">37609000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMS0xLTEtMA_821a9fc4-b8cc-4d62-b9d0-fc663a951b8d"
      unitRef="usd">1801000000.0</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzgtMy0xLTEtMA_a7182324-27e1-49eb-a7a7-3366c64d4479"
      unitRef="usd">1579600000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzktMS0xLTEtMA_59a40ea5-5c5e-4943-961c-b58b424c8fa1"
      unitRef="usd">-35800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfMzktMy0xLTEtMA_35e56850-0052-49f5-ac27-f8abd2628266"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDAtMS0xLTEtMA_c0698e4c-b551-4b9a-88f8-fdce7f40bcaf"
      unitRef="usd">3794400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDAtMy0xLTEtMA_49312791-22ff-4e58-9392-4f765ca0b6ba"
      unitRef="usd">2705200000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDEtMS0xLTEtMA_711a1fcf-f445-4455-8580-c3d6ac8fa1e1"
      unitRef="usd">600000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDEtMy0xLTEtMA_1925d27e-3908-459f-9c82-0fba14ada9c1"
      unitRef="usd">2100000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDItMS0xLTEtMA_f9ba4a96-2662-4474-ae6b-62b1ee1c8d03"
      unitRef="usd">3795000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDItMy0xLTEtMA_07fa4c21-ea09-4925-b12f-b7ff5011e5d7"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDMtMS0xLTEtMA_64f2bdeb-021b-40b6-b8b0-6f401afe7b06"
      unitRef="usd">8044000000.0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yMi9mcmFnOjdmOTRmY2ExMTIyMTRmZDFiZTRiNzc4NDYyNzgyODUwL3RhYmxlOmU1ODA1MDFiYTU5MDQ4MmRhNDlmY2IyMjEyZmY0ZTY2L3RhYmxlcmFuZ2U6ZTU4MDUwMWJhNTkwNDgyZGE0OWZjYjIyMTJmZjRlNjZfNDMtMy0xLTEtMA_76746c5b-eb29-4091-af39-3db2603a3a49"
      unitRef="usd">7195800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i58ad3a928b064f93a707adcef8b085ef_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTItMS0xLTA_572cd419-2e0f-43b7-b860-2154328dffab"
      unitRef="shares">292323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i58ad3a928b064f93a707adcef8b085ef_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTQtMS0xLTA_7807e2df-95f9-4a19-ab10-d4ae5f5d1605"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia86f19e338624c03becbf38fdc443b83_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTYtMS0xLTA_ee383d0f-ed7d-41a9-bda5-47c17bc4e096"
      unitRef="usd">5769800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52eae1f2a4d04d28a7067bbadc18fd4c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTgtMS0xLTA_ecffbfcb-a492-412c-855f-51b127a106ca"
      unitRef="usd">-2688700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9527df9991fb4a508abd170595d3765f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTEwLTEtMS0w_c848d181-d195-4079-9ae6-e3de617a0642"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i2f0f7c20571c473dbb3538c19161061b_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTEyLTEtMS0w_1a0fe963-f255-40c4-ae9e-81e99e4f608a"
      unitRef="shares">24638000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2f0f7c20571c473dbb3538c19161061b_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE0LTEtMS0w_f5113719-8929-4831-a797-8dbc956694e5"
      unitRef="usd">-926000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE2LTEtMS0w_95de2594-2a34-4e9d-bac5-7053758f960c"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquity
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE2LTE4LTEtMS0w_39e957d8-700c-45b0-988e-015105320c5c"
      unitRef="usd">2115700000</us-gaap:StockholdersEquity>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE3LTE2LTEtMS0w_7e335d61-cb7e-4978-9e25-041be5fa2a86"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE3LTE4LTEtMS0w_66558f70-f845-4542-b118-15a946d6dcc5"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockholdersEquity
      contextRef="id5308a8db9a248b4a503886d28172438_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE4LTgtMS0xLTA_8ed23669-518c-46be-8ff4-f58d693c6d76"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5308a8db9a248b4a503886d28172438_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE4LTE4LTEtMS0w_38cddd73-1329-402d-b0f9-96196f9b3a37"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTItMS0xLTA_670ed7c5-cfd6-411f-bc86-3a871d3d4c20"
      unitRef="shares">540000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTYtMS0xLTA_29ee4db6-1623-46db-ac86-63df08adbae3"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTE5LTE4LTEtMS0w_aa83bcc1-4e45-4824-9182-03a9634708e1"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="ia5daf1129bdc4e6cb9afa466e9f36dc2_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTItMS0xLTA_965f5382-6f74-4752-a3d4-bb2bbac08545"
      unitRef="shares">476000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTYtMS0xLTA_93bf9386-3fd1-4c4b-80b9-b33d945ab48d"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIwLTE4LTEtMS0w_0a341737-4016-431d-a74a-46ec48a87544"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIyLTYtMS0xLTA_8e8f4f6e-b0f9-41f0-8bda-4a1091b5adc8"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3cc3529ed51740c79041015bb67a3a29_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIyLTE4LTEtMS0w_7c1efbb1-36a6-4178-910d-219c968a0d55"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTgtMS0xLTA_2c8fc1f0-8a65-4db2-b833-d6e3914c719e"
      unitRef="usd">386100000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTE2LTEtMS0w_d623c24b-fdec-4c49-b7ed-b49fa72a9163"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTIzLTE4LTEtMS0w_a8527754-06e4-4f8b-8555-555d52dc58c1"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI0LTEwLTEtMS0w_a2997a34-fd6a-4b16-869d-3aaf44616a51"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i09f5454aa2824bcab58a6537096e94de_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI0LTE4LTEtMS0w_ba520e5c-051b-4ae1-b31d-e1f30ca6006f"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTEyLTEtMS0w_11f3e365-d788-415c-9249-2f2e47aa50f6"
      unitRef="shares">1545000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTE0LTEtMS0w_0d934c04-2293-43b5-89ff-7ceb9490a497"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI1LTE4LTEtMS0w_86690f80-52d8-44ed-b03e-d6c7aa6f5162"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i47eabd0fa5944397b44eea01f33db5f9_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTYtMS0xLTA_74c74638-c17c-4fa7-b2c6-2787494977cc"
      unitRef="usd">-41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTEyLTEtMS0w_fdda401c-b0f9-42c8-9a62-a11609ae898f"
      unitRef="shares">3279000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib818c1316ec4415d8c9e28e66af39afd_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTE0LTEtMS0w_fabf0f3c-0a08-4fea-b3b2-9fff12fe6a97"
      unitRef="usd">-164000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI2LTE4LTEtMS0w_1c7ec856-5483-424e-8fa2-117f68aa4ba0"
      unitRef="usd">205000000.0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI3LTE2LTEtMS0w_3a486c72-945e-463d-b5d7-7a8f6f4bc503"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI3LTE4LTEtMS0w_635a1991-cf7b-460e-a969-d3d0f0f05bb0"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="i0b0a1c130c914da2aed9de46ede4189e_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTItMS0xLTA_902c669d-b2d2-4d42-983f-4ec88a0efe0b"
      unitRef="shares">293339000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0b0a1c130c914da2aed9de46ede4189e_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTQtMS0xLTA_57e08429-b927-4b33-ada7-cb2bc8bbf7a3"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib58207b8d4894dd4af272ce1eca54244_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTYtMS0xLTA_49a0fc8d-4777-4c18-8bce-79c5dc6dbff9"
      unitRef="usd">5749800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f07a9be8b684974a2a20fab9aa2e50c_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTgtMS0xLTA_4f511b92-0c78-4f16-ac26-4fb056b84359"
      unitRef="usd">-2302300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib48dedaf55ee438786b6134c8b28e49c_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTEwLTEtMS0w_1996c870-efd9-48a2-b531-7878175b2312"
      unitRef="usd">-28700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i6bee588f40e14c72bd3cc02f47cadda7_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTEyLTEtMS0w_962079ff-3b56-4657-841f-f1cf509e607c"
      unitRef="shares">29462000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6bee588f40e14c72bd3cc02f47cadda7_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE0LTEtMS0w_138d74d0-6c1b-4dd1-989f-496f921f1c38"
      unitRef="usd">-1170900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE2LTEtMS0w_40f9778e-5c5a-4b02-bdad-dd91e891004f"
      unitRef="usd">6900000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTI4LTE4LTEtMS0w_5d06a664-d049-449b-afa1-95d5ac115a78"
      unitRef="usd">2257700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTItMS0xLTA_534518b8-f705-4aac-88d9-2b1db295bb15"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTYtMS0xLTA_89a32d12-102e-4c5a-88d3-bc5c885f3ebe"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMxLTE4LTEtMS0w_ed27a188-2b49-471f-8364-b64c8bfe8384"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTItMS0xLTA_a41f106c-c5c3-4965-b717-26a46d58da85"
      unitRef="shares">86000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTYtMS0xLTA_b4007f54-a4a8-4fa4-b4ec-9830b07837ed"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMyLTE4LTEtMS0w_0c9c65c9-551e-4bfc-9921-450d147166e2"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1887e40fc1a846418f4866d791b032b9_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTItMS0xLTA_10a9e6a8-b125-482d-9e6e-86d963b7d314"
      unitRef="shares">214000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTYtMS0xLTA_db944108-b9e2-4cd1-ab0c-846886d9161e"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTMzLTE4LTEtMS0w_5e974db6-2646-4e37-b5e3-2182ae98e6cd"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM0LTYtMS0xLTA_82288097-282f-4ff2-99b6-6e33a3314e32"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8cfe57b8e8f74e7b838a6079f880f90c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM0LTE4LTEtMS0w_506fee77-cb21-4689-932e-8fc617965c07"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTgtMS0xLTA_76970be9-0167-4d3e-920b-a6880287d88a"
      unitRef="usd">96300000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTE2LTEtMS0w_7d260b99-1772-40d3-aaf9-9494ab096783"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM1LTE4LTEtMS0w_e047f7ac-39e1-4746-99dd-b6ca27e7d761"
      unitRef="usd">94800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM2LTEwLTEtMS0w_277034a4-1083-4778-a94d-d5e7c5bd290d"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM2LTE4LTEtMS0w_8c6c7263-8127-49eb-9e5c-685f3de67500"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTEyLTEtMS0w_5e3406e0-d66e-4bfa-984e-70c904bb42be"
      unitRef="shares">5851000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTE0LTEtMS0w_fa87a166-168c-4cb9-8ee8-5dce932968c7"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM3LTE4LTEtMS0w_9ea5d305-eaba-48c5-ab58-2e3c01db0108"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i1346cd591da04b58b5fa11814d85df61_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTYtMS0xLTA_1af3e77b-851e-4105-9b9d-1dd1d5f9630d"
      unitRef="usd">41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTEyLTEtMS0w_08bcdcc7-36a3-4bed-b768-4381f0b24b51"
      unitRef="shares">628000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="id9bd1ea5944946a4996d84b1b085b6b2_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTE0LTEtMS0w_5f744cb0-2ec0-4954-96a9-a24f7fd63895"
      unitRef="usd">-41000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM4LTE4LTEtMS0w_5e93f148-eeba-499c-90c2-fee9e25462b8"
      unitRef="usd">0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM5LTE2LTEtMS0w_459ec84b-dbf7-429f-bf0e-5f65ea3950c1"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTM5LTE4LTEtMS0w_18f94d5c-f297-495c-b237-528dbcf5ccfc"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="ibfc98874159a4652a12358cbde3c0dd0_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTItMS0xLTA_07150006-ebdc-43c7-bd26-f14da2a0c2ff"
      unitRef="shares">294142000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibfc98874159a4652a12358cbde3c0dd0_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTQtMS0xLTA_19960f88-fde6-4f46-a242-4cd187a02439"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id01ffa50611c48bcae532eb4d244ad15_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTYtMS0xLTA_ea09a2a0-3273-472b-b4b4-de1782929322"
      unitRef="usd">5827600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57574c7cb017407e95bc7d6674fc7041_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTgtMS0xLTA_4a3b5ee6-7431-4308-aa59-4a71412a16d7"
      unitRef="usd">-2206000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTEwLTEtMS0w_fa855de6-3f9f-4e13-b4b5-40c2e9ad1335"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTEyLTEtMS0w_9dafa533-e60a-43d8-b17d-72121fe9a39c"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3fab2581e1cb4bb6926b6bfcb16a2aa3_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE0LTEtMS0w_6f5e79d4-8cc8-49f0-9009-cb0609adb09d"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE2LTEtMS0w_9d819ea6-689a-4e7d-b766-2a7b97fa6d8f"
      unitRef="usd">5100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQwLTE4LTEtMS0w_b2726eac-778b-4bef-82b4-44db28eab5f1"
      unitRef="usd">2091200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i37479dda543e4e848a6b2a065e778421_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTItMS0xLTA_5ecda383-5304-4ee4-850f-fce7e6c98bcf"
      unitRef="shares">533000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTYtMS0xLTA_6f689819-1309-491e-9d53-760f4940a26e"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQxLTE4LTEtMS0w_816684a2-1d17-4815-bbc2-44031f6c6731"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i37479dda543e4e848a6b2a065e778421_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTItMS0xLTA_3bc8a690-2c7c-4cc6-8eee-1528201169b8"
      unitRef="shares">9000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTYtMS0xLTA_f11366ef-2438-4f97-af33-02cf2ce02d95"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQyLTE4LTEtMS0w_6043d1bd-e934-416e-9c8c-f5db2c52c6ff"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ0LTYtMS0xLTA_5bd7e64f-6c71-4a1b-96fa-ca0679e1f7cd"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3dddd95fccfc49948c076375b0943ab1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ0LTE4LTEtMS0w_d21ccdb2-370f-41a9-8ce9-11a40a1dff1e"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTgtMS0xLTA_55c8718a-23ce-4dd6-bec5-a726875996c9"
      unitRef="usd">137900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTE2LTEtMS0w_3f8eb117-e4e9-4f8d-a182-c1518f654b5a"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ1LTE4LTEtMS0w_5db6b79b-a9a3-43c2-82e0-497e7e2e6ff9"
      unitRef="usd">136400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ2LTEwLTEtMS0w_e60def84-530b-4ce6-a154-b4de1f1d197c"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i410c502357bd41b9a39fcd2f7d361376_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ2LTE4LTEtMS0w_f47158fa-981f-44ca-9be4-dbf1fa04d6c1"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ5LTE2LTEtMS0w_7f2962b2-eb70-4b40-b3b5-f6edb52f35fe"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i11b77e43473c46b8b4204599c1a09739_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTQ5LTE4LTEtMS0w_be23c36b-dace-417e-a7b6-417a396b7f08"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="i55a0a29026de4c14b1ca906b3d06512f_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTItMS0xLTA_e36cfc9e-e121-4330-813f-660185bf754a"
      unitRef="shares">294684000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i55a0a29026de4c14b1ca906b3d06512f_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTQtMS0xLTA_2e6b0c53-4bca-43a2-ad64-f008e03e2326"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00148f02d5ac434ab8455c4bfdb18794_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTYtMS0xLTA_383970e2-a774-4ab8-bb48-2bd3187512f3"
      unitRef="usd">5861700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b1b90c41f7d4bd2acfb7ecf220b375d_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTgtMS0xLTA_033be2b2-4e9f-40be-b65f-b0034ec9f01d"
      unitRef="usd">-2068100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i13a5203734044addaed9c920967a2c5a_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTEwLTEtMS0w_2e99eb56-e8fd-40cb-855d-685523995f7b"
      unitRef="usd">-61900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTEyLTEtMS0w_12cfa15e-b4c1-48f6-a1b3-02c8f4e0ae37"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i4aaf80429cf74fe2a9695145c5bd6dae_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE0LTEtMS0w_7883ccb3-751f-4e0e-b318-4f2a1fc22634"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i70e7059977d242968ebf9c8a01c8083e_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE2LTEtMS0w_69c96945-3f11-47c4-971c-fab6cc8fc8ce"
      unitRef="usd">3500000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70e7059977d242968ebf9c8a01c8083e_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUwLTE4LTEtMS0w_42ade7da-6396-4e10-b088-32afb2b316fc"
      unitRef="usd">2258600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTItMS0xLTA_4d15ebdd-172b-444c-8f64-0fe6d53f3585"
      unitRef="shares">185000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTYtMS0xLTA_86663dd0-9899-46d1-9ca5-fdc4f65f696a"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUxLTE4LTEtMS0w_a4848293-8e1d-48fd-ba58-cb47368e01d9"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTItMS0xLTA_463423be-a7c4-49c7-8086-42be40d83b2d"
      unitRef="shares">40000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTYtMS0xLTA_5dada3d3-0c97-49b0-a97e-f9d08f8c4576"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUyLTE4LTEtMS0w_fb0becb2-c317-4a6e-be0b-79eea4a0066e"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia1f082e810b140ca926b1bdcda4b4620_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTItMS0xLTA_a2fa438d-00bc-48ef-ae69-3f572275dc05"
      unitRef="shares">198000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTYtMS0xLTA_972ba0cf-4858-4548-be75-e1a47432e609"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTUzLTE4LTEtMS0w_f7a00fd2-6513-42bb-ae19-2ccae5d5ee53"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU0LTYtMS0xLTA_4ed45cdb-5acf-4f54-acc0-9d5642c23094"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i76facb4c329748dc8fa17c913d51f8aa_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU0LTE4LTEtMS0w_d63f3b88-654c-4423-8261-fbce0105c302"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTgtMS0xLTA_636d2788-ce39-4808-9f6d-b265d869e513"
      unitRef="usd">494900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTE2LTEtMS0w_0235bcdc-4bc1-490d-8b76-8a6c3a6afcba"
      unitRef="usd">-1400000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU1LTE4LTEtMS0w_8e83574e-bd60-4a27-ad54-f50849092748"
      unitRef="usd">493500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU2LTEwLTEtMS0w_fa5da5ba-a0c5-4145-b2eb-c27f37b2ff9e"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72758f99f79f4e0a964b817bf9558808_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU2LTE4LTEtMS0w_9b7e5c17-9a8b-489b-ab96-7304c2dbb4cf"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTEyLTEtMS0w_489a3970-ba88-4f3d-becb-a0951c6612cb"
      unitRef="shares">1668000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTE0LTEtMS0w_3aaf8b90-007a-4f30-badb-5df1691e06dc"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ibd50b93acba342a4995202317212867c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU3LTE4LTEtMS0w_b47cff8f-03c9-4159-9f38-85f5e7df4cfb"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i6160ec5704084a74ab06ae3ef0b25d89_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTItMS0xLTA_972f46e5-cc7b-4461-a201-8043ac98dfc6"
      unitRef="shares">295107000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6160ec5704084a74ab06ae3ef0b25d89_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTQtMS0xLTA_80447a7a-222a-4b3e-96a0-a4ff373fd6c2"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32babe6c9a5a4075a97af1479d07d7f5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTYtMS0xLTA_83779072-b08b-4262-9a3d-1875f3e11591"
      unitRef="usd">5904800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1e162ffb5f4d46748b4e62688b0c4db3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTgtMS0xLTA_1b668a55-4a71-45c0-ad26-4519f18df196"
      unitRef="usd">-1573200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9d9c4520de640f7837c8a8db74e7a29_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTEwLTEtMS0w_6e76d3eb-deea-429e-87e2-5399250be686"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iaf7dda3e20214bc7b64a4430da73c356_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTEyLTEtMS0w_e0f54e74-14fe-446a-ad37-c7bcaa3973b8"
      unitRef="shares">37609000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iaf7dda3e20214bc7b64a4430da73c356_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE0LTEtMS0w_b18dbded-d7ae-43a6-bae5-bbc2da754e87"
      unitRef="usd">-1579600000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE2LTEtMS0w_f40e11ac-c9c1-4fbe-bc71-b6a565cb52f2"
      unitRef="usd">2100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU4LTE4LTEtMS0w_7d4d2f99-9ee1-47fd-92c8-5d1986d09f6f"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTItMS0xLTA_e6df127f-5c79-4dc4-93a7-e6112e704cd3"
      unitRef="shares">490000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTYtMS0xLTA_090987dd-0e8a-4532-a22f-16a246ae60b2"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTU5LTE4LTEtMS0w_b9ce04b0-cee0-4c6e-938d-8e04f4e00bf2"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i97cd06537f6b4d82a873366f36d723a3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTItMS0xLTA_6891edd8-4b3c-4f3d-98a1-5ecd79ead789"
      unitRef="shares">936000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <holx:ChangeInParValue
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTQtMS0xLTA_6c7b046e-0c3c-4b8e-9d2b-1c65efe00180"
      unitRef="usd">100000</holx:ChangeInParValue>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTYtMS0xLTA_e86b8bf8-2578-427d-8787-a4d07f9e7f03"
      unitRef="usd">46500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYwLTE4LTEtMS0w_0cf94a1a-3a04-403a-9e32-05d50d460d5d"
      unitRef="usd">46400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYyLTYtMS0xLTA_9f023bb4-00e3-49d7-9161-12d2bfbe7a9e"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i47759bf2f11a4074a56c410f5f7b51ae_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYyLTE4LTEtMS0w_028d0280-40c9-4188-9403-7077a19b6e51"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTgtMS0xLTA_61d01c6e-ab3b-4278-a6ec-eb884edc1195"
      unitRef="usd">654400000</holx:Netincome>
    <holx:Netincome
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTgtMS0xLTA_ced73742-63c6-4d2c-aad8-14f24f3c2c41"
      unitRef="usd">654400000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTE2LTEtMS0w_408e8cda-2553-465b-bfa8-a17b8085f192"
      unitRef="usd">-1000000.0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTYzLTE4LTEtMS0w_37e03f26-76be-4d9c-8a82-ae12512b5f9a"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY0LTEwLTEtMS0w_4d35d18b-cd89-4952-a903-a825ff6145a9"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ae2066b3b68407db7a000e8062132cf_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY0LTE4LTEtMS0w_2cd278f6-d5d5-430e-86f2-556d7d25a291"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTEyLTEtMS0w_b427a8e8-9cf3-427b-b87d-a4e679148685"
      unitRef="shares">1469000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i6dbc202a9bf745a8bafa96892c0a5947_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTE0LTEtMS0w_65bce905-8c54-45b3-9f03-6a90298919e2"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY1LTE4LTEtMS0w_86f17a80-104f-4680-a15c-bf594f2dec9c"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i1cff19231e714132bf4dc7ccaa04d77a_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTItMS0xLTA_b016693d-40a1-487b-9671-35326f5a1e45"
      unitRef="shares">296533000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1cff19231e714132bf4dc7ccaa04d77a_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTQtMS0xLTA_b369323e-f4c9-455c-a356-af970dd95b0f"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id823f47b65a04844af628de4c871ffb5_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTYtMS0xLTA_791d4b13-3f35-44b1-a8e0-5b5de3fefba3"
      unitRef="usd">5895300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i599e6bb573174ab9946c1b0e7a65a1ee_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTgtMS0xLTA_ed246682-afa9-41fc-9aab-a12165f70150"
      unitRef="usd">-918800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f41c1c1b96640ce8c37aa114378b5af_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTEwLTEtMS0w_ea649f2f-3e5a-4c4e-9f86-0fbad14b82c1"
      unitRef="usd">-30700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i2c8bb166454744ccbffadde0265cdfd4_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTEyLTEtMS0w_e46424f6-ef93-4823-ad35-471675a8eeaf"
      unitRef="shares">39078000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2c8bb166454744ccbffadde0265cdfd4_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE0LTEtMS0w_c0c3df78-ba2d-463b-80f9-c96c53bb2f19"
      unitRef="usd">-1680900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE2LTEtMS0w_d3880deb-a7ab-4687-bf7a-9c3a59d6dfba"
      unitRef="usd">1100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY2LTE4LTEtMS0w_0b081170-2aa4-455f-9176-9175744da9b7"
      unitRef="usd">3269000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTItMS0xLTcxMzM_7234820a-7c8b-4285-9492-f8ba40701c4f"
      unitRef="shares">146000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTYtMS0xLTQ0MjY_120a063d-f870-424c-b928-fca0d077ee22"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY3LTE4LTEtMS03MTM3_db350894-ec69-46a5-95c4-6f86bd0d69d4"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTItMS0xLTcxMzk_bbe595b4-4793-4837-a41f-a077296ba8b1"
      unitRef="shares">17000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTYtMS0xLTcxNDE_95d39cfb-c92e-4eb0-85aa-5ac47b3e53fd"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY4LTE4LTEtMS03MTQz_0f1ec5b3-c74f-4bfb-98a6-58e408a7ece6"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iaa190e28827e411b84f1d88465f9b354_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTItMS0xLTcxNDU_dfb2206f-0ca3-403e-b172-fe37d3f93ac7"
      unitRef="shares">191000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTYtMS0xLTcxNDc_21311a5c-f213-4af9-b97f-148f556a2f80"
      unitRef="usd">9200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTY5LTE4LTEtMS03MTQ5_e8138374-15cf-43d7-8dc5-014d888e347f"
      unitRef="usd">9200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcwLTYtMS0xLTcxNTE_080fcdf4-a5ce-4c35-9761-80f5ba034e2b"
      unitRef="usd">17100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idae4b4e9a118462286491d9b0cf8a0d3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcwLTE4LTEtMS03MTUz_04ccabb5-0331-442a-8596-55524293b109"
      unitRef="usd">17100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTgtMS0xLTcxNTU_97ff2a01-f4a2-474a-b6c2-3be6f333302b"
      unitRef="usd">619900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTE2LTEtMS03MTU3_a981a93f-020c-4bf2-8b78-e78f11d22795"
      unitRef="usd">-500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcxLTE4LTEtMS03MTU5_c039186c-d99f-4120-a816-475bd8b39e09"
      unitRef="usd">619400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcyLTEwLTEtMS03MTYx_fab6561d-4159-4e1d-bac6-dfee8fb31166"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTcyLTE4LTEtMS03MTYz_be016ea0-12ed-40e5-9ddf-1c36cec6dc13"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTEyLTEtMS03MTY1_489d7da4-a115-4898-a397-61cdc883b4f9"
      unitRef="shares">1604000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ic0d02f4cf04649afb5a18cebe0b0cd5e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTE0LTEtMS03MTY3_7c6de8a2-2105-4a98-905b-a49ee90ca9e8"
      unitRef="usd">120100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTczLTE4LTEtMS03MTY5_faa85b30-eb7f-4360-b646-9879dbd16c1e"
      unitRef="usd">120100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i247efccf5d6947e48ecee24ca732c483_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTItMS0xLTcxNzE_bbf7153d-2c5e-4b7c-8365-87e4f83c8ecd"
      unitRef="shares">296887000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i247efccf5d6947e48ecee24ca732c483_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTQtMS0xLTcxNzM_b4cc6d34-c2ec-4776-9784-6075f1b52ea6"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i13e744d8762c4825aa1a4d2b4bdf2cf3_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTYtMS0xLTQ0Mjg_82268788-3ebe-4dcf-99fa-b1303e4cd51a"
      unitRef="usd">5927100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b0da21f00cf470eabc24e01c7fc5fa2_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTgtMS0xLTcxNzc_40004f1c-a246-47e8-ae61-630d02e267a0"
      unitRef="usd">-298900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTEwLTEtMS03MTc5_c7da1f9d-fa3a-4255-aa3c-00d7f37007e3"
      unitRef="usd">-35800000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTEyLTEtMS03MTgx_cc6231f9-155c-4b98-b465-fdd52cfba02a"
      unitRef="shares">40682000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i758e6e9cc9e5487a926aea0aa53a2a71_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE0LTEtMS03MTgz_fd78429c-3ba5-4bb4-932d-5df6b1a4bf1e"
      unitRef="usd">-1801000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE2LTEtMS03MTg1_d90f916b-b87b-45a6-a7d4-482943f50e45"
      unitRef="usd">600000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yNS9mcmFnOmEyYzI2MGVmMmEyMTQzYzJhZjc4ZDExOGNkOWE2NjQ2L3RhYmxlOjg1OTg4Y2FkZDhiYTQyZTI5MTVjYzc5MGFmYWMzMzQyL3RhYmxlcmFuZ2U6ODU5ODhjYWRkOGJhNDJlMjkxNWNjNzkwYWZhYzMzNDJfMTc0LTE4LTEtMS00NDMx_3d1b09b1-9b9d-4c70-bc5f-bc048396fb6d"
      unitRef="usd">3795000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMy0xLTEtMS0w_d988bd82-abef-4291-be07-1f8739649e3e"
      unitRef="usd">1272800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMy0zLTEtMS0w_7a0b928b-652c-43ea-9b10-8959c98852f3"
      unitRef="usd">480700000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNS0xLTEtMS0w_46af07d4-8b84-4e28-88aa-73b1e9f6745f"
      unitRef="usd">41500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNS0zLTEtMS0w_1c5dd15a-7aff-42ea-84ec-6d5602d9d1dd"
      unitRef="usd">42300000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNi0xLTEtMS0w_cea9452e-5a56-4cf7-9c1e-8fd42acde9d2"
      unitRef="usd">146500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNi0zLTEtMS0w_26d996f1-b100-49ff-9447-cbbd5f6ea3de"
      unitRef="usd">145800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOC0xLTEtMS0w_43109a73-ad76-49ef-9a4f-d86d25a85427"
      unitRef="usd">35600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOC0zLTEtMS0w_e798a514-9dc7-4134-8aff-f1a005e7223c"
      unitRef="usd">33800000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOS0xLTEtMS0w_b3425b4e-6f36-450a-b08f-626b0709a1e7"
      unitRef="usd">-23500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfOS0zLTEtMS0w_c8204689-48a9-419f-9d8d-34b7243b3d8d"
      unitRef="usd">-44200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTEtMS0xLTEtMA_ef5e6e88-9b46-405b-838b-309af8b28b96"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTEtMy0xLTEtMA_f55fb0fc-f5cc-402c-ac17-359d6c980606"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTMtMS0xLTEtMA_1b774da0-b635-4e5a-895f-fb09f96004d1"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMTMtMy0xLTEtMA_ae3017f8-6f9b-43c7-ad93-d2903c77640e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjAtMS0xLTEtMA_ef8d66e6-3f24-4bd4-ab7c-6d963dfe6c65"
      unitRef="usd">-18900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjAtMy0xLTEtMA_77bd8058-45fe-4c55-a0e9-e2d361e73e35"
      unitRef="usd">-14800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjItMS0xLTEtMA_0a3b6e57-4529-47ae-a42e-3502d4eec8af"
      unitRef="usd">171400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjItMy0xLTEtMA_3d2b2956-ba35-4d31-bf3e-3972cc710e16"
      unitRef="usd">300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjMtMS0xLTEtMA_a187f630-8bb2-4bb7-8216-a6d910540780"
      unitRef="usd">46000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjMtMy0xLTEtMA_88e46ece-ff8e-49e1-843d-2c3568a7b3ea"
      unitRef="usd">33300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjQtMS0xLTEtMA_52eef0c7-03ca-4734-b5bf-dac57af344be"
      unitRef="usd">46600000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjQtMy0xLTEtMA_900554f5-286a-4547-9d7e-3f3afa6aa0e4"
      unitRef="usd">27700000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjUtMS0xLTEtMA_e7d9766b-ab86-49ad-8622-e3ce2640c03d"
      unitRef="usd">36700000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjUtMy0xLTEtMA_b35d7e16-34d7-46f5-a911-1c76dfe41a41"
      unitRef="usd">317600000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjYtMS0xLTEtMA_946440a2-6def-4ddb-9ad7-fc4f6d8787ec"
      unitRef="usd">32800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjYtMy0xLTEtMA_80a717c3-9c61-469d-aeab-8a0ff50f1092"
      unitRef="usd">-47900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjctMS0xLTEtMA_bc1570f9-17d6-4ddd-b920-1253aee932b3"
      unitRef="usd">-50100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjctMy0xLTEtMA_6fcedd72-ac7c-452b-8ee7-2e1aaad8959e"
      unitRef="usd">-50800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjgtMS0xLTEtMA_b728dcc4-18ad-44c4-914b-35c4e9c04d8f"
      unitRef="usd">6800000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjgtMy0xLTEtMA_62e8ea4a-de6b-4b65-a23b-01c5728e152d"
      unitRef="usd">5800000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjktMS0xLTEtMA_a477342f-fa46-420b-b092-141755e4d4da"
      unitRef="usd">1202200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMjktMy0xLTEtMA_74f9155a-0593-4a06-8b67-bf6f591e9931"
      unitRef="usd">231600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzEtMS0xLTEtMA_efc89981-3700-4da8-989d-fe7fa0f7fa93"
      unitRef="usd">440000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzEtMy0xLTEtMA_d2d8f23a-fdb4-440a-9263-a8111e758bf2"
      unitRef="usd">43200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <holx:ProceedsFromSaleOfBusiness
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzMtMS0xLTEtMA_f3cc9645-df84-44a9-8e03-28b60309b2d9"
      unitRef="usd">0</holx:ProceedsFromSaleOfBusiness>
    <holx:ProceedsFromSaleOfBusiness
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzMtMy0xLTEtMA_c85fb1b1-7aff-45d2-a95d-25ee578414af"
      unitRef="usd">142700000</holx:ProceedsFromSaleOfBusiness>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzQtMS0xLTEtMA_e574a665-9204-4240-beb1-d21913681fc0"
      unitRef="usd">51700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzQtMy0xLTEtMA_5979779f-2d2a-439a-be55-b098b584a5c9"
      unitRef="usd">29600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzUtMS0xLTEtMA_15bf3a9f-ec0b-4955-a7b2-f24608d7db6b"
      unitRef="usd">27800000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfMzUtMy0xLTEtMA_a0e61f47-d598-45d1-8e01-6b90275497f5"
      unitRef="usd">33500000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:Purchaseofinsurancecontracts
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDEtMS0xLTEtMA_e427f461-f320-45a4-b509-5baf53c01a69"
      unitRef="usd">1600000</holx:Purchaseofinsurancecontracts>
    <holx:Purchaseofinsurancecontracts
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDEtMy0xLTEtMA_0a736f46-51e6-4989-9c3c-1a0dc492030c"
      unitRef="usd">2400000</holx:Purchaseofinsurancecontracts>
    <holx:PurchaseOfIntellectualProperty
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDMtMS0xLTEtMA_198b9d54-044d-4fcf-9107-ecfa42a848d5"
      unitRef="usd">6500000</holx:PurchaseOfIntellectualProperty>
    <holx:PurchaseOfIntellectualProperty
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDMtMy0xLTEtMA_ab2bbbb6-f742-44ce-99f1-03240a88da16"
      unitRef="usd">0</holx:PurchaseOfIntellectualProperty>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDUtMS0xLTEtMA_e5caa76e-cef6-4dba-837e-d3b970255010"
      unitRef="usd">500000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDUtMy0xLTEtMA_a239d07e-8e44-4ccd-b883-ffd70c49985b"
      unitRef="usd">1400000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDYtMS0xLTEtMA_a93ea678-1e26-49a7-ad94-f60899e6c786"
      unitRef="usd">-528100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDYtMy0xLTEtMA_c943bd32-613f-4875-ab73-632b5d854376"
      unitRef="usd">32600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDktMS0xLTEtMA_69e7f5b1-52dc-45ef-8ff8-fa1787e0f95a"
      unitRef="usd">37500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNDktMy0xLTEtMA_170c2bc4-7e2f-41cb-b54b-7c1887b3cc15"
      unitRef="usd">27100000</us-gaap:RepaymentsOfLongTermDebt>
    <holx:ProceedsFromSeniorNotes
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTAtMS0xLTEtMA_321a2f05-dfd0-4a86-bbea-34cfb0bdefab"
      unitRef="usd">950000000.0</holx:ProceedsFromSeniorNotes>
    <holx:ProceedsFromSeniorNotes
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTAtMy0xLTEtMA_d12daf08-c396-4927-a848-21922ecbede3"
      unitRef="usd">0</holx:ProceedsFromSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTEtMS0xLTEtMA_10d2872c-f701-4337-9a80-bdc3a369c2f8"
      unitRef="usd">970800000</holx:RepaymentOfSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTEtMy0xLTEtMA_a480ff21-0ef8-4760-922e-bfbca32dace8"
      unitRef="usd">0</holx:RepaymentOfSeniorNotes>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTMtMS0xLTEtMA_4a106725-4364-4354-a599-6f2d9b364472"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTMtMy0xLTEtMA_478f8876-5804-4576-83ba-1b21df9c8334"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTQtMS0xLTEtMA_50ec0659-1aae-49b4-8425-9f4314c80067"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTQtMy0xLTEtMA_5d20888c-788d-4c78-a841-f40d0c648d62"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTUtMS0xLTEtMA_21d1b730-2d32-4e7d-b7ee-9ea337b4f74d"
      unitRef="usd">0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTUtMy0xLTEtMA_db94c4e6-0e11-4d8f-8633-aa9472346515"
      unitRef="usd">16000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTYtMS0xLTEtMA_a4dd24f6-8c0b-418e-b123-4cedf6b5e3f6"
      unitRef="usd">0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTYtMy0xLTEtMA_5916c549-31f0-4368-8303-74880e3979d2"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTctMS0xLTEtMA_c493f71f-90fc-44a0-8f2b-8e16afff16f6"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTctMy0xLTEtMA_05830674-5be5-4399-acde-91d3a4dbbcfe"
      unitRef="usd">1700000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTgtMS0xLTEtMA_7b062f7a-7d17-4553-9ff1-5964247b9087"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNTgtMy0xLTEtMA_aa777be5-b870-44ce-9fe5-4dabd0f04c11"
      unitRef="usd">24300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjAtMS0xLTEtMA_1cefb2a3-63ec-437a-b15c-c7630fd7d682"
      unitRef="usd">13700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjAtMy0xLTEtMA_6338a84c-76f3-49aa-a7b9-763828f9c208"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjItMS0xLTEtMA_3e3c369a-2408-4767-8473-5748067852e4"
      unitRef="usd">221400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjItMy0xLTEtMA_25067832-0398-448b-8e00-ef7413b157e4"
      unitRef="usd">553500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjQtMS0xLTEtMA_2a84e30e-ec3c-464f-8885-9fc576f88e4e"
      unitRef="usd">33600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjQtMy0xLTEtMA_a600771a-acbf-4a0c-ade3-9a8c46a200e3"
      unitRef="usd">36600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjUtMS0xLTEtMA_9379850c-9035-457f-bf0b-94bd13d47b15"
      unitRef="usd">46700000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjUtMy0xLTEtMA_b42071dd-47c7-4100-9dcd-f47994da0f02"
      unitRef="usd">12500000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjYtMS0xLTEtMA_fa3b6564-c2c2-4a44-b40d-979ca2b70fa6"
      unitRef="usd">900000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjYtMy0xLTEtMA_28937963-185d-404a-8fbd-162e9917ee47"
      unitRef="usd">800000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjctMS0xLTEtMA_fd66e322-cc2d-4ada-a623-e87acd974e84"
      unitRef="usd">-557400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjctMy0xLTEtMA_022e1bbe-5f69-45bc-9dd4-f8f632df6e7f"
      unitRef="usd">-67300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjgtMS0xLTEtMA_a7164859-a433-4796-9354-acdcd17027b8"
      unitRef="usd">-1300000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjgtMy0xLTEtMA_d8154071-2fd5-42ab-be23-d98316815fa1"
      unitRef="usd">1100000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjktMS0xLTEtMA_1a8e076d-022f-4c1d-8da0-905e08082a8e"
      unitRef="usd">115400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNjktMy0xLTEtMA_1d07e529-dc58-4c11-a533-d44b18e1eba5"
      unitRef="usd">198000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzAtMS0xLTEtMA_ade6a9e9-d772-4c5c-99ef-09963ebcb0dc"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzAtMy0xLTEtMA_ece19ff0-c0a7-4ba9-888c-7636fef4cdc8"
      unitRef="usd">601800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzEtMS0xLTEtMA_97db4150-f5ca-4737-a32d-4ecfbead6947"
      unitRef="usd">816400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8yOC9mcmFnOmZlNjZmZDIyZDE5MDRlNTJhZmQ4OWQ5Yzg1OWQ1NDIxL3RhYmxlOmU0NWZhYzMxOWI5YTQzMmNiOWNhMzQ3Mjk4YjQzZDgzL3RhYmxlcmFuZ2U6ZTQ1ZmFjMzE5YjlhNDMyY2I5Y2EzNDcyOThiNDNkODNfNzEtMy0xLTEtMA_9ef5098b-ac26-40e3-9337-df499b8f7f55"
      unitRef="usd">799800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i87367de631f24b48bda162d20ba2e661_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNC9mcmFnOmFiZGQ5NjlmNWEwODQ4M2JhOTM4ZGRjMmQ1NjUzZmVhL3RleHRyZWdpb246YWJkZDk2OWY1YTA4NDgzYmE5MzhkZGMyZDU2NTNmZWFfNDgyMg_7066f15f-e15a-4123-8c69-25c2136b356b">Basis of Presentation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of Hologic, Inc. (&#x201c;Hologic&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#x2019;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended March&#160;27, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU No. 2019-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended March&#160;27, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was one unrecognized subsequent event related to the acquisition of Mobidiag Oy ("Mobidiag"). On April 8, 2021, the Company announced that it had entered into an agreement to acquire Mobidiag for a purchase price of approximately $795&#160;million. The closing is subject to certain regulatory approvals and other customary closing conditions. Mobidiag, located in Finland and France, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. The Company expects this acquisition to close in the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3d291e0f9c0b402da8343bcc6b51f9f2_D20210408-20210408"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNC9mcmFnOmFiZGQ5NjlmNWEwODQ4M2JhOTM4ZGRjMmQ1NjUzZmVhL3RleHRyZWdpb246YWJkZDk2OWY1YTA4NDgzYmE5MzhkZGMyZDU2NTNmZWFfMTA5OTUxMTYzNzY0NA_80f919d7-f694-4d36-8e68-4a3e3b2f3bd6"
      unitRef="usd">795000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNzg2Nw_66086564-a0a1-4ff8-87b6-588acefb903d">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,930.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,468.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,178.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="ie2dff062ce5742cd9f8ec548f170b3b3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy0yLTEtMS0w_cf02aea0-576c-4ef0-96a0-7c13129178b8"
      unitRef="usd">76800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i90763f49a0da4076b8324779a162e6a4_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy0zLTEtMS0w_80e10e16-2cae-4915-ab4c-0923bc2e44b2"
      unitRef="usd">40400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb9a123d4d3f4bd282939064c3e109ab_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy00LTEtMS0w_6948ab65-fbae-4412-afcf-36a29c03f30c"
      unitRef="usd">117200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26ef905de85948f8bdd806e8ca63fe1d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy02LTEtMS0w_96eca4a2-5b8b-4fcb-b935-32936e4cff6d"
      unitRef="usd">73200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec54e8e340d5457e910be1d441c98063_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy03LTEtMS0w_b9aa4a65-66ec-4a0b-937e-f22a1f32c97a"
      unitRef="usd">40200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26927080ee34404080aa7911ade83d18_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMy04LTEtMS0w_80efb9a1-7231-4cc1-a17e-1e409dc7ff5e"
      unitRef="usd">113400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bf8f71a8497491c86ce651b76d4b795_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC0yLTEtMS0w_625dcd16-9c16-4755-a56d-1e1e68958ec3"
      unitRef="usd">616400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id6ae7d35265f4897bdfb34c7ccae119e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC0zLTEtMS0w_67b4e102-1f4b-496a-af19-abaa9189e304"
      unitRef="usd">318900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22cc0d7ae9e74ca8a9ff4d198d78501f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC00LTEtMS0w_a932f9e7-dc8e-4332-9940-4ce4f88e6d97"
      unitRef="usd">935300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied817d099e4b480faed0980ac29438b8_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC02LTEtMS0w_533650c6-4be1-4809-bfd0-48a3b65e9e4b"
      unitRef="usd">149800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if128eb894bce4b3085c7eaa916a5bfb8_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC03LTEtMS0w_e2cf1387-57c5-4092-994c-755db44706e6"
      unitRef="usd">40800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5bfd76ed5cab498ab2ab0d727bb2b083_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNC04LTEtMS0w_15e26ec6-175d-4678-9669-94ffac562008"
      unitRef="usd">190600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib64a089977c64ec0b379ab8be5a289a0_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS0yLTEtMS0w_0091c686-ea2b-4996-aa91-745d12c3db24"
      unitRef="usd">12000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2fe9760506e145efb1273a91972bd7e6_D20201227-20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS0zLTEtMS0w_019a7c43-fca4-4acb-8f6a-a03ab70f41b6"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8a06780affc4452b0a0a9c31aecf31b_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS00LTEtMS0w_4793a6d6-0268-4902-aa24-06f7871f8a16"
      unitRef="usd">12000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic51d744e73d9470889480aef44867b64_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS02LTEtMS0w_8a5d29f7-208d-400f-ba29-9aa11ccf4818"
      unitRef="usd">15200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ffa4cd943fc4ae697fcf28ee9dafa69_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS03LTEtMS0w_624ce350-0db4-4865-966b-2310d8ee2f53"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id617caf99d314fb4a8f7f5fb37a854ad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNS04LTEtMS0w_1a99a69b-d337-4f1a-a18a-62e497d677c5"
      unitRef="usd">15200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9eb8417c24934037bf730f4f45fd1dac_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi0yLTEtMS0w_34fa77db-9e35-452e-bd5c-8854b3100374"
      unitRef="usd">705200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic949542e55314c0e90e75d07a6a7cc95_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi0zLTEtMS0w_ac277fd4-0f17-4364-a53d-5e2fd16da412"
      unitRef="usd">359300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi00LTEtMS0w_e5e5e382-5a50-4671-9136-4eb960459936"
      unitRef="usd">1064500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40ca6cd87d9346f8b4d6b257b76f1599_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi02LTEtMS0w_62ec9f68-06e8-4c85-bb80-8be1cc855268"
      unitRef="usd">238200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb9fc6529dcd456a8fe760d48006a3e4_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi03LTEtMS0w_95117953-3e60-40e6-be9d-895ab1a4bd78"
      unitRef="usd">81000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfNi04LTEtMS0w_df1a61c1-0cb1-4be2-8f96-e6ba432fb186"
      unitRef="usd">319200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c343532655149f1a030365f026ac439_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS0yLTEtMS0w_8ef00a2c-0734-4339-9e8d-ec692ff4b935"
      unitRef="usd">198100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c0120a99d97456999e5ddc37d3d7309_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS0zLTEtMS0w_15f939d1-0aed-48fa-92bc-53c49b687fb0"
      unitRef="usd">71800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3faa6d77c258415e86dcf4d8129eac6e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS00LTEtMS0w_d936843e-7e8a-4308-86a6-87514a336cc9"
      unitRef="usd">269900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i857265c2f31341619b24eb60b43b0fb5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS02LTEtMS0w_260e0636-9d9d-4e1b-896c-72de363a3545"
      unitRef="usd">186000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad34163568284cdc83c1e20070c4cea2_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS03LTEtMS0w_0d5e086d-4f91-4d31-a11c-210c56531c23"
      unitRef="usd">64200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7082eff3d7ef4efc80ee731afa776eac_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfOS04LTEtMS0w_50dfaeb9-2dee-4be8-98c5-cca8eb2b0d4a"
      unitRef="usd">250200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibc01a3ba376e4dbcb32a1e598e325b13_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtMi0xLTEtMA_9882d9dd-6ed2-4a6e-90a1-b90dfbf8e74f"
      unitRef="usd">54900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f692bdf106e49fd9aaf7fce303fffe4_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtMy0xLTEtMA_c83c1ad4-695d-44ec-a594-a5aa3a540b0c"
      unitRef="usd">11500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c3a06fe0c864a24885a1ba3a58df54e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNC0xLTEtMA_1ac90d82-e9ec-44ed-94c3-c5e0b672a86e"
      unitRef="usd">66400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85c810b9218b4cd4a2163bfaa2fb7c03_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNi0xLTEtMA_1f6d4997-7019-4b4d-a801-ed3277d8ead0"
      unitRef="usd">48400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i942d891a356341019e4507b3365c2ba1_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtNy0xLTEtMA_e9cedebd-6c4b-44d9-b00c-a1b08b26a1dc"
      unitRef="usd">9200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6e50b3ca2f146f9a5608d79b8d0845f_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTAtOC0xLTEtMA_d948a29c-f34d-4cdb-bd26-aad1e03dd92e"
      unitRef="usd">57600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d9a60d400a14336a1e90394d3d649fb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItMi0xLTEtMA_cbb49f25-2aa5-49b2-903a-a8dbd05a5602"
      unitRef="usd">253000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8341e0c83b50432d92002e51dc1d415a_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItMy0xLTEtMA_a66d0de5-b739-41ca-9f82-69c5b3654c3c"
      unitRef="usd">83300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNC0xLTEtMA_be13dd62-85f0-4b9b-8374-0c3db49b3f46"
      unitRef="usd">336300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id259ac18b2c14a708dcfb664de4fede3_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNi0xLTEtMA_5f83c477-120b-4b2e-b80f-b86da7a343c5"
      unitRef="usd">234400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i765b92cf3fcb456b940d23ea47f28bd0_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItNy0xLTEtMA_644f2a3e-a047-4649-8a27-6edda2b7caaf"
      unitRef="usd">73400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTItOC0xLTEtMA_dc958e22-a514-47d9-a0ed-a00778997301"
      unitRef="usd">307800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1725b5668d3e4a858551fd8eb7138677_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtMi0xLTEtMA_b677771d-0c71-4e73-bf45-ad8037fbd562"
      unitRef="usd">91700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb26cd5cf96841d99340d97a2844a812_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtMy0xLTEtMA_c378d4b1-0d92-41f1-bd3d-d5680835cb28"
      unitRef="usd">22500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNC0xLTEtMA_1cd8ec2b-6512-44bd-bfc0-162515e3c9e7"
      unitRef="usd">114200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ce8a0b09e77488b9facc4bf5ffb533d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNi0xLTEtMA_f203bf3c-3950-45c3-b869-caa7fb5b1e1e"
      unitRef="usd">86700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4bbb18bc92ff4414b39e894a76fab932_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtNy0xLTEtMA_946c21b0-be3a-449c-8a07-f9554425f8c9"
      unitRef="usd">18700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTQtOC0xLTEtMA_7751225b-afa2-4209-836b-dfe417157783"
      unitRef="usd">105400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i231dbd6cca1f4e44b1648addc4f9b83d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtMi0xLTEtMA_5635cc3a-5bde-4e45-9d70-0c8b740def56"
      unitRef="usd">14100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i136ee5e50cad46c9878d11c256642bfe_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtMy0xLTEtMA_620cf09d-2538-4f3f-9865-8a914fb33ac6"
      unitRef="usd">8500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNC0xLTEtMA_28a50c44-9345-4789-af33-c7019409ef22"
      unitRef="usd">22600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i014ec62aff694cd984436a0315313b3e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNi0xLTEtMA_b8540369-bd0f-4c1c-8564-0f645b1867f2"
      unitRef="usd">15600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i921dfcf8a3d74f3c9e2967faea2a2c23_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtNy0xLTEtMA_21397bd7-57ad-426c-9cd8-bfd4ad56c6da"
      unitRef="usd">8100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTgtOC0xLTEtMA_7f003961-51dc-4cd7-b078-f51d1dc53d30"
      unitRef="usd">23700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktMi0xLTEtMA_f7f440b8-95b6-4888-9c54-b60d49269d40"
      unitRef="usd">1064000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2e0e2bca7514b3c85c5bf5e035db201_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktMy0xLTEtMA_2b39b91c-d564-4640-a1d4-83c4088f8b22"
      unitRef="usd">473600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNC0xLTEtMA_e0958dae-9fc1-47a5-900a-ae78e5d805f3"
      unitRef="usd">1537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNi0xLTEtMA_b9cfa1df-bb14-491e-a7e0-5a30497afa74"
      unitRef="usd">574900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c75b6298a974b8c93d3c5a118504b01_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktNy0xLTEtMA_497d4042-478a-4a92-a549-7861eda8358f"
      unitRef="usd">181200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjIzMTg4YzU4NGM5NDQ3NTQ5OGY4NGUxOTNiMzQ3OTUzL3RhYmxlcmFuZ2U6MjMxODhjNTg0Yzk0NDc1NDk4Zjg0ZTE5M2IzNDc5NTNfMTktOC0xLTEtMA_ee356dd1-4ad6-4ba9-9a89-53f019cf447e"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c4f0fb353d74058a1441937e80c0438_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy0yLTEtMS0w_4de84d90-49c7-4867-b471-b39c4f5c9a59"
      unitRef="usd">156900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecf735ef79384b248873abab375129b4_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy0zLTEtMS0w_6cddc522-5440-4062-ba3e-f5cb885f3b44"
      unitRef="usd">85100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie927f60bf6f24e25bfd16b54244ee885_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy00LTEtMS0w_a701970c-1bb3-4568-8e67-55f6754ac825"
      unitRef="usd">242000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e9b232304f94408904a99c1ae44eafe_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy02LTEtMS0w_e6d6f1fb-a41f-4d82-8e99-807ea9ebf8d0"
      unitRef="usd">150700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i95f2ae3f5fa742d7a917b5c8ed7f9fb8_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy03LTEtMS0w_0d3bbfe7-7c1f-4165-a64f-3dd95ab92e37"
      unitRef="usd">83700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i736988332f4142f9ac9feecbb79164b1_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMy04LTEtMS0w_f6e6de0b-cff1-4d6a-881f-e111a8177912"
      unitRef="usd">234400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i90ddb6816eec49e8ab3f15d0f66f2334_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC0yLTEtMS0w_bce74ccc-dee2-4dbe-9c88-57ee09872f03"
      unitRef="usd">1291600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie78313136a484fd781c8813953a0cf7a_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC0zLTEtMS0w_5b4323c9-06cd-4a05-b2ff-4fded733515b"
      unitRef="usd">639000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i145a6fe21b194a67bef28af17d19bc6f_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC00LTEtMS0w_0d343df1-20ff-4dac-8d17-ab38a514f275"
      unitRef="usd">1930600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i190143611a554923926b1ae36be81fda_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC02LTEtMS0w_fc7105bf-bd43-4434-82b4-e7da83b42332"
      unitRef="usd">291900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2269cd37c22f4b219c9519c04e7be995_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC03LTEtMS0w_4d080c5d-7d77-4680-aa9b-40cc0e411f43"
      unitRef="usd">77200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic23b5154647642809bedb5594b430f24_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNC04LTEtMS0w_6d8ef6d3-7124-4973-a1de-0df8cce6f5da"
      unitRef="usd">369100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba116bd00a7046bf8c91f0d6b892314b_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS0yLTEtMS0w_ca87aab5-41ff-44fc-a0a8-07b4e6f34064"
      unitRef="usd">20100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i995e19c951b14bfea6e4d26e9cd4d486_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS0zLTEtMS0w_85d2dcca-3c62-4d1f-92f4-1e4c12c23972"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c1c56aa05ee45ffafd1f1ffda0164a5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS00LTEtMS0w_d6e895e0-496c-422d-8cf5-db37ecc345dc"
      unitRef="usd">20100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18d6a37b17e74d0fbf1668eb8dcd7a91_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS02LTEtMS0w_6c701e2e-f396-4aad-8d5b-5696f49ed11d"
      unitRef="usd">27200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i56dfdce3eb6d424d86b58122d2f5ee1f_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS03LTEtMS0w_008e1ba5-b6c9-477a-b582-ae2454302726"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i280feb419f2b4e1bbd5f84cbc2b56e78_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNS04LTEtMS0w_9cd50424-ef61-4242-a647-a14e2d8f9e66"
      unitRef="usd">27200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia9a96273a62543e085fdd72cbb24282e_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi0yLTEtMS0w_a4ad6f2b-b6d7-4656-b956-a8f387307035"
      unitRef="usd">1468600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65621f54c26c4015a221bacce5212e11_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi0zLTEtMS0w_e1c954b4-041c-4070-ad6f-dbe34500e6c7"
      unitRef="usd">724100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi00LTEtMS0w_c878d0f3-be3e-4081-8034-75135ffa64a3"
      unitRef="usd">2192700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida7b7a78e84c49fc9efb0c922ae148a2_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi02LTEtMS0w_52de160e-bc83-46d4-8881-a8d516c1c30c"
      unitRef="usd">469800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54b99b53db764f00a7bae9226ea58a55_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi03LTEtMS0w_6ff1af5e-c607-43b9-a2c1-ae79067e1224"
      unitRef="usd">160900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfNi04LTEtMS0w_6b4cf48a-778c-44d9-a379-b3211efa6e8a"
      unitRef="usd">630700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1996dc2670f44d885b459e6b7844ca1_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS0yLTEtMS0w_8b045927-f2b7-4371-bdc1-6c9d60f096c9"
      unitRef="usd">401100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a7aea66c3b64c15aa4fc1fcbcd3ad08_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS0zLTEtMS0w_b1edaebb-386f-4d2d-87f6-3b601da3750d"
      unitRef="usd">136500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71e20d39915246d8b5d89b9fedd7385f_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS00LTEtMS0w_1d243321-8820-4d3e-8d99-1396efba41f0"
      unitRef="usd">537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaacb7d97fbf041878e9f9f0a4f583432_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS02LTEtMS0w_f0de75a1-53ac-41e8-9a60-5579d86dd471"
      unitRef="usd">395400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f6361d96ee24d73b8046575850f64d3_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS03LTEtMS0w_9b04a7a8-2d87-40ea-8bfb-9b6a2927534b"
      unitRef="usd">129600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib66008fadaf74341aed6338aed1d6e58_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfOS04LTEtMS0w_4bea4c3a-b281-4b7e-8f70-065a1fe2fd90"
      unitRef="usd">525000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7a75015d04d4338ad7cfca21a6493a8_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtMi0xLTEtMA_d2a0eec6-b4a0-42c2-9d2a-d9f103ce9bb0"
      unitRef="usd">110100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i20fc49c576e34cc69859aff92990662d_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtMy0xLTEtMA_e813ca72-a5f6-4866-94ff-24c7d06087f7"
      unitRef="usd">21400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7973bfa616db4dc483c4bd851ccb1a56_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNC0xLTEtMA_afb6bc2f-f981-44da-8955-755fc7a2b3b7"
      unitRef="usd">131500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieaa248859d134c8f8dcb2fb68862b1b0_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNi0xLTEtMA_b8d9da18-94a6-4674-a8a6-08bafa602f35"
      unitRef="usd">95500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id274d4645da042b1bf61995fe9215df2_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtNy0xLTEtMA_ff010210-a4bf-471b-acc5-8d6ce33c6dd3"
      unitRef="usd">18400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ac781329d4b4af88611a402bc50fa21_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTAtOC0xLTEtMA_d3e03c10-f2c9-464d-b9f7-291bb8a77132"
      unitRef="usd">113900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c130431784f4c5b939e3a7eb06020d9_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItMi0xLTEtMA_ee4ae0f5-8901-4229-a550-5487a8d421d3"
      unitRef="usd">511200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e191d17f2624a8e81a271bf9ff484f2_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItMy0xLTEtMA_202f94a2-9194-4713-8703-b896abd17801"
      unitRef="usd">157900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNC0xLTEtMA_280478ec-f1e4-47c4-8c20-8146d055bcc6"
      unitRef="usd">669100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a9c15aeb74a40068d4ecb624e590739_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNi0xLTEtMA_62786eed-083d-4e11-8a05-4bd0e41164c1"
      unitRef="usd">490900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425d67db4aff4b68954adb976a9fc71d_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItNy0xLTEtMA_3c539884-cebb-4f97-ba3c-a6f357ceae05"
      unitRef="usd">148000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTItOC0xLTEtMA_95ce9a35-27a4-45e9-b01a-9165b4ebc11e"
      unitRef="usd">638900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5450315dcdd74fee9c2c005920e5f504_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtMi0xLTEtMA_df3d3e98-17b7-4e31-b88e-e2740a88e08c"
      unitRef="usd">192800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1be8d9825a04deeaa24e83a941f2408_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtMy0xLTEtMA_7adcd239-b8eb-4fec-8140-5258cc719cc7"
      unitRef="usd">45400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNC0xLTEtMA_facd7111-44c2-4adb-ab31-58db211ecd09"
      unitRef="usd">238200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40ab6df387644866a1e1f37f2257d845_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNi0xLTEtMA_2db60439-13da-42d4-bb88-7904c2b0e57a"
      unitRef="usd">185500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9617c714041343938ba7ef699d01cf6e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtNy0xLTEtMA_2efcb3d4-49f6-47b6-8b39-718d393ae3de"
      unitRef="usd">39000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTQtOC0xLTEtMA_77767863-dcdf-41cc-a30c-78a11f8d69db"
      unitRef="usd">224500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8973c410d7ec480da813338cbd127421_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtMi0xLTEtMA_e92ae872-37a1-4746-b530-2852d8397f1b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie54e7336610d4110af7dd72bfff88912_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtMy0xLTEtMA_ba49af41-d282-465e-b6e5-910f547020cb"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNC0xLTEtMA_3c79aa8f-710f-4137-82dc-6b90b53abe92"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaae83a94d7df432fa13620889d678fae_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNi0xLTEtMA_77506ac5-8796-4edc-9418-dab7274ed8e4"
      unitRef="usd">30900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d5a0963e8a641ba8cb8cddc994ab7ce_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtNy0xLTEtMA_d8a06f02-67c9-4a52-91bc-68a2eadec9b2"
      unitRef="usd">34400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTYtOC0xLTEtMA_698295af-9e50-47a7-bb23-3c05e0b79b14"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d453c23af194ce1aba1c816f84a132a_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtMi0xLTEtMA_9d90e369-1655-47ed-840d-49f88b1ad6bc"
      unitRef="usd">29100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6291de291de2479caa52ef9e87358c20_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtMy0xLTEtMA_430172ad-1373-41e8-b02a-3dd38703b6cd"
      unitRef="usd">18300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNC0xLTEtMA_28eda619-4d09-4561-bda7-313681975474"
      unitRef="usd">47400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5631a9f85ff741a3a15fdc5c8a9c57b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNi0xLTEtMA_511b6015-0263-47d4-8f5c-250e90e1c1db"
      unitRef="usd">30500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54761927cec14e1084e6842f2cc38ca3_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtNy0xLTEtMA_b1bda767-9930-4e4e-92b0-407a4c378fca"
      unitRef="usd">16700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTgtOC0xLTEtMA_6fbf4bb8-6732-4547-9930-d8f14fd4f970"
      unitRef="usd">47200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktMi0xLTEtMA_03d02c2f-e1ed-4a15-8010-68f019b2606d"
      unitRef="usd">2201700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d34e883adcf48439ad208f5fae59f1f_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktMy0xLTEtMA_5a8c22f6-5271-49e0-a4ae-ea923cc60c3e"
      unitRef="usd">945700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNC0xLTEtMA_708d1d9d-2337-4c9d-b366-e87c5883d83e"
      unitRef="usd">3147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNi0xLTEtMA_99496313-9cb6-4731-b7fd-154af8eb64d4"
      unitRef="usd">1207600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd6b40e625a344d7a0f8da5f98f78b54_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktNy0xLTEtMA_783e5594-e71d-4194-ba52-f7081ad5198d"
      unitRef="usd">399000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOmQxM2EyN2Y0ZWM1ZTQzZWU5NDhjY2FlNTI3MzdmM2Q3L3RhYmxlcmFuZ2U6ZDEzYTI3ZjRlYzVlNDNlZTk0OGNjYWU1MjczN2YzZDdfMTktOC0xLTEtMA_6280f345-a267-46c0-9563-a8c71ee0ee1e"
      unitRef="usd">1606600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi0yLTEtMS0w_34a87f9c-4826-44c8-b0dd-d2131f14e38f"
      unitRef="usd">1064000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi0zLTEtMS0w_ec557357-122e-4e19-96d5-9e9b2a41e640"
      unitRef="usd">574900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi01LTEtMS0w_60c03e25-963c-49db-9365-624869baee59"
      unitRef="usd">2201700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMi02LTEtMS0w_8f68a635-f33e-4a1b-b88f-7e7a5ce77764"
      unitRef="usd">1207600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy0yLTEtMS0w_8aa9f846-5633-4c1c-b4e2-765fad3a3ba8"
      unitRef="usd">336800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy0zLTEtMS0w_4f79aca6-7e42-4a2f-9a6e-b0b136589d10"
      unitRef="usd">111800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy01LTEtMS0w_19663015-a0fe-45aa-b905-e344e93fb2d0"
      unitRef="usd">675000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98200202399d411bbdfbce88f2f94963_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfMy02LTEtMS0w_fe9b1041-9f32-4eb2-ba66-e91031bdcf50"
      unitRef="usd">221200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC0yLTEtMS0w_ffd02491-b957-4344-aaaf-b998453e0ec3"
      unitRef="usd">90100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC0zLTEtMS0w_3400020d-9fba-4229-baa5-517a2a30e6db"
      unitRef="usd">41700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC01LTEtMS0w_ca74b75c-9ca3-4afb-806c-c8481ced6be6"
      unitRef="usd">178500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNC02LTEtMS0w_fe013bf9-c28b-45d8-9dbe-93e8b6b07603"
      unitRef="usd">111800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8edfb836d2d449d190d430b4b98bdcfc_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS0yLTEtMS0w_1ad1f548-8774-4147-9484-161b4246644f"
      unitRef="usd">46700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1bafcaa157cc4f9d9b98d3058f7eeebb_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS0zLTEtMS0w_cfcfc74d-622d-4f2b-9bd7-daec299ec1e1"
      unitRef="usd">27700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie7997ee1de01404282896cf8569615c5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS01LTEtMS0w_55a679a3-4877-429c-a493-4112ff5f3f12"
      unitRef="usd">92200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17cf60230e4e486ba1456a31ba6436af_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNS02LTEtMS0w_6a735ece-9d44-4747-aa92-23af5eddb5af"
      unitRef="usd">66000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi0yLTEtMS0w_e937e86e-5987-423a-bb32-71c3bc608d37"
      unitRef="usd">1537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi0zLTEtMS0w_f6cd78ed-ee8e-4eea-89ab-6b57f42fb864"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi01LTEtMS0w_742aa66f-2795-4069-a82e-5bc75a6419af"
      unitRef="usd">3147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjgxMGZjM2YzZTEwODQ1N2Y4ZjRkNzBhYmMzNTA0NDRkL3RhYmxlcmFuZ2U6ODEwZmMzZjNlMTA4NDU3ZjhmNGQ3MGFiYzM1MDQ0NGRfNi02LTEtMS0w_f29cbaaf-59c7-40cb-9be6-8b9f17b555dd"
      unitRef="usd">1606600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i89fb351d8bbc4b2fa26f6615870eeb22_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi0yLTEtMS0w_af66284f-2d74-4532-934a-c6e3e9f87a12"
      unitRef="usd">1178100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6757b7ae6a1b4d1294b382cd6f764364_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi0zLTEtMS0w_e6e497e6-9c8d-402b-8c46-422de91b1406"
      unitRef="usd">457000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i32bcec04d2a142c7bd7b162f66b47ad0_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi01LTEtMS0w_d5b4f963-1234-4dd3-a6dc-1b81e4fd76dc"
      unitRef="usd">2441500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic26482dabb124918adc0604c2a60d13c_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMi02LTEtMS0w_eb740e1f-b2f4-4f5b-8a68-d912820d4066"
      unitRef="usd">923400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26f3b7da661c4ac082d4c50ea8fd4d7f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy0yLTEtMS0w_78d451bc-0df3-4ba3-85f3-d1d1ef411823"
      unitRef="usd">200700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if17dd3ec43b24fc5a2f910d62e42f2d2_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy0zLTEtMS0w_d7d74f58-96d1-4b19-89d7-ce31599668e7"
      unitRef="usd">166600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecac37f9117440f69e07c69f6c281b92_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy01LTEtMS0w_ef0f7c77-867c-410a-8833-00d5f7ea2366"
      unitRef="usd">392700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21cde2e619f4402f8c02912c9692b840_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfMy02LTEtMS0w_2b7aa2d2-8820-4701-b25f-187edb2a19e8"
      unitRef="usd">399500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd830b6572e0425dadd30a387a2f967d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC0yLTEtMS0w_44d15bb9-df2e-4339-85aa-34b3fc22931f"
      unitRef="usd">141800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i50ffcc41a2144eca91b9b631142afd54_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC0zLTEtMS0w_5e718351-147d-4019-8cfa-75a4f11cfb6a"
      unitRef="usd">127200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7270d96442eb4541ad8022d39d4faa96_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC01LTEtMS0w_66df5740-8237-48fc-8cbe-b16595e590ec"
      unitRef="usd">278900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a971158920f420a836957e0f5793380_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNC02LTEtMS0w_4e459b0e-1fc4-402a-a6ab-c37b550bb977"
      unitRef="usd">272200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2d8b948617f4e3896d6b721b4c3de4c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS0yLTEtMS0w_13d20854-0ee2-42d2-b9df-97a6dbfff925"
      unitRef="usd">17000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i692dade7414a46f982273b0535c5635c_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS0zLTEtMS0w_be31acd5-8e3c-4bb4-8782-18caf3c81edf"
      unitRef="usd">5300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib847a33bcd64486598d58cc210134d1a_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS01LTEtMS0w_f38766a9-3cfd-4eba-a143-96b5d739dd2a"
      unitRef="usd">34300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a8c6e16440945bcac1fc0101a8a1fa3_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNS02LTEtMS0w_fea951f2-86f2-405a-946d-a7be263f1191"
      unitRef="usd">11500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi0yLTEtMS0w_f13b432f-3d7f-40b5-b6d4-b465e5970594"
      unitRef="usd">1537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi0zLTEtMS0w_c67643e7-66bd-4ae3-9cb7-0872528d82d2"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi01LTEtMS0w_09138993-8961-4e1e-bc41-8019fb7f7b17"
      unitRef="usd">3147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RhYmxlOjkyZGZhMDNmN2ZlZTQyNmJiZmI1YWE0ZjgxY2EzMWQyL3RhYmxlcmFuZ2U6OTJkZmEwM2Y3ZmVlNDI2YmJmYjVhYTRmODFjYTMxZDJfNi02LTEtMS0w_359e94ff-2615-4234-9c54-975efdf9678d"
      unitRef="usd">1606600000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjA0OQ_00ff37ee-835f-435f-a6db-06bd94d118b8"
      unitRef="usd">749800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="if46e15e1bfd3413a999b55b314fd2cac_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjI5MQ_530ace4f-2af2-4fb6-a431-b04361c93bfe"
      unitRef="number">0.22</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i3bd010f371544b988fa10466d658968c_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjMyOQ_2abd9870-ad28-449b-a0e7-2ba40b543940"
      unitRef="number">0.33</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i182d5713bd6d47afae7e3dc66fab5669_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM0MQ_6d2c7daa-6aa2-4415-903c-127eea062e3a"
      unitRef="number">0.23</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ief14d4f38aad49c6b6a004ccbac446b1_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM1Mw_69dd8b2e-76da-47ff-a4d5-9460bb7a05d8"
      unitRef="number">0.14</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ied9231b3ebdc44af8052059ea35f7d96_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNjM2OQ_a184619c-a91a-4cbb-9174-e7f3e30d8db2"
      unitRef="number">0.08</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUwMg_94fd4b05-4750-455f-8e2c-dda17607b405"
      unitRef="usd">30100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUxNw_cbb7c75a-7b63-49dc-8b3f-79908d409b1a"
      unitRef="usd">80800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfNzc0NQ_58a73ee2-59b0-499d-95a0-916c95cba57e"
      unitRef="usd">26200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV8zNy9mcmFnOjYxYzdkNjY2YjA5YTRhMTk5MmQxNmI1NzZkOGVlM2NmL3RleHRyZWdpb246NjFjN2Q2NjZiMDlhNGExOTkyZDE2YjU3NmQ4ZWUzY2ZfMTA5OTUxMTYzNjUzMg_a3c07be8-02bf-4c4e-8ce4-6b1ad766fe5a"
      unitRef="usd">77500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfMTA2Mg_5c45e558-bf4a-4364-8835-3cd2d875c6ab">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfMTA2Mg_c11210df-d8a2-4832-95ed-4213b48c83b3">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80My9mcmFnOjcwYWYyNjc0MjNhZjQ4NzFhMTc2Mjg5MjllYTkzYzI3L3RleHRyZWdpb246NzBhZjI2NzQyM2FmNDg3MWExNzYyODkyOWVhOTNjMjdfOTQ2_16c2b04c-d1cd-4231-afd3-b02da290a10b"
      unitRef="number">0.05</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzM4MA_c1bd8e71-b730-4394-81b6-fb0638ed5c9d">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at March&#160;27, 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended March 27, 2021 and March 28, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure of Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#x2019;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.&lt;/span&gt;&lt;/div&gt;Amounts outstanding under the Company&#x2019;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of March&#160;27, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#x2019;s 2028 Senior Notes and 2029 Senior Notes had fair values of $421.7 million and $932.2 million, respectively, as of March&#160;27, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#x2019;s debt.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzM3Ng_d3ec9398-06b8-4a6e-a1a3-7d7fec393d52">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at March&#160;27, 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended March 27, 2021 and March 28, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idb420ef6cfc84582bf032f47d6a027bc_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS0xLTEtMS0w_9a3bae98-d30e-4eff-a6c9-d2ace580528e"
      unitRef="usd">1100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia8a5fc5bf9d241f8b4cb0d73a7fec6cc_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS0zLTEtMS0w_f88445f1-f240-4e1d-8010-a50aa1679084"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2734474741b84d60825585c9ac1c91f5_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS01LTEtMS0w_4be869c0-2a31-4e87-af47-c3bce8dc8eba"
      unitRef="usd">1100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i46916ca5297d4242bef1fa39c66d7e97_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNS03LTEtMS0w_b1940142-27a8-4582-b18f-4fdefae7abbe"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy0xLTEtMS0w_540145f2-96a3-431a-a320-936b240a09c4"
      unitRef="usd">1100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id6010a3ff92e436b8c62582e9e6636cd_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy0zLTEtMS0w_8bac669d-e80a-403b-b68e-770b8fe58130"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy01LTEtMS0w_d5df74b9-8516-407d-bcaa-cf85fcdde684"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3a1637c5182047b68c601bf5077bf90c_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfNy03LTEtMS0w_eb667d3b-cf40-4af8-877c-91d4c312b5c6"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="iea5abde7d1984b098731ea86ba1d2df4_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS0xLTEtMS0w_ac08a450-7248-41d2-be5f-af5e7d906d58"
      unitRef="usd">71700000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7e512ddea06f4f369efec1ac01a1f83a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS0zLTEtMS0w_c794ce79-c8e0-4d37-8106-7f2b1ce778e8"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i11affe9143244d30961013f4deced4e9_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS01LTEtMS0w_93ae5c89-7b84-47aa-a452-54ba2003091a"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i5f0083bdc783434585b6f36d4e8c4070_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfOS03LTEtMS0w_e50ed49b-66a2-4574-b486-bb46902fa39c"
      unitRef="usd">71700000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i411f528b6c8248d19b4b06059ce6bcca_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtMS0xLTEtMA_d81c93e8-2df6-4f3a-b58b-962ce263085b"
      unitRef="usd">24900000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie108ffe2f2254cc596ceea6a1cd09226_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtMy0xLTEtMA_c9084a8d-9978-4a90-b8b3-11dfa0afb36d"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3d2a977915524e99a25863296c0eccea_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtNS0xLTEtMA_84adce18-1f20-479c-8b9b-d2fb91fbc007"
      unitRef="usd">24900000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i04083b4b022e4637936c0abcc453bb78_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTAtNy0xLTEtMA_d98f240b-6116-4685-95e1-c1f175ff0df0"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ifac27ddf7a3c42c6973c1c345f1d6188_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtMS0xLTEtMA_1abc6b63-bba2-4f20-b601-1c8d90877df7"
      unitRef="usd">3000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iee78cb2f382242a08b2526f42f5e8853_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtMy0xLTEtMA_2e900847-a0ad-4dd7-9a9a-419f4278fb90"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic97ef3233317455a9da5ec9463b03856_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtNS0xLTEtMA_5d1529b0-8aaa-4b6d-8042-07b85f68493a"
      unitRef="usd">3000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2ed7e22fc59649ab8ef2826b21239f52_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTEtNy0xLTEtMA_b05ac325-a117-4ec4-92e9-3433fd46af0c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItMS0xLTEtMA_fbf67b75-a949-401c-87e3-f7b790454255"
      unitRef="usd">99600000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id6010a3ff92e436b8c62582e9e6636cd_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItMy0xLTEtMA_b06db864-997b-416c-a33b-8e855cd4b513"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i919f2e21689049f3ae7c0eb9aa5427a0_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItNS0xLTEtMA_4ccd477f-7892-4110-9b0c-ebc8d888d0d5"
      unitRef="usd">27900000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i3a1637c5182047b68c601bf5077bf90c_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjg3ZTdkNjZkOTc0ZTQxMzA4Nzk3OTlhOTI0YjU2NTkzL3RhYmxlcmFuZ2U6ODdlN2Q2NmQ5NzRlNDEzMDg3OTc5OWE5MjRiNTY1OTNfMTItNy0xLTEtMA_598ccccf-df77-4501-9be7-239bdb5356b0"
      unitRef="usd">71700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib547cd16894c496aaa14272f3e33f8fa_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi0yLTEtMS0w_6c40832d-5eb0-4bb1-a436-1da9e0f3d955"
      unitRef="usd">86400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i254148f3b274432aa86d0721403fa1d6_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi00LTEtMS0w_b8bee9b9-66fb-4fc7-adeb-6e7d35cce3c9"
      unitRef="usd">10000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi02LTEtMS02Mjcw_de42f989-18ba-4e67-b96d-1bf226aca41d"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMi04LTEtMS02Mjc3_9f85da77-8ac0-4dbd-b62a-d12b16f0acd0"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy0yLTEtMS0w_a164794f-56d1-4eb7-a2f1-f6dcc2479cd9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy00LTEtMS0w_ba0860b3-c37c-47e5-9561-38947eebff2a"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy02LTEtMS02MzMz_c56c269e-a244-49d5-a4fa-370e87ad6bfc"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfMy04LTEtMS02MzE4_e3a8c074-ef6d-44b8-a50d-1c72dbf27711"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC0yLTEtMS0w_61772224-5f2f-4c24-b762-d846e343cb34"
      unitRef="usd">-14700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC00LTEtMS0w_4d6b3422-427d-4e7b-b699-3d8a877bfb4b"
      unitRef="usd">-500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC02LTEtMS02Mjg4_f9b74c72-4704-4d2a-aade-504f29c6baf0"
      unitRef="usd">-10100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNC04LTEtMS02MzIw_37f2eb71-c24a-446c-83ac-ee858ddff758"
      unitRef="usd">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS0yLTEtMS0w_218000cc-6113-4c6a-8b0a-4b2e14e5a9ac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS00LTEtMS0w_3a24f0b3-9328-4fed-ace7-4d287939b609"
      unitRef="usd">-9600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS02LTEtMS02Mjk1_6bee01c2-7d3e-4577-8bfb-19bf419aa148"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNS04LTEtMS02MzI2_bb102792-766c-4c75-b0b7-8a20e23951b0"
      unitRef="usd">-9600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi0yLTEtMS0w_ab81fffd-5d07-49de-8b8c-2ae495ce13f4"
      unitRef="usd">71700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi00LTEtMS0w_7ed997de-dd7d-47d8-84e3-5e774bd9eb32"
      unitRef="usd">800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi02LTEtMS02MzAz_22a5ecfb-4a49-4c54-a658-0d563a01fedb"
      unitRef="usd">71700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RhYmxlOjAwZDExNTE0NTM1YjQ2NjU5ZTI5Y2ZmYjUxMjk3YTBmL3RhYmxlcmFuZ2U6MDBkMTE1MTQ1MzViNDY2NTllMjljZmZiNTEyOTdhMGZfNi04LTEtMS02MzI4_cbdd37ea-74f6-460a-82b1-38159a1e39a5"
      unitRef="usd">800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie0c62e4c25694a3cbdeaeda3e071ac2c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMTcxNA_02e03b04-3e9e-4ae0-b152-47fdeb9af51e"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMjg4NQ_a11ace27-013a-4b32-9d76-482ecff9a7d0"
      unitRef="usd">1400000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i792a247ac57f4a1089a48d766d5774c8_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzE3Mg_8a6c57d1-3e6f-4cbe-b693-acd7c0a4351f"
      unitRef="usd">421700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i13ed6c8444b04ecbaf65664fe32f3d62_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80Ni9mcmFnOmUyNTMzZGNkZTNhNDRiZWVhMmM3OWE3NGRiZWY0OGZlL3RleHRyZWdpb246ZTI1MzNkY2RlM2E0NGJlZWEyYzc5YTc0ZGJlZjQ4ZmVfMzE3OQ_29782ffe-8837-4399-8946-9f013eee3d9f"
      unitRef="usd">932200000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfOTQ3Mg_0e076a8e-b0c5-4a69-948f-103d8b23f32e">Business Combinations&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Biotheranostics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $232.5&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's consolidated statement of income and within service revenue in our disclosure of disaggregated revenue in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranotics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Diagenode&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $153.4&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Somatex Medical Technologies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2021, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.8&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.0&#160;million to goodwill. The remaining $9.3&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NXC Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2020 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acessa Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the three and six month periods ended March 27, 2021, the Company remeasured the contingent consideration liability and decreased the contingent consideration liability by $14.7&#160;million and $10.1&#160;million, respectively, to record the liability at fair value as of March 27, 2021. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Beacons&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Alpha Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SuperSonic Imagine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#x20ac;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#x201c;VIE&#x201d;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million, and as of March 27, 2021, the Company owned approximately 80% of the outstanding shares of SSI.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkwOA_81ae4524-2683-4a76-bb6e-8bebb8ab40eb"
      unitRef="usd">232500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkwNg_1f11ecdb-d4fd-4ee7-a130-6c1c074a7854">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMS0yLTEtMS03OTEw_839bd759-c7f6-4219-98ed-162957c83674"
      unitRef="usd">9600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMi0yLTEtMS03OTEw_aae7ee7b-acd0-4f54-b141-e4da5326dac1"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNS0yLTEtMS03OTEw_8282bbb8-717b-4716-a21d-2b56db6ae8dd"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNi0yLTEtMS03OTEw_fee4d564-002c-4ea5-a441-b4a14940d14b"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfNy0yLTEtMS03OTEw_745e1724-ca39-426c-9970-ed40dd83d89b"
      unitRef="usd">8100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfOS0yLTEtMS03OTEw_1c59bd12-76d4-4ac0-87a6-37bb08ae6112"
      unitRef="usd">160300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTEtMi0xLTEtNzkxMA_f13443d2-1108-4e2a-869c-a68d82bde1ee"
      unitRef="usd">2100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTQtMi0xLTEtNzkxMA_566da1af-7ce1-482e-bff5-5935a3fb5381"
      unitRef="usd">18400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTUtMi0xLTEtNzkxMA_489d18cc-d250-4ac0-b97b-0a59f7f8c9de"
      unitRef="usd">85800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOmJmOTVhZTA3ZmVlZjQ1NzI4Njg4ZGZkYjFlMjU0NDIyL3RhYmxlcmFuZ2U6YmY5NWFlMDdmZWVmNDU3Mjg2ODhkZmRiMWUyNTQ0MjJfMTYtMi0xLTEtNzkxMA_05d52a5f-68a9-45d1-932b-1c01b8bb62c7"
      unitRef="usd">232500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkyNA_09a92d8d-6bd8-43e3-abd8-ef2cdc9c2058"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i77d742a0b7de451ba3f3018189978ceb_D20210222-20210222"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzkzNw_0281ac40-eb3f-4d29-bd5c-896af2658394">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3f9778c427b44c7882e336e11228595a_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk1Mw_d735430d-7ab3-4741-be05-4b108ad4e703"
      unitRef="usd">153400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMS0yLTEtMS03OTQz_84dbf0d3-f977-449b-8e70-668f989e1039"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMi0yLTEtMS03OTQz_bc4436cc-2830-4a2b-8fc9-97bb13aca0e5"
      unitRef="usd">9100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMy0yLTEtMS03OTQz_a5dfc416-dcb0-4bb0-b634-1180732e3dad"
      unitRef="usd">9200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNS0yLTEtMS03OTQz_f7c451a4-c79f-4386-bbe2-d3252fd2c19c"
      unitRef="usd">13800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNi0yLTEtMS03OTQz_7d7f98a3-53ce-4947-84a8-2a38caca0f1a"
      unitRef="usd">9200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfNy0yLTEtMS03OTQz_a2499a8f-8a22-477f-b1de-03c06ccc354c"
      unitRef="usd">12900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfOS0yLTEtMS03OTQ1_c56adf40-e280-4c2b-ac73-03fa40ada589"
      unitRef="usd">69800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTEtMi0xLTEtNzk0NQ_e751148c-d680-4a19-bf18-807e333ae1bd"
      unitRef="usd">9200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTQtMi0xLTEtNzk0NQ_7012e7d2-1a33-4014-9a2a-a3b61f915b4d"
      unitRef="usd">19300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTUtMi0xLTEtNzk0NQ_922c2c69-37f5-4082-9849-a81f867895c4"
      unitRef="usd">78100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i20c528f3a3ae4a45a9fa4200c53cdf1c_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjY1YTA5MGEyZTBjNzQwZWU5NTY5OWFiNjgyNWYyMDFlL3RhYmxlcmFuZ2U6NjVhMDkwYTJlMGM3NDBlZTk1Njk5YWI2ODI1ZjIwMWVfMTYtMi0xLTEtNzk0NQ_a69b57ae-2bd6-40d4-8caa-e39107252f1c"
      unitRef="usd">153400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i2161ff7d37284a2dbbe1f9d7e633bc5c_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk2OQ_faa64ab3-1ab2-4446-a4c7-5439ac7abf4c"
      unitRef="number">0.145</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i435467f75e1440c58e0143cfcc330473_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk3Ng_85dc1a8f-18d9-423d-a105-8493fa591be3"
      unitRef="number">0.135</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3f9778c427b44c7882e336e11228595a_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyNzk4OQ_06efdf4d-9f41-41f9-bdf6-58c5976b5282">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0181482365764743a89827be06286048_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAwMg_25c43ceb-f639-43e0-8e41-08c63d0a6c06"
      unitRef="usd">62800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAxNw_5626e0f4-6464-43fb-b2a8-a48be7602301"
      unitRef="usd">38000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODAzMg_c9d34511-0fca-4498-a89d-da128e10fc98"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA0Ng_9b6b3dd3-c419-4f34-b9ff-0e4a55df4ac8"
      unitRef="usd">900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:Goodwill
      contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA2MA_6489b4aa-d870-4488-8167-36db5273562c"
      unitRef="usd">32000000.0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i7a3eb8aa964f49c7ae7543d0e7494502_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA3NQ_59e65b93-122a-4023-a0dc-c4ec872f6e9b"
      unitRef="usd">9300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7426f16cedf841448aae7ae840121295_D20200928-20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMTA5OTUxMTY0MTExNA_92e98df8-6e0c-43f8-aabf-01d360e26ff9"
      unitRef="usd">5600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaf6cae33a60643238b5a53b8e12438d0_D20200928-20200928"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMTA5OTUxMTY0MTM4Mw_6f2e2f44-f148-42f5-bdb3-9eb09aa35ddb">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzEw_ea5a6a1a-8b0a-47a5-865e-6285c392304a"
      unitRef="usd">161300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie9edcaeb855249e29f00eca57f1ce93e_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzQ0_5d86c05c-4402-4962-b884-d2146640e997"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODU3_cf13d7f9-eb11-4d4d-9967-17797d043fdd"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:AnnualIncrementalRevenueGrowthPeriod
      contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfOTQ2OA_9b2ab7e8-200a-47a0-874f-f5489d1acb0b">P3Y</holx:AnnualIncrementalRevenueGrowthPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3ca8eccdc4f847d0aeb6a2cca823b5f3_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODA4OQ_f51b1eb5-2de3-40a3-9b0b-55286deb1c17"
      unitRef="usd">-14700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9dd0231067df452087445e7fbabe93de_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODEwNA_36940b0d-cc22-4e10-9a61-a4641ba66bda"
      unitRef="usd">-10100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMC0yLTEtMS0w_beeb458a-a052-4410-ab77-c5e2606a65b0"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMS0yLTEtMS0w_797032d0-fe34-4e06-ae3f-e3dc050f16e7"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMi0yLTEtMS0w_25daa91f-2a73-4fca-bc60-1cd850ca3003"
      unitRef="usd">4400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMy0yLTEtMS01MTgy_bb273bd9-0b63-4cc4-a99d-23c7d59a2af3"
      unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfNC0yLTEtMS0w_f6c0c4de-3dc6-4059-ac03-0ef80b0c3065"
      unitRef="usd">127000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfNi0yLTEtMS0w_1238e88a-1150-4d74-8689-9e6fe26bbd9d"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfOC0yLTEtMS0w_3b073546-b18f-4c14-9242-891e413c2379"
      unitRef="usd">20200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfOS0yLTEtMS0w_30a04dae-3a11-499d-b23b-902cea979423"
      unitRef="usd">48400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie02a040d45524cb3a962860ca78ed797_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjA4YjU1MGYwYjc4ODQ3OGY4ZTM1ZjQ0ZGQ5ZjNiOWUxL3RhYmxlcmFuZ2U6MDhiNTUwZjBiNzg4NDc4ZjhlMzVmNDRkZDlmM2I5ZTFfMTAtMi0xLTEtMA_f7364af7-87d2-4e8f-964c-3c7cef4d5910"
      unitRef="usd">161300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i8f81b629f370490ebe7aaadd9a1e63dd_D20200823-20200823"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzQ0NQ_cdf22860-8677-4f6d-9fee-ea323ddc592f"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i617c581a0868425eaa81de8cdba59691_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzc1Mw_8ca838a7-5795-4a7d-aec1-be70630605b0">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if077f38ecd2c48708cc0f3b18a2b893e_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfMzc1Mw_c84267d0-1078-4de2-94bc-bf4ef306c544">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7de817e6de5942b5bda9b79a83fe36ea_D20200203-20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDQzNw_69131652-6b98-492d-ac20-b6d203c81b45"
      unitRef="usd">19700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i4af1ff49936044139ca360cf68be0400_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDQ3MA_aacb7dc0-ad58-4980-9c36-28dc60fe9421"
      unitRef="usd">2300000</holx:Holdback>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4af1ff49936044139ca360cf68be0400_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDY1Mg_ca5aa65c-4db0-4bde-9947-7bf9e28e7b95"
      unitRef="usd">10700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i4af1ff49936044139ca360cf68be0400_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDczMA_46067d81-93cd-43d1-8b57-4975a7d545c3"
      unitRef="usd">6200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i4af1ff49936044139ca360cf68be0400_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNDc2MA_4c5b57ec-3205-462e-ab19-bba1ef46d433"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie858e36180d444f9b36ec6e99f4ec80c_D20191230-20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTI3Ng_4a3c4375-a514-4b43-b0d6-7c3f7e20ea47"
      unitRef="usd">18000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="if549c33be4504150b2d638a7c2ab1792_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTMxMA_9ea246ea-a7dc-40b3-9b38-53e51cd4ef58"
      unitRef="usd">1000000.0</holx:Holdback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if549c33be4504150b2d638a7c2ab1792_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTM3Nw_04b46c31-5cfb-43ea-8b33-27acb9eb86f9"
      unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i60c529de5f984b318d75f347b0e4df65_D20191230-20191230"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTcyOQ_503ae42c-6baa-4e28-afed-5475181df62f">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i3b8f228b16744f66922f21381cb7e421_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTc5NQ_ff43b528-ca76-42d1-9f10-8b696696354f"
      unitRef="number">0.46</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2bae2329807348b380f218edb5d9aa9c_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNTg1OA_36a9b20f-fc40-481c-8cec-12ebd486acdf"
      unitRef="usd">18200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessAcquisitionCashTenderOfferPricePerShare
      contextRef="ic0360e3cd8884f838b4339be49501e41_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjEwOA_fdd42338-1bd0-4d49-b005-3c463f7210a3"
      unitRef="usdPerShare">1.50</holx:BusinessAcquisitionCashTenderOfferPricePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ie9f6eb5453d7428e9d35cb9246d2bd17_I20191120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjQyOA_ca6b4108-021d-4199-85eb-4e420edec908"
      unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <holx:BusinessCombinationSharesAcquired
      contextRef="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NA_65d03eb2-b249-4723-80ff-3547387b9a16"
      unitRef="shares">7600000</holx:BusinessCombinationSharesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="idd22930c14694e51b8e4cd68c1aa5089_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjYxNQ_ee1955c2-1dc2-42cd-b54e-7b88f3a37951"
      unitRef="usd">12600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationOwnershipPercentage
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjY5Mg_fa52042d-ab43-4641-88c4-3cb804a8f5f2"
      unitRef="number">0.78</holx:BusinessCombinationOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i3b8f228b16744f66922f21381cb7e421_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzEwOA_81dafa50-7051-4826-a465-f1efff13d494"
      unitRef="number">0.46</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzIxMA_57f07831-24e0-4b0d-bd76-498a4f0daef7"
      unitRef="usd">3200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzI5OQ_ceed993f-423c-49c0-8fa8-706b095b47d8"
      unitRef="usd">69300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzMyMg_b1ce6854-1f8d-4d51-9b91-3b8dd3b9f0d7"
      unitRef="usd">17900000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares
      contextRef="i304fc8df211141afae93e91cffb8fe19_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzM2Ng_350c647c-30fe-46ac-9ebe-a4f8a59d31a2"
      unitRef="usd">12600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzQxMQ_1cf2d5ef-f4de-473f-8a60-79b4b5dcd9d8"
      unitRef="usd">30200000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest
      contextRef="ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzU2MQ_5e22771d-27ca-4576-8e78-f3da69095015"
      unitRef="usd">8600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODMwOA_723b5690-8d60-437c-97e8-d78c121e604b"
      unitRef="shares">1100000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="if2374d44b4a14f1bb1bbf1c949a6f0b3_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNjU5NzA2OTgyODI5NA_ae323317-3ef0-4d95-9df0-f24c16a1a83d"
      unitRef="usd">1800000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="iae67d1fe265e4f30b9319216ed36d801_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfNzgwOQ_5428891d-99f1-4d41-a91b-569afe4d7de0"
      unitRef="number">0.80</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMC0xLTEtMS0w_b4dcc9fa-1304-48ec-8893-b6c641d85e52"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMS0xLTEtMS0w_ed7ab451-e5a8-47ad-804b-4f1590d12abb"
      unitRef="usd">7100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMi0xLTEtMS0w_0e40c558-7679-4908-902f-6f62619ba2f4"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMy0xLTEtMS0w_a8de70de-4c3f-4cf9-a59f-ccb381dec4ee"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNC0xLTEtMS0w_c835aad4-55a1-49c7-b00c-53ff18448f65"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNS0xLTEtMS0w_da8102a0-cab9-4959-b76b-a83ccd647200"
      unitRef="usd">24500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNi0xLTEtMS0w_1832d769-c467-487b-bccb-2b43e385ccb3"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfNy0xLTEtMS0w_599ebf17-dd29-4223-b4ee-303724d8b26c"
      unitRef="usd">8800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfOC0xLTEtMS0w_59fb0553-0d62-490f-87c4-f644a3aecada"
      unitRef="usd">3800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTAtMS0xLTEtMA_cd7f0ab9-fedd-49a1-a4fc-136630eab77d"
      unitRef="usd">38300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTEtMS0xLTEtMA_155dd2a2-6979-4c93-a3c5-27587982e57d"
      unitRef="usd">4000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTItMS0xLTEtMA_1ea828ce-6f40-42dc-a652-f88ce0a2ca06"
      unitRef="usd">3000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTMtMS0xLTEtMA_d8852cb9-7986-42b0-992d-5f8a802d6e21"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTQtMS0xLTEtMA_c01482d3-2d38-4d51-8b24-00c1db4db542"
      unitRef="usd">34300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iedbd096de9694df1a3c2ff99b2436eed_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RhYmxlOjhkNTNiMDc2MzMyYjQyYmNiZGU0NGEwZDgzNzFjNDBkL3RhYmxlcmFuZ2U6OGQ1M2IwNzYzMzJiNDJiY2JkZTQ0YTBkODM3MWM0MGRfMTUtMS0xLTEtMA_e05d82d5-bfba-4d9b-b842-adde480b3d97"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:FairValueAssumptionDiscountRate
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODU5Mw_d5a43f6c-da74-47ea-838f-8dae94f6e23d"
      unitRef="number">0.120</holx:FairValueAssumptionDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia6b0c817b1c74f18a87cbf0cda7cd036_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODg5Mg_8e26388a-cad3-49f2-becd-50c87bab64c1">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i96962f8c6503408c97e137b4ff6b485d_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODkyMg_e4a8ef60-37d3-40dc-9b0c-47db01cffe9c">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i985c7e4ecc8945d29a5d65e3cacc1ebd_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81Mi9mcmFnOmExN2ZkYzE2OGM5NzQyMTFhMTVkYzgxOWIwYTU5NTZmL3RleHRyZWdpb246YTE3ZmRjMTY4Yzk3NDIxMWExNWRjODE5YjBhNTk1NmZfODk0NA_bdc94cef-79d3-41ec-92dd-6f64b5f72985">P8Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjU5NQ_5986dd71-a294-4e75-baa3-6daaad9a066c">Disposition - Sale of Medical Aesthetics&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp;amp; Rice ("CD&amp;amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions &lt;/span&gt;&lt;/div&gt;primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first and second quarters of fiscal 2021.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i47bae11f6c164f1fba7c9157ff4bdaaa_I20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjE3_b4b01b98-0472-4644-8d93-cbda8ea1fae0"
      unitRef="usd">205000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic07ffd9a39b1497facd26bd931d9a0b6_D20191120-20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMzQy_49ebe28f-c507-4518-9aa4-9f7c475bbecf"
      unitRef="usd">153400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup
      contextRef="i3c59ec3344504f85a8c3c6bf6b0a9e13_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfNTI0_73dca631-43ee-4dd0-9e18-86b18992e989">150.0&#160;million</us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup>
    <holx:IndemnificationLiabily
      contextRef="i6e0da39af5cf4280a9f5c65fb51b024a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfOTEy_4d315c98-2a5d-4e91-b8ab-228625334cb1"
      unitRef="usd">10900000</holx:IndemnificationLiabily>
    <us-gaap:AssetImpairmentCharges
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMTg4Mg_891e6c06-1a53-4077-a47c-e1f6477a3526"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i7491822dd55f413ea8c24c98a7aa72d5_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjAwOA_a2e23748-edcb-40a2-a247-c38ccc63874b"
      unitRef="usd">25800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3a56920a822e4f1fa2a21d3567b1df3c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjA1Nw_79325238-8aee-4a2d-8e33-b88c81128250"
      unitRef="usd">4400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV81OC9mcmFnOmQ5MzE2OWYwNTFlZTRmNmM4NzRhNTdjYmM4NzBiYWIyL3RleHRyZWdpb246ZDkzMTY5ZjA1MWVlNGY2Yzg3NGE1N2NiYzg3MGJhYjJfMjE3MA_6a3cf3e4-d0c6-4c5b-848b-c2ef65d5ec75"
      unitRef="usd">46500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQ0MA_2d1308cd-bf95-45ad-b653-809756275ee6">Borrowings and Credit Arrangements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,672.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,747.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Amended and Restated Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of March 27, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of March 27, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of March 27, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of March 27, 2021, the full amount of the Revolver ($1.5 billion) was available to borrow by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of March 27, 2021, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, including a premium payment $20.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 27, 2021, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 27, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQxNQ_001c3add-1720-4b24-8a0f-336ba4dcc550">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,672.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,747.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="i469614de5d734baeb90118c04073db54_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMi0xLTEtMS0w_96ecec5e-50c5-467b-ba08-9f15950f9b69"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMi0zLTEtMS0w_a8d83022-d607-48a6-be18-c493d9eb42df"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMy0xLTEtMS0w_fff340b0-6cb8-4f59-8129-b961745412a8"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie330a629ad37467d89cd606e0af17679_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMy0zLTEtMS0w_f00c7eb1-04d4-4656-8ff9-855572c73cf4"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfNi0xLTEtMS0w_47a56c60-fece-47d1-8d8e-fec68501ee07"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfNi0zLTEtMS0w_c37a7909-5514-4320-899a-fc2c3a6c62c8"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i469614de5d734baeb90118c04073db54_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfOC0xLTEtMS0w_c4ee7665-9c94-480c-9eb8-62b1c0e07cee"
      unitRef="usd">1343600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i9a3064623b1e4dd1b1bf25d74c32d175_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfOC0zLTEtMS0w_fcf39c80-6d51-42c2-948b-608f4d2457fc"
      unitRef="usd">1379900000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="if3bea13b544c4f13b09760c5c6e726ba_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTAtMS0xLTEtMA_1f7b585c-bcb4-482b-b607-ce6d4b169946"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="id15b184ad14442c987ce0303bbedd19b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTAtMy0xLTEtMA_39c92886-f66d-42dd-9447-edfeb056d271"
      unitRef="usd">939400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTEtMS0xLTEtMA_4e4faa28-d47b-43ab-af6b-41bff7ceada5"
      unitRef="usd">395000000.0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i47d3d66108d5494eaf7a55ca46e00d87_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTEtMy0xLTEtMA_bccd1436-0f88-4e7d-b854-d225b930056c"
      unitRef="usd">394600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i77ff68ab585743f5bd2a75882d831360_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTItMS0xLTEtMA_ec451138-331e-404c-b988-65624766aad2"
      unitRef="usd">933500000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="id9cffcc6d27f4a828ad2f580a9df3cbd_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTItMy0xLTEtMA_3cb73ea3-81e7-40db-869b-dd9cca528070"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTMtMS0xLTEtMA_8bb4c781-b3b4-44cf-ac49-6f8c8bb58f89"
      unitRef="usd">2672100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTMtMy0xLTEtMA_df7d6c4c-0b4e-4b6f-b3ac-cbb85643ec3d"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTQtMS0xLTEtMA_1a24e65e-958e-49d0-8842-10f0dfad8060"
      unitRef="usd">2747000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjcwZGMzOTFlYWE2ODQzNzY4NzI3M2UxMWMzYzAyMThiL3RhYmxlcmFuZ2U6NzBkYzM5MWVhYTY4NDM3Njg3MjczZTExYzNjMDIxOGJfMTQtMy0xLTEtMA_8ccf4282-b100-4ebb-9b00-cc935eeb08b5"
      unitRef="usd">3038800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="i469614de5d734baeb90118c04073db54_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfODAz_d0ea5fca-61e9-4957-854b-29925add9b47"
      unitRef="usd">1400000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i723b2fa7383c40148a7b8c9527df6ddc_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfOTQz_dde551e8-5c02-4cdc-9721-3e29c0a77697"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1d4c152cb32642be87eab1b00b94cdf0_I20181217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfOTk1_786475f6-ae86-45c6-8cec-73f7270fe321"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebtCurrent
      contextRef="i18b2329bbd884176a354e0fd702f2ff9_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTM0Mw_d9ad9bfb-1dcb-4c1a-aa9c-b08cb8793b69"
      unitRef="usd">750000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="ic1975b32bc204e5683343cfb111a310b_D20190929-20200328"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTM2Ng_9dd357cf-11f5-4e86-9b0f-1bad517e33f4"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="if3392dcaea61411f8afc5b0dcf1dec2f_D20200927-20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTYwMQ_fc2e1842-90e7-48da-a9fc-19ebaa4d0b6f"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="i3b11a0ad7fad4b97816c007b3f72e4cf_I20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMTY2Mw_802d5e09-2c7d-45e4-9739-049635cf935a"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQxOA_70c55e14-9be7-484c-8871-45f702288d07">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi0xLTEtMS0w_05e436ad-aae7-477a-ad58-e7cfb6476c66"
      unitRef="usd">5300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi0zLTEtMS0w_de82dd7d-5a28-4058-9c10-26a1697f2c60"
      unitRef="usd">13000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi01LTEtMS0w_7e842fc4-bf85-4511-bef8-07208e397a12"
      unitRef="usd">11800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMi03LTEtMS0w_0ca86494-4c6b-4d50-a8e1-e5778177091f"
      unitRef="usd">26600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy0xLTEtMS0w_73e848e3-4fe3-4010-b805-bb6808c22f57"
      unitRef="number">0.0112</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="if464b82cf5f44b3397772c7345ca8380_D20191229-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy0zLTEtMS0w_d4676d3b-2c49-4a27-95aa-5f929a32e614"
      unitRef="number">0.0275</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i51c76608f9f441a2b6102a7e7010aa66_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy01LTEtMS0w_ecfc9d95-666c-4610-b658-293697320a27"
      unitRef="number">0.0117</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i35f14bc0230645f9a716b63cff83acdc_D20190929-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfMy03LTEtMS0w_a32178ea-9d10-4e6a-85a8-d5963eda140d"
      unitRef="number">0.0293</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC0xLTEtMS0w_f5099d17-83ab-42d5-b60e-de574a421ed6"
      unitRef="number">0.0111</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC0zLTEtMS0w_83211a4c-28a5-4c8c-b603-1e5a33ac8a4a"
      unitRef="number">0.0233</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC01LTEtMS0w_75bdac0f-e3e9-4916-b456-864096eec3d8"
      unitRef="number">0.0111</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i3cf93b0a20d24052ac858da6ba3db4ac_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjU5Yzk1Y2E0MWQ4YzRjNTQ5NjI5YjYyYWM2NDM2NGEyL3RhYmxlcmFuZ2U6NTljOTVjYTQxZDhjNGM1NDk2MjliNjJhYzY0MzY0YTJfNC03LTEtMS0w_f3415fcd-a8fb-418d-b07b-5654b62eb075"
      unitRef="number">0.0233</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:SeniorNotes
      contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjI5Nw_e22676d8-6ee3-4b5b-819e-101a662cc32f"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjMzNA_8877124a-c7a1-42ef-be82-d65efaabc974"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="ia50b3adc77744a7c824bbecca70c011a_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjQwOQ_2cc8607c-6c68-415b-9838-2db8b305905f"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjU5Nw_d11ff5a3-cd91-400c-b0f8-57de46aed166"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i091fabb2fcfb4658b0d9f415869cc240_I20201015"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQyNg_63f20246-601d-4418-b960-6b7d870da994"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjc0Mw_15dddeb4-e555-4c7f-9554-9123951621d5"
      unitRef="usd">970800000</us-gaap:ExtinguishmentOfDebtAmount>
    <holx:DebtRedemptionPremiumPaid
      contextRef="ia1f0bb774af7448ebf710328c9bd4aef_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjc3NQ_5cd678c0-2ad9-4bb2-aa1f-cd0c098aa906"
      unitRef="usd">20800000</holx:DebtRedemptionPremiumPaid>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMjg5OQ_095206ff-f5ad-4521-a646-ccd87dcedf31"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzQ2Ng_090b6c0a-0559-4d56-a53a-36222c6d142e"
      unitRef="usd">21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzgyNQ_560fd4f8-b158-4559-96dd-0a5438c3bef9"
      unitRef="usd">5800000</us-gaap:InterestExpenseDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzkyMg_85f1fbca-4e97-4137-bebb-83a9227ec115"
      unitRef="usd">7900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfMzk0Ng_64a69b9b-79c3-432b-8b5c-236706a3e6e3"
      unitRef="usd">6400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f8b998b09854bb695d9efc1050df7c4_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDEwOQ_49417f1d-cbd3-4ef2-98a8-3a46463cdecb"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i16fc2d53465c4a2f86d1e10082fc4c89_I20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDIxMA_7323cb5b-5b07-4e49-b291-a73a2ee89c15"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNjQzOQ_fed16434-cb19-41a1-89be-592375449a69">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 27, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDUwOA_ecc24487-1e9c-44c5-aee5-bb53bcdfa738"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDc1NA_f217092d-b69a-4d16-bfbc-8271fbac44f3"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i5a4f39288d0b45248bab5af271dabb3b_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNDk3MQ_83021e0a-a801-450c-9b49-f242d18402b2"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ib3da1322564b4ca89777bef210350bd7_D20200928-20200928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTE3Mw_c3f92d27-e67e-420d-a2fc-965a3c0fdd68"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i377b4457fa40451d9934553b73788461_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTM4Mg_f95772b5-5b94-4e6a-8553-5f40639abfb3"
      unitRef="number">1.03250</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ida3f87ee7c184b3d92090d91611fff9e_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTYyNA_2aa24711-b7bd-4f28-be85-2624c07d761f"
      unitRef="number">1.01625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i83419ad698fd45cd9a641d83cdf6a7fb_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTY4NA_ac93831c-707a-4a88-bfb5-9f9d3cfdefeb"
      unitRef="number">1.00813</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6f7fe74bada44325807efbeacb2146be_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTczNg_6ced5c13-21ca-4db5-bc61-b80f9078bc63"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i42acc5ed62724f79bd2e68d140fe8dce_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RleHRyZWdpb246ZTBhYWZlNTFiYzdhNDhhYzlkNTJiY2Q3NmEzMjEwMDdfNTk4MA_e04e05e9-5a5e-4d5b-8b99-f32d3e96b7b1"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7560c0f9556346c095bd908abc52ce26_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC0xLTEtMS0w_a30a561c-1657-4088-8848-94213982a6a6"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id264070af63b43f48399ea213c8af8a2_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC0zLTEtMS0w_a06309ac-bd2d-418e-8c4e-1724e6190b26"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i765ee743cd8d4c30a3e089f9a5063ad1_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC01LTEtMS0w_978e687e-c12a-488e-b257-a602206da549"
      unitRef="usd">10900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i4a626c6885434dc39de0b254189dd899_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC03LTEtMS0w_2cb54290-7964-435c-bf8f-8d5f950d68d5"
      unitRef="usd">2300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i976b8217dd0340c8848abf4604793c09_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNC05LTEtMS0w_cc3747e8-d55c-4297-9af6-3c761a510fe2"
      unitRef="usd">21800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f8b998b09854bb695d9efc1050df7c4_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0xLTEtMS0yMzUy_c870dc39-feed-4142-8c04-da0844527338"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ida59e22f7f6c46b19f9d458fa92fe312_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0zLTEtMS0yMzUy_bff1dc90-cc67-4e5a-9fcb-55b3f2cf3eb0"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i54dcf56176214275896ff1d60bc84906_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS01LTEtMS0yMzUy_afe23591-f9f5-41b7-9e29-a80e4560b86f"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i88918075f107400cba5e6d495691837d_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS03LTEtMS0yMzUy_2f5ed0d1-3794-43bb-a92f-3e5424264f18"
      unitRef="usd">9600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iade8ee6fa1e44937ad93cb3264cfa057_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS05LTEtMS0yMzUy_a61257b6-c63c-4b58-a437-aaf3a95d2049"
      unitRef="usd">9600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a63a83e4a8948c0b7e5f409fb64e8fb_I20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0xLTEtMS0w_aa14541d-8e38-45ff-8260-b93209e7939b"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i2015de2d01ea4eb6b943c7070cd7b61c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS0zLTEtMS0w_6d518206-5f8a-4e45-8ea4-990c37933d88"
      unitRef="usd">8300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i166a72cd198a4c67b1e33412975acb38_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS01LTEtMS0w_7c47219e-79bf-4d76-a10b-a07c80f1b14e"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i2018dad9ea214f19a994a89fec2b62b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS03LTEtMS03MDk2_644fd9d3-61d4-4c3e-a186-8cb5902dca7a"
      unitRef="usd">16300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i9b31ce11b7874197821ee16e0e8acb8c_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNS05LTEtMS03MDk4_3a2508f9-b8c6-4a16-84d1-df2956a48ff5"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi0zLTEtMS0w_691a38e4-4033-4b70-8bae-cb6bb89c24f6"
      unitRef="usd">13100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi01LTEtMS0w_0a45919a-c779-4440-a20f-818de43cdac6"
      unitRef="usd">15700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi03LTEtMS0w_a7e0b6ba-6a03-45b8-8c1f-01b81d8dfcdb"
      unitRef="usd">28200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82MS9mcmFnOmUwYWFmZTUxYmM3YTQ4YWM5ZDUyYmNkNzZhMzIxMDA3L3RhYmxlOjE2NmYxOTI0YTJiYTRlODBhMjViOWQ2MzE1NWZhYzkzL3RhYmxlcmFuZ2U6MTY2ZjE5MjRhMmJhNGU4MGEyNWI5ZDYzMTU1ZmFjOTNfNi05LTEtMS0w_846c6071-16d3-44e2-aee4-b0842cca8c12"
      unitRef="usd">31400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RleHRyZWdpb246NDM0NmVhNzEyM2RiNDZlOTk5MjQ2MmIxNGI1OTk5OGVfMTg0Ng_5a8c7ae6-71ea-4372-9170-d64a033bda43">Trade Receivables and Allowance for Credit Losses&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses as of March 27, 2021 compared to March 28, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassified as Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RleHRyZWdpb246NDM0NmVhNzEyM2RiNDZlOTk5MjQ2MmIxNGI1OTk5OGVfMTg0Nw_5f152cc7-ba8a-47ca-9a10-9d1273ac88a3">The following is a rollforward of the allowance for credit losses as of March 27, 2021 compared to March 28, 2020:</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi0yLTEtMS0w_a1507788-4b9a-4cae-9183-be4e0c4a4d08"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi00LTEtMS0w_30864c94-7b1b-4cc6-9673-80bb8b834ea9"
      unitRef="usd">12500000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi02LTEtMS0w_a5820047-e37d-4f34-97f5-3abfdc919a4c"
      unitRef="usd">0</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi04LTEtMS0w_7286540f-f303-43a8-a829-6c9034c54ca2"
      unitRef="usd">2400000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMi0xMC0xLTEtMA_cb25ac14-e2d5-43ba-9ff4-3e4776ca7cab"
      unitRef="usd">41700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy0yLTEtMS0w_e48e50ff-4c0d-4dc2-ae3b-bbef59321251"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy00LTEtMS0w_7bd4a0fe-61d7-4fcd-b436-6bd0b55474d3"
      unitRef="usd">5500000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy02LTEtMS0w_9af5d1c4-59ea-47c4-a8a3-622977f71116"
      unitRef="usd">5900000</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy04LTEtMS0w_8e7be188-3917-4aad-921c-110e0624bfeb"
      unitRef="usd">1400000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV80OS9mcmFnOjQzNDZlYTcxMjNkYjQ2ZTk5OTI0NjJiMTRiNTk5OThlL3RhYmxlOjQxOWZjNzAxOWNkNTRlODVhNjRjYTNkMmQ0NzE3NzdlL3RhYmxlcmFuZ2U6NDE5ZmM3MDE5Y2Q1NGU4NWE2NGNhM2QyZDQ3MTc3N2VfMy0xMC0xLTEtMA_4d709963-6b48-45b1-aa8d-3815bae993e2"
      unitRef="usd">16000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjU5NzA2OTc3NDQ1OA_3ed1081c-45bc-4c63-b848-bef6390e66a8">Derivatives&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7 million, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap agreements matured as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $24.9 million as of March&#160;27, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended March 27, 2021 and March 28, 2020, respectively, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;27, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $415.8&#160;million. As of March&#160;27, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $133.5 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of March&#160;27, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="id5aac920f34f491293ef3c6b911a0e0e_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTM4NA_319ced0d-653e-49f5-abcb-78d53d3cdaa7"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTc0NQ_2e0ea4e8-3b56-404f-b0ed-77cb66ef9c9a"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjIzMw_2a51d447-2b07-4b54-80f8-20ee816a06a9"
      unitRef="usd">1000000000.0</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjgzNQ_f9fcf1c2-f8a1-4f47-b296-8afa3026eb00"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjkzMw_abf7e49b-2176-46e9-95ef-5e0c759a438a"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMjk5NA_7d9efc5e-9375-44cb-96fb-92d2df1d6208"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMzM0MA_3d74ae74-4b73-454a-b680-a7ecbde61de7"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ife8fbca01f344a7bbc6432bab75cc30c_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMzU4NQ_46e03fe4-ecf5-467e-8803-75398c4b6815"
      unitRef="usd">24900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjExOQ_9c0489fa-f08c-4a32-ba46-8dc329f5e0c2">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy0xLTEtMS0w_7c71c1fb-224b-4e03-b62d-8af07256eb35"
      unitRef="usd">3400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy0zLTEtMS0w_1d76d0aa-6cc3-4f8c-a7fd-3f74669af7ee"
      unitRef="usd">100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy01LTEtMS0w_2d63e309-bc3f-4d2e-8e4a-1d6d65e90cee"
      unitRef="usd">500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMy03LTEtMS0w_a21830de-103d-490b-b0bc-fa75e5cf547f"
      unitRef="usd">100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC0xLTEtMS0w_cdb3a3ad-dc07-4b87-9cb3-db2fcfc9d746"
      unitRef="usd">-1800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i728508ff257d45269fd226b6e4007b29_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC0zLTEtMS0w_bbdb690c-e44f-4773-bc8b-4a68c6337663"
      unitRef="usd">-500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC01LTEtMS0w_fadb46a7-abd0-491d-b7f0-fb370e2b0ff4"
      unitRef="usd">-3000000.0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNC03LTEtMS0w_f375b76f-e78f-4a17-93c4-38c5714d2f1e"
      unitRef="usd">-700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS0xLTEtMS0w_0547872b-1c3c-4783-96b5-5f03ee9bb84c"
      unitRef="usd">1600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS0zLTEtMS0w_73a37875-81eb-45cd-8239-bd02345e0448"
      unitRef="usd">-400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS01LTEtMS0w_4f837d33-e9bb-4757-bc9d-2d36e987c068"
      unitRef="usd">-2500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfNS03LTEtMS0w_a5884341-eabc-4219-8107-49841687818c"
      unitRef="usd">-600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="id3907019a3ad412091f514188bc3ca5a_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC0xLTEtMS0w_4512bf32-656f-4070-99e5-5bf8c6288b89"
      unitRef="usd">3100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i8dc1138d96864cfb82603959ee4fe463_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC0zLTEtMS0w_468316f6-632f-4f20-b975-6ff39e8c7a81"
      unitRef="usd">2600000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i0fce00ad4b33466f84ed7f0d4369f1da_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC01LTEtMS0w_b564e3d8-27cb-4894-a20f-4a1c58fc6841"
      unitRef="usd">-3500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i370c0708703f4720a2fcf9c2431ce3a3_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOC03LTEtMS0w_72751c28-1021-4cbd-883c-27da68d75ea2"
      unitRef="usd">1100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ie7d7e794e805469d9872e723c8a64170_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS0xLTEtMS0w_de5e5fc7-0898-4c19-96ae-8826cdad3574"
      unitRef="usd">2100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i728508ff257d45269fd226b6e4007b29_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS0zLTEtMS0w_8863936e-d3f2-42e4-bf98-b4bfdde1fecc"
      unitRef="usd">1100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i14082a39d21644148e4c5cf118f3358e_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS01LTEtMS0w_c9f5299d-45e6-4814-b7a4-f38c44878b50"
      unitRef="usd">-5900000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="if945c9fdbbc741149e9ebac49a4159d7_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfOS03LTEtMS0w_4456997f-9b82-4b9d-93cd-8668ddf4a532"
      unitRef="usd">-400000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i8f5cb3f9863f4f69a7e5d9ed5b7b04e7_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtMS0xLTEtMA_c46dabec-af25-4001-a0a6-705577955e69"
      unitRef="usd">5200000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i4ab6bd47604045a198b6be4ecc92f0cc_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtMy0xLTEtMA_576e64f4-5989-443b-8568-60481e7f7e35"
      unitRef="usd">3700000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ifab591a08e2640cb90a862d4fe809a8f_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtNS0xLTEtMA_f6468c92-4da1-47c8-b7b1-09cbdd6a176e"
      unitRef="usd">-9400000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i72404d2b015d4b2384cbedb21aca87b8_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTAtNy0xLTEtMA_ec7df6b5-b3a2-4ba4-9711-e9a219121eae"
      unitRef="usd">700000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItMS0xLTEtNjgyMQ_bb30e1fb-6470-4dc0-a98d-ecd807dca1dc"
      unitRef="usd">6800000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItMy0xLTEtNjgyMw_9fd56013-920d-4e7c-aecb-47022c7c06cb"
      unitRef="usd">3300000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItNS0xLTEtNjgyNQ_c8a6a9b2-829e-43d8-99a8-b5e3a44aaae7"
      unitRef="usd">-11900000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOjYxZTJkNGI3NzhiNDQyMTRiYzIyM2QzMzgzNTkxOWY2L3RhYmxlcmFuZ2U6NjFlMmQ0Yjc3OGI0NDIxNGJjMjIzZDMzODM1OTE5ZjZfMTItNy0xLTEtNjgyNw_b97ce2e6-e351-417b-8f89-e6d30e8459d7"
      unitRef="usd">100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <holx:NotationalAmount
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfMTA5OTUxMTYzNDkyOA_45a6fbaa-bc64-415b-af0d-4b37267cc866"
      unitRef="usd">415800000</holx:NotationalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2c0e131c95e14da199d151225685419d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNTUxMw_b2c52310-34cd-4a40-87c5-1835d8091de8"
      unitRef="usd">133500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjEwMw_212a4a4b-f997-4a61-97c6-066f22913e7e">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of March&#160;27, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i9310ce69fb254103a98583ec7e3a8f90_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfOS0zLTEtMS0w_5d442449-82c2-49ce-8058-5ad49e97065b"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i87ab14cc2c1b434da9b16b16b3ce59e1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfOS01LTEtMS0w_599b3c36-0ea6-43a9-96ca-7eaa5aa24322"
      unitRef="usd">1100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="idbc1821170fb4c9a801bdfc34109bcde_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTAtMy0xLTEtMA_67dee021-03fe-4c72-82a8-db0d3b157107"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i17d059976369410a807492037e5cb3e7_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTAtNS0xLTEtMA_695ac405-6704-4f4c-a30c-c04ff452a952"
      unitRef="usd">10100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie88aa4de2fa84889ad42f389e367d075_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTEtMy0xLTEtMA_42882011-98ca-4f51-8363-43a606432893"
      unitRef="usd">1100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i11b59cf4e28d42bf8a4e9c8c7e429ac8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTEtNS0xLTEtMA_0b97804f-3daf-4185-b750-04bce3a7ba3a"
      unitRef="usd">11200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ifd16785dea0a4ca1bf8304136ec99d08_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTUtMy0xLTEtMA_5e0be365-37ef-4fc4-a07c-c60f507bc2d6"
      unitRef="usd">11000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ief9fc2fa9591462dad0bf17824d2a9fa_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTUtNS0xLTEtMA_313abfe9-2b15-4319-b2ce-692f6da546ce"
      unitRef="usd">8200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i93d55ca8ee94483dac7f5b658cc31fa8_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTYtMy0xLTEtMA_7391daec-8166-4263-ab6a-b0bda2974ac9"
      unitRef="usd">13900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ic413e8139a5c40468c33462fc5941e98_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTYtNS0xLTEtMA_cee94c7b-311c-42cd-abd1-5ccfd8cddc8f"
      unitRef="usd">23000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTctMy0xLTEtMA_2316f235-6011-4ddd-930c-e39fbcf339db"
      unitRef="usd">24900000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTctNS0xLTEtMA_3c49fe06-5ead-452b-aa8f-c567af974d5a"
      unitRef="usd">31200000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ie803f3fd1bff41419202ea94b2221474_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTktMy0xLTEtMA_1c6c2dfc-0fda-4927-9c91-f5153a9c4fe2"
      unitRef="usd">3000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i9a81172412bc4ff681f76e0d333e25d1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmJjMjEyZTI1YTQzZTQ1NjE4MzAwZTY1YmNiMThmYmJhL3RhYmxlcmFuZ2U6YmMyMTJlMjVhNDNlNDU2MTgzMDBlNjViY2IxOGZiYmFfMTktNS0xLTEtMA_ab0f6e93-0435-49ec-9126-6ded927adac7"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RleHRyZWdpb246NGM1ODA0ODIyMmEwNDM3ODg5N2Y2YTM5NDgyNzkwZGFfNjExNQ_348be35a-65eb-479c-a9cc-9a99628eb0ad">&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ied2f2cfebe3b48139e592af29012bf6c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy0xLTEtMS0w_87572c60-35c7-45a3-9bcd-1fe8bc6e3aec"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i561329732ffc467eb03c4950ee15a00e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy0zLTEtMS0w_743cf288-5ac6-4efc-8350-4b5d084069d9"
      unitRef="usd">25200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i16d36f0eba664708ad3e485d531f2d15_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy01LTEtMS0w_ec618e11-ba8b-43be-ae20-6c0ec384374b"
      unitRef="usd">5200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic190c456cf6a49e5b0ec99b8038929ce_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfMy03LTEtMS0w_b95eaa53-7ae6-4576-886f-118fb02c41c1"
      unitRef="usd">-20800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i86fb83a62a8c4fd59a58fdd0e8af7e97_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC0xLTEtMS0w_9094951c-74f6-4fc1-8a67-a72695f4fec6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i298880826ca146b98d400d387598be5a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC0zLTEtMS0w_d81ef466-7cf7-4796-b5d7-217591ea2d37"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iba496bae81354f87b7905994ea233dd8_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC01LTEtMS0w_9668b594-9645-45c1-bfd1-51cc8871e8ca"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ib5715660627c4c0c814c4bd2577fe6cb_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNC03LTEtMS0w_575febf9-9500-4eeb-bdce-c193a30610da"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS0xLTEtMS0w_34b303f8-7087-437d-a2d6-f9e0761dc0c5"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS0zLTEtMS0w_1129d57e-b259-4f32-a70a-3c21a656f16f"
      unitRef="usd">-25300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS01LTEtMS0w_d288391a-f0dd-4fcf-b3c5-238e35e7a9d8"
      unitRef="usd">5000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82NC9mcmFnOjRjNTgwNDgyMjJhMDQzNzg4OTdmNmEzOTQ4Mjc5MGRhL3RhYmxlOmVkN2M4MjE5NDQyMjQ2ZGJhZDE3MjQ0MzhiYWU0YjExL3RhYmxlcmFuZ2U6ZWQ3YzgyMTk0NDIyNDZkYmFkMTcyNDQzOGJhZTRiMTFfNS03LTEtMS0w_0b8aabc6-de69-4ec5-bb11-e358b4c384a4"
      unitRef="usd">-21200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfNjg0NQ_41b64dd8-7594-4aaa-aa77-8337dd56154c">Commitments and Contingencies&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses or any reliance on collateral findings regarding invalidity from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review proceedings. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#x2019;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 7, the Company has agreed to indemnify CD&amp;amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $10.0&#160;million accrued for such matters as of March&#160;27, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <holx:AmountAssessedInDamages
      contextRef="ieb56657e29a54018978922a7e1c3a629_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfMTk4Mg_6e8ffeb2-a85f-45fc-b4c2-5172f3c28bd5"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="iba238290a69f46b1a533fe0940b1cca4_D20160304-20160304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfMjUzMA_e8e5e332-ad1e-437a-8689-0c90047c9bd8"
      unitRef="petition">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <holx:LegalAccrual
      contextRef="i8b0b8127ce934cd9b79a11ee9f9c7acf_I20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV82Ny9mcmFnOjk3YTUzYTI3YWY5MDQwZmU4OWQ2Mjg4YzY5ODcyMjgxL3RleHRyZWdpb246OTdhNTNhMjdhZjkwNDBmZTg5ZDYyODhjNjk4NzIyODFfNjAzMQ_f78e7aba-ecd2-4965-8782-7b58aecf4a69"
      unitRef="usd">10000000.0</holx:LegalAccrual>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RleHRyZWdpb246NjlmZmMxNTAzYzY0NGE5YWJhZDViOTFmNGQxYTFhNzBfMTA4_ba6e9ee5-94a9-4c76-a94c-5af046fa84a8">Net Income Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RleHRyZWdpb246NjlmZmMxNTAzYzY0NGE5YWJhZDViOTFmNGQxYTFhNzBfMTA2_f567918a-9682-4bed-9f25-087fc1f6c893">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi0xLTEtMS0w_391fee84-ca73-4b67-b9c5-fe1dcbe47467"
      unitRef="shares">258473000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi0zLTEtMS0w_d5be14d4-8159-4d10-bc50-454640983d1e"
      unitRef="shares">263238000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi01LTEtMS0w_fb25923a-78a4-4d4c-81a2-3c6c92f79ef8"
      unitRef="shares">258539000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMi03LTEtMS0w_d7c370e3-db16-41f9-b4fd-e54027b28287"
      unitRef="shares">265566000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy0xLTEtMS0w_b5e8773e-bbb0-4ef3-a3f2-3e660ccc19c4"
      unitRef="shares">2276000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy0zLTEtMS0w_c805f5dd-7a0f-49b4-a372-b032b6682d81"
      unitRef="shares">1268000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy01LTEtMS0w_48f4e926-bc18-4784-a045-dfe70737957f"
      unitRef="shares">2728000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfMy03LTEtMS0w_01377580-3367-45c0-8b96-7fe793fd2df6"
      unitRef="shares">1548000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS0xLTEtMS0w_c14a51f7-e3c6-4d70-aba3-f4c7a50acbde"
      unitRef="shares">260749000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS0zLTEtMS0w_a98801e7-4f6b-4971-86bf-bbc5f79daef7"
      unitRef="shares">264506000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS01LTEtMS0w_a91eb562-d8f2-4ae4-8f6c-6089ff5fbe30"
      unitRef="shares">261267000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNS03LTEtMS0w_6e75cf1c-3e1a-4c93-91b2-3faa52bf9cbf"
      unitRef="shares">267114000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7c9f918de2cf4d88a84b71df72163bf3_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy0xLTEtMS0w_5e21e475-0660-4010-9055-ae8fd6efa9f2"
      unitRef="shares">552000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie144f499b7fd4eb998be1642c636dc03_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy0zLTEtMS0w_1eca100a-da88-452b-bb1c-733504c55b12"
      unitRef="shares">1677000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7e1e58fe46ca4c779247bd692e2e4185_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy01LTEtMS0w_ec516545-6b50-4c3c-9ed3-ffcd9909b10c"
      unitRef="shares">446000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i070793615ded4840820fd755341d20f1_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfNy03LTEtMS0w_6387ed5c-8adc-4577-a13d-d1fdd64f4a59"
      unitRef="shares">1483000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia8577ab468434cffae8cbb51873099ce_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC0xLTEtMS0w_857967b5-d45a-4c2a-bf4e-1145af07218b"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic7e4f871073d422ea5def9c529807699_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC0zLTEtMS0w_19e61294-89e8-48bb-a15c-ee82ad86ec32"
      unitRef="shares">10000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i46d86786c1ac4e81846655e4acbc0c6e_D20200927-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC01LTEtMS0w_fd16ab81-79cd-4601-9a56-1c5080a92eaa"
      unitRef="shares">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2d272ac0e09f419a956e9fb6c0361bc3_D20190929-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83MC9mcmFnOjY5ZmZjMTUwM2M2NDRhOWFiYWQ1YjkxZjRkMWExYTcwL3RhYmxlOjI2M2FmZGE1YmU3ZDQwZWM4ZWM0MTU5ODQ1YzdhNjM1L3RhYmxlcmFuZ2U6MjYzYWZkYTViZTdkNDBlYzhlYzQxNTk4NDVjN2E2MzVfOC03LTEtMS0w_6c8f85e2-6e16-4297-b75b-a181806e61fb"
      unitRef="shares">6000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMyOQ_94ec6866-b6fa-41b9-a71a-58cd208338aa">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted options to purchase 0.6 million and 0.9 million shares of the Company's common stock during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average exercise prices of $68.64 and $45.82, respectively. There were 4.5 million options outstanding at March&#160;27, 2021 with a weighted-average exercise price of $44.53.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.5 million and 0.8 million restricted stock units (RSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average grant date fair values of $68.51 and $45.76 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.51 and $45.76 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years provided the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$68.51 and $45.76 per unit during the six months ended March 27, 2021 and March 28, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the three months ended March&#160;27, 2021 and March&#160;28, 2020, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31 and $43.90 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At March&#160;27, 2021, there was 3.1 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;27, 2021, there was $23.0 million and $71.7 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.5 and 2.1 years, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMzNg_cc9d5af0-a9b8-43db-ae0f-2ef5e3a7d930">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i5089e6cd6df24ba38788f0b1f4ec9aa4_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi0xLTEtMS0w_23e263ff-455b-4688-9b43-5f4892217d09"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1385d9f85d114662986d5770c3b9c5eb_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi0zLTEtMS0w_14f82ae1-dfcb-4f57-82a3-6dbc8f2a7d0c"
      unitRef="usd">1700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i042387ddd4d94b5f97f7b3f7f7794495_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi01LTEtMS0w_8f330dfe-f0b4-4ce9-9ba9-d47ee7a97850"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifc6eacddf2c14e2da413620ca0ddd0de_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMi03LTEtMS0w_6513c38e-9f63-45e7-9e32-d1c5abbbd23f"
      unitRef="usd">3800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4081d628500a407e83b46bf2fe3b0005_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy0xLTEtMS0w_7116012a-ec5c-48b2-b196-e8deb9152727"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3b5c87f950614503ba2efd4bb0004547_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy0zLTEtMS0w_c82d290d-fa5d-4814-91ad-eff6e0cd8443"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia0df38cfcac340ca926931a8815bd86a_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy01LTEtMS0w_310d74ae-073f-4a3a-9f55-9f6f6fdc20a9"
      unitRef="usd">4800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7406c1b94a0341b89142d4308dd7bd26_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfMy03LTEtMS0w_51d2a6a1-14f0-4ab3-a412-78d90fd3d8d7"
      unitRef="usd">4600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibd2eec347a984124b6b6980c85d40599_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC0xLTEtMS0w_f2409565-0878-46db-9567-b48f6f5a6538"
      unitRef="usd">2700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaad3c625ba65468dad8446d8c5ca3463_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC0zLTEtMS0w_dea82c64-5cd4-4733-a52d-066798205869"
      unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic72750901e9646aebae40d076b3f86f8_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC01LTEtMS0w_1f875503-0fb0-40df-b86c-a1a07ece31ac"
      unitRef="usd">5400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i47c626852f1c4ff2a5ab8807eabc7a53_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNC03LTEtMS0w_8c5f206e-f8ad-4c5b-8651-027efa77a298"
      unitRef="usd">5600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7d4f38c2b6ee4d35ae4e4fc855b5c593_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS0xLTEtMS0w_a1a0c45a-0339-4874-a607-d93f3d9cc097"
      unitRef="usd">9700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i662994515dee4071be41921dd55091a9_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS0zLTEtMS0w_a9c1eb84-3c6b-4673-ab8e-45fde0c95c12"
      unitRef="usd">6500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie20cab64438a419fb7e15f3b2d30abfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS01LTEtMS0w_ab68d38c-c480-4428-882a-3db544986a0a"
      unitRef="usd">20900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie4f3dc155fff485eb786e0c5e0b8f79f_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNS03LTEtMS0w_3d0a7fc1-10d8-4022-8131-1b04c79528b2"
      unitRef="usd">17400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9ecf187b743a46929a3cbc82c74daecd_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi0xLTEtMS0w_517ef977-8a9d-4094-9ed8-083bd3ed784f"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia292e0f0da204d90bd17cc07a6c83088_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi0zLTEtMS0w_72f518ed-953f-4ac2-9da1-88c46b85d180"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8d7d1bb69ae44c12932fd6147a4a1819_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi01LTEtMS0w_338f2f8a-5137-47d1-9626-4a6502b04ed1"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3a10ffdc26ba439aae8e83d553aa4523_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNi03LTEtMS0w_ee943d30-b6e4-4113-a756-3d10b6cfd18e"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy0xLTEtMS0w_8ea8d099-3668-4f38-8d0f-c395cb99193a"
      unitRef="usd">17000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy0zLTEtMS0w_cf1b7aca-7f83-4a04-8242-c9418ec2bf5f"
      unitRef="usd">15700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy01LTEtMS0w_43109a73-ad76-49ef-9a4f-d86d25a85427"
      unitRef="usd">35600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOmFiNjRmMjIzN2E4NTRhNTRiMmJhNzllYTZhNTQwOGE1L3RhYmxlcmFuZ2U6YWI2NGYyMjM3YTg1NGE1NGIyYmE3OWVhNmE1NDA4YTVfNy03LTEtMS0w_e798a514-9dc7-4134-8aff-f1a005e7223c"
      unitRef="usd">33800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTg5_4591423f-6619-4581-8479-b9918218dec8"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTk2_493cc8d2-fed6-4d75-a4d0-ba9491abb5b2"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzE2_2444ab25-b740-46e2-a105-2819e23e1c5d"
      unitRef="usdPerShare">68.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9fe9ad3d9a5e465fa035632f2652388e_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzIz_718af4b0-5419-4426-b8b7-e09a522e86e5"
      unitRef="usdPerShare">45.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzUy_6a1a0f63-3d3d-46a5-8007-7845e155ff8b"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNDIz_9cb48532-957b-4005-81ab-5999cb17ca20"
      unitRef="usdPerShare">44.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzMyOA_100d81e9-f984-4b41-9541-46015f7febd2">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi0xLTEtMS0w_5eca8588-6477-4205-bca9-4d838bac613d"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi0zLTEtMS0w_25cea9fb-9e27-46dc-ac41-50715a78cef8"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi01LTEtMS0w_ba5a08e6-bb16-4746-ab3b-5d928da4a142"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMi03LTEtMS0w_0381bec8-6f49-4ae7-9b5d-7f997935e6c7"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy0xLTEtMS0w_add71567-b618-45dd-b853-5984e2516e03"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy0zLTEtMS0w_d7648433-9290-49c5-9374-e86f09a5dd1e"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy01LTEtMS0w_e11b0bb3-0568-4c04-b02a-0bedfefe2f24"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfMy03LTEtMS0w_f8a2f03d-8018-48bf-88f1-d9ab9f7968e5"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC0xLTEtMS0w_e78666af-7614-4e1f-be33-32ec836bddee">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC0zLTEtMS0w_1b03556d-6d09-41a5-aeab-0a35e7d10430">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC01LTEtMS0w_3f80f59e-6f97-4c62-a834-ae960153053b">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNC03LTEtMS0w_c9860d77-f879-4bf6-8fd3-92d5541c4ac3">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS0xLTEtMS0w_e5b77474-889a-4f8d-a8e0-ff949631faa4"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS0zLTEtMS0w_00a4b4a3-5997-4cf4-bf4b-1a31467e9fcc"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS01LTEtMS0w_c9b7c233-641e-46f6-a4b0-1aa5204901aa"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNS03LTEtMS0w_3f031f88-a0d4-4e65-9532-c59f6d771b96"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi0xLTEtMS0w_97650a89-e0f4-404a-bf3f-0a25220df2ba"
      unitRef="usdPerShare">21.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi0zLTEtMS0w_350af76c-ad0b-425d-982f-75a267c14fdf"
      unitRef="usdPerShare">14.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi01LTEtMS0w_6ed14d94-1dc8-4736-92b4-4f85ba462bc9"
      unitRef="usdPerShare">20.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RhYmxlOjc3MmJjM2I3ZmZmYjQ2MzNiMDE5NjZkOTY2YmY0MjZlL3RhYmxlcmFuZ2U6NzcyYmMzYjdmZmZiNDYzM2IwMTk2NmQ5NjZiZjQyNmVfNi03LTEtMS0w_6cc36892-6d63-437e-acd0-c220a512ca65"
      unitRef="usdPerShare">13.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNjQ0_13b3888f-0eea-4ce3-acc6-42a7efe9c600"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNjUx_cf15308a-1994-47c8-bc79-7ac021056fe0"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNzg0_d11ef31b-6945-4580-8413-263116f00c9b"
      unitRef="usdPerShare">68.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib1ad0ba68fb54fbb9fcdba185cc4cfcb_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfNzkx_dc8a29ed-0ae6-47a7-b933-906227493cf9"
      unitRef="usdPerShare">45.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfODUx_9c6afc63-9af2-4c7e-a97a-d53cb6dda4ac"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic1102657f7bd4468812eef9239214f33_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfODU4_82b9fb73-3845-4809-b243-7af884e91e8a"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3d5f5b557a3147648839ed2fbf831d8d_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTA0MQ_48f727e4-1e05-49c2-86a3-704db165f8a0"
      unitRef="usdPerShare">68.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic1102657f7bd4468812eef9239214f33_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTA0OA_59699cc6-f951-42b9-a28f-e7b9673eaf84"
      unitRef="usdPerShare">45.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTEyOQ_ea10ffa0-413f-46cd-b860-7962a3ae6b74"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTEzNg_73ffa8be-2582-47dd-a386-c2ed3d30b04d"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTIxNA_308d72de-22d7-44d6-9665-3c840f663b09">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTMyMg_128b1f09-03eb-4e12-a330-dba4622676d3"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTMyOQ_88ab5832-ea7d-4660-8367-68cf4e4efa23"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTQ1Nw_bad345a0-b4d3-4c47-a09e-2f978d226f4f"
      unitRef="usdPerShare">68.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib2969a9b054748939924c1c7ae655da5_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTQ2NA_12aa1d0c-5cac-4eb1-8e5f-5d2621b77c8a"
      unitRef="usdPerShare">45.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i3e0176c16d5c4efdb07e4c91130cb0d9_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMTYyOA_b44a95cf-97c4-4eae-b1f3-eb170e727808"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjQwMw_4b434dd2-3bfc-4901-865e-196785d17a3d"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6780dc391a714a25af687af04d21768a_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjQxMA_9df11df3-0788-450a-b98f-606d45f6daca"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjU3OQ_ea10ffa0-413f-46cd-b860-7962a3ae6b74"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjU4Ng_73ffa8be-2582-47dd-a386-c2ed3d30b04d"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjY2NA_308d72de-22d7-44d6-9665-3c840f663b09">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7ee5156236054a94ac9c4da1c2abd8ba_D20200927-20210327"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjc4MQ_b88e7539-5682-4dc8-894c-42fce7e1e303"
      unitRef="usdPerShare">82.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6780dc391a714a25af687af04d21768a_D20190929-20200328"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMjc4OA_9e89bba5-df66-4c37-9287-ea52f0bcf508"
      unitRef="usdPerShare">43.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if74ce39dfecd44f08e7d1c91ebc01c9d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzAxMg_d7723bc3-353c-47af-8386-ebede2c2e3e9"
      unitRef="shares">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i99a9d88b27994530817b5d3d5f55a648_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzA4OQ_c4942900-6881-4f69-843a-a7ff5173e701"
      unitRef="usd">23000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5862a7e8fb46483da33faa01de3b39c5_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzA5Ng_4b8a71f3-dae1-45ff-b859-2ed7c19d29fc"
      unitRef="usd">71700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzI4OA_032ca53c-bd75-4977-8046-5e848192abfd">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie2be7bd149774b8590d633a72161f25c_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83My9mcmFnOmQwMzY4NmE0YWRmNjQ0Nzg5OWRhYTFiMGU0YWJjYzdiL3RleHRyZWdpb246ZDAzNjg2YTRhZGY2NDQ3ODk5ZGFhMWIwZTRhYmNjN2JfMzI5NQ_db15a625-810a-4447-a559-5e8385c74027">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <holx:DetailsOfCertainBalanceSheetAccountsTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNTA_81a79570-eb92-48a9-b308-53fabd9687a4">Other Balance Sheet Information&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNjg_75457b0e-59bf-43c0-aff1-5db27a3e7f50">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMi0xLTEtMS0w_450703b8-72b3-41f2-aa7d-703be779c8e3"
      unitRef="usd">154200000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMi0zLTEtMS0w_77f4ae23-ca57-4184-9183-3b6d5c6dd89d"
      unitRef="usd">152300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMy0xLTEtMS0w_0a20f3f4-4cc0-447d-9e71-3c9b001d6822"
      unitRef="usd">56400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfMy0zLTEtMS0w_2cecf3a6-319f-41d4-ad27-62eee4d26161"
      unitRef="usd">46500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNC0xLTEtMS0w_3854b3d0-9913-4b6c-b0c4-50d5fd594656"
      unitRef="usd">245600000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNC0zLTEtMS0w_ad4f37dd-9bf7-4cdb-aa1a-62e269beb670"
      unitRef="usd">196300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNS0xLTEtMS0w_063ce310-ab17-4148-aaa8-d23db2320ac8"
      unitRef="usd">456200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjEyYjM4NjU4MmI4ZTQ0ZWE4M2JkZGQ4YTAzOTA4NGRhL3RhYmxlcmFuZ2U6MTJiMzg2NTgyYjhlNDRlYTgzYmRkZDhhMDM5MDg0ZGFfNS0zLTEtMS0w_b70652c0-78dd-420a-8c52-49c50d8fac6a"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RleHRyZWdpb246Y2E3MWU4ZGY5MDM0NGYwZmJhNjQ1MDZhYjc2NDlkMmFfNjU_d723fba2-79b5-4d05-911b-ef425effc50a">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMS0xLTEtMS0w_17a84bb2-7e95-4ada-9469-3e2a5a834d4d"
      unitRef="usd">491500000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMS0zLTEtMS0w_9eddce4f-d688-4cc2-89f9-9b72392d0c24"
      unitRef="usd">460700000</holx:ManufacturingEquipmentAndSoftware>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMi0xLTEtMS0w_94ec958b-c4e4-4a5f-a62e-42f6f96d2455"
      unitRef="usd">471600000</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMi0zLTEtMS0w_d68b0946-2035-4d2f-bb7e-528727b6986a"
      unitRef="usd">456800000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMy0xLTEtMS0w_361e1feb-8e7b-48b6-ba0e-b362b0d73ce2"
      unitRef="usd">178700000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfMy0zLTEtMS0w_436086b1-b991-4fdd-a910-da2ee996b05f"
      unitRef="usd">167300000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNC0xLTEtMS0w_d76f6ca3-07af-4eb2-91d4-c77cef6604a5"
      unitRef="usd">47000000.0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNC0zLTEtMS0w_f292cf35-4a0d-474e-b296-ab55f98c0df8"
      unitRef="usd">44300000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNS0xLTEtMS0w_bc5a3302-6774-48b3-b46d-b6fe436194a4"
      unitRef="usd">41400000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNS0zLTEtMS0w_6b250587-cff0-45a6-af5f-019b78764f0d"
      unitRef="usd">40700000</us-gaap:Land>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNi0xLTEtMS0w_221ca66a-5815-49aa-9484-2309d0e8f90b"
      unitRef="usd">16800000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNi0zLTEtMS0w_ad7b7bc6-80cf-497e-bf75-a1c3fc2a7caf"
      unitRef="usd">16100000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0xLTEtMS03MDQ1_dc88a994-1541-4d28-9661-f3daaa36d29e"
      unitRef="usd">8400000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0zLTEtMS03MDQ3_0fcfd3bb-0a47-40c9-84a5-ed0873d7372b"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0xLTEtMS0w_7aa025a5-090d-400a-a2b6-3ad9cda3a9d4"
      unitRef="usd">1255400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfNy0zLTEtMS0w_9a07d2eb-5b71-4353-8d8e-909e73347245"
      unitRef="usd">1185900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOC0xLTEtMS0w_146d3b26-674a-467f-bd2d-573402299210"
      unitRef="usd">721800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOC0zLTEtMS0w_c61e4490-ea73-466e-92af-3afd10d54bbd"
      unitRef="usd">694400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOS0xLTEtMS0w_cffb5a69-9fcc-40c3-a516-a8cb04574b28"
      unitRef="usd">533600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83Ni9mcmFnOmNhNzFlOGRmOTAzNDRmMGZiYTY0NTA2YWI3NjQ5ZDJhL3RhYmxlOjhiMDZiODRiN2NhODRhYjY5YTgwYWY5YjhmYWUyNjU5L3RhYmxlcmFuZ2U6OGIwNmI4NGI3Y2E4NGFiNjlhODBhZjliOGZhZTI2NTlfOS0zLTEtMS0w_1c92da61-450e-4152-aba2-26f817355c4c"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk2NQ_0c1d33e0-17eb-40fa-adce-3ad5fda9aabf">Business Segments and Geographic InformationDuring fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. Segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of world&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i532492042bba44aa888e1a014048de52_D20200628-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMjU3_6641f83c-8d23-4d8f-a010-a03267da5460"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="ib7935a6d79614132b0ef2b639930f553_D20190929-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMjU3_7c66ffd3-4b6c-4020-a9f8-a1a96937d734"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="if07be3a2248e454e9dd29011bf561fdf_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_291570bb-a1af-461d-8917-5356f29285c3"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i34b3b1ebbb344b0eba9a071b5285028a_D20190929-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_52e3f242-8213-42b4-845b-e54ea2ed3df1"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib7a70e04c2c044d488ee49e04a7c4fd8_D20191229-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_7a57222f-74e2-49ea-88f9-63113e184aa5"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cedd2956ea24251b4f2e787ee87f9a5_D20201227-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTEyNA_9bb5e2de-b696-42b0-894e-f4dc8d2d8850"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk2Mg_374ab25c-8e80-4c2b-918a-765fd8472609">egment information is as follows:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;796.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy0xLTEtMS0w_41f8956d-6576-4236-a15c-9a210045e1df"
      unitRef="usd">1064500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy0zLTEtMS0w_6327c1f3-7937-442f-b414-046c34c8ec30"
      unitRef="usd">319200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy01LTEtMS0w_1a1dc459-b628-4d8f-8f9c-6b758782eb22"
      unitRef="usd">2192700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMy03LTEtMS0w_b45b39f1-e76d-4da2-be45-07dc901f2839"
      unitRef="usd">630700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC0xLTEtMS0w_615624ad-65c4-4248-9885-9629eb360b66"
      unitRef="usd">336300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC0zLTEtMS0w_2d0fe4c6-17c5-493a-9a73-42a5bac771a4"
      unitRef="usd">307800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC01LTEtMS0w_fa037f6d-e579-4395-a163-1178be8121ed"
      unitRef="usd">669100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNC03LTEtMS0w_8e66f0ac-dcc1-498c-a59d-65a9c10c13da"
      unitRef="usd">638900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS0xLTEtMS0w_95b7bd11-1ab5-47a8-885a-8db8092ca765"
      unitRef="usd">114200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS0zLTEtMS0w_c328e74b-7111-4818-a0a8-6ea6b3509967"
      unitRef="usd">105400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS01LTEtMS0w_b1e5ede0-c21a-4093-939a-fc88acaf4d21"
      unitRef="usd">238200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNS03LTEtMS0w_0356cd5e-e766-4d54-81bf-f272aa7beb00"
      unitRef="usd">224500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi0xLTEtMS0w_e6ac245e-cfa6-4a5e-acb8-976f354ff7b0"
      unitRef="usd">22600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi0zLTEtMS0w_5abc0ed2-c475-42e2-93f9-c12bf348b8cb"
      unitRef="usd">23700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi01LTEtMS0w_6a643646-bf53-4ae4-ad1c-94fb315268d8"
      unitRef="usd">47400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNi03LTEtMS0w_0618b25e-532c-4aeb-9fa2-c189b4e80717"
      unitRef="usd">47200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy0xLTEtMS0w_ee839144-fb9b-488b-9a36-ccd536df70dc"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy0zLTEtMS0w_00da1a17-a26e-4a06-97ee-509e82aaf0d3"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy01LTEtMS0w_eb662142-9634-43cb-a6ac-f9e937de34b0"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfNy03LTEtMS0w_2075aa15-a73f-4533-a70e-53365f7f631b"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC0xLTEtMS0w_25040906-e80e-455f-84f6-8c8a3ef5b11c"
      unitRef="usd">1537600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC0zLTEtMS0w_e2bedb8d-f22a-4003-b654-41e1d6770962"
      unitRef="usd">756100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC01LTEtMS0w_6693e929-02af-4979-ba99-9950ec258fcb"
      unitRef="usd">3147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfOC03LTEtMS0w_4d3f2fa8-6ab9-4908-9ae8-8584e83e4f66"
      unitRef="usd">1606600000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtMS0xLTEtMA_ee7c9d2e-576d-4339-8177-99d4b43c8ceb"
      unitRef="usd">700600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtMy0xLTEtMA_a946e6c9-26fb-4b95-bf5d-ae7a350e066f"
      unitRef="usd">57300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtNS0xLTEtMA_7b665d81-b4d1-4933-87e6-849c039039b0"
      unitRef="usd">1485000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTAtNy0xLTEtMA_064d1611-12db-40fc-bd09-a5efdb56dde4"
      unitRef="usd">106800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtMS0xLTEtMA_4f21c936-ce5d-465b-aa94-2de27b4edda3"
      unitRef="usd">67800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtMy0xLTEtMA_a5a1cdbd-153e-4625-be6f-78f0acf1fcb1"
      unitRef="usd">75900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtNS0xLTEtMA_660d7588-5dbb-4e69-85c9-7b912f115cc9"
      unitRef="usd">154100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTEtNy0xLTEtMA_3c6ef7a6-81e4-4403-809e-0ca2ac944754"
      unitRef="usd">169800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItMS0xLTEtMA_f82a9ede-ceb1-4cb3-adfd-37aaec6764f3"
      unitRef="usd">28600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItMy0xLTEtMA_627ffc03-be14-4c8b-860a-4afdc665945d"
      unitRef="usd">23900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItNS0xLTEtMA_7e26c0e1-ddf5-4d41-a291-aa7e2292979e"
      unitRef="usd">42300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTItNy0xLTEtMA_797e9cb4-ccc7-4530-98f5-eb220c97defe"
      unitRef="usd">55400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtMS0xLTEtMA_f858d95b-10ce-418f-aa95-091cbb393407"
      unitRef="usd">-200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtMy0xLTEtMA_8e4da37f-62bf-47fc-a9a4-6914916ff85c"
      unitRef="usd">1700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtNS0xLTEtMA_39cdd5a1-c35c-4961-97de-591cf0779f97"
      unitRef="usd">800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTMtNy0xLTEtMA_2c9b7764-7201-4bb6-aa0e-8ae5ec36e2e2"
      unitRef="usd">2600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtMS0xLTEtMA_0751cdba-26cd-4365-a091-e847a0d41c64"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtMy0xLTEtMA_f453a31f-131e-482e-8a67-4f8fae156a36"
      unitRef="usd">-2400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtNS0xLTEtMA_293007fa-b49c-43f6-ba01-62046e096142"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTQtNy0xLTEtMA_abe3ded6-9705-4825-9289-7c37b3b20edb"
      unitRef="usd">-53400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtMS0xLTEtMA_30e42645-44a8-4316-8a27-cdea94463e84"
      unitRef="usd">796800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtMy0xLTEtMA_ef59999d-bdf4-4752-9150-3e42f95ef2e7"
      unitRef="usd">156400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtNS0xLTEtMA_0ff7096b-594a-43a5-96e8-2f459745e13d"
      unitRef="usd">1682200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTUtNy0xLTEtMA_76e8ffc7-8cf2-47d2-95b7-998d47de854d"
      unitRef="usd">281200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctMS0xLTEtMA_535e03db-2c69-4c1a-b3dd-6710c4aa95af"
      unitRef="usd">59100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctMy0xLTEtMA_4a276573-cf89-4f00-9dd5-62146edf434c"
      unitRef="usd">59300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctNS0xLTEtMA_5140a430-3b2c-41df-8cb4-91b569faf2a1"
      unitRef="usd">115400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTctNy0xLTEtMA_168456a7-a178-4182-9e04-6066074655eb"
      unitRef="usd">118400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtMS0xLTEtMA_cf0c54b6-9455-4270-993d-b74df79120db"
      unitRef="usd">12900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtMy0xLTEtMA_d8d6b8a4-7715-408a-982a-4f38a4b6d8c1"
      unitRef="usd">13100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtNS0xLTEtMA_21dd866a-3a31-4290-9580-e34a3b8310d3"
      unitRef="usd">26000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTgtNy0xLTEtMA_0b1a703e-f404-47b0-9b23-20557dfefa7b"
      unitRef="usd">23100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktMS0xLTEtMA_e373f175-e8e6-4cb3-92d8-18f7d3221da9"
      unitRef="usd">23000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktMy0xLTEtMA_5a23c2e0-5c5a-42fc-8df6-98f931b8de4a"
      unitRef="usd">21100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktNS0xLTEtMA_5625c20b-cdeb-4496-8769-3c37d741ba82"
      unitRef="usd">46300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMTktNy0xLTEtMA_ee10572c-9bb4-4c4e-a985-6bd2883071dc"
      unitRef="usd">42100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtMS0xLTEtMA_62188058-6e22-4c9e-af5f-ac6f998029a0"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtMy0xLTEtMA_5db72edd-a8b9-4c90-b6cb-3376e360101f"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtNS0xLTEtMA_978d4f63-595b-48c0-abb7-bcf012cd67dc"
      unitRef="usd">300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjAtNy0xLTEtMA_9648560a-0714-4274-8ffc-238952edd445"
      unitRef="usd">400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtMS0xLTEtMA_2a6ae426-5067-480b-b021-32685cd469e3"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtMy0xLTEtMA_f3bee36e-ca92-4fa2-ab5d-6a3ea9ae7806"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtNS0xLTEtMA_c3253fe5-4e43-49b7-bf78-8750e4e427de"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjEtNy0xLTEtMA_b7963ff5-7fd5-435c-878c-a9ae5751a3cf"
      unitRef="usd">4100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItMS0xLTEtMA_d6196c5e-a620-4fee-a57f-869df76d5033"
      unitRef="usd">95200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItMy0xLTEtMA_886194e0-70c1-4478-81c2-b4ec7f253644"
      unitRef="usd">93700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItNS0xLTEtMA_2c33a92c-2ecb-4813-9f14-6769d391daf3"
      unitRef="usd">188000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjItNy0xLTEtMA_763dfc11-ee27-49a6-b2ea-1dd9d580ca01"
      unitRef="usd">188100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8075aba6cdf14c40a3d787e74c1ea531_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtMS0xLTEtMA_817445f9-8b06-4442-9c2e-f4e2d3454bff"
      unitRef="usd">39300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iba491e97a32f4ffcb939e405c091f88a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtMy0xLTEtMA_c6ba5122-97a8-4092-8b94-b1953f353cf8"
      unitRef="usd">17100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i757f94911bb24d859c5047220bdb4dfd_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtNS0xLTEtMA_cbadb346-426c-4f52-9270-dfa47810180f"
      unitRef="usd">77600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4a8ffd9055124ad3b3c4688ba15bf3b9_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjQtNy0xLTEtMA_c671d9cf-b6ee-429e-b93d-98fdf6b67899"
      unitRef="usd">35300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3e3ccf56fc5d402a8b2efaf00d29f87d_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtMS0xLTEtMA_e51166dc-68ba-442f-97b0-eef18f8a3fd1"
      unitRef="usd">2700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic4c4a57b80114b4facfdf698809a0d13_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtMy0xLTEtMA_d70154ef-d17a-424f-bb4c-94b99cb81b7f"
      unitRef="usd">8100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie56e0d6f350042009a3d532ea134b1f7_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtNS0xLTEtMA_78374cf6-6eda-474d-95d9-0c30ea601846"
      unitRef="usd">5600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5fafd907ef6544dab31e96d331494185_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjUtNy0xLTEtMA_220de8ff-e999-41a2-a503-3b52b143278b"
      unitRef="usd">14500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id70cfee3e323440082edf592f7d7027e_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtMS0xLTEtMA_fba870ce-2aef-469b-9c0b-75e606da9a7d"
      unitRef="usd">3200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3de5ea0839824682af01158b31c8c29d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtMy0xLTEtMA_2a2f90d0-17d7-490f-98ea-520348db96d1"
      unitRef="usd">5300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i869159fac07b4ccf879e6fdd7f6175b5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtNS0xLTEtMA_72204e9e-ccae-46fc-8c9e-fc04be0e5545"
      unitRef="usd">6500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i6275f58a40b64569acaab24f8c540cdc_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjYtNy0xLTEtMA_1e1bb384-8f12-4a1f-a008-5b7acb969401"
      unitRef="usd">10600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i07683bbb0590441099493cf63c5bb8bb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctMS0xLTEtMA_3bd04f6b-c46f-4dbe-8a7b-221632186acb"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iae013e42c76e4e96a4d6d19a3a079899_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctMy0xLTEtMA_607f3ced-0dd0-4871-8581-3c29acdecc3b"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4fd36cd7c4504f3d8024bcdd83dacb97_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctNS0xLTEtMA_202bf543-61bb-463c-b355-d180e6bb8979"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i7bd4f9c4544845aea68ab52f90fd738e_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjctNy0xLTEtMA_c01ecd0b-bea7-485d-a318-2c5220e9705a"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5eba43b648eb4390b4680e8985387e4f_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtMS0xLTEtMA_d46e4369-a014-406d-b1a2-7377e0c4803c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia18ca918644345dc984fdc0f5a69dd48_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtMy0xLTEtMA_61f51920-65fa-4a4b-9b80-63daf7f37c84"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic1bfe4ff65af4b51a8cf7ea9ceac1995_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtNS0xLTEtMA_95d0ca0b-03fb-4ad3-b007-c4fbb4504296"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8bf033a9cd204f288043165e481f8c8b_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjgtNy0xLTEtMA_b5b1b170-5de2-41ae-8d06-366ef2e37197"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iec342590d7ad4942a989e8c33e8523db_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktMS0xLTEtMA_f57d902b-a2ae-47f1-9795-43c3dc2937f7"
      unitRef="usd">600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id20db54379ba4b51b5f77937a37f9d8f_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktMy0xLTEtMA_f72759be-d15d-4c14-b2f5-dc7ae2bbccf1"
      unitRef="usd">1100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i505981465edc4002ab0c7d672cbd8b85_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktNS0xLTEtMA_ef8b3b42-48f7-4a54-a2d9-3bb6123699bd"
      unitRef="usd">900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iaa735e311c9c4edcb8b2ed934d611d72_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMjktNy0xLTEtMA_c1983f91-7a14-4219-858e-307c56d39849"
      unitRef="usd">1100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtMS0xLTEtMA_9010f757-8c89-4904-8f65-470b2fc3d541"
      unitRef="usd">45800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtMy0xLTEtMA_70aba4b1-c3d8-41a2-bcb2-c4d72bcd02c5"
      unitRef="usd">31700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtNS0xLTEtMA_8ef3dad2-daf5-4768-b2a5-ec2d71b52cdf"
      unitRef="usd">90600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjdiMmJiYTJkNjgwOTQ3ZTQ5ZTY5ZWQ5NjRlYzk0MDRmL3RhYmxlcmFuZ2U6N2IyYmJhMmQ2ODA5NDdlNDllNjllZDk2NGVjOTQwNGZfMzAtNy0xLTEtMA_99bf2181-9797-43fc-9ef4-8d35d205b795"
      unitRef="usd">63100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="i88906e66fdfd4730958ab7edc6ddc342_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMi0xLTEtMS0w_5e350b19-eae8-4b7b-850a-ee901a581ea7"
      unitRef="usd">2584100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i115120608b9744b4af122d696c198769_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMi0zLTEtMS0w_3aaa5651-d9ce-4cf8-a7a2-024a19310192"
      unitRef="usd">2161400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie4e33c2ae18a474398d2f7aa204f4b0a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMy0xLTEtMS0w_6d1c3e32-4ffd-4403-a8a2-a0edd6703bed"
      unitRef="usd">1266800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9b0538b1651d4e9fa01727c276c6aca8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfMy0zLTEtMS0w_b50b55c9-dbe0-49fd-98bb-479730d59e02"
      unitRef="usd">1200900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id59d4cf165f84163b8612267a6672818_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNC0xLTEtMS0w_db780417-075f-4465-b816-c54301b574a2"
      unitRef="usd">1402300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia004d21122de40a7acb047f75711b230_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNC0zLTEtMS0w_74aae4ec-f105-4cfb-8f50-3dde81610d31"
      unitRef="usd">1438700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie735f493b8a74552a82fa762497a7e0c_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNi0xLTEtMS0w_c485e79d-ac09-4ab5-9a61-c374817566fa"
      unitRef="usd">30400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i360d05187d17434f9f024ea0b654414a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNi0zLTEtMS0w_aebdf8b5-6c5a-46f3-9865-6b169e6324f1"
      unitRef="usd">38900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ied7d8695f726474288c5904ad677e50a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNy0xLTEtMS0w_e12c71a0-5782-42d8-85b2-b73f71f006d4"
      unitRef="usd">2760400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i66e72d51c8ba435b837b8d83097e66c6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfNy0zLTEtMS0w_159621ee-7316-4082-8384-768debebb680"
      unitRef="usd">2355900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfOC0xLTEtMS0w_7e35c30d-2f4e-42f7-a320-60ad15c795e8"
      unitRef="usd">8044000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjBlMDBlZTNkZmNiMzRmZWY4ZDY4ZTMwMWEwMTU4MjY3L3RhYmxlcmFuZ2U6MGUwMGVlM2RmY2IzNGZlZjhkNjhlMzAxYTAxNTgyNjdfOC0zLTEtMS0w_31dc259d-8bb4-4bb9-80e9-cc54b372a17e"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RleHRyZWdpb246ODRiMDk0NjBiNzQ3NDcyM2FlMDAwZDkxY2EyODQxZTRfMTk1Ng_9cfc0585-c5a3-46bf-afb4-3490418aaffe">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 27,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="ide51705bfd1a4c0db1cce9b6643a6a32_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi0xLTEtMS0w_2d28df0f-c126-4a69-b455-c23a4c0d62c2"
      unitRef="number">0.692</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="id7d0d556bf6e4ccfb8c77b781337f468_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi0zLTEtMS0w_e724bf82-c223-420e-8942-614b7cf70243"
      unitRef="number">0.760</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i4f51407a3ab143819e20f3382aad4818_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi01LTEtMS0w_ef2bab88-594e-4d5c-b5d4-a68af590eff8"
      unitRef="number">0.700</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ibeb111175b0c4ec5b4cb4b0af0e88c99_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMi03LTEtMS0w_69e041ac-ed66-478e-b4ed-b563d850db13"
      unitRef="number">0.751</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy0xLTEtMS0w_2f12073a-6a85-48c2-a4d3-f3ade70aad1d"
      unitRef="number">0.219</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="id9cb88e2a6cf4dfcb551a8119f0cfef6_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy0zLTEtMS0w_56643d18-eb42-4653-9757-db7833cdc67a"
      unitRef="number">0.148</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i81f2870f8cd3430ebb048d5b84161037_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy01LTEtMS0w_ba19456e-022e-490b-afcf-29337a17707c"
      unitRef="number">0.214</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i98200202399d411bbdfbce88f2f94963_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfMy03LTEtMS0w_e9b99ac3-be6d-4d29-903c-88074b6587e4"
      unitRef="number">0.138</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i603d43ad1e8b4f63aa6705ff23303607_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC0xLTEtMS0w_32378d55-00e6-4350-9330-bc5e0a6b61ac"
      unitRef="number">0.059</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="icb7a0f9ae2634ef79d70b1a0902d9f3a_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC0zLTEtMS0w_40df99d2-09b8-4bb0-bf9d-bf4958a5e102"
      unitRef="number">0.055</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i36e0f50304324efc9dfd6371ca30218d_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC01LTEtMS0w_9f598794-cf63-4a29-bac7-e1227fcce9d7"
      unitRef="number">0.057</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i0614a83526534d2eafa2e509f444cdd8_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNC03LTEtMS0w_316a2de6-fb42-4818-8bbb-844a8ef99b3a"
      unitRef="number">0.070</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i6c207776416743ffb080dcba5b532a33_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS0xLTEtMS0w_d713e1ed-4e0b-41d0-9424-ecfda711ac89"
      unitRef="number">0.030</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="idc0c502bf9714b0abe90c2966356a47d_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS0zLTEtMS0w_d5d1db2f-49b2-489e-b675-fcf1d85532b8"
      unitRef="number">0.037</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i90941e17deef4e38869d1a6989d08bc3_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS01LTEtMS0w_85100377-a384-4e04-aa1b-fee6fca208ae"
      unitRef="number">0.029</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ic405c49964c945a2b2cccad0f50d104d_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNS03LTEtMS0w_6ea1b0cb-0bbf-4582-8415-a6eeca8f2e7e"
      unitRef="number">0.041</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi0xLTEtMS0w_4e53e00d-85c9-4207-a766-1dfd6cbcb623"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi0zLTEtMS0w_bf645248-b324-40c6-919d-f45d8c6733f7"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi01LTEtMS0w_377f2278-1d78-4f7a-9d0b-2c2d9be51a89"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV83OS9mcmFnOjg0YjA5NDYwYjc0NzQ3MjNhZTAwMGQ5MWNhMjg0MWU0L3RhYmxlOjI1YjI3ZjUxNTg5MzQ4Yzk5YjQzYTc3ODEwNGIwNmJlL3RhYmxlcmFuZ2U6MjViMjdmNTE1ODkzNDhjOTliNDNhNzc4MTA0YjA2YmVfNi03LTEtMS0w_1bb2045a-5a85-4f9a-9f3d-7ff31298249f"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfMjkzNg_847803c9-0be5-4c71-aede-51a983570329">Income Taxes&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rate for the three and six months ended March 27, 2021 was a provision of 20.6% and 21.1%. respectively, compared to a provision of 20.3% and a net benefit of 122.1%, respectively, for the corresponding periods in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended March 27, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes. The effective tax rate for the six months ended March 27, 2021 was higher than the U.S. statutory tax rate primarily due to state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended March 28, 2020 differed from the U.S. statutory tax rate primarily due to taxation of foreign earnings at tax rates lower than the U.S. statutory tax rate including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, partially offset by unbenefited foreign losses. The effective tax rate for the six months ended March 28, 2020 differed from the statutory tax rate primarily due to a $310.9&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Income Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ica30c3f907d343549ada504d940ce936_D20201227-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjA1_1a38646e-16ac-4939-97a8-2e425583486c"
      unitRef="number">0.206</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjU5NzA2OTc3NTgyMQ_d372c673-bcab-4392-ae5b-f3a956cef3ae"
      unitRef="number">0.211</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i26c3182e58be4dd083e8df5175a73bc5_D20191229-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjU5NzA2OTc3NTgyOA_6b6c99f7-0b0a-4731-af88-4eeb9b699eb2"
      unitRef="number">0.203</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfNjM3_81459108-0087-483f-b63c-12fb5e03b9e2"
      unitRef="number">122.1</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ife89e43900064dce8b3534de88f844cd_I20200328"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84Mi9mcmFnOjJjMjZkMWZkZmQxNTQ2ODA4YWU0NzhkOGJlZjExOTVlL3RleHRyZWdpb246MmMyNmQxZmRmZDE1NDY4MDhhZTQ3OGQ4YmVmMTE5NWVfMTMxNA_cb4051ba-c883-474d-88a1-70ca4d0b4b7c"
      unitRef="usd">310900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ia5e8738289d14090b2a313cca454526f_D20190929-20191228"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQx_2eb17a77-0c28-495c-8122-02766c6955f0">Intangible Assets&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,033.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,718.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of March&#160;27, 2021 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQ2_fd6964b5-4992-4577-bd2c-ba7e23147ae3">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,033.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,718.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,224.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8b99bb878ba141d7a47254b83dc0764a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy0xLTEtMS0w_f5303e44-9477-4049-8da4-83a97ae9029e"
      unitRef="usd">4320300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8b99bb878ba141d7a47254b83dc0764a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy0zLTEtMS0w_3f372455-875c-4792-989a-88828132d086"
      unitRef="usd">3033900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if6926d7469494d35baaacd55a1ab864f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy01LTEtMS0w_bf183f69-cdef-41fb-b512-dd8c456739ca"
      unitRef="usd">4054000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if6926d7469494d35baaacd55a1ab864f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMy03LTEtMS0w_ff2638f2-9653-497d-88fe-356cfde181b6"
      unitRef="usd">2907200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i74a66f6cac0f45bca6d865851d97bc1a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS0xLTEtMS0w_6855de29-ec7d-461b-b40e-b0b892467099"
      unitRef="usd">570900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i74a66f6cac0f45bca6d865851d97bc1a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS0zLTEtMS0w_9ebaa851-7e39-47a3-8511-17daf72b8c7b"
      unitRef="usd">493900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i35518212539f4b2e9962deef5956862b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS01LTEtMS0w_2c6358bc-675c-48f4-b628-34dbe8be719a"
      unitRef="usd">549100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i35518212539f4b2e9962deef5956862b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNS03LTEtMS0w_2e811b10-46f1-47c8-a6bf-2fedb8799e7c"
      unitRef="usd">477800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7d4e68863886433791b7edc1d16c8b5f_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi0xLTEtMS0w_0bddd6e6-783e-427f-80c0-79d01033b27a"
      unitRef="usd">248600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7d4e68863886433791b7edc1d16c8b5f_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi0zLTEtMS0w_b85c866d-de90-4f9f-b033-c75cdf9a9450"
      unitRef="usd">186200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi01LTEtMS0w_0a1be65e-f97a-41b8-928e-bbb6ef8f86c7"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic1726a4e4bc74dfbbc94f75ca61716bc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfNi03LTEtMS0w_0db2a122-277a-4066-b940-7b3885b5bdf7"
      unitRef="usd">181200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i81080c9b2330438fa474bbe7a4003179_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC0xLTEtMS0w_b1dfed13-00dd-4221-ba95-c29ef65a3f33"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i81080c9b2330438fa474bbe7a4003179_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC0zLTEtMS0w_7a5cd81b-0891-4457-beaa-1605507b868b"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i662c27c8d79044699ea38a30b7e68432_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC01LTEtMS0w_63a7f8d4-86ce-4a5e-8ac3-e4530c794951"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i662c27c8d79044699ea38a30b7e68432_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOC03LTEtMS0w_eeff1ee0-f28f-4541-957e-779c2bea0f8c"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS0xLTEtMS0w_4a76e34f-2f2c-448b-81f0-30b970198ccc"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5e54ac0cf511489ba40e0ab74f1a1964_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS0zLTEtMS0w_44177386-c5a4-468e-ae87-08eb0a16b1fb"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i922d3d1beef1487f9f2d4c412ede7a12_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS01LTEtMS0w_ec9f75c8-92cc-4b7d-998e-f9ba7f7e5c81"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i922d3d1beef1487f9f2d4c412ede7a12_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfOS03LTEtMS0w_9e37429b-0bc2-4450-9256-c69aab4b17a6"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7cf7b370790144619ad4a8964a5c1818_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtMS0xLTEtMA_c2bdfc41-cba3-46c0-a796-8e5bff86d99b"
      unitRef="usd">5143800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7cf7b370790144619ad4a8964a5c1818_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtMy0xLTEtMA_da8b3067-fc64-4608-899f-daba6469982a"
      unitRef="usd">3718000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie5923eed9f67437e97eaed167c1389b0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtNS0xLTEtMA_624e2185-31e4-4182-a084-3418242e7bea"
      unitRef="usd">4852500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie5923eed9f67437e97eaed167c1389b0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTAtNy0xLTEtMA_02d090fc-1049-4396-9e96-03cafe406ccd"
      unitRef="usd">3569800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2f0ccccc76e945f4978ee19754f4ad89_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItMS0xLTEtMA_5427b1f4-9c53-40a5-bc92-470b162b307d"
      unitRef="usd">55200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2f0ccccc76e945f4978ee19754f4ad89_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItMy0xLTEtMA_26d68e47-5406-4f1c-9312-303731adef67"
      unitRef="usd">46800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItNS0xLTEtMA_27b31df8-0055-46ed-923a-ada4ec4c8eaa"
      unitRef="usd">51800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2f3d48fe9bfa4beab7f9310c388ddeca_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTItNy0xLTEtMA_c42e5f9e-c4c0-4a81-a530-a959020168f3"
      unitRef="usd">43200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib4c3b36745514581af776cf34c7004fc_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtMS0xLTEtMA_dcebcb31-409e-4bad-91cc-58a04390bade"
      unitRef="usd">25900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib4c3b36745514581af776cf34c7004fc_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtMy0xLTEtMA_ffd402c2-3ee4-406d-b331-16a8047f883b"
      unitRef="usd">12500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibfd85d51ab164407876eccc003e0ccf9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtNS0xLTEtMA_90fdf294-4663-4aa7-8a0d-bfa99e41933e"
      unitRef="usd">26800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibfd85d51ab164407876eccc003e0ccf9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTMtNy0xLTEtMA_cc45513b-091a-4166-8c56-4c800dc96eb3"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtMS0xLTEtMA_c7e815b4-584c-4bff-8fff-93209912e2a5"
      unitRef="usd">5224900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtMy0xLTEtMA_5dac457a-9261-4308-ab97-6539a787f1b8"
      unitRef="usd">3777300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtNS0xLTEtMA_4bb6cc05-9f3b-446f-84df-3da92963776e"
      unitRef="usd">4931100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOmI4YTQ1YzQxNWU4YjRiYzU4NDE0ZTZlZTI0NGQ4Njk5L3RhYmxlcmFuZ2U6YjhhNDVjNDE1ZThiNGJjNTg0MTRlNmVlMjQ0ZDg2OTlfMTQtNy0xLTEtMA_01f1b508-326b-4d47-92f5-633fb4f8fb9d"
      unitRef="usd">3623600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RleHRyZWdpb246MDY0Yjc4NTQwZTE2NDg0Yzg1ZWUwMzMyMzFkNjc2N2VfMjQ4_853c0dad-1a4f-4443-95ae-284c826496a4">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of March&#160;27, 2021 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMC0xLTEtMS0w_d8746217-694a-4ccc-b018-535cae4963fe"
      unitRef="usd">153300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMS0xLTEtMS0w_5206ee0c-f31b-450b-a8e5-b663cf80b327"
      unitRef="usd">303900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMi0xLTEtMS0w_f644a562-8981-44ae-8bb7-48d75365193e"
      unitRef="usd">207400000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfMy0xLTEtMS0w_6b874991-107c-475d-a912-88468a590f07"
      unitRef="usd">195300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84NS9mcmFnOjA2NGI3ODU0MGUxNjQ4NGM4NWVlMDMzMjMxZDY3NjdlL3RhYmxlOjJiYTA1NjUzZGM0NTRhYjFiM2JmMjIyZTRiODQ1OGY4L3RhYmxlcmFuZ2U6MmJhMDU2NTNkYzQ1NGFiMWIzYmYyMjJlNGI4NDU4ZjhfNC0xLTEtMS0w_731f2523-e062-4ea4-b8d8-00c463648297"
      unitRef="usd">181900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RleHRyZWdpb246Y2VlNzIxYTIxZTJjNDU5Yzk2OWVmZGE1YmFmMjQ2MzNfNzU_5667a4a1-7af4-4785-a9e2-1c4ac58b79b2">Product Warranties&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RleHRyZWdpb246Y2VlNzIxYTIxZTJjNDU5Yzk2OWVmZGE1YmFmMjQ2MzNfNzc_8399406e-a377-44d8-8ff3-75d6178a4bd1">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i1e832ad751c74be3a002a605f07e03a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0xLTEtMS0w_fcd10b56-7df9-48cc-8aa2-51082afa9385"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0zLTEtMS0w_989f8961-6d57-4976-8e73-318d11f5c8d6"
      unitRef="usd">4800000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi01LTEtMS0w_d70d33ad-2f7f-424e-b8bb-343e415b963d"
      unitRef="usd">0</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi03LTEtMS0w_ade9dfe1-f076-4a40-a4fe-564806e8a268"
      unitRef="usd">0</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi05LTEtMS0w_0b7c311e-ce7b-4f00-8bf6-8bad2bc8f671"
      unitRef="usd">5300000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i64d64acb56824c3484cb34d66ff95151_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMi0xMS0xLTEtMA_efded1eb-9569-4dc1-9199-b7106cbfa0cc"
      unitRef="usd">9400000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0xLTEtMS0w_b810c0c5-b8fa-45e2-a766-461c50fb86aa"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0zLTEtMS0w_6bdb9bc8-a98a-4b43-9ad3-9c63ac552b0b"
      unitRef="usd">5500000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy01LTEtMS0w_cedd6429-001a-4302-9545-9f05de799ddc"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy03LTEtMS0w_ba4547f5-f8af-4cb1-a389-c429e8c2eba7"
      unitRef="usd">-6100000</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy05LTEtMS0w_227d67e4-9e7a-4f4f-8042-3f37d53e1b35"
      unitRef="usd">6200000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i7e39d9d2d3834458b5b783ab833c8b7f_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV84OC9mcmFnOmNlZTcyMWEyMWUyYzQ1OWM5NjllZmRhNWJhZjI0NjMzL3RhYmxlOjg3YzM3ZmMxNzM0NTRjODE4NTFkNjU2ZGNmMDVkM2M2L3RhYmxlcmFuZ2U6ODdjMzdmYzE3MzQ1NGM4MTg1MWQ2NTZkY2YwNWQzYzZfMy0xMS0xLTEtMA_b1bc50cb-7512-45e2-9da1-88cf5d38e273"
      unitRef="usd">7600000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RleHRyZWdpb246MjlkZTA5NDI0NDgwNGIxZDgzNjZjYTM2NzMyNTM5ZTBfMTky_f332e61c-56f0-48d6-9a13-1e01061d6b9c">Accumulated Other Comprehensive Income (Loss)&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RleHRyZWdpb246MjlkZTA5NDI0NDgwNGIxZDgzNjZjYTM2NzMyNTM5ZTBfMTk0_80fc12e1-4a6d-4bad-8839-cc63a279d5e1">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Six Months Ended March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i800b03ee604347afbc07632cb45b6fc2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xLTEtMS0w_8b4cf1a5-72ee-4f46-9d9f-f1e4f163d128"
      unitRef="usd">-5100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fd2d36767f54a4ebd52a5d5864f3448_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0zLTEtMS0w_49f4b175-7bfe-4505-b33d-1288da1afa74"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i78273368483c4226a5ea04c7d811d3fe_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi01LTEtMS0w_a5ad289f-d461-4f49-8837-7efcb4eadb4b"
      unitRef="usd">-600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id10dfe3110de4427967f3a4b8e5a5f11_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi03LTEtMS0w_767d06be-c972-4649-a50c-71be9570c7e1"
      unitRef="usd">-23200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f41c1c1b96640ce8c37aa114378b5af_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi05LTEtMS0w_96fb0629-f732-4362-aafc-24ea2a48a583"
      unitRef="usd">-30700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4363fed50fdd460494577b4618dbf686_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xMS0xLTEtMA_1089ec42-cd9c-45b2-b199-ca0400ccc4dd"
      unitRef="usd">-22900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79509a51d6da43a78e7aff6191ec7651_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xMy0xLTEtMA_3d136000-b21f-41a0-b7b0-93b9fa2faf17"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70664359f90341ed8b7b4035eab2e658_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xNS0xLTEtMA_7e8ac80b-2548-46ae-ab2e-97d5df638a49"
      unitRef="usd">-900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c63fca0f209477d9e2d3001848cc2d0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xNy0xLTEtMA_7a8d9dc0-8d63-4eaa-a01a-4f5f33ea8fad"
      unitRef="usd">-24100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9d9c4520de640f7837c8a8db74e7a29_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMi0xOC0xLTEtMA_9d02d6e1-c2f9-4918-b314-c84a9b801187"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5f9926be54074c05bb1382ed55335276_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xLTEtMS0w_71d22965-750f-46d8-8b7d-0284bbceba1e"
      unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0zLTEtMS0w_335072b5-f9bb-42bc-9114-df82f969374d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="idcc5a52321694c0f850b13ff882001db_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy01LTEtMS0w_1384fa6b-9874-431e-b064-85934aba6d4f"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy03LTEtMS0w_0c4011d4-0145-49fa-806b-1ae936fe977d"
      unitRef="usd">3700000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy05LTEtMS0w_3df443f6-2f6d-4a53-9847-e9d2259d88e3"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xMS0xLTEtMA_991e1282-c344-4d72-981a-8438b88efdd9"
      unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xMy0xLTEtMA_644b5bd3-e9a8-49ec-97eb-58e52f12d633"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xNS0xLTEtMA_d9977fc5-ad61-4866-9594-1503000c98bb"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xNy0xLTEtMA_813c1445-28ea-4dd2-a449-50e49c6eb845"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie4689b60d23744f289cb544253b4f814_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfMy0xOC0xLTEtMA_6b887257-54a8-42cc-96b7-fe8803ea09cc"
      unitRef="usd">13400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5f9926be54074c05bb1382ed55335276_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xLTEtMS0w_e10c6907-83d2-472b-bcc1-32ee7a4d7c73"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3a20d41b757d41ff98b26903116948f1_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0zLTEtMS0w_4ffebf4a-a614-48ed-9121-0d4b7144d3eb"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idcc5a52321694c0f850b13ff882001db_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC01LTEtMS0w_5b97fcc4-a196-4987-97fc-a256fb311d7e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6f560feaf4464fd78d8b154ec69b7677_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC03LTEtMS0w_6f68af97-2900-40c7-90d1-bc7bfc7217d7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2dff29c897d844009df891f2dd3d1423_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC05LTEtMS0w_2426ea69-0cae-468c-b432-66eb64b425e3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i78847172fd444ab6b11d3b10e7fe38e6_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xMS0xLTEtMA_7ffe71cd-785f-4bb5-a74e-5dba6c4d152b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0d547c6283ed4be5b123e6f6bd7e762e_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xMy0xLTEtMA_7880b666-9faa-429d-9f5b-e2b9c24fdec5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic6116b3b0315413484a79fac5bb6c6ea_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xNS0xLTEtMA_bb564afb-05a2-4e6b-a485-705717846762"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5efb91daeb2e4466821c8e751cb080c5_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xNy0xLTEtMA_fa976ac6-713c-4a3b-9bc3-22ba3abdea6c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie4689b60d23744f289cb544253b4f814_D20200927-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNC0xOC0xLTEtMA_576554c2-0a96-4fd3-b3b7-ee8d44032738"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ia06b01fcedd04f3a85eb4bc29746d312_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xLTEtMS0w_d4815685-d32f-4ad6-942d-fb580fdcaf39"
      unitRef="usd">-14500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3fbe154820b94abb9f5b6c0d26716326_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0zLTEtMS0w_816281a2-f0b2-4176-8200-8aedef83acbd"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab882e96099247859e4ec48ec2cb938a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi01LTEtMS0w_0db19bc9-e129-4c4d-8db3-59cce7d277e3"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi03LTEtMS0w_937faee7-8d59-4ea1-8fe1-f522288deb5e"
      unitRef="usd">-19500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi05LTEtMS0w_9a09d903-0a0b-40ad-b9d2-565c8ed00d4b"
      unitRef="usd">-35800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia06b01fcedd04f3a85eb4bc29746d312_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xMS0xLTEtMA_05a6103c-828c-46f4-8696-c6fd49a60a36"
      unitRef="usd">-14500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3fbe154820b94abb9f5b6c0d26716326_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xMy0xLTEtMA_649f874b-c258-4a92-86c1-2249ef2d381b"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab882e96099247859e4ec48ec2cb938a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xNS0xLTEtMA_141fa22b-0427-4dab-b203-fa584b00d090"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f5fc37bd9fb4e43b2b02932acd1121b_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xNy0xLTEtMA_051b27c5-e6d0-4f46-b825-76e5efaa8120"
      unitRef="usd">-19500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96a2d286b76948e3a2d91063189e66b9_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOmFkOGExZDQ0Yjk3ODRkMmNiYmU1ZTFlNDljNjMxMjUwL3RhYmxlcmFuZ2U6YWQ4YTFkNDRiOTc4NGQyY2JiZTVlMWU0OWM2MzEyNTBfNi0xOC0xLTEtMA_4482f441-4a1a-4803-adb2-33036f0a2183"
      unitRef="usd">-35800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ae07c79726f4de98b04adaa90df5781_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xLTEtMS0w_f9cf5ae0-d4ec-44dc-8de1-92fcbf4c1b62"
      unitRef="usd">-33100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic38386d5f6ba40fb9d5d20588a27487e_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi01LTEtMS0w_0771c384-5e79-4261-affa-4cc51b0a0a35"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0efa40c8aa78435a86f84bf7940cae2c_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi03LTEtMS0w_3d3ac212-065d-4806-b502-27cb3fbf00e0"
      unitRef="usd">-1400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2dd1ea20daa4f4089320c0fa6f87da0_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi05LTEtMS0w_3f13fd61-ca9f-4097-aa42-94508e491d00"
      unitRef="usd">7500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib48dedaf55ee438786b6134c8b28e49c_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xMS0xLTEtMA_12b1a1b8-db13-474a-ab04-cdbf2f303f6e"
      unitRef="usd">-28700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a5a29aba88e419589c3a2f9fed50569_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xMy0xLTEtMA_5303a1cb-f0ac-4a69-9ba2-67b8a2198fc8"
      unitRef="usd">-41400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7430ac3155b74726add1cbc2e862b58b_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xNy0xLTEtMA_ba330520-4ee2-49b5-ab94-6483d0cc6c94"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8b78544c617454991ea1abde3fc0128_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xOS0xLTEtMA_aefbbc62-2938-4e05-8ed0-81e9acfe3ca0"
      unitRef="usd">-2700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie6dda121f07348d9b40b999f1945cf6e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0xOS0xLTEtNzA2Ng_e245498e-bf95-4f28-b667-3b3c02f80d90"
      unitRef="usd">3500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9527df9991fb4a508abd170595d3765f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMi0yMS0xLTEtMA_db5e419e-4fcd-44b3-bc5d-efb81ae9a1ac"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xLTEtMS0w_42fb00fe-b148-40ba-87ac-cedf559d5622"
      unitRef="usd">-5400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy01LTEtMS0w_8bf75849-bb1f-4029-9953-20c3c4facd21"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy03LTEtMS0w_e8a1394d-64fb-4e01-a3e1-a3a3074a2ff7"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy05LTEtMS0w_ac2dd21c-a52e-4aaf-be84-15af1c8b0bfb"
      unitRef="usd">-25100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xMS0xLTEtMA_0fd92d51-6f58-4c8f-bafc-d4d89c2ea31a"
      unitRef="usd">-30600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xMy0xLTEtMA_9656c54f-04b3-4d25-94a8-fd338cc065d7"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xNy0xLTEtMA_af0e55c1-8b1d-4464-845d-f0ee3ae66d63"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="idaa1b4b017d74905880304f384c057b2_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xOS0xLTEtMA_9284b27e-1c60-437d-bdfd-a5cf1f1d3650"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0xOS0xLTEtNzA2OA_ffbf38ec-fbe7-4901-9708-780546f101c9"
      unitRef="usd">-21100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfMy0yMS0xLTEtMA_937b4a44-78de-4125-acc2-6eddecb0d4bc"
      unitRef="usd">-18300000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6161dc791bfe495db9f9ebef318e34e8_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xLTEtMS0w_93800da6-b1ca-467e-959c-3018abca5277"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6b07ee08639f4c65bb13ffc01a312e4f_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC01LTEtMS0w_1f62e122-3c91-475f-b791-3b9843a1dd2b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2e39709b000d47ce9eb6d331ffdaf400_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC03LTEtMS0w_63c89377-ebd4-4efb-b5b4-b9f4d26c297e"
      unitRef="usd">400000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ideab3a78b91a4fd8bbc5037f05a93e95_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC05LTEtMS0w_7564e642-eac0-40b8-a02f-58264dc64897"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icba927ef54cc4dc7856d1c1a77e77405_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xMS0xLTEtMA_fe56a83b-ef66-402b-af09-60f048b7db9a"
      unitRef="usd">-400000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6c2d072af77d4257bcb0af7e2e6f1787_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xMy0xLTEtMA_e5b17b78-e3d0-4c84-bd8f-0468b9493ffd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i409d61daed1a4a2181886bdd4ab12506_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xNy0xLTEtMA_0f0014f5-bb21-4519-baf2-996b6e3e415a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idaa1b4b017d74905880304f384c057b2_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xOS0xLTEtMA_c4ee9557-de54-4456-9221-ff4a885c8e51"
      unitRef="usd">1700000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7004eb65dc804c44ba07d10e00ec6414_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0xOS0xLTEtNzA3MA_abe3ef87-a307-4750-aff1-608d597a1ae6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i832dbcb45b6e4a34a98ab2963851c528_D20190929-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNC0yMS0xLTEtMA_cbcd296a-a3ea-4268-920a-dc9e5c21fc85"
      unitRef="usd">-1700000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i1d0130d8988c45bbac97673c8e2ce744_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xLTEtMS0w_1154d656-d170-492e-ba65-c7301f996275"
      unitRef="usd">-38500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd0078ba73a24f819d70857c6b061aec_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS01LTEtMS0w_c1c46e79-cd7a-48ba-a1a9-8767cbaa11a0"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e7212338e6d4a7fb971feed57bf398c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS03LTEtMS0w_596c3625-3946-4a52-b960-b83121075db7"
      unitRef="usd">-1100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04964732adf14196a87e9aeb38f71672_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS05LTEtMS0w_047f6698-d0a6-4a46-8033-56eff261471b"
      unitRef="usd">-17600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04964732adf14196a87e9aeb38f71672_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS05LTEtMS0w_24c6109f-3fe0-44ac-b6e5-d024247bc98e"
      unitRef="usd">-17600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xMS0xLTEtMA_1f417929-2ed0-40ea-ad19-6121d08a95e9"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1d0130d8988c45bbac97673c8e2ce744_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xMy0xLTEtMA_2b667977-4755-43a7-be2a-f7d4c1f886a0"
      unitRef="usd">-38500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd0078ba73a24f819d70857c6b061aec_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xNy0xLTEtMA_8496a3f0-2b2c-4f8e-b9f1-df3b2b46cca8"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e7212338e6d4a7fb971feed57bf398c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xOS0xLTEtMA_ab54f945-87fe-4288-8ad1-640bfa502a24"
      unitRef="usd">-1100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04964732adf14196a87e9aeb38f71672_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0xOS0xLTEtNzA3Mg_9cb4b7d2-7703-4fee-bba4-fe02ca7329b2"
      unitRef="usd">-17600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22b1aad0446c43c899085af5db94daa0_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85MS9mcmFnOjI5ZGUwOTQyNDQ4MDRiMWQ4MzY2Y2EzNjczMjUzOWUwL3RhYmxlOjc0NDI3MWZhMTliMzRhMGVhNzliZWI2YzRjNzQ1YTM1L3RhYmxlcmFuZ2U6NzQ0MjcxZmExOWIzNGEwZWE3OWJlYjZjNGM3NDVhMzVfNS0yMS0xLTEtMA_6ab86e7e-f150-492c-80b0-3b9051b6f699"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1c79daa201df43a4b63c18f0297a823a_I20191211"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTI3_4bfc8eb0-5467-4740-975c-93ccdf67a768"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNDU0_279fa5bc-c91e-444a-b719-b022c9e1e44e"
      unitRef="shares">1500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="ibef4092b503f434cb9d51286564a8b17_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNTEz_7a64778c-6340-4b9f-9467-824354ad3b36"
      unitRef="usd">101300000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="id7a12e09486e470bbfebd7bc5df72fa0_I20191211"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfNjU2_84a0bdeb-46a7-422f-b33a-3a09767585bd"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTgxNg_59e7b203-2902-4358-a8ea-cd865a799bfc"
      unitRef="shares">1600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i4339389cb5414635ad98e9a24d1f7d52_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTgyOQ_d5aee2cb-8cb8-41bd-84b5-94cf8fce3bc8"
      unitRef="usd">120100000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4303fcd9add84b19b7bd0ac918b9aa95_I20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85NC9mcmFnOmIzZGQwMzQ2YzIxOTQ0ZWJiYjQ1YzliYTcxYjEyNDA5L3RleHRyZWdpb246YjNkZDAzNDZjMjE5NDRlYmJiNDVjOWJhNzFiMTI0MDlfMTA5OTUxMTYyOTAzNA_305e4eee-21ae-481d-98ad-498b1d0dbc92"
      unitRef="usd">880000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85Ny9mcmFnOjZhNTdjYTkyZGJiYTQzZjg5ZjM2MmQ0YzdhNjQ0YzUxL3RleHRyZWdpb246NmE1N2NhOTJkYmJhNDNmODlmMzYyZDRjN2E2NDRjNTFfMjgwNQ_56d27527-1e66-4c00-a570-e99fd3f02de7">New Accounting Pronouncements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 1 for Recently Adopted Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Scope. &lt;/span&gt;The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5e045725247943fab0ef47b9a123aded_D20200927-20210327"
      id="id3VybDovL2RvY3MudjEvZG9jOmRiMzY5NWU5ODM1NzQ3YzZiMzQzOGE3YjI2MmU1NGVhL3NlYzpkYjM2OTVlOTgzNTc0N2M2YjM0MzhhN2IyNjJlNTRlYV85Ny9mcmFnOjZhNTdjYTkyZGJiYTQzZjg5ZjM2MmQ0YzdhNjQ0YzUxL3RleHRyZWdpb246NmE1N2NhOTJkYmJhNDNmODlmMzYyZDRjN2E2NDRjNTFfMjgwMw_f977c78c-15ae-45c7-b740-5c4799482826">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Scope. &lt;/span&gt;The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128813247080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Apr. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 27,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,233,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802685832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductRevenue', window );">Product</a></td>
<td class="nump">$ 1,378,800,000<span></span>
</td>
<td class="nump">$ 623,600,000<span></span>
</td>
<td class="nump">$ 2,834,200,000<span></span>
</td>
<td class="nump">$ 1,322,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ServiceRevenue', window );">Service and other</a></td>
<td class="nump">158,800,000<span></span>
</td>
<td class="nump">132,500,000<span></span>
</td>
<td class="nump">313,200,000<span></span>
</td>
<td class="nump">283,700,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,537,600,000<span></span>
</td>
<td class="nump">756,100,000<span></span>
</td>
<td class="nump">3,147,400,000<span></span>
</td>
<td class="nump">1,606,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Product</a></td>
<td class="nump">300,700,000<span></span>
</td>
<td class="nump">223,300,000<span></span>
</td>
<td class="nump">585,200,000<span></span>
</td>
<td class="nump">460,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmortizationCostofGoodsSold', window );">Amortization, Cost of Goods Sold</a></td>
<td class="nump">64,500,000<span></span>
</td>
<td class="nump">62,900,000<span></span>
</td>
<td class="nump">126,100,000<span></span>
</td>
<td class="nump">126,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Costofservice', window );">Service and other</a></td>
<td class="nump">86,600,000<span></span>
</td>
<td class="nump">74,100,000<span></span>
</td>
<td class="nump">170,000,000.0<span></span>
</td>
<td class="nump">163,900,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,085,800,000<span></span>
</td>
<td class="nump">395,800,000<span></span>
</td>
<td class="nump">2,266,100,000<span></span>
</td>
<td class="nump">829,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">71,500,000<span></span>
</td>
<td class="nump">49,300,000<span></span>
</td>
<td class="nump">130,700,000<span></span>
</td>
<td class="nump">110,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">131,500,000<span></span>
</td>
<td class="nump">110,600,000<span></span>
</td>
<td class="nump">259,500,000<span></span>
</td>
<td class="nump">255,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">88,900,000<span></span>
</td>
<td class="nump">67,000,000.0<span></span>
</td>
<td class="nump">180,400,000<span></span>
</td>
<td class="nump">154,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="nump">19,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration fair value adjustments</a></td>
<td class="num">(14,700,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(10,100,000)<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and divestiture charges</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">289,000,000.0<span></span>
</td>
<td class="nump">239,400,000<span></span>
</td>
<td class="nump">583,900,000<span></span>
</td>
<td class="nump">548,400,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">796,800,000<span></span>
</td>
<td class="nump">156,400,000<span></span>
</td>
<td class="nump">1,682,200,000<span></span>
</td>
<td class="nump">281,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(21,300,000)<span></span>
</td>
<td class="num">(31,300,000)<span></span>
</td>
<td class="num">(49,300,000)<span></span>
</td>
<td class="num">(64,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,600,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">4,700,000<span></span>
</td>
<td class="num">(7,500,000)<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="num">(4,200,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">780,500,000<span></span>
</td>
<td class="nump">118,900,000<span></span>
</td>
<td class="nump">1,612,900,000<span></span>
</td>
<td class="nump">216,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">161,100,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
<td class="nump">340,100,000<span></span>
</td>
<td class="num">(264,300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">619,400,000<span></span>
</td>
<td class="nump">94,800,000<span></span>
</td>
<td class="nump">1,272,800,000<span></span>
</td>
<td class="nump">480,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income attributable to Hologic</a></td>
<td class="nump">$ 619,900,000<span></span>
</td>
<td class="nump">$ 96,300,000<span></span>
</td>
<td class="nump">$ 1,274,300,000<span></span>
</td>
<td class="nump">$ 482,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share attributable to Hologic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 2.40<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 4.93<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 4.88<span></span>
</td>
<td class="nump">$ 1.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">258,473<span></span>
</td>
<td class="nump">263,238<span></span>
</td>
<td class="nump">258,539<span></span>
</td>
<td class="nump">265,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">260,749<span></span>
</td>
<td class="nump">264,506<span></span>
</td>
<td class="nump">261,267<span></span>
</td>
<td class="nump">267,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization, Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Costofservice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Costofservice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128816106440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 619.4<span></span>
</td>
<td class="nump">$ 94.8<span></span>
</td>
<td class="nump">$ 1,272.8<span></span>
</td>
<td class="nump">$ 480.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.4 and $1.2 for the three and six months ended March 27, 2021 and $(8.1) and $(6.4) for the three and six months ended March 28, 2020.</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(21.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statements of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(30.2)<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
<td class="num">(16.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">614.3<span></span>
</td>
<td class="nump">64.6<span></span>
</td>
<td class="nump">1,286.7<span></span>
</td>
<td class="nump">464.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComprehensiveIncome', window );">Comprehensive Income</a></td>
<td class="nump">$ 614.8<span></span>
</td>
<td class="nump">$ 66.1<span></span>
</td>
<td class="nump">$ 1,288.2<span></span>
</td>
<td class="nump">$ 465.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128809138392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Change in value of hedged interest rate swap and interest rate cap, tax</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="num">$ (8.1)<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="num">$ (6.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806307528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash less assets held for sale</a></td>
<td class="nump">$ 816.4<span></span>
</td>
<td class="nump">$ 701.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves of $41.7 and $31.6, respectively</a></td>
<td class="nump">1,212.3<span></span>
</td>
<td class="nump">1,028.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">456.2<span></span>
</td>
<td class="nump">395.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrepaidIncomeTaxesCurrent', window );">Prepaid Income Taxes-Current</a></td>
<td class="nump">85.4<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">92.1<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,662.4<span></span>
</td>
<td class="nump">2,222.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">533.6<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,447.6<span></span>
</td>
<td class="nump">1,307.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,857.2<span></span>
</td>
<td class="nump">2,657.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">543.2<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,044.0<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">324.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">225.1<span></span>
</td>
<td class="nump">178.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">534.9<span></span>
</td>
<td class="nump">547.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">198.5<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,036.4<span></span>
</td>
<td class="nump">1,239.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,672.1<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Finance lease obligations - long term</a></td>
<td class="nump">23.6<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">229.8<span></span>
</td>
<td class="nump">201.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">273.7<span></span>
</td>
<td class="nump">303.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,887 and 295,107 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,927.1<span></span>
</td>
<td class="nump">5,904.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(298.9)<span></span>
</td>
<td class="num">(1,573.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 40,682 and 37,609 shares, respectively</a></td>
<td class="num">(1,801.0)<span></span>
</td>
<td class="num">(1,579.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(35.8)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Hologic's stockholders&#8217; equity</a></td>
<td class="nump">3,794.4<span></span>
</td>
<td class="nump">2,705.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Stockholders' Equity Attributable to Noncontrolling Interest</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,795.0<span></span>
</td>
<td class="nump">2,707.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 8,044.0<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrepaidIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income Taxes-Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrepaidIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128809173944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, reserves</a></td>
<td class="nump">$ 41.7<span></span>
</td>
<td class="nump">$ 31.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000,000<span></span>
</td>
<td class="nump">1,623,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000,000<span></span>
</td>
<td class="nump">750,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">296,887,000,000<span></span>
</td>
<td class="nump">295,107,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">40,682,000,000<span></span>
</td>
<td class="nump">37,609,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128805459656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Share Repurchase Program </div>
<div>Treasury Stock</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling Interest, Increase from Business Combination</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,769,800,000<span></span>
</td>
<td class="num">$ (2,688,700,000)<span></span>
</td>
<td class="num">$ (42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (Accounting Standards Update 2018-01 [Member]) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">385,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(80,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (80,900,000)<span></span>
</td>
<td class="nump">$ 164,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,749,800,000<span></span>
</td>
<td class="num">(2,302,300,000)<span></span>
</td>
<td class="num">(28,700,000)<span></span>
</td>
<td class="num">$ (1,170,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">386,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="num">(205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,769,800,000<span></span>
</td>
<td class="num">(2,688,700,000)<span></span>
</td>
<td class="num">(42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (Accounting Standards Update 2018-01 [Member]) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">480,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,827,600,000<span></span>
</td>
<td class="num">(2,206,000,000.0)<span></span>
</td>
<td class="num">(58,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">482,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,257,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,749,800,000<span></span>
</td>
<td class="num">(2,302,300,000)<span></span>
</td>
<td class="num">(28,700,000)<span></span>
</td>
<td class="num">$ (1,170,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">94,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (267,600,000)<span></span>
</td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,827,600,000<span></span>
</td>
<td class="num">(2,206,000,000.0)<span></span>
</td>
<td class="num">(58,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">96,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,091,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">136,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,861,700,000<span></span>
</td>
<td class="num">(2,068,100,000)<span></span>
</td>
<td class="num">(61,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">137,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,258,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">493,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 26, 2020</a></td>
<td class="nump">2,705,200,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">494,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,707,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ChangeInParValue', window );">Change in par value</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(46,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">653,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,895,300,000<span></span>
</td>
<td class="num">(918,800,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="num">$ (1,680,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">654,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 26, 2020</a></td>
<td class="nump">2,705,200,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,272,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 27, 2021</a></td>
<td class="nump">3,794,400,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,927,100,000<span></span>
</td>
<td class="num">(298,900,000)<span></span>
</td>
<td class="num">(35,800,000)<span></span>
</td>
<td class="num">$ (1,801,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">1,274,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,269,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,895,300,000<span></span>
</td>
<td class="num">(918,800,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="num">$ (1,680,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">619,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(120,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (120,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 27, 2021</a></td>
<td class="nump">3,794,400,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">$ 5,927,100,000<span></span>
</td>
<td class="num">$ (298,900,000)<span></span>
</td>
<td class="num">$ (35,800,000)<span></span>
</td>
<td class="num">$ (1,801,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">619,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 3,795,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Acceleratedsharerepurchaseagreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated share repurchase agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Acceleratedsharerepurchaseagreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ChangeInParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in par value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ChangeInParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchaseProgramAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802985928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,272,800,000<span></span>
</td>
<td class="nump">$ 480,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">41,500,000<span></span>
</td>
<td class="nump">42,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangibles</a></td>
<td class="nump">146,500,000<span></span>
</td>
<td class="nump">145,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">35,600,000<span></span>
</td>
<td class="nump">33,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(23,500,000)<span></span>
</td>
<td class="num">(44,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">18,900,000<span></span>
</td>
<td class="nump">14,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(171,400,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(46,000,000.0)<span></span>
</td>
<td class="num">(33,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(46,600,000)<span></span>
</td>
<td class="num">(27,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(36,700,000)<span></span>
</td>
<td class="num">(317,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">32,800,000<span></span>
</td>
<td class="num">(47,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(50,100,000)<span></span>
</td>
<td class="num">(50,800,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">6,800,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,202,200,000<span></span>
</td>
<td class="nump">231,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(440,000,000.0)<span></span>
</td>
<td class="num">(43,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSaleOfBusiness', window );">Proceeds From Sale Of Business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">142,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(51,700,000)<span></span>
</td>
<td class="num">(29,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(27,800,000)<span></span>
</td>
<td class="num">(33,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseofinsurancecontracts', window );">Purchase of insurance contracts</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchaseOfIntellectualProperty', window );">Purchase of intellectual property</a></td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(1,400,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(528,100,000)<span></span>
</td>
<td class="nump">32,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(37,500,000)<span></span>
</td>
<td class="num">(27,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSeniorNotes', window );">Proceeds from Notes Payable</a></td>
<td class="nump">950,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RepaymentOfSeniorNotes', window );">Repayments of Senior Debt</a></td>
<td class="num">(970,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment under revolving credit line</a></td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromAccountsReceivableSecuritization', window );">Proceeds from accounts receivable securitization agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments of Accounts Receivable Securitization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(250,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of deferred acquisition consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(13,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(221,400,000)<span></span>
</td>
<td class="num">(553,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">33,600,000<span></span>
</td>
<td class="nump">36,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(46,700,000)<span></span>
</td>
<td class="num">(12,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(557,400,000)<span></span>
</td>
<td class="num">(67,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(1,300,000)<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">115,400,000<span></span>
</td>
<td class="nump">198,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">701,000,000.0<span></span>
</td>
<td class="nump">601,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 816,400,000<span></span>
</td>
<td class="nump">$ 799,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchaseOfIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of intellectual property</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchaseOfIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseofinsurancecontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of insurance contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseofinsurancecontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RepaymentOfSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RepaymentOfSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728112872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BasisofPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and six months ended March&#160;27, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and six months ended March&#160;27, 2021. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was one unrecognized subsequent event related to the acquisition of Mobidiag Oy ("Mobidiag"). On April 8, 2021, the Company announced that it had entered into an agreement to acquire Mobidiag for a purchase price of approximately $795&#160;million. The closing is subject to certain regulatory approvals and other customary closing conditions. Mobidiag, located in Finland and France, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. The Company expects this acquisition to close in the fourth quarter of fiscal 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasisofPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasisofPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128801000312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728080056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at March&#160;27, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended March 27, 2021 and March 28, 2020 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:6.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div>Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of March&#160;27, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $421.7 million and $932.2 million, respectively, as of March&#160;27, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#8217;s debt.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128801168216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2021 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $232.5&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's consolidated statement of income and within service revenue in our disclosure of disaggregated revenue in Note 2.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranotics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $153.4&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2021, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.8&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.0&#160;million to goodwill. The remaining $9.3&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2020 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the three and six month periods ended March 27, 2021, the Company remeasured the contingent consideration liability and decreased the contingent consideration liability by $14.7&#160;million and $10.1&#160;million, respectively, to record the liability at fair value as of March 27, 2021. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million, and as of March 27, 2021, the Company owned approximately 80% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728123752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Trade Receivables and Allowance for Credit Losses</a></td>
<td class="text">Trade Receivables and Allowance for Credit Losses<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses as of March 27, 2021 compared to March 28, 2020:</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified as Assets held for sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128801184184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Dispositions</a></td>
<td class="text">Disposition - Sale of Medical Aesthetics<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions </span></div>primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first and second quarters of fiscal 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728110648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 28, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Arrangements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of March 27, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of March 27, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of March 27, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of March 27, 2021, the full amount of the Revolver ($1.5 billion) was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of March 27, 2021, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, including a premium payment $20.8&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729539880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7 million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreements matured as of December 26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $24.9 million as of March&#160;27, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and six months ended March 27, 2021 and March 28, 2020, respectively, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;27, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $415.8&#160;million. As of March&#160;27, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $133.5 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of March&#160;27, 2021: </span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728049896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 7, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $10.0&#160;million accrued for such matters as of March&#160;27, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728118360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income Per Share<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128727998808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase 0.6 million and 0.9 million shares of the Company's common stock during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average exercise prices of $68.64 and $45.82, respectively. There were 4.5 million options outstanding at March&#160;27, 2021 with a weighted-average exercise price of $44.53.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.5 million and 0.8 million restricted stock units (RSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, with weighted-average grant date fair values of $68.51 and $45.76 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the six months ended March&#160;27, 2021 and March&#160;28, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.51 and $45.76 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$68.51 and $45.76 per unit during the six months ended March 27, 2021 and March 28, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the three months ended March&#160;27, 2021 and March&#160;28, 2020, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31 and $43.90 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At March&#160;27, 2021, there was 3.1 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;27, 2021, there was $23.0 million and $71.7 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.5 and 2.1 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728154824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text">Other Balance Sheet Information<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728018248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic InformationDuring fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020. Segment information is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended March&#160;27, 2021 and March&#160;28, 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729303192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three and six months ended March 27, 2021 was a provision of 20.6% and 21.1%. respectively, compared to a provision of 20.3% and a net benefit of 122.1%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended March 27, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes. The effective tax rate for the six months ended March 27, 2021 was higher than the U.S. statutory tax rate primarily due to state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended March 28, 2020 differed from the U.S. statutory tax rate primarily due to taxation of foreign earnings at tax rates lower than the U.S. statutory tax rate including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, partially offset by unbenefited foreign losses. The effective tax rate for the six months ended March 28, 2020 differed from the statutory tax rate primarily due to a $310.9&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728067352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,143.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,718.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of March&#160;27, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128727889752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729379656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss)<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 27, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729644088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 for Recently Adopted Accounting Pronouncements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span>The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729398216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span>The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729428616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"/><td style="width:30.358%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"/><td style="width:31.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,178.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128800995432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at March&#160;27, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and six month periods ended March 27, 2021 and March 28, 2020 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:6.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728164248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729456808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">The following is a rollforward of the allowance for credit losses as of March 27, 2021 compared to March 28, 2020:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128804060952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,672.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,747.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Schedule Of Interest Expense Under Convertible Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 27, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728143048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of March&#160;27, 2021: </span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128727801544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729627912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802298520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729504648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">egment information is as follows:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,147.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">796.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 27,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728030632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,033.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,143.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,718.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,224.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of March&#160;27, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729426872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 27, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728030072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 27, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 27, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Six Months Ended March 28, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729543352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation Details (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagMember', window );">Mobidiag | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 795.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802483272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,537,600,000<span></span>
</td>
<td class="nump">$ 756,100,000<span></span>
</td>
<td class="nump">$ 3,147,400,000<span></span>
</td>
<td class="nump">$ 1,606,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">30,100,000<span></span>
</td>
<td class="nump">26,200,000<span></span>
</td>
<td class="nump">80,800,000<span></span>
</td>
<td class="nump">77,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,064,000,000.0<span></span>
</td>
<td class="nump">574,900,000<span></span>
</td>
<td class="nump">2,201,700,000<span></span>
</td>
<td class="nump">1,207,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">473,600,000<span></span>
</td>
<td class="nump">181,200,000<span></span>
</td>
<td class="nump">945,700,000<span></span>
</td>
<td class="nump">399,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,064,500,000<span></span>
</td>
<td class="nump">319,200,000<span></span>
</td>
<td class="nump">2,192,700,000<span></span>
</td>
<td class="nump">630,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">705,200,000<span></span>
</td>
<td class="nump">238,200,000<span></span>
</td>
<td class="nump">1,468,600,000<span></span>
</td>
<td class="nump">469,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">359,300,000<span></span>
</td>
<td class="nump">81,000,000.0<span></span>
</td>
<td class="nump">724,100,000<span></span>
</td>
<td class="nump">160,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">117,200,000<span></span>
</td>
<td class="nump">113,400,000<span></span>
</td>
<td class="nump">242,000,000.0<span></span>
</td>
<td class="nump">234,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">76,800,000<span></span>
</td>
<td class="nump">73,200,000<span></span>
</td>
<td class="nump">156,900,000<span></span>
</td>
<td class="nump">150,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">40,400,000<span></span>
</td>
<td class="nump">40,200,000<span></span>
</td>
<td class="nump">85,100,000<span></span>
</td>
<td class="nump">83,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">935,300,000<span></span>
</td>
<td class="nump">190,600,000<span></span>
</td>
<td class="nump">1,930,600,000<span></span>
</td>
<td class="nump">369,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">616,400,000<span></span>
</td>
<td class="nump">149,800,000<span></span>
</td>
<td class="nump">1,291,600,000<span></span>
</td>
<td class="nump">291,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">318,900,000<span></span>
</td>
<td class="nump">40,800,000<span></span>
</td>
<td class="nump">639,000,000.0<span></span>
</td>
<td class="nump">77,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,000,000.0<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
<td class="nump">27,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,000,000.0<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="nump">20,100,000<span></span>
</td>
<td class="nump">27,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">336,300,000<span></span>
</td>
<td class="nump">307,800,000<span></span>
</td>
<td class="nump">669,100,000<span></span>
</td>
<td class="nump">638,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">253,000,000.0<span></span>
</td>
<td class="nump">234,400,000<span></span>
</td>
<td class="nump">511,200,000<span></span>
</td>
<td class="nump">490,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">83,300,000<span></span>
</td>
<td class="nump">73,400,000<span></span>
</td>
<td class="nump">157,900,000<span></span>
</td>
<td class="nump">148,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">269,900,000<span></span>
</td>
<td class="nump">250,200,000<span></span>
</td>
<td class="nump">537,600,000<span></span>
</td>
<td class="nump">525,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">198,100,000<span></span>
</td>
<td class="nump">186,000,000.0<span></span>
</td>
<td class="nump">401,100,000<span></span>
</td>
<td class="nump">395,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">71,800,000<span></span>
</td>
<td class="nump">64,200,000<span></span>
</td>
<td class="nump">136,500,000<span></span>
</td>
<td class="nump">129,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">66,400,000<span></span>
</td>
<td class="nump">57,600,000<span></span>
</td>
<td class="nump">131,500,000<span></span>
</td>
<td class="nump">113,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">54,900,000<span></span>
</td>
<td class="nump">48,400,000<span></span>
</td>
<td class="nump">110,100,000<span></span>
</td>
<td class="nump">95,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="nump">21,400,000<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">114,200,000<span></span>
</td>
<td class="nump">105,400,000<span></span>
</td>
<td class="nump">238,200,000<span></span>
</td>
<td class="nump">224,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">91,700,000<span></span>
</td>
<td class="nump">86,700,000<span></span>
</td>
<td class="nump">192,800,000<span></span>
</td>
<td class="nump">185,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">22,500,000<span></span>
</td>
<td class="nump">18,700,000<span></span>
</td>
<td class="nump">45,400,000<span></span>
</td>
<td class="nump">39,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">22,600,000<span></span>
</td>
<td class="nump">23,700,000<span></span>
</td>
<td class="nump">47,400,000<span></span>
</td>
<td class="nump">47,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">14,100,000<span></span>
</td>
<td class="nump">15,600,000<span></span>
</td>
<td class="nump">29,100,000<span></span>
</td>
<td class="nump">30,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="nump">$ 18,300,000<span></span>
</td>
<td class="nump">$ 16,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802945864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,537.6<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 3,147.4<span></span>
</td>
<td class="nump">$ 1,606.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,064.0<span></span>
</td>
<td class="nump">574.9<span></span>
</td>
<td class="nump">2,201.7<span></span>
</td>
<td class="nump">1,207.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">336.8<span></span>
</td>
<td class="nump">111.8<span></span>
</td>
<td class="nump">675.0<span></span>
</td>
<td class="nump">221.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">90.1<span></span>
</td>
<td class="nump">41.7<span></span>
</td>
<td class="nump">178.5<span></span>
</td>
<td class="nump">111.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_RestofWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 46.7<span></span>
</td>
<td class="nump">$ 27.7<span></span>
</td>
<td class="nump">$ 92.2<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128812716696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,537,600,000<span></span>
</td>
<td class="nump">$ 756,100,000<span></span>
</td>
<td class="nump">$ 3,147,400,000<span></span>
</td>
<td class="nump">$ 1,606,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">30,100,000<span></span>
</td>
<td class="nump">26,200,000<span></span>
</td>
<td class="nump">80,800,000<span></span>
</td>
<td class="nump">77,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Disposables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,178,100,000<span></span>
</td>
<td class="nump">457,000,000.0<span></span>
</td>
<td class="nump">2,441,500,000<span></span>
</td>
<td class="nump">923,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">200,700,000<span></span>
</td>
<td class="nump">166,600,000<span></span>
</td>
<td class="nump">392,700,000<span></span>
</td>
<td class="nump">399,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">141,800,000<span></span>
</td>
<td class="nump">127,200,000<span></span>
</td>
<td class="nump">278,900,000<span></span>
</td>
<td class="nump">272,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 17,000,000.0<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="nump">$ 34,300,000<span></span>
</td>
<td class="nump">$ 11,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128808832040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 749,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 749,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 30,100,000<span></span>
</td>
<td class="nump">$ 26,200,000<span></span>
</td>
<td class="nump">$ 80,800,000<span></span>
</td>
<td class="nump">$ 77,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806504072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128728083096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 27, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total (percentage)</a></td>
<td class="nump">0.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128804072936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">99.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">27.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128805051944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 932.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128812666632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 86.4<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Accruals</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(9.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(9.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128721453096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 22, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 20, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,447.6<span></span>
</td>
<td class="nump">$ 1,447.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857.2<span></span>
</td>
<td class="nump">2,857.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment', window );">Consideration related to equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares', window );">Consideration related to newly acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment', window );">Consideration, portion related to loan repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest', window );">Consideration related to fair value of noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FairValueAssumptionDiscountRate', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 153.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="nump">$ 69.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 78.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember', window );">Somatex Medical Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net acquired tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AnnualIncrementalRevenueGrowthPeriod', window );">Annual incremental revenue growth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14.7)<span></span>
</td>
<td class="num">$ (10.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Contingent Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Remainder of purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare', window );">Cash tender offer price (per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationSharesAcquired', window );">Shares acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredShares', window );">Additional outstanding shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredValue', window );">Additional outstanding shares purchased, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AnnualIncrementalRevenueGrowthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Incremental Revenue Growth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AnnualIncrementalRevenueGrowthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cash Tender Offer Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessAcquisitionCashTenderOfferPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FairValueAssumptionDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assumption, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FairValueAssumptionDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Holdback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Holdback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802858728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,857.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Short and long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128809632360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 31.6<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit Loss</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAllowanceForCreditLossTransfers', window );">Reclassified as Assets held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write- offs and Payments</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 41.7<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAllowanceForCreditLossTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Transfers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAllowanceForCreditLossTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128804669288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">$ 205,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 153,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IndemnificationLiabily', window );">Indemnification liabily</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup', window );">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150.0&#160;million<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IndemnificationLiabily">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification liabily</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IndemnificationLiabily</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the segment that the disposal group, including discontinued operation is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128812721864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 324.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,672.1<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">2,747.0<span></span>
</td>
<td class="nump">3,038.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,343.6<span></span>
</td>
<td class="nump">1,379.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">939.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">395.0<span></span>
</td>
<td class="nump">394.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 933.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128803179160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 15, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 17, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,747,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,747,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,038,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan | Percentage Added to Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtRedemptionPremiumPaid', window );">Premium payment</a></td>
<td class="nump">20,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="nump">$ 970,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Debt Instrument, Offering Price, Percent Of Face Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.813%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Offering Price, Percent Of Face Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentOfferingPricePercentOfFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtRedemptionPremiumPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Redemption, Premium Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtRedemptionPremiumPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128805964728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 28.2<span></span>
</td>
<td class="nump">$ 31.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="nump">$ 26.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">1.12%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">1.17%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">1.11%<span></span>
</td>
<td class="nump">2.33%<span></span>
</td>
<td class="nump">1.11%<span></span>
</td>
<td class="nump">2.33%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802404120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 28.2<span></span>
</td>
<td class="nump">$ 31.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 16.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806304536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Interest Rate Cap Agreements Aggregate Premium Payable</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotationalAmount', window );">Notational Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotationalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notational Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotationalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128802401992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Total</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="num">$ (11.9)<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="num">$ (5.9)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128805071352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">$ 24.9<span></span>
</td>
<td class="nump">$ 31.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Foreign currency option contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest rate swap | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest rate swap | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 13.9<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128819952024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="nump">$ 25.3<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="nump">$ 21.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.4 and $1.2 for the three and six months ended March 27, 2021 and $(8.1) and $(6.4) for the three and six months ended March 28, 2020.</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(21.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.4 and $1.2 for the three and six months ended March 27, 2021 and $(8.1) and $(6.4) for the three and six months ended March 28, 2020.</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128729327928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Detail)<br></strong></div></th>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>petition</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MinervaMember', window );">Minerva</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Petitions filed | petition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LegalAccrual', window );">Legal Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LegalAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LegalAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MinervaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MinervaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128812785736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">258,473<span></span>
</td>
<td class="nump">263,238<span></span>
</td>
<td class="nump">258,539<span></span>
</td>
<td class="nump">265,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</a></td>
<td class="nump">2,276<span></span>
</td>
<td class="nump">1,268<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">260,749<span></span>
</td>
<td class="nump">264,506<span></span>
</td>
<td class="nump">261,267<span></span>
</td>
<td class="nump">267,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128804070328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 35.6<span></span>
</td>
<td class="nump">$ 33.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring Charges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128808897560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices</a></td>
<td class="nump">$ 68.64<span></span>
</td>
<td class="nump">$ 45.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock option outstanding</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding</a></td>
<td class="nump">$ 44.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 82.31<span></span>
</td>
<td class="nump">$ 43.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember', window );">RSU, PSU, MSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128726799352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 21.17<span></span>
</td>
<td class="nump">$ 14.45<span></span>
</td>
<td class="nump">$ 20.08<span></span>
</td>
<td class="nump">$ 13.87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128808857272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 154.2<span></span>
</td>
<td class="nump">$ 152.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">56.4<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">245.6<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 456.2<span></span>
</td>
<td class="nump">$ 395.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128805010328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 460.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">471.6<span></span>
</td>
<td class="nump">456.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">178.7<span></span>
</td>
<td class="nump">167.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">47.0<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">41.4<span></span>
</td>
<td class="nump">40.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,255.4<span></span>
</td>
<td class="nump">1,185.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(721.8)<span></span>
</td>
<td class="num">(694.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 533.6<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128831995800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>Segment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,537,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 756,100,000<span></span>
</td>
<td class="nump">$ 3,147,400,000<span></span>
</td>
<td class="nump">$ 1,606,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806187832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,537.6<span></span>
</td>
<td class="nump">$ 756.1<span></span>
</td>
<td class="nump">$ 3,147.4<span></span>
</td>
<td class="nump">$ 1,606.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">796.8<span></span>
</td>
<td class="nump">156.4<span></span>
</td>
<td class="nump">1,682.2<span></span>
</td>
<td class="nump">281.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">95.2<span></span>
</td>
<td class="nump">93.7<span></span>
</td>
<td class="nump">188.0<span></span>
</td>
<td class="nump">188.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">45.8<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">90.6<span></span>
</td>
<td class="nump">63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">8,044.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,044.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,064.5<span></span>
</td>
<td class="nump">319.2<span></span>
</td>
<td class="nump">2,192.7<span></span>
</td>
<td class="nump">630.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">700.6<span></span>
</td>
<td class="nump">57.3<span></span>
</td>
<td class="nump">1,485.0<span></span>
</td>
<td class="nump">106.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">59.1<span></span>
</td>
<td class="nump">59.3<span></span>
</td>
<td class="nump">115.4<span></span>
</td>
<td class="nump">118.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
<td class="nump">77.6<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,584.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,584.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,161.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">336.3<span></span>
</td>
<td class="nump">307.8<span></span>
</td>
<td class="nump">669.1<span></span>
</td>
<td class="nump">638.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">67.8<span></span>
</td>
<td class="nump">75.9<span></span>
</td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">169.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,266.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">114.2<span></span>
</td>
<td class="nump">105.4<span></span>
</td>
<td class="nump">238.2<span></span>
</td>
<td class="nump">224.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
<td class="nump">42.3<span></span>
</td>
<td class="nump">55.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">46.3<span></span>
</td>
<td class="nump">42.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,402.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22.6<span></span>
</td>
<td class="nump">23.7<span></span>
</td>
<td class="nump">47.4<span></span>
</td>
<td class="nump">47.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">30.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(53.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 2,760.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,760.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,355.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806422648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">69.20%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">75.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">21.90%<span></span>
</td>
<td class="nump">14.80%<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="nump">13.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128810093384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="nump">20.60%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">21.10%<span></span>
</td>
<td class="nump">12210.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806549336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,224.9<span></span>
</td>
<td class="nump">$ 4,931.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,777.3<span></span>
</td>
<td class="nump">3,623.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,320.3<span></span>
</td>
<td class="nump">4,054.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,033.9<span></span>
</td>
<td class="nump">2,907.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">570.9<span></span>
</td>
<td class="nump">549.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">493.9<span></span>
</td>
<td class="nump">477.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">248.6<span></span>
</td>
<td class="nump">245.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">186.2<span></span>
</td>
<td class="nump">181.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Total acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,143.8<span></span>
</td>
<td class="nump">4,852.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,718.0<span></span>
</td>
<td class="nump">3,569.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">55.2<span></span>
</td>
<td class="nump">51.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">46.8<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software embedded in products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128806509032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2021</a></td>
<td class="nump">$ 153.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2022</a></td>
<td class="nump">303.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2023</a></td>
<td class="nump">207.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2024</a></td>
<td class="nump">195.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2025</a></td>
<td class="nump">$ 181.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128809118136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition', window );">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease', window );">Standard Product Warranty Accrual, Period Increase (Decrease)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at End&#160;of&#160;Period</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from a business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128804036200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,705.2<span></span>
</td>
<td class="nump">$ 2,115.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">$ (9.4)<span></span>
</td>
<td class="num">$ (5.4)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(21.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">3,794.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,794.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(33.1)<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
<td class="num">(41.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(38.5)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(38.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(30.7)<span></span>
</td>
<td class="num">(28.7)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(30.6)<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(35.8)<span></span>
</td>
<td class="num">(58.9)<span></span>
</td>
<td class="num">(35.8)<span></span>
</td>
<td class="num">(58.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(23.2)<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="num">(25.1)<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(21.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (19.5)<span></span>
</td>
<td class="num">$ (17.6)<span></span>
</td>
<td class="num">$ (19.5)<span></span>
</td>
<td class="num">$ (17.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140128812732824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase Share repurchase (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 11, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Repurchase of equity</a></td>
<td class="nump">$ 120,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 880,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharerepurchaseplanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for share repurchase plan [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharerepurchaseplanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M.?.XU _ _;40ZG"B7U!MI$[_ U!+ P04    "  ,@9Q2 E&??-0'  "*)0
M&    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*5:37/;.!;\*RC5'I*JV"(
M?LEENRJ6M)D<LI.*=V;.M A)G)"$A@#ES/[Z!2A:E(D6Y)KD$$M4XX'=?'CH
M1_+V63;?U58(37Y49:WN)ENM=S?3J5IM196I:[D3M?EE+9LJT^9KLYFJ72.R
MO!M4E5,6!/&TRHIZ<G_;'?O:W-_*5I=%+;XV1+55E35_/XA2/M]-Z.3EP+=B
ML]7VP/3^=I=MQ*/0O^V^-N;;]!@E+RI1JT+6I!'KN\E'>K/DB1W0(7XOQ+,Z
M^4PLE2<IO]LOG_.[26#/2)1BI6V(S/S9B[DH2QO)G,=??=#)<4X[\/3S2_1_
M=^0-F:=,B;DL_RARO;V;I!.2BW76EOJ;?/Y%](0B&V\E2]7]3YX/V#B<D%6K
MM*SZP>8,JJ(^_,U^]$*<##!Q\ #6#V#C >=FX/T _M89PGY ^-8!43^@HSX]
M<.^$6V0ZN[]MY#-I+-I$LQ\Z];O11J^BMHGRJ!OS:V'&Z?NYK)4LBSS3(B>/
MVOPQ6: 5D6ORN5[)2I K\MOC@KS[UWNBMEDC%"EJ\M^M;%56Y^IVJLU)V%#3
M53_APV%"=F9"3K[(6F\56=:YR,'XA7]\[!D_->2/"K 7!1Z8-^"7K+DF+/E
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M-4 .Y(P( $H#:-4 E$4S%'4)H9%7A<&O4+]A^21JDV5EIT*6F^ZJ4-IFW5Y
M*5P/D:9H%YD#9)R@"K( 2)J.KW$O!+)0H<^WT<'"T.3-FZ_=<[*5V5X:TQ$Z
MFP\4)@&E"+F'.43B*NPBV1E=0,P9\\DRF##J=V$_OQ&[=LF1Y")D<1FR!)#0
MNT8&6T;]OFQNNFU3&ZP&*UFK(N_JLDF3M9&&[+.R-7+D?[9*=S<.H JN5[JB
MX\SMU0!0V.[ F#"5E@#JDX8-/HWY?9K92W1C7'K;O)32W)0.I0MS1)#5-FLV
MN!EBKFVBT+4 (/:M ,BA94% GV%A@V%C?L/F[MB0NFN96%]$'?( RF>H!BP
M-$K'O'H! #1,O0DQ>#;F]VS]';-U(RLB=_U"P3*XUBF9Q="\ 2B-8BP#@,8I
M@XT<P+*4^NHF&\P;XQ=TT*(Q"\&43"L(%("?2=@Q>Q='H;$"0.BJT,2^MHT-
MUI+YK>61=9__D+;KZ:X8)#1'4'Z&.X!B_[E$T'C<"+T68#"5S&\J%^+)DK<U
MH"W4MMLW2]/%0"%<6^<(<!&R ! C)RJE2V^TUX0'_\C\_O%7VY?V24[>]9?]
M_0=2"^@&F.O@\"X(@%<)W 8!$E<]$'%\:_2U"(-W9'[OV!>])[&69M?KQ=#9
MCS/UWW5K21K ?@) *86&>X&@,85;Y1)@3<IX-X#!,+*+M^WV1?<,[=V3Z2U,
MZ_Z>&%DNJ^+:-W/^R,W, 93A&QD R4-LD0#TBL4A]XDR.$CF=Y#_$=Z- -R;
MHW"7GP/H+(1W,0"2LH0A[!)@35!?7\4'A\C]#M%2MQ609%HWQ5.K,]L]:$EJ
M:02I=2,/;7C1;QU((.XZ-FB)YP@(._7%FY%+B/3=X..#7^1^OSBDA:/.+[*4
MFV(%U:#N\R Z@UTX@,YBN'\"I$F7<?KWBKC8,!T_DGDMR> ?.?/>]#J1Q+A'
MTV]5E2DEW6/7<QKY[HKQDZ=^?L/VD*EB1=X5-6E5WLW=3?H>7H%#J.2T %V'
M8^U=4'#-D['N+BJ\GO&QXBZ*7J?LC-B#7>-^N[8HRM8^]'XCZQ"PYNF8MHLR
MM.,Q;1<57J?IF+:+,K3I&=J#2>.1-\?^Z%Z=,+RSO6E0-H+4;?5DJ,OUR_-]
MV6JE33=K"I,WNP:;Q/TV:<BNPPQ88->AL"@-$SZ6&.!BSL:78H'C17PVEAG%
MBZ(X/B/TX(NXWQ>=YI>/-[ C<9"$LS%OA NCP$DNA*,L3L:\$2ZA-!SQGIZ\
M6U*)9M.]U*-,;6IK?7BOX'CT^.+0Q^YUF='Q!WHSI^#X@MXL#Z\%#>$/;RE]
MR9I-42M2BK69*KA.S,DVAQ=_#E^TW'5OMCQ)K675?=R*+!>-!9C?UU+JER]V
M@N/K5_?_!U!+ P04    "  ,@9Q2&<5ID$T$  "S#@  &    'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;*57;7.C-A#^*QI//L0S"2",,<[8GDEL=YJ92YJY
M]-H/G7Z003;T0'(E^>7^?5>"<!ADU]=FQ@'$\^RRCW97TN3 Q5>94JK0L<B9
MG/92I;8/KBOCE!9$.GQ+&;Q9<U$0!8]BX\JMH"0QI")W?<\+W8)DK#>;F+$W
M,9OPG<HS1M\$DKNB(.+;$\WY8=K#O8^!S]DF57K G4VV9$/?J?JR?1/PY-96
MDJR@3&:<(4'7T]XC?EAB0S"(WS)ZD(U[I$-9<?Y5/SPGTYZGOXCF-%;:!('+
MGLYIGFM+\!U_5T9[M4]-;-Y_6/_)! _!K(BD<Y[_GB4JG?:B'DKHFNQR]9D?
M?J950$-M+^:Y-/_1H<)Z/13OI.)%188O*#)67LFQ$J)! #MV@E\1_#8A.$,8
M5(3!M1Z"BA!<ZV%8$4SH;AF[$6Y!%)E-!#\@H=%@3=\8]0T;],J83I1W)>!M
M!CPUFW,F>9XE1-$$O2NX0!8HB?@:S7D!N9?JI-A3](E+B>[1E_<%NKWIHQN4
M,?22Y3G,MIRX"CY%&W3CRNU3Z=8_XW: 7CA3J41+EM#$PE]<YH<7^"Y(4.O@
M?^CPY%\T^$*$@_S1'?(]'UN^9WX-/3)TSQ;.__.^_,_>3\08U$DQ,/8&9^S5
M>=!-@V<6\X*B/QY74@FH\C\ON MJ=X%Q%YQQ]PK],#-V;8E4<B/#U6UO/POQ
MV DF[KXY/5W4.'"B4]"B"\+^R&_#EEU8$'G.J$:=!#FL@QQ>#'*>$K:A4I<-
MM'?H7PS*6PC*XF\(E&0R)V7G3/Z"JM?BV\0H?8P;GW;?U<("&K9!BRXH:F.6
M78SOC.TRA+4,X;4R[$F^HSK#4IILH/MD3%%!I4("L@_) ]E*1%A[/(;A.\2H
MR4U%COIR@YW 0.'&U_(BE5+X"4K-L,R.J"C[!=7] D'!Q&E=<"7U-G)PO[H-
MG:#_ W:JRG-L,Q9V- R<06O"NIA[?^CXK1DK4<,&:MB:+YL=W+!S,F.C>L9&
M%V?,-'Y!XYQ(F:TSB'HM> $K?+PK=KE9-SC()%!\TBAR35/<*"A/UI7SI3[J
M1.BUE!IU(O0ZF6W#M)7J8O"Y H]JG:*+.OUB$>%6J]"_$'%D*U7<"MH"&GB=
M].BB\*!1K67<%E,X=$)[Y.,Z\O'EFCZ)^7RPXX[S$'>+P8(*G.&X^=>*O,O
M?A0VYK.,O0L+P#*VQXZ][QLH[XIYMZZ2M[IV^G?HM>Q6OY+C'7KCPO3Y1Z5$
MMMHILLJIKI-7#ARF!(<M%=N A;+I6;=6WK]G^-P"PFW0XAK0T@J*SLC6V'?B
M'TB:Y[-)4YF)6ED3M<.UP$+'NY0V%@KD3=0NK*4%%X3#SD+H-C;A!14;<_J1
MT!!V3)5;KWJT/F$]FG-%:_P)/\RQ97RA3V1FT__=?'F<@V5HDS&)<KH&5[!5
M@18JRA-2^:#XUAP!5ES!@<+<IG"JI$(#X/V:<_7QH!W4Y]39/U!+ P04
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MKW\N.*=2D1SP7R'!3KENHB]#A!M@OH?7#OXIJRW^;LW?O8R?%CH1DOW!%9.
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M<3?YM\URBWE" ?T)+JI0GW$CDF$N6<;1B%@;*# IH-<@A0G9A24FM9"CCQ5
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MVDDV0B+91@8OKA(@CPC)0HGCG#0B)))'Y%'KJP1*]8&&7$Z2#1+)LG'</'Q
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MCNCH]8T'N=L;^\;DZN+ =V(MS)^'>PVO)MTLJ<Q%44I5$"VVEZ-K^FD93>V
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MHK#K8*@+" N#MS \=<*1CC$O+%9W/V[7[]^B,$<A%IS)P@X@EB>;J@0#6.7
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M):%>M "_%Q9-.7VA _JWU5?_ 5!+ P04    "  ,@9Q2LZJ=0KT#  !]#
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M>QDV+\/F9=C\?X=--KD2HEZJ=/$5RZBT_G8X[HYWZZO^2ODHWE_,<3.K4!/
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MAB6232Y-HI6M0SLSA.)L..W:ZI1^VEQ %IWYD2X/YJ@+,IX[1= ',47]% F
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MA=, ?#XUIJS_H V:'^=Y^2]02P,$%     @ #(&<4EB;H$M)!0  =PP  !D
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M(9G<*G8[U!29W!(Z3 BW!A15W1B0I7%1,A.98@5^L<1IEU(N;D")C$8-%4*
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MW!NY,CON"\,P,C2.NHQ;)T_":V]'&!14I3*J>! =AV+(#I*F'9*(19+WT,2
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M#*WOE"F*Y+=2FZ81Z^= F:QQ/,82R+$NG*W&#.;RK5_/-EWH:9L*W6>Z@28
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M+D;"AI]3A ML)O@G#&OCO<GYZTY)Q#8-P/.-@:75!2W0_*;E];\!4$L#!!0
M   (  R!G%(_4K5NK@H  ,(A   9    >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;+U:^W/;N!'^5S"JV]HSCJR'WW$\X\=ESFVNR<1).YU.?X!(2,*$)'@
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MGKRJEM*<&-YR!*S8</A(?EXS\%=-5",' H0&%OPJ.^,?V01M5G/SZZOP]H6
M1#Y15*Z)D1UQ&(KT!-6_:0)V)R-J=K:^<JB<A?9AS$W$I&HEJDAJ2$\#Z1%?
M(K#VUKWG/6B]5T^57?!_#[APJAY>L==WZW]0N KOY9OEX;\;8,8%-=Z)FF,K
MFIBC07@M4EUXD_-;^IGQWJ3\<ZDP6EE:@.=S8WQU00SJ?]NX_#]02P,$%
M  @ #(&<4ID"]V^1"P  5R   !D   !X;"]W;W)K<VAE971S+W-H965T,3<N
M>&ULK5IMC]LV$OXKA*]H$L#QVMXW.YL$V.RV:(MLLL@F[8?#?: EVF8KB2Y)
MV?&_OV>&I"S9WDVO5Z#(6A(UG)=GGAF.^GIC[!]NJ9077\NB<F]Z2^]7KTY.
M7+94I70#LU(5GLR-+:7'I5V<N)55,N>7RN)D/!Q>G)125[VWK_G>O7W[VM2^
MT)6ZM\+592GM]ITJS.9-;]1+-S[IQ=+3C9.WKU=RH1Z4_[*ZM[@Z::3DNE25
MTZ825LW?]*Y'K]Z=T7I>\*M6&]?Z+<B2F3%_T,7/^9O>D!12A<H\29#XLU8W
MJBA($-3X,\KL-5O2B^W?2?J/;#MLF4FG;DSQF\[]\DUOTA.YFLNZ\)_,YB<5
M[3DG>9DI'/\K-F'M^;@GLMIY4\:7H4&IJ_!7?HU^:+TP&3[RPCB^,&:]PT:L
MY:WT\NUK:S;"TFI(HQ]L*K\-Y71%07GP%D\UWO-O;TQ9:@\O>R=DE8L;4WE=
M+525:>5>GWAL00M/LBCN71 W?D3<A;B#@*43/U2YRKOOGT"U1K]QTN_=^$F!
M=](.Q/BR+\;#\>@)>:>-O:<L[_3OV"MNM<L*XVJKQ+^O9\Y;@.8_3^QZUNQZ
MQKN>_5->_C_$B??:ZX4,F,?#3ZJ07N7B3GJOK!,?*_'!K%4Y4U9<D%]'YWWA
MEPI2RI6LMF*N"RR7R%/MA5P@L9T7=U#!KJ5XJ.U"9[+HBY^K;"">?_^OR7@\
MO(J/^6IT]4+HBD5^J31M_>"A 7O76YUY[%1;+\ HO*BY;>;B%LINI%5](8M"
M+6 4ELAF>Y(_NKQR0E6Y*15>DX60LR)8FZNUSA3VGEORAA-?!@\#<8^]*P]3
M)Y?C_FAR*I[3IL_HUXH?O>AW%D[ZT^FD/YE.V'OM)]/^<'K>/SV;1!'T*XH8
MD%M_D54-8A/C<W;K1=>M$O%"3O"]#/<*.-8+;Z!O5M0Y;N).Z0X\3FZJJ[G4
MEE]37I.Q?5B;J151F@!,\?J*P K[ R2\L5A6.TA'U.?* AP*W.*78E8[B'8.
MG!H<YY9ZY=B"']7,L@E'+6B H3*#+9)!'6-DGK-^"-\VQ%#]4Q&<]L=GE_WI
M9!K=3[_:[@=59$MQEC1O_!>TIF1P&V">O).9FMRRY_&6K7T8J?X@^,'-A;02
M_MR*W^M\05DG3-5>W-B4Y)%SG%.6DG(_K!V'_J^A[1\))V+!/%7#D9V(]L4,
M91HN05ZE10$;++30,U4$W-:5$N-NQ"E!<U7I"-A]2TO#\2(#)-13A49M(N#H
MZO>Z"@47_VD05 A1VS=1[CXBK/JS5B[PPB,B;>0R .V85@%ON9C+PJFX5?*D
M(PX*E&G50MH\<(MJ<+*R)J\SW_+(A%TR:;MD867ENSYYYE)'L\-'<(]C%T0L
M\WU2J:*,7\M"(U&V(816N16ZE&06VW-Q10Q%+\3+'=L@5S\W&L%4<TRM8Z$Z
MT)-*A'-Z4>$A7&]6*P5FWRPU4#.3*!;[,6IICM8'O1ERE#  ,%/$)*$20M&5
M4* L(#G7%;FZ[?66D+DU9< T;+-4)"PH +T<HI$IQ6\>6!OQ@V@3M/=53'KU
M(['RCMXU,7G,$3NM^HA1];(=.+J#4!7%O"Z(.OLIDH?9&_$#]@M="^%'SLE
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MR_.>L.$S=KA 7\B?CG&6\*;DGS@?PRY:@.=S P_%"]J@^7\)WOX74$L#!!0
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M!'L6MBLP;(X>6*.5>6S0*Q.8 8D;NZ0BQ&JPF2:[G*E3;[^I1>KDE',&"^!
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M.1; _W-K0WW#!IK/EA?_!U!+ P04    "  ,@9Q2H&Q]/"P#  "7!@  &0
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M2#42P/Q282L/'5*P^Y!T\7]02P,$%     @ #(&<4OL>N*S !0  C \  !D
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M"BIEH\-KN_F#6GV>,[_<:A]_Q2;=G<T&(F]\L'5+# 2U,NF_O&WMT",X&3]
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M8<[$NTIIVF.](*TP_?C>2)92#-%/:W8DPK^3S:[&N]&COB)YAYT+)6I)2)$
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M_@ZZ2%>O&_%T@07>:$)/):^A.AF]/!B02Y?"M BVCA>QE0VXUL7' O=H=B*
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MJL*+0;S(1QS5<K):I 7 AN4\)26@&E6*!.TFKP*/.K=VNB:F67N*4Q*#+.<
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MX@'8GQOC^PE>L/WO._T'4$L#!!0    (  R!G%*(-1_4^0,  (L)   9
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M;"]W;W)K<VAE971S+W-H965T,S$N>&UL?511C]HP#/XK5I\VZ41+X>X0*DC
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MO7:T+^%8T .%QAN0_J")Z5;P ;HG;_X/4$L#!!0    (  R!G%*L>9A%%0<
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M'(Y(MJ:YF)N!TQM_&2ZUHZO5=POZET'#!O1]I;4[##A ]W<T^P]02P,$%
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M/2? ;#RF_ _Z/54YT5&[(PEWOJD;*%0K;=?YAM7AW;CNVN6C>??HT/W8<6E
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MMV)=(ZR,06N RQ(^*57N1%W#;P^<MLSO\\A2,.<2%7O@RQZ8O0$\AJ]*VLK
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M#XQ+H/\;K7'ON 6Z1W3^%U!+ P04    "  ,@9Q2;,#8:8H#  ")"@  &0
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MX.$^ -4^G38QLO*W;RN-O<L^+.QO@\H5V/E<2G-,W(7N_Z_T-U!+ P04
M"  ,@9Q2;X)2S"H)  #P/P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6RU6^%OV[@=_5>$8!CN@*X629$BNR1 8WN[ I=#T: ;AF$?5)NQA<I6)BG-
M==@??[*L^&>++XRL0OW0V/(C:?*)[]%/Y.537GPMU]96P>^;;%M>7:RKZN'=
M9%(NUG:3E&_S![NM/[G/BTU2U6^+U:1\*&RR; IML@D/0S79).GVXOJRN?:Q
MN+[,'ZLLW=J/15 ^;C9)\?W&9OG3U06[>+[P*5VMJ]V%R?7E0[*R=[;Z_/"Q
MJ-]-#K4LTXW=EFF^#0I[?W7QGKV;L[ IT4#^D=JG\NAUL.O+ESS_NGOS87EU
M$>Z^DLWLHMK5D=1_OMFIS;)=5?47^6];Z\6AT5W!X]?/M?^MZ7W=FR])::=Y
M]L]T6:VO+O1%L+3WR6-6?<J??K%MC^2NOD6>E<W_P=,>JZ*+8/%85OFF+5Q_
M@TVZW?]-?F]'XJA 70\NP-L"O%O@I19$6T#T;2%J"T1]"\BV0-/UR;[OS<#-
MDBJYOBSRIZ#8H>O:=B^:T6]*U^.5;G=WREU5U)^F=;GJ^I/]9K>/-OA+</-8
MUI^59?!\Z:>9K9(T*W^N/_Q\-PM^^M//EY.J;G-7<K)HZ[_9U\]?J%\$M_FV
M6I?!?+NT2U!^YB^O/.4G=5\/'>;/';[AW@IOD^)MP.,W 0\Y ]]GVJ>X;HJ'
MJ#L_UOI\<.LG@R$.[(NF/O%"?;.T3%:KPJZ29M;F]P?R__UK#0T^5'93_L?3
M4'1H*&H:BORW68ENH'U)U93<"=NW:R9%K,+=O\O)MV-N7&@L%0/(F8L4+(HC
M )V#]E6H.NV?]%H>>BV]O9[6MVY12V$]IZMU,&UFLRW>!+^FR9<T2ZOO;P[C
M_<DN\M4V_1^<(S?[9N1Q;T+4[:D+Y(JC\7&!.M1H=%Q@'$O/V*C#V"COV'S>
MII5=!G=54G5OBY/ZXD-]\;BWLCXTI ??RMH9+!:J_4W79<J%RC@RB"H7R7G(
M8D06:)^'W:ETTFMSZ+7Q]OK#MK+%MAG;)/.,(@O)>,)Q"6-''L<&4]86/1ZS
M*!90?0"4:0:G%X":2$+. %08$WHX8YPZSKT=GZ7):IN75;KP33%&=L%&]@M&
MAL&&.T9;M#O/)"3-Q0IF,&DNE-=0S)J+52*,?:R1:S"_;1RQ%OP_Z"N4C)27
MJ9%9)%%F\7 68]=:0HF8F0(H%QJ3Z$)9I#2:T'. C931/A+))9C?)DY)["V?
MI,?,C$LB)Z7FX6 2VZ(GTTL:@4@$4,V0-\X ,N816O#, ;1>O1D/A9QL@_MM
MXY3"Z?<JS_+5]^#/R>;AK\%'6Z0UH5XV.0DUYR.S21K.Q7 VA3N:+(93$D(%
M6F#/ )1''#$_1U 113XZR5&XWU'ZT7F&XG)2="Y'II?$G?O7U5YZE3NO%%KU
M3Q%20+T%2"856LC.(=3KF9R,AON-IC>Y?968D])S/3*Y)/K<OPKWDFM<,PO1
M?)Q")";716J)=1@@A8]:0?8C_/9S2NUMGMG%8Y840;_%K2"Y%VQ<'@7)O?"O
MRWT\MD5/?CH("1T50)D)T5)G!J$"8N< *Y1A/C*/ B>_^_0@\PP%%B3^(AJ9
M7!)[X5^^>\EUXQ3%%)RE ,JB[N*T)1= N6&87! 1&>9;, GR'N'WGG[D]E5@
M0>(O1LY^!(F]&)[^"#=^$4PC*YP": 3SMQE *M&-!UIJ76C<7;R==IN,1_B-
MYY3!FRS/Z]FY**S=IMN5+Q\FE8]&CH,B$OIH>!P4@8P'+E6G" E_O<X DL/X
M=HZ07@8CLIRH=Q3D,GB&Y$8D]='8#Q>.GB[\P.,%$!:]P"A OL H2(I>8!0@
M_8R2ST3GQ$0NHWUU-B)]CT8.CB*2]&AX<!2YL8U#Y:N0V>N0N1=RVC$RD,AO
M(#>%3<HJ^,4F6;7V#15I<S1R$B1)I.7P)$B")$@HN&Y%T#"&]@>@REF+MD^J
M %1T[?>TXV09TF\9)ZR=H9:2]%F.G !)$F8Y/ &2((!I?WPX+/;):EH67:AD
M\,G)'$ CXPWT)-F$]-M$E\6^"BF/'OB.'/1($F,Y/.B1;M*B!9Z**.C!'*+T
M)H9!#X)&.O1Q2,8@_<;0Y;!]_V&3K/Q+44D2+4<.="1IMQP>Z$@W4N'*P)\3
M""IQI .@+^RVF",HESX:%3F)\CN)G\8S%%:1AJN1\QU%8JZ&YSL*)3$:[N9
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M[8<.2K=2\;(&ZPQ*PJHG?JSK< 30<=H!?@WP7P)>8PAJ0' I0U@#PDL9^C7
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MDR",@WZ_YEP=-H:@N7GCWU!+ P04    "  ,@9Q26W7^R.L"  #K#P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6S-5VMOVC 4_2M6I$F;U)+8X2U
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MQ$^:S.)&PA7D+1+WKD@<Q5&-/_-F^ (2A \<G [KPFF&+YE&>-];IS7PF[?
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M/[H$0)?@[8JSJZ#+%ZKS7.O^!@Z8_GR[:C3U:H@#P%& EUQ(D%X%BC)+,QZ
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M@/S[@Q#5^D7]I<3-=ZA/_@]02P,$%     @ #(&<4IZZY@HM!@  ,Q\  !D
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M>!R&F/T^)0&]/QK P>.%&_]N+9(+H^/##;XCMT1\WUPS^6V4:UGZ(8FX3R/
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M6$P>D7D;E0^T6-@^X4EH[#KLZQP[3Y F +]/A=";@1%PO6S_#U!+ P04
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MK:M0$)F!?K_D>L\4G<Q!6=<.?P%02P,$%     @ #(&<4A4I_=$U P  ) H
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M6[BP4UD X/M&"/W\4CBH_P4P_Q=02P,$%     @ #(&<4I@@LDS! P  41$
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M'50-MYW#;;O+I92Q:2FSNO?*A:3)6RK,(LKF50&TC_:Q46]6 ^ODP#H_LX_
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M\X&QMP9?&.S5R9B83!9"/)G)7^G(\4U P&&I#0/%SPYFP+DAPC"^5YQ.[=(
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M@D!G!914^[("@2=KJ4IJT%2;0%<*:.Y )0_"P2 -2LJ$-QV[O1<U'<NMX4S
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MX&1QRP)G/RCK@.=K*<VG8<=+^V\R_0=02P,$%     @ #(&<4J5_M]N$ P
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M-.;Z%^SSL3TY.,RXH$D!RQDD),W_T4N1B!- ZE0#;@&X;P&_!O *P'MO!+\
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M_[;?/"!9813[437)7DFR]U\)B0_B+A6+MCX?>Q7YV#J@?&S3\>,#QL%>(<E
M+5Q]U221N3#%"US.EB5\Y"K7P?P82WM1B?_"%/\%^+[B.Z,)ASE"AGX'[X(J
M:FTQ,'+ERM63-%C\7'>)OR>@K &NSZ4TNX'=H/SA&?X!4$L#!!0    (  R!
MG%*BBRL7)P8  .8A   9    >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;,5:
M76_;-A3]*X31AQ9(;).4;#EP#,26N@9HMJ!IMX=A#XQ,VUKUX8ETW +]\:,^
M(DHB30ESEKXDDGQXR7MY><XEI?DQ2;^R':4<?(O"F%T/=ISOKT8CYN]H1-@P
MV=-8_+))THAP<9MN1VR?4K+.&T7A"(W'DU%$@GBPF.?/[M/%/#GP,(CI?0K8
M(8I(^GU)P^1X/8"#YP>?@NV.9P]&B_F>;.D#Y5_V]ZFX&U56UD%$8Q8D,4CI
MYGIP Z\\[&0-<L3O 3VRVC7(7'E,DJ_9S>WZ>C#.1D1#ZO/,!!'_GNB*AF%F
M28SCG]+HH.HS:UB_?K;^/G=>./-(&%TEX1_!FN^N!\X K.F&'$+^*3E^H*5#
M=F;/3T*6_P7'$CL> /_ >!*5C<4(HB N_I-O92!J#80=?0-4-D#M!M:)!KAL
M@/OV8)4-K+X]V&6#W/51X7L>.)=PLIBGR1&D&5I8RR[RZ.>M1;R".$N4!YZ*
M7P/1CB]N?/\0'4+"Z1K\QG<T!:LD$BFWRW+AB8+;V$\B"MZZE),@? <NP9<'
M%[Q]\PZ\ 4$,[H(P%//-YB,N!I.9'/EEQ\NB8W2B8PSNDICO&/#B-5UKVKOF
M]A-#^Y$(0A4)]!R))3(:O"/I$*#I!4!C!#7C6?5I[N3-QSIWSNO=^\^]-X*!
MJ[3 N3U\9EI\3!A[!_[\*)J#6TXC]I>A<ZOJW,H[MTYTOJ3;((Z#>"LH("2Q
M3W7A+$PXN8F,#9\6:#JVAV@^>JJ'30.#T!Y.*UACA'8U0MLXPM6.Q%O*LA4@
MN%J042S6:IK2V/\.>$IB)B*7T^#Z;[&$!:]RW0*QE;%=SH96TX&5!F2W06X!
MFM5 3AOCJ1@TG.G#,*G",#&&H<@,OY$909D989X9CS2+CU 4/R2,!9O SP.C
MY8N),D!KB%O14#&72)ETMT#9-93="H;.#JS9:81C6H5C:@R'8")STBZG2K=X
M.K.4Z>R$-8;G5,-SC,-[7V;JZCE3/\M,-:S:665^]OJ4 <=2Q\9GD\:RM#%K
MKB;82C(="N,VS-7!4'U-%:FF@UGPU&3"FG##5^"@LI.9F81T*)6%-"B5AC2@
MDSP$D0P&,@;C)DH.,6<UHA%9R!/ N,C'S'>0;$IJTD8!*8PQ;H>@$^)V0SPC
MI.F[E&J(SZ2=TD!C^J UM-LN:F#8:</<?M:\3FM-=V5Q ,W5P7VY2[D7[C(3
M=4@QA_9/8"XIHM"LHOV82Z-8<.BT9U"+FK8GL(\MK\M6TUNID= LDB];,Y2=
M&1=N)\3MAGA&2#,44H^A69#/)2VGV_=.B-L-\8R0IN^R6("S<TEKUBOCM2@E
MX_O8\KIL-;>5LC)!YLKD<\)):-J@2LE'\/6)"DF116:1[454I8TF[8_;,[+2
MP9"C3)P.9LW:,$\+0[7=0]-C*:W(+*TO2E8>T@FG<W*44A&161'/Y)'2NHE'
M2DA]Y&.E_-. +L=*6:!!G5YC4L*1>4/^LJJ"U+VR9IN@0XE,G[3#HL(@/E7^
M(UDU('/5T$V@2"/@V%885 >SG?8VQNUGS>NTUG17E@W(7#;<QIRFE'&0BIP&
M/MDS< G6- V>2';2#'Z .CG^0L2NJ*#!"_ KY1=@1=@.O ]%MQ_H>DLOP#U)
ME2U1<VQ2QY'S$VA92BDR2VD_6M9HFY*K*QT*J@M=:ZN][]6AT*F5CJ6:8K.:
MONQ*Q^KF7(V*!B3\;1\':$VU=[]=III!D84!-I\%G*D I763 F#-"8 J 7I4
M6P)TJ),:@&5Y@LWE23<CXNYM/M94$E"=Z^Z=?I>AII.U<WES15+QX*>,!Q^.
M9/\_4!^6I0>V7I_ZL)1];);]7M2'-3J-</O0>*6!396S#ZTMJYT?G@:&3YU\
M8"GY^#6/V[&JU%@ITS6@[,!=60^ZL_M).RCZ0_=32T*6!MA<&IQ+?MU'"-T0
MMQOB&2%-WV7I@<U'"#TXSU%?(,&9<O:GA4V58K:?-:_36N'NJ/;>.J+I-O]@
M@(D,%_-9O*NLGE8?)=SDK^);SY?P:@4USUUXY16?'$CSQ1<0=R05U,% 2#>B
M*[$_%=.2%A\5%#<\V>=OS1\3SI,HO]Q1(BK.#"!^WR0)?[[).J@^[5C\"U!+
M P04    "  ,@9Q2W0(B%!8#  !T"P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W."YX;6RU5EUOFS 4_2L6VD,K=063A*15$BD?FS9IE:)$W1ZF/;AP$ZP"
MIK9IVOWZV88 R0A*IB4/P38^YQ[?"X<[W#+^+$( B=[B*!$C*Y0RO;=MX8<0
M$W'+4DC4G37C,9%JRC>V2#F0P(#BR'8=Q[-C0A-K/#1K"SX>LDQ&-($%1R*+
M8\+?IQ"Q[<C"UFYA23>AU OV>)B2#:Q /J8+KF9VR1+0&!)!68(XK$?6!-_/
M<5\#S([O%+:B-D;Z*$^,/>O)UV!D.5H11.!+34'4Y15F$$6:2>EX*4BM,J8&
MUL<[]L_F\.HP3T3 C$4_:"##D36P4 !KDD5RR;9?H#A03_/Y+!+F'VWSO5[/
M0GXF)(L+L%(0TR2_DK<B$34 ]HX W +@'@*Z1P"= M Y!/2/ +H%H&LRDQ_%
MY&%.)!D/.=LBKG<K-CTPR31H=7R:Z+JO)%=WJ<+)\2HD'- 2THS[H<H?RA=X
MM7 U!TEH)*[11_2XFJ.K#]=#6ZK0FL#VBS#3/(Q[)$P'/;!$A@)]2@((]O&V
MDESJ=G>ZIVXKX0/AM\CMWR#7<7&#GED[? Z^@GL&[C3 YR? ,=9P?-=RFDY9
MA8[AZQ[G@_@)^"F<W9*S:S@[1SC%82'3B"3HYS>U#7V5$(M?+4%Z99!>J_"5
M9/YS_?%9<+;A)+Y!DTR&C-/?$*!)S+)$-F4Y)_<,N7:HUW'/*7Y#^[5!EU?J
M\LY)Z&&-]SC[)6?_<@D=E$$&ETSHX*^$8J<]HW>EL+O_]HABIW(?YW(YQ363
MPV=E-4#SC--D@Q; *0MN<M<333Y2,/?J*>VUY!.[E2BW552MR&R-X"6C\KU1
M@=M05-QITU#Y#C[+>%K?$UPY#[Z@]>#*>_!YYG-Z5:<%\UY5O;:,5L:#VYWG
MQ*I."YJ]JJK7JDU#952X_X\FL@3="^H<U>RDMO&HLTR+D'6]@T&SL]BU=B0&
MOC%MG4"^ILZ_\.5JV3I.3,-TL#[%][.\ :QH\GY4??XW-!$H@K6B=&[[JI(\
M;_'RB62I:7J>F%0ME!F&JBT&KC>H^VO&Y&ZB Y2-]O@/4$L#!!0    (  R!
MG%*BQ%.(* ,  .P2   -    >&PO<W1Y;&5S+GAM;-U8T6[:,!3]E<B=IE::
M&B C)2L@;4B5)FU3I?*PM\H0!RPY=N:8#OKU\XU# M2WZ_JPP8)H['MRSCVV
M;VJ+86DV@MTM&3/!.A>R')&E,<6',"SG2Y;3\E(53%HD4SJGQG;U(BP+S6A:
M BD78:_3B<.<<DG&0[G*;W)3!G.UDF9$^DTH<+?/Z8ATX_<D<'(3E;(1N3]_
M^V.ES/6;P-W/WIV==>XOK@_CYQ5P04*O:/\%HI<=7-=BF'3\(NEGE#'AJWWA
M5NAWQ(&7V-FEUL,)ZR49#S,EVY6)B M8=9JSX(&*$9E0P6>: RNC.1<;%^Y!
M8*Z$TH&Q)6'3=2%2/CJXZWI0+;5.SJ7256Z7P?V=U8\? -L>&.1"- 9[Q 7&
MPX(:P[2\L9WJX2KX! KJ]G136(<+33?=7I^TA.IFD\R43IENTG3)-C0>"I:!
M'<T72[@;580 &J-RVT@Y72A)*P];1MVPLG,FQ!V\2M^S/>UUMK-N'5@UV32M
MH;KI9%P']'?5G/:N;.]5ND'!'Y3YM++#D54?*I3=:I;Q==5?9XT!3+V+J].B
M$)N/@B]DSMS@7YQP/*1;7K!4FC_:;% J<QM@F@0/3!L^WXW\U+28LK79EM,Z
MPSWW3M#SWYWG!9-,4[%KVM;^,<_RJQU'5__*<O5?Y="PUV.]/QZ[R?XIF(Q/
MP>0)U&24'+_'^E1T=";#>O_>.23L'1&:: !'L1'Y!@<[T28-9BLN#)=U;\G3
ME,DG)P4K;^C,'N7W].WS*<OH2IAI XY(V_[*4K[*D^:I6YB(^JFV_06&UXV;
M<Z#-Q67*UBR=U%V]F%7-P#9LUOH"PB%R4UU^!.,XS(\ AN7!'& <Q\+R_$_C
M&:#C<1CF;>!%!BAG@'(<RX=,J@^6Q\])[.4?:9)$41QC,SJ9>!U,L'F+8_CZ
MU3!OP,#R0*8_FVM\M?$*>;X.L#5]KD*PD>*5B(T4GVM _/,&C"3QKS:6!QC8
M*F"U _G]>:"F_)PH@E7%O&%O,(XD"89 +?IK-(Z1V8GAXU\?["V)HB3Q(X#Y
M'401AL#;B".8 _" (5%4[8,'^U&XW:?"]O>M\2]02P,$%     @ #(&<4I>*
MNQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q
M%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(
MMB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!
M;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B
M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M"  ,@9Q277TQW-H%  "-,P  #P   'AL+W=O<FMB;V]K+GAM;,6;6T_C.A"
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M%J+G,W'JD5 62I@M1&/BU".A+)1\U=K/SFE7',V4LE"ZS_T$7C13RD+I5XV
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M"^HM!'H+ZBT$>@OJ+01Z"^HM!'HKZJT$>BOJK01Z*^JM!'KK9+.$0&]%O95
M;T6]E4!O1;V50&]%O95 ;T6]E4!O1;V50&]#O8U ;T.]C4!O0[V-0&]#O8U
M;YML=A/H;:BW$>AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z.VHMQ/H[:BW$^CMJ+<3
MZ.VHMQ/H[:BW$^CMDX^5!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>@?J'01Z!^H=
M!'H'ZAT$>@?J'01Z!^H=!'H'ZAT$>L?D9Q,"O0/U#@*] _4. KT#]0X"O3/J
MG0GTSJAW)M [H]Z90.^,>F<"O3/JG0GTSJAW)M [H]Z90.\\^5F00.^,>N?O
MU'L8/X]EN/5\K?'YWTGU>+FWW!Y_77Z=1 E75YSK^XKA^2]02P,$%     @
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M+GAM;%!+ 0(4 Q0    (  R!G%)'9=7L[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  R!G%*97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ #(&<4O!,6IPK!0  5!4  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  R!G%("49]\U <
M (HE   8              " @6\-  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    "  ,@9Q2&<5ID$T$  "S#@  &               @(%Y
M%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ #(&<4@;-
M7$29 @  Z08  !@              ("!_!D  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    (  R!G%)5O7'?V 8  %(;   8
M  " @<L<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  ,
M@9Q2"0$^V0D#  "F"0  &               @('9(P  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ #(&<4J6"(NAL#@  .&8  !@
M         ("!&"<  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   (  R!G%( 'WCD>P@  (8E   8              " @;HU  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  ,@9Q2D3%EE"H)  "Y%@
M&               @(%K/@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ #(&<4K.JG4*] P  ?0P  !D              ("!RT<  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  ,@9Q2@ :YB]\&
M  "5$@  &0              @(&_2P  >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    (  R!G%*;@3I<D1$  *A'   9              "
M@=52  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ #(&<
M4EB;H$M)!0  =PP  !D              ("!G60  'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    "  ,@9Q2-T!C2NT%  !%#@  &0
M        @($=:@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   (  R!G%+:QK,^]@L  -\B   9              " @4%P  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ #(&<4C]2M6ZN"@  PB$
M !D              ("!;GP  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    "  ,@9Q2F0+W;Y$+  !7(   &0              @(%3AP
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  R!G%)H8$=^
M_ (  *L&   9              " @1N3  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ #(&<4D(0-W8+!P  PA0  !D
M ("!3I8  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  ,
M@9Q2H&Q]/"P#  "7!@  &0              @(&0G0  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (  R!G%*R*4.830<  %02   9
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M970R-2YX;6Q02P$"% ,4    "  ,@9Q2_TZUV\@%  "E#P  &0
M    @(''N   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M  R!G%(NLUP8O 4  %</   9              " @<:^  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ #(&<4EYU(H3,!0   PX  !D
M             ("!N<0  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    "  ,@9Q2B#4?U/D#  "+"0  &0              @(&\R@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  R!G%+I>[3W-00
M *,+   9              " @>S.  !X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ #(&<4E0X0JM) @  _@0  !D              ("!
M6-,  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  ,@9Q2
MK'F8114'  #L$@  &0              @('8U0  >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    (  R!G%)@Y. 'L00  "0-   9
M      " @23=  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ #(&<4J<IQOL+ P  M08  !D              ("!#.(  'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  ,@9Q2U0,-_^0#   I"0
M&0              @(%.Y0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    (  R!G%(1(@DB3P,  %D'   9              " @6GI  !X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ #(&<4O#1K$W4
M!   D@L  !D              ("![^P  'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    "  ,@9Q2=)[SB^\#  #3"   &0
M@('Z\0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  R!
MG%*JH4_Z= (  % %   9              " @2#V  !X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ #(&<4FS V&F* P  B0H  !D
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M=#0T+GAM;%!+ 0(4 Q0    (  R!G%*=&Q6AI (  (4'   9
M  " @<</ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @
M#(&<4EMU_LCK @  ZP\  !D              ("!HA(! 'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"% ,4    "  ,@9Q21F'8LPX"  !H!   &0
M            @('$%0$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4
M Q0    (  R!G%*DN]JX:P4  .0B   9              " @0D8 0!X;"]W
M;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ #(&<4C#"G\F) P
M[@P  !D              ("!JQT! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6Q02P$"% ,4    "  ,@9Q2G<PLF3<#  !9"@  &0              @(%K
M(0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  R!G%(&
M Z#R9PH  $\]   9              " @=DD 0!X;"]W;W)K<VAE971S+W-H
M965T-3$N>&UL4$L! A0#%     @ #(&<4IZZY@HM!@  ,Q\  !D
M     ("!=R\! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  R!G%):+U7C* ,  -<*   9              "
M@1]( 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ #(&<
M4A5B63V6 P  XPX  !D              ("!?DL! 'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6Q02P$"% ,4    "  ,@9Q2%2G]T34#   D"@  &0
M        @(%+3P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0
M   (  R!G%+):&UD[ ,   X0   9              " @;=2 0!X;"]W;W)K
M<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ #(&<4I@@LDS! P  41$
M !D              ("!VE8! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q0
M2P$"% ,4    "  ,@9Q2O Q"5Z@#   O#0  &0              @('26@$
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (  R!G%+QMHH9
M; (  *\&   9              " @;%> 0!X;"]W;W)K<VAE971S+W-H965T
M-C,N>&UL4$L! A0#%     @ #(&<4IR'86+! P  _@P  !D
M ("!5&$! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    "  ,
M@9Q2.9':N>,#  "=$   &0              @(%,90$ >&PO=V]R:W-H965T
M<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    (  R!G%)#O^X2: 4  "X9   9
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M970W,"YX;6Q02P$"% ,4    "  ,@9Q2<WR<:2H'  !@)P  &0
M    @($Z? $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (
M  R!G%(KS:O$/0,  +$.   9              " @9N# 0!X;"]W;W)K<VAE
M971S+W-H965T-S(N>&UL4$L! A0#%     @ #(&<4A^YKH>Y @  2@@  !D
M             ("!#X<! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"
M% ,4    "  ,@9Q2B#:?CJ$$   B%@  &0              @('_B0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (  R!G%*JC/M[8P(
M .X%   9              " @=>. 0!X;"]W;W)K<VAE971S+W-H965T-S4N
M>&UL4$L! A0#%     @ #(&<4DX:NS<? P  _ @  !D              ("!
M<9$! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    "  ,@9Q2
MHHLK%R<&  #F(0  &0              @(''E $ >&PO=V]R:W-H965T<R]S
M:&5E=#<W+GAM;%!+ 0(4 Q0    (  R!G%+= B(4%@,  '0+   9
M      " @26; 0!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%
M  @ #(&<4J+$4X@H P  [!(   T              ( !<IX! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  ,@9Q2EXJ[',     3 @  "P
M@ '%H0$ 7W)E;',O+G)E;'-02P$"% ,4    "  ,@9Q277TQW-H%  "-,P
M#P              @ &NH@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M#(&<4GH$ UU< @  (2X  !H              ( !M:@! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ #(&<4BXH"M@5 @  _"P  !,
M             ( !2:L! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %8
,5@"1%P  CZT!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>511</ContextCount>
  <ElementCount>418</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>111</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126108 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2140111 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148113 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152114 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2157115 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2159116 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2163117 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2166118 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2170119 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2271201 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Derivatives</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2353310 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2360311 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2364312 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2367313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Basis of Presentation Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentationDetailsDetails</Role>
      <ShortName>Basis of Presentation Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails</Role>
      <ShortName>Fair Value Measurements - Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionDetails</Role>
      <ShortName>Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails</Role>
      <ShortName>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails</Role>
      <ShortName>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - Commitments and Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesDetail</Role>
      <ShortName>Commitments and Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2458433 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2465436 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2468437 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="holx-20210327.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2469438 - Disclosure - Share Repurchase Share repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails</Role>
      <ShortName>Share Repurchase Share repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="holx-20210327.htm">holx-20210327.htm</File>
    <File>holx-20210327.xsd</File>
    <File>holx-20210327_cal.xml</File>
    <File>holx-20210327_def.xml</File>
    <File>holx-20210327_lab.xml</File>
    <File>holx-20210327_pre.xml</File>
    <File>holx_q2-2021xex311.htm</File>
    <File>holx_q2-2021xex312.htm</File>
    <File>holx_q2-2021xex321.htm</File>
    <File>holx_q2-2021xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20210327.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 511,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20210327_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20210327_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20210327.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20210327_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20210327_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20210327.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 589,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 10
   },
   "keyCustom": 55,
   "keyStandard": 363,
   "memberCustom": 49,
   "memberStandard": 51,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20210327",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Leases",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Fair Value Measurements",
     "role": "http://www.hologic.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Business Combinations",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses",
     "shortName": "Trade Receivables and Allowance for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - Disposition",
     "role": "http://www.hologic.com/role/Disposition",
     "shortName": "Disposition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126108 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ieb87cc8f02ec4d0aa6b71fc92c233996_D20190630-20190928",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - Derivatives",
     "role": "http://www.hologic.com/role/Derivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140111 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - Stock-Based Compensation",
     "role": "http://www.hologic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "id4b5d24a079a4126b7edfc9226d41264_D20190929-20200328",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148113 - Disclosure - Other Balance Sheet Information",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformation",
     "shortName": "Other Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152114 - Disclosure - Business Segments and Geographic Information",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157115 - Disclosure - Income Taxes",
     "role": "http://www.hologic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159116 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163117 - Disclosure - Product Warranties",
     "role": "http://www.hologic.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166118 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2170119 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.hologic.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2271201 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.hologic.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Revenue (Tables)",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Derivatives (Tables)",
     "role": "http://www.hologic.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.hologic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - Other Balance Sheet Information (Tables)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationTables",
     "shortName": "Other Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353310 - Disclosure - Business Segments and Geographic Information (Tables)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360311 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364312 - Disclosure - Product Warranties (Tables)",
     "role": "http://www.hologic.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2367313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Basis of Presentation Details (Details)",
     "role": "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
     "shortName": "Basis of Presentation Details (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i3d291e0f9c0b402da8343bcc6b51f9f2_D20210408-20210408",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Revenue - Business Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "if2e0e2bca7514b3c85c5bf5e035db201_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Revenue - Geographical Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ib6e2fc7894ae44b7ac39a13bf31f830b_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Revenue - Revenue by Type (Details)",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i89fb351d8bbc4b2fa26f6615870eeb22_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "if46e15e1bfd3413a999b55b314fd2cac_I20210327",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
     "shortName": "Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "if46e15e1bfd3413a999b55b314fd2cac_I20210327",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Leases - Additional Lease Information (Details)",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i51a6fb1e5035470f90aa39f8c1cbd1fc_I20210327",
      "decimals": "-8",
      "lang": "en-US",
      "name": "holx:PrincipalAmountOfBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ib547cd16894c496aaa14272f3e33f8fa_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails",
     "shortName": "Fair Value Measurements - Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ib547cd16894c496aaa14272f3e33f8fa_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Business Combination - Narrative (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ifbb56ed6f79740c39f43a3c62948ecc3_D20191121-20191121",
      "decimals": "2",
      "lang": "en-US",
      "name": "holx:BusinessCombinationOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ibd1490c4f1854b5eb44df1462cf8ab1b_I20210222",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1e832ad751c74be3a002a605f07e03a4_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Disposition (Details)",
     "role": "http://www.hologic.com/role/DispositionDetails",
     "shortName": "Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": "5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i469614de5d734baeb90118c04073db54_I20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:LongTermDebtObligationsWithoutConvertibleNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ib3da1322564b4ca89777bef210350bd7_D20200928-20200928",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ide4245759f62417f848f84c2e9a9c13c_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ida59e22f7f6c46b19f9d458fa92fe312_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivatives - Additional Information (Details)",
     "role": "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
     "shortName": "Derivatives - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia5e8738289d14090b2a313cca454526f_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "role": "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
     "shortName": "Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "role": "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "role": "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
     "shortName": "Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ieb56657e29a54018978922a7e1c3a629_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - Commitments and Contingencies (Detail)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
     "shortName": "Commitments and Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ieb56657e29a54018978922a7e1c3a629_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia47eb1b8e91049b491b3bc0f0e28d23c_D20200927-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Other Balance Sheet Information - Inventories (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail",
     "shortName": "Other Balance Sheet Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail",
     "shortName": "Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ia0c14b34a4d54eba985a7ab73c22d9e9_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i532492042bba44aa888e1a014048de52_D20200628-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i532492042bba44aa888e1a014048de52_D20200628-20200926",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458433 - Disclosure - Income Taxes (Details)",
     "role": "http://www.hologic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "ica30c3f907d343549ada504d940ce936_D20201227-20210327",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i64d64acb56824c3484cb34d66ff95151_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1e832ad751c74be3a002a605f07e03a4_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465436 - Disclosure - Product Warranties - Product Warranty Activity (Detail)",
     "role": "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail",
     "shortName": "Product Warranties - Product Warranty Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1e832ad751c74be3a002a605f07e03a4_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1e832ad751c74be3a002a605f07e03a4_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468437 - Disclosure - Accumulated Other Comprehensive Income (Detail)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
     "shortName": "Accumulated Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i800b03ee604347afbc07632cb45b6fc2_I20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1c79daa201df43a4b63c18f0297a823a_I20191211",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469438 - Disclosure - Share Repurchase Share repurchase (Details)",
     "role": "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails",
     "shortName": "Share Repurchase Share repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i1c79daa201df43a4b63c18f0297a823a_I20191211",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i5e045725247943fab0ef47b9a123aded_D20200927-20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i87367de631f24b48bda162d20ba2e661_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.hologic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210327.htm",
      "contextRef": "i87367de631f24b48bda162d20ba2e661_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 111,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes [Member]",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Acceleratedsharerepurchaseagreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated share repurchase agreement",
        "label": "Accelerated share repurchase agreement",
        "negatedTerseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "Acceleratedsharerepurchaseagreement",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAllowanceForCreditLossTransfers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "label": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "negatedTerseLabel": "Reclassified as Assets held for sale"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTransfers",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Securitization [Member]",
        "label": "Accounts Receivable Securitization [Member]",
        "terseLabel": "Accounts Receivable Securitization"
       }
      }
     },
     "localname": "AccountsReceivableSecuritizationMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccumulatedOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Abstract]",
        "label": "Accumulated Other Comprehensive Income [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.hologic.com/20210327",
     "xbrltype": "stringItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Total acquired intangible assets"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AlphaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alpha Imaging [Member]",
        "label": "Alpha Imaging [Member]",
        "terseLabel": "Alpha Imaging"
       }
      }
     },
     "localname": "AlphaImagingMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Term Loan [Member]",
        "label": "Amended Term Loan [Member]",
        "terseLabel": "Amended Term Loan"
       }
      }
     },
     "localname": "AmendedTermLoanMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Cost of Goods Sold",
        "label": "Amortization, Cost of Goods Sold",
        "terseLabel": "Amortization, Cost of Goods Sold"
       }
      }
     },
     "localname": "AmortizationCostofGoodsSold",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountAssessedInDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount assessed in damages.",
        "label": "Amount Assessed In Damages",
        "terseLabel": "Assessed damages"
       }
      }
     },
     "localname": "AmountAssessedInDamages",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AnnualIncrementalRevenueGrowthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Incremental Revenue Growth Period",
        "label": "Annual Incremental Revenue Growth Period",
        "terseLabel": "Annual incremental revenue growth period"
       }
      }
     },
     "localname": "AnnualIncrementalRevenueGrowthPeriod",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_AssetsofBusinessHeldforSaleAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets of Business Held-for-Sale [Abstract]",
        "label": "Assets of Business Held-for-Sale [Abstract]",
        "terseLabel": "Assets of Business Held-for-Sale [Abstract]"
       }
      }
     },
     "localname": "AssetsofBusinessHeldforSaleAbstract",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_BasisofPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation [Abstract]",
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationAbstract",
     "nsuri": "http://www.hologic.com/20210327",
     "xbrltype": "stringItemType"
    },
    "holx_BiotheranosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biotheranostics",
        "label": "Biotheranostics [Member]",
        "terseLabel": "Biotheranostics"
       }
      }
     },
     "localname": "BiotheranosticsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "terseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessAcquisitionCashTenderOfferPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cash Tender Offer Price Per Share",
        "label": "Business Acquisition, Cash Tender Offer Price Per Share",
        "terseLabel": "Cash tender offer price (per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionCashTenderOfferPricePerShare",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Shares",
        "label": "Business Combination, Additional Shares Acquired, Shares",
        "terseLabel": "Additional outstanding shares purchased (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredShares",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Value",
        "label": "Business Combination, Additional Shares Acquired, Value",
        "terseLabel": "Additional outstanding shares purchased, amount"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredValue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "terseLabel": "Consideration related to equity method investment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "terseLabel": "Consideration related to fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "terseLabel": "Consideration, portion related to loan repayment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "terseLabel": "Consideration related to newly acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Ownership Percentage",
        "label": "Business Combination, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "BusinessCombinationOwnershipPercentage",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Short and long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Intangible assets, fair value (percentage)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Shares Acquired",
        "label": "Business Combination, Shares Acquired",
        "terseLabel": "Shares acquired"
       }
      }
     },
     "localname": "BusinessCombinationSharesAcquired",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business licenses.",
        "label": "Business Licenses [Member]",
        "terseLabel": "Business licenses"
       }
      }
     },
     "localname": "BusinessLicensesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software embedded in products"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ChangeInParValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in par value",
        "label": "Change in par value",
        "terseLabel": "Change in par value"
       }
      }
     },
     "localname": "ChangeInParValue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income",
        "label": "Comprehensive Income",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Disposables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Holdback",
        "label": "Contingent Holdback [Member]",
        "terseLabel": "Contingent Holdback"
       }
      }
     },
     "localname": "ContingentHoldbackMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.",
        "label": "Cost Of Goods Sold Impairment Of Intangible Assets and equipment",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Costofservice": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of service",
        "label": "Cost of service",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "Costofservice",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement",
        "verboseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DebtInstrumentOfferingPricePercentOfFaceValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Offering Price, Percent Of Face Value",
        "label": "Debt Instrument, Offering Price, Percent Of Face Value",
        "terseLabel": "Debt Instrument, Offering Price, Percent Of Face Value"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentOfFaceValue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_DebtRedemptionPremiumPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Premium Paid",
        "label": "Debt Redemption, Premium Paid",
        "terseLabel": "Premium payment"
       }
      }
     },
     "localname": "DebtRedemptionPremiumPaid",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_December112019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2019",
        "label": "December 11, 2019 [Member]",
        "terseLabel": "December 11, 2019"
       }
      }
     },
     "localname": "December112019Member",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_December112020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2020",
        "label": "December 11, 2020 [Member]",
        "terseLabel": "December 11, 2020"
       }
      }
     },
     "localname": "December112020Member",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DetailsOfCertainBalanceSheetAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of certain balance sheet accounts.",
        "label": "Details Of Certain Balance Sheet Accounts [Text Block]",
        "terseLabel": "Other Balance Sheet Information"
       }
      }
     },
     "localname": "DetailsOfCertainBalanceSheetAccountsTextBlock",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagenodeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagenode",
        "label": "Diagenode [Member]",
        "terseLabel": "Diagenode"
       }
      }
     },
     "localname": "DiagenodeMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment under customer usage agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FairValueAssumptionDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Assumption, Discount Rate",
        "label": "Fair Value Assumption, Discount Rate",
        "terseLabel": "Discount rate percentage"
       }
      }
     },
     "localname": "FairValueAssumptionDiscountRate",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "GYN Surgical"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_HealthBeaconsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Beacons [Member]",
        "label": "Health Beacons [Member]",
        "terseLabel": "Health Beacons"
       }
      }
     },
     "localname": "HealthBeaconsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Holdback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holdback",
        "label": "Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "Holdback",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IndemnificationLiabily": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification liabily",
        "label": "Indemnification liabily",
        "terseLabel": "Indemnification liabily"
       }
      }
     },
     "localname": "IndemnificationLiabily",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InterestRateCapAgreementsAggregatePremiumPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate cap agreements aggregate premium payable.",
        "label": "Interest Rate Cap Agreements Aggregate Premium Payable",
        "verboseLabel": "Interest Rate Cap Agreements Aggregate Premium Payable"
       }
      }
     },
     "localname": "InterestRateCapAgreementsAggregatePremiumPayable",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total (percentage)"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LegalAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Accrual",
        "label": "Legal Accrual",
        "terseLabel": "Legal Accrual"
       }
      }
     },
     "localname": "LegalAccrual",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Awards [Member]",
        "label": "Market Based Awards [Member]",
        "terseLabel": "Market Based Awards"
       }
      }
     },
     "localname": "MarketBasedAwardsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MedicalAestheticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Aesthetic",
        "label": "Medical Aesthetics [Member]",
        "terseLabel": "Medical Aesthetics",
        "verboseLabel": "Medical Aesthetics"
       }
      }
     },
     "localname": "MedicalAestheticsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinervaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minerva [Member]",
        "label": "Minerva [Member]",
        "terseLabel": "Minerva"
       }
      }
     },
     "localname": "MinervaMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MobidiagMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mobidiag",
        "label": "Mobidiag [Member]",
        "terseLabel": "Mobidiag"
       }
      }
     },
     "localname": "MobidiagMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NXCImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NXC Imaging",
        "label": "NXC Imaging [Member]",
        "terseLabel": "NXC Imaging"
       }
      }
     },
     "localname": "NXCImagingMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Netincome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income attributable to Hologic",
        "label": "Net income",
        "terseLabel": "Net income",
        "totalLabel": "Net income attributable to Hologic"
       }
      }
     },
     "localname": "Netincome",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotationalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notational Amount",
        "label": "Notational Amount",
        "terseLabel": "Notational Amount"
       }
      }
     },
     "localname": "NotationalAmount",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PercentageAddedtoEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Added to Eurodollar Rate [Member]",
        "label": "Percentage Added to Eurodollar Rate [Member]",
        "terseLabel": "Percentage Added to Eurodollar Rate"
       }
      }
     },
     "localname": "PercentageAddedtoEurodollarRateMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrepaidIncomeTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Income Taxes-Current",
        "label": "Prepaid Income Taxes-Current",
        "terseLabel": "Prepaid Income Taxes-Current"
       }
      }
     },
     "localname": "PrepaidIncomeTaxesCurrent",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "verboseLabel": "Borrowed principal"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsFromSaleOfBusiness": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of business.",
        "label": "Proceeds From Sale Of Business",
        "terseLabel": "Proceeds From Sale Of Business"
       }
      }
     },
     "localname": "ProceedsFromSaleOfBusiness",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsFromSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Senior Notes",
        "label": "Proceeds From Senior Notes",
        "terseLabel": "Proceeds from Notes Payable"
       }
      }
     },
     "localname": "ProceedsFromSeniorNotes",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Revenue",
        "label": "Product Revenue",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PurchaseOfIntellectualProperty": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of intellectual property",
        "label": "Purchase of intellectual property",
        "negatedTerseLabel": "Purchase of intellectual property"
       }
      }
     },
     "localname": "PurchaseOfIntellectualProperty",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseofinsurancecontracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of insurance contracts",
        "label": "Purchase of insurance contracts",
        "terseLabel": "Purchase of insurance contracts"
       }
      }
     },
     "localname": "Purchaseofinsurancecontracts",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RSUPSUMSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSU, PSU, MSU [Member]",
        "label": "RSU, PSU, MSU [Member]",
        "terseLabel": "RSU, PSU, MSU"
       }
      }
     },
     "localname": "RSUPSUMSUMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RepaymentOfSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of Senior Notes",
        "label": "Repayment of Senior Notes",
        "negatedTerseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentOfSeniorNotes",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Schedule Of Interest Expense Under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ServiceRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "ServiceRevenue",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program [Member]",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that must lapse in order for the restricted stock units to vest.",
        "label": "Shared Based Compensation Arrangement Restricted Stock Vesting Period",
        "verboseLabel": "Performance stock units vesting period"
       }
      }
     },
     "localname": "SharedBasedCompensationArrangementRestrictedStockVestingPeriod",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharerepurchaseplanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for share repurchase plan [Table]",
        "label": "share repurchase plan [Line Items]",
        "terseLabel": "share repurchase plan [Line Items]"
       }
      }
     },
     "localname": "SharerepurchaseplanLineItems",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharerepurchaseplanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "share repurchase plan [Table]",
        "label": "share repurchase plan [Table]",
        "terseLabel": "share repurchase plan [Table]"
       }
      }
     },
     "localname": "SharerepurchaseplanTable",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SomatexMedicalTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Somatex Medical Technologies",
        "label": "Somatex Medical Technologies [Member]",
        "terseLabel": "Somatex Medical Technologies"
       }
      }
     },
     "localname": "SomatexMedicalTechnologiesMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SuperSonicImagineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SuperSonic Imagine [Member]",
        "label": "SuperSonic Imagine [Member]",
        "terseLabel": "SuperSonic Imagine"
       }
      }
     },
     "localname": "SuperSonicImagineMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20210327",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r169",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r189",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r169",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r189",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r306",
      "r308",
      "r508",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r195",
      "r306",
      "r308",
      "r508",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r196",
      "r197",
      "r306",
      "r309",
      "r547",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r196",
      "r197",
      "r306",
      "r309",
      "r547",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchaseProgramAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.",
        "label": "Accelerated Share Repurchase Program, Adjustment",
        "terseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201801Member": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-01 Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842.",
        "label": "Accounting Standards Update 2018-01 [Member]",
        "terseLabel": "Accounting Standards Update 2018-01 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201801Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r33",
      "r201",
      "r202"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves of $41.7 and $31.6, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r81",
      "r84",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50",
      "r250"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less \u2013 accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r81",
      "r91",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r78",
      "r80",
      "r81",
      "r534",
      "r555",
      "r559"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r77",
      "r81",
      "r84",
      "r131",
      "r132",
      "r133",
      "r410",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r81",
      "r84",
      "r410",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r34",
      "r353"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r350",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r122",
      "r241"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of acquired intangibles"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r369",
      "r370",
      "r371",
      "r372",
      "r510",
      "r511",
      "r512",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r325",
      "r327",
      "r355",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r40",
      "r203",
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period",
        "terseLabel": "Accounts receivable, reserves"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write- offs and Payments"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r122",
      "r234",
      "r241"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r122",
      "r246"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Intangible asset and equipment impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r125",
      "r177",
      "r184",
      "r191",
      "r208",
      "r406",
      "r411",
      "r456",
      "r515",
      "r532"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r20",
      "r22",
      "r66",
      "r125",
      "r208",
      "r406",
      "r411",
      "r456"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r328",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r422",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r24",
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r323",
      "r324",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding shares acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r395",
      "r396",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r121",
      "r400"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration fair value adjustments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r121",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r394",
      "r397",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Purchase price withheld"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Remainder of purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net acquired tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree, percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r28",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
        "label": "Capital Lease Obligations, Current",
        "terseLabel": "Current portion of capital lease obligations"
       }
      }
     },
     "localname": "CapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsNoncurrent": {
     "auth_ref": [
      "r59",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
        "label": "Capital Lease Obligations, Noncurrent",
        "terseLabel": "Finance lease obligations - long term"
       }
      }
     },
     "localname": "CapitalLeaseObligationsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r48",
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash less assets held for sale"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r119",
      "r457"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Interest rate swap at fair value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r131",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013750,000 shares authorized; 296,887 and 295,107 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r87",
      "r89",
      "r90",
      "r96",
      "r524",
      "r542"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r95",
      "r108",
      "r523",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r103",
      "r508"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r516",
      "r517",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r468",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r127",
      "r295",
      "r296",
      "r297",
      "r298",
      "r467",
      "r468",
      "r470",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r467",
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Debt Instrument, Unused Borrowing Capacity, Amount"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r51",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r122",
      "r126",
      "r368",
      "r375",
      "r376",
      "r377"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r122",
      "r248"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r67",
      "r70",
      "r426",
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of realized gain (loss) recognized in income"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r423",
      "r427",
      "r433",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r419",
      "r423",
      "r433",
      "r438",
      "r439",
      "r442",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r432",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r68",
      "r69",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r416",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r415",
      "r417",
      "r418",
      "r419",
      "r421",
      "r429",
      "r433",
      "r440",
      "r441",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r446",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Derivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
        "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r247",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup": {
     "auth_ref": [
      "r1",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the segment that the disposal group, including discontinued operation is reported.",
        "label": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share attributable to Hologic:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r147",
      "r149",
      "r154",
      "r155",
      "r156",
      "r160",
      "r161",
      "r525",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r149",
      "r154",
      "r155",
      "r156",
      "r160",
      "r161",
      "r525",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r135",
      "r143",
      "r145",
      "r163",
      "r212",
      "r294",
      "r299",
      "r350",
      "r351",
      "r352",
      "r371",
      "r372",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r447",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r448",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r315",
      "r316",
      "r321",
      "r322",
      "r448",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r315",
      "r316",
      "r321",
      "r322",
      "r448",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r448",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r447",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Payments/Accruals"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r422",
      "r429",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r206",
      "r207",
      "r216",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "verboseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of Fiscal 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r235",
      "r237",
      "r240",
      "r243",
      "r509",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r240",
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r235",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r315",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency option contracts",
        "verboseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r122",
      "r287",
      "r288"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment loss"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r230",
      "r231",
      "r514"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r101",
      "r125",
      "r177",
      "r183",
      "r187",
      "r190",
      "r193",
      "r208",
      "r456"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r419",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r122",
      "r244"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r129",
      "r177",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r11",
      "r12",
      "r13",
      "r254",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r364",
      "r366",
      "r367",
      "r373",
      "r378",
      "r380",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r144",
      "r145",
      "r175",
      "r362",
      "r374",
      "r379",
      "r544"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other activity"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r156"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r92",
      "r171",
      "r466",
      "r469",
      "r527"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r106",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r169",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r189",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r65"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r44",
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r43",
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r105",
      "r170"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r23",
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r24",
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r125",
      "r208",
      "r456",
      "r519",
      "r537"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r56",
      "r125",
      "r208",
      "r407",
      "r411",
      "r412",
      "r456"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r53",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Trade Receivables and Allowance for Credit Losses"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r30",
      "r285",
      "r517",
      "r533"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Petitions filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Dispositions"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Disposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r64",
      "r125",
      "r208",
      "r456",
      "r518",
      "r536"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r119",
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r85",
      "r88",
      "r94",
      "r123",
      "r125",
      "r134",
      "r138",
      "r139",
      "r140",
      "r141",
      "r144",
      "r145",
      "r153",
      "r177",
      "r183",
      "r187",
      "r190",
      "r193",
      "r208",
      "r456",
      "r522",
      "r540"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "holx_Netincome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "holx_Netincome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r300",
      "r389",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling Interest, Increase from Business Combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r177",
      "r183",
      "r187",
      "r190",
      "r193"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r76",
      "r78",
      "r404",
      "r409"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r404",
      "r405",
      "r409"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r74",
      "r78"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "totalLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r425",
      "r430",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Amount of gain (loss) recognized in other comprehensive income, net of taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax",
        "terseLabel": "Change in value of hedged interest rate swap and interest rate cap, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r86",
      "r89",
      "r91",
      "r95",
      "r294",
      "r458",
      "r463",
      "r464",
      "r523",
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income activity"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r89",
      "r404",
      "r405",
      "r409"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r86",
      "r89",
      "r404",
      "r405",
      "r409"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r78",
      "r82",
      "r83",
      "r420"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Loss reclassified from accumulated other comprehensive loss to the statements of income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r445"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.4 and $1.2 for the three and six months ended March 27, 2021 and $(8.1) and $(6.4) for the three and six months ended March 28, 2020.",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r21",
      "r228",
      "r229"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromAccountsReceivableSecuritization": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Proceeds from Accounts Receivable Securitization",
        "terseLabel": "Proceeds from accounts receivable securitization agreement"
       }
      }
     },
     "localname": "ProceedsFromAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r112",
      "r345"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r113",
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit line"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Repurchase of equity"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r280",
      "r281",
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at End\u00a0of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from a business acquisition.",
        "label": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition",
        "terseLabel": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition"
       }
      }
     },
     "localname": "ProductWarrantyAccrualAdditionsFromBusinessAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r49",
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r251",
      "r538"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r99",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r81",
      "r84",
      "r91",
      "r458",
      "r462",
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to statement of income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount",
        "terseLabel": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfAccountsReceivableSecuritization": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Repayments of Accounts Receivable Securitization",
        "negatedTerseLabel": "Repayments of Accounts Receivable Securitization"
       }
      }
     },
     "localname": "RepaymentsOfAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r115",
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayment under revolving credit line"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments of Long-term Capital Lease Obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r358",
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r122",
      "r256",
      "r259",
      "r260"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and divestiture charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r257",
      "r259",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges [Member]"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r299",
      "r353",
      "r535",
      "r554",
      "r559"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r135",
      "r143",
      "r145",
      "r212",
      "r350",
      "r351",
      "r352",
      "r371",
      "r372",
      "r550",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r93",
      "r125",
      "r168",
      "r169",
      "r182",
      "r188",
      "r189",
      "r195",
      "r196",
      "r199",
      "r208",
      "r456",
      "r528"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Changes in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Assets at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r423",
      "r433",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r235",
      "r239",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r235",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r25",
      "r45",
      "r46",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r53",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r100",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r177",
      "r180",
      "r186",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r177",
      "r180",
      "r186",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r328",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Utilized to Value Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r164",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r166",
      "r167",
      "r177",
      "r181",
      "r187",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r521",
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units (RSUs), weighted average grant date fair values"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r331",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based compensation, stock option outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r326",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise prices"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r338",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Period Increase (Decrease)",
        "terseLabel": "Standard Product Warranty Accrual, Period Increase (Decrease)"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r164",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r199",
      "r232",
      "r253",
      "r258",
      "r262",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r62",
      "r131",
      "r132",
      "r133",
      "r135",
      "r143",
      "r145",
      "r163",
      "r212",
      "r294",
      "r299",
      "r350",
      "r351",
      "r352",
      "r371",
      "r372",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r163",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r31",
      "r32",
      "r294",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r32",
      "r294",
      "r299",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r31",
      "r32",
      "r294",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r62",
      "r294",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r31",
      "r32",
      "r294",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r37",
      "r38",
      "r125",
      "r204",
      "r208",
      "r456"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Hologic's stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r125",
      "r131",
      "r132",
      "r133",
      "r135",
      "r143",
      "r208",
      "r212",
      "r299",
      "r350",
      "r351",
      "r352",
      "r371",
      "r372",
      "r402",
      "r403",
      "r413",
      "r456",
      "r458",
      "r459",
      "r464",
      "r551",
      "r552"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r465",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r465",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r465",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r206",
      "r207",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r61",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r61",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r32",
      "r294",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r61",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 40,682 and 37,609 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r294",
      "r299",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r369",
      "r370",
      "r371",
      "r372",
      "r510",
      "r511",
      "r512",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Amount of unrealized gain (loss) recognized in income"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r359",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r148",
      "r156"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r147",
      "r156"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r571": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r572": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r573": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r574": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r575": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r576": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0000859737-21-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-21-000012-xbrl.zip
M4$L#!!0    (  R!G%+N%8G?=ST# "(8+  1    :&]L>"TR,#(Q,#,R-RYH
M=&WLO5N7',6N+?R^?P4?SZ<7H0C%C;$69QACV.R#;38VBPTO>R@DA5W0%Z_J
M;F/SZS]%7XSM9<#@ZLK*=($Q=<G*K,HY0YI2*!1__[_/C@X_>*KKT]7)\3\^
MA+^Y#S_XOY_\_?\[./B?3[_YZH//3OC\2(_//KB]5CI3^>#GU=GC#[X3/?WI
M@[X^.?K@NY/U3ZNG='!P\9G;)T^>KU>/'I]]X)V'U]Y<?YQJ3.I*/0#-<(">
M\: E1P?D7<PJJ7HN_^?1QY52HQSQ %#Z 2K5 X+<#F*.B=1Y3IK_CWPL+=@)
MM980,V9.+6 HE)M/7J-]:ESV\9G].ON%QZ<?KYZ='9PJ_^/#QV=G3S[^Z*.?
M?_[Y;_;\;X].GGZT.CY<'>OXQ1^=K>GXM)^LC^C,[LA'WD$\<.4@P(=7YWEV
MNGKE'#^'OYVL']F!#C[ZG[M?/>#'>D0'J^/3,SIF??&IMCY\]7/CE>M/AH]>
M/]Z^[9N/_J.OZ@]\>OFB\NM57[YB^NCRS>M#ST\/'A$]>7%LI]-V<>S5&_89
M[PX<_'HCWG03H-;ZT;-QTZ_/^_CD\-DK1]H+)X]6_#<^.1KG!!=\?O&C3T_0
M0_Z]VW1YQ/4'[%;\]#M'C[<;G;ZXJ:*OW8QK_.V-?_^!'Y^NS_[]?MB+;SAT
M]>RWO@:$ER"[/IQ/SH_/UL_?_&6NWGS#59[]V^]]Y;Z/=R\._?B0CA_]XT,]
M/OCVP8<V")3DD[\?Z1E],#YZH/\Z7SW]QX>W3X[/;&@?/'S^Q.X07S[[QX=G
M^NSLHPL(/_KD/_[C/_Y^MCH[U$\&C@?7>/W]H\L7__[1Y:G;B3S_Y.^R>OK!
MZ=GS0_W'A[(Z?7)(SS\^/CE6^P*K9Q^/ W5]^7 EHL<7#^W]>V9?UBN^O/ZS
MLV^T_^/#552',?OH,5<,G9K3CKE5 A_L//*_GXV;XZK/![]RZ)B.QJ5U]?$M
M,UDRS-;GA_3HPP]68J>4\,_G[;.3IU_Y;YY^'^Z>RX]WGO[P1?WQ_M$WJ[N_
M?!_O??=MO/_97;CWRW^'[W_YP5[[[U_N?W$G?/_CE_[NT;=P[XM_/OXJW#O\
M_I<G/WW_XUU__^$_#^\_?/3+O8?L[OF[WEYS=W]Y_/B>__+YO1__Z_#>PV\.
MO_]G<5_Y'YY__QVG>W:>[X_^ZZ>[#SG<]7?QWA??_GSWZ [<_>Z'PWO^FR.[
M]K,?OOBOQ]\__/ZI?/'YJGWQ;;K[\*?XP\-[1_>_^Q;N?O83W/OLVU_N/_SI
MYWN?_?#X^Q^_]_=^^?;G^U]\^\S>N_K,/^U:\?B'AR?/[C\\/+1O99^W8QY^
MZ^X]O!OO/[SE[AU]OKKWX_?AWL-;^,/#.S_?_V=Y_M7#.V=W'[AG7SV\];]%
M#:F:_4&B@ <H"0_(93[@Z+75:,;5P8>?=#H\U;]_] J$-XGHM1_Z?'7*=/B]
MTOIS>^5TC^T?8?O+R]@V13%/ZP^B2#M \.6@H<L'M74'$'KNZ#[\9-S_R:#]
MVLY_(GMPWPI<]S*X&;@+9#UHV=4#K#$>U-+B06A5"4M5#/[#3_[;;Q':.\?F
M)Y[?-G#7=/CEL>BS_Z?/][#^$:SP,JS:H]G=I <F:,P>1Q:3RQ@/<DZEY=IJ
M9OKP$V?_E%ASR#<.[Z7@M$\_._M8+"8XLC,^%GK^,O"WS]?K5ZSUG6/YS([=
M8_]'V/N7L8>6@N^>#WH0BY<4;'"W /:7KUILA$,('WY2#WSY,ZAW3 I1H74)
M"(%,.[88[;S8Q3/Q_W[Y^EB^B@$^_D:?ZO&Y?F,!SNIX=?S(C/4%&RQNN=\.
M5X\NXI [SYXH6ZCX<'5DA]SO#^S5TTX\WKNT[C Q#>[>KD=\]/GQ_7&>7QA^
M>&CO&63W?OEF=>^+_\;[7]Q]9L?_=/='_OF'[[['NY_==5^%;QY_?_3L\+Y!
M]L-W/SS^X>$M;Y#YNS_^]\]W?SQ\?._''^R__WI\UZ"]^Z/\>._A]_'Z,W:M
M\Q_\M^G[[_[K\(>CSP_O?O;#X=V'WS^_]]FMY_>_N^/O'=EYCNX\N_O+3\_M
M>\.]'P_[W96[EF4__Z^0+SYV/B#-9@,(X*!&<@<A@FK-SBFE#S_Y.MW],S0(
M31RX'C)$Q%9+Z00.4Y(42TUE3X.=H,'SEV@0DB]],"!4,AK H 'F?A!"[>BY
M@6]L-(#O_PP-H'B)&8P-23!3-XII$$[)W$%,J>YIL ,TN'?[)1I4224JZD&J
M7@ZP9Z,!H!RPJ8%2&BB$^*=IH-U.@3T4(L'*J25R#ID;,6)JL*?!+M#@P<M.
M(7NN;-*,&8P&.9C>[PX/&G"3J-F!IC]/ ZD^0 O:Q'"G7EST+EH $6+/4M.>
M!KM @Y>U@<GU!E#AP)0[&PTL4FA2XP&5')OC[E+]#1I\]&HN;JU=3;2SGKXA
MA3A2BQ^?7J2VC2@?7*0:/SY[_L0(<+HZ>G(X4JP7KSU>#QZ]DBW\V[-3L5-\
M].HY+J__ZT6OOL/IR?GZXME%POSC*W)><N*OA"O7)]*+4/3ZV4K&\[[2]0<7
M7TC?."MP^\O_]VID]?J'/[E^Z=6S/[E@\O6STS-:GXW@YY/+A*[)]1>G^O6]
M%U]3K@^% Q=>.O3ZG>OGUQ?YZ)4;=7V>\^/5Y4T[?4QV4U_<AB.ET_.U?G)U
M^8LWKT]Q_=[U\W&.-^*0P4G& CDHH6^1LLMVKYVO+I+6<F4DT/L=N/V7$RMG
M5W<4#[Q_<:*K=_[D'3V_8/.KM^QJ6N+C;Q]\]J?O)E-P''IUV<*Q$+&24'0H
M%1UK#>F2U>!WFM7@M\'J5^Z;3QQ,O&HL(ZTIK@0MTB-DXV-H',=],[OH?3VX
M, O!EQV[;U O[EM]F_OF+NY;V<!]$VQ1/)++%D6 3RVK=*[>F_ZWIWAYW\R*
M[O)]&U;TYN_;RV/>Y,F#82Y?W M9/;7?\/*A%YZ5SD[6?]$\_-OGQXN?Z?&)
MB:4WG?9MC?@KI_CHU6__1]8IC1D@8@L%BT<.6)!;L-=2[S5"?#DNF)XDK]KZ
ME^W,G[/UK]P!T!(\28[ &9L&BXL\)1>[R^H"X<4=&*HC[=8=N)0::0-W(!:2
M0-67YA+V&H:_)V'M]H)%HGW<@0N+<>.&XHKQ^FA,&%T^%;O8LR>'*UZ=W=6C
M9I>0E;U[6<YR'9P\.!N):OO,G7^=CQF)DZ,G)\?V]/36LY6)H^O#[/6CD^,'
M9R?\T^6Y_O[1&R_QXJZ]^"9_"IHK^U4V  V5U*%J""79\'2A*3<+XON(WD(K
M83'0W!)9C2B1#K^FE7QY?)N>K,[H<"8P1:^DT#VAF++SQ490RJW9( +#"GDQ
M,'VC9Q;^J]RA]4@"G,X$GQI]EEYKA=[0U'>A)I!=K%%"3G$Y%NX6\_G1^>$H
MY;M_]EC7X[BU/AYG>ZI?'O/)D<X$,M]=SSP*!X$Q!VDMQ%#8%'\"EZ M!K*'
MZPM)]WQ6;LDQH.E$LW<1M5$M%I11RX&]EZIU>^!,=@>BEAR*+U4 777-4X#
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M?:#P:F/ST0MZ[BAM-:?QMAW7+]M8;T("8LZQMNX[P- 92#$Q@NNQYQ:!='F
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MV$(^SX"438=P;RFA*'85W4=].\R8B>:%4FQU[+G4N6%,K:(-_:"$N?O2Q,V
M,7L',B%_&!DIYE8< #;LQ%UZJJ6XL=$ S,'B[,W!2SNS91];3*E(4*022XS0
MI6C+$$K*>09Z8,<<R!?/CQ^<KQ^-+[!$Q<'-)Y;(O::"('4LU)2:R1<T_H"?
M/V&F73.Q</I(=MQ5+0SQH['X*%*1'JOOV=[Q>6DS7@M'$WETW&FN:LY82JLF
M!QA;C[VW&,(<EOJ_K]YCHD4VK36+5MD&?$<T 1FJEFJ1:^K4:IA#!>7>>TRX
MKX!H5'(EU.(Q%4_=HI!86@ N[.L<[,T>S5\["P:0)HF9H*,B-DA82(2QUU;"
MTG*1#W[20SVCPZTD(][";\U2<4!(:C8@.B;!Q+7D(@#L+81%W_K2].-6.?-^
MS("XG$HP&>)B=29!7*U8 _<4.+96VASF7&^,0?,$%% YF1;HJ8X>>04Q)'(!
M8H#0@BY,%"S,C4Q4?^9!.O<R&OY@#US5UY0[*7GR[)>6Q5ZT&YEH+: Z"(J>
MQR(9K8E0DD"E0"[7,HMF0[OJ1B9J!J01LAN;.0 A.VG K'5,I@=*%!:0V%YJ
M3-"].O6-*<>14>(23<KUJ"Y$:0;9_)%[/Y2Y9'$28VK=3"IS;X5S;KE "+EC
M6L#6/TN54XES;,G70C6CP5:#6#A% "4Z;&X.Y?P[-@*GZH&%W?46XI#%+A8"
MBY!KR%H<.PSETI*Z.E]+NKL=%-_JE^W.QL*#=77[&WQPSR%JSS44;&/!9 [4
MJ 5S_;XVG#]!Y]*Q<4_7MZ&K$;$G9X*F>U1_$5RD%M$CJI829T#7/7LF8T^Q
M\-,''QSVBNA*=4BU,I :?:A?)3:-/;-557MOO#FY. BZ[2QJ[)XT]-@IHY=,
M%7*+7%1RKR_V:ITS0??>>$%TS6'4J8?1K1G0]TI<NRJWEBLD;# #NN[9,YVQ
M<R(M%4A&&:Q:+.CH$,7U9.(NA 6$'LOUQMO?27BB>".7 /9O(BS8)1?@4B#4
M&,A9Y$SSY^C[XI#?%\8"1DI=/32H2"DW[;Y0ARQ0&Z<^ \;N"30I@:H## F
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M[;UU(!/-8?HH*<M0KAU;*C4B2:LY4>V<06; F+T#F;)F>BRJ-]NB/45$H19
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M+*CGW"0W2-Y&8<-,,H=:T%T!<*)%8CYA\4*M@<<*A81=<LB>DA,(<UANO"L
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M?<V"'GTSS=LIF-A-DK7F/5=NGBMA)EPQ4P*.0N_5*X;4"B=O2D&KIC3ZM<Z
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M6C1+(:*Z+MGY/NIUKVQM"#M;2K4#L6TX")LHS66H.=J@:.P=:DPEA-%KNP$
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M_=UC[V^N=\M[;06$0B]9-3.,QOA2O:M.*B2 WGO5/9NWP>:'/Y_LV;P!-I>
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M:RG%%9^8QJX4M0@ZT^XEQUJ:7G9O6*Q+O7%,I_&HS4QN:C126!%[R2W745J
M2CX$D;)HC[J-<3J!0VTQ0TS))9\9V7$!9&SB8\Y=$[=%.]1MC-,I5GXW0S1F
M]>9(T4&IV<21IZS P\O6D3D9?7AW;WB*KC[^2A_1X9V+[_-2Y["[JV-=/Z6;
MS!*,+E3Y+^>NSH]7E[?_B=K%[->\N+='2J?G:[W\'=?O7I_E^LWKY^,TOV%\
M?2B^.DJUCV[M%$/HZBJZ!LR$%P,UN>#PX/K!'MU7!V,:(\SA6PS&UP]]%W';
M7"M@UE5K0)9J3I, 5&NOG(G[[B;7?P<NE173X2TSHX^-SSR7E')FN^M01#UW
ME%*H8,L@/7M(H?4PHT#CEIU!5H?GP]T]4#Y?7R11[SSCPW-1^7Q]<G3[Y.C)
M^=E%[O5^OT/KX]7QH].O=?W@,:WUT^=O/L%KC1//3OBG<1Z[^L6)OCZD&UCN
M,GVTHH"C=Z(-SBZHK8X8!1)Z3B$)NSGU!ELJ,:8)>4PS:2RC/YRY6,ZY>LQ-
M4O7J%:',*8FX5&),$S>Y['(-:727%RRCF8GKDF,,"&(/849QTU*),4WP1<5"
M9VJ8"IK>ZYVT<&L12@ZNUNO]+/<:X_HBWYB(7*_X3.6"(M]:_'/ZS8-OEZ@R
M1ME\+QE<#H+>*YGQL"@@^FK!>*IS:J&U7&I,M/MCDI)R20S$J 4*IA2C(G%C
MQVE.[;"62XUIE(87GSVQ4U?[V,F^QJ2UMV1A28+&<^H+NEQJ3*,UHBM5$TN2
M[K%1*+F4[AIT5*YTF1.<B=;X\IA/CO2!0:_CDV^N&KM]<GIVOS^@PX7N.11*
ME-KM+P"S_R8+DIB8=!R:J01M,]('NP7G1 W"T=N(%!&4BBWVFGMNH=O?N2+6
M.>4.=@O.B5I,F@PC%C.U#*A>:*RX]([)&<1.YE1ZM%MP3N,[T160-)H:.T*7
MM02+V5L?6Q\WN^EQ:;[39)'2FA_?LENF3_7PY,DX]JI?P1*]:6B12^XUN@08
M76CDM0NV@2Y&S$OSIA,"/(U_-</;0^'.Q&/C>ZH^U0!4"L1FT?2<-N#8=8 G
MZA")+C&TBN0"0BL5T L&5T1R$Y^6YG&G'<$3^& #4=4&;Z9:$"R$32W5XM@B
M(!R5A4OSP0_T\'!U_,CPO4OKG_3,'B_8 1-)X.1CHQ0QC4U1"XX\)T>F,*\-
MMW8:W6F\+V>?HZL.M"9,I(T4G;B<+,0MJ<^I&'BGT9W&]6*VD9M*]!W&XEM/
MD5HI%B91XTQQ3DGGG49W&K^;!8=R]BVIHH1H0U>QF]N-%C/%.J<ZN+="]PL]
MUC4=&KJWY&AUO#H]6U_4B2_8^8[T<<4XZE/,+F=H.OHZ@$@THPTTI[GFW8=X
M&@^L(_G8$F(H9.#VEA5B#\U+<-2Z+,T#3SV*)W##9I6#,,38>\<2M>62U'%4
MUTK/M2_-#4\]BB?PQ56YPUA+AX$P&9(4N''QG%%(69;FBR^FY\_Y['QM&NOV
M8UH_6N9D+OGJU74GY!U*=4T@,[M,B4MPI2S- 6\?UVF\;I$LT%JJ)IJ1P=?@
MNR3 3$A0H"[-ZTXR7J?8?IG ]2[L4R,,E4B+EM%(,A!A](N+>"<9KU/48V/6
M!JUH!8>U8846&IMA'CVM?> 9C==;HS'8P^=/]%4D[QP].3QYKGI1[G936Q)-
M/T!KUTH2I%)43+&3"S&9\?7)1F<I<ZJ_V!4@)U*\E:J4TGP>&0K30I!;-&!C
MCY$2SJ ][Y3XW4P';]\TFT+%FC,VNV%.4@@TUL5"]W$!1O(]*AAO,!JP4RJ]
M1>RMU<[23)M&9N0^JY8>NP3F-,;RPBRV&#,%BS',.I901P_*L><#2)E3DN\W
MP/Q:U_UD?739,)36RXPN&,"94!D5P(*82@&OVJL/U0/V,*?H8C=@G&CB3#5"
M3#XD%Y$J$E<>^YVRIR:ES:GD[#48+_MZ7,Q]?DJG*A=O+W(H!G60$T.2R*A=
MFLN*7 &"X^9D3@F<-V'X]8-O/U^KWJ;3QY\?GOR\1 2;K\EBB&9C,&.IH5:/
M#)Q)4XQ"<;[&=/L(3F-'4RY..%2@#$@^4D\E4Q_[@=O8+#1S!+=L1Z?!L&=D
M#56ZLDF:[HIF ;.CVMC9_V>PY_>;H+,PPL;?W9L()FXD<H\EC<Y^%NMANMCK
M*(1.Y$ TM%!Y!OLF3AWC;0J6%PT KR[^YOY_#R[?O#['V[?_RS5$2I)K H3@
MF]/N6S+?%UR/_UZ0EVX>\)NU4FE#J_9<;AK(>RR*$;6*C+T:H/68H$N?@=H[
M79]]?/OD^/3D<"47$SE?GNG1:XO>+[J:7IWRSN'J:'6YU\<2U5_ %IIYF=8"
M8AO]_2N- K<XUO+Y66B'G45THF4@F;)3A^S9(0J6HHK57J \^L'/H51BEQ&=
M8ND[Z["S,2EY]!$:=J^Y9-6Q(I/FL+AV9Q&=:(L<'641S32F-@S5C09G3DLM
M,931UFH&B/[:BNZJ,.+3\]/5L9Z>7FFRT^UVN)T>4X+"5*&,$F*,PK68M663
MDY1,)N$<[.X.8SI143@',[C522;!BIYJJ3HV&M42?9"VG''Z:Y^*]9.3M1VZ
MQ"$JWDF+&'(U\]O,D<;1/29D"N9'I?3E#-$MPSG-Z(PNU@*8H@JC<YZ:XRPI
M>Q[31[-J)[Q;<$X3BA+E$#4 C&E @[25YE5J0$D DOT,0M'=A'.B?<A*=>G_
M9^]-F]I*DK;AOZ)@YGEN]QLNNO;%/0\1M,%N.AK1!KE]PQ='K4982(PDC/&O
M?[..! @,-LL!+91GV@;IZ*A.95U796;E$J5,(06>R_4*;9T"N<H0\K8Z^[[4
MVZA!:VW[J=L;S%';!D($H5AB[8SBW'&;8,,+TDA/C%;2S'XGX%F22XV]<'ED
MS%,;B;9<@56H TW*YH27Q!VVBX&7W_O1#H9_1-L9[L\)8/+1.-..2$$"CR99
M3!15GBKII?56+P9@GDPP]2$F"!.X3R"8I'GN.:,E4)E45H(.J,D<A#[?1C!O
M3[L[Q_U/V=B>$\!87(4>Y&TE<FR5]0YSE910A#C*\&( YJGD4N,. _IUX@9P
M8A47@EI-DU62<J.LBM@O!EYV/L=.'-K.7.TQ3.* <UN+0&#KY\DD3'FTV$G!
M.>%V,2#SA**I$35!!2V-2(I*T,NHUEX8S&V02D6Q 'K9$UBCCX(9*:.B01"O
M\V&*<)HIIX,&2U.!V>GEW&/F:053'V*DIU@I)4$G S)+R>$<G^BL<()1R^:A
M(%(^KSR7SMO8^]2W1_O5><<%FZUV.EO#_=A_W3ON#OOMQ2R\$#SV E.7C"+9
M"G718$^-E$Q(,%/#'+C,9U"6T_&7&VPXB42%&!./3,.N%HB51IN ];CWR8S[
MRV=0EE-*@>)8>&Z,Y-YP8:FCWGL;<!(X$#"_YL!9/H.RG%+L=]0FYC 0C"4/
M/FK'!.,A:ITTYSZ,%9D9%.&,!0Q<UF8FI?, ;48[8YS3"K1,PDE0L.M1P4';
MA*T1=)PYT/_?M+OM8?RK_26&C2Y,PZ>VZ\35P2 .![^?;MJ#7O]UQPXN><]'
M!;-C:$6_W^UU>I].Y\0H2!+T_:"X--SD8IS.6NN#$)98IR5/LV\4S+ZTZK,4
M%+=2)NFMQXD+YVUNW">T(,$HY\E"8NOU\6#8.XS][=BIXAL'^^VCP6N8E;[U
MPWDY1&1"$$T)%<PD[F@$181FM5(8(;6D;A%A-D7!U8BXP*,$S3]K_YPQ94AU
M)D\"D5X[D18,<6<?:O5MB$U[^!@*Y*, S!-%P<".W.72E<DY4/.3$L"01!'I
M_((![(GE5!^>-,$:>^,H8Y@SG?+1O7,1M$10V(DR"XJG9B]7Q3N*P[CZJ1\K
MU7]>D"4E]51Y'93!'/1$$RW3EF'@P=QEG"XHLIY<8O5A3$3!04/T21#"=8[=
MQ1%;IW@BEAC)%PQCHW",L2']5]OG6LWS BY#:6"!.% %050JF40#]YS0&( 3
MR:*!Z^E%5:,FZ',#586!!@GP(#$V<*L!3E9X,A?1,W<7U:K_[W&['T/[_');
M73XGZ(K"4!9C,"D?K*EH5+01-'?E"0->G(/ FCD167THHPG[_$?):'B.OE$Z
M1F*4X(G;H!=-/ZQ$5B5R=FWG&,BPEX8GMC\O(04TL<!UBL:!(N\BZ!C),((]
M6,LA1#\'83BS+ZWZL.6X9X[)',M&N-#$)J6D3XQ[A3%/<Q#/=@\GE#UJ#VVG
M_2V&.<.62T&+((AU1'*.E09*!&($,SD"1:8YR#N8?6G5Z-? V(%DHL0\=Q1-
M+A]V,>H=%TXF/U;D<[CUK$KK_$QR'12(X>EK,'Y[W?A=<-6J]\>'QQVX-K3Z
MMCL8^797P\'Q8)@__<CRRF$@M<1<I0"6EU12)3"6>71!4 MPRV=>C(_+@"^8
MO-9B L,K_!Z[\,/P[PY(;^[DIC15C$G--?,<I&-%M!@VL* )"2S%193;6]ON
M_M4;#)IQ>%:6\8\8/L6_@1Y_*KB[L+7M^K;M;'1S;XX\PFOJC<3!<!O&!$0]
M)PLF$!Q2SI+%(7).E0'$,U!6=116)$+*@GF2!;-S,C<KAC,)1!($3B%PV,_!
M#E7*<4ET<$GJ>8J3GNFMO#;'G!'86$&"#)8SJW0$_2M)8DCT2@JRB/*:YE9>
MF]RPE)P)DPQFG,2@': ,,]C0'8U2S%.>Z#PS\^-OY74M&.R!F+W%B6+#E0HF
MYF:SF( RZ#T-<^#.78@%\P1;>6TGH<G :G!1<*RXQ\(YPC2-N:\>$U3).<BL
MF?D]??HY-\Q2'#AQ2BCX)R6C'96PJ1 B#=>)++24GU@3F+ZT@_=@N5%&LW0]
M3EI@0'5*6@/WD_FL,3?/V\&CZ _37V8R"8E3M(ESR5-0&O13(GCTTC@EE2K+
M;!&TCNFO,Z4U5T31%#CGUDF7_9B.X*A29#K*.4@RG#<590KIAS@(KKRDFL7
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M$"^H7NAU-IUXU.D(F@1,& [::.U!VLYZHZ1B7D?JH^)\CAH]S9H*^BBMGU+
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M]\EB;*NZ?J2&FKVE7T!]R/Z[W_O2'F1,OW"Q&U-[^$O>U1_NT9E?;_+TG39
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M2 W'$XI2$,Z5X('ZC'91T+ZX:)]. $U!^Q.A_6)OMU8G[$5 D42&.&COR%D
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MU8UA5G6<OI1[S,X]GENV)&P/H]3'6R*AI$%.O5S33\\&FY=$MS&67%$ [J0
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M0#*F<B#"A$2V=MFV4FQM29M-:?J%[MZ:&A!T]U7<?6XB47"!$.DA6!%!>&_
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ME::G! 7-!(R/16X[2BSUTL5@BMPV.[1%U1[H\DC,B!*BA"@A2H@2HH0H8<"
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ME! E1 E10I00)41I$U"ZU\K%-^[T;(32J^Y@..I.3ILME\-A+Z81MKY<,J7
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MOGX^+KESU'.#^R[SWSS*:W,A_XLSI!NC\VG!;PK,F&->DO<^S^>8*7$V*6?
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M;SW$MX+(VQN$WG%=RS?#4;W IY/)J.N/)Y4W#X:+F1,)<GF"G%7?>J:92BZ
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M6[!Y\V D]\F"J%["!2%1S')SPV>\XGO-!1A.'='!E*9)1A(+EI-L?.EB2EF
MC+01;MW%<F&-6=&IHNL-J(+$DLZ-5?D_>/DODN[G$GA(UC&&VP+G1H%ET7H:
MLG$TBA_M$)<G,G^[0S1'T;Z_053.?-T-8I+[]P?=^_#V/</-@2H1<4= [@P<
M O&6&Y(#"I!JG1+G&UORDO28"A!/%"#J!E'E7^5?Y5_E7^5?Y5_E7^5_TSL\
M0.%7Z_!Q6X?3B(K8.]P3[Z,7DAH+) 5E"2@GB94!B,I&^4BCLA%68Q[6RB:+
MJ.E_TF"( RX1E1):[+?#,,5Q<*6H[.!9JYN&3<"E\;ZW/K6'Q\>I$TO0LY5.
M3CN]\Y1:0_<YW2P*\]7$U3X *XRS_#F5^%RARQ%N-IT 1B_\VNL?NL]_%;GW
M.F6"!S7:LAA<PL5HR]_OO4_22@\$=).6+31QP#)Q5&MNE7?&EPX!WQ[)J'T]
MUEJ?:_>5AR"E15+ E\Y-O\+<$2?]&GBOPMM*3Z^+MV^G>+O_XN5[*Z.P(7L2
M+$\$DJ?$2.>(= &T%TF*'#>VZ*WJZE4MKEA;I52E5*54I52E5*54I;3.4EK$
M!@A.T""RI3H*$!*LBTY2B+84O+!"51M@/6V >1?U'U_>T\Q2*#T+@B[EM3V:
M ]8X1:1)0(W3*22U1D; D\GJWYEKP=AJ-PJ VAA3OS4\3C,7\^C]:>_&TX[K
MWG?:_\.#O75.['\YEG3SH5=C.;]",5=_\X+8)^?]S?LOWKR/V7-.5284]S("
M5"3BF>8D)X%[6K;"!5TZTM[Z4&CM"O(0R&:5TIJ@[CWG0ER)N)5L+@RX\P[G
M\)XSP9B3@63\C8#+EGBK,V%@LI3*\6Q*.<E-7@'W8:ER!=PJI2JE*J4JI2JE
M*J4JI6H(5$/@HB%PP>LLWR?#A!$:"),A$Q!1$Q.#))1!-,8D 3JOFR7P9+*?
MF_5./"[V\J GIZD[<&7N:R9SC7I6*54I/3V6L!T_G V&)ZD['!SVMG'FR@A<
MYY5KQ]WNCCMM#UVG"=<TH+DSAYE_IO^>M0?M87J=^A_;(8WHQ9\I](ZZS54:
MIE$)Q4*$(GRZX%D\?/F>&II#S$"<#(E $))8K5@I;BR]HP(2]^7HP-(*?%:U
MK^!<I52E5*54I52E5*54I;264JI&0S4:YHR&>2_DFR_O*83@O)>$"L$( '?$
M2*N(E)(#M\(S:M?.:G@R&;#[:=AJ=T/O)+5^ZO0&@V_RC6MDI<:_JI364$J+
MH]&:R^<RP=1UO43RM;3#1,>]SN?GN'.,-HY*D1:C2)]GS;^+7_7->ZMSYHXR
MDL%Q AH<\2IP(GQ26>#_:/&K*F8OZ1;W>/#L46KGH]MUJI2JE*J4JI36Y73S
MM-OM1;?0Y=W+=KM(6G8;TO([VKI- \C+/SF8M9"L]&9A>C/M"5D\0.*]LX8Y
M*S)!889R^ID3X[4A29O,6$3Q6EE./\M;G'ZN:O[XS8ZI<L\K<57/Q=5SWD$K
MWP<J+#,JD&AM)L X)<XPA8:(]-%X85-QT!;S ];(_'@RB:+-+M6DB/;3<>H.
MVA_3Q&-;A/"Q/3RO.:,UL%BE5*54I52E5*7TD*6TB/7,8\[<!F-U-("7LS$;
MRS*/440&_#JY%%=8SPWEV)EG'#.^/2D05GGW8KS['#GWIQGO?OOY?79>2<4B
M4FYI"23\#5>R(C&G9+(7C"E5^E9\FQ=1*P.OJ_Y6E*U2JE*J4GHZ4JJ,Y3$S
MECE/X=LO[WVB3"5'">,):0M-DM@8,V%!J)""BH&)-6(LC8OP'\,2Q,%_8_OC
MUK_PQ^36XU4,?%-+7.FGO4&3]?N\GSINB OHGY_:<7@\<7?/?7%TD^=T]A7G
M![W.V?#JK\R-.Z028EJVKC+Z(V7E94QZ*H9F-N9_'O<G@SEU1XGX?G)_$Y=Q
MK,]=YY,['VS\X\(CG;2[Y*LI_/KIKWS&G)?RC/J29QPM$<2,7K_)\G[>E',M
MG\(QN;492^NX7Q#Q_[2C%\K*9(V0&G107H P3GNN>)*0W'N]L7585G#I@[93
MP+0['/SK'V[K,DG.B\?UCU!"X[5:I#-^I;2MDQ?WE.F2;%1EMLR;-G<X51UW
M.DC/)[_\,[8'IQUW_KS=;1ZX^=(EWO+Q<K!V$^V;LB+&SOKQY<>+9;-9+%^A
MPO@]N2F9OO)MNLEN^)X4\D;?_-Y@Y:9A-QW/JL>J-H%>_>ZZC=4:\T#&:C;%
M@UD#J)4/9E[5IK+P0,8J-ZU\*/-J-RD\%'PUFTQ?;SQ/YNC.GVE:D1ZY09@K
M95^SZ&MN8952E5*54I52E5*54I72/27#7MK:)M!(>8:0*2BP+GOIF G))^II
MB#)=H[5-[O5/W!"O]7GXO'MV$GO#\?M?^\4/^\D-SOKG<TW6M\-_S]K]%&MG
MF\7<X5]^/WQY/N<.9^_!V*BC ^(8DP3_,L0)JXEB(09CA(=<*AL\4W2=$F>K
M1B_[%,LM]?F;_/8+2MM4(9GH["O7;_[>2\/C7JP!K<4UF,YIL'BO@XK).$Y0
M+*C!#C784NF) YN2I<'99%"#.;U52*LJ;R5-54IKU0:U0NS=0>Q\SH!\GYTS
MT@M*DM>E"+VBQ"M0Q!IMHX],!9;6"F*?S,&B7US'=4-JN6%KS_7#<8OK9ZVB
M/O=]G&@<>1['K@7.9>R=E<CT9$K&'RBA[#+3@UZG'9LW'R ,+F8[<M IAY!E
M5!9_!9-PX7,(3@L>P(CWN[<V&>>[05<;<3'XHQ>ZGWYY^=[[K)D4D? @$P&O
M S%"26)0=MF(@/*+&UO<JF?&Z"75OUN2^JPH:W()H_T::^X37RY#^/N$E_^Y
MI]6SP*I9)]"])&?U9HA[>0^DXUX'YV[P$JGF\+QRRX7!]8\Y<-U[[R&@_2Z
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M$9,C<!=BLI%O;#%0MV<(M;SVVFKJTAE"U=0E:>J,+J LK%69$8_B)6"1,U@
M38+W46:5G(C%30V7%2RX/TW] 5^8Y _A8-/WE7M5GWQBSHTF!Y]X-TCE<4].
M4W<P(COI<_D]58?'JLA-4WCAER*(G3DY5+Q< "\/=N9='X)1Z[0@+FID-C8A
M7CK()!H5N71& DJDU'=9ULFSZOI8/RU=.K&I6KH,+9VQFJ2M<9(!L3%H DP
M,<4=DIFC5";-N0BHI6*M(N]/S GR(N74'SD]1E$P]_FI>3T6J1BR!&9P11FX
MB2!&<?A#]_GEB*3]DKHIM]?G).2#0*'Y,(D7P*6'1%06R!4D=<13DXG"'8-J
MI!$L(5?@XA(G2&T"]QAT=@D\H>KL*G1VQAR"X124L02,PQ_,(K^/)A(!7G,0
M7N ?&UL F]\65EO'KF+5$W+/<+$[C>BTW&"0ABW7C:WTW[/V:7%CMMHGIZ[=
M;WX-: ,<W9 !/06C:\DYT%]2OQ?=X/@;'W.1TNY4+#LCJ51 720S<02F(R*T
M_3YEF50RAEA?:HZ7/KA&&$\$,J!L/#?>JFESU36RQZK79,V])E55EZ.JYU-5
MS5)F3W,@68: JLH#<8%I(J2-*EA#%2V=K^@E[&=M_2:/@ (]=$>/'[9P>#CT
ML_;@N"$[G=[@B?EZ5L=TKK8:?W/M[J <M$B#@^[+"Q(YR$5,%3L7PLZ]>9K#
MO-8076E#+22!)%TY?9$) JK-5E$*D6UL<7;[R%!U^:RMZMZ2XUS31JEZO'0]
MGG$@EP1E.ANBLO4$1-#$12M(Y);B'UH!34LS5ZHGJ ZX#K@.>%T&_-C<KTWQ
M[9:;.X19_*\X(:0Y;=D>II/J<5U]R+D12RF\BT(8A;#&\:M*7!8A+A^V+_I9
M350J*2(R!P(^ G%>EY,_5HF8DPI*;FRQRUH[5B?K8]'9NPLY5YU=FL[.C VM
M?314&@(R)P*AM NDR9+$HU L:9%$T5FHB6KWIWT[QZY[A%=K=^<K,I38PXA-
M=-K.MSM-=89GK?1Y7&N^A>K2PJ=.83@]XC<JMEUK.%QK57(Y*J^]QBMC.X32
MSF50RGJD]L=2IO9ID<D5)S!>W)!P$^HG-T@OTNC?W>Y$'G].Q5'WIH7VIMUY
M/DF=\"I)C7L3L@70+A$'/!$A*8^04C NX]ZDV2;<OL-9Y9)KJ+)+C]A7E;T+
ME9W121&YYU8JXEV)047!B,\"5=9J'H)F-#%5VF)]6_OA7A1VF43R ="%W>['
MU!WV^NUZSN%>:<*<'"K8+ 0V%P+>CAF=E:#$>,]+#U1-#&>*.!4MHQ*H-G1C
M"]2M&J#66/?ZJNH*Z$%5U5NHZHP7&)- (<,B.9M43BTS8D!$PH.0JO1=$LDU
MYR%O0PQ6%\M^;'Z$5_UTZMI+. GY)*R2%3"$L4 .BR J[BR$.W_,4P3)$1)H
MT(2*X AH <1+GTET06J7!8!/#47X-B>N>A >@ZZN@")47;V-KLXX@J542LB2
M<*-05R5H8J-.1&3ALE/.T00;6UQ?4D&\.@]6QQ'&%91&H:?>*+VEB455E\+]
M$X;)L>QQ9'R[&YNH>7-0J8+38N#TYD)NBXY6*^6)\Z:477*1&,4Y22(DW$9H
MH*(TDU:W J?J:UA?'5X=D:@ZO%0=GA$,+R3R"::(@*@)**0:SC)&6- JY@0,
M!8LZS/2MK('JA;AU-L.I.W]ZJ0SKQ2<FLG@U$D6%G85@Y^T\=;"@ *CC1,72
MB"U&3Y ^:)(#9!6--CJ56G"/L@O;XU;9]2C%5)5WZ<H[%[B@3C,=!+%!,>0,
M-A*7G"?&T9PES0PEMK$%^I*<]NJ46 EEZ)^E2YT2<UFQU3.Q^A,VEZ)2D=7O
M,[E48%H(F,(\J_"!24VS)4Q'55A%)-YR2AB7PJ5D!?=B8TO23;8>MDQU2#QL
M0E%5]Y:J.^,4*H<4H^;$!1U*<C/2B90081-SSL72,C4UJONM05#=$"NL"]U/
M'U/WK+HA[M$-,9'%GR-15-19"'6.+A &S4T, 0@S+A( _,TR\$3( ,D&"M'D
MC2U5O1"/6&-7$,2H&GM+C9WC"3R9Y,"1F)0GX)4DC@M/* L(NR8QR2/RA+72
MV&7Z'X1>;Z*P?]V>Z;?Q/_A>/Z8^&?9.GY=Y&?0Z[=B:/-JC!JLEUUONGIW$
MWG#\_M<XAJ+<04F^&@ORE_,W@U+;_F BS.VI+"N@+01H?U\XL %:"^ 95U8I
MQ,RI)Q[E1Q@P+66""-%M;+%G*,[;%WA=5'\>D&/CZ6+"T@E,5?R[4_RY*B.0
M+9/2$2JM("@^18Q7FOBLLK0L62M*:5*QO-JD=Z[V2W**K#._V=W_S\O7A[O[
MO[6V=PYW_[-[N/OR]8TJAXP?_5HRN5%)D.O:?W<RR"=6C69[5DBFU)7Q9P/\
M2*D$^ZS534VIF8833UK*U]C;RMQGK]QY4V+PL+<]FOQ?IK+!;>X@EXUN_$ZL
MN]DBN]F7K_J)!&.M843HTK(Z.D.LL9'DI+.C&7]845HTT7KP^)&J[M)I:%7=
MNU3=&1&-/)J,\$IR]$!*6AZQ7 GB#&,L:6E\+ND\HG97J^5]K^L"/.WW4.!Q
MT,K]WDEK@*HYSXMJ]/!^VJD=]SJ?G[\:B^97E,QK%,Q!GN!J!=&%0/1"W94L
M0K *)(G9%!!UEIA$!>%HTU-!K>?1UGYJCU^#E\:"JJXN65=GA"<8F3WSC.C2
M?AY07L19&0F7*4EM@$%30Q'X)0<7'T<4\0&PB!UWVAZZSBB+.;:'9_V:LWR?
M?A.$HE.<F_-7'=<=;G?CRTF[W(I$"R'1A5(L"#?@E))H<%%D#1PH\0F!*7)F
MF5"&Y4 WMB2K)Z@?J=[>O=.DZNW2]';&(*355FN;"8_<$1#6H=Y*62+WQDL#
M3@9D^]P^D$/3U65RWU'%<<I@:6<PZT./CY?ZK7 VP''A+V<#=Y1:[JB?4J/B
M3\N+<B]L:&2$32%USW7/,MX>N>@41M\4(>V,9?2FB&A[*J$*L0M![(7B,DSZ
M+!Q"; K4$["E"8OVG&0.BIJHHU>^J7QUFP,AU9&RODJ\9$]*5>*5*?%<VU::
M%$/H)5':TDXILN(5941Y2[F68'6638E;N1Y*_-AX4AUP'?!#'_!C<VR^.NN'
MX\+U>QGI_N"L[[HA-5M?@;[JXUP5JQ^+H9>G0IC*H&[Y"VSY^R\N)H(!UQD4
M(UEPBEN^*]6EJ272NRQ%H,PIN[%U65)S]6@^!BU=,FVO6KI$+3V?:R.GA4(U
M)9*E4KK56&*#"(0Y&@-83@4-:%W?JHE<]5\^&?_E14XS3)U.0@/;=4H>6!-]
MJ+[*U;*:@[P[)X9)#*@BYD*(>2'!BUGC;91 *$ DD$,FEE%-4L@.N#-@HBRE
M(M;$DU'=D6N7U_7CS,RJO$M5WCD_I.<>_Z=(UL!+G9=$K,V,H)B .F.B*RTX
MUR\[\_'SGH?MRSD8M?H8G8>^&<EY$D;A"JIB-:+8[W7#6;^?NL/:&> &F'FQ
MNX<,SFF52$BY%-/TCABA$XG"6TVYE)31TK;X-H2G.G+65V=74!>KZNQ2=':.
MYW!A(T4E-0F 0 B1>&,$R3EJ&L!:(WUQOCX,M\Y"U.K!%,;ZZ6R02E?1GR^4
MR&IW/Z;!,DID+5*RX7$"U]W5[[ZB,,[N1':U,,X-0>Q";Q!G17)*&\(2;]J*
M:>*B!9(5-=8F%;1!8TUR<ZLRWHOJR0-RQ#PRW5_#4EA5XY>@\7,'\A"G?12<
M*"8R :,E<5X+H@1'>1H)0JNF&]"M*V&M2NN7Y =99T+SZ^[^]O[.$BIA+5*=
M[$95K*YK\MW)(!^_"^]AAR[_3*>CU. 2N^STND=DF/HGN"GX80U:KLR?-Y7"
MX"#_CD(X1!F\0!'4776A7?5"95EED\[2,R)Y+"TU4B8F9X.+AY7^>C1;Z7!7
MU35D^4BU=.ELN&KILK1TQGV9IH'[ $0GCMR7!4^\!$]T8,9H+T)@LCGGM 1C
M=XV8[4.A!Z\N%K)*W7:OW^KVAD^M&,7JR,%W*N TL[]?)K\BSB*(<[@]SPL$
M9XYG6DI514K &46\3XX("-E3'Q.*;&/+RLM*==ZL\'2-[ZV?EMZ2'"Q<::[J
M[LUU=ZY6)^/196I($+;XQA%#2^HAX0PEEX)/,8FE)3*M::3O ;"&"TZ%6Y.&
M)V&L+)4U3.?_(%?@N2GP7#C6Q6CD1O- LJ:,@!":6&<H\3$()Y0-/!LD#?IV
M#3JK-^$I\X6JM<O1VKE\(# T9\X(@JDAH!4EA2<0GWUP JE$2*;F/=>\Y]MY
M1?KI8Z_SL>0NA7Z*[6&K?*&Z1^ZGQO>T$."<\?5[*1E\D'<:Z50\70A/+QP"
M \>H0MDA 5* /R00)ZTE*O-H/;X&FJ^C^56=)VM%ABXIVUFU=5G:.F,_H$TV
M1BLB3:FN*_$W([PCS',6LPU&"-C8TFOFZ'RRKI)1N<OED8D':Y6M3R9&1:(;
M(]&%.M^2ID"5M(0YEPA8#\0 T@B;03 (AB*KV-CBER)1]9ZLJYZNS_'QJKQ+
M5]ZY8M^14V-,(-J82"!H4V(NC&2@D08%)JKED?Z:J;$<GX0+ 1]M.$ ^$5+[
MH_.=U!JD<-9O#]M?7*.NTTK:U56Q/JZ*[;'<_IR*[?4%J54@6PC(+ISH1JN'
M>2THX>6L!20=">Y#B=CDA- >LH98O1>/7ZWOU'M1%7C9"CR7_>$M!$B*T,08
M@6@R,4H(XIP%S04H67)%F:K^C/7Q9]PY$7D*YM.*B,B\^51Q;*DX=O&$-T3<
M?[(BINGMP4PB'B6)MA5N1,K+)/):EN.J7I&'=$*E:O"R-7B^ 1I308(E@F5:
MHJ&&&$$%T6 ,3<)J&_E:.32?FC-DKB OSCUIBF;W.IT25RD%>OMI4-T>]^WV
MF+4D:G=[B$OGKX]=/QWW.L@;:]K;8N@4YOE% "NR9IE8FD-IQDZ)R=P3DYAR
MB"A,+9%?5$?'$^(756>7J[-S'0DD$@BE@4B?2GZ5M<2%F(AE4:"]X'W(J92N
M6Y-.R$_,J_%J=IPEIISZ_11;KC08'K0;'42M&[11!1IB7=T8:T$L?NWU=_#N
M.)OXQ\Z\@'YO.]_N('C]VNZZ;JAUK&Z.84?SO$-[JGC6CNC(- $I!;'(-HBT
M"G@1-#6Z^C4>J)ZO ^^H*KT:E9X[0>.TUH61>*/IN'- +@0E.A]IIA 8V]CB
ML"D>A)^CGIQ9)R+EAZWV8' V;@ YJ,T?5YCG^FKJ)RX5C';'8M@I4JAXN0A>
M?KA07(2%E#UWI79G"FC&(1GR3 82M!(T1QV5X6C&B76QXZK+9>UR2Q;QG5;M
M78+VSMB.$L(X X%HE44IO>V(0Y#%/X7A)MO Z?+."]?^D$_&??1G.IT+2(7>
MR4FO#*$7_GY:OJ*U8#QH1,[D<9!W&FF\+L*HT+D0=.Y>J*J61!#*.L*!-J46
M-#&@!9$:#%7:2)X #45^N^8KU>FSO@I[9\&FJK#+4]@9U^&RJ*7@A J+"@NF
MQ(<I)2EK8 *-%ET45DJQ+O61'S_)>>"NG0L'D*:.G:\(3PL5N;PS; U[K71R
MVNF=IS1YJX-W?UH^H'LE1'/'%B8FY$%N OJ#-R5Y>Q=?Z [;']-V-S8O_X(
M'!%_3U-WT+C=7Q6)X<<Z9V7>&TP^."UO5#-T,6B^<%RZM--.@B:2@@@$%&1B
MC"G'I8-$R]28! @R0MR^'TSU)*VMNM_I*:6J[O>N[G,Q-D6IULP1%WPF*/%
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M^]O[.[O;O[=>'^(+>R_W#U\_N$?[Z4W7G<7V,,6?KQS["L?:7/%Y.9G6#M=
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M0G%HBD4?J2SD@Y?0HUA:#M.]5E^HZ/-4T<>@B5I\L\)+"H(C8:.4)XG6$(O
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MW./$:\TBH4$S DD+XC-(XJ*A0F<?I>(;6Y9MZC4ZH5M1XO&B1/!<A2A#MLH
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M=\A1NH8>%IR<O^& ?,TLJU$0[=>0J\+O/02HU-G!ZPY'G5>(6_&R2O MR_9
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M5$M+C%D+>%MA%8 6(EN(;-O"/2;TG'NI-'#GE,JDE+(F0)4E#N4;D3Z@3%/
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MQS[%(G%ZJ(.E*81<5!(0O$\J%0PG,[ELJF!<6#S7;\ZS#*\_:'ZRD-++7E:
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M?BUWWGZ0@KJ02L=,5PY!9J^( \&(IR 4"U;XC,8ROUJYYW]K3U,)I=>1J49
M' FN1MR[D8#PD3**;,8D@+?&9,<H*!65-%:9E@263@([YPAMW"&$&4V)B]P0
M .N)HTD3[ETYX@7" MW8%E>/EO_O9*/Y73>:&1ZE9KC?*H)VV26=1 PHU!P*
M.F7;C5[Z1E/D=85 JJ-S1#F'O Y,$DM%((RC8'-4\20<\OKU&RWNNM$I,XB0
MA7$N@@W**T<IA.!= %#^&NVEW>COV&BV<_9!V1B-YXEH%1T!G5%9@2C+\7;J
MO7941E/J^EZ[T5!'1^^XV=%RP;Q(/N+NNFRHY%3:Y%!9TM&J=K.7OMD<X=LQ
M XK90)QEN-G!>V*9!I)T%DG0:*+G&]M7M=+_+4HA*H+%JW]1MSNL+99>L5[J
M>%"YI;ANBM87NZE.QRSV^#0$_765MF$^78H<#H;=@VY_\O0Z9',Z"4D5':.$
MT\Z3&Y8(4"^-9NKLS+WH!Y_2D[+T7TQS+I^/1FGBW?S7Q$/:34_)SK\0G>V.
M0F]0',*35-91,P5K5,*$M5TR,X?Z54)\196_NEY%L>\.4[6BE7>V.^ST4W%V
MX]R_5$\I?LZTU9EM@*LW8)&Y=B7"?C7AZZ++JSBNSP;#CU4'/33&<%0E&Z9P
M&>YL;YYB4=MF5>P3WW5U-)/+?$*NFN41IGZ<9U=,[Z_CRYM%=3]+O=XT5;#.
MO9TQFJ_79A.O*;GAQU,?W WQU,=':;-%[LT9;>&^3[+XIL17H@ E:W3JSJY6
MU<5/-3[F"W!9101OR#^89JLU$L!G@9'-.O%WDGH^,<0V+V<>-E(HZBS8RG,[
M"?)/,J)*WOWQ:3BLP#8-I]&*B2MW\TH*<.7.G^0(=AO3+N.I;<'%T]WJO+PT
MW"OK6;D7OIIO6]/W%>](4_A,<OJ6X 4IUVWB3HV[/1Q_* E)PXZ@Q<7([.8D
MY?M3JM(0=DID")_V'/\\3%6RU^0Q#:9MTE-Q'5X,@=7!M<MAL.K:6>BM9%F2
M*K.I^?W@JRAW33[6?#MPO^[BJOS.6BYW<5E.5^\OW-<7$T*<2L#SF0(YG="3
M]5WN[#V7;_;^_+RS]_[+[M&?9SL''RSD")Y*M HD)2!E)B;Q0&)T3"NJ/5")
MQCZ]ML#!Q)=9T=]=J.,[CW*WU''?U/%Y]^P#&@\Z:.F(]DH0L#$0XT4FVEIJ
M(E#KF4-;@E[;#V9*'=/$TCJOK7)4=S_766WED%H!ZLO1F9)+G:I >N]\<W)Z
MR\V27./EU+RYZ)LJ*$7Q>9=.QC4F<U4]F%Z+<G<AWN\LU=(2[_*-WR\XGK<?
MI,$-* 6@2P5Z)%@;B96.H@6L@I7!.ZF+^UI=6WK^6^'L.T]GMQ1QWW#V!86=
M$P$E6C*$<I\)!$C$A 1$(8Q%K51.$N%,ZVLK/-X=SDR-.LN',U.KF,LTNFKR
M^%K.(8B-]4BY6915N;']-_'3U$^Y>XJ<T0U+T#LN,N"_BB&4WDP/3_RKG#T8
M[>$;?NT-PL<?RV9T9\9FX>S]7^_QNT!WCG8/]X_>PNZ7WY#5 M\Y.I [1[W>
M^[V/7]Y_>2VNL-F77_'ZUQS'=K[#?SO>?7D@=OYZ]7GWR_OS-R\_GK_YZS^'
M;_9VCW:.8F$SCJPE \@DI2$^@R,@%)1&L)*($'DT6@;E? V9782G^+P 7601
M_PO6N,0@<^E$E"GJ!(HY!%&ZT4F(72>%NH:G:58LXWZW];<J;RBUFXJ;&AC#
MI8J91%,"1$9PE*8I$N"E\*,)1GAQ>5-#Z;1 )<L&;8=HI0^@P7&+Z"%4".GR
MIM8+/<7;R=YN7_W[&I [=L.#;K\N:<$OEL%9O<?H6K_M8JCZ^Z72&!,:^RI7
M7%QP0"7<<I:C#!E$#!ZDR]X:ZU20+-+KWO/UC;K$K6BZTQ1M$#(!%6"8M2$+
MX9.SC@9=MG(T0L'XO$BY(KA(I][<XG4:ILX_<*$/D&\GA0;JJQ?4!UGPR9-Q
M*R[>JF_=XJ]OV8MIM8W*5;S9\+C%QI'$QI'-S<HI51VWJV,W,S]F[:UL%A6H
M/&\'D\.)E<8S3Q9MG%6<GT(L!XQ*5C8IIQLG9_H:ONCK0DE%&[MPTG*8W,'4
M.3=UF>&%I\?5]].TJVN'6F;8*#LRJ?$QR<D>?.J.:A]BE2M?KIVF.U=*W/10
MV#3;NIY%Y8[+5<2JFE0=D:A\[J?#DQ*E:+@ ZY/5G]SPO)Q_NN!8+0>IITLW
M.)ED&<Z'F"[JD/B^QD6U2_22/_FOBC6;9W*K>@"U)SA.-O72.=$+J[79&94S
MA+,3F[5B7.K%3.EDYC^<G *?I?A.BCQ,U[G4>TC_/2V.341^,CW2>7PRZ)?/
M_I:V#K9F>_M332E;G7>7"&92L:81E2CV_N1\X>1,Z71 /HW/TN3T]F1FU>G6
M*R^OZBW,\M>K<WUDP<$^',Z_+LQX=F:_.J(ZJKB@?\<P^G>Z46?Q],-![_.S
M:G@3&W$>,W^3]P8HM":?KTT$?>5JSYN]M_P#4X%["H%$%HJJ(QAQ.0KB*8\H
M'JECU&]L7[40_W?A.=JYLWU*$]7A<P2TZ6'.&85LW486WL7<NTZH?:?]IQ;9
M?PT]3"U4PWZ4.0CW;@[^YKK#_Y1 \$Y=[ZC XNO^R>EX]+(.0>-GZV)(['8G
M''7\Y_GNWLZ7_=]W/^[O[1[NOORCNX^<L'.\(][\]4KL_E[^?D_?_+[?N\Q1
M^WNOV<Z7W8_O^1^]'?Z*[O[^S][^7Z_.WW\)\CV^?[_\C1RZ?_R?O/-E!W:>
MHR'AHTF:$:\%)26#D!CF%<F>*F$2ZC4V7M8WA?0N0O1>X!8%23U/$7762)W.
MD4EQV9 HV]"I]J'3V(@%ED63[!>J35]_\\61*N,%*L^EWKT&HZ)3 I5JU+RD
MR"(FMG$W3ED'@^6Z8Q1%2_RYD5LR7>I82<X_9J?ZQIW&=A1W:OGN=#@LHO)7
M-^I>GY2R3LMSZUR3P\J35\*\TTH<*(&'W4_58?$+VE51*895V;>JRE5="*<4
M#BC)*)W1F3NIJG"<N6%U;!U?V)^$>\/YI1#WE:]K7:]9>&JNHU:9*G%:>:#O
M>N=%5:JKY$QS$LJ:EH("]6'$[K#$\8=HQUTZ37Q30<<G>7!>M ?GUV,L]W-P
M?J&,^"KF7Y(17'I;- H!V@$%;I.1TBFI2U/XR.T=9<0/(O7:T"V+4((9:%UU
M1\V#O9,R(@-?,HBJY>U6>M#FW! J\/,OU(1['3YQ.M0&6B[BH@*I:5D_-*,:
M&#J'OGE!NHOG]Z;YG\WST--RGW4A252\3] $O=9>'I7*?J6('5ZQ.\ O;:6L
MY]-AY4(H"86G5;V^NHI:XXSXX#J\OQR>N5]-]%TX3/&TA_;<3">M1?;S?FP(
M[:G,?M.?">5*)E<<\80U5;%[\"&*%*RPIASD,P2<2L0Q)XB..J<@K(B27XE+
MK*L_^A;*7$7*S3RQXZ9"-VPH=',.K16ZX4RA\X5XZNS5*L_M2CUCO+L*A]9!
MU&F*Q[,I:RQW]OP.)_._IH5.M)(BAIL;6V_:)!%PJK]4I;5+W45W,DK/IK_\
M,NV>U^U7@ZANNEQ$&Q\Z$?-6;E%NBZ2?]/2;/'ZB!&Q52L"E>N#U=T)O<:JO
M_9INL6N_N^FQC&^AZ/RFQ][\G51V^8.%+2:N_[H=[/<,EIO;D<%7.E)>*C/_
M8_I6F%LU9UA<A?^)S>G:!J%,WF;^M67V8U;@BO50K4##,8%RZ8_9X8>711W\
ML]C'%U:G)>?UWLYI#KM;4.)C&63>:(%VA^X9Z[UF;T_1NHDU/?R["ES5OW?[
M562@"N"G^J.=RJ2K?T=[I_K^==4. J=2?UPKDM4W?ZM,N_IC]M,MEO]6:_JD
M]N;=O!]%M:1OBNU9_S8SJ^M=J$SK>JV;Z\[;=5_&NO_9']QNO<5/=Y$77^VC
M^!#Z>=4<_^PV=/:57D7?3X!+:'#>#G(-!_D5/KJF*7U[Y5>O;!?VQRSL5=[(
MU7\/"OE_^UK,\=8]ZQ9,_K$ULUPTQ<?3CM(#IRFKD(,!:;C/5/ ,.BI'N?;7
M%.>ZVJ3\]3QL/@M:S/-FUN7TTK>&(R8-* _$_EXY\;3_\4T).^R]_;SSY3GL
M?ODHWNSU#M_LO:;OC_[DNWL?OUQI0/DR]JH33\=OY>Z7/WJ[+U]]V7EY@/<%
MB>^3.T=_='?WWK,W>[MY]QW]/&M :9WP+EE#HJ")0"HU?U2P)'(7DBRU> PB
M%_O^QN6+4>Q>6X]?>N6M6X^WF/.P,<<9)W.0/MO(@67C(7@:M7 E-J?"#9C3
M/%SY)0T'T8T.6R2Z3R3Z,D.B; R S(QD#K2T 8^E S@E3E+GF-*6&BC>2<,9
M_Z5%HQ:-'@@:<2T -/Z/>0-14<.E-#)8%UBP+,M6 _H1N,-FN ,^&64#)=P)
MAKAC-'&HH)(@?$@F!I.\:S6@%G-^^-SN@#F@2B4+)[G5$3APGS++3MB@5-3)
MZE8#6A\D$C,D\LP"9< )U\Z08BT3STPFD&,JQ8Z=]VD=-:#65;@NKL+%0:)J
M4X5><^BNSA;>FGR_%C!XU++K;I-_-%+MVYN:M/+KON37><.7*(OTDID3JYP@
M()@C3G!*K% >;7I';8"E:-)WHO_[UK&_$OYL$:Q%L'DT1%%&G2@E51(@5YB@
M.*IYR2:EA JQU<O7!]?FGDF#]*N4C209Z@A0X8E7)A&MJ3<Y2<,$79I>WF);
MBVWK,^L[8)ME-O/$F3*6@LT"#=9 D[?.24"#EK;8MC[8-O=^1AFS!F^)D4PA
MMNE(?'".A&QD#C$FM<2H2XMM+;:MSZSO@&W",25TD,QP"AJ%?T!%SF=)M?;9
MTC:BO$;8-O>G)J^4CJBMA5PBRBX;8K0.Q+((03#N95 /"]N>0NY@XP3ZMZ6.
M3^;<V F!RQT'I^4<[E(RGK\25FM'^6!&^12.8;RH*HR4:H@76T?=%=J>@%[S
M.+67Y*3S,>G(K %/K=&")6>4=RSRF.&V?O,Y(;UHTM&+6>NAYZ-7_SWMCL];
M+>;[M)@WS0Q=%ZAQ("G1' P!W#+B4^DCGB5NJ:4JRM)"G&WI):DP#\@(:R%I
MG>9V!TC223(>8VD?G"$+95-.@2&I,\>R$>[[#*H6J%8'5',W>= 60M*6!)/0
MW(I"$\.H(CISS_ +;9)9MKG58E6+5?>-58RYG)-E(#@@55.K&&4B ^)2BI"N
M:3O?8M7Z8=7<[6V%2S(82[0W0$ [1U#'XD2"=Z7M%K6E8UV+52U6K<'<[M(N
M,U-JA(]!&P$"I)%>H7J%,&4"4'U#$*Y%I1^%2@V'M:0H4:PG2I5&2E(#\6 4
M\1Z4I;S*X%X[4^\I^*1?7RF_?:UGFM]MY@O1]4%#$#"6)3=>!</!1&8]>*JH
MM"$I'\(-IET;%;LGD-G9>UX IO8I/?\0#0M6)$-XS(J@^>V(E\83JWA(7 F*
M4F-CF\.67:-#!LN.)SQY/DV,&K1K>.9<0@C2*I0)3CD6(BT-:=N8]CIQ[_F,
M>T,Y".U,)-;J4GK:4N*-%X2QF!UUV:.ZMXZGA%H&7G922N3.:FV9E!R2M8Y+
MHP1'/J8)];M6T/X85MV="UKDTQ@2,X1E3@EH&XCQJ-Y'GKUEV0=*=2MH'SN?
M4B@F.2K!G"=00EN!'.I0%08IO->F%;3KQ+US01NM*:5(T!IG)356&5G:&C,2
M6&9:YDQC7E[:_^J.XSZ*G);?OMK[ZIL,]-NZ/Q\T'F47N(XQ:R<"\*"L%H$%
M46KO1,7,#7C4(L^](<^KIH'.4#HHKP3QOO@!B_+@%66$!1-1^]<:-V]C6VS1
M-7(#+KM:[)-GTY2T"9YG83@'[JCQ7'*5@6>9C)&B51O6B7GG:@-/EJ*%K@D:
MXY% C)I89QT!9G'SM$'5?^FG!5L&7D,&#E:G++@0@FF0TMGH9 H630!/A9$W
M.-A:5KU'5FW8YS(RR:VGQ#B'#.I5*3D(G%#MC<S*@!6NE;./G$UYBCIQGHL'
M'*SS)F5NN/((S\)FR5LYNT[,.Y>SGDH7!)?$,:8)I #$HNPE H3($93+-*RC
MG%U2O/PQ%G6Z>(YGTE5QP5&>6[>3>6RY2\M?H$<#X\LJ#C5#Z5MTPGWC<8FJ
MQ*A1B^1W0O+737=']EEIKQ')+5@"E 5B=!(DXX>6@@0NY<:VM5MJ25[6Y?'/
MFA=P;9&T1=(U*U+5XNN*\+6I*:OHC8*2,>(),!6($\(3DXR4(8*73"P[D-5"
M; NQ+<0NOU96"Z8_ DP;/D,(B)A:9Z*-Y0BFC!+K:2#)!Q.-,9%&5%:Y7EI.
M3XND+9*V2+K\REPMDOX0))VKI=*:@/]E$K/6!"1EB*1)$RZLCUX*J3Q=SFFG
MM4'2RO?[\[@TB\9_8_?3]M_QQW3@QVYXT.W7KS<7P>OH=#3NYO/ZHVZ_=%9_
MQG4%K_?$H-43GW7'^/YP,\OR2U6[.E.^Z;A^["#KE%7%/\:=PF2=BLLZR-6N
M,V.K3L57L_V\86'LCUZ7&U?AQ:'K'^#CNOW.^#!U<IGOIWJ^N3.<S;;Q^7&]
M5E6 J',Z*M^.NK,6XXA\\_;B^-326KQ3=Q7OB)\V.V>'W7!8Z#3USNOB3J,Q
M+C6^+%Q3]*G3FV_49B>>5N,I8QT?#E.J=FS4_=PYQML/.R>X"H,XZJ1^V< =
M-\27<;W9*9!:73KYR%0?T<Y9&N(C1IT\Z/4&9XWR;==LZ(03%:[M#;1?-X''
M':WX9L;E-:_BSO;<R2@]F_[RR[211K=?[4]UTV6NQ-?\<M:-X\-GUFP94<F<
M24AF\OCZ6[95?74)8.KOU!8#<^VW=(M=^]U-3Q5V2YKKO_[6QS*V!5I\TV-O
M_D[8;[NS'>R/&NPMJ>LK8<H[U.O[ZJ7VRJ4+U/<:!5:CIII+8*\7QS8KQ-RI
MD/)50<A;5*M\K&OQ#F5&M1*C!4NQ0E)JF*>W+<2ZW@M[4>C>IA[J5^?]Y!9O
MHIXL@ST?ZQ*U]+5D^EJ(>>IQ'<+YU?5</Z1BV?F$VGN_V!)H>]1F0]O*K2VH
M?ZW;SDO0(9;X!P2PRCG'@&N>11(BFUR?7::,<W5+M]W.W([^JSL^_+-A-[^N
MS.;BA^@'M'QKQ]U%C][4>W%>/>N1./6>G^V_?/5Y=^\5Q7O9^Z.W?/?H3[F_
M]UJ^Y_O'[X_^_+QS]%&\W_OU^+)3;^?EKQ]W]EZQG;VW;.?+?[J[+]_SW;U>
M;^>H=[1_O-_%9YZ_V8N'.[_OYYTN/9\5,%*AG'7ED<CD*0'O&7$@%&'1V42S
MB+9D\ABU!0^BW'[;2J1%OJ6GFTM@8++P7 ,([IQ1D6K.@(KL6*Q.A3"+R&=:
MY%M[Y*/SWLW&IV2])4IE3R '35Q,GJBDHY!(ZR+8C6U&EW:6I$6^%OG68-9W
MJ:.;4#5P44L6-/@D'*7<*2HSU8D*5[<AH-2V.M\#0#X^03Z^<Q3./L0$/%MC
M"3/>$4A*$V]5),QG5.%=<, BZGULR[3HUZ+?DT0_1P,#+\!!E)"\LT8Z[;P6
M@?-HZRKBS"+ZM7K?^J,?--!/?+#9R.BT)L:%TOC 1^(5=R0R[IG*U(5(-[;M
M ^E[_KWG$Y?1!>PA(-YU;;5*GL<LX\6%_YYV1]U%[;;: FFS0@E.T""RI6@J
M@9!@77220K1 0[)"?7@Y<09JLI23)W=$SFN \]^GPW#H1NFQY "N"#S/&^Y"
MQQ1H"YE(%1FJC1Z-9IX9R2J&P$N]Q&C7L<):6R)QV4XQ%00S/$GC$\1(C4@F
M9LDTZDC"!UD0H'**65+9B.*^M*26UY?+ZPT'F:-&42]($#H0T*E44U2,"&/Q
MC^1SYFYCF[:E4!\SG\M$06HN"[:#R,[3E$%[ZQ@7#E6F6M*C$=1*^L? _7,G
MT9>=+Q^"5($KFU#& Q"P41('V1&A:3+:1>7S\@JVM"BPOBA03AQ'#HYJZX!Q
MY76*.92> ['\";6T1Q1HI?W#XO>Y6^3+*_B0A#.!:B )]7D"X U!LRX2%C2/
M/G.M&5LWB?^]M9._R?GQ %._?IN?8'&Q',*I#K \L9K+?UNMCZ.<"\+?[AG\
M?G?=_K\&H]'K?NB=HDKVNO_*#4MF7XN&=T'#W1?-M"BF-><<B,P\$PCXF]>*
MDVA )22'4JEJ8YO!@I../[4U)A\#^R_!P=&R_\-B_[GK ]"T$< Y :Y1$4K:
M$Z^L)2(:9\HY=0^^*$*RY?['R?U+<'NTW/^PN+^1'W, '[+U&M#L(: I$(C<
M$8<;3U #S-P&Y5UI)</H@A!Q"P%K"P&/R.71,OZR&+_A WE]]D'HS)/7C*#.
M[PB "L0(%TA*1IH8<];2%-&_K/,0;0+(ZMC_W^Z\\GK\_#R$X2GR:9OA\;@R
M/-ZE\;A7EV9I4? N*/BNX?O@S" 9AE"ZZ D"03EB/"W=-GABD*2SKHWZ/%@,
M>)0^D);OOYGOYTX/X3CDDN]A<1\)Y!2)"TD7X\=H*ZQ7U):DV*LUW6]O\;3L
MOKXB_V&F>K2L_\VLW_!X?&0?E$^)LL ):GR)("5H%/O9$V9]!F;+>7_3BOV'
MB@-W$?M+<'VT8G_->;_I]. ?O&>4:XN\KU1 E5]+XJDOQV,X35Q8R3Q=(]'_
MQ$KUI'[\[B(]BTOHM@<:OWMIUAOV?V0[KO:XXX^"]V:!'^<-0]R-1$:J2PYO
M0K7.!,)= BM#8B+#<FIV+Y&K'L8Q\!936TR]&5-U$C;:R*,P D :+[TV EE2
MB&"\SI,"&O<6.VPQ=8F8.O>4H3UDK48DC;&D!^EHB($DB$Q:@X\V><%+C'#)
MM3-:2&TA]<E#:JNF/B)(;1PW>_[E ^=.IE"*L;G2539(($Y)0VB42CC*<HJ^
M555;7&UQM5556UR]"5>;WEWX$'R,0B='-&1%0%%'#/?E(#^3UC'<>"<?B[JZ
MH%_79%*[I\?(1.%[VE3!EI:S3E7;?_?#G[<?1 >LZHFW[PSV?#1*XSLT!=L=
M](=W[PNF?O2JW+@&>X>I\V)PC&\^[Q00JY9BM*!'6$!J=%U<AGK1REHU&G9U
M3D\&=6>Q02@KE(I+OW%7^E2"5UN==Z?A</:(84)H/CX9=D=U9[#TWU,$PDZW
M_RE-CFW6KQGT#TBO^ZEL2G7G)EY2DH'+-IP,!R?XCO/-SDFOM"4K-Y3GG)3[
MRX5CUS_H%J9L#/Q@,(AGW5YOJX/3QU%4W<'Z@\ZHC&ZV"O4(QH-%XYJT45O0
MFNQ"3[(:5ZXV)IM\/FG/L-5Y.>]VEKO#T;CSWU,W'*=A697<+3*ANG"SNF*R
M7?^O4&XL -%YCN,Z3 @6HP[28'=41.!Q&E=7AV$7']1U92(>_^SA.G1SMUK,
MR9H@1?0BR8-A9X3"9[,:YO@"74QYHO-_[B!I$PV*)PA<*@M.(#HGEZ(3B6KF
M @^3/ O%#;FNO&HSSZ)_>AP'X\GWEZ5QQ<JO<;C=8=F@%X?(?P__E'PO_>./
M\_V_XHGGH%!\HDC<_?B>_]';X2A:?_]G;_^O5^?OOP3YOO3&+'\?O87]X__D
MG;WP>??Y!\H3%9X"$<DFM#82)9[)<M8CQ]+3.4N6-K8%W>)7)&('L:97=>4;
MC"HFJ(F@HHN*:CI%))X4F.PB/S2PHI?PAC 8U;PS2C6;=9%GD-[PV](AD#6[
M"R(J(!/M#L:IH\N.=XIX+(- RN[V:Q+ O[8ZMT%;QG\TW-Y1"+U$]L8UQK4H
MS-X4.?A7M^]0<\1U>-T?C8>G%X^R/P:94Z79Z%^0@&93[<ZGVCE&V3'O'UD)
M%#<ZK "J^J4@,U)=N19A*P14TO N)-74K13PS0787?"MR 7$?'SDT"'9C<[<
MR68AO3.')([_XFC[G8D<JUX_+GPQVKSZW>"D@L'&)3C^TV$5TFY\.!O;B3NO
M>D66*2 /XISF+7LK<803&P[/BS1PQ_4M..OQ@A6[VTI45UX=Q0G*S\\(J.,B
MRQ+27H.1(_X?.;B\>W0X&(X)+MDQXNYX0JOXQ2@UMZL>_^5Q?MM25^/]ZFI7
M.D2SJN5\^ L7<[J6"_;HRJ,JX5F6=E2]'77Y^L&;17 .RWH7G=&?=WY__OS?
MTX:GC04=71G,5)[ZU.LB#(XFK[BZW051"X(2%.*'@[A0,6KL7.,]%\&A@'K=
M;O6THK +<#%A2>"5LO_+R: N!OILF'IX\:<T:4,Z,; ;-T[L'3J_Q7FT;D['
MU]^RJ&?JCT >!I<6J/'S<#COM7:0B!\F]Y&XC(-]YGIG[GRT\?-%N$6LO;2&
MEZ=_[21S7LHDK_3^PDG6(!\+(5=[_NRTD&ZY"L?DUF8L'=2<44G\GV[T0EF9
MK!%2@P[E/+HP3GN.NJ.$Y#YH%!@56"%CE,JVM0QTVXMV<EUU@AN)\N^7N+16
M5;GTMN0C"] .*'";C)1.2:UI<5]9-%^G@'$Z'J&54YE#U0(O%!><,M-Y@9#5
M'7>>'Z#94G"D\S?$LIA0^!8H2[W!V4]EF>^BY4OF5/8L22HD:)HM=4[8; )#
MA9_EZ]K<FULH]X>#WN=G_T;+*'1/7*^>[IO\ZV X')Q=. !JGYIZ?W0 NV\_
M.(9V5.*:4";*L27!B8U:$3 \A9RMTZ6Z-UMPA+/C)]J].T!2."A"Y&2ZSD6\
M(0TLM%]11(Y._5$*XZ(9?')H5];MOQLBOI9@TT^\JXS[J0P?HTHW_)@F5]:F
M)KZO&-X7C-L;9>1<^6@H3[<2O0UNX ;-CGX7S8UB>=3Z!GYJ+WYZZ&+C6:.[
M,H>VW'%DX"!U!L>HL0X,;I&*R,<0S/5!O%M;OB]1B9Q;!S.O]-,U?;^\$CL'
M'XQ3N.B1H>FK2F$CGTIE$T%<B#I0!T*RO+$-?%&0;6;[%IJXRW8SD:(*!@#0
MZ$[!NZRD4I"3X%E$Q=OMOI?M?O/V [?:\)P3,49H L):8BPH8C-B8TI)1(O;
M;06_P=6QB5K]Z 2Q#97?WOGF#3@X [7:9D(#8N*+[(8":L-T@D]*51'^SK^N
M.CS04$)Z*7)Z4+L]3.7VN,X:*)\7J!V<CBI_Z:"?;C +BU&YM4#SO\YK<'?'
M?TU?7U/;)-]HW'3C$^];[5JDFFYL_TW^U/G[A9#)$HZ)76367T]'^-K1"/?(
M=_O51LS=/7OXIE][@_#QQW(LVYEQ[*O/NWS_X_LOK_B;WW<DON=\9^^WPYV]
M_^!G!Y_?_/7Z[/W>GW)W;__X,L>^WWLE]H__.-K9>P_OOWP4NR]??][Y"Y_W
MUQ]';UZ^DN^/?CW<W?O(=H_W\YN]MP6@::):.8.P3(,DX)0E%DPFN)#1>"ZR
MX*F&5Z3A%)\7<)1>9FXREX%ZT$I:R5'%X> ,7DP58E]"&#PI5#U$3-R>KG^G
ML0&C*W&R6W&&OI$M%FKP7Q_MQ=GEF"%818VS'D GPPUDO(\Z;JGB_EJ3>HU\
MG(M9[;=9"(-UGL_[CESORKS]Y+X2G5P'JV_QFOS:'2!\#UU_,"J!FZ>Q%(L-
MX#?]SF_)#T_=\+S#>2UC+UH#1>SUTCA-X@]S$BI2\-)*;G9>]\-6YV\;ES[?
M^&FSCBYT3B95E&N!?6>=7D<-W%&O8P+)O$.H0MN:&8LZ2$B^D@N,<L[)])=O
MUO86") 7S8X^>SB[$6H2:-:S=5$!5RY02F[)[I?G.+Z#\]TO'\_>//]@F,.]
MX4"X,@*%"QK%WJMR(B1Y;YP'FA!..:J#5RL;UKK>1"?<NDI=*+)=H<1NO_,.
M>>5E-QT,-CLOD+-P6_M=MXDF;O\TX].J2/KQH)?":<\-.['K#NJG=-"T+$$S
MI,;B9AS58>OC-,9?7?D^%-_TL#9*3]*PT$MM"?><KVZ>A+Y#BM5+9E&X4.42
M71GU_RNJ[6FOUAI+P'QJ,U<^[Y/!<#*AB^'EE[,!CR975=;^*!U4OJ,\'!Q7
M=\3B/\ '-_FRC+Q;12 ^I7ZQG"^\ZJP[/BSKEX:?"@>6BZOQ3B^_.I82 BH9
M--72EU6J_5>5JP'1H7[&Y+&CR6,;#QN<EO5O1MKPKYGS(S8OK31ROG5/@'R_
M"N>[<(@4T4MO<LEC.>@C",?795A5Q+_.=ZD$, +&\W[\USR! [_#,<7*T_I4
M-=/+0+)[\(%EQE*(GD3(I4!JTL0Q08D*K!20=]I(N*S')0-"0W"Z=).(+)D$
M658B@T=#F;^LI3X,(5V\:.,!:GR7Q>=9R2/I35$13=HKV(/6<*][C/(+Y?L\
M':< Q(0TIT[$!:DZS1RCIMG=*2!X7+VRZ9^K;?8%VD1Q,J9Q@=SQ8>WIOA6'
MU]&J;]2X)B&(2;SL4DQ^%@>;@.HTME8E#>*F]MS)*#V;_O(+PM5)SYT_Z_:K
MK:ENNIPA.!Z<3$)0BF\9)4ML87)Z?/+X28!JJPH[7$ISK+_36U;9:[^E6^S:
M[VYZ:AF/%$M_+)=;1IM;/?8KI0.GRXO8G&[.7/^^*[^WB\-#2%!_X4:'UQ8<
MO,<C $\@E?]QIN3[R,#2 )FA-/4R>12;F8'B(:.NSOS$;;[ D/JJM715#2K
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M6%(M,=>UYR68H]&+AEWSOGSPSNN-TZV#?2H\Y![1H229R?(%&.D(WAAK+UG
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M7CL0;SR57HX?L- ]DE73K;!69I6"X##B+D1D#%=(N60BU5$Y(PI1W%5,A#E
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MPWQZ\-J0@BPX S*G!3D-SK6%=LXRQ6Y]KB@5"<9VSF*_Q4JTM%4Z1ROKA>D
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MZ;!)JE$MR"9_  H_Q(/\$+N']J3Z8!S,?/N9F>7V[B;>5RQXB!X(XBQ&Q$/
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MC)?;&[:UL2\M\XE%C@+V$G$O'-)<.^1I3%($$;W*9/7+Y33J1;=6.^/XO:K
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MM6R'@D?4F 81,;@:KP)$E)%#>L4,PMQ()GPR3-C%$66K#B:KLH[]!L%;"<\
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MU4PX$[Y(\_Q29*2_GF?FISL5]MF1)F">+GS7B^WX?=24=&'TK8YO#PO? W+
M4O:!._+MXXZA$SJ-E\G9SK?>\'C@3]<710L8R'I?@*[5GY6I]:E03;@B?S-%
MUG$OT N$+0%5+Z9!?LNT/^LY#BZ\.T^F^"//M@![GNQ(^@J#EN4"A$I@Z';[
M91SG@&?^91,P_1['<G)=X\)L39N5[NYXST;G1W\8P[ ==]-6Q2F5!5IL4;!
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M"TNE4S$D;RB5N6Z0Y'=HZUECWP-AWXP5V#SYXHSRD4:)(A,$<:(<TDD;%&4
M]UCSG.^\S.:?]X]_)6[Y[X&%AVZ.!]T$ONFU/'P.K>^;_Q_\,Q[HD>T!<U5!
M43P/45^'_4$KG59?M3H!..\5504D'UA,:=D*Z.=M@!W;\X<5Z:E:;V138[TQ
M.(R-U]TC&-1IX]"&1G<XZ ]L)Y,REW>[ILP;W&X'C9/8BXU.%]9C(GKYGL8A
M2%]L6._S1D1^(#RWNGC8ATL&W=$5J3WT@Z'-K-'/NQ)Y3']O?-R ]6VW;2^/
MW<.RY5T,^+,[[#6\[1\VG&W;C@<J 7F[1ZWJO:/;WPQ[W?*ZO_]OXSCSTGK#
M]N'=[7;^;YX0/")?#_/H]"NVO/1!ZS-/V8*5[<$BPR)NE]&M-U[;C@US7QS"
M"O1C8W\(7^9!_&&!ON6;V&F<M :'C?S#P4$O'L"[,NG@]1:&-MFR^>];(*OD
M07+KG9":<L]XWD5E\)U,R0@BR)?WEUF50(<C.X!'_!B\Z@R/0G<P^GV,M8?=
M]H]7@*FV&F"UI?34<;,=__>OT\^?PK&C7#;? <9M;^'=;<#+HS?PC!VVNWT@
MFG2?[N_MB/S,YMFWD\_OWN8=4;&[]_>/G;W]L^;VM]/=K2]<6)F<M<AYR0$#
MA4,V99_8,46E\EY+N;8)WU\:"P1Q;\.GC<;/"^G5Y]<?3$9O*55C\?PS"]9(
M*NXJ"M3C2!CQ1D22$VZ,"2  E()H"$Y,N(,HG#<[FMU:*D JFEDBP!J@7E!&
M,&+< _];CI%67B"BF0@:&Q*B!D^(751:IS$6@HE)4'1MOBPO;ZM3,=Z<]ATI
M.$XWE  E>-SMM_(UKWJQ75;GMY-6&!R.[=29&T?V Y[>8EV_VQX.+K]E1K-[
M4.6Q]TAZG+(% LW\>]@;C^;8'D3D>M%^ RR"P;ZR[1-[VE_[][SU J;+ @T7
MIW_I)%-:RB3/Y2W )"N3"62OVRMK_@K (?;R53 FNS)C:1SV,N#\5RLX)@%M
MC,XE%)27H'F9MLI12:/@T7X!$W@O&Y09REYGK.KDDB)V\Z*57.#W"D>B2L9'
MEFR,B8.I[;A7/K_*1RXUP6N7&:7RL6W2\L17K0&\WU]+[+7-MZ C.KX%X#_U
MUQI_]L!NZE0&R#S)YLSS)03<YF'^HP>]-VS'W30%_*U^/P[Z6X.WMM7[Q[:'
ML2SL'KSV]W;7?WMIN/_US0G@/B74 MH[E(Q1N7,S0> 72H3!_J34$!85B$L$
MY7B<D;0WC*O+L%>"[Q[8+<4U;+C8[IXTCBO.[!>#)@%+-+YGGLAR/F.O_2O;
M/V,&:J0)B[>F(8E9SP3NA ?YMNWW6PG\U (#W<IH&OD[C?YAC(-\\<7FXJO&
MO)R<I_5( V;(G_5AJR!>-<6)KBPNM\\VWG$_OAK_\5MH]8_;]O15JU,(56Y:
M]*WAH5.5LH$KM3+*"AH]?_3S1OEI(0Y0_2;P!B7BTI_Q!KGTMZL>2^2&UO2G
M'GOU;X)=_M*?'BS83,0\H<%2?J/'7I,F=HO$M2L2QRJ#;942,W\?R?''(L?_
MZ?IYY7;]+)\;00J(-<;X]8()\3$>#^*1B[T&E848>(X83SII^88["I6-]>I>
M4I*?1$;MTQ[D-2PZ-AO <(]7C^DI7UD3H29"382:"#41;D>$9W$N9.:XX>)^
M"[CLAU5"PJS[_W.VSC4I./4S[G(<Z8IR70QO4+'B+'C[]FS/U9OXLQ>/+=BL
M\<=Q[/3AN7G/L3LX! ^K(DJ.HV6'8QD$N7$:W$U+(:X<.6^>Z';1%)]-*IMA
M!/LH37)4<(*9-5IH%KV*S.ID\,UVF<]BKQML_W!QY^$U?/>VW3W)N6OQHB2W
M<]L03WWKN4ID.\J)9V]./^^])_M['\X^[WT@S:]O^,[9ULGGO7VR?]1L[>P=
M'NT?_7&XF,BV?[1SNK/W1WOGZS^'S>UFN[G]-]V!\>YL_]YN?OVGM4_?_]A]
M][FU?_1VOM"R")Q3S@W2U%/$C8](8Z&1L"&7[E18"K>V^3__I2FAOSV_8LLU
M0CU3A-+*.L*]IYXXSGBPQA&9_X_Y*$RL4L+R!JB\.L>VQJ+[QJ)I[6AA#"P/
MDPA'*Q$'K8*,]!:I:*VPEG)&E],@9H6*T3Y!R_HGF\4\,R_W?@WKFSJ$5]4;
MOX"H3Z3>^&T.53A/P#8A"B?'O;$:$Q>29V"5&N=#O-P2O2RI<0+DYQ)?:F2_
M!;(O5+>4*L28^WYAEB+B7N4#8U:CX'!@C@A%L%JUYE^UL"Y96(D*&)2\DDP:
M$% 05L4-Q4S%7'0[JIL:9;6PWH.PSI1LE$98S[% 4F&.>.(>Y0HNR&.>$A?4
M&I$-L>4=;%J%@F:/O=7\LR[JC;:HG['_>O/Y/QL<C5I;RT.DR6JNM;&!T\2T
MB0S4+%:B-GH>#4??S!H]G&I-,2'(:'!C>1($:299=FTEEN#.:L.6Z=#>6!16
M/.I60]J+@S1"G# ^\4@U@)E+VO)HO/8J<FJLU[5I^(B0-F,:8F>4!C,0L6 3
MXD0+Y)3 "'.7VVTK9YDMY3[NW'3EH3!M9#>.!S)F8%&=!5B1#?Q'>,8,X1<J
M#=PY0?-Q1_D2DHC_T[*NU6X-6O%NF<2K[ARMQ#->5E+7W,&M^=PN6Y6E2/EP
M6#DT7V=V/:G,+KJQZMM/[_.!E=@?-'JY;$C_Q!Y/=IY>2D;7EO>]89QN/-6)
M6W5:Q,T[* 4BE18A6FRYMP0<+88Y83)Z8P+6-XT<U6D1]^QT_3W7&BYB%YD4
MB*D(3E?R'%FL//(2)X&5\S3(XG3A%<J,J*&HAJ(K@]C))$^3-<(0+FFP ;M$
ME*8\4&N2K3.T5@:*9N(_C##K4C2(.B(09\0@1WU$TM D@Q5<^KBVJ9<6_EFY
M'*V79R,_06]UM^1AM;N= P2T.&JTI^&0.AWK?@\&!"&\U3$:SC4+UJLDG!3:
M>T:2K>W+50'U_5G[4C%#@HT>:2(EXE0R9)VTR&$7+#6*6V]RY;H+:GC7V5G/
M1G8]^(%1$V:L\!SGIJV,@6&6O#"<1'/C+;A:=N]==F<,,I^AUBN'&"$>9-<'
MD-U D/ ^!>U#\#KENHEW]PU7*%?KB5ED%W;*6XFMBSH9HT[&6&8][<N2,6;V
M(VNPOQ78^UE#C3(B$V4"R9Q5QD,(R.3$W,A,<CXQ9H(#L.=W-]3JC+(:Q)XV
MB)&H&;5!">(5=Y%9C*F56"2L(F:6WSZCK :QGP>QV1"BYR9%+)&(-B NJ$/6
MZH2\D,HF\#:#L&N;[.FED#WKD-K+K.I3)\'5%8'J_)'[,L<N;F3ULDRR&]+@
MV9AE46.66 K$I<0))P:LL&@-=Y12PA6O=PA6Q&;[-NMX$B\]#<DCG()%//>-
M,-X0E 01S!K/4Z2YW_&R$E!N)1Q/P_>LP>[E@9VQFA!%.:$.1"1)39*2$0?&
M6*0B7%&%J*Z3MA(0...V6H>3C(8AS)D "(P>&4(EDB$&P$.;][J772GM06!P
MON?GI._8;.?/A^HT-,?1_?<=WQ["(]YWP&8='@W;V=LLJ1VYM4PO'H+]6OC=
M=X]B;FG[TKL1_6A^^,*X=I$)BZ2(#L&B> 3Z&7C5&B.IC@[;<,-N1$2O?#NB
MU&T#N^3(0]6U9ZXET;#3BS#R,W!V#G+KU%_:P"._-GK1=P\ZY6OX<FOW]?M&
M:9E7-7O,-[;F,JB 4E5UI];YQ*K<0'(P-XY>/.[V2A_)8YA6-\S$06[=C.A\
MKXY\)'&UVA-QL:'IS[7FN::)CI3RZ73\>3J#-1L UT]HK.I!.BF9I]DO9^^P
M%V-C!ZX[[#?> "2'930/>J+$^-CZ<3DIEM=JZS;;":M-L%NWG5I:SY[G1D)]
M0;.JFM%J1GL01GL)!0VV)MW0+S?E1]579WU#^#H[A^N-3BPW#^R/.U9$>*9M
MR^I!/E #N&=7$?K\<:.[9!0_M_CW15-\-N'M&&BB/D47F>/YY$ 4AMI$#2;4
M)>FKV!^A<[&_JS;UK@KNS<4&WX$2R%_^'O.&_E]QOE_T5B?LV1_/)-C]SS=X
M-GS_1C2W/\!]'^CG=W\<?MY^P^#O_+[6_J>_\?[7-S\6@]V?/^5YP+OVON'F
M-HQI^_.W_:.WWW;V//R=YP;/V8.Y[[U-D[V^7(A?*Z&HEQ@QX17BPC*4BVDC
MDJ)V7D9FHU_;Y!MLA8X4+"GMIL:JIX15O]P"K(0DC!K%:$J>2Q4=SHF( L=(
MA,4X9K B!L#*H+)CP:BNP6IEP6K:P4AQYA/5N661EXC'Y)%F B/N1,":8VF"
M6=NDXH)TTE]KH%HA87[.0'6;O'49F$PX.BLE5UC;P"+7(@A&$@U$7+BA6N/4
MBN+4M+M1])+H2 AR5CO$F8O(1HJ1]#AZICE3W*UM7@13M5%58]6*&E6>&.RY
MD#Y)R\']<S@7$G,:,VVH\2.C"L#J<J,J'R. OVK46B'48A/4<D;D[FL,*1O!
MNA)*(JUE0H3HY##UG'@"UA7>T*MA7;VT<PWO%U-5&O:@%V,Y@7-IF/NJ4A<W
M+:NV>KAUF^Z0,CG-K*16>YZ",%;H% *.VB85C;I!X.HF"9J78=C?D\2D,7CM
M=F;.5VWU6GV@_?:P!__^6;*(*G"KD>QV2-9\/1/4 BT$[C[Q2/$D<Q%%@K25
M"EE%I1&))S#0GG&GVV<N_+<Q6JC16F--I;>$2V=T@&<&II4PVD5A;Q )NJ71
M4@O\@PG\-# 4-(F)2XF43RIGPDKD1 !$)[#0)%H:F%K;O*B)V<TMEUK.5UC.
M';@DTME<TTKPI)53)K<?Y+#TC(6@;Q!)J>5\5>5\&E@Q4FHG#$=&<@$N"BAV
MEW(%+.*]UHI$[6V6\[O$?VLY7V4Y%XH(*;&DRG./O2;<<Q>H4"I%Z=WR@Q"U
MG#^8G$]#$4*)%%TRR B,$8_1(1=\1)X89AF6!(<BYWPUY/REY0%=6.3NAI4K
M+C_@]F(+-RV?0*L-^+<).N=FQ"P9K +C8-H9&ZS /!B.?31,UFE'3P?@/\Y$
M:!AW#+.DD<(:'#:F @(G3:)D(E:2!%#M8IEI1\N3K17?7ZM1MD;9GPB32<^(
MIE%H%WD(6+.H0Q)$":N8\V+Y8;(:;Q\ ;Z<!,D*H"4)%Y*@PB"=&D578(N8I
ML5+(1&0JF5/G ??6>WLUUM98^\*P]C:YJ3]31*.V:%<48:>AR4"U9H98E' (
M><\Q(<>\0)3IR$14U@2=<[Z659N_1MD:95\8RM[&H@TY)YQRBY6QG%#I5 S)
M&TIER!]YG:WV)/%V&B+&3EOKO$0A2K!H(T"M<X0@ %OM>,ZRM1PLVHM*2S]!
MB_8&A;ORYRP"K<ZP,-A<_:&+J@M5-'"]?V^>+UM4\:)CTHAH-!.**R\=XTQ;
MY:@$3Y%'^T6JM0MJ'9TO(W7O>''N''VI&O4+P;\V[KF@&0#!46M0<O! HE\7
M^A_$CF_%_G:K[]O=_K"W.G7*3L="_HWM[_U]MK_WGNU_VA<@Y">?C_[FNY\^
MT)VO!WP?QK"[[4&0#WXLUBD#(#AL[C4/=[Z&P\]?OP%0_'[T>>] ?-[>/]W=
M/OS:_/J--\_>P]^Y3MD!;G[XPHF3/ 2-5-ZZY=9:9*U22#.F0A"2".XK^ ;>
MC6$KI]HQC'5*3B>&(U>2@[2[$*RFQ@0.-R[6-9M9AU+ :VXESLO*++\OR$VU
M1->_?WZ\RGLEI0%NP9+#'2:ZR)T1QB2;J&:75EZ3CUUXK3SQ56L [_<W*,7V
MG]:@=5 1*M/YKU$YM1T[ %3IGT>22T%A56K+5>;W^7^?X%1V.XUF]WL\<K'7
MD+EZ"!'KI69=-E=LY[216NU<Q+_1'[8&#9O+:_0'C1UX3N^[;7P< E." EIO
M@$&ST?@EYT=2_-OHY_*)_/9KKKZ1'_DWV%[PK(\#6/Y^ [!N )(U@#<->X-)
MK;S)U]W4V 9..;&]N-ZP[78L+00&AW;R^I*-J7[K-V(G@#4%M]EV _1=Q6HA
M?F_Y7.(CY7UV>.'?&Q\W&G_"NSL#F*I6=)UHUO@EO_1?^:_C\M.OZW,7ZG5C
M]+HVNK#N["]F'1NQSK@>/2+_-7K$1@/(^H<%=.B=-J@H9)7S9 6-D(M0E>]R
M39(V$':0*PRVJK*6#3#]6D?]<Q3/9!IVDFU5I4SBH)4GNY[MT'B<TPL:@Q[H
MH<9QL5Q\K*!MD(L.=H?]JDAABKFX?6R<M :'#3?LPZ/[_:K*(3RK?]@Z[I<9
MO(VN5Z9PX0PFC!$!UL)D0G.3R69,?B8LWVFUAG%9*VC6006O&VU&Y,]_S9*_
MJHC#QR.?T*\:=4:B_@GP?*:.S\5C8F^!XC-S78=)QF^9_4(VR7L6Z'G:^#H,
M!UE[-+J=V8LG<QH_+Q.GWX]5V<?+7W+[I5V_8#G'#0N&0,BY%5UON%ZT0!*0
MJ_%%%6^4A[9;+K8KOAUV8H/.KW@64$"JUHAA%V=ZU"WKE2=@<Y'-=NNHU<F,
MT^I\'78JQRMK25"TU1+-TF;TW$6.Z,7_-\PG%_)#+WGD0EW.Q5%5_!8:"=RS
M.'K5F)+]C$&5ZN_% ]L+%;;$"9\<][IAZ <S%"FUE8B>)<E!SW8&\S3Y5Q^0
M\NC(SO)'19Y^(<&(E\OW>4B=+/'?036 H)Q62]B+_>/H!^-IE?G(WS)"Y1M&
M'Z=H [*Z-QD13+5[T; N6JISX\SZN9]=6/@12-\]/HZ [">'+> :9WO]<VLT
M,_(04^D7T<@\ ,R<5\QFKH2'EK*CP*C D@DT'LQ_ENHS#TF][E%CK$17PW8I
M$@:4[@VFO3 >0T\#P;ZWX%' ES[&0L-SZSZ2).#[+.2+BS5>H?61BBFT'_0G
MW'D92TS79QVXM8-F63A_ TS;;J=A.RN1]3%/G\>QC6NHE])]4N\QEZX@".B_
MJL!=1A";,E/9QN"D"[?&;XVB^.![('POR\Y@V.L4Y0H>?LC&4%::KQJ_D%\;
MV2 *\\+=^._;5.5Q0DJA(C56<!B-4=I0:E4D/A]Y,KGH/-%877VFJ3,\"MW!
MZ/>Q@WO8;?]X595BR[7EX?_"^\ZV/;('J]02[8$=VIV];WSGX(N,X!M&1Y'5
M(B$NDD>.>XH$430Q3[4+)7OE_$')!K!DNSB98!%5Q"RRNBC?\\['E:&=$7MR
MNJ%RWN!QMU]$]%5E,'R/T[K/_V?>"1V%L_#T%NOZW?9P</DMEX61'EH**5\@
MT,R_A[UI_<V#B+*A] T5(7UEVR?VM+_V[WE?'!SQ!1HN3O^^<>ZB\%7E4X)0
M=GMES5\-P2+OY:M@3'9EQM(X[&4D^J_K@X5J;;,4[<_J+$=GJF.K=O.BE;PP
M)'.[$,LC1"$O,SJF*O:WQB_T5Q#X83;5+W*=YDS*$UOUWQOIY-^*/OZ%C1\P
M=K+'BF-JA2T^=<XGVFB,4'P:P2K>7>D5EAO\C:WF\<_]8EF,1E;<'G 1Q^;T
MCCT=^1=FUIAN]?OYN;UANQB(9:XS/D<VP5JQ_Z\&0,\ 59[BR'29M6CF3?%Y
MQR2"_NID*LWX$&/'#J8#IM5AR[5F?.ULCO9CNUV9J9/)5'XI4.7W+ICKHX$U
M+)C+MCW1S# E&,!X-O-.QODI7.^R7JKBQP;6N>--E&EJL)4F<>F(%8REB W'
MCGAOJ]TLB1GF:/S'K,)_WWP[I_&!E7W6^B?=7NC'SF),N^QD3>*GIR 'KPOG
MO,UC;PYS>&EB >"79@%\_?ML9^M+U%%$EK.H HDY?]4B+;5!V!N, ?Z,R[O]
M8!*>MP#&2PQ,5H4,_O[XY]YN8>O:6[K*6\HU?>=C<T70/L;C017R)'.!CC_W
MMGXO(9Y6MKY=D>X)Z0$AQCY8>5+5[??TLG=L'?=:[08AEP2@)@^N5_'&JS@-
MTA8*[_I!=QJVGEW"V0#(A,Y5CQ90ZX-A:4M[S=.WHQ^Q2!7]5#//'ZFJO)@=
MP/"37FL ]Q7T[+>F+K,M$;_LCH_"7:-7S41T9EXXB;::RDV<#Q=/E4NK/WW1
M*$0T'UBOU"F\:ZO<U)]H_;<QE"#,ZU;/YVC^+VN+EZ[].LN[YKR2GGFJ3:G5
M.QI1.9,%U-TE])C7?HN4+LXQD5>^[(K@XYP@Y00+VZOT=;FZ(MPU(ZCF2VE5
M/?TF\PWC70J?+YN,Y5S\I-+_>3#)?H?QC3A@O*SP<3X 6#'I;( E?W/NL<4X
M.A>KFPO25=:+/\Q1T,[!>.:3%\VSXBQV[5TX^9GXTO41X(L,K3R/;N>@6[H@
M=4]MNQA-^88Y _9R$;EP7)<$CVWOH&HS75X )!X[SMU>WDL">.L41[=]FH,N
M'4"!8HU-S=,1*XQTP,C"&W-:K QIX'!G.WX!1RX88B4%4UZ_AM%&<YI]];]F
M]-#Y5U<\/#P GV72 F#] C9M%/\[C[Z(Z82;%O>8W'"0 ^2GI0UP],.R?L>Q
M1&YS=#H[_"6D?S[(.">,'X?'/5C5T0QGQCK5OPR/AWNI?AQM!.1W7_3 \>Y+
MP>0\I'-B45XYV>04XQ?^+VBQ@Y:?O-#WP(9%2W[M>!.P6A52K<K\\\;*ZE)2
M5OMHO;Q'=_4;9[=31K/[U_0Y,)X,_F/1:+B28W;!@$Y*Q_9V%M<Q,I)J^!NW
MV."NM^:7$#>>,R+5HI#,;<G/60LYF^5T<.HG&_2-/ZO]+/"5__.?UY.-^G+1
M3VW3-[N]G-38F=NO?PUTA LZ+;NP87_A]MQXD)-O0$8M##@VMK;_V6J^?K-]
MPVWA1<DIV\3'XVUBHN4ZQ7IC0CPPH,9>__QN91[1Q;KK2AK/A0F*?3:9R&BH
M(% G\'O^;^P<YFVQ,-%(LZT#9P,9[2Z\\+C73:V\:, '\)P($#72I?_.QDY1
MHZ=S0"/.[U+.Z\AS49$+]U;G+5(ZV;@8S,9B1@1O?.WF[?X18*Y7)!A%*3*6
M# #@^BGV>M.MVHN2/&9"('3.&-RQ!_GR7,'N#U!9<6I^C\QJWRT];4>;PI7%
M-6_PY7Z'Q>H'.A_UQXQ>L<AXAW-N7!7EJM?9T#T>5#UDLBT_VIXMV[EC%Z0"
M2&(J*Z7;:QT4#5LQ;L@CAXE6NG^D\ IEOEN?-[#GO)D1UHX4>/6$2GOW1XU0
M\\P)1@'LE.IGER6MD^?:G=@!9H38C:U!M2"#5FYTXVP_%F"WWVVK76*K($<E
MS+-HJ,,][4GBUGSJ!_PT[)2;BU-L^]W\Z;2D.8RTU!#LNZ,R\>$@ISI7YA'<
MZ&$$>9,XQ+P6P),Y&2,KVGSU>MD^;@##')0[QM^#!,"GXVY>KSSCW-\G]G]"
M'5V6O+KRRF KVX5]WVNYBA.;0(N&FE^60]NOZCN&*I$HQ*,.3*'Q>OM_[-'Q
M;W\5B?>Q-\@]D@"><_BQRL%;3*78B:%HC2U8@$.P'WQ_FB=4 #W^ $G)G%@!
MPIC%LYR-=H;&!GLU-#\$\>\,VM4@;[-?J1UVFE"5S^YS'XQ3QA(2HTG&*^M3
M:9)][LS3C;<K_Y/)L)4#V?F'%[I'V?RZ=;;SX4M2.BKK+(H^4,2-%$@K39%R
M0MOH$[?2K&T2?.F!I/%.9;4Q$$8I!8"M8S:S)0920+ZZ8]ST;:/QZ;#5CG/L
M[$ QQ>^QPI,Q$N1$L[PUT9^\!%3'%(, 0<8,/GEG+Z?[M')2Q,C]+!E9D\RT
MZD'9\0*8!:O7Q=(XK&RRCQ1%&@Z&64'5YN\#3F5O7N'88G6<9H3Z;GLEF;'J
MZ%8!V4Q>3)73-THPJVHM92TT=M"[6<%EJR9KU7Z!K;Q9-<:W>=R:X<&">CE_
M;&0#=^'>,8]-H=FZ[O?"QL!UF?,ZW=$P9P>88;@:W]BK'EN8K<&\]ISWMBM#
MI6+30POOL7D$L3*/P_>8IQ-3RLECHW2[[.EW?&5#="J.;Y0P61]>482Q"Q:O
M'>U!O:\LG*RB^\78*PF#BSVKYY5._&[;P^(IG("FR#,M$9=!7K Y?3T2W$K#
M3W^:Z/IR#2PT$,H5VR(OXXQQ42% _J%L)3>V/KYN<('75RMVOGB*X/&BYQN-
MHMM@X?N#"@7CC^.< 9;34;.CD55RV+A!VLB-3*<7F5,B+L\IN?F1*(77ZD24
MYY.(LIK'VLB]'VM[8WO9!^W_&7L?#^W*G&!C.Y-CJOOB\]'GKSM[?Y_LP/7-
M[;\.=S^];>U_^D#VOW[[\?GK7]]V/KWYL;_G3Q:-Z>;7]M'GHYT?S;VM,S"Z
M<?/=&['_*1]7_:>UN_?VJ/GN ]SW]K!Y]GO:V=OB7YR5T<0HD.'6(.Z51-9P
MCX1-F,MD-;=Z\3P8=CP22CT1%/.@J4L^18NM-H0$3^GB^;5F'#2J<\0-H'FC
M$/TGCJU=^]K->V:<CZ.XQFY:9*'?;;_EMSIANY7502@B^(+9BGY)0BI#M$5&
M@E_&P>!$)E&!L%;)DR2]-N>..:[J(<*KPQW%!P,;JMVR8^O796ZH]C@J?FCT
M,Y-,',)6\2]3M]WNGLQT<5X$Y1$-1F9'5IDS5!$74@6(4,Y13TV6<G:[G&LX
M[L=7XS]^R_&/MCU]U>J4*96;%D]IPVNF2GH#5XIZ5 ET]/S1SQOEIX43Y]5O
MH.TQU9?^C#?(I;]=]5C"-@0Q/_78JW\3[/*7OHS!D@WYI 9+Q8T>>TT=VY5H
M(J]O5"KDXIHZDSF9F\RI\D8>9U;G++^J[B[8N+&Q ]<=]AMO\@G-&[2WO[:J
M^!,EQL?6C\M)\6(X>:;PTBUJD*SVRH[V#=5Z"5)D2W-9T[]4!IXQ&?6$C'@9
M:/&,*54SW+TRW)+Z]:UT\;;BY#:J2W)L%L9F#TI1B*-\/B6[./V\?]$?V+)7
M<)>^?7>K>[=ZY=TNW4>NR+;DRO#L!IO*XZ#&I]%Z;E7+61V!V4TEK-'?G:YF
M6?W)QC-[FD&-JJ1;?C=]>_3YW1NR?_0W^YPWJS_M</@?AN? >.'>LW#8_+I#
M%DNZ[7S=/]O_]/G;_MX_K<][X5MS^W<8^R'\[\./YMXWWMS^YVN3OJ$[9_^D
MG=9L47A#4HR:(V\50]Q)A9SQ J5(@G>1*YX+CE&AU[FZ<V'XVPK1$^H!]+*!
MX:ZUS&M@6!%@F&GO)UPD/'"D2:Y>'@A&L) 8<<$EQT:S0"( @V3KE)T_<U\#
M0PT,RZB\70/#B@##M.AVRNT,8/60TI8#,' /$&$I8EYZ0Y,R,>G*8A#,U,!0
M \.%P'#76M$U,*P(,$RK0P?EF<*1H>"(1)PD@QQ/ 47!,56.:JJS*R'%NI#R
MJ0##DMH,KG0 Y=-EH9-!UW]KQ/\W;'T'B2B'0?-)'=OO#X^JHXT]WZH20*M+
MN\>C(@OY2 Y<5=6O&_^: :'_4\&7"VCZ+$'Q(>,K[SN^5TX,V_;KLMP5'&X-
M!KV6&Y:-][WN.(DDAC_M:;YXJU?23<O1X!HI;X.4IS-!%R>B5HI%Y)S+K583
M0Y8E,*&BE-A[3XS/=?37J;HS3E[1]?21>H_4$O](@9-:XA]:XJ?1%*^Q2"($
MI"Q.B!O'0>(510Y6U$FI:=!D;9.L4WGG6$HM\2LM\0\9$:DE_J$E?AHFX3KQ
M:*A$SA.-N-(@\;#R**2HL&+*")6[/ZXK6DO\\Y;XAPQUU!+_T!(_TQV+,*6$
MQH@QJ1 7'B/MC$0*)-ZP%&A(,NMXP5=)XJ\)<(P3LF&P\6J0J*^<O_(EI-Z,
MSI4\=O+-\]<A*Y!Y,UKK<U'S6F'<0F$T/\Z$@3SA5I"D4&1>(AX41M99AA+W
M"E;7>A?*%CM>5_S>=]*>W3;:\P>%%<BZJ4%A.: PC119HS4F$0S()!WB1A&D
MI4O(P8(F98*-J>RB\76![WT7K0:%)P<**Y!Q4X/"<D"!S( "R6V'* HZ4<1M
MY$@GZ9'$VJ0DDHL,9U#( 615@T(-"JN7;5.#PG) 81IODE$)GXA'+!*+N#<,
M&>(H M"W@KIDO,L19JG6">%/ A1>4K(-&H=*;&?00J4@0^FK645,IN4D7]WD
M6-QEA)E9+@9K$KK#7(3A9P[,_?0.0#W*51_ED@*5E=XT*RY^,YIG/FGM+H')
M9V\_*&^2(3I$ZA,/6EO-G2(A*4HD<XG=(/PX;R1L >B-,>]C],->*]?#?O.C
MM.X.;WO=HUP><3@HM6O.US6J>F36IL-M3(?9!#01*8E<"82EQ(AC@I'!0B ;
M=0HR)FL27=L4@B[);'BB'L.SE^M(.$_<&*=2X-$9HUTDDE,OF0P>LV5&$&N1
M?P21G\852?066,2B8+5&'!P$Y!PX#XHQ@;D7PA&:=Z>E6E8 H1;ZU11Z%4D4
M.D4NO>5>*4.Y<D$:&FGD1(L;1 AKR7YTR9X&!Z,71 HND'3Y?*YG'ID8&$K)
M!V.P<03[M4W.E[5;4,OU:LHU5E@9)HD H>.:8TUQ"DH(QDF /\DR@WRUR#^"
MR,^$_IA6,0B/M T>E+E2R!(64" I! DFG16YT<0ZU\NJV;%"X;VG$6CX6((+
M?]=GWJY!+:N!>ZWC4G/&?4K@@GKG!-&*86-\K$,+*P]-NZ]G0@NPG$8J)U#@
M(N]*4(M<XA$1PG/M;D6)=FN;=PXLU#GO*RW57D6>M")8L< IC1:,DF2\H$9C
M)8VY06"AENI'E^J9Z(&)DE##D391(ZZ= X,#[(\8-;5!R^A9CAY<UM>J%NOG
M(=9<PEHK+3VQGD=--)=2B,BM=QY[&>O0P5,0ZYE:/H%(ZS1!ROB N,0$&2LD
M(EY@C:T!X+8@UK54/VNIIH$J:CV.V"1.C#5"1I.<])A)XCR[0>"@ENI'E^J9
MZ(#728M(D8RY$ \U"CDELL8&Q,82-'D"$WR52DN4R,"_R_'$S9E&:G-]>"YJ
MK#8>W$P#DDE<8-R#A9>V7FM7]V"[8:,QMK:YTDVJZ-5-JGXJ#7!>M+=;?=_N
M]H>]N)NR$,=.ORS'7U7"TNO<*^_<^=+^RO0<&O>%/?IP N_AS:,W>/_37T?-
MKQ]P\^Q ['X"$=Q[V]IY]S=\_P<(8&@M]ASZO+UUUOQZ0/?W_CK\_&X?8. #
MV]W^)CZ_>WNX\^G]R>>]+,9-$,T_TL[9SNGNAR^&1R^UE,C)!#XQ<09912P2
MV@>*-0,NLXO-K"164>(H@@(VM$I:*WSD@7B3F'=:+G8I*O$F5*C>F%V8GVAH
M=?VK%X9J:4PZ$&VXY"QJL J3I%II(8/SN93-/37 *@V(I]VOIGPW2X W5=/&
MU>I]]?!\>-8\^.*]"3D(@ZQQX,6Q #HAXH1@^41D5@7#\+/H?I4[T%9]K$K7
M53!Y2OFRDO"%JA;N?H9%QHT]Q^V*1ZU9_^>_-"7JMW[N6%@R74M*YD<P6ZJC
M\KFT6=4_;CG-LB:M.%>M5Y;8T/3G6B\]JXY.]6#OK5<6?X1>64>M$-IQV0CU
MV+VR'F963Z17UF,2XP%[9:TP)]]7SYW'7-EGU+IH!<CX1'IEK0"E:H9[#KVR
M[H<"-PP,Y_A,=EMZ\7L$__U<:LI/G_];9(8+ ^4K1X[_OK_Y7QL!?=2)7[I!
M,.R'Q8("6)LH?9 A4>XLTTKKA!U)/'IC+;\N04><:U=^89AF$NZ73S,V4X7[
MC]ZVFE__.MKY^OZL2=]P>.8A_*^U<_3'8?.LW=[?^PR?/YS .,^%^_<_O:?-
M=_NG.U]WV/[> 8S_#?SO_>G^T1NV^^F?0Q@':6YO\?V]A19>E$4J64J("^$0
MEUHCXSA#(G%M*"4J8+.V23=6N'W71!:6F1Q<8UF-90M81I@6P23XAQ N)35:
M!J$4]BPWO8ONNK2D&LON!<MF\HQXTM1&@D+R@&5)* 2?&<H;"3I1"UCFUS;)
MQKT7.:FQK,:RU<8RS"G88B&$7 72B6144HXE^%<9SLVUQ[AJ++L7+)LF5^G$
M& XI(K"6.>(^&K#+K$&!JQB5-4H+O+;)-T2-9366O6PL2UY&ZP-XF)[P2(/E
MA$F*O<6 ;SC$ZS+0:BR[%RR;22D3A'FF(S)),G THT(F,HH"\<(ZYP)E:6V3
M;:QP)]AY+'N@4E./*H!_Q7XL(<_<CRW$[['=/<Z)"P]_'NVIX!#'F@1)03%C
MR[&*FCDN7:(I,@>#%'6LZQ%P:+9PC2* )H1:%+WP^1P*18X8B:(.T1DBJ*)J
M*;&N.R6W_IS9].@IZT]%2ID37JMD!):$"\Q<SC\,W&41Y8*K.HKS*%(ZV^V,
M!FIP $X1 :24<&2(#0@TNXS8!\TYJZ7TF4LIV.Z):9^\]8R#*6^H-(Q8K8EP
M04M;QR<>14JG\0E&<%#<1H052XA;9L&Z%R*;^/#_@Z?8FAR?>-QN1;64WJN4
M*HZE)\YPBQDG3AO":> ,ZQ 4>'6R]KP?14JGGK<@@5II"2(\89!2QU ^NX.4
M#@:GP((.*DOIXQ[GNJ-S_00S:3[&=CL?+LB^]9'M?8N#.W:W>MXX U@2(Q@"
MRAH-[,N==-)H[+4('(NJ($3M63\LSC1GZ[8DRK$14B"LE49<!H?@HT*.:[ &
MA)6"Z6RS/VYUR'O9D*BE=&*SV\"\I,+!<G.I@\VNF@S:"V\9E]?6@ZVE]%ZD
M=.I9AV@U]9(CX0-'7#&P!@0-N8ZS,IIBH67)]5I6'+Z6TA644J^H$MA@$HWD
MTD9G(\<!*^E8TC+IVK-^%"F=>M8D:24$9@@GE\NKAX2<EAY98K&*/C)B_=JF
MV%A65Y9:2E=02G,%"2JUH(EXGA*UPCJM8?VMR^T]KZVJ4DOIO4CIU+,&JR91
M+"-*V@;$O7!(2T$0IBHFJY2E1F<I?=RZR2]OV_I=[,2>;1?/VH:C5J?5'_1L
MKB54;UQ?&L8+/ ?;J9,Q\L $6 21)_"NA1->F&L;M-1@<P]@,]OK.:M^GRNB
M8L8,XEIQ9"56*!B66##>8Z/6-LW=W>LZV+ZZ4II/'!@N<H5VL-@5<9$30TD(
M8"P:8J^MBEI+Z;U(Z6SS94^BTQPQGYLO2P7NM=,1<9%"Q-X(GYNDR+NG[-92
MNKI2&G/BJ9,\%W\#^4Q.12(2<S0P;%VZMH-R+:7W(J4SW9"=U &L'>2Y!O>:
M4XVTIA:QX 3G1DN+[=HFQ1NF%M-G+*9@\09/A("I<BVB4SHG%XF(G4[*I-J_
M?A0QG?K7+&"KDB>(X* 1QY0B31A\=)A[9035+M<,5W</@]5;U[?-"Q_TAGXP
M[-5;UE< C(D^$:V<XLQR"3ABF7=>4Z]XL-&'&_C4L_V4SF*O&VS_L(:=Y</.
M;#D$051,1BFDK0D .X;G=F@:8<U<8#$HS5,N6Z4IH;^M4&BO#L O>S.;&AIQ
MPL%2S(/!+A#E/596>LVPUK6W_2B2.O6V%4V"Z!B0$24!U5-D@B5@S'LN72[2
MH''>S*ZWR9ZQE.J@ G%.&ALY]X0:1E.0A"O+<[UZ<P-ON]:R#R6[,\GC3">:
MM$6",(4XK"$RDDJ08BDP!0L_!E)KV1<@O\P2G/)I >DL9\;:J*-F00AF+1>T
MWN9^'$F=NN$Q&LX"P\C)R!$GA"&KA$0L$.RD3Z!EXZIIV;MN<]^XY,3HOM%Q
M\U&5=@:C#MUAKL$^%K476Y-B^01Z-LCG+<.>)8-58)P);FRP(GL:'/MHF*SW
MW!\!^68/B^MH=<#&(":E1CE! L'GA#PSPCMCB&&V!""7U;9P>5+RR+L,-5[6
M>+ETO*32,Z)I%-I%'@+6+.J0!%'"*N:\J.,QCX*7,\?V$W'*>HM4T@P\.<R1
MIIPB;SC8B)ZZ)!+@I5A:DE*-ES5>UGAY:>'MGVF,5N/E?>/E- ;&&<'&YARQ
MH"3B)B9D+$\H:!FHL%KP7(R(+2&#O,;+&B]KO+P&+W^JNVF-E_>-ES.12&6T
M%;D85/ *<<+ OK0IH40LQB(J2ID'O%Q"%<F5P<L;-#:^N+\FH2O?8'/4);-Q
MT+.=W!BS>YR7JM\8=!O'PYX_!,%IW*X1N>4J.N)T- 1SX[@A#AQ#G'"D.@!S
MW'(OL#,\"MW!Z/>;"?=6#R9S4-I[_GYZKH_QUHGMA=UJFN_RK/OO.W\" ;OA
MJ8/"SW>6W3L07[C(98-80E(2@[C0!&DP6E&.L6E*-"R!7MO$%]A!#>#-=F:,
M?-CK=LQB4C0VL&"LB%R*9#$3DM%$I:!,ZYO4#*Z9Y:&9Y1O]P@WS'L09I1C
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M]BC\;)IVP<A'2*DB49%: LQ)XI+SA#HADXZ,@J#5S^[2SVZ5<JA^]BC\;$;
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MKIW=*()^T?]T@ 2C>;TS>.VDK^7GU$%*AK3JI--'5&PN'"2$U4'9P7>N>=-
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M%)')@&$6(_=<DEK38CUG.8F9C.9<R[A5C9)J&4MA&7+K[6[T#*D,E\0PZ@A
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MZ(SV4N=5?Q];=]+!$"UU_RYB< /TL6'9&O6_]*KJ8--ZIPFQ_\68716G'[W
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M48A*%YY/JZ+N4W;<UK5_JN/>D>-.9URKP,@B48^A.)3]ID!*217"A;&R3,4
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MQAA, 2"^B55=\:WBV_/&MQ9$B2J^W0>^S=9=""5YP /A*91-(TP0FQD0I9'
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MVOCWV<V"G5I:^.4UNW1E4OII[=%JD@6L&HX*@?TZR2>4Y*M@3'9MQM(Y'&4
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M_19^'@/\W*BEC: J)$ <DARW FM0GXC"PHC E!2I5:%N'8A.%QSRP8GL8HR
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M,BY%L2V6_$0LF2?):Y>4T-P@V/&<J@4;;(Q@L,N>>9ZL#Y2LNF_T.H+*@P2
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M#-:;X><9@4I('B6G*%J/<T&01A;3A(2FD@<ON3:/PC!X[$S_\Q(#6SZ_0P?
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M[S/%9ZD[&@[@5U_.B:SVAN/W<;P=AL>@K=PU$YQ.W=T?#O?VP]'[_4^G'UX
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MGT7C?8-!P"UC6)Y^Y[A8_E7QAY3'#*NX=+F+!]U!5M\[-F4?R-SS(FK/2_U
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M0S=_-8F$ :R6WO"XSH@<%&]Z\Q',-S_SH%MS.PPG&S5 9*-/$6ZO)CY359J
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MIRX8(-**.U FU I =>&Q%>7:@/I&MX;#P=]CUU=<!M3<N2-I>8$_N8+G9Y8
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M-#34S$&F5[A-^70EQD#L*^'=PV;\V<ME>PW&NL##XO373G(\?I!)EAECM4C
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MM8$VA$0=$.+[8! [.(:8B60BF4@FDHED(D^8R+U]$7V%42U?9*/G\4%&DJZ
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M8CA4?\9R+NZ=2&OO6)$$?KNI>+-Z3BN9C^7EP@K2UFP;944)T@<T<LKGK&N
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M*!UV#=A66$;?'4MPRV#(/.AJQ8?1TOEQ$)+W\KR57QJVL3G/QFP8>"Y*YG,
M+4WK]OK#[=5-\,>5HR4QDC/2,/C_NME33NNHTXE!.N@\>#$E2@-4=K)%![ &
M].21!J@'MNW(*H4N8+#Q1I\W<P:I7"=C=X;H1QJU8';K2W4^ZT%N@<S6 UH]
MT[6@[?1*M26'^]1$D)Q5&RS0A"$X#6H/2A__W@W@UZ'06*L1\*0?C*2"S2U,
M'5BHH-&JYQ"LW!#EU9 BCVC_K5#4[6>F%_RCJ3N<YJ@$3SQR(Z13;];GGH#]
M..W-QSE/F_8^UA D"1@-@078]TG @B25'2"<)^"0"6U$0$S)&)BF')UL(& '
MD*@I%D,W3O<3L\"3P\3#XX2<QBV/ S\9XWM90"SSS8I ;'=SBTLI$)_WN_6<
MTALDH@%:&)GCU^"[;>M6^GC \UL0HSU][K3SD#.O(K277A<S96D&01@&]_!9
MA1P<-91W@7='+C@80!<<#6 )CNSD5T4<&4;,8XF\]& &[%&.3HUL8W>%F!P9
M<C;W@H4TYO3>C:=3Z8V6Z([ ]<+=:!Q[*>)1W8%H7(U"ESP(^B+,PM4H?][L
MYGP9'"\:3L&>XT8!F Y"FH/DT@4RF[Y3;_2L&S7S:Z,YMO5[P7S'>F, ECO1
M\R<1DZVGM3<,AE*.E';WEZ22_YC37Y*@IKV9+2EZYP /HW:"'H+J^U'>EZ4'
MD%ORLPR'KG(C%3^".=FMG;2P*FT*R[?*;\$#/GU;\J?:]]*.%7U(/"8?*>\>
MO(4(?.F17LJ?XW&?-3!+Q[I]-*T3Z,JB6Q>ZD5HAC';GQ]R"<+7_L5M.^LT7
MF9KHOS7-W[ZIE2"7<-[,[R *(RPIP3=JM81A>JO#-/OMG+H4AFG5\\.<%+3+
M05$JC].?UOO<I4&#$-OHT<E/*-4R*=7!#FPJL'FG4 [2RNJC?8D%^LMTK.]2
MJU*U ;@&5JE#R)'U 18#6D$U*_%W/R4"/#5X.<.Y((BM4&:]0 OZK%06S[ZA
ME<GZ7OB?\&7X*JPZHF;]9E_;M&T!74O])/C ]0@\<O#70MKHPD 2NR3>WE-D
M'S#*^D62-B*)O[R\L=Y%42)#I1%#&<8"MX;H95H>/:CWL.6**W(\" T/<#(W
M>$WD+_X9Z3N@8<:7B>%+ZAO6RL=1W'H_C .Z^R%>=:T7S^A_5OFT8>.Q#:B.
MW4ZANN[4]WCGM^401Z$LPY3\/9)MO%9@>6?^U?Z3W)LY2WQNY=C\U.S"&!BG
MDT:_/#T)YN;Y"@-_7SD]Y,0U+FW92AO!YH:N5E.K]$(9!6-J/N(??H$_&*L@
M8/.#^Q[0IA'H3(EU<9JO4:M89 \F,B.E]:M%SIP;R7V@AV4(@E,JJKRGG*D$
M22[TELA*YK050VRL%=P2;<URU_-(@AND9\[)X#]R2#MZL[3 KSQWYN(!WLX(
M/@,_"ZVU$B[(+#(G*>7*;0TP8"(]\12X;)I#4;S0P<T8_*A/X'Y(8+-'@1O#
MA?4!__S"M:6M0B1^>??]^P_TTC>P=TLB\EOF<P\\"#SCP\?SCGPZ,#:;U.MO
MVKJ)W'[E#&R9B0%[R41*)J!H?"MP._DC6#W:W=)$UE"\$YGF]L_*-BPYJ@O+
MY*H(:"N=@Z^Z:5;S"#5.&W:C\?5Z;.X.QB];58^[I<3SD1!/!W1,T$Q\DKL<
M=VS@O9N>3--AEMY/AGC7@^=[>.+PO&\WN[GK(AH0?)RK8HMR&)R.Q,C6T('U
MZF-2;WRS/4-^J]OHDRW&(USGT;_8)ZPZ*H8A?>A6SF-E$?4#3:6&H9R!2<6'
MS(7R9KM"P3XJOF*#@(Q!X,"J?&!5]PB!565VH;H;$EQ GN.%:7IP5&*8]?46
MN#M*KTN.B=8O)VAK\.X)%A+C--C6._@0>$)QT>$@U0/HJV--#"?2]RAX_S4.
M0M!&'6Q4NE.BTP)RR4KLFW%F\/Y.T%W?/#WACK(ST>)1;#270W?LXD"+N3IN
MHFMC?2?[HL1="J6Z7Z+-&T4D1]_4U*&="QMW5/I(7Y!&24@V (_V@%ON'B.:
MJ\/R^11-/'!$X(JL[LZ3J*:,%UU2U SKRTV0?E2%=]74PKI8PH"&1:+/*!9+
M)Q<!GCZK(>*I&X[,SR6?-* QQ 4)2#Q]7$UOY>/ F]D@"2-]*@F>ZL0$#Z U
MQT!7S<U?9 S@(A%F1SZ&#^-X6DO#<$#]\'(E!!7]6](75]ZUK=M5.9&7K+Y>
M6]DGP-R 2^H(/C^7\0J@?\S.!G .,%M\8>8F,RL(83WRA0=:=/H.]O>9<Z>N
M;-0F#0!*N+RB8RC<90!N\3(UO6@O_)E>Q!]2=\]5=@5!HF]AX#^&U3KL0__+
MB(@4$G[]+_O6IG?=D2M""K@B(!D9R\]#J6])K!]!'/*SF,T]N<E573V"PSN?
M(,[/&,0<R=)XD7@JU!LQV(I(A^)H]2'KA'Y $L[Q?1@<^: U$6,Q/9 WJDGI
MT)IQ)CX'[-XD%+,S0-;ZTT\P8BA&0-P84#13!ZXH>Q-F9*$E]@5R2MV+*XT5
MV7X&8T34#821W\J97DW'N]))0SJ>N7XD%S$! 5'(T6)I"00R H!L3,$[!FED
MF6!$?$>OFQ09@VN*'/DR4NO)!,]H\T\8O2%@*]C7 ",3O.7'I5"&$S)J82%J
M >_J(P*46>[H/?1$Z20=U[XK#\-0,*-# 5,,-:EHV# N"3 PHK%H^57'TR,\
MY'8'B7ZTQ"2JY_)36_IR_E/Z, +DZ"F&@:<>T;CTQ6S)U/%(*@Y,K?(BE\G@
MPJ8W@7T+? NCOY:<D_4ZK%=7O*Y7/H9+P$KMA+[:5_M_-]A\).]%089, SN\
MXP>N -;TFD*SN!<ABMG5/@2FBBAC-I)CD7AQ'GKFYES_"?B CNZ0 @LVCUU+
M89M[>1BJ%!3U;^T5*@IR!%C)'!U)PVZ\Z(:9A4%J?X?*XE[T+GP' Q7?!SD0
M95;DA=#WP>BJ>L#]$-690&9$DJZ#Y%6F?_X&-%Y$9+%$NOYY I[3\?^$#1VD
MHN/X;>NZ=$L GC:=MR#B09Z@@>C'F@UTE#.C.RTG%4_20G']Z[^M'U-QW( O
MG(#%ODY@X2;?0_@^K*]#%8%-UUVT<+LQ28/\6W1B,?H%_5=]A$8K/Z[;= ^?
MOZ2'!\%KE^AP9*__OP1<:I51A0<*[\9I<"LZ"#,Q2H/\9A((&ZDP$P_CKU29
M$/HHV&3UPU!2+ X%;[E1MG_RI?H<7?&E%HW4&&SOTNJV-D! V=Q[C&WTT=>9
MX]^!8_?DSG@ +5^MM^IH#@\>_>$4(/')N@\2;X1;EMQBJ -\B!FT4)K#>#?2
MSXL18#W",&%8$G U59%^^0- I(A&H0<P@E=&:2C2\J-3.9KDXK+.WEK1B*\P
MUM =[A2#4(C#.'/V;+4.RB2;8'Z9.Z-;.><K1K  @I>#5(RK4'P0=5QEB'C&
M TU\XX/F=[XE6QMZ5]WBHW+3"KTRQD!$0 RFDYB@@J6!_@F+?S##R-GAT@YI
M';UJ@<!8!8HBQ:./[& >A08?K=$5DEF0_I_P$W1\&GT3_R%F@<ZHT40HGTQ/
M)0B5&_*G]+P(]LWA)*"HBYKUF] ^\'44!3KYHH9?B4, CY3K:)YIS]"W?I2#
M$(E1)P2-FGH8O[9R14+1ENJ&03W=LCM.^VOU,QX[8SIM+0W3CF O?Z4NAS ^
M<.53])'K9 *$FM^8Q1D'LF&Z9*9!9&!KUZ"*KJ 6&.QM<GJ!\^9#EII.4]WO
MP)^'V0V-_F2]KNDWN^82:.N#'W!>%2ER5-,70#J('R>2^#H.7O$+%H^QI>08
MZ##5D9S1/D?=)JHM/KKP5_?3@!(FU-G'RB%@"J*4(^1(:[;0A:R:0K.]\US6
M:FEZ-Y"%?>>."=/3 15S&< "$ZJ#C9P8*!N+#AKQ7SA]_-^!A$G)4KCAT6NL
M$@L,B\IEE<?;$\N+>$]\GXH[M;M24:3X_$:$8IY$J"XX7JTB,YZ&03*9%O_0
M HZ863MVL^%DLYZ+\/7JXVO&:>?&:=CM5F/S..UUXW1RX]3M;K=>& <YNOJ*
M\D-@+T:W.[D1EMXN[$7=L7H)%XRR[=4P2.9X/:3OZ$=RB$L5*HO*=XK(_J69
M5D4E4CX]K$"EQ^?"5Z F)U9'<2N3!#HZPLNPGM/HOH[66*(UN&TL818VXD6L
M'H3/E#[")]^)Y>_$>E6]$ZO49G!_;[C/WO"!WG!_U1M>BOQ./;5BYL.3>\.;
MG=_^-D?2:K1U'/PV)])JVDZ[?K#_V%YU(-M+'F0M'_100F%CC8M9E$"9BYD+
M?.BM=S(MM!'62;N65FNG&:P%^F,[E*N"V.9-@E 4\)Y:,,3DK>YC,7\D[SZ6
MH,XX;+D_=5,7TD*O#WUFRSAJ*R.TUH_05B/4[5ZCF8U V9S%4=JKSEZ*_1-V
M\4HLP2J8&@9(3^S8G=4B6Y[>=IV[KSN#\_7W&# :NI[5R]TOJ'L_@K$Z-$J3
M3^@0:4CPM7X-!K@43ZSW@!0 I/EWC9(XX:T4- J?>*,Y!PWY[&+>-:R?S[O]
M7 J:*K9!5UBFM!I&ZZ(&XO$R/H.+=*2(HF"!MQ@M$F)$3O9M+QC2L19HX(^N
M[YF: 3]2N$\ME_Z,GD))AK1%^PER7W :$Q&!_J-F8-HZW?W2"3;==N*-W<P=
MAO!QRA+$9!'RL> KX,BK&T:\8-!7J^9-Y;D,O8!B-L'BY"./TCM(\_<L&BMW
M_&_.YVAH^,,+]QLZ2P=;3J[% -<PBKM7<,7/21&J$"A:N8 [OJMK[OR( =%3
M:X*75CZ2C=9"7[#0G>0+%\87>.N%EU8^#(WYK3+$+97UHE__^ANS<JEE4]DM
M=7]E8#*0X/NHR]$P7AC;DH(DPQA2!!^$+^8NN/1]320]#P<V:S@8N+S'F<5_
ME(Q;%N"%4 Q!>KC48^QIA)3K&*]2VI8OC,T%32HT#*)S?175H>+%"$9)E%Z!
MZ!FLDZ6^5S8K4O[>G6ZF\$:';J>(-S)63G009GZ@<C^MCE)HZX6ZKR$W3(?H
MY2^VLG53>Z"F-(&9FAL.DYG"-?+EMA T",;(PSHIL1N--9E QKUP[U0I,G7O
MG,83(NL5KLG28'4%' PODW*1$.8Q:192%9%67N*L<5KWG.7+"M:R Z8@Q&XP
MZVRD*_%8/XC0OWJ?Q-;O.L+P,A;?M14> $N^,J/+T6'Z+C$?3J.KE]U)%<$3
MZFS+S%YD(:H9]R7RFP+_3$1G[.H;9!F"*L_(&@W!,*+=J&7N%56&4.5#)V%P
M'T]37WZHW3T3ZV(%%)^;BW!5D>X%E]3<^J)71XYE1!JD#LGP:B9(+_S_?WM7
MWMPV<NR_"LKQ>[&W((H@==J5K:)E.:NL;6DE^^7EKQ1(@!1B$. "I"3NI\_T
M,0= @-=*(DC!E>RN27 PT]/3T^>O9V=O"D4R)U/($.'CE 0IUL="SA23(C>L
M#E['*AC%!@@D%<>)B>AD/))?*P@,(7V,%_5DC)D@DF06&."<)N/,S3F&B+/$
M8Q$+$&_L@=D/<''S-U'MG6$_RO6G@J\%U7L0$M.(5!*OZ87HMB7*(.*"*"KV
M,H((,Y0&OIGES*@(4 L5X-UE9,#EE;^D&$<MZ/,;)[@+B#)"4)1IQDZBW$FH
M,@*X'86>=&4$-SLW9]9)\] N7P+EA4 B%5C/G)T-VH@"Z\E.&N>@%^DJL+*I
M1=IJ3,<)=,,A@0>Z0B&Y<\.);]Q]Q@R,*R_&?#T^;2!8!/T00<70G8K%AYO]
MCJ],,N>_P4VJIXDKV%/)1VA3"FL.H.$4 +'VA[#9"SET>AV* M(H!X>=(!KH
M$V0#"_T!QY 0:F+%T/<>"7(#U>E#F2EW@9!<(.<(2XLR'GWY%WG99XA8NIL&
M<ARDNL@CGD>>\X2B@'(+K0?;_&JL,+E CL==/1Z#!;(;2<IUN<^<U@@FM&]*
M/TUWC:"3(K(3/!# RE^Z>"$PG.GB747>58@Z)J,#KH.X!U)7.Z_ @9*Y$(PS
M1<]FC]:\*T.=;-<:"GX*1@3OQB6E6&O'%E+^NJ=;G2K8$,8[6\"F_,:!KF1#
M.X.\3A',2=C&DR'>XN(2+Q%O+%6*R0=U14N*-Y4GIDXX8A<QC\O?%$JT15LG
M#.@P^$,BLGX1/_"M,S<)8W'[#J56H0C=GZ##7I)3G,3_L*$L7RE%G\V(ZNB,
MIVQ6.*VYC>"#'@RI[.8NAA>&E"KH83XY)N:[I :Y'AP3 /<Q!45!32Q9*7J1
M0&I]/8PQU3M+K=?'CD;5(G)'<2'3(1=3TJ'8>\JZ@Z3"]=61 XP+;H_(*#:+
M;A <ZUK['Z^H4F)S, >O?JYK/3-Q[=,ZKOV8 $Q4L]PD,?\A=A-,)?XH-, >
M)=V16^X/D#E6)-Y/J'N&BQY@YV0NLQ!8*N46E9(^_ =<3E3:8OQ,P6@T*7(I
M"U/9L#8K_TSL0&-\#45!Z38,6D^.*9@5BDSI(2,?;=Z<1QD+RY+KQ+NB87W4
M -_SX.X=QJV2J_(L W*92%6(@$@N:XZ>9V\UA%1K&0B^98GYKT].FI)X\HU4
M= Y[=><&(5Y;TD49I+DUO@S5L 1?WQ]0;C_=C+U@3B;']IQK1GS@< 9J?EAG
MBYR?8@%):(6X=(Y 4Z 94O]#-QA23=3L$0&GS[R?V:8;A910:!A#'JK OT^U
M)8/1T!@=+<CY*<+T@^*H?&98MEQ\5GW4GF!PZ?C5Z)\ZBDA*'*J=:K:RB%I/
M!.O5!4W"> 21;;"W=>4?O1WL.U>_'T22.*?@48I2/[15@HE6X>%_;CB%=)+,
M0@U_E!@%C%*BGP%>BJ!P_B"0E6D]T/1TK0VHXP>'0DX_L2JR8D)4X1':!._;
M!'O?,^>#FR,#ST'?EC9X/ HB%K6:<1%RG$M+Y";!?4:&>L@MER98-R6+@^1C
M/<0%LL"M$$?BX:EVT8C-1!^0T+320%7Y*A,DQ0(["F!."0J<(H3JNDFD*<C6
M'<=49"!)5<'0R<E!X+MI.J'TBU05UA25Q&CF*_#W9H[1181.:7TJC+I[O&3
MK!%;,4E4^*</?<!@1I!"8#E-:3!G'#>ZXLIPX>!^B3%_(V*(M5ZC,PE3F<0T
MQ&![ORG=PYA9D"(<>S**J<D&&+T!HO@GT.- L,=*ILZV7W>?B-T^![]/ @]L
MR4S,YT6'>/YI>DC9->R3J@I7%Y?>"@L;DZ.40)<'II<M5,;#?0^F=1B(NX52
M<"AR2J@5H =RM@%HQ[0O9O B$^U$D+WF^VOP&WQR42''CYSWV40VP*"V+BYL
M(6M\<2@Z= 46'!Q]2;I0M2,F!QHR(A)X?MI+@BXI"S#/#HF=V1/WJW(WLB*,
MSB>*\*KP+F,F452X:;& HY"S%#J3;NK_/B%5I1^$F#X +V-_)Y;_<-XG2A6A
M:X W+;-T&.B&P1%0OEP+125!LT',]U[\Y][G.,;&089@X2Q,N-']L:+6EX__
MZPY'[SNVN86XI7/[#-GT";5T,-OY<-*&QP$N^'E.+5=%E3-P.L@YG-\%^A#*
MVG32[P?B9HO@!HFHE1\V5 2&@4_(I8;\[(/S1\C#T&RS@I$OP*?1#4#N?(FH
M_B"((GA"K)F ["GR%<;B0DGV"/92"9 @-?U*F$7#S*QC7$8 ,Y]<21D]1OA&
MMC^0+GD:2ZZJJ#F"G<6MAU79N7!LR2&%8")GR"C@ #2R]!%PNX(N.IYKQO R
M8 PKX&C;1043!'2=S;'3K4)HT4PMVBX5S31 3PB>Q.7ICZ05"=Y&5*ZSO7#,
ML+)LH95%84C]N9)'R1L2-YQWW'D*L?%4S=].*MW\[>SZXMO%6>>SU3D[N_S^
M]=O%U[];5Y>?+\XNSF^P']SYS;>++YUOR_6!JSY^"\CV29K*R+MI01FM,\A1
M0@)#1NA1>8;'# FG[#$42JK>.QBB1:?T33UJJJX%79$OO>.(54*9B3,6&:8$
M\OT$6G@/0%Q\3^+OX%FC9(U0%@_0<&8& Z53S)_6+ +)CXPA*V@AC.(!9X]@
MU3W5Q7,NK3B'OJ>A_S70BQ'1M&50@\%&.#W!9DI3!Q)#M<\&2LOZ:UVB21Q'
M>X.8@!#%ME(>EM2HS!!0!FZ E!*C]XD,ND (1$CCL>S>H8)F?B@QEW3B@ UP
M4/$];AIV:(LGW7%_$BJ0)%BW8-T[[N &2#R,L1.#1]P?^ZIG%%*)YLWX-]GH
M/;RI9]RSI7$K8U$JQBYTQ"[G\0$.CKS!^1XT] M-H6ST*1]V9K=G2-&AU,@+
M-6U"[$ #J!!R/XAE"$V$XTZ0MQ,#EG%PAWD):JL'<>R!FF(7)B0@IQ4W -4_
MS'2-(R0+[D5$O8IMB50S5?MDJQ2L?.\SFW"7)K+9D%ZRI#@WZROOMY=)YL@<
MC['[H%F%#D6>2L#+4.*AVNC!;XQERUDH'M+,F:*"U"7(D,1TET66T$R!^WJL
M_P@^E%?WG2N()&3"[+XJ*#'68F5T5GDH?"-U-9-R*10A2@&3XI4T#B_ @@&)
MGICQI 50X)".S=DI%<N<E!=C-JG8'?2"\91RZ&T]81Y1/#2:\EM]3"(&[9&"
M[\KWP6T"+9;S*UT42FG2EX_X_C:^Y^5IYNF3^D/JJP8<T3%BT)<,:^W,Q7QN
MR#I0%H?4G5"OQ+$?W;2KMD6W73FS\YHZ"+X""AFWO#X)>?/?8)<A5&J9=H2^
MLO'"56-,C)[O.7V!HDB+M 5&^Y*C8$H6,4B2XXDOROFI*GX^9G6QCJ&+93&1
M]/&ZUL?K,FMI\BK(UEG!Z<<-I)_"H.#\%ZWA81H,BQ/I/&6;J6BO1V+NZ%J.
M32G-8A$.W8QSXFGMH8SQLDXNQDO,(3ALEN<0K&!&MIQ73YYY4$":?O_);$^2
MM!XD&>$Q?H=* CPEYN169B[6;>+W__;J+XOWZ%A(;=DP%4)55-#@KI#*L:'>
M'<6> =0!V@T2"K/__ UR]Q"7F)6,WP 6EO_^41EOJ=7I@O[UQ4U^"&D%*LAV
M(,&N&)O4M\M%!'8!6X27J+&4? E4^R@F<$=$.X.<#71X&D]M,LS9,"8>Z"G)
MUE$$ UCJIRZ !K9EX7D&117JRL4>6ZIWB:=I\J9/?G54\E&U?YM%##31]=)[
M=V3TF;4-*'3C-S/]C96?VJ@K:5CGB).+UV8^16A)WZI=G&.:^H8J99+5*"!-
MN?RO)PS2J09#)\=.=D1NX+G,A$P<_FP/1TQ>>GW0,E(Z<8C7I^U,ZWJ.OV+?
M=&$UK=_@L:@U0&Y*;K;O"MB?N%V)3.U0FZ]2(F2T:TC")C'2V5,,I^>"+7Z>
MP'J+S!JCS,9HZB_7WWKS=L:*DNR*L]@-B2T.PXBD^6;%D9ED+_<8IN?S]"@4
M3[D[X'W(< F*",J*CKQ9H>,_<(6(>@[=)(2/K0:1I3V0XFVT/BHY +E36=2O
ME YJ8;/?;\4(?(4G&VV,?O#@>]D%"T'V(8\@7WXX=3)7(8Y,:8,IQ'WEOE)(
M?)W<1">!FB0U_P>[Y4"*R7)P\)L_.W,9LH,5RSJ"5RK+;,;?X,8H6OJ!?[P
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M-7Z#]B=TP7V=:.4W[J-F>H/=4^@C*?8]_.;-7][2QV^<MRO0I D4>;4[Y.L
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M2(*VP#?< S09(N8CG#LCC!B8DS &8D9R#Z^ &IAU_5LW[,O2?G\X"N.I#T#
M!.V?J+(O!8X.J!IQQ&O +G30Z@_QK>3/)91]?MIF T)JKA7Y/8VA@LW<H)\]
M/%JZ [I7I>H9##41@*XV@@J-A77&6WMP6I4[.)=&![Q3*D&@D_$AQM[,?>NC
M8%,&K"#&0\!7P>WW=&8,#L/MPUY'^J/)"#[(=^LC\)RA(,+TKVFN"8-F3ML
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MK<T\4*"MS607+ H952@F6YGPZU%Y^'6_&WM3\:_;\3#\^;]02P,$%     @
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M,@>Y IP:O<S>];H"<(;:!\[R7[Q@,J4/(5\M8<R-!&?=2BT84<<AOI@%/-@
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MU>X]BO??>+"&.>CS+_\%4$L#!!0    (  R!G%*:N9>N#"H  %J] 0 5
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MYS&D=2+&%%@HI_B#Q5RFD/=M%R]M\]49_1H1)9&XF%) @EKP0[.GX8(WB+E
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MLK:-,>G _[8:K'(;<B"2(NVI0XHY01R1@-LJO:GODS*JKOV% 3%0\"5#7]=
MW"6S<Q*-Y2X&B5+._^#8>Y3;#B EO?0"N!:QBF&Y)YUCNOLJ?=Y4U%BYK*[[
MV65..VR"(/E-:P)T")XO. 1B(@5P)[$'^KY%CM^PE+5K[O);.RI(B8(S.3SI
M-+();']GA9 45"U\E12!#;2,R>$:B(-MZ6F'2+[XC<%;^R7'J:]IH2ERSY-&
M,FJ2RT;!&8@Z(F>T<U:'0'$=JWLC.6-RO@H#H8#\2V*ANXIA X<F)>H= %(%
M8A#78-<9:< /D($2QU,DI(H7_B!%8W+#RB.B@!9J)9/= !0.W,0)0XZRG T9
M@<-( J(DD: (U=Y7*<?>3,Z8'*["<"@@_]J)S#=L6L6US$^%D-P!-S?O,@&.
M,FP)-D(::D65.H_M9(WI3J(P-@KJ8VPY8SS9X!,7X%/D1"8M K*6492X<\D1
M1JRO<N+4R!DK<LVC(^SUUBE$%FD#.#\.KFU$RE(I-0N:V2IV^6/7/&.[!ZF.
MML?3YO;25;&%=[?SYH3X!#N 4BC%&! /P)Z.'"/A)&%*$>)H%<3<)61,UOL(
M\#)(3X43)B>:N(@%MBA9R8"1'+KAFB)@P5/!&)%U"@(V/?0X-.N3BV"L!>)E
MH@EQJC@RRA&4"*,,2TEUG53(+5F?8TAYW$O']YR1@R5<,.VEO8S=_,O;J9WE
M=L(_7C_QFW.L@O>>L1"1\+D(GU@."Y$HY(WDFG&PG</=O*9"Z0$/$S6F_:X
M!(K)OV RX^VG+8&0^\]98NZT5PZ\8R$P[*I4(^<(13BHY /7"8M*28Z/$S>F
MZ$4!A!371[EW)*]G=\*H '!$6EN*>'(2+#)PNBQ.*EBE$ZN3)+6/QH^;'3E(
MXP?)M6SQV@IJ7RNDI(:]2%"#7,CIMECKW!*+HB 4 (TH;TV5:YF-U(PIZ%!
MW\,E?JP..+?:G13M>+-EY)HM6X[5T6:]K<X&GW^@\!X9O6*+H,=XJ2;$7!_T
M>MI^*OLZP,V@-;LJ;::\4+N@7 H#$X!9^;&!T5Y\^:W/]?.OFQF /C]"[>?-
MQT6(=)*X(A)[B^ +;%F*:&29L$A2RHCSDE!3Y9GGW4DLX-QX\/H7+Z/<KQIZ
M'V&KA7G^O=#MA!NI8A 4T<A5OA1D2'MGP.)V5D1&(TN54OUW)W),_F\EI&UP
MD.KHL)P+;;\LEO;KMGL7+Z\Z?YXO#-):XN]$<N$8#0RQF)O3\P@"( ZC$)+
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M:'(7:0^'-H5_<<DCH0'.\RJOUNU.XN "JXU!@ DHGW &C-/ $^+$"^2B-L@
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M%^!>)4F8L?"E!@:/R^81,X!B=,H3RI C81$IULAY2U!P.)E$K,6J2OWFH1E
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MD?S1%@OV8\#V3XR>CS<=% C*9XY,)8%,1X\,5%$L>XTB9.D<7[X@V5,J] +
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M?0\\Y/25WZN86U22P3B[C2'<2&=@"G(K<JHMIFK8J!:X\9SV:XX.3"Y%YN5
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M:>;1!"92\9'68AF<:<'2#;!])^0Z0O:MV+Y#.J]I _TT&I;AHIC1XA3\ZT!
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MA=D\7/\V261LW>JML\462(IQ=(5IE>GXBG29D4,(J%%+A&X]879__WE"/91
M!^P9LRYH6'=^SI-;QF'-^)HT'[V71<O:A BJX>(9>"S,**DXDA):V:WYPN%U
MGC'F PIX;S>9$[%?S=:9PM4UJ>*L+/^"^:;NS%L?P";/4K9DH12#9*]&PYS.
MWD)4RL=N^1M[EWC&B \CUOM@VWYN 'R:+.&J)CUO4142V1Y*)](Y*^GX$;:V
MZ.7,B\"Q<AO*=H^H/;;_OB6>,=C#B/4^V&[4E)ZO#_2O%LO)Q^T7I5=_?ZKW
M5>.4B Y+CY0><:P0ME(E@@2MO"A1I*2%09".]K?DQJ80;8!NJ1+'B>,H3;B9
M\_#?,)_#=#DY+>7H_D?ZH_, 85MR-HZ$R5U)TJ(N2@=MC.)6R!1#4J)<'B2Q
MG\1.3]7:]ZD&TNN0ED47DBLAI&*%TD[E6(47$%+.0*8GW)=ASV2L>]_[]@^^
M7-3RK<FR1VNZ(U=H(/<C6-J" V4.0MF@G"&[WY=(IK^S GPA. +*^W!T9NXH
ME.ZD%MS4.W_\-,</->;^>3UPZP1@'OYH?RR.)'Q+_ DR*FM,X*%HD5/06BIE
M-?(4D@_E\B@6AI7XZ2=.UT^/(/T.)Q+G2G/OG(<8M+4ZJH0E1!U!*N]B?!B#
MGB?4P>^OZTI//YRZ?[PQ&OL9V<)#&2T0'') T$($CR"\*RY9X9%<U<-X?+-,
MSVE0#Z]3T?_M-EVF2.F4X)IQ+E(=.4"^M3' BI4E@LY*^":U)\<2VK]2;Y;^
M2>B3X[!X]:]K.OTO@U:02P%&SH:N#2XB RB:"0V.IZB\4ET&49]0GK=-ROB^
M7U,]N5^*UTOV+29U[N'YY]D<)^^G+Z[G<YRF+^_(7%A NAD2N/II_61UD?_G
M>K&L,>C7N/R]O(._WU3_@_YBN9Q/XO6RGJ[O9F_(TYTN+RTW=#X'8+;HV@TY
M)N:#D\PX;4.=$%!$DP;3HW+YS'7X?#6FP>OG(7%>?*9;JA)+G+^%*WR+Z7H^
MJ5;V?18O77+5VPS,B53;[7%D 95B'L#XP$$(WF;Z[4 ,?*=*W13G!L^T^TTJ
M @SS3?>*-U>T&X_;A\F0?UGEZL@Z99IN)@:9?LQ"1DZ6G8EF5/WMR]!WJL^C
MZD&#&:_[^*I=6M9Q]5\(BRK'WZ<O<3[Y#+6]S^)B/EE,IN]?TKZ=OG]#?SXC
M$12ZL%9;-M@8D\Q,1%&OF%28KW,:1!TX*+B3Y&..J=H]>/E.M7HL]!N,8/D#
M4WU<JIT>5];1SR3A#C)=6UG+-3.WEP\92\4[EUD"[<F7X*LD^T@,22$M>12J
M;.=:#*+)0S+QS%7XT? >,!V@B]&TWF#;W"XJU<BU):I)<MG6[@5>L  &F2K!
MN)0C,=1D*O-IY#YS?1P!PP%S$P[$4;#8%'/AK"3/F2[2DA!L9*5(QRT9)M9O
MYQZ-$L-J%KF\F9.<N2*P"T,'@:ZO0/:8S9EY%6W!2$2WL<N/(7*LJLA1-TXS
ME,ZH1A*F:0)7OTX7M%[]Y*KL)87:.38K)D.H<\RB9M[D2/N?Y^0L]XXWB>'M
MH>>Q:A_;X7^_5*@W#FWJ J:+0H?>Q32_Q?GG2:H-4\L.:A?OZ).+W7]UDU#5
MA9>699!#,O-H-9+]M>1^#<+C0GSN:BN,S38(9-S5FHPZ\M@7Q6NPS^62,_>F
MR5%X_NKZ<)GE>6OK,<@VT-)54C NEJMVU/!IT_8M^81@.8L:ZRU"=B[D.JRE
M!"G 1*ELDT*;G=2,[Q<]'L"SH=%I\)![EZBW?]U2A28*[[UD(3ID&J%.9>>1
M\62(5:+4QR8-PG>3\T-I^N#3HOO.INWHVG6M1NQL>MMV5$&03JO(A"F>::@6
M:XF"91D$49>+U$TBXP>I>O8&_W"8-'A@W*+I9F-T(:JE_;Z3JD?NW]P?O>UI
M%8.)OL%!LILX;92G0RPS$VSM5NL<H_^UCDO@R@0%OM&K\8CZT+6O\TCJ<(S$
M&ZC!G4-R9\K/IH95%Q>CE:QH3A:2PCH*2Y#%C\XX$;P2:KMB<.BHY0'RQK=2
M!L!R?WAR*" :&*UWJ#R8F7!#;2*+*%H QJ43M>,.L"#J$)Y0!QF++*5IK38=
MR'QFZC,T,&U/G4T"P&M<OH#%AY^O9G_]%^;WN$Y?V11;9B4E #(RR41M>0FL
MCOAC4NGD<E)<B"9.T9%T/C-%&AR:!N9M!R-_<W)BEB(;R0!B?3LJY/AS,OBY
MR206#IA*DV:DG2E\9MHS(!RCC-1\^P'JV_FGZWGZ  M<_3B__;''+,EN'^Y?
M#W0" UNU0,*@39A-2!FU)*"S2<F4(+,RVFAWV6V)'FT,MK[XB2ZOKZ^_.5L.
MRB<F4AVIR[-E@*28/FF9:R2OI.WHQNY.!H=6&233X:N(WLSK=-J/%]?+#[-Y
M37B[^%AGRXI+X\&BR8YE6U.!3*JM Y1F)08GE.(H7:,)6YWH&^\P&A;WG04\
M \/1P*[>(C/?37U<R69QZ7C*423)4-5$WAK&#!Y<O7)+S23S*;1IIOT@:<]4
M5_J"T,!N)O5-B'E1DQ"_$OI[N4FIXL)P$<@E= $XTTXBB]X[9B.98J 2\-PD
M_'N8K.>B'@,*OX$AO/N@^P.KP$B+OYYX7__-[=G',W?*<I9T((,O06$@Z$<C
M?712!F%SDU?QTTE^+BHU$FA#=P[<(8_U*TK6' /'VN12 =-!DAA$028=6!-+
M 5>V'[P[6VBC9":V@7LXH9U+KN&6([ QJU8I(<DEZ:PEQ>2%:2$C"\H61F=A
MU$8J$V4;PW8O26,_0 X(]_9Y,8S86[Q+[Z1LDTK6@;:F4V(/$/=(CXX# =E)
M/WJ@,+:FZ.PA@A<,Z3Y@VM;)FW7\9JYSZ5S!K*#-/-G1->2A9\A'4)!CA#_\
MS(*TLL"$D&1%;[HCNZ!1(&>Q6/*V')DWOAZ:/DARO8Q =2]DNV]<P?VO/\*0
MV<&$/QM2<D-/)+A+D.2;WJC2Q RF/E1*5?-K3*W<B$Q 4"59Y0MVG3QQ_^O/
M$<J3)-?FJ0ZO<%XC^EM,+U[2'ZY.I*BT%44),F12KC:Q(7,X&59,*BABL"B;
MM"/J0-OSL?V&!J+-8]PA$F^V1Q<B6UJ#G:A\'+-P<(R/TZ$> (U_\MP0RZTM
M"KAE;I7)@-RP(#P1ZU'D$G)]RWQF6O2 Z7@>2G0,+J,8DTYEI1TF5K*+]3(-
M+&97&&3K$8OPZ9ZBG+,QV0"%!ZW*8T0XBE6IK40?Z$9& Z:.UK#,0W"L$"U%
M(2]1;^<%G;-5.2*F)XEP[SX=,@_C-?Y%<JA![OKX-I]-Z;=I/33GE.R+0Y_K
MGW/1F=BM3 M(3MH4O>&"ZV1DR%&!=LEQ';Q3]K(CV4-)]LWL:I).[!3?Y;--
M);V;^.W6VSQCDL[0I>>T5E 1X-YDHWW.M ,.2?PN&S>J7G^)M#'_\]_^#U!+
M P04    "  ,@9Q2<+XOZM44 0"5=0L %0   &AO;'@M,C R,3 S,C=?;&%B
M+GAM;-2]>W/DN)4G^O]\"ES[AJ<=(;CY $G0GID-=7556['5576KJNW=Z+B1
M@:?$=2JI(9GJDC_] GSD.YD $Z3HG8VV2B*!<WX@?C@ SN,__L>WQR5X%D69
MY:O__)W_)^]W0*Q8SK/5_7_^[I>O[R#^W?_XKW_[M__X?R#\7S]\?@]^S-GZ
M4:PJ\*80I!(<_)95#^#O7)3_ ++('\'?\^(?V3.!\+_JE][D3R]%=O]0@< +
M_,._%G^.TR@6'DZA+Q(?HH A2&./0!)X42)XG 8,W]S_.24Q)4F$H(^XA$B0
M%!(_H3!*HI@(+V"Q2.I&E]GJ'W_6_Z&D%$ IMRKK?_[G[QZJZNG/WW__VV^_
M_>D;+99_RHO[[P//"[_OGOY=^_BWH^=_"^NG_31-OZ__NGFTS$X]J)KUO_]?
M/[__PA[$(X'9JJS(BND.RNS/9?W+]SDC58WY1;G V2?TOV#W&-2_@GX 0_]/
MWTK^N__Z-P :.(I\*3X+"?3__O+Y[FR7Z??ZB>]7XEZ/["=19#G_4I&B>D^H
M6"KIZ]:JER?QG[\KL\>GI>A^]U (>;K995'LM:JE3+64?JRE_/VYSKZ_0GQ'
M\E;'LCH0KE;W@RL9^S#]X$S<KXH?Q/@"[W1SM<C-!_5VQ:?Z=C==72WZ^!*[
M^BSRBBPG^"RVW>R(O-2_>*]^:KO1#?60:=U/2]T[HHIOE5AQT;#E7M,@X__Y
M._738EW">T*>%E\>2"%^4$3+W^2/3V)5UOQ]6Q1D=2_TDOC#R_:13^1%_^KV
M-U+PM_^]SJJ7.[4(%/7267ZL'D3Q]8&L/C[I)LJ?5!-5>;=J/J1%E'#".(X@
MYBR B"4$8A)QJ%:^)/0\2N+47U2;N;(0*_C+ETZM6O;7$?QW%B-1G6&40I3Y
MNF#;M?AQ>6J!56NK7HWQ]ROR*,HGTKZ@M-=F2P/(?]5*E>!>"RGX?WR_Q6=&
M@[W\EQW"Y02C![5AP\&NTF!':T!?P.YSK>:@5OT&-,J#'>U!K3ZHE/Z@!> &
M-!" ; 4:$,Y^*3G;TW:I3;B\.!RVG+W:L.U1;3UDDI2TQKP528U?X'TOEE79
M_0;JWT#/;\W&WT\N^_='L_&VZ( F!;OP*;9/?,]R96 _57#OJ]0;DM<=D2I_
MW8G<?*D*I-^!O."B4%N\$X!OZ.\A7WY;_"AH]5EP\5@W_*D0C]GZ\1/)^$)Z
M!,6^B& 8"*%6IB""*?,1C+ ,@D02Z0ENLC+U=S.W=:05#3PUPV&VD%Q LI_V
MW>$S,DEK&<%6R!O08:7E= (4;\\;ZGDR 6![_<T-..,%R R/=KE0S^I%P/?"
M(*F7@ MO3T+89AIT]&KXM!T9<I$MNN.NK^K51>S[.,58P( F"*(H9#"EPH-1
M@$3(_$0FB3"AO\.&YT9XFS,^+9S9+#["JI_@KD%@;$HS4MYX)I[3=&NJE9VM
M5@KVI_O\^7OU2F.FJ1\.K;.CYB:9C.>4Z*;?V;_;3;C.2*I-FP_Y*G\2A>+A
MU?W=BN6/XNTW;3")121%%,1I %D:4X@\E$!"?!]R+'"*<.*E<6JS/^[O;FZ3
ML]G!9+6(X#O1"/G'&[ 2AI:)(<IF&U-WV(T\K1O8=B4%=RV&K;!_=+?O,T/%
MY6[M0H^3[K',M#_<&1F^-8Q1]$4,7R_%1_FIR/F:57\G>LM5O;S/",V6:F?U
ME="E^"J^53\H5?ZQ\%'J\]#CT"-A"I$,4IA*SB&-2$I3CX:>I%9G<)8"S(UU
M6JE!)S:X957VK,2V/%:S'0?#X[$1T1W[F*L5'>02'(&\$1_\6BL M :@5N'_
M=WA*-1 ]IZ=-MC),>VHT$*&CTY^A[0QCO7<D*_Y&EFOQLR#ENJC/E_Z>50^_
MK'):BN)9]W6W>EI7Y6>AD5 2U-M>]:]U42@*_H&46;F1[8NHJF7=2+GP@C@A
MB>+'B,<8HEC&D*"$PC!,O##QD<<1LN''\42='9,VITCE][>,%6NR+.T8=,0Q
M->/:>8S4R*RLE02UEC=@1\_&V6574]"H"O9UO0$;;4&M[LV6RF_ CLKN2'S\
M87%)]R-*.^G",#[JATO(!#T.6VS>Y(^/656W=+OB;_*5MN&%$D"4/V8E6^9:
MVJUAQ[V$4.0G,/4)@DBM&I F#$$O]I+$QXD,@]AF ;'K?FZ+PH[T@*STA>>.
M_'8+A.4XF)'^>.B.3.2]P(*M[,K 'L.T'H:;2Z:UE&!2]AR&SB$C#FQE&,O]
ML"ZSE2A+U2G-5C6S?JG$TRW[[W569OJ?W46MH@U15G>K^D^%$)^$^J17%;D7
M"Y8DL8<QAB*,4L5]B$&22@D1I@*E/J4>LG+P<2'4W!BQ]=W(6I&U=P9IA;X!
M3QNQ[;C1R>B9,>;48S(RCW;J@!U]E"6K- ([*NVXW&R'[78S;)\N#YLUP[K$
MV27O.I%K4C9VB>0A1SMM>QAS?RUJ@_GE2Z56@9_%(Q7% J<!)])7]J='0X@B
MP2!F 8*8^BP,)&'4]VR(^$0?<^/53D10RVA'GZ<@-&/#*X$9F=SV,0&_-@(Z
M- -[U'?).:>ZF91">O0\9(2^1YV99GH+?+_*_BGX'5<DDLE,;X]ORU(H6[$A
M&*YLQFXWK"Q&];?UH^ _"BD*]<>OY-O.'Q>8L)!PH; 740 1HA02KH8B24*)
M8B[2$'N+HV"&(;:"8\F-)IM9S(=;+ZA&V.XZNR+?1#G@*GN"H1]L];W&2+ZF
M3;C5%^PJ#!J-.VN0U[OQ';U J_4-V'P42O'=)T:U&4<:I9$M2M=2O[:].=(H
M&%BC8_4\T%U!%,\9$ZV)E?@DQ$Q$,/*(LE)9C"&57@QI% 1ABJE,L-5=VU[K
M<[-/6^$LW0KV\#+T&1B*PM@. 8U<(UBA)S5V>HF_U\&T-_2G=#NZ?C_YT( (
M";U9?=(GCK^LU!MOUF6EK)?BEU+M4F_OU::UN4\5*"!"I+$R%".F=I=JRF*A
M=I=>E#(_3'W&?&D<+6'4Y=PF\T9HL-92 ]:*#=9:;D V@EN$"IAAW\\!XR Z
M,C%LP:P%!IW$H!89W(X'ID4,AG-0)XK'^*G(E2%+'O.UPI=4H'H0@)*ESMH
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M2#@,N<<@(ES"E#$)PR#P6(1DR)B5$\J%_N;&WYL\!:W[\4&Z@AOPP3:-Q27
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M.P)I*CED5) HC7&42L\\#=/E#N=&1^UM7"[!)L)$2PV5V%#+#7[M)+?*1F2
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M,*$>P9$'@X $$"&20H*%#SGEH0P37YF-X:+**[(T6PO,N[8R&C<"C,<E2G+
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M*>/>W]?<V.)K7FEOC"MO4TQ [B<,Q]"-?8]R%J_+>TYKX"Q"2-P!.%&(R#5
MVH5]F$'3&]9QH8GIPC;,=-D+RS!\99@55IMZS265-OC:_%.AB&DJ_!@&81)"
ME/H,IJ'P812D,E(DB[F=-_')7N;&I\U.:LA-]&D0S<RLJZ$9F2\;5!H!;\!6
M1'>V52\"+NVJTQU-:E/UZGIH3_4_?%7-Y<_B2=]7-Q4"EWFY+L3VXI"PD'AJ
MAD.&HT395)Z J9 >Q%X<^A&. \.,-A9]SHT+-@76-]6)M?/6SK7?W:H.(]9+
M[*#2S;T#8'ASZQ;6L6]@VTJF&W'!5EZU7QOEYM0<H!&*0O=V^QJEHDUP.%-
MVNC5@:YSC;<61T$:A2B"*(AT[JS0AZE,(DBBB$4B2*GP\:+2.QXSSAG@"K=I
M?/0MVQ!GMP8F%DJ*)/*AG\88(IVK->4X@1BA2(B$XA@Q*T_"67H,WG'US64R
M(X-= ZU< &?GZN?:GV\\O[W7\,_K]\-SX6]W]_A$LJ+)&W7HRG>WXD)FJZP2
MR^Q9\+??VE++/^4Y_RU;+A>8I2SRO0!&(F00A11!G(04)HK=4(BYCT*KNE;7
M"#.[B;W1I<FV?WAPH(TL7=KJZ;%OA^%^S,R(8JJ1&)E>]@?AR(]8EZ7O=(&U
M,N"[C3J@T^=\_*M]ZBD'L#K-3'6-/-,FKG* W%%>*Q=M#DE[]0^Q%,HZ^JL@
MR^JA/3^-*2'$\Q ,B$>4N:/+Q?M) GV&)0VC.(HI-3[=/]7#W BRDQ$T0MHD
M.SJ%G\'!_;6HC+UMW =DR!G]261LDCM=B=!$Y_$;I!YJ.9WE7.K1OC^3TJD7
M)\R/U"/W?M:CO@<'$%GM*;$BRW6I!E=6OY%"M-]<&- 0LR2&21P'$/D^AS3"
M4E%:1'$4\B0./6,V.]O-W"BM$Q0J24$GJL7T/8^G ;LY06EL>^P40$.([CQ2
M%FSG!+&)*&\@<G8$>!&07A8\__9T5'A1@ST^O/STT"3)C0?9VV\ZLYS0^9D7
M0<2]-.((,JZ#YU.I P?B%'*$4A'(-,:!96KDHSYF28?:F[.5\09H*6V3(!]#
M:;B%O0Z@*9C0')L!28[/:N\VM?%Q-Q,G-#ZKYW$:X_./#IOG;_+B*=?5R]NU
M!_DAC2@G4":1VL.QE$)"F8!QB(@(.4]$@&WF^$'[<YO?&_'LIO0A:F;3^0HL
M1I[*&\FZ&]01(GK.:.]R*A]V,>DT/J/?X10^]]A !P&=6:LO!^P/+]M'/I$7
M_:M;'0"G2ZI7+]N2"XT7^=<'LOKXI)O0/@PZ&;#@']9-U&"*:2CB"'H(^_IP
M1T 2!1CZ$ODICR4+N%WD^522SXUR:JT@[4^K35_ [G.M_J &X 8T$.P4-BG;
MP))*H0!:&&KWGP8(]6,-A:7OPV3?EAE]SO*+&?M ;88?B[UGQ]0#Y]0_9#+A
MI_4RF7I,CGQ5)A? OF#E%\'6A>K,#^C7K%J*1<2#*!;2ASS5Q8$BAB&6ZI]>
MPC C4G*!C,M3'C8^MW6J%DK?.?K!=_2/H!/7O/CD$7K]-'\M)B,SL2T<5H4D
MS^E]1=G(HR8G*Q)Y3IG=DI!GGQF8"38KG_*2+'\J\O73FR4IRTQF38F?VV]9
MN?#2)*!2*FO5XQ2BF.L"LS[6CK)Q%/(@)+Y=0MC^_N8VE3MQ02TOV!<8_*I%
MM@Q7O 2XF47G$,:19_]5"-HGCC7#Q6G^V M=3IM&UDS_HVRRAJ]-O-5NS9*?
MU(/:*:.IO_)WD=T_*!OE]ED4Y%[4?_R15.(=R8JF3">*N!0Q(5 0968@2B2D
M-(DA"<(P3$@<2VR5IF=B^>?&@9W @#02 ZDD!<]:5+VJYXV2X%XK(@SK5KW6
MIS'R?GG\ 9__KGFS+VY0T-D\&AQNP.9+:J%H'@$:#*#1<%5$]I7'<1:;Z($J
M_&MLI:\;'V<;ZBO%&+B:KFDI_GNM9'C[K/[S5;52&XXD$B@)XDB79H\ADGX$
M<1)S*".9Q(@)$0=6L:QG^IG;ZK05$]1R BWH(,O\'+"&:\;U<(W-[4.0LN?<
M?AR<<N.9KJ;EL'Y]C[CFPN,#@\M65<:SY5K7@V@/"#)1-G[+@NOLFIK9UE6;
MMODM*5:ZBHPBK(;87DXW4'_^OL<B*GD,XR1F$/E)"-671J'T<!CXON0\L?)=
M&5'6N7'3KJ1@*^H@=AISB,T8;B8#-S)+#APS^V"U\=%T&@$WHKC3AM6-C_M1
MK-X$70[U82IUD3&R%%TFGQ"'+"8>AZSV8I*>!U/BJ__$+&)AXJ5^:L7V1SW,
MC:.U@$W5Q";)O:T[TR& I@Y-5\ RNDM3@T@MW2CN3&=T=^O0=-C)Q"Y-9W0\
M=FHZ]^" D(P?EGG.O[!""$T@G5\B12D)N("4AFISB%D L:\F."4A$C'QL6=6
ME.=L#W.;T;6,8".D16#!2?SZ)[035$:>T > # FY.(F,1;3%M0A-%&AAC91=
MB$4?"KW1%2=?G"ZPHD_NO9B*W@<'FBCD*=,)2P0IQ4>ZS.Y)YZK2Y1]# GN$
M>@*BD(6Z,J&GJ,YGD""<$DY"/_"M_"LO]C@WPFO*= N@$^8)D&]%!A L<_49
M*R$>+>V:BZ@;VCDNL1S;[FED!;6P8$?:<=+!&4/CU"RZV.FT9I(I!D=FD_&+
M3H*X%G$BHQ@%(0Q\B2"*=-HF/Q60B"#E@L;8YWBQ$DH,P<U8YJ 'HWF0-O-@
MMY_QIL,F2$DT$EX5NC4L;&M&Y' 8LC5:L-88L_ZPB]<,TCHWH\\]-F ;]'.V
MRA[7CU])<2^JQI6UJZ3>E%;_N*JKK7\219W<4*E17]XQO:[Y(D0$^S%,@YA#
MQ'2=8U_'L@?42S!!B/M&!R!72S(W*Z/5!0C%MG4:G:=&3GV/7^6@$$SH(].J
MUA6L:F7U,4)9JZM_8OGC$UF]_'NI?WK,5Z#4NEOL0JX:6(-]W%3#-3)7=2/5
MZ-$&)8"/LO':*$&C"_BX K4V8$<=<%=[:S#CM%37CXO%+G*J\9EHM]F-T_Z4
MV9E6V]E3/9 *_):OEQQ0 ;)F !OWFVX>@:<B8_6L['1WE1K%!>R]V]NK.IAN
M&^P"A[WMLI,&AQFX/PO59U'6.=?+K#:>;U>\\0-M_KE-@5IN,_;&?A3Y09C"
M,.#*#B8^A22),$0\2D7(HC@) IN]]C QYK8T[LIK9R8/' 8S:WI\<,=>R!H%
M;L"N"G7RQ%TE=A(LER-E6+X.29>F_$!))K7XKT/K<&-P96O#Z/%3D3,A>*DO
M9V\9TV5GR\^UA:MS]79WL$T9](6,$S^@ 8$)]B.(/"^!E <1] CW4AIQ&096
M_N8VG<^-"CO9FZK3I)6^W1W4>8[+/?D!N2^$L$^#:C5 9G0Y%NPCD^0^XIW@
M8"LYV!?='2L. <PE%UKU/RD##D'FD/<&M3&,[;HJ$&_R1YJMZA953_G]*ONG
MX+M)RIOTJ%VA'D7#[]6O=?TS[8ZB+-9'P=^0\D']0<<:/Y.ECC)>)$$8"NY+
MQ8\X@"C%/DR#$$%*1$Q%$)$DE8MG4=#<E"''%=AF<N^*/>;51&F8(W6B(35C
MU/D,T]@W[%T9E1U-=4G:3E>PE^F_T19L"HMI@W9'8=!J? .TSO5?=[1V1]_3
MC(Y+PA]9XDF7B&G0/UQ4)NK5;ADJBTJO=GS-JH_%%U$\9ZR)O* B"2),./02
MJM,FQ@DDJ2^@"$*91I+Z(3$RK,]U,$/C6<M83_E63"M?\;- ]M.U"WC&-W)M
MD3'FPTOJ]S"8>G6'O=2_#IGK;-N3<,TES3IVN/C<@$NX'T5%LF7Y4;X1A?II
M]0-9ZO/++P]"5)TYNSW0DHQ$ <$<1J$"#XE40C7OU6::>'Z,?(Z3Q"@]C'W7
M<^. )L-4*S*H9;8OPC9@! RNQT;#=63R:.76-V"MY ?X;C;-1J>'UR)M<>$U
M&N(3W7!UR.O+WQ9YVB)?ULAW!T2NKJH& =9[-V77XG2748,TW;M]&M;"$+?T
M_TO=FS9'CF/GPG\%$;[AMSM"&',!2,+^I-IZ*J*FJVY5M2?\]H<,K!(]J4Q-
M,K.ZY5]_ 2ZY)Q- @A1]XWJZ))'$.0_(!P<X6[DTI$87RVI=\FW/Z!RG!1$1
MI#C3QEU>8%@0A33O,US@'!,<*?NX]'-#3(W:CX1T";\^BZ %9=^,R] ;YT/Y
MO$+3S[]=#K'IMV(T5G"ZY>OC&)/>IWU_4/K9.T>,2N^3_# LO?=*OS/3]T_/
M\^6+E*VY?+Z&Q+:@8ETNHJK;8N[_W63__+I<_Y=<[W;A316)#\M5^RMS73P3
M*">*YC'D280@BK2I3$U-X5BD,94H2YERJL,VKOA38^*N1@?L2AH]UU(#;68;
M5U4GM[%;-HO5[ABO#K1IR][P/2#NP(ND*T??_\AOD-V1[73?BX%7HK,5C78E
M8/;*_':%CNH\2:VFGOOUWEGO75ONJ'Z9]I0-=W#[.G,4\B!W9 U&/=A]G=DY
M/NA])2E&+A"XK:E4'TDWU9B.ZB^9>'*N?WQ7_BB%7(B9D)G(LAC#3,0Y1 JG
ML! BA3E#12$096GAM)*.*?S4UM%.+O!2ROE8I?]\)MUN\9OJ5(ZX]'D6_=M5
M[P-[$)RI^-?! #H<)E#M[X;9FT2I/Q_Y_W?4^;MA9H(5^;M%!L]J7IS+N32=
M;D0MTE?YK#_U1RU890H)UAZ]),JDC!B'&5*F8S"6D*8(0T54%.>9Y#3F3E6Y
MKH\YM<5G3^2&FL">T'=-55&O2EL6\-NM)X%!'7@9"("G>Q4L>X2"5K.R&';<
MJE3V.)Q4EW*XU;=*U&*]HGS]]W+]^'93K9=/<M6%@[Q\;>HF[38(LT*F3)-3
M 4VY;8A(S& A8P*C-,EX1B*A_^A60LIE^*FQ5"<]^$.+#SKY[[8!7R\F3JS6
M8>\,P;4(E=/\V''7<*@/3&-A ?>H;N6#6]C25TX2C%P7RP>=TZ)97D_Q9;^G
MIW)=]TNZ7P@S=*DMQ@4OY5[BR3VK:HEF*.:9B@2'N31I<3'BD!0,PUPEF61I
M7F34J0JST^C3X[ZM\'7DUH'X>VE;VJQH-7 TU=SFQI;X!D)\<-X+![8'ZWF
M%I;T7 08F?,\L#FE/)^'^#'>=L?[<?&\65>?-*'.X]:OSEF,4IHR*$E$3'B>
MA$RF$A8L)3'A>9H5R(7?>L::&IO]W\U2V]C_^B]Q%OW'%Y-K7S7_+A?@GIO2
MK,V/?Z.K?\AU\V_C FJBJCF=-[]J@_]_JC5M?A7_[,9Z??-CQW&!4!^8T7:'
MBG>@$51;<494$ ]0EM0"DY"$U3?<J/1DH?<Q&=G<$BP3;<MU:_VOJA1FJWMX
M<E>]?33__+BX?S)!:Y_5I5O,IQ?/,IJ1A,8Q3# R$<8HA902I/^'(\R*3*0R
M[FIY?;=GLA%$M_HV#XN$?1]IB]O(#/B^T/N-HJCX;VVH/_5F,+W:&V%'FE.9
MX-=,:=N;Z@/Q]UU%FJ4;I4WKIT9M$TASZ=:[)A]NT+RVH>9IX.2VX&*_=H;;
M4/-@D>8VV-!^"UV=YF$\42OY*/7#?^AQ^?))?EIJJ6GU^&&^_..O4CS(7VBY
M,+]\([4Q:4XU#KLS+L1W^N<,Q;' >8[UN\7TDI;J_Z$D9S!*8Y0D+.&,)AY+
M6E A)[IX[0CJP:0G_*1W4M7/8"_F3_^RCAZM _ZV0.A?&R3NP$+6-Z_IG[+Z
M=[>E+>P[8+>(C3^EXRQ73=K4@6*@T4QOM<R4MMG41C]0*W@'?JDGO/TKJ_4$
MQXK61RE:U7#+TR S$'(A"BO@J$O.(-@>+R[##.);IYBO3 WD=[+Y[\?%QX7I
M*[9<E;*:90+'"N,,8D9BB)2BL. 9AR).N)0YXDPICV6A=]")TOR>A*Z%C/L0
MMB/=VP$;J\AQ(Q_XJ9/T9[/\V6#G4?;8 I.P19#[!ARY)+*%[J<%DFUN"D4C
M70+@%_IBRD',4)Y'64099#F.())<0(IE#A/$4Z%PK@K.7,Y]KXXXM=/?;8[P
M<R/?K2QR#+ OD]P V^NPR1;(+U> #$ I%\ 9EE:.!WUE:KF P75ZN72C+\4T
M9/7RE?[Q-[WJKTHZKWZ5>IO]559R]4,OI@G-LAQE&41UIZH$Y9!)'D&A,D80
M38A23G44KP\Y-9+1@H*G3E)7AKF*KRW%A$1M<(YIA;T#!KNMO'?@UV9?WLD<
MDF5L\0E+,U=''9EG;%$X)1KK._V8YIU4<K62H@T$VNM91(32_R]7D&9IKHT8
M)?6_N-X4)4621C1".7>J7GUQI*GQ2B=HU^72C5HN VK'*$%@&IA(M@BU0@[3
M\^DJ$B$IX_)@HS+%59V/">+Z#7Z\\-M"&S9S<Z;;'<Q\7KS3]/.#FN"-:A87
M428P3V$D\Q2B@D:0Z9T-U":)X(DJBC1UBEN^,M[4.&)W$+[9"MYS)MZ<?[L1
MR;49L*.3@+@.3"H[2??/FDW'CCUYP[&+)3 A.>;:D*,RC:7^QWQC>UO0_I5O
MN^:5"+-,R ABSKDV22("&<($9H1GE/%$D-BJ"I+=<%/CG%8L\+Q<=?4V>-N%
M\:2999 &EF]#=*_T '-@HNEI7?EVI+Z5;T=O6OEV0ATKWWJUJSR^RZ.VVJ?E
MXN&[7#V]DVR]]V23&;'<F+B%'U)_6FRNS:BU7F%5C&56* 5QD2BS S*! ED"
MF22,)1(I2JS2$SS&GAKW?.HZXP*AY=]GFK\ ^2>?;X3I ,UW6H"%4<.A,IGC
MW/1STL"(#TQ0-=A&<F!$WV<HT H/]J0'OPZ+M$-QN.$0'ZEJW.77O$Z0,\B?
MO..AJG'Z@==;=,[QD>-5H_/3]:!,G><C?$_)V/KCHEJOZI>PJ2G ,BYXG$%.
M9 P189%>'%0$]?\QI%+*$EJX'8\=#S&U-: FHYV(7N4"S@!I>RQV"SR#GX<Y
M(>-Q$G9)^;!'8">CC'SV=4G+TT.OBU=Z%A$1HJ[-1>=?:"D^+EH3M$T32DF<
M\CC)3/TKT\\\T]O./,:0HT1EF91<8>I4/J1OM*E]]3MA@9$6E@O0RNM8**07
M8CL2" ;<P'QP&;,!4K&L0 E:#Z1WP'$K@=CH?E(#Q.HFC^WEEV^_?5A)V84U
MMJ^VUBN6'%&81Q&'B)MP<X49E(F2*$JSA-HYZB\/,37*T$("(^5>$+%'J>KS
M:%KL^V[&:&!V&!(>A\W:S3"-M"?S@<MMY]6+1.\&Z_R=X^VC>B4_V"[U7^EI
M-2W6I2CG&W/RW[58E-6O>B[?+9]HN9@1&I,4%0@6B1#:<)(Y+ IF@B$3(HEQ
M&J;8R7"Z,N#4B'!?7K 3^ X8D<'OC="N!=>N@6YI2@6$<FAKZC84W0TJ2VB"
MVE37QAS7K+)$X,2RLKW/P[@RY94_JU^62U%]6\[%QZ=G6J[,\O-9?=1KT.*A
MW#;BHPLA_[DIG\U?9S*-4&*V;(5F;X@2PF%!.8&"9#RF*$L*%%F;7YY"3(V7
M=G(;)V*YE1S0IMZ&2>/:"N]@D_C.D851-P+R0[L=307\SPK4.@"C!-B;!_V'
MG1Y=T].QY\'!>AQA/D:R+[\_ZO=^&\Y3[J;$!/(<Q?%P,X?ZJN>VPV)%Y[(R
M?U@_;MMB:-DV<Y,*W?08-W_Y0Q.AA&+Y1^VT-[_A=+5Z,=?L1J:+DR\1K)=[
M92%".1ING+I>@]CWV>.9S#=J?V!4W_HLCV6P"3PSS]3_7WQ<O*-/],%XZ41&
M"Y2E,!'89"^*!#*EU[I<X2+"A4AS8E7BN&^0J2UCG8! -/(Y,.0E&"U6H@#@
M#&TP-YRRA>?C KP+AI##&A$ J9'6@!8QVB&F&;U]IT*1[A4L>DGUTKWCD>85
MZ0](\=JU_F65SY07>?/R73^O]B.*!$5YJCB4A22: >,8%B3%4. 4HY@@E25.
M7IJK(TZ-#B^6&V(OP,CLY;"]CKO=>4-0- >WU&\#TJL,LA4XH2L?]P\Z>K%C
M*PS.U3>VN]$S]J.LZ,/#2C8!)B;QJLZT^%0NY,>U?-+$$[$T(R2"S/AV$*,<
M$IIITRM#F<),)@HY97M?&W!JO',H;Y-'V)0,_]W(#&JA7>-$KH%NQSHAH1R8
M=&Y$T3VFQ!*:H!$FU\8<-][$$H&3Z!/;^P*6EUAMI.B*MI=U]C<F1:889%&J
MM+$3:<XA"=9[OIC3*$E901RSOZ\/.C7>:24$\D_3H4@VQV5-];'Y3NH I2>.
MP;?CGM"0#LP_EPM0U"!_LD T3 V*"Q -7H;B>-S7KT1Q 0FK8A27[@U?@/&D
M5->V>.T'K>;]Y[<?#S+$ZN1U4X(OCRF5.$>0XD*;35*S5Q'%#,8(QTF1"RZE
M"%R&T5-4JZ]T_"I=G]KSZ58E_9'6!\Z4\\W39EYWICI7B[$^UEXOZV/H:JTO
M:[H@U(X@]RS5(=X,.WY]K8F>3(G&D^J+.RV;-\'H>90_NRWU,5J5QANG8JQ:
MC;YB3J9BXXTXN]1MO'4HWQR,[HG[MEC.1$93E4+.,8.(JQ@6**4P9GF:Y!RK
M.'=J4'QVE*E9OCLAMY;NBVL>QCDP+3?5MT(T]$YZA\ZGJ^AXY&+T:!\V'>/<
M0"-G9/3H>IJ4T7>QAZOS;UI2K@V9U;N2/BR6U;KD51OF*G,6%W%&(!51 E&:
M:MLQSU,-I<H2E$<\IU:% *Z,,[7O?BLIV!/5P:?7@ZB%XS,,3@-__&<A\HFO
M[L'*P04:!K.1O*">V+DY0J\CTNL+[;E]/'?H=1T./*(6E_NFK6W[Q'Q?FAZ.
M"U[.I;:W=K;:]Z4)^?ZR6IIFV^+-RV^U3_;S<^TE63S4O;AJIMXV_A.I(@GF
M$929R7;+LAP6*N<0*X4IYFDF4>J6[19>R*D1\YZ.9FN]ZK2L&QXTVVKS>_,3
M-UD,SZVJQJ.X[-34._=.3\?>"(.\!W;&X&O/[L#+R='$;A6LM]$'^W'SYSI#
MY<O>W/[T6Q--\C/8J@MV^@[27'+("0F;13B G",G'PZ']&G.XH!C^2T^=?_T
MZF-5;:28L11'*2X$5$1AB'*] R=)$4,F:98I&K$"HUD3(/MM35=KNZ5C?P@7
M4C@>:#A^>$/UCUQS0+D 52VM8WO* Q0EIXJE(H-9Q&.((A+#@JH$JB2E2!8Q
MXYBV*+Y?B#$P[(;YWX*@W:+EB\G BTTCUAUH! NW))Q3-R25'SQ_5 H^I]DQ
M=9Z]QH_RMMW233*3YM0O<J66JR?S_NY*T+S_\UERXP(JG_0EG]4W_=M*&=MN
MN:@IZ1U=-Y%S-(^2)$5*4R5)-6DR_;EC*6!"I,I2'BNFG"HLAQ5O:C;VMM;P
M5C^PI^!>E:P[T.D(&B6-OV-?S3M0*PJ,IEY!D8'? SO2>KW9'9CV7F=BG5ET
M&/Q#\G!@"4=E\F'0/5X+!AKEIM7$^,Q,#*LQR4WULK?:T-<F_6J[$<]X00B.
M4X@)DA!AI2!+8P8S&F.J,(X5=2JU;3GN1/F_<6UW@M=E^4 GNLV&^J:I<&+J
MD "/0\&W8NO+J;9(#4"65X=^#1:TQ>,"O5G?[N&4^\8?I=C,99WA*/4[N'[?
MA%_^MA F8."P[.)WTPOIN_QS_49K^8]97&"&8J9@D6@Z0RK)M.D;);#0_Z18
M19A(JWH@-TLR-6[K=&G3P&MM0*L.J/6YJ>+K39-FX1D<:RJ&WG][S +XO58'
M&'U K9"+D_&FB7%P0XXU02,Y*K<3U52O:":J#0,'FWJB!BO3&P+*7@_G30.,
MYP,-@<.!ES3( SU6M'>2U[[8.#:60E?R,^4RI1Q#+F,,$8HB2'.LC0B:\S26
M5&6)?8#)N1&FM@)U,H(XO@-&3 <6.XN@Q;)Q*RX#+P<GD/B$D9S%QH&Y;\5H
M)$:V?WW<V+9/_5X6/7OC>.S8)_<!Z_5>Z)U IJW][_3/=V7%Y\MJLY*[X(Y$
MDC2/*4P202!B)H1.*0%EH7B&548S:M72PF*LJ3%<ZZW7LH*=L-XG!GT@VYT2
M!()N8!+T1LTG&>P:'H%SP"X.-W;JUS6]SV1\7;W%ISV.R1YKSQ"^2/T"Z67C
M0=MCWY=K.F]_/^,XS7'"(U@HH??P"19Z^YY'D$B6I#*B29'8U].S&7%J/-*T
MC6I[@P): 6HJ?[6BU_6]C/#@I]TO+1W:]G-@85N%1G9@FFE W7J"=A*;O7@M
M<_?'T%BZM+<)C.E836UNQ]:QDXT#3OW]:VP>-&+7&@>]#GO5N-SH[4Q:SG^4
MBX>W*RG*]0?*Z[R7=L/!64$*(3G,F) 0I9A!5A0IU+]*LRQGN8B=LJ1Z1YL:
M86^%!8VTH!/7<3]G![6UBR@,@,,[AGRQ\W$&7<<DL NH9\"Q'3_7=3_C[K&X
MR:?())=51?\JZ7S]V#&(S$F*L@A*;LHHBR*!M$ACR)C4+U%:2!$A^_J2)\^?
M&F<T$H)&1)>JB:?(61AKM^$Q, 4<0.%S!'8&$Y<BDC=A,U;]2*O7Q;%BY$7%
M^XM%GMXV8IW(BS(?EHB\?)FO]5-)?=/C_4*\T^;4?%G7V6W]![."X@AAQF'"
MJ2F6)!5D4<(U@:&$Q5Q%A70Z].H=;6I,U@E;5T<2.W%=;9X^@&UMGD"P#6[S
M["&V)VGG"@YI\5@@$M;BZ1MP9(O'0O=3B\?F)L]\E@VKY#\WYGEZ0[;N[)XT
M+AAA&"8%,2UL,DT;:88AH21"3%*%A5/+^;.C3(TS=D*"6DK'A(RS0-IQQ,WP
M#,P-Q\@,L WJA2!HVL;9@<;-W^C3]221H_?B&Y+8WM!*"E/K1K-(4]!FM=*3
M7A?&>O.RN^0+?:G[C?Y!5^+S<]UN^/-F7:WU.J$W87^7Y</C6HK['W)%'^3[
M/^6*EY7\LBJYG,44BZQ0$8RY-CP0*5)(5&*:B1:*$)8G:>R4ZC&2W%,CIDY6
M2!MA@6RE!<]&7'/ZOFP4!,N=AA[Y9".\$I:$.+V)'IIBC3J0&7W OLY@3VF3
M6[U_7:LXJ#6_ ZWN^A\[[>] IS]H 0 = J"&('"^W7AS%CR5;P31Q\\2'&\^
MSB8@CCB\3U2W?#"C?I7/RY5)%M_YE3]M*VYG1"]@B8P@SM+,A(X(R!17,$WU
M[IIPSFAAY4.P'7!J:T\K,MC*?! 0\<FUTKDU[A;GAX'1')K@7PE(EWCIL(".
M%19],[".H=#V*/5'/%L\9\3 9GNM#N.7'>[SVZRT:T/U?7G/_[DI]8JQJ?2C
M3:>=NL:FJ?_1_D7,D,*(Q4A"P?,$HH+FD"9ZS:=%G%$1*\&P]"BO["*#U2<R
M?MWD6KRJ[-HLL*T"=W6!)OVKND83;;5PVSTXS9'=%B XY".U.6_%-H616O'
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M.(.%RC5=JC2.$*4X2IV,28>QIV9![HG>Y"R#U59X0!]64KK7QG:9"NL]\1
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M2=)*5GN>*%P@PI& -*>F*0]5D$6R@)1'2+$XCBEF3E]L[W"3^X9K\1R_W7Y
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M$5(XOB6<PE.N"?+K3HT[\-SF^ZUDT\=]O01ST[]JU<E_6UR![V1:T/7K3-'
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M!"%,%32-,[?R9/T#6GT(H]83^R;7ZWF-?O5OX%[\M]X<US\X-JOKA]F.0@)
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MK,OURX=RWF[+9T3QF!/*("61@BC7_RJHPC".<EZDN<AC8E6Q\]S#IT9"C7S
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MHR/W03?S(]'ZR:_N6O<P9S03D43FN)WIE596"(@ED3"5B,M<K[<2Y+32>CG
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MS4JAMCKT7K432D'?PU8#3_M6=L'BZ!WM]&%/0:GU1BYO5^_^Y'=F5U?_I]G
M;1),&4I$5*0*Q@7B)B^#0,KS!$9$$9*H-!.H<-* ZAEL;N_GQCCS1C8V U[)
M>?%G4"46Z"64JX13']!V]!,*OI%9IS$3M':"%LKPPA@VB 35'^H;;UK)( O/
MCU1^;#XSURZ-'W<MGG)1%!G',2PRFD&4QC$D,HFAY%)P'=6:-MGS:M7X<:Z]
MNFK7P<[W*]!X#RKWJ]AA#T"G;VMI=A8/^P2:-7P+ ^CB /9 #.C^->4WS(Z.
M9_J]&9G=Y_F5F6'_R:/)^]=J0OGQ=7JMO<*\3-^.\M@$O[?NNS_-[O[CLKPS
MAGY6IA#R^KM1N%I(RK'(S4L2$6:R%PM(D:"F8E$2FD6QS)P.'<\/-;=WVJ&E
M9MN@[DI16^OVTND!V.X=$0:VD2G=$S%GSKT,1DB*[!EM4D:[[/5+ K+XQ/".
M229%OFWMD\N8"\T5<8XBB'*-)55,A]81SHE0F2HB)\6#T\/,C2<^'C1(N@(K
M67WU^6$K)?\./QV D8@%RQ"!(LT+B&220Q83"9-8)"HN:)&GN7]7*C^(IVE,
M=;,VXDZ'O:C\Q;3.P&M'Q<,A&YF&7[91TNOT)C2>JJ'2,2QC]53JC/1J;96.
MO>WKK'3B:L\*%WG[O=L78)>@E,4RECIF@UF<Z4!-9 )B)"2DD2PD55F*H]2I
MX.3,0',CXL;.3H<*BYPD-VCM&"($8"-SA!=6[M4&%X (FOQ_;JQI<_$O>'R4
M&G_I^@'5;T>R#-=_+LM%DG*52T)@3GD"4<:-OAUF,"TD8;&.X)+4J1_'^:%F
MQP]GQ4",M:X4<1YA2Y((@MO8-.$)F5]=4B\:P0N%3H\V?>5.K]<G2VGZ/^&A
M5-66]5?U^F6U+64.BV^D4;#]K)3<?-DLN?PB-]7X"U10@K$2,":97M[E&8,T
MU@$'S=.H2(HD9\AJ4\AG\+FQ2I42L:V,U<L^;2UX,.:"GQ[TCU7>IF7:IM=,
M]'/-V/B.S#X[89..Z5=U#DIM/:C,!Y7]IJ2R3@(=$6X'I:P189](/"LT_&Z2
M6I[X]:ILN=YS.N$M3V\/M+A\[^%]4K\QTLR_R/K?'U9M8\M]"\M%3'&*]5L!
M$H451*Q((<YIKE_):2%(DF4<)QXB\39C6SU0TZO#MX:"C6=/7BO<K0^>P\ X
MV8EQ92;XJ37X9U-*OT/4HLNQS_&N-42!SV4OCSOU@:HU$B=.0NT_&T*!>7<P
MNF"LH#*B&:19*B&2*8.,1J:'5R$U!1&$"J=*HC/CS"TJ?:$?/"!?YARP=A03
M *Z16<4+J8%JRT<XC*>X_/%UTB\N^-NOO'Q\N><N6$?BJY:26*0\22*1(<B9
MC"$JBAQ2%F<P0ED>Z\A$"*7IP!PV6>Y^'0WAQ 2[@<8^.?O;^GY]N^3_4=;%
MA8W%__YO.(F+OU8U$MMGQPVP8W"S/.&Q,KCF6011+!5DO" PCVB1)DHQE63N
MA4'#()ZN"NC-KM2'U9D^@_%$DHL(%1E,"I:8Z%E_63FC4*22X401'43'KE4]
M(= <OX1'CQ 22,L=V4'0C+T3:R-7^(6:<\6 N[)G$0FZ&WL\RK2[L&>]/-I]
M/7^E[QNJ20[\K.IL05.FL_[^L)%W<E4NGV3SVYT$""Y(K!?.4))$1[-YH2 1
M*(4L580R+M,D=4I9=QQ_;E'NSGR3<'-@-VC2B[U/@!TGQI9A1H-[=/H)@+0'
M_WCA%9:<W$R8F+F\\#FF-;_;!-/U?[O6PX@FJ_EF0U>EDIN-%/$B4BK72W0,
M$X(P1)3HD#+/"D@528I,T5S'\0-%^\\./C>V.S 4;/>6#I;?/X^_':^-A>I4
MYTL'POF',-]8P!Q"#?\B7B-+W9\?_[5U["\B8R%2?_D>GHG0'57[E3BQ\I!%
MGJ=%P6 61PCJ\(V:1I(<JJS(TUBEE!'NLM]P:<!Y[CYT6H54=5VA]B NPF]'
M7R%!'9FR/KY \ET_:NY9O)90!,WGO33FM)F]E@@<Y?C:?LXW:EK>FST1<_,/
M.C1;/U416_GK9EV6BRS#"6$IAQ(KO2Y$"88,F:+FG-,8822HH1F7,*EGM+G%
M1:VQU0.Q[%CK&A?U(6P;" 7";?3(I[&SPJQKJ1$IU[:&C'4L( D;W/0-.'$T
M8^'[<?AB\R'?PBT3%IDZTENYXIJJ]N=Y!<^*5!AUV3B-=*22Z956S!%D&49I
M)#E2Q*EJX/Q0<^,/8RDX,'7 <6D/PI;!2!#<Q@Y#/"'SJ"JZA$;8RJ*SHTU<
M773)Z^,*HXN?&) 7[-CNBYYJ]Z5774)^,M^IA524R"QB,,ZYB5$2335*"5C(
M*!**%$(AJSK1$6V<&T=5EH'J"H_TUL#SUT]D,YF55]D[&MQTL9[G3_.89X]L
MY]>;[ZF3HJ>?=[_\Z7%FQ"K-.O#0TV=CCX/=R:3MD8;R6R9<<_TL/=Z;G.BJ
MX\Z)PR 3<'R2V\_JAOZYD%QQ0O,,YDDD(.(%AB3B$BH5,XI1%$49=ED[.(X_
MMY=UQWRPKMJ \8,3T_N^!7:0";%;:HP(\\AOWR["=:.UDV?2/QGS?ZY:&9MS
M:^U#N)6))W@AERNN)DRZAO'$Y^7"QO<V0^0G]7WVFEPW\L_M&^W8?R^X3"@3
MFM80+2*($#?+EBR#DG!.)8\+1UV%OL'F1FG- Z6-=>V0V0NI'4^% FID4MIC
MU%$K!'\84T%E:W#9P7Y(PNL$GAGO%83]^CT_K<1WX3-NC"'D<O%.!V?;YVLA
M-B: TS]^WMRL?ZP6J2QRA' !)<X*B+)$0L9% 3.:"HPD1QFW"H=ZQI@;/]1F
M@L;.*V LU3@"8ZL=7_0!VD\3@6 :F1V\$++F!0L,]G10MGQ02OZ7V_73_]:?
MKJE __"2 ?KN/,F#;^%:^[S;7.HI;]^V$'WSO/OQ;TNYT3>Z>_XHG[3G1OI#
MI44J<I7#6$69T<@4D!8TA2B.:(HQ21ER:@%J-^S<R&#?N!CLC*VV/CY=_]U+
M;,42?;MH(CRF(S/'$#C=E?"=T FJB6\W\K3J^$YH'.GDNWW:CYGV7>^KG)/?
M3<_[K]]^;QI"H(0HQ&(,HT)J&DIR DF$.<Q-%SV9R @GPH60>D>;&P_MC:TS
MSL"C,=>->OKAM6.<8*"-3#0=O"I#064I^$G;6OX\0M<-*UQ"4DS_@),RBY7O
M+PG%[D,>![WFQFOUC_7F?M>R)TORJ. "JE1BB%"10\RD@'D1907+E$BPO<33
MT>WGR!1FA[ RT>'@[1@WB[/106A,0 $[("X_\C:(.)PB#D)FH@- 1X3<#NW.
M M![WG;\J>F.RLY:?'#*=?ZJ8#5$-J=FOZ[7XL?R_O[ZU.G9)[E=Q 465&0)
M+(A*3+A40)842$=/M.!*Y'F649=T_9'L=*+/";+\O^SE(9>NY=IC3:5=:#:#
M"1J9T0<E+%R!UM.K\[D+VM]12Z-"3LC(551!3'WM@JN0>%O49@4=;M+7R4EK
M.K]9")5E.4H%3-*8ZR!:Y)"BB$))<H99GB 5TX'5JR'LG%\T_ITN&T%5L),>
M?ICLW7)Q7D=]MX2<K3F_6\Z_4#J_?/47B^ULS.#%<M'4?X47BRW>@5XLUL/Y
MO5A^E2NYH?=5N[?OR]72""ALET_RW9\/<E7*19+BF$JLH,))#A&7!<2F1ECD
M!"<T5ZR@3MW5+HPW-Z)OS*V8@!X8[,;SEV"VX^N X(W,NUW<#FT%C;'A>-,2
ME9#\=VG(27G,TO^7?&3[,8_-V@\Z-/J^TG3&*YJKV>IY(;(L*G(9P83E&41$
M48@YYS!%44[,K@:F5EDG/6/,C3]>6-GH#%B*"/1A:;&+.QRAD4EB-' <-G2'
M@S31KJXK6&[;NOTP].[MGOGH=!N\_;8?[/)>N-0S\T9'<RN^I/=[?=@JV8.2
M&$N2F%0;P2!BBD""8@4ETZ271ID0D7)*M3D]SMPH;V?F@6:Q3T[-&5PCRE%!
M2*(#4?,:R3"#C* 4)ACE,8^+G''FUF,R ++3-)D<'5N[.#0 7B._6GR <L]$
MZH<A:.K1F:&FS37J]_<HN>C"Y5Z!I6:P>NU,[]L$HA07DK(8ZH5J9O(8$\A2
M3;A<_S:EE*DD<8DJCP:8&[\>F.@4*QUC9Q5%#D)D]!"R8YU/-L I5)S"QT'H
M3!8[.J'D&CJ>A>!"W'C\N2F#QK-6OX@8SU_G%R[>Z(]]5M=B_6!NVGSE4HRP
M4)&.$"5--(F9F";.34,B_4M6%#G"3CTO3PTR-R(S-IKSD]9*\,<O:W.LXAC*
MG,33+HX9BM+(Y-:TH#'"8=^V="7H1I3@]P=!M_(R5L[13!\8(4.9D^-,&L?T
M>?HRB.F]UK-V74^I6-X_FLVV;Y(W?<[K'NA2O-?FFA+2Q_JE\%F]HQO3LZ%L
MNZ)=?S=?BH6(2)*E4:Z#';WV01+IL$<J!J.TX)*K.(V8E41-4*OF1C'_D,O;
MNZT4D.KU&;V5@&HO8>MFW?RR!#\M5\V/EHTPP\ZD'5=-/C]CDUO''[!W"+0>
M ?/<@HY/YE71>K7OY7@%:L\"ELV'!#IH,7T0PZ8ML0^)Y5'A?=";^\HKK_3K
MX>U&BN7V/>7F3/;YXTY/+Y68B3BE,.$ZM$.(%Q!G.8&"%"3-"V74XIT4"_M&
MFQOW&L.J7@R5N:"U=XAR82_8=C0:#,*1Z7$0>AZBRA:HA%54[AMP8CEE"]^/
MM91M/N3'*96*R"=M/"WO:EV -DL QXPKGDF($<L@4H6 C#("&<>$)43A(LL\
MFM6>'=#J>9B^0VVMIT/%?SV6VTIXMDHS6*U7T'@ EF8.W)CE/.1VK#(,P6D8
MI4:M,7*G/]38>3[P=>:2BUB$Y)'S@TW*(1=]?LD?ES_@QQVUDKN)>]8K_634
MFP2+C"",\R*%142P7BO*"!)A=LPCFJF<9P7A3BUF3XXRM_BCZ4"WL])S>^DT
MHG:T,!BGD2G!'2)G-NB%("03G!YH4A;H]?4E _1?[-FLC]])\7AO(A/-*^_O
MUS_^)L6M+#7#5&NBJJNUC5C9C<E#W8M@$2QYG&8(IBFA>AT3Z76,S&.8R+PH
MHB3!C#DU;QC)SKDQ4.NFB>-_7VTDO:]2SBMI\DX*NND0__GM!\?V?R--M1VQ
MS6 "1Z;&[MP9'X%Q$M1>@M;-:NI<A![!'Y7#8!3%M9$G)6C/PI%,G;:WX;AX
M'_5 ''FX 8O5,P-=/]'EO1GL_7KSC=YW-NFN=VNWO4(OIHP6D8)ID@B(4I,M
M1QB%.,8YHHGD!7+JHQC*L+F]5#Z?D.M=-AQS7W$,DVJ]D6 C^3TMRUVRH\^2
M.,3$.JR@)YZNL1?<;S]<@5\DVW:.-Z[ SAFH9PD:=Z[ KSKTVTD!4Z6_1F#O
M6;6Y$508.#36P1?T(6R;?OT?$-&3VP4A[Q_NM*-*D)'E]JM^[5QOO\C-<BW>
MK<1"I'G.9)K!6*82(I822&FFH$*<<$&(H&DT].SCS-ASH^S63+ QF1MT"Z1^
MHDWA<&7P\#.0<U/@?R(2 -C7.1^Y CNPOS9@U]8#;?ZXYR47,!O[].3<\*]^
MEG(!%YN3E4NW\)92UVOR4OXBZW]_6.UV91\W&Y.M7!7B+E3.41SE%&:,,H@P
MC2%+I8*(<D4501EBD<>IB^7P\SZ#X=OEDW-37%O@[?@K)(Z3R;!7EH*?6IM_
M-CL)^P.:VNY&CB"H)+L+4H'5V:V&GEJHW06/$YKM3A_W+- W336_;-9JN5VD
MJ<"YYAP8J2(W.7\2ZO\V;3!9)@J4Q+&*7<2_.O=VBIDF$.RJ3 ,/E6V.I?8=
MP.P8Q!.&D5FB1N!+/P+NQ?+'O@8MC._<?MHB^&._C@K>3USB]TSJF^C8??O\
M14_8]GHES%G.0[/.6JA,H2C'"G(1)1"EG$%"=;B04823@F(1I;G+PJ=OL+FM
M=%I;K\"#L;;:NI"MO5=@U:/#Y@XTSI3$>8*ARB(.4204I%@54$0%4E(I%,>)
M"QL& WH*/<,I@;9CT5#PC4RK>^2^[)![MT<NJ%2@#20AV;=WO$GIV,;SE_QL
M]1GO$OWE5GY</IECDJW^.BSW.DO?UYOM\I_5%GF3@_.?DFYN]+S(14+CB$A-
MWFF:48A(2B'#40&)) KI/](\<6JHY6G'W&C^_;+D]![H;R%R+COWF@<[!IH
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MQD8OLCN#D0O;#<=J(KHSF+6]Q!M;_Q**Z/I!Z&>Z,Y^=D.KZK3_DN@O7^K:
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MRD622AF;5195S/!$(B&35$.(\YS%$B4)M^*)$_>>&S4TUCF(PKS JO\!'XC
MR,]T8QAH+/,'P4$0QQ^,B71P;$%QD\ Y[7:O\LV+CTPG>'/:U@.=FS.7^,4K
M1L)JH^_VN#'%/)K3;F6YR$6$LU1&,!8D@BC'"21I5D"..4\+&7&<49=8Y=0@
M<R.C QNK@D&Q?-*_6^K?2,!KH]T"DY/8V@4E0Q$;F;P.P7I[ 1SG0*3/^Y!!
MR,EQ)@U ^CQ]&7ST7NL1>'S]]ON7;[__IO^_3N<KXHPG9I.W2*,4(DYS'8/D
M!2PDERJ/,BH+JT[GIVX^NZ?]V^]7X(OYAS;1X=W[$C.+"&0 $F,_Q5T0?#3Z
M7J+A$(H,0&6B6,01';>0Y(S[O3')R\],%Y2<L?8@*CEWC5]8\G9=[=/H6=8_
ME4M1;6^O5V^;KJQ27)=U$_CW=+GY.[U_E'N9F@5A25XHF<$DQ0(B(1.3#\^A
M.:^2><8IBIV4YX<8,S?BV_L">-<9M\AFT/3814!3@3XRQW;P/O #[!T!M 2U
M*U? . ,J;\#>G7"!50A00P9@@^R9-% +@=S+@"[(/3T"OS>/Y7(ER_+M^CM;
MKAHQ+[Z^72W_*46KD4CWHOE&$V4CA5X3?=QKJ.B_Z;>P>/M8;M??Y:92 S.J
M*7?+AW*1I3C+E$QACB)AZFHD9!@E,$ZX2A%A>1';BT&/;N[L.+HQ$FRZ5CK$
M9>-/L$7<.ZMI&YGE6U]!Q]DKL'<7=/UM>E."UN-JLZ'C,VB<-GF2S1?AZVR_
M" XA_ZR^$!,M(N;QQ7!;FTPV3[VKG?&MF&[]-!FB!RNRZ4;UB$$^_7]O/WRG
MMSK\:?8.$(\8Y0F!,3&ERX3H19N,8XBYQ)(+Q1C.K$.&EW>?VQM>VP<: QW8
M_ @SB[?P$"1&?FEV0/#9?#I"P^%5- 25B=X<-E\1-UX_YW0O#1]]:#K6/&?O
M <F=O<BS5(GKR7VLA(U_D4K3IW@C5_J'K6FL6%Z+_](\:":_^<KQG.8L2Q/(
M3><;E,<IQ$PB2(G >49BD2*G3$>WX>?&:E^,+LYZ534'=:UR<L/=;@MI/#1'
M9L:.X:"Q'#2FU^""O?%GE'U'T#/P@S-H%9:;!=.6:7FA<U3'Y7<7GSY>^Y'.
M25OM$NFD*FB1& UQI,R&ND@TS;$<%FD>X2SA*(FLBK]<!YX;P76?RQXQ-U=M
M!N?YL(C[1D)Y0N)[38!=FHR- _14C<>" >[8E<P=M?Y.90[WF[![F;N7AQW-
M/#[O\2JXD9OO']=TU0:U2"^W):60"*2#6G-R2IE9F"L<48&0R@JKED0G[CTW
M0C?6 6.> X^\0,N"B_TQ&)EN=^[[K+]?X.! F?YX3,2*#KBXT=YISWN9[<5'
MIB.OT[8>\-.92[P[J3VL2WK_ZV;]^%!J=JL;-)@CS^J<]%&3X$-S1%H:,;%?
MUM_I<K4@*4M2%14P81F#B"<"LKQ@D.21R&)$];^<"FL\[9@;M;5N@,J/2N0.
M_%&;ZB@SY#LQ=HOT"> >F46]D/;ICC8$I\!=T;Q,F;H;VA"\3G1!&W0[/TZL
MVA\V@O=U*LB^\4^2*4X*H:.T-(6(I@J2%"/(68IBGF6<959K\LM#S8W9NI;^
M^[_A)"[^"F1EL6/A8 ^Z=MP5!K.1Z:EKY'\TB69G-PU'J"J\#%)(;NH9;5+Z
MN>SU2X:Q^,3@,XT^$?N/RY7\L)7?RT7"2"YBGL(D)@E$,I.0\(C#C!42<1E)
M$CM%5*X&S(UP+#=)FDY[?Q@_0.6(8Z#E/%'.QR#!X9_'?J +\D../9S@&^G@
MP\Z&USKZ<$*HY_##[3[N.G>_-!L)M9C6%[E9KL5[_;MR861GBX1R6!11IN.J
M.($$)PE,)5(DIG&6V O=G1UE;@S7&MK*N-6F@LI6>Z6[\Z#V$U4PJ,9>Z/F@
MY*1U=Q&% 6)WY^\]F=K=1?>Z<G>7+P[;^:OWO+7M\/-EO3$KO&[X?+.N@^>%
MPD:M04=,C @.4<PRR H10X+T_^6$17$>M]T)[0*GL4RU>J8.6QJ.3$ ]7<9^
MNJ]>[DRJ]4:"C>1->02OU]IAFH\-GGR[4.Q5)_3UFIS]5'OY,S"O[ZN3*2U7
M@"K]IC.=SZJTYZ\OYKF3\7(U>C/KL:=IBBYK@VV=16>V4(C;=G,+-I[G?I\1
M%7I#2RF,;=JPZKM_O=F8UM;&A#?/^TN:_IC7/^A&?*Y4SLI?]87;\L.J?ELN
M%"590E,&\T05$"D>0RJ+",8$J52@2":94R%L6//F%@0W1H);8Z44CGN)86?.
M<O_QU>9C[#U+8S5DQFS0=0UT? /L&72O:_P#E8-7H''1M+\S3IHFY+6;NR:;
M[]<;)2MYEX#2)>-,2= =TK 63KNK.@JZ1SNQXXSB]TIHJWBJ\IQR65E25^JT
MYZR((T9-@^*8"0P1H3DD'!$HJ>!4JA@5N95NB_6(<R/N79%=Q^*KMHK.]]3[
M,NYV'!T4S9%I=RB0SFQI#4Y( KP\Z*2<9HW!2YJR_Z"O^#?;?E@9S2E#<%^E
MD-\K?ONR67*IN8V;1*Q;N2!YE*$X)Y"+.-=1ID*0"9K K!!2)%0AFEKE"SJ.
M.S<6,F:#O=VFRK>U'%2F7X&]\:Z"WW8S89EQ$Q[?L3=>@T#K(=SM!%18J6Z[
MH2<6YW;"XUB.V^WC U)F/I3EHQ2_5$IY=116!6SEN^\/]^MG*:N+ONBOYYT.
MX:I5_B*619H)R6$<"P:14!ED,N$P2A2F!>59+IQ*^3SMF!NKO6WTNHVA8%FY
M QY7>CK ]DX"V?C1_/VA\00\Z'N GY:-SG?YLT=>CL<4.B3MC#LQ4V3T@-H%
M4/NP6]O6;ER!UA%07]RZ<J$VTR^YQQ_,X)D_'J9,GQ;DC]?)G*$!MW,_.'^W
MVAI!JN6]W+RE6WF[WCPO$!)Y%A<$)D62053$IHLZBZ'"699AEL4ILEJ GKG_
MW"BQ-A%4-H+62/M3\E,(7CX?'XC+R(SD!HG3D7B/XP,.PT_==;)C\!Z7N@?@
M?9?YJFJ:EWG%!TW5#BVR-$V9@$I)"A%&%))84)CG&4$*%QQ3)Z7OHQ'F]O V
M\4QEH:OFY4OP[.*-09",_-QVT1A!,>"LZV$U)%\.,K$PY!D?C]4>SUTX.*WW
M9J-?ZK4PTY%4!E8BI3*C,!9%#)'*<X@92J%*<HHRCG!.G>H$[(:=VV/_?KV1
MR]M5TWF8/X..[=Y)NGVPVW%#>#!')HQN0NX1IJ\L2F*!X$@YN7TCOU8FK@4:
M/?FW-I]VHZURLVT[EY37*_%-;IZ67);-64I1F$@D4U 1O7! >:$@25 "4Z$2
MPA7)8DQL6*IWE+F14MOMQN0[-98Z'E;U@]K/0<&@&IERO%"RYA$K%'IH0W^^
M0QGZOU[21?\ D["#E8\M&=A=/'%ZTTX NY*CK$_9_Z%?/G>:JJZ?Y(;>RK^O
M#5W=ZQ735]-</1*<25*%/40O;&))(,9Q"E.69D@D:<PRIT/QZ4R?&TN9EL+<
MO.^?=F9.E!KE/NN6.\"SG,NQ-XV'IU1UFA-T +@"+02@P0#L00 &A1ED5WG/
MW"PRK]RM_]?(RO*>E6 96_X6^+T!]9OU06ZVSV8;?JM?KZ;0]\%88SI/5XVG
M%P1%2F">P*3@7(?"^O7%<D:A("@W<GM"8:>DW<M#SNV-4Y<0O*'ZESK6^W8G
MI3G]5^O-]YJQU@JT3EU5!UIU<+ASS.WU9#$E=J^5L$"/'U6?!Q#\<5,MW$=I
MAVX/4TCNM1AU4LZT1^$EUSE\TJ<IH-1AGB:^9AM+)FD:8<H@1Z9KN<P*R'A!
M82(I3_,TSPL2V?<$/+CWW%BGM<ZE_]TA6/TT,1""D?F@-<RK#> A#"Y= +WA
MF*H)H#4LCOW_3CK>W_[O\",3=O\[:>MA\[_3E_C%2.^7J^56?EP^2?%!3_#J
M=KGK4?'K9EV6"QGQA,=)!K&*J9$^*B I\@(*Q07*59))XJ1/<FG N3%5911X
M2S>;9Y/Z4\6O;C'/18CM(IZ0P(W,;[6IL+(5[(UM6NZ8*B%M;[@@QQ:9D"'.
MQ3$G#7!L$7@9WEA_SJ?IC-S61>6+A.215)A!FJ8*H@*GD&1I!N-4(*Z77RA-
MT6*[WM)[B[AF=ULGHMC=?+POO2ET:ZKHZ8L#N;^M[]>W2^[2;V4'7D:4D"AG
M,*<LAR@6")*$)I#':2JR*,FCR(I_!X W18^>'7A>(%D$@UZNC\R3 [UVZ<'C
MX_U4S7?\'QS'GCPO0>AOQK.[>L(N/"\M/&R_<_17SY,AN5JN-Y_66UDN<H%2
MC(5YOQEE2X(BDY,60QS+0D6%$$RY5:WO[STWCJE- RMCF^.A2@<PRU,//QC&
M/I:H$?C4BX#[.<&QKT$W\CNWGW:G_=BOHZWP$Y>$J/_3P9C4$[\UF^#?MB9'
MI%-XEO$8Q322L&!98E9D>FT6*0XY*3*5Q7F,B%,:J?W0LWNB*_OTRZ,V&6SZ
MSK^&PF[WX(\#YLB\<%3RU]I=G2A>@0;G\<O^;/ :K_*O=_17+/ZS0:6__L_J
M#MZ';$]+TXGN_7KSR_J1;=7C_37GZ\?5UFP>82Q3',&BD!55Z94?DQ)BE;$$
MHYAIKG(\7CL[V-S(Z>U&BN6V4N%R/B,[CZCUZ5@0G$;FG=8D(T FET\FZK\"
M'=R 28=9E1+\]%4^Z2FC]^>+&WV.QBYB%/A0[/QX4Q^'7?3\Q$'8Y<]X[!*=
MZ)O\=KTJEZ*1]Z]R8Y7<Z"]%JP1V;^:VD@';)11\5I^TZ^O55L.@1[IM^6X1
M%7F:*ZZ@Q DQU7(Y9%)'37G.J<Q1G&"56.^>C&OK[/BKZQK8R#H/72_*E<E,
M>JHRD]9*+Z>ZSNQB,8<-C9&_ A9[0_.9V)$)=Z<YT_%4,^[!3'><O0*-NV#G
M+[A9=U/3/BMPZ/0N=)S/%\!AFVP^7X2)]M[F\(5PV\2;9HIZ=P9'-F&Z[<9I
ML#S8PYQH2+^UC(DR5X_RJS3I]W6!?Y4(IY'\S.Z7MY6%;8KVS?*[ON2S^J9_
M6RK**W652A$@7A0\)HSHL"//LPPBA K("$EA@A+.THA%*'+:H@EEV-QBC,8O
MHS'4> 8ZKH&];U=@EQE?NV="CZZ#5XTHA]M2*]B$VRW+7F,:1XXH)IQ!YQ5>
M:+A#K@:#V3;IRC$THB]7F<'O/T#6JIO<;M(_FX0[5&2DX"2#E!1Z11DK!9DJ
M$BB)2$P/3$6%$[7WC#4WMO[\N"VW=&5:\34J!JV*LTEHKE6I'E?+K>OI6@_:
MEJ=M83 <^_3M5+%/IQXH?+VV!2[!1:'.##>]\%._WR?%G2Y\9+!TQ"_R82/Y
MLKJ__OE>5O'M2EQ_-Z'N/^MQSV6<F\UTGIE3^I28WKL$)9!%L8)9C'B,4"J)
M%&XM3T*99O603=KBY*-9TU;]*N._ MK141 =/RO:HAT'O<4IADVL'<E-.EG3
M"UQT?3)=2QJOJCGJ^G7ULASIRK(>:8C:11# 1]+#&&;;:REF!$&T1U,CS/T]
M#C2JM_Q&MNJ<1IRSJN]:X"*+<98I6$B"(<(1AE0* A.9IG'!<R)P9GT4<6Z4
MN86,E20IV!M:BY76%6\N52]G4;78W0^!U<A$.#I,#GO@(>"::/?:#S:W_>9+
M</3N%)_]\'1[O)?L/]B=O7BQ7PC\8<4W4M_O%UG_^X.F7OE E^*&_BG+!9%4
M18D.;!43"B*14XAYJE][-*8X)Z;37](&MC?V*^O^43UBUIM)9(HJ$]N$Z*TQ
MU2TLO0"V7; 9 +MIF+,U%/S4FOISU7VH@?&F%S_GD- .EI"!WH41)PW?[+Q_
M&919?FH$ ?KJC\T6U;L_Y88O2[U"SA*44,0$S"."(%(Z!".L0)"3&.4H1;'(
MK*JL_4V86Y#6&F9VY.M=O'6SKS>.JOSI>7'8ZAL-[0EW (=V6FO]ZS1;FTAI
MOA?ER43F3ULQ'WWY7I2<I.7[[^0I3DW+._,_L^1]HO?Z"U9^E>5VLS0'*^8/
M>CE\^(O.E;5QQ[S.[Q_-V<"[/W7PJ+_-)MGXG5*2;Q<R3U@4<0:Q4 E$4:XY
MU_3[8%@O@W&4IR3/;"I 7\=\)[Z>KM*TCGOTT\^U?]4F6/6#W'OJJ+D][7?"
MCN_G.],CORN,*U? _!-T/#+G[*VS]1_K_LV'OSOX0 T".!$HFSJ/!@K08E%5
M?( :C8#:Y*\RBT&%SZ?U8%I5]5>9G2/)]M>Q8EBCT$X:VR_+DM^OR\>-W&N9
M<9QQ(E-IVO-E1EXNA207.32='G#!"5+2JUMH_[!S6U^<2C)U?#=9XFWW3@F/
MXLCO@E, @KW)X(]1M./<8!JC:>B%D5^E<Z@=&N?:AUI^VEO+R61*?334]]7(
M:GY6OY>UG,M"Q'D<*9) EB0%1*S((*$IA0++G,01H01S1QFG<V/-C7X:4T%E
MJPZ@C+5PK:"VMU8DN@)4:4- ]SCZVCLMH&\6[/@I$+8CD])XL/H(0%T"++#V
MT]GAII9]NN3W"<6GBQ_Q9)\V.;_\10=C3WJ*GV39Z,I6LK(?S3SJ>7_SO+_@
MK<GAIWQ[H\=\\_PW*6YUM/:++)>W-4G6IY>18@G-10)C3 5$).*0<(5@%NM?
M9[%@B#B)E(QGZNRX;U>94X*.KU<O!'];?Z_,[N/^.M#Z#(S3;N?1$WPM+-ET
M%I,]-AE/.<_N_#SZ% 2E]_&LG?;M,#KJ1R^7\4?T>S<==&>MM]*;!/,DEPF6
M%$&""8-(4@I9EDF(8\:D0HJ@U"DN/CO2W-X,WSH'?57>C..*_#RD=K0<!*@)
MS^M.9.RWIW$C9.Y?1"<DX9T?;%*^NNCS2[JY_ $_MGC1D^+3H[GG9U6?QG6*
M8-[0<LD72C*<BQA!B62D@U,502(C"G-9Y"S)%8YB)X%DI]'GQBJ54?YI V[(
MQT(2%4<(\B*G$"61A)3%>I60RRA/\@*C(EWH.['UJV/?M6)L]'^T'8)HTR&(
MUXUGZQD!Z[T;8TZ.W5M@-,!'?C,<=6&J+:]J6FN8.\:;*+P,H6(Z"+60;PPW
M R9]BWAA\_+-XG>3$,J/YH[EMX>-I.+SZN]TLS31KSFVBA<1)S*F-(5YFF"(
M4);J*%73G4Q0&O,\)S(5_KJ/YP>>XSNF!&5E*M"\]M08.UC^L0=[.S8; ]&1
MB>Q(^K%&]]L.W=;PP,WE7*$:3_6Q9^Q7U'R\C$B_XJ/%YV?05O3KLOSO]QLI
MN_J4"Y&(7)!8P#Q.]9)<T1R:VBE("6,Q(PG*<RO-MLDLGAM!&ANATD8.4<8=
M?Y[M.'56LS?A?D/@MJ'&<V!</]3VG6FWT+YYFFV3T)-&_^OV!NV;@U%;@O8.
M[/?2NC'I8(^;YVJGJ([B%RS'>:8PAA)Q$TZG$M)<9C"2J%""RIPCIWV;$V/,
M[<70FMA4>7AOTYR"TX[-!X(T,O_N\*G,NVJ6\N$XLL?[D*QV:IA)>:C'SY?,
MT7>IW[-NA*/-F9)>GLL57\JR/BQ6%&>*1!A&1 B(J(PAR?1_%H6B&1$9C7*G
MU?/I8>;VQ%<JV@=F^IWBGP'5[J$?#M7(S[T'2L[/?C\((1__,R--R@#]WKXD
M@0M7>_+ <B4_JUI-_CWE55/Q;DC1+;1:J)C%F+($YB2/(4I("BDJ=#! *"8Q
MD7DAG#*,7 :?&V?\X^7YP8!5I-,D6++)2-".S3':;',\T+0W:"U_T6L%U-8'
M+^CT 2TH)[F,/RU3>2!SQ%\^]PC3+.&KY.O;U?*?4GP0>E&U5-5&7]W"\YK_
MS^-2&T57XJ/^M3%+<VNUTC("24_R?OU@5"WXW<KTV7M>Q%1$*8D5I$5"(<JR
M"&*:2*A),(IDIA+]OR'=$D(:.S?6W)D(MCL;AVG@!YW:?FZ=VX2-S,6G5>_W
MSH*NMTW78M#Z6U5<=CP&C<M&M*[]"MS,\2LPK _":WT57K41PK1?B<&-$,:8
M(]=."$%M>-56"&.@>:D7PBAC#I#6T7;J3Y2FTM:$-$TY;=N9H=.M]V9]KON*
MS)"("Y-12\UI'C>G>5$*XS2."14)IA%VD7X(8Y93]#"!I$/7J_\ M5_=\OQ=
MVY47#9('-=\)/--2":EH7, L(0*B(DD@SA6%,54\3E*59M1I0_T59GJJO.M_
M\9FV/+F=?/[&/IZ=:.K\Y)J"(1U<PFFX9=/+.@5#\Z344[B[^[W;/V]NZ:HI
MPS7ME];W2T$;A>0O^OYMO/U9U?6B2WI?M8TU@7AY2G@AC9.(I"B#K* %1'D>
M09QQ!3-&""JPS KFM'\:VL"YO07J++NU EUGW+@\^!S:L?IKSLS(_-YUK6Z"
MMW.N6N%UW3-SMW,0[#T<7Y9CK D(2?O!;9ST!3 6PB]?!:.-X]FH1(BE&8[>
M?Z%+\6'UECXL]<IGD3(A$YRD,"IR(YB:<\A(+&&1XR).=50O$^G"[6?&F1M%
M[\T$1JT6+E>0UY8ZM@DY ZL=W08 :V36[.#TI5:N!F\OX.3>BJ,?A:"=-<X,
M-6VCC'Y_C_I>7+C<6TYHN94?ET]2WW*KIWRYWXKJR+@T/=H_:1:Z^2'OG^1O
M.ER]*Q>YS!+*<@F5HA%$19I K"($,5<HR@7B"7%*XQYFSMS8Y;VF;_W$Z"]A
MXBPO-&16[%AG.JQ')J?:$5AY O:NM )%NY:4AQV&_E/2#?B\"I@='0;0P")&
M0RR:6N<H 'HGI)!"W'50J^%R00DI2(ICR#(C0)'B!.K@*H)<H"PC)!-QK%SV
MQ]L;SVV'N[7+JT%ON4CS7(\@4Y@4B$)$<0ZIH@+&*F4I3D6.J%/ZIA=,TW5$
M]H6I2+,$\TQ!GF4Z5L]2_;UBO( 8R4P6*BH8Q6XE\3Y 35/M?F.^M6 S##"[
M]Z$/""._V2Y^47S;)8_RMMG=^S7:%9]] QS]W?.DE-])\7@O]3I]WZ!>=76/
M3$E+FX?.J.124[VF=AT6XRS5J^DL@BEG$4&4FAZ?3J=D#H//C>Q:VZO-M%WA
MVA7X;)HJ'PB753[XI:X[S8[ER=9(F(]]?A48;O=S*@_<@IY&N8P_[9F3!S)'
M)TL^]_!NZ+;^+F_HGTUP_$:NI%IN%YQF!+$\AH1'&42$*DA2*6&F9);GDM*(
M.#5'/S/.W'CLRV;]M"S-J<!/K+;P9Z#6FV%-W$X";,=/ 6 ;F8IJ"TU[-M#8
M"'YJK#Q?B^C3KJT/A\!]VDX.-76#MCY_3W1FZ[U\:#2TUWAL5M7;'3%5)+0_
M>HQX%B$=%<&$<@41-SGGIBHWC4V'H"RC3!"_H,C:AKEQ2O=EW5%J;3)/Z;;S
M!O>-A^SGQS4L&@7U":.C"X WD1$8Y7QW (KCQ$KV9KQ2R.2,T_G(R?U6?B2I
M(P8NI2C?:[=^,2JYV^7V<:,-:'."S5X.H;'(20P%SSA$1563J#0I(ER8>D0A
M1>Y"BA9CSHT$6Y.!F7[0,=H\I'NSW0C0!GL[P@N,Z,@$-Q1,9R9S@"<D<]D,
M.RE3.>#PDIE</NJ9]<'YYE%V*PK>/FXV<K5=H$02+B*SEXR-8D*602*X7LP1
MQDC"N'!LE'MVI+FQ3F,HD'58[$@OYP&U(Y4@,(U,)2U"'2.O0&-FP*R/2T@$
MS?LX.]BTF1^7?#[*_;CX 4_)?+I9+5>WIK->)<ORR_+^<2O%HHCS3(E"QR)9
MI4):$(A9P2''2@FN$J44<A+,/SW.W#BA,:O23'HL!7B0FUH[R5$ZZ1RL=MP0
M *R1F:&UT"@8U/I)5Z"Q,J Z?C\,0;7QSPPUK3)^O[]'NO@7+G<C!"&7"].W
MX_[+W7K52"$O4BZII%BO34PZ*%*<0Y(K J5"698II"([I8!3-Y_;HU_9!RH#
M&YEONT?^)'#]S_E0.$9^N!V0L'ZF^US>/\AE^R27DO_E=OWTO_7'ZH=8__#R
MV3UYRTD>V#YGVJ>T]QI?"?%VUV(O %Q>KT333.>:ZS]5H<$^:?R:E577G45*
M\S@7*((HYTR_SW$$*>(*1BAE0B4L2=R4CP;8,K<'O[,+V/&E*@5IO %[=PX*
M/UJ/'(^JA\RC70 QT>R,S$-C3HR'DOE@2,.*F_N;,['>^6#<CB70A]_2DX&7
MY<.ZI/>_;M:/#[N"3C-,)6NG%VB?]8JAKN:I?S"UG.;XS6C?+1#6@5.24)A%
M59]P3"&-D8 \XQDEDE%>..7*#S-G=CS<> ,J=[H5UUV/P,ZE*[!S"C0'S3\9
MOQR7:@/GU)*0)YNIL3EY]$ER9^8@V 8EYV$63<O/0= [HN@P=_5CZ5\?Z8:N
MME*6N[!)9 5.4)S"@F$,D<QCR$B1P20C6+ H3X7"+LQ[/,3<V'1OH7><>@)'
M.[8;AL[(#.8&C#,;G?<]),.<&&52UCCOY4LFZ+ER>.(1V[[(8,F+-(M41"!*
MLAPBK"@DN8P@5@)S&J<I2YV*F/L&F]L3;WHRT-7S?Y3@S7JS6?\P>X/^.4-'
MT-H]^J$ &YD$#K. V':R5)]SF(R5TW,TWJLE[YSSO"]+Y^QG//5PMG=R8QZ3
MC;R3J[):0+8Q1Z>5]?_[2.^7ZMDL)4NSIC1"Y7\ND%(B15$$$2?5-IH.(3#+
MH,0)1P5%L8K<M&\&&#,[ZKDS'6",)L!3E3BGGZH[8ZLX%!4'Y0_Z4.W?'/Z:
M4[V2V-(_'95QALRF'9M--4<CLUWE!CCPXW Q=M5)A2S!WAU 2U [=&62N .J
MVP0 -JB2S1![IE6M"8#<D4)-B'L./=/XN%S)#UOYO5P()G!>T @JA!A$!:>0
MY2R%3*:F\)5Q'COE'IP88VX$VMGJ_L,8"2HKO<\5]EBZGA=X(33=.8 5. /V
M]H_<'V?/?C_,*^W%'_EY?H_]^%+?)UW3"U_6LN2,RY0Q@2"7L5ZLQ1HL2O4C
M3HI()C+FDKHU_^S>?'[/]MXVUP>Z YGMD^P'Q.B/L 4&'L_ML;-A']C._2=^
M4H\].WY$3USCT6[DRT8^5'I239G8/I,U$FFB7[D8<EXHJ%_&##(J)<0%94@E
MD1"9U6Y*_S!S>UX;0]L(N3(57LIZ=8&U_TD.!];(S_3H.#ETL@B"UT0]*+QP
M<VL:<1&.WG8/YS\]7:.&BQX<M%BX?+5[,N2[U7:Y?;X60L]]V?S+Q$+Q(DMQ
MGN!801(+"9$J.*0$93##O,@SA%-DETO5.\K<6+$V%#0F7K4_@"H@[Q-1<P"V
MGQB#P34R+WHCY91,>1&) 5F5Y^\]67KE1?>Z>9:7+_9;LE2B[-\?Y%9>WVYD
M+<C[FZP2?"6.%"M$H=<NII,DC@K(.$902I2G0M- 3IT.E,\/-3<BT);"VM1E
M+9F]L]=M<=,#KMU2)PQD(Y/!WDBPMQ+\4=L9< OC,A@A%T8]HTVZ3+KL]<M%
MD\4G?$.%=]_EQN0?_KI9_]C>-:>QBQCQG$<R@WF441TLH!@2Q214/%*JP EC
MTDKSXL(X<V.)YB78V@IJ8T%CK6NP<!I:VW!A,&#3! RN6'F$"[U(# X83M]]
MXI"AU\7CH*'_<I_=%/I<D<K-^C>Z>E24FT)NTP'FP?SZ]Y6^S=O'<JO7*9O?
M2WK;H:&%*F)62,PA9SR%**(2XB27,&:1PC@7."+Y8B5OZ58*FPT7;TNLG@U2
M/QM=>\9[1/3*;B-I61TQR]8%\&A\ +QQ CP:+YSCD:&S9K.;,^Y,3+3=TS@!
M;M:@XP;8^0$J1T#K":A<Z40]TTR'RZ;1)-,RT:[2S9W)HRCOP/IQJ^[7/\!&
MWIL'TW0FVS\Q#_?ZT\+('.V>FNJ]H4TK*RV['W=+?@<T,][K9ZT$J_46;#=T
M52JYV=0WV^J!]JEF[6W*OX3:NAH\*?U[6_ZWGW#S:S &A[MCPV\WH+?HA[)\
ME*+;&[W26:K^]OFA^N:]^U-N^+(TL@,DC4PM(N1*11"E D,28?T/EBHA9(12
MDCDWEW2Q8'9Q=&.82:DJC<%@75OLT1'2:2;LUN"CXCOR"ZVR#]3&@]IZ4)M_
MU4KFUI<T/H"=$X%;.OK@%[Q[HY,1TS=J],'H9$]&KQOYRN?628ZM[N8N*WN1
M)'F>DC36DX$91$F<0)R2!$J><UD@GF;421W\[$ASH[/6T%9TR54N]QR@=FP5
M!*:166F'4&/DE4TVOX=D[@4DPHKFGAML8MG<"SX?"^=>^L#@1@+G>]/40O6"
M%2FG.(68J!0BBC@D%!&8<:2* D68(-\V A>&GAMS'*C:][5[&MX_X-*D6(9&
MHT ]=DP4#N4A;0,L 1NI:<"ET5^K98 E*CT- VSOX)OA6>\2G%.U)PA'>4X*
MB'$20Y2+%-(B%H;;<)10)A!R6MQ=&&]N#-::.Z!?P"6$[9@I(&XCT]$.LFD:
M"5@"$S;%M'_(B;-.K?P_3D2U^Y@OJ[#M7N?EJQ3R>[5,JQ=O[_5WK<D:(#)E
M@C,%$T5-6A9/(1&9@#)!453P)$^Q4U<2VX'GQS-LVQ%,N@)[TZ^:#0Y@K'>E
M'LMIL.6@\.".3D9VN(Z0W>&*5EB&LAQ[8JIR0^28LQP_[W$4W/1G7OY3BG*M
MMC_H1C;/2,0C%E.*C/*3@"A2 M*H8% A*0DA!2^4E>9V_S!S(Z:.H:"U%!A+
MA:BB(O"P68M'[G12>!YCBW/9(,B-S#HG0;O(,"Y .9R8!@%LH@-1/^#<#BLO
MXM%[%GG^T],=-5[TX. D\?+5?C'>Q^5*+T_?ZAARN7U/N5$X?_Z-_KG\_OA]
MM^NFQ]9_V3XO=""7Y@5*8"81@DAF%)*8%3"B.<T*4C >%2YQGLO@<Z/4K_)I
M??]D3JYX93]0C0. >6K .$V%7:PW%L C,Z\QV^R#U8:#UO(KT-B^WY@'K?7A
M(CX?S$)&?4[C3QKY^2#S,OKSNH=GXQ5-DN)&?_;ZSV6YX"BGO(@55$610T1(
M5E=4<BSC.&="8N:T1CVX^]S(J3(.&.O '\8^QQWY0^3LJ,8;CY&YQ!X*]_8I
MIUP.VC+E8(!IVZ2<\NVH-<K)BWP;ME6%A,T&EA$5KK51ZFK">JN\W6Z*)%5)
MA&&6* )1D6/(LC2&"<T4SQ/,F'0ZFK,?>F[/>5O0VC92JA2>UI7F$*^M![0R
MW[6!F_5<V)'#. B/S!PMN.^ZX#:"3@VX[8%<\&TG=\#"-GBS'GWB/F^NJ!RW
M>W.^@Q^=]1SX77.]"G^L4H2OOZ\WV^4_Z_6_DA$E7"60I9&.4-(,0QRC F(A
M,J+BA-+$Z9#.W82YT5O'3-"UTXW-/*;"CM7&!7AD=NO/,;@"SM@[<YP_?"&Y
MSL.*23G/'Z67W#?@3GX<V+;0?+O^SI:KZHY?)5_?KLPNU@>A"7>IEK1CQ/\\
M+O7"4)-RI]F>_MOC=UG3M"DA[3+U@B(4Y05CIJ-#;N1!.2014S 2*!=(:$)-
M\>));MC:EC1'M]F% KJ6C\<$=4CC$R>./\%V1#RK21N9MUM?0<=9<R#:N@NZ
M_K8!:NMQ%<)V? :-TU=-7+OWN_ED.+:?;(Y"OAS&-WK2=\ED<_#RU3/=P-Z;
M#W4B356,4/5T+*\?MW?KC3%PD68DS:A,(559"E&&$*2Q4##-$$FH$#'-A..&
M0\]P<XO"=];695!7@.Y,K;JU5EU:77O_7$#<>ELA$([C;R4T$'ZK(:QM!7MC
M@VX=6( 2>+N@;\2IMP@LO#^Q+6#S*<^M +K<5)5.GY5Z0_7W@LMO=U)NOR[+
M_^XT2ONP4NO-]XH;/^Y$A".2*4HPAP65IK4&3G2 &^5Z!B0G-,YXDN5.>P+^
MMLR-EHPK;;6@]@:RVAU0^0,JAZZZK0D[/@U0>AXRF9:["M-,T=C;"V//COMV
MPW!<@^X[##!GV@V(X;@=[40$N.5 +OY-4C.$R8;ZL'IXW':&[?0T2C!-I<PA
MCBC2["LU^Y*X@%3JWZ>2BI3YL:_-Z//E6] QOUI1=O^[]J=:D>H O>IDH:_0
M\?IF]XL_;'K]!)@^1[X-/2F3,>PD\^'/MRZXCL*P5@:\#J>Z8'.619UNXL>;
M7^66:@H6[^AF93+;FM-?+D7.)(WT%' .$4M2R*(\ASG5O^2"<Y9:95/W#S,W
M)FRM!*V9;B1V!DL[MAJ.T,BT= 3."*?C_2"$Y) S(TU*%OW>OF2%"U=[[H_5
M.D;OUYNW51?96_T?^J=R*9I6LNTVW?/[Y4J'<P>]P!<L3FB>80(C94YI$JD@
M$7$*HT21*.&89 2WZGHW#KMH0XRR>F(.A?9NIMAKJWTRR:^BW3*B9C>TK"5_
M>=<_QQVW07-HN2$W^I1,JKA7Z;+M/0$'KNS.49ZOP,X;L'<GX(Y>"%2#;O@-
M,FC:_< 0V!UM%P:YJ1\5OU-*FGO)7<WO5TU.M1V/>J!==^]RD2N>1HPKF.C%
M*D0Q$I!2*B"6J50(XT)*IU9/]D//+6+;JR;*U@<C E#UP'1C40?X[2AS'%!'
MYL>=T5UY &-W=1"],FG]=%>=RV6([BK^>(5D/H?1)Z4Y=U1><IK''3PKSM;F
M'+BA3?[\2?YX>T^7W\OWRWLI/CU6:R%3JZ$P4U!B02&*2 %9)F)3L9'I)2>-
M=1#I5&AV><RY4=:7ILM#"90QTK&4S )C.WH*C-S(O&2L!1USKX V&-06@\ID
M_9O*Z(#U8O8(!2T3LQAVVNHP>QR.BL(</NK93T9NW]+R[LMF_:2#-/'F^??2
M9$%^6#W)<GNXTE&$1!31 JI8:N[)4KU:31F'4<H%1AJ8F*G%=KVE]W;<8S^T
M$P7M#!CO:=*6U\+6/SV6E4S ST8GH/("L&?]WXT'>H5Z<=$S=%;LV&H<K$<F
M+0.SL1I\Z8#[T^\MY#OC1UE;NB,6M)N-_>C3=K=Q1N6HVXW['89*6E9I*V^H
M'L<L=^2JK,*UZ\U&?]EJ4?$WS_MKFC5L7<)7B2OF@HE<$@9Q$G&(!,&0Q%C/
MF4@(2XD02>[46"N897,+S;I2C979.BXU3VO7.=#USCS0W0O;[:6Z-G6@:.;0
M:;=CUE>9S)&)=^)Y'"#+&0CS<50[AQKW2J*>@3 ]K_D9:@#/]X+WZ/NJ[I7X
MHA^83_H1^F7]G2Y7BT@II:-@"O,T3R$J,I,('6/(L"0X225'TBDA9@PCY_:V
MZ H0U!:Z4OT8,VG)^J\\/R._ %RFQIV]1\0N*)&/8>>TG#XBTD?T/N98[OTO
M;S94Z-7$M^?O;'V_2 K-P#P5,*.4Z @^1YJ9&8,\)PG-.)$9MQ+&.+KSW#BU
M,0[4UMGWM#R$JY\#!X$P,G%9^N_4I_*DKP,Z4Q[>;[)>E"?=Z':?/'V!A\BH
M9U$;/5749D11%SG''&&::#2)7H!31B&A$8)1$9-(%@2Q)''(DQG%R)GFS7R[
M6V_JW-?[]>H6:@[Z#H0VUT&F,_AT]M/+Z\W.OW2=\B^O/*D.DJVO.;D3*;V^
MQB2[Z<2.-0F]\K+!!YU.E78LO [$;$<;Q%,H<J]^4JM!Z<A^(^]T<+]+AS G
ME/5V*:)(A]E8P0SC B*D,"1)BF""6*Z02N,B=]H"<1E\;F%X5R.H$4;K6M\F
M!_UD'/C9;Y_;:6[L-C7&0GSLS8J@8+N+77J@%E0+TV7\::4R/9 Y4M+TN8=G
M5Y=ER>NL+CW6+JGK>B7T'Q[6);W_=;-^?"BO6;G=4+Y=,,;31"$!%68"(LP5
M)"124.2TR"3/"&;$J;F+V_ASX[RN^6!O?Q7,M!Z V@7P1^N$(^FY3I$=[XT(
M_,C4%QAS]R8P?L@%[07C:,*T+6'\\#GJ#.-Y&V\>W-_T[3TM2QUT\FK,YHPD
MS6.9,19#)3(,4808Q)AGD(HD050F)'43W[@XX@RYKO-L@4.3/4^S+L-NS6;A
MP!R?OX;@Z,-7=M@$9J@+@T[-2788G& ARP_Z:HVMN92B?*]--BW1C?I%DRQ0
M_K[2]]'AGED!/YF#HM/'3>;XJ-27W3]6.]F=!NJ++,DQ2Y4.U%BN.0ME!60,
MQS"6"492QHJD3IPUJK5SX[O666"^3F#9N&O2@W0 _ET_JI4 &GAXW)B_;,%V
M#>3WA_OULY3MGXROKDIH8WX?[,AT-K,\,A&W?EZ!#YW)K?V\.IW:M3_9O0([
M]T#M&GCWI]SP91E6OFV"J0BK_C:FP1.+QTV _;'VW!2##I1+>O/<U6FJ7HUZ
MI&9'-!)I+I("TB3-(*(DAIBC0O\49S+&.2D$\E))ZAET;F^.KMP9>P9O#M3.
M6LO]=D"MYL".YD,C.S);AP'57[C( J51](KZQGT=F2(+),ZJ$]E\UH^=3('%
M^_OUC[])<2M_D9OE$ZT+6-OFLLWQT79GRX)'F3",!!%)$$29I) EF.MU?<((
M8X)(YM0ZR-V$N3'7AY4>19;;JA8>E#_H Z"FF:%^])Z,O6YDY3$E=M0U+M C
M$UE5W66L!Y7Y8&]_IZMU>SQ.3</#EOC"L9H_@"$YSL.*21G/'Z67_#?@3GYL
M>+.I9.">J_"O?K0$TAC$F8 ,YP*B1'%H&J=!DO,LS_.,<80\A)>.1YII5EAK
MZ$ZX?*L7\IKJ_OW?<!+'?P4HNLIQ4ATCI,55'I%&R_P*Z'\\U'((]^=;B]I.
M@QW#>:(Z5<)I@V2C7QZ8G,[['I)\3HPR*;F<]_(E>?1<Z:D:U*C!?9&;:@FY
M%TDM*,TCGG.8(-,7-2T49 1'IO23L23#:<JXDTC0N9'F%OB8LNO#G EM<KT'
MY"@)=!9;NP<_"&(C/_\[,<<=1B.IQEX$(ZB:S]G!IA7ON>3SD5;/Q0^$26<_
MT#2[V=!564L2?C$MPM:KZWLSGWH==[-^]S^/II&SW-ZM15WC;D*<!1,JU@LM
M#B75#*.76PSB/"Z@XB)-1<J)R*UT?,8R<&Z<="@PN)%UMI<Y9JC,!]\K^QOE
MC>]]NEK3S&\_P<UAUD;FQ=,)T(?3V/'P"C0^@IV3X&8-:C=![2?X,)?9'9;K
M/N4LOVJZ^^BS/3CC/=14N":]#Q[W5?/>0Z%V*?4]V#AA7OJ??ZSTF^YN^=!(
M-]);N> QS@M*,$0J$T832T":9Q'D*D,DS])(\G3(>_S$F'-[->],! \[&X?Q
M\RF@_5ZH ^%[E7?D'L\O(^(Y[!4V$-=7?2LYX3OX#=.#E.M+X]2M7O4]T./;
M)6KO^ZBG>NJ^ *IM6M]F@4<YXEF24<B8BB'*(P8I1Q3B!"N),Y$3Z92H?WZH
MN7%S8QZXWUO\?QP%4\_#:K>)$P:LD9FX8Z0.6QO0QDB8OXQ&4"G4\Z--JX!Z
MT>LCX=/+GW#7!'FWVNHH\=N=O+]O=,\7(HE9EJ,8\L3LPYA,=A;+&%*%:%H(
M49#(JD_/Z=O/C0YJ"T%E(FALM-<(.0%?/P4,!V7LS5L7/)PT0\Z[/4 XY,1-
M)U,/.>]05T*DYRI/L39Y:P+%K_+!K/E6MR?;A^JE%TI(D>I7NWZ2$54*8HH9
MS"A3>9Q1@0NGW!6;0>?V:#<V@YW1@=JZ6DV 7200&M:1R2$ HN[2: X0!94Z
MLQEW6NDR!R2.I,A</NLKF_[CFO/U8R7-_F6S7ND?>2US]F5]O^3/]3_W)YZ1
M$)3'*8(Y$1E$!960B*B 128525))9*%<.,K5@+GQE6D_L'< ''K@*I;N.!=V
M=#4FPB-35R^X9O/=& [^:/X]RG&U+WIA1=0=;9A82MT/H6-!=<_[#*_2,VQ:
M?E9O-U(LMXM,I%&61@)&,F(0"<US)"\P+! J"HZP4FY-H<^.-#<N.ZR.V\BG
M]?V3>>YX92W0HSHFSIS'V(ZZ@B W,D<=@E99:4K.:CO'J1H["<58%5^'@[U:
MM=9)G_LJK4Y_P'/UMJ7;BHD^JZ;?'[W_LJX[=NZV$5'&XA3G#&)N<G%3H31M
M1"G,A(AP1',9NS7CLQET;@RRL]D\ CNK06NVMUZ*U018KMX"PSKVZFTXHNZK
M-P>(@J[>;,:==O7F@,31ZLWEL^=XJ3NIFM'^^__^K_8W^A^FD/G__J__'U!+
M P04    "  ,@9Q2Q[!,W0&M   :O@< %0   &AO;'@M,C R,3 S,C=?<')E
M+GAM;.R]69-;.9(F^MZ_(F_-ZT4E]J6MN\="6Y;L*E,:2=G5,R\T+(X(=C+(
M:)*AE.K77P>7V$B&&.0!#T+395FQZQQ?/CC<'0[W?_F?7R]'/WV!Z6PX&?_K
M7]A?Z5]^@G&<I.'X_%__\OOG-\3^Y7_^VS_]T[_\/X3\QXN/[WYZ-8G7ES">
M__1R"GX.Z:<_A_.+G_Z>8/;'3WDZN?SI[Y/I'\,OGI!_6_RCEY.K;]/A^<7\
M)TXY>_C;Z3]KIS10ZP@#PXCD49*@J2>>4V4@:<>C_7_/_]EY';Q1DC"9,I'@
M'?',!**,TAXHCQK,XJ&CX?B/?RX?@I_!3\C<>+;X]E__<C&?7_WSSS__^>>?
M?_T:IJ._3J;G/W-*Q<_KO_[+ZL^_;OS]GV+QU\PY]_/BMS=_.AMN^T-\+/OY
M/WY]]RE>P*4GP_%L[L>QO& V_.?9XH?O)M'/%S+_+ET_[?R+\AU9_QDI/R*,
M$\'^^G66_O)O__333TMQ3"<C^ CYI_+Y]X]O[[WR8C*:G _C7^/D\N?R^Y]?
M3A -'_QYH7;QK^??KN!?_S(;7EZ-;GYV,86,CYF,OI*B5BJX*>_\'[?_^.?;
MUU]-88:(6;#[#G^P>D9YVT&DP-<YC!,L.5R_9#2)]_YH5.0[F:[_Y<@'&"U^
M.D@P'"R>?!9F\ZF/\X'4U'G/)=$@*(*+!>*UL42:$(6V@0F='G".5,^0[(4Z
M9A#_>C[Y\C,^&-7":?FBB(42RE;*^!\;+UT*Z##J/T&\G@[GWQ@/GX?S$0P0
M_")FB2]T&E='L(8X'O"#YCQP;GE4K@,&'K[W/@]WU7PVC3]-I@FF:%+6+_;3
MN*'R^W!>_<7/5WZ*#R+Q8CBZD7NQ+5WH;S[I2(Y+12')?_D).<\PG4)ZM]33
M3@87W,W1V,+B+X_!P-H.?Y[Z\6Q89/X1KB;3^4!;I9P-E'CK-9$6!'%@@,08
MM%1"VFAI!UC8]?Z],,';Q40G<FT$&__KVD_QB:-O*Q:BRU':5%A ZJ6RE@23
M&.$H$ A>>NVZA,:#U^^%#-$^,HZ1:L_ >#V>H[E[B_[=%$E?R/X3J@!>3J['
M\^FWEY,$ _3%E)?2$Y9T(M)G3T+TAGB1DP9.A>!=;(9[D+(78&2[@.E:VDV
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M78H8>J0JB?--4OINBUL%4$=*O(%CXU^'X\D4Z;YIPBNH$%9HA?&GC\M1Y=Z
M*7,(F;*!1Q6J9)4>$M)OP]N3Y)*.DGV3]@9MZ/*RYU/:/L<<&-?2D,0CQB/6
M4-SRT754/AC ;WFJ4[39#?E[X=0]:YSVH.<&+./W1#MPI:%"D)PDX3'&$8J2
MX-#PTYPPUC'2F#J>W/<(VR]S2I\U)#M5SC-H&GZO3VRG3<(?>7+59K<G;0*^
M^\H@6 >4RDR2*<DP@RZ@+6DQ77(6461)Z\Q /$GGV]%H\F>1^)O)]-7D.LSS
M]6BS@]VZWC$Y$8)EO+06<B@))TC0# A(;H31(-%SK1*8/H7*OD^%.D;41H!:
M36,-N(OW#[]P_;^?+@2:%NF?#S!=C)L>Q)!YMN4.B1&ESY6(*#^147XI!.T5
MA5PE -F/O+Y/F2H#L(*.FD/><JKYV?7\ J.O?T :<!<29<H1RC'8DM(J8C-G
M!->62#EE%UR5/>!QLOH^DSHITH[22:,(>SN;72,GBD7+%(K&I#)< 5<&<5Z4
M_!(88QT%R%7.QW>3U/>A5 _(.D 7#:#JSNG_3E.<HT)Y<$U\L,B2H>5B@0%B
MM0W4BVB4K7/)[/NT]7UP51EG76NG+<!M6&0 YD56N&)R,LOK5<Y$0YR.$O=\
M+@2O<I3P"$U]'U*=#F!'::-%8*T,,B0TQ R5SB1^D$IC"%/:EV89E!<&.%55
MFJ?MH*?O0ZI3 ^H +30 IGNU TM&!M'$R&6PA!JEBJ$5Q+/@B#+*6>0#-*_2
MBWH++<V,:JP#HF.E_PP&B-V=7K@EOWYDQO4[3Z\YBO%[S'2?>7TD_V]T5#QZ
M3[(2EDAO*+%<E3-S 50Y#2Q7J0'=B[KCST97+_E<,G8#H0VW/%$B1$0_T(52
M25+6'PW,,>\4J],*XCX9S61/.T+%YD'EP4)O8%M;V-*/<'4]C1=^!A^FD_.I
MOSS[.IP-N+(L)R=(BAJ]/2C3YVV ,B@R^,"IL5 '/CM):@1*!RCZ(6:ZD7JS
M^'DUN?3#\2#H,BB926)-"N7 (!!+K2*92M!9!&E$G0F/CQ#5,X8Z4OQ>>#I
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M#0!T.WL8^9: !MZ@G%]<SU"DLQF&2V$X7BAT4$:'!59L=,*E+%7VQ#F@R#.
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MQ]3GR5/EZ:35(#FZL]P6>>IR7B?0(Q%46:$L>M%5FN_78*;?B\DG!G/O:&C
MH+X"?',<+EN4T*BH$I%CB%;Z1,GBTP;EB9(II)BM8[(*DN\2T4RCOYX@,>E(
M/PU@ZU:8;R;3L\L28?UCR8@VVEEN-&&E*E66U(#W1A ?$DBI$FA;)2;>25&_
M=J\YU'6CN08@N$A#O7A8-CW0CK,0@>'RL9%(%BSQ/",7"6+,CB6?ZTWHVB"G
MW_8+S8&O YTU@+Q7J]<NI?C9?WW]M? "+V ,>3@?:$T5VG-.>$0S+ID$=&&"
M(2H;ZBGZ+4Q7Z6?T';KZS?<UA\4NM=@ *,]F,Y3EY94?3HN07^)*.X?90%LN
ME=>2&%U2_SIDXJ5/!+2C@OF@@ZO32'PK.?TV;6@.@AWHK 'D_>*'XUD1'LS>
MCU]_+7*Z'LXNEEFP5Q#F ZYYJ1^D!'U<=&Y9ML0J#.Q2BH8FEY2$*E4MWZ6L
MWZ8-S>&Q6TVV<]QW4X*#LES*=F7K!RI2 0P$$<X D1Z=CN"](-P"2RQJQ7R5
MX^6=%/7;DZ$Y1':CN7:0N'ER?R.YU6W0.V++1BM>+JJ8TG["*>(B-R0ZZ[,%
MPW.N<O*T/XG]!C<GSBA6TEP#^_<F9ZN9 C.T ##\LBA/1'8B3^")EAX-/Z<H
M.NI*?BI0P"4M1!*G0>,F<:WU;NT&&-_%WY%::MDHOAU_0<E/IKAX!\;&9*+"
M$$PGBQ]X(KZ4&<D04(HR9EDGFGZ4JM:ZO)X(<H?JI66L?9@"!F#IL_^*3"GO
M@G:ENQXK%_3 8=!?9I8Y([P.WD7FJM0Y/$Y6:TU<3X2V@S7S#."VSCZMW-FS
M\7) XB(C,!M$)95%KX1X]'&)S((16T8+"!>UB)IJIZLTQCB,W-::MYX6GMUI
MLF78KIV-#_[;PM,(MK2?]0ZE* V1TI3N8M[B%B!B20*85&<<TW<I:ZTO[(F=
MP4/TTVH,,KU&.H8^#$>+,&X 0O.HC2.Y#$>3 7ER20IB@($561FN3N0);A+7
M6OO7T\'N&"TUB;RU0?\(Z.Q>PP "U4E+2<![B28\2)08LJ9]$%0IK[U-IX'=
M \I:Z]]Z(LP=HY\& +=_WFK * ^4!4]H,(4S"L0)E8BF#K1+$;RNTKY_?Q+[
M=?U.7R%;0W.'8W*"BZPF)DNX/]LA2.DU6*,-\8QYC,=4Z6*393'XWAJ:(?LJ
M5O'II#8RH.Y$-P*ZTED#EO+VZN&JG=)Z]AXL6\@5]F_:?$4J+?,^HP"S*]5K
M$KDLW2,,2E2Z&+6OTH#M*40V>9^@,\#LO#C:L?;Z#Y,75[)1CA$@S<I0R$]^
M!._SFL%!%B@;6UP=M/SXH<1=R![1QFHT_(YQ\= V;K\!O_L=35;S=PVE+N7<
MHCU#UM!WF'\KW:_G9^-4+JY>+>[R&PK&H_-*DL'M0'KA2> Y$@XZ 3"M(%:Y
M_K0_B4T>_I[,EG6CN6,M60=&[/9VOQ]?9Y33]11NF/E]C%I\>3V;3RYA^OO,
MG\/9NMO$;*"%HJ ,((H4+Y/' PG9&0S[?3*.<LGTPT+_'4;N8!J:C#[J&,'3
MZ*D!0*[:FDSR<#R[GOIQA,4]?>1X-K )+3H-EL024$F0C#@-BI@H!+ ,C&]T
MQ]H!N4?>TF\"^:2@ZDK6?7<E6C/R/I=&#J,1X/+PH[6-'G#EC9,T$1=*1A*B
M(I;J2(+1+(!/TO&GP6;[>_I- ?<!G [DW;\S_T@^<UU\>#TM&EB=Z'G@,EJ,
MU#%R]Z5S>1G QP)QF6=CL[+<G*HN;QM]_2:%3^R7U=!9.XC<7YB#;",50202
M/"V3;$OO+RI*5R9'4[1,I#KQPOXD]CNPZ\2XK*2Y=C/%;X9C=!^V"U)H%D7
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MO-JY?3?9\8+>07"LWB8="[%O(/R*SXK7(S_=#'^=Q:"G%(M0)M E<H;CA@M
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M18X]6XK7U]/)%:S/5X51P1A&@DE(MY""6,LLX=D 2 POL^OLV.#NBYO,%AX
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MXL'FHQ,Q-F KOIMH NF-"A (<^5^I1&<!"HQY/.<E0%?+/YW/K>#$*>*/AK
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M67@K=!DTE&P9]IT=<09#/N^99L[QX#9Z,M:WTUL(;:ZRL#$+?:QN?R2<;\V
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M-,!]+=BTPH+/68.I+:.RX9*%)@\$?J"QKX?@Z.2QKX?(JZ-<T.:022:L3'6
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M"IMM%J)I>J/I[KIS2/L[(,,@XP?S/%[70'"M=UR_3:^RL%'4L@];FS[2#6K
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MQ/5MGDP_;)?#J@.FU(4EF4@%(YFSJHZP=Z80XT66)J%)S#8IW#G3_L8Y &U
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M:ENH""X44L&!.:4XRRPU"2P<3NI>P&LXAVE8X#46U=A6."GF\(UJ5EQXEY*
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M$6\FZ?Y]#/-.!\WJ(_OZ/D9:#EYJ!Y:3I4U78=%\LS9CAYRW+S!.*&= B0_
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MDGE%+H/5X*(0]4J.PL<B,#?IB?@,3>,V23L'L :21P?0VIE67QT4NHJ]REX
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M*G(W2>,VKCLGL 82R]BFT7U-ZF^35(.(]UNPII@2D@2&MH"2F11MI$N;/)^
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M(./YL. 4-9T,MJ^XF,XS\;Y8-83<XV;U^W)YBWF"G!N1:X<5B76XIA3@7<Q
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MIS9/?F)47N,'3^'3J_/_ 5!+ P04    "  ,@9Q2L-(? 5$%  "&$P  %@
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M>"TR,#(Q,#,R-U]P<F4N>&UL4$L! A0#%     @ #(&<4LQ8!+$("   &B8
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J;'A?<3(M,C R,7AE>#,R,BYH=&U02P4&      H "@": @  W-$%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
